data_2m4f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m4f _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.7 pttm . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 120.813 0.34 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -144.43 166.99 23.54 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.17 0.988 . . . . 0.0 110.724 171.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -134.93 135.48 41.56 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.713 0.405 . . . . 0.0 110.896 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.72 162.94 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.694 1.598 . . . . 0.0 111.457 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -64.32 159.3 21.32 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.258 1.023 . . . . 0.0 112.499 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.0 tp -153.26 136.94 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.891 1.276 . . . . 0.0 109.632 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -130.24 156.49 44.54 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.815 2.046 . . . . 0.0 108.952 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -128.78 159.52 35.46 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.527 1.131 . . . . 0.0 111.914 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.58 117.04 23.48 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.93 0.492 . . . . 0.0 110.568 173.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -71.8 -179.96 2.89 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.309 0.644 . . . . 0.0 112.298 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -56.14 -26.87 51.98 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.64 1.576 . . . . 0.0 113.424 172.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.1 m -80.07 0.59 31.27 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.668 1.587 . . . . 0.0 114.148 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.44 34.08 87.04 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.657 1.122 . . . . 0.0 114.411 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -123.49 143.2 50.32 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.75 1.62 . . . . 0.0 109.744 177.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -67.33 126.62 29.83 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.967 0.907 . . . . 0.0 110.834 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -136.72 142.05 43.08 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.437 1.495 . . . . 0.0 110.18 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -57.55 140.19 51.49 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.1 tp -118.69 -48.59 2.47 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.828 0.851 . . . . 0.0 111.623 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.85 -119.83 0.86 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 123.261 0.458 . . . . 0.0 113.236 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -144.92 159.58 42.69 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.582 1.553 . . . . 0.0 110.284 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.5 tp -124.52 104.93 9.0 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.707 1.603 . . . . 0.0 110.131 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.2 t -78.76 99.43 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.073 1.349 . . . . 0.0 109.563 175.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.4 t -85.27 101.98 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.969 1.708 . . . . 0.0 110.239 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 . . . . . 0 N--CA 1.475 0.807 0 C-N-CA 125.901 1.68 . . . . 0.0 110.773 174.978 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.81 0 CA-C-O 121.432 0.462 . . . . 0.0 113.967 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.9 mt -122.83 141.72 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.003 0.921 . . . . 0.0 109.609 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -130.7 127.5 38.96 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.881 1.272 . . . . 0.0 109.609 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.0 p -121.44 148.54 44.28 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.7 -0.625 . . . . 0.0 111.526 -173.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.96 124.99 2.47 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 121.497 0.498 . . . . 0.0 113.081 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.77 135.44 53.97 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.029 1.731 . . . . 0.0 109.827 175.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.4 t30 . . . . . 0 CA--C 1.544 0.748 0 C-N-CA 126.086 1.755 . . . . 0.0 110.448 -177.038 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.728 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.6 m -55.37 132.0 47.11 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.257 -0.902 . . . . 0.0 110.529 169.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -99.83 -50.86 3.89 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.032 0.933 . . . . 0.0 110.26 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -163.42 159.92 22.83 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.894 0.878 . . . . 0.0 112.349 170.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.75 148.3 30.82 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 123.151 1.453 . . . . 0.0 112.873 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.424 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -136.18 157.85 45.82 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.046 1.338 . . . . 0.0 111.527 -171.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -78.49 167.5 21.19 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.29 0.567 . . . . 0.0 112.312 -174.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -56.74 -35.61 68.8 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.324 -0.86 . . . . 0.0 112.354 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -68.52 -5.05 17.37 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.846 1.259 . . . . 0.0 113.495 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 t -117.46 -5.22 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.247 1.019 . . . . 0.0 111.292 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.7 t -49.35 -63.81 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-N 120.455 1.479 . . . . 0.0 112.006 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -69.88 -28.85 65.98 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.801 -0.562 . . . . 0.0 112.138 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -63.05 -51.09 68.05 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.881 1.672 . . . . 0.0 110.899 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -59.93 -45.34 92.9 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 125.032 1.333 . . . . 0.0 110.522 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 37.4 t -59.24 -39.87 79.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.062 0.545 . . . . 0.0 110.523 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -59.28 -52.5 65.39 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.479 1.112 . . . . 0.0 112.183 174.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.29 -10.43 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 121.509 -0.744 . . . . 0.0 112.641 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -103.41 0.12 30.79 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.445 -1.41 . . . . 0.0 112.614 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.6 p -123.42 -12.62 7.74 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.236 1.015 . . . . 0.0 112.77 169.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -137.8 -14.36 1.42 Allowed 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.23 155.74 26.85 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.111 1.339 . . . . 0.0 113.954 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.09 -169.58 32.59 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.712 1.148 . . . . 0.0 113.829 -174.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.8 p -145.25 100.71 3.51 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.213 1.405 . . . . 0.0 113.34 -168.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -129.99 146.85 51.69 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.83 1.652 . . . . 0.0 110.037 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -74.95 157.52 34.84 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.466 -0.771 . . . . 0.0 111.021 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.7 p -121.66 147.65 45.6 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.28 1.432 . . . . 0.0 110.812 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.424 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 7.6 t -60.79 -43.6 97.9 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.686 0.794 . . . . 0.0 111.407 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mt -150.27 142.4 24.06 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.454 1.502 . . . . 0.0 112.251 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -134.02 106.04 7.03 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.078 0.951 . . . . 0.0 110.14 174.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -90.45 -47.77 7.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.297 1.039 . . . . 0.0 112.571 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.32 175.46 30.09 Favored Glycine 0 CA--C 1.544 1.847 0 C-N-CA 125.679 1.609 . . . . 0.0 114.595 -170.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 49.7 t80 . . . . . 0 CA--C 1.551 1.006 0 C-N-CA 124.722 1.209 . . . . 0.0 112.568 169.783 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.456 0 N-CA-C 112.689 -0.165 . . . . 0.0 112.689 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.4 mt -110.63 115.11 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.785 1.234 . . . . 0.0 108.76 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -73.97 148.49 42.06 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.109 0.481 . . . . 0.0 111.873 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 57.43 22.35 7.86 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.224 1.81 . . . . 0.0 114.277 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -63.71 126.2 26.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.009 1.323 . . . . 0.0 111.682 -171.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -75.88 121.39 22.57 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.609 1.164 . . . . 0.0 111.907 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.7 mm -114.8 112.07 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.296 1.039 . . . . 0.0 109.537 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -105.94 104.34 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.899 1.28 . . . . 0.0 108.387 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 47.6 p -89.8 156.89 18.19 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.456 1.102 . . . . 0.0 112.006 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.4 137.74 16.65 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.093 1.357 . . . . 0.0 111.586 175.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.7 mt -77.99 132.93 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.141 0.577 . . . . 0.0 109.684 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 . . . . . 0 CA--C 1.539 0.544 0 C-N-CA 125.435 1.494 . . . . 0.0 110.976 171.326 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 121.053 0.454 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -111.3 167.83 9.99 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.939 1.295 . . . . 0.0 110.743 173.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 tp -124.75 131.46 72.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.599 1.56 . . . . 0.0 108.395 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.8 p -118.82 154.47 32.81 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.677 0.791 . . . . 0.0 110.124 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -152.83 145.07 23.92 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.431 0.692 . . . . 0.0 112.155 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.6 m -82.32 111.03 18.01 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.539 1.136 . . . . 0.0 110.443 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.17 -155.61 19.59 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.374 1.464 . . . . 0.0 113.302 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.49 170.42 2.45 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 169.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -94.9 102.16 13.99 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.596 0.758 . . . . 0.0 111.13 173.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.73 0 C-N-CA 123.924 0.89 . . . . 0.0 112.163 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.468 0.448 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.92 116.61 5.44 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 169.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -118.19 149.19 41.49 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 122.362 1.077 . . . . 0.0 110.297 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -137.97 174.84 10.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.106 -1.406 . . . . 0.0 111.9 -169.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.61 130.06 16.79 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.81 0.844 . . . . 0.0 109.791 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 69.8 mt -121.9 138.99 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.192 0.997 . . . . 0.0 108.807 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -63.82 95.89 0.12 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.744 0.818 . . . . 0.0 109.7 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.3 tt -53.98 -31.27 50.3 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.876 1.27 . . . . 0.0 111.879 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -69.38 -28.09 65.87 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -86.77 -26.7 24.03 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.165 0.986 . . . . 0.0 112.522 175.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 27.9 mt -62.9 -53.04 60.23 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.412 1.085 . . . . 0.0 109.796 169.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -46.53 -37.69 8.3 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt . . . . . 0 N--CA 1.485 1.299 0 C-N-CA 125.033 1.333 . . . . 0.0 114.149 177.028 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 121.622 0.725 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -135.44 175.53 9.5 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.966 1.306 . . . . 0.0 110.523 171.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -141.19 145.17 35.31 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.411 -0.805 . . . . 0.0 111.172 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.4 m -139.88 152.48 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.782 0.833 . . . . 0.0 112.341 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -56.63 139.5 49.92 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.666 1.187 . . . . 0.0 110.782 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.8 tp -137.53 136.32 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.798 1.239 . . . . 0.0 109.278 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -131.15 158.61 40.0 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.485 1.914 . . . . 0.0 108.826 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -130.37 161.4 31.41 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.423 1.089 . . . . 0.0 111.707 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.38 122.52 31.97 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.186 0.594 . . . . 0.0 111.026 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.22 -176.98 5.88 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 176.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -58.07 -24.48 58.71 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.441 1.896 . . . . 0.0 114.145 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.0 m -88.12 2.64 51.57 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.394 1.078 . . . . 0.0 113.386 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.5 35.48 91.99 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.698 1.142 . . . . 0.0 113.882 -176.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -114.51 143.4 45.02 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.374 1.47 . . . . 0.0 110.392 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -73.26 119.93 18.17 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.269 0.628 . . . . 0.0 110.622 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -129.14 135.3 48.68 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.77 1.628 . . . . 0.0 109.69 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -57.39 142.18 44.68 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.1 tp -117.33 -48.01 2.63 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.777 0.831 . . . . 0.0 111.4 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.84 -109.89 0.37 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.29 0.471 . . . . 0.0 113.698 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -149.72 156.84 42.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.222 1.809 . . . . 0.0 109.819 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 tp -122.46 102.29 8.0 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.593 1.157 . . . . 0.0 110.124 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.3 t -75.76 101.62 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.56 0.744 . . . . 0.0 109.263 176.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.0 94.25 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.731 1.612 . . . . 0.0 109.159 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 47.9 mtp85 . . . . . 0 N--CA 1.473 0.72 0 C-N-CA 125.258 1.423 . . . . 0.0 110.458 172.555 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.949 0 CA-C-O 121.457 0.476 . . . . 0.0 113.469 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.5 mt -128.18 143.13 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.769 0.828 . . . . 0.0 110.168 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -131.71 125.58 32.38 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.422 1.089 . . . . 0.0 110.703 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.2 p -116.56 146.01 42.94 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.617 -0.677 . . . . 0.0 111.813 -174.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -139.99 123.67 2.5 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 123.278 0.466 . . . . 0.0 112.083 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.33 137.19 54.44 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.24 1.416 . . . . 0.0 110.179 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.0 t30 . . . . . 0 CA--C 1.543 0.675 0 C-N-CA 127.182 2.193 . . . . 0.0 109.48 179.564 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.739 0 CA-C-O 120.478 0.18 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.7 m -56.51 131.35 48.36 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 121.212 -0.93 . . . . 0.0 109.191 168.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -98.0 -49.65 4.69 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.503 0.592 . . . . 0.0 110.142 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -167.35 159.09 12.24 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.867 0.867 . . . . 0.0 112.503 170.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.36 149.5 32.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 122.961 1.362 . . . . 0.0 112.525 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 pp -141.04 156.12 46.06 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.363 1.465 . . . . 0.0 110.836 -170.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -83.2 167.81 17.37 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.287 0.635 . . . . 0.0 112.111 -172.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -55.67 -32.0 62.86 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.022 -1.049 . . . . 0.0 112.535 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -66.4 -6.13 13.32 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.25 1.42 . . . . 0.0 114.022 174.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.88 -3.17 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 119.451 1.023 . . . . 0.0 111.555 -175.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.3 t -52.6 -64.53 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 120.314 1.415 . . . . 0.0 111.524 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -68.38 -27.24 66.06 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.317 0.647 . . . . 0.0 112.237 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.06 -54.2 41.87 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.413 1.485 . . . . 0.0 110.43 174.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -60.58 -46.13 91.36 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 125.135 1.374 . . . . 0.0 111.373 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 87.8 t -54.46 -34.84 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.011 0.925 . . . . 0.0 110.72 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -72.69 -53.96 10.3 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.117 1.367 . . . . 0.0 113.539 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 m -68.86 -16.65 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 120.813 -1.179 . . . . 0.0 112.374 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.37 -4.55 59.19 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.247 1.819 . . . . 0.0 111.971 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 51.0 p -130.96 -15.76 3.33 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.34 -10.63 4.13 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.1 1.76 . . . . 0.0 113.668 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.01 156.68 7.58 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.459 1.504 . . . . 0.0 113.642 -173.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 156.33 -170.61 33.96 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.379 0.99 . . . . 0.0 113.712 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 93.7 p -146.05 95.36 2.61 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.608 1.163 . . . . 0.0 113.229 -168.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -125.97 141.13 52.11 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.751 1.62 . . . . 0.0 109.737 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -69.09 156.8 38.05 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.708 -0.62 . . . . 0.0 110.569 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.4 p -120.53 156.61 31.2 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.302 1.441 . . . . 0.0 110.804 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.9 t -70.11 -44.54 68.78 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.004 0.521 . . . . 0.0 111.169 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.6 mt -148.29 140.32 24.01 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.566 1.546 . . . . 0.0 111.352 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -134.92 103.41 5.58 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.934 0.894 . . . . 0.0 110.39 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -89.84 -44.32 10.02 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.195 0.998 . . . . 0.0 113.36 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.02 -179.94 12.81 Favored Glycine 0 CA--C 1.543 1.808 0 C-N-CA 124.986 1.279 . . . . 0.0 114.307 -169.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 67.1 t80 . . . . . 0 CA--C 1.551 1.008 0 O-C-N 121.603 -0.94 . . . . 0.0 112.03 169.407 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.275 0 CA-C-O 121.59 0.55 . . . . 0.0 112.934 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.1 mt -126.3 108.13 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.962 1.305 . . . . 0.0 109.192 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -63.98 141.26 58.83 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.7 0.8 . . . . 0.0 112.006 172.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 58.29 22.67 9.57 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.719 1.608 . . . . 0.0 114.456 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 19.0 tptp -55.21 122.94 12.17 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.352 1.061 . . . . 0.0 111.52 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -69.73 129.81 40.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.228 1.011 . . . . 0.0 110.22 169.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.7 mm -127.28 119.75 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.197 0.999 . . . . 0.0 108.661 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mp -113.13 96.45 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 125.053 1.341 . . . . 0.0 108.311 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.9 p -77.44 153.99 33.04 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.835 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -150.61 137.83 19.42 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.857 1.263 . . . . 0.0 111.115 175.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.8 mt -81.85 131.54 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 . . . . . 0 CA--C 1.537 0.474 0 C-N-CA 125.434 1.493 . . . . 0.0 110.644 173.991 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 CA--C 1.538 0.504 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -107.59 166.13 10.9 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.991 1.316 . . . . 0.0 110.367 170.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.6 tp -119.9 133.68 65.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 125.15 1.38 . . . . 0.0 108.341 170.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.0 p -121.9 155.5 35.33 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.45 0.7 . . . . 0.0 109.909 175.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -148.11 140.85 24.64 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.889 0.875 . . . . 0.0 110.925 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.5 m -79.48 110.12 14.49 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.713 0.805 . . . . 0.0 110.197 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.02 -162.17 27.85 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.214 1.388 . . . . 0.0 112.535 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -68.26 162.88 24.09 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.641 -0.917 . . . . 0.0 112.874 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -76.26 108.19 9.03 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.293 1.037 . . . . 0.0 111.185 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.856 0 C-N-CA 124.283 1.033 . . . . 0.0 112.612 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 10.8 m . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.01 114.46 3.71 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -117.5 138.85 51.6 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.309 1.052 . . . . 0.0 109.898 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -134.68 169.6 17.08 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.416 1.486 . . . . 0.0 111.199 -169.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.03 131.58 19.83 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.4 0.68 . . . . 0.0 109.909 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 59.0 mt -124.78 138.26 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.072 0.949 . . . . 0.0 108.739 177.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.2 m -63.71 94.82 0.1 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.224 1.01 . . . . 0.0 109.649 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.03 -32.2 61.68 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.325 1.05 . . . . 0.0 111.849 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -68.48 -29.59 68.25 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 176.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -84.19 -31.37 25.14 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.906 0.882 . . . . 0.0 112.095 174.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 17.9 mt -57.63 -49.5 76.23 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.012 0.925 . . . . 0.0 110.953 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -50.01 -40.79 45.7 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.443 1.097 . . . . 0.0 113.448 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 60.9 mttm . . . . . 0 N--CA 1.48 1.026 0 C-N-CA 125.43 1.492 . . . . 0.0 114.259 -178.336 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.9 pttt . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 110.788 -0.079 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -143.06 168.14 20.44 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.949 0.9 . . . . 0.0 111.118 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -133.97 131.98 39.62 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.645 0.378 . . . . 0.0 111.229 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.5 162.01 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.959 1.704 . . . . 0.0 111.229 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -62.15 159.03 15.5 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.13 0.972 . . . . 0.0 111.776 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.9 tp -153.98 136.43 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.45 1.1 . . . . 0.0 109.876 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -128.82 159.49 35.56 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.105 1.762 . . . . 0.0 109.26 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -130.53 153.8 48.46 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.687 1.195 . . . . 0.0 111.03 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -81.47 119.18 23.4 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 122.152 -0.343 . . . . 0.0 110.505 174.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -71.67 -178.84 2.37 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.563 0.745 . . . . 0.0 112.752 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -54.77 -30.7 57.38 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.702 1.201 . . . . 0.0 113.552 174.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.7 m -81.09 -0.87 41.93 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.071 0.949 . . . . 0.0 113.515 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.99 29.95 73.83 Favored Glycine 0 CA--C 1.536 1.37 0 O-C-N 121.505 -0.747 . . . . 0.0 113.379 -173.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -111.3 135.46 51.81 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.415 1.486 . . . . 0.0 110.043 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -69.01 124.73 24.54 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.031 0.932 . . . . 0.0 110.8 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.2 t -137.89 137.48 38.1 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.782 1.233 . . . . 0.0 110.787 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -56.04 130.75 45.26 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.965 1.306 . . . . 0.0 112.027 -173.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.0 tp -106.54 -47.35 3.79 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.233 0.613 . . . . 0.0 111.521 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.03 -115.83 0.62 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.247 0.451 . . . . 0.0 113.267 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -146.48 157.13 43.71 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.218 1.407 . . . . 0.0 110.087 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.5 tp -121.51 102.72 8.43 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.284 1.434 . . . . 0.0 110.342 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.6 t -78.19 95.13 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.185 1.394 . . . . 0.0 109.07 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.7 t -81.84 99.48 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.735 1.614 . . . . 0.0 109.582 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.2 mtt-85 . . . . . 0 N--CA 1.479 1.001 0 C-N-CA 125.007 1.323 . . . . 0.0 111.808 177.395 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.086 0 N-CA-C 115.337 0.895 . . . . 0.0 115.337 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.6 mt -119.3 137.34 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.233 1.013 . . . . 0.0 109.797 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.26 104.05 6.01 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.271 1.828 . . . . 0.0 109.364 -171.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.9 p -98.07 156.14 16.79 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.32 -1.488 . . . . 0.0 111.455 -173.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.52 122.98 1.79 Allowed Glycine 0 CA--C 1.526 0.726 0 O-C-N 121.271 -0.893 . . . . 0.0 112.16 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.87 138.39 50.16 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.002 1.721 . . . . 0.0 110.403 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.6 t30 . . . . . 0 CA--C 1.546 0.809 0 C-N-CA 125.808 1.643 . . . . 0.0 110.482 -178.632 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.4 m -55.36 127.17 28.22 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.427 -0.795 . . . . 0.0 110.132 170.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -95.09 -48.33 6.0 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.096 0.407 . . . . 0.0 110.644 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -162.9 168.67 20.89 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 122.201 1.001 . . . . 0.0 113.162 170.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.84 139.49 18.81 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.316 -0.865 . . . . 0.0 112.381 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.46 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -129.45 156.13 44.6 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.848 1.659 . . . . 0.0 111.187 -176.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -77.48 167.46 21.61 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.433 0.635 . . . . 0.0 112.363 -174.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -55.41 -36.33 66.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.105 0.962 . . . . 0.0 112.394 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -69.4 -2.92 12.27 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.758 1.223 . . . . 0.0 114.1 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.3 t -119.59 -5.66 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 119.56 1.073 . . . . 0.0 111.453 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.4 t -48.96 -65.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 125.279 1.432 . . . . 0.0 111.85 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -68.45 -27.02 65.81 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.497 -0.752 . . . . 0.0 112.632 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -52.04 65.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.435 1.494 . . . . 0.0 110.596 175.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -60.83 -45.84 92.92 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 124.586 1.154 . . . . 0.0 111.617 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 87.6 t -56.29 -34.16 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.432 0.693 . . . . 0.0 111.25 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -66.98 -57.75 6.27 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.01 0.924 . . . . 0.0 112.278 174.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 m -69.8 -22.19 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 O-C-N 120.821 -1.175 . . . . 0.0 112.551 -175.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.61 -6.64 56.15 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.933 1.693 . . . . 0.0 111.88 175.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 81.7 p -131.4 -12.26 3.52 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -137.45 -6.03 1.78 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.668 1.587 . . . . 0.0 113.771 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.07 156.29 5.3 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 126.04 1.781 . . . . 0.0 113.843 -175.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.99 -171.37 33.27 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.165 0.888 . . . . 0.0 113.12 -174.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 85.1 p -145.1 104.04 3.92 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.507 1.123 . . . . 0.0 113.366 -168.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -134.29 143.77 47.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.179 1.792 . . . . 0.0 110.277 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -71.64 162.66 29.1 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.374 -0.829 . . . . 0.0 112.106 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.2 p -129.56 144.79 51.42 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.456 1.503 . . . . 0.0 111.023 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.46 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 6.7 t -59.07 -43.75 91.79 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.354 1.462 . . . . 0.0 112.534 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.0 mt -155.73 134.41 11.85 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.829 1.652 . . . . 0.0 111.296 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -129.54 102.1 6.23 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.643 1.177 . . . . 0.0 110.696 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -90.38 -41.81 11.28 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.613 1.165 . . . . 0.0 113.965 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 58.15 -173.53 2.97 Favored Glycine 0 CA--C 1.547 2.058 0 C-N-CA 126.222 1.867 . . . . 0.0 115.465 -169.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 19.8 t80 . . . . . 0 N--CA 1.476 0.85 0 C-N-CA 124.509 1.124 . . . . 0.0 113.966 177.254 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.434 0 CA-C-O 121.749 0.638 . . . . 0.0 113.646 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.4 mt -119.41 115.53 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.6 1.56 . . . . 0.0 108.152 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -72.96 144.39 47.29 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.097 0.475 . . . . 0.0 111.55 173.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 58.41 24.89 12.25 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 125.754 1.622 . . . . 0.0 114.042 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -62.72 122.81 16.81 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.698 1.199 . . . . 0.0 111.817 -173.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -73.22 124.16 25.1 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.322 1.049 . . . . 0.0 111.428 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.7 mm -118.3 117.79 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.809 1.244 . . . . 0.0 108.882 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.8 mp -110.09 103.37 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 124.984 1.313 . . . . 0.0 108.231 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 59.1 p -85.08 153.14 22.9 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.805 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.17 136.67 20.23 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.163 1.385 . . . . 0.0 111.15 176.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 17.3 mt -81.09 131.67 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 . . . . . 0 N--CA 1.466 0.372 0 C-N-CA 125.793 1.637 . . . . 0.0 110.109 175.37 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -107.69 165.16 11.64 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.416 1.486 . . . . 0.0 110.522 174.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.8 tp -122.21 132.22 71.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 125.327 1.451 . . . . 0.0 107.848 172.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 p -119.47 156.59 29.94 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.188 0.595 . . . . 0.0 109.794 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -152.03 141.51 21.64 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.103 0.961 . . . . 0.0 111.297 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.2 m -78.7 114.38 17.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.478 1.111 . . . . 0.0 110.484 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.33 -167.26 43.13 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.308 0.956 . . . . 0.0 112.876 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -68.08 171.47 6.87 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.749 -0.853 . . . . 0.0 112.62 168.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -81.05 136.26 35.94 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.243 -0.911 . . . . 0.0 112.114 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.779 0 C-N-CA 123.815 0.846 . . . . 0.0 112.729 171.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.09 117.16 11.31 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -106.1 148.81 27.38 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 122.009 0.909 . . . . 0.0 109.743 171.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -132.8 172.42 12.6 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.122 1.369 . . . . 0.0 111.491 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.86 133.09 23.08 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.518 0.727 . . . . 0.0 110.156 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 64.0 mt -126.47 138.66 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.133 0.973 . . . . 0.0 108.918 175.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.4 m -64.54 97.39 0.2 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.362 -0.836 . . . . 0.0 110.225 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.5 tt -54.16 -31.03 51.44 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.111 1.364 . . . . 0.0 112.179 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -72.73 -26.03 61.43 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -89.43 -26.03 21.19 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.972 -1.08 . . . . 0.0 112.053 173.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 14.5 mt -61.49 -46.55 89.52 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.849 0.86 . . . . 0.0 110.813 172.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -55.18 -36.93 66.4 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 177.825 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.9 pttt . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 121.069 0.461 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -144.3 169.39 17.99 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.553 1.141 . . . . 0.0 110.587 170.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -132.6 129.35 38.83 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.742 -0.599 . . . . 0.0 110.17 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.35 167.99 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.196 1.399 . . . . 0.0 110.896 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.34 164.22 7.47 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.639 1.176 . . . . 0.0 111.428 175.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.6 tp -158.72 137.26 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.774 1.229 . . . . 0.0 109.558 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -127.82 162.63 26.22 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.417 1.887 . . . . 0.0 110.073 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -132.12 156.69 45.92 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.304 1.441 . . . . 0.0 111.232 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.51 121.27 24.37 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 171.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -63.88 174.6 1.41 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.065 0.946 . . . . 0.0 111.992 171.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -57.58 -14.79 5.81 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.343 1.857 . . . . 0.0 114.857 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.2 m -115.56 14.16 16.51 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.885 1.274 . . . . 0.0 112.872 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.04 21.07 78.95 Favored Glycine 0 CA--C 1.537 1.438 0 O-C-N 121.335 -0.853 . . . . 0.0 114.393 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -96.59 125.79 41.31 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.68 1.192 . . . . 0.0 109.649 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -66.87 126.14 28.15 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.898 -0.501 . . . . 0.0 110.873 174.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.2 t -140.75 136.02 32.11 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.715 1.206 . . . . 0.0 110.81 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -55.7 131.57 46.9 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.771 1.229 . . . . 0.0 112.354 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 38.8 tp -104.87 -47.73 3.95 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.985 0.914 . . . . 0.0 111.279 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.75 -118.96 0.78 Allowed Glycine 0 CA--C 1.529 0.963 0 N-CA-C 113.978 0.351 . . . . 0.0 113.978 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -141.16 151.73 44.11 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.356 1.462 . . . . 0.0 110.366 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.4 tp -116.96 101.45 8.52 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.409 1.484 . . . . 0.0 109.878 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.1 t -77.45 97.46 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.098 1.359 . . . . 0.0 109.336 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.3 t -84.3 84.42 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.614 1.566 . . . . 0.0 110.296 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 . . . . . 0 N--CA 1.478 0.938 0 C-N-CA 123.795 0.838 . . . . 0.0 110.406 170.319 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.115 0 N-CA-C 114.051 0.38 . . . . 0.0 114.051 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.1 mt -119.71 142.95 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.938 0.895 . . . . 0.0 109.431 169.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -132.72 92.43 3.05 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.331 1.453 . . . . 0.0 110.573 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.8 p -84.54 150.36 25.28 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.24 -0.912 . . . . 0.0 112.508 -174.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.73 120.01 1.57 Allowed Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.42 -0.8 . . . . 0.0 113.791 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -70.88 139.92 50.93 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.53 1.932 . . . . 0.0 110.588 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 . . . . . 0 CA--C 1.543 0.696 0 C-N-CA 126.193 1.797 . . . . 0.0 110.708 -178.775 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.879 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.3 m -54.05 124.42 15.52 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.3 1.04 . . . . 0.0 110.791 171.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -92.07 -52.64 4.61 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.883 0.473 . . . . 0.0 110.426 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -163.92 153.05 13.97 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.871 0.868 . . . . 0.0 112.691 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.56 128.11 21.46 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 122.75 1.262 . . . . 0.0 112.553 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.96 163.79 16.04 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.13 1.772 . . . . 0.0 111.38 -173.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -79.72 162.05 25.41 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.404 1.082 . . . . 0.0 112.436 -175.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -55.44 -33.05 63.24 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.319 1.047 . . . . 0.0 113.055 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -70.33 -8.38 50.02 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 37.5 t -114.29 -14.56 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 121.3 -0.875 . . . . 0.0 112.028 -171.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 42.2 t -48.15 -55.81 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.502 1.121 . . . . 0.0 111.372 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -65.41 -32.87 74.72 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -69.8 -43.63 71.71 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.029 0.932 . . . . 0.0 111.343 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -58.83 -46.88 86.64 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.632 1.173 . . . . 0.0 110.736 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 92.6 t -53.94 -37.51 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.395 1.078 . . . . 0.0 111.377 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.87 -57.38 4.67 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.5 1.52 . . . . 0.0 112.656 176.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -71.91 -7.5 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 O-C-N 121.212 -0.93 . . . . 0.0 113.125 -175.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.58 -5.69 45.26 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.01 1.724 . . . . 0.0 111.932 176.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 47.4 p -128.89 -14.85 4.41 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.909 0.883 . . . . 0.0 112.958 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -131.97 -9.73 3.44 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.617 1.567 . . . . 0.0 114.593 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.63 157.14 7.51 Favored Glycine 0 CA--C 1.539 1.574 0 C-N-CA 125.294 1.426 . . . . 0.0 113.76 -173.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.52 -153.62 24.66 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 121.543 -0.975 . . . . 0.0 113.175 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 80.1 p -145.52 151.98 39.02 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.18 0.992 . . . . 0.0 113.148 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -148.27 -177.69 5.9 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.55 1.94 . . . . 0.0 112.177 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? -117.41 156.16 28.4 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.937 1.295 . . . . 0.0 111.657 170.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.9 p -126.17 130.81 51.73 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.977 0.911 . . . . 0.0 111.892 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.9 t -51.9 -37.55 52.85 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.409 1.084 . . . . 0.0 112.995 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.0 mt -147.62 141.31 25.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.233 1.413 . . . . 0.0 112.364 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -136.35 93.55 2.91 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.525 1.13 . . . . 0.0 110.643 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -81.7 -49.06 10.9 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.829 0.851 . . . . 0.0 113.121 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.21 177.42 43.2 Favored Glycine 0 CA--C 1.543 1.816 0 C-N-CA 125.06 1.314 . . . . 0.0 113.874 -169.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 44.9 t80 . . . . . 0 CA--C 1.551 0.986 0 C-N-CA 124.085 0.954 . . . . 0.0 112.253 170.382 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.626 0 CA-C-O 121.317 0.399 . . . . 0.0 114.055 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 52.7 mt -123.39 120.44 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 126.095 1.758 . . . . 0.0 108.866 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -82.31 145.01 30.2 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 57.79 24.49 10.81 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.478 1.911 . . . . 0.0 113.938 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -60.34 125.74 24.82 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.856 1.262 . . . . 0.0 111.363 -173.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -76.61 126.61 31.29 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.845 0.458 . . . . 0.0 110.925 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.3 mm -119.95 120.59 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 126.094 1.758 . . . . 0.0 109.065 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.1 mp -115.06 105.93 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.233 1.413 . . . . 0.0 108.231 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.8 p -80.97 161.63 24.21 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.777 0.799 . . . . 0.0 112.203 174.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -152.15 142.22 22.24 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.91 1.284 . . . . 0.0 110.77 171.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 52.4 mt -82.61 132.14 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 . . . . . 0 N--CA 1.467 0.388 0 C-N-CA 125.303 1.441 . . . . 0.0 110.273 174.28 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 . . . . . 0 CA--C 1.538 0.514 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -107.93 165.9 11.11 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.821 1.248 . . . . 0.0 110.055 170.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.9 tp -117.0 137.28 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.332 1.453 . . . . 0.0 107.922 169.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 p -124.88 156.87 37.21 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.571 0.623 . . . . 0.0 110.098 172.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -149.63 135.89 19.02 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.988 0.915 . . . . 0.0 111.158 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.2 t -70.61 127.89 34.22 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.065 0.46 . . . . 0.0 110.381 172.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.59 -154.25 26.06 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.816 1.674 . . . . 0.0 112.044 175.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -69.07 169.33 12.07 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 121.936 0.874 . . . . 0.0 112.352 169.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -87.98 112.07 22.19 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.451 1.5 . . . . 0.0 111.528 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.477 0.892 0 C-N-CA 123.628 0.771 . . . . 0.0 112.009 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -65.94 104.28 1.08 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -104.53 145.7 29.92 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.523 1.154 . . . . 0.0 110.86 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -134.47 167.15 21.29 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.679 1.591 . . . . 0.0 110.719 -169.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.02 134.93 26.87 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.346 0.521 . . . . 0.0 110.349 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 51.3 mt -129.67 139.89 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.802 0.841 . . . . 0.0 109.334 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.7 m -63.73 95.46 0.11 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.018 0.927 . . . . 0.0 109.848 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.07 -33.32 51.55 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.602 1.161 . . . . 0.0 111.516 175.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -67.56 -27.49 66.98 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -86.73 -31.53 20.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.991 0.916 . . . . 0.0 111.949 172.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 18.9 mt -62.1 -44.1 97.4 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.847 0.859 . . . . 0.0 111.264 174.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -50.5 -41.8 53.9 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.31 1.044 . . . . 0.0 112.84 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 81.1 mttt . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.92 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.1 pttp . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 120.919 0.39 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -145.89 165.69 28.18 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.769 1.228 . . . . 0.0 110.495 173.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -131.76 125.79 32.82 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.596 0.358 . . . . 0.0 110.464 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.9 m -118.79 165.96 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.021 1.329 . . . . 0.0 110.927 177.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -68.06 161.79 26.01 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.544 1.138 . . . . 0.0 110.995 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.2 tp -153.37 136.29 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.436 1.095 . . . . 0.0 109.667 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -127.21 161.3 28.86 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.197 1.799 . . . . 0.0 109.741 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -132.01 154.37 49.43 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 126.098 1.759 . . . . 0.0 110.749 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -76.09 124.74 27.89 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 169.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -67.43 175.68 2.67 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 122.241 1.019 . . . . 0.0 111.327 170.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -59.81 -11.73 5.92 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.234 2.213 . . . . 0.0 114.778 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.8 t -116.51 12.93 15.26 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.111 1.364 . . . . 0.0 112.821 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.31 19.71 79.38 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 121.312 -0.867 . . . . 0.0 114.615 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -95.59 129.38 42.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.778 1.231 . . . . 0.0 109.477 176.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -68.98 127.75 34.25 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.637 -0.664 . . . . 0.0 110.567 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.7 t -138.86 147.04 41.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.878 1.671 . . . . 0.0 110.241 -175.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -66.49 137.38 56.77 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.051 -1.031 . . . . 0.0 111.626 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.8 tp -110.83 -46.9 3.29 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.876 0.87 . . . . 0.0 112.291 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.27 -133.31 2.39 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 121.703 0.613 . . . . 0.0 114.612 -174.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -132.65 155.91 47.9 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.511 1.924 . . . . 0.0 110.953 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.8 tp -122.96 104.27 9.14 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.275 1.43 . . . . 0.0 110.539 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.4 t -81.57 97.48 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.48 1.512 . . . . 0.0 109.462 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.03 117.47 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.914 1.286 . . . . 0.0 109.671 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 . . . . . 0 N--CA 1.475 0.822 0 C-N-CA 126.925 2.09 . . . . 0.0 110.535 -179.342 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.838 0 N-CA-C 113.964 0.346 . . . . 0.0 113.964 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 68.5 mt -122.1 136.84 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.928 0.891 . . . . 0.0 109.52 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.65 142.82 47.29 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.15 1.38 . . . . 0.0 109.253 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.1 p -133.54 139.85 46.85 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.277 0.631 . . . . 0.0 110.016 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.61 107.83 0.65 Allowed Glycine 0 CA--C 1.521 0.421 0 CA-C-O 121.843 0.69 . . . . 0.0 111.61 -169.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 33.1 tp -64.09 144.56 57.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.616 1.166 . . . . 0.0 110.174 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 . . . . . 0 CA--C 1.542 0.661 0 C-N-CA 126.917 2.087 . . . . 0.0 109.294 179.144 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.7 m -58.82 118.34 5.63 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.024 -1.047 . . . . 0.0 109.313 169.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -82.22 -48.45 11.26 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.001 -0.437 . . . . 0.0 109.949 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -164.82 161.4 20.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.836 0.855 . . . . 0.0 113.074 170.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.87 149.41 33.2 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.985 1.374 . . . . 0.0 113.08 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.401 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.5 OUTLIER -135.92 160.31 38.99 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.31 1.444 . . . . 0.0 111.715 -175.55 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -80.13 165.99 21.92 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.3 0.64 . . . . 0.0 112.387 -175.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -54.18 -34.85 61.49 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.136 0.975 . . . . 0.0 112.771 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -67.65 -4.58 12.43 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.578 1.151 . . . . 0.0 114.086 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.84 -3.57 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.336 1.054 . . . . 0.0 111.399 -175.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.9 t -51.21 -65.38 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.261 1.424 . . . . 0.0 111.352 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -69.11 -24.06 64.07 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -50.51 68.76 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.321 1.449 . . . . 0.0 110.438 172.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -61.43 -42.56 98.95 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 124.666 1.186 . . . . 0.0 111.798 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.5 t -56.04 -35.14 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.103 0.561 . . . . 0.0 110.882 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -69.94 -54.26 14.15 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.939 1.296 . . . . 0.0 112.949 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.0 m -74.34 -6.33 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 120.933 -1.104 . . . . 0.0 112.967 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.77 -4.85 36.18 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.028 1.731 . . . . 0.0 111.742 176.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 44.7 p -132.06 -17.5 2.73 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.733 1.213 . . . . 0.0 113.496 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -131.76 -11.13 3.46 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.15 1.78 . . . . 0.0 113.667 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.21 155.8 11.62 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.977 1.275 . . . . 0.0 113.738 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 164.12 -159.43 32.25 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 121.784 -0.833 . . . . 0.0 114.299 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.6 p -154.09 89.35 1.29 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -168.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -124.42 141.71 51.87 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.769 1.628 . . . . 0.0 110.528 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -69.87 162.62 27.6 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.462 0.705 . . . . 0.0 111.54 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.2 p -130.51 147.64 52.22 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.507 1.523 . . . . 0.0 111.391 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.401 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 5.1 t -65.27 -40.36 93.82 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.874 0.87 . . . . 0.0 111.858 -178.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.8 mt -150.73 137.71 19.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.686 1.594 . . . . 0.0 111.794 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -139.03 100.54 4.05 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.642 0.777 . . . . 0.0 110.868 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -94.95 -38.59 10.62 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.13 -169.78 16.58 Favored Glycine 0 CA--C 1.543 1.815 0 C-N-CA 125.032 1.301 . . . . 0.0 115.478 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 31.5 t80 . . . . . 0 CA--C 1.549 0.936 0 C-N-CA 124.169 0.988 . . . . 0.0 112.62 169.73 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.003 0 CA-C-O 121.626 0.57 . . . . 0.0 113.574 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.2 mt -140.83 101.66 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.036 1.335 . . . . 0.0 107.738 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -69.32 145.07 53.3 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.191 0.519 . . . . 0.0 111.32 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 60.38 20.79 10.37 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.673 1.589 . . . . 0.0 113.821 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -55.37 123.65 14.56 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.864 1.266 . . . . 0.0 111.161 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -71.58 127.62 33.16 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.832 0.853 . . . . 0.0 110.319 170.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.3 mm -123.01 117.69 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.687 1.195 . . . . 0.0 108.56 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.37 99.01 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 125.178 1.391 . . . . 0.0 107.8 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.7 p -81.55 157.06 24.92 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.726 0.774 . . . . 0.0 111.064 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -151.52 137.56 18.22 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.467 1.107 . . . . 0.0 110.808 176.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 52.4 mt -80.6 132.67 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 . . . . . 0 N--CA 1.466 0.333 0 C-N-CA 125.375 1.47 . . . . 0.0 110.314 175.156 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -107.02 166.18 10.8 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.154 1.382 . . . . 0.0 110.382 171.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.0 tp -118.08 137.87 50.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 125.414 1.485 . . . . 0.0 108.296 169.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.6 p -125.94 155.95 40.52 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.44 0.696 . . . . 0.0 110.024 174.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -150.51 137.47 19.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.167 0.987 . . . . 0.0 111.213 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.7 m -78.81 119.19 21.67 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.526 1.131 . . . . 0.0 110.691 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.4 -156.29 32.58 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.929 1.252 . . . . 0.0 113.256 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -66.51 161.78 22.17 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.253 1.021 . . . . 0.0 112.694 171.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -77.93 110.06 12.52 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.665 1.186 . . . . 0.0 110.506 173.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 121.21 0.528 . . . . 0.0 111.929 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.472 0.655 0 CA-C-O 120.845 0.355 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.83 130.22 43.89 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 168.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -128.0 143.73 51.09 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.571 1.177 . . . . 0.0 111.488 173.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -135.55 169.8 16.95 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 126.093 1.757 . . . . 0.0 111.069 -169.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.83 135.22 24.3 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 122.934 0.494 . . . . 0.0 110.248 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 63.2 mt -127.32 141.24 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 123.738 0.815 . . . . 0.0 108.98 175.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.8 m -62.2 94.74 0.06 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.204 1.002 . . . . 0.0 109.753 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.05 -32.93 56.01 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.904 0.882 . . . . 0.0 111.464 174.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -66.74 -30.62 70.89 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -82.57 -32.14 28.65 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.053 0.941 . . . . 0.0 111.851 173.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 18.7 mt -60.39 -45.98 91.64 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.645 0.778 . . . . 0.0 111.39 175.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -51.29 -42.63 61.28 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 119.044 0.838 . . . . 0.0 112.833 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 86.8 mttt . . . . . 0 N--CA 1.484 1.23 0 C-N-CA 125.244 1.418 . . . . 0.0 113.996 -178.439 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.3 pttp . . . . . 0 N--CA 1.467 0.411 0 CA-C-O 121.287 0.565 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -140.95 166.6 24.33 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.935 1.294 . . . . 0.0 111.42 170.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 m -134.74 130.35 36.06 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.591 0.357 . . . . 0.0 110.744 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.1 m -128.24 165.27 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.795 1.638 . . . . 0.0 110.853 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -63.42 163.02 11.48 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.58 1.152 . . . . 0.0 111.736 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.3 tp -159.28 137.04 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.787 1.235 . . . . 0.0 110.044 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -129.06 162.62 27.25 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.043 2.137 . . . . 0.0 109.362 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -129.3 157.9 40.59 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.152 1.381 . . . . 0.0 111.116 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -78.83 119.96 22.78 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 169.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.89 172.47 1.7 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.51 1.124 . . . . 0.0 112.154 171.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -53.29 -18.02 2.17 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.199 1.8 . . . . 0.0 115.518 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.9 m -112.07 13.53 20.68 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.322 1.049 . . . . 0.0 113.16 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.54 20.67 79.49 Favored Glycine 0 CA--C 1.537 1.45 0 O-C-N 121.213 -0.93 . . . . 0.0 114.181 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -97.4 125.87 42.29 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.797 1.239 . . . . 0.0 109.703 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -67.09 126.22 28.5 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.772 -0.58 . . . . 0.0 110.628 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.3 t -141.16 140.1 34.01 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.834 1.254 . . . . 0.0 110.842 -174.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -56.77 135.03 55.47 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.229 1.012 . . . . 0.0 112.781 -175.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.6 tp -109.18 -48.39 3.27 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.695 0.798 . . . . 0.0 111.139 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.5 -113.14 0.51 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 123.137 0.399 . . . . 0.0 113.663 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -146.61 157.56 43.74 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.439 1.495 . . . . 0.0 109.949 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.1 tp -122.9 102.19 7.87 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.504 1.521 . . . . 0.0 110.022 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.67 95.58 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.636 1.574 . . . . 0.0 109.561 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.8 t -84.18 104.57 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.211 1.804 . . . . 0.0 110.252 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 . . . . . 0 N--CA 1.476 0.858 0 C-N-CA 127.098 2.159 . . . . 0.0 111.346 176.556 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.056 0 CA-C-O 122.056 0.809 . . . . 0.0 114.026 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.3 mt -111.76 140.32 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.12 0.968 . . . . 0.0 109.404 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -128.99 130.1 46.24 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.282 1.433 . . . . 0.0 109.6 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.2 p -119.79 148.51 43.35 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.375 -0.828 . . . . 0.0 111.198 -172.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.49 125.01 2.64 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-O 121.513 0.507 . . . . 0.0 112.788 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.8 138.2 52.48 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.077 1.751 . . . . 0.0 110.402 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.2 t30 . . . . . 0 CA--C 1.546 0.808 0 C-N-CA 126.119 1.768 . . . . 0.0 110.885 -176.254 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.695 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.5 m -54.89 130.76 42.45 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 121.382 -0.824 . . . . 0.0 110.612 170.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -97.5 -50.91 4.33 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.897 0.879 . . . . 0.0 110.175 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -163.86 158.45 19.94 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.883 0.873 . . . . 0.0 112.728 171.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.46 133.25 27.29 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 122.092 0.948 . . . . 0.0 111.943 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.43 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -108.3 160.38 15.9 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.108 1.363 . . . . 0.0 111.669 -178.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -76.95 165.4 24.72 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.91 0.862 . . . . 0.0 112.334 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -60.04 -26.6 66.25 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.021 0.928 . . . . 0.0 112.764 172.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -74.21 -3.96 33.02 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 172.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.1 t -117.91 -2.7 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.347 1.059 . . . . 0.0 110.883 -173.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.2 m -57.14 -29.33 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -176.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -98.96 -25.91 14.43 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.281 1.033 . . . . 0.0 111.851 171.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -71.27 -49.16 45.86 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.906 1.682 . . . . 0.0 111.6 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -59.68 -45.33 92.39 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.373 1.069 . . . . 0.0 110.918 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 73.3 t -55.67 -39.4 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.724 0.81 . . . . 0.0 110.367 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -60.58 -55.22 35.93 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.533 1.533 . . . . 0.0 112.224 174.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.0 m -70.9 -14.91 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 121.12 -0.987 . . . . 0.0 112.785 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.3 -4.6 55.71 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.274 1.83 . . . . 0.0 111.824 178.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.5 p -127.84 -15.56 4.85 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.63 1.172 . . . . 0.0 114.002 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -134.24 -9.8 2.58 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.272 1.429 . . . . 0.0 114.281 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.97 156.42 9.89 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.159 1.362 . . . . 0.0 113.825 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.03 -170.61 32.64 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.65 1.119 . . . . 0.0 113.524 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 56.7 p -144.36 103.81 4.01 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.756 1.222 . . . . 0.0 113.423 -168.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -133.81 156.54 47.85 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.145 1.778 . . . . 0.0 110.289 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 165.01 20.13 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.272 -0.892 . . . . 0.0 111.288 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.6 p -131.91 146.57 52.19 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.299 1.439 . . . . 0.0 111.273 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.43 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 9.4 t -54.88 -44.33 74.0 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.96 1.304 . . . . 0.0 112.084 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.5 mt -152.67 146.49 25.2 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.366 1.867 . . . . 0.0 110.942 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -139.72 111.38 7.25 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.27 0.628 . . . . 0.0 110.253 174.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -98.19 -39.56 8.81 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.129 1.372 . . . . 0.0 114.038 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.63 178.12 7.47 Favored Glycine 0 CA--C 1.544 1.906 0 C-N-CA 125.003 1.287 . . . . 0.0 115.409 -169.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 41.2 t80 . . . . . 0 CA--C 1.551 0.988 0 C-N-CA 124.894 1.278 . . . . 0.0 113.006 170.22 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.509 0 CA-C-O 122.046 0.804 . . . . 0.0 114.755 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.6 mt -114.07 115.0 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.149 1.38 . . . . 0.0 108.643 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -70.7 144.28 51.06 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.028 0.442 . . . . 0.0 111.198 172.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 58.14 26.36 13.61 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.334 1.454 . . . . 0.0 113.518 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -61.79 125.66 24.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.543 1.137 . . . . 0.0 111.187 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -72.32 122.81 21.76 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.542 1.537 . . . . 0.0 111.953 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.9 mm -119.58 116.17 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.122 0.969 . . . . 0.0 109.477 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.6 mp -110.32 96.66 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.928 1.291 . . . . 0.0 108.425 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.9 p -80.62 156.46 26.38 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.983 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -151.53 139.58 20.11 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.88 1.272 . . . . 0.0 111.495 174.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.9 mt -81.07 134.08 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 . . . . . 0 N--CA 1.466 0.36 0 C-N-CA 125.055 1.342 . . . . 0.0 110.73 172.736 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 CA--C 1.543 0.696 0 CA-C-O 121.22 0.534 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -103.4 167.57 9.72 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.833 1.253 . . . . 0.0 110.69 170.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.2 tp -122.09 134.02 66.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 125.634 1.574 . . . . 0.0 108.103 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 p -120.77 156.71 31.27 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.198 0.599 . . . . 0.0 109.849 173.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -150.99 140.58 21.62 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.705 0.802 . . . . 0.0 111.312 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.7 p -71.79 118.94 15.26 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.929 0.892 . . . . 0.0 110.999 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.06 -154.39 16.18 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.717 1.151 . . . . 0.0 112.19 172.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -79.98 166.55 21.48 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.659 0.783 . . . . 0.0 111.202 169.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -79.1 105.99 10.82 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.95 -1.094 . . . . 0.0 111.286 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.701 0 C-N-CA 123.474 0.71 . . . . 0.0 112.06 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.29 115.67 4.77 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -113.04 143.97 43.41 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.84 1.305 . . . . 0.0 111.231 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -134.65 168.06 19.68 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.202 1.801 . . . . 0.0 110.225 -169.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.89 133.46 23.54 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 69.5 mt -124.87 140.32 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.6 m -62.11 94.08 0.05 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.744 0.818 . . . . 0.0 109.226 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.54 -31.83 57.18 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.513 -0.742 . . . . 0.0 111.497 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -63.88 -27.71 69.34 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -94.78 -29.86 14.54 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.59 1.556 . . . . 0.0 111.597 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 16.9 mt -58.04 -49.66 76.11 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.435 1.094 . . . . 0.0 110.766 170.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -49.33 -37.92 26.15 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.411 1.084 . . . . 0.0 113.445 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 48.6 mttm . . . . . 0 N--CA 1.48 1.053 0 C-N-CA 125.664 1.586 . . . . 0.0 114.268 -178.451 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt . . . . . 0 C--O 1.234 0.273 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -140.0 161.29 37.96 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.158 0.983 . . . . 0.0 109.951 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -132.6 124.92 29.28 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.739 0.304 . . . . 0.0 110.595 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.4 m -122.75 162.25 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.439 1.496 . . . . 0.0 111.18 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -60.42 157.87 13.08 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.345 1.058 . . . . 0.0 111.189 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.4 tp -156.74 137.82 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.218 1.007 . . . . 0.0 109.267 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -130.52 161.97 30.28 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 126.69 1.996 . . . . 0.0 109.628 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -128.73 159.3 36.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.042 1.337 . . . . 0.0 110.899 174.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -80.08 121.44 25.53 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 122.125 -0.36 . . . . 0.0 110.319 170.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.53 171.91 2.33 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.452 1.101 . . . . 0.0 112.258 171.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -55.13 -14.76 1.77 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.425 1.89 . . . . 0.0 115.343 174.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.9 t -113.03 11.46 18.98 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.95 1.3 . . . . 0.0 112.786 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.9 21.3 78.71 Favored Glycine 0 CA--C 1.537 1.409 0 O-C-N 120.553 -1.342 . . . . 0.0 114.334 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -98.17 127.79 44.31 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.843 1.257 . . . . 0.0 109.483 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -67.15 126.83 30.44 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.783 -0.573 . . . . 0.0 110.631 173.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.6 t -140.07 140.09 36.05 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.186 1.394 . . . . 0.0 110.138 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -58.19 141.05 51.74 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.8 tp -113.11 -48.9 2.95 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.758 0.823 . . . . 0.0 110.927 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.4 -111.85 0.47 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.141 0.4 . . . . 0.0 113.32 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -147.15 146.36 29.87 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.473 1.509 . . . . 0.0 110.008 -175.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 16.5 tp -114.68 106.66 14.49 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.674 1.189 . . . . 0.0 110.513 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.8 t -77.56 100.95 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.624 1.169 . . . . 0.0 109.137 173.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.6 t -90.02 123.79 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.156 1.382 . . . . 0.0 109.603 173.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 . . . . . 0 N--CA 1.473 0.677 0 C-N-CA 127.475 2.31 . . . . 0.0 109.792 -178.266 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.934 0 CA-C-O 121.362 0.423 . . . . 0.0 114.075 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.2 mt -117.33 142.88 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.717 0.807 . . . . 0.0 110.075 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -128.97 143.78 50.98 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.296 1.438 . . . . 0.0 109.664 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.1 p -135.31 148.83 49.61 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.299 -0.876 . . . . 0.0 112.043 -174.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.62 124.74 2.15 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-O 121.698 0.61 . . . . 0.0 112.739 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.45 139.06 43.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.147 1.779 . . . . 0.0 110.436 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.4 t30 . . . . . 0 CA--C 1.547 0.849 0 C-N-CA 126.097 1.759 . . . . 0.0 111.106 -178.421 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.708 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.2 m -56.01 128.34 34.84 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.523 0.729 . . . . 0.0 110.382 169.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -93.86 -51.11 5.03 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.478 0.711 . . . . 0.0 110.218 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -167.05 164.81 15.93 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.894 1.278 . . . . 0.0 112.661 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.89 146.29 28.99 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.608 1.163 . . . . 0.0 112.563 176.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.465 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -127.53 158.27 37.87 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.417 1.487 . . . . 0.0 112.111 -176.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -77.5 165.33 24.48 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.606 0.717 . . . . 0.0 112.494 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -56.0 -35.78 67.18 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.151 0.98 . . . . 0.0 112.335 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -69.0 -8.88 49.08 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.153 0.981 . . . . 0.0 113.5 175.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.9 t -113.31 -6.58 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.494 1.118 . . . . 0.0 110.834 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 67.7 t -49.85 -67.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.609 1.164 . . . . 0.0 111.87 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -67.12 -24.86 65.96 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.697 -0.627 . . . . 0.0 112.633 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -53.56 54.47 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.527 1.531 . . . . 0.0 110.813 173.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -62.51 -43.62 98.36 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.445 1.498 . . . . 0.0 111.642 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 74.3 t -56.62 -37.83 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.471 0.708 . . . . 0.0 110.733 176.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -68.1 -53.18 27.33 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.431 1.092 . . . . 0.0 113.059 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.32 -14.51 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 O-C-N 121.003 -1.06 . . . . 0.0 112.427 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.5 ttm -92.54 -4.65 53.18 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 120.465 -1.397 . . . . 0.0 112.802 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.5 p -126.75 -12.06 6.02 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.34 1.056 . . . . 0.0 113.114 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -136.98 -10.85 1.75 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.934 1.694 . . . . 0.0 114.415 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.27 154.64 10.02 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.728 1.632 . . . . 0.0 114.18 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.09 -168.66 33.04 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.672 1.13 . . . . 0.0 113.953 -175.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.7 p -146.24 107.38 4.18 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.873 1.269 . . . . 0.0 113.502 -168.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -136.44 149.42 48.24 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.308 1.843 . . . . 0.0 110.243 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -76.28 163.32 27.14 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.247 -0.908 . . . . 0.0 111.334 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.5 p -128.83 142.37 50.99 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.981 1.313 . . . . 0.0 111.32 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.465 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 8.4 t -53.52 -44.15 68.9 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.433 1.493 . . . . 0.0 112.256 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 mt -151.34 142.23 22.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.846 1.658 . . . . 0.0 111.691 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -136.12 102.66 5.08 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.072 0.949 . . . . 0.0 110.811 175.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -87.22 -48.53 7.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.01 0.924 . . . . 0.0 112.984 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.98 165.5 34.0 Favored Glycine 0 CA--C 1.545 1.933 0 C-N-CA 124.748 1.166 . . . . 0.0 112.584 -168.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 5.6 t80 . . . . . 0 N--CA 1.474 0.773 0 C-N-CA 124.479 1.111 . . . . 0.0 113.908 -178.194 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.56 0 CA-C-O 121.312 0.396 . . . . 0.0 113.86 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.7 mt -125.72 115.83 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.807 1.643 . . . . 0.0 108.612 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -74.47 146.92 42.39 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.992 0.425 . . . . 0.0 111.836 173.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 57.47 23.36 9.01 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.136 1.774 . . . . 0.0 114.467 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -63.7 123.24 18.36 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.715 1.206 . . . . 0.0 111.727 -171.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -71.33 125.38 26.82 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.538 1.135 . . . . 0.0 111.636 177.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.7 mm -120.97 119.51 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.755 1.222 . . . . 0.0 109.169 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.3 100.27 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.88 1.272 . . . . 0.0 108.67 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 47.9 p -79.26 159.62 27.19 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.068 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.1 141.48 20.66 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.114 1.366 . . . . 0.0 111.305 171.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.5 mt -83.07 136.31 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.598 0.759 . . . . 0.0 109.275 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 . . . . . 0 N--CA 1.469 0.514 0 C-N-CA 124.877 1.271 . . . . 0.0 110.974 173.964 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 121.228 0.537 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -105.42 165.25 11.26 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.486 1.514 . . . . 0.0 111.009 170.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 6.3 tp -115.7 137.04 50.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 125.743 1.617 . . . . 0.0 107.793 169.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 p -126.95 157.63 38.96 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.499 0.72 . . . . 0.0 109.772 173.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -151.27 138.63 19.42 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.015 0.926 . . . . 0.0 111.603 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.3 m -78.88 111.28 14.88 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.074 0.95 . . . . 0.0 110.821 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.71 -161.95 32.74 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.435 1.016 . . . . 0.0 113.125 175.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -63.69 170.58 3.19 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-O 121.898 0.856 . . . . 0.0 112.568 169.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -92.21 108.21 19.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.623 1.569 . . . . 0.0 111.517 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.477 0.876 0 C-N-CA 123.36 0.664 . . . . 0.0 112.192 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 120.47 0.176 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.45 108.89 2.54 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 169.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -110.11 143.0 40.81 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.378 1.085 . . . . 0.0 110.675 172.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -133.39 170.15 15.89 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.97 1.708 . . . . 0.0 110.696 -170.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.31 132.26 20.23 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.532 0.333 . . . . 0.0 110.174 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 67.3 mt -125.2 138.88 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.3 m -62.88 99.2 0.15 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.735 0.698 . . . . 0.0 109.294 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.27 -30.57 62.63 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.588 0.755 . . . . 0.0 111.829 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.45 -31.57 69.96 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -87.84 -22.4 24.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.091 0.956 . . . . 0.0 112.356 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 18.1 mt -64.25 -44.02 93.1 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.94 0.896 . . . . 0.0 111.085 168.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -55.07 -40.7 70.64 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.921 0.889 . . . . 0.0 112.153 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp . . . . . 0 N--CA 1.48 1.037 0 C-N-CA 125.733 1.613 . . . . 0.0 115.319 175.379 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 121.736 0.779 . . . . 0.0 111.907 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -147.32 155.93 42.46 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.974 0.91 . . . . 0.0 109.346 166.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 m -122.24 131.19 53.81 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.572 0.349 . . . . 0.0 110.775 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.0 m -129.27 166.09 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 125.646 1.579 . . . . 0.0 111.605 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -63.89 159.24 20.17 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.706 1.202 . . . . 0.0 111.806 177.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.0 tp -154.27 136.68 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.241 1.416 . . . . 0.0 109.571 174.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -128.89 161.93 28.71 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.498 1.919 . . . . 0.0 109.848 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -131.4 156.65 45.2 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.842 1.257 . . . . 0.0 111.338 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 119.59 20.18 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 171.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -63.27 175.51 0.95 Allowed 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 122.053 0.93 . . . . 0.0 111.728 170.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -60.36 -11.45 6.67 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.725 2.01 . . . . 0.0 114.6 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.8 m -115.64 13.49 16.3 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.169 1.388 . . . . 0.0 112.86 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.71 23.18 77.28 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 121.281 -0.887 . . . . 0.0 114.318 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -100.26 124.23 45.45 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.807 1.243 . . . . 0.0 109.674 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -64.93 123.94 20.75 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.974 0.51 . . . . 0.0 110.952 173.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.0 t -138.49 137.4 37.09 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.207 1.403 . . . . 0.0 110.402 -174.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -57.43 137.08 56.59 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.345 0.658 . . . . 0.0 112.516 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.8 tp -110.39 -47.65 3.26 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.667 0.787 . . . . 0.0 111.173 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.03 -128.98 1.55 Allowed Glycine 0 CA--C 1.528 0.86 0 CA-C-O 121.341 0.412 . . . . 0.0 113.665 -173.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -140.58 155.75 46.49 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.734 1.613 . . . . 0.0 109.621 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.8 tp -120.19 99.46 6.6 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.453 1.501 . . . . 0.0 109.662 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.3 t -76.71 101.96 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 125.321 1.448 . . . . 0.0 109.491 175.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.1 t -92.08 92.97 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.088 1.755 . . . . 0.0 109.712 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 . . . . . 0 N--CA 1.471 0.606 0 C-N-CA 125.814 1.645 . . . . 0.0 110.564 175.277 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.996 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.4 mt -124.12 145.49 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.159 0.984 . . . . 0.0 109.657 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -137.1 128.81 28.79 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.184 0.994 . . . . 0.0 110.593 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.8 p -117.54 147.25 42.96 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.381 1.072 . . . . 0.0 111.318 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -139.16 120.83 1.97 Allowed Glycine 0 CA--C 1.522 0.497 0 O-C-N 121.909 -0.495 . . . . 0.0 112.444 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.71 121.81 17.25 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.459 1.504 . . . . 0.0 109.107 173.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.1 t30 . . . . . 0 CA--C 1.538 0.516 0 C-N-CA 126.453 1.901 . . . . 0.0 109.112 -177.085 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.738 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.1 m -55.4 136.21 49.66 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.05 -1.031 . . . . 0.0 110.887 171.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -106.49 -51.46 2.95 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.564 1.146 . . . . 0.0 110.417 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -164.4 154.8 14.67 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.412 0.685 . . . . 0.0 112.388 170.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.55 154.85 44.83 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.431 1.11 . . . . 0.0 111.44 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.423 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -141.34 159.75 41.56 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.967 1.307 . . . . 0.0 111.647 -174.504 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -79.83 165.71 22.44 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.592 0.757 . . . . 0.0 112.029 -175.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -55.74 -32.31 63.28 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.138 -0.976 . . . . 0.0 113.422 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.47 -14.13 62.79 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 t -106.83 -8.23 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.38 1.072 . . . . 0.0 111.262 -174.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 81.0 t -49.92 -63.38 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 125.23 1.412 . . . . 0.0 111.462 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -69.63 -25.67 64.04 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -52.08 59.19 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.217 1.407 . . . . 0.0 110.72 174.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -61.78 -43.34 99.04 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.633 1.573 . . . . 0.0 111.505 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 73.6 t -54.5 -38.27 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.252 1.021 . . . . 0.0 110.566 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -69.37 -53.75 17.93 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.585 1.154 . . . . 0.0 112.541 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.7 m -72.3 -20.6 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 121.028 -1.045 . . . . 0.0 112.248 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.46 -4.67 58.72 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.239 -1.538 . . . . 0.0 112.103 174.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 79.9 p -128.53 -12.56 4.94 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -137.68 -10.5 1.6 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.036 1.734 . . . . 0.0 114.166 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.33 155.33 11.05 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.879 1.704 . . . . 0.0 113.86 -174.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.87 -171.66 33.8 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.673 1.13 . . . . 0.0 113.292 -174.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.0 p -145.47 103.83 3.85 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.518 1.127 . . . . 0.0 113.184 -168.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -131.66 150.53 52.12 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.962 1.705 . . . . 0.0 110.152 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.71 157.22 30.19 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.265 -0.897 . . . . 0.0 111.578 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.6 p -122.94 155.84 35.93 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.162 1.785 . . . . 0.0 110.687 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.423 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 77.1 p -71.09 -38.09 72.41 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.7 -0.625 . . . . 0.0 111.568 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.8 mt -154.43 137.67 15.71 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.147 1.779 . . . . 0.0 111.809 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -134.89 102.62 5.3 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.878 0.871 . . . . 0.0 110.48 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -86.77 -45.2 11.14 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.381 1.073 . . . . 0.0 113.381 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.29 -178.77 30.14 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 124.8 1.19 . . . . 0.0 113.865 -169.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 24.4 t80 . . . . . 0 CA--C 1.554 1.13 0 C-N-CA 125.291 1.436 . . . . 0.0 113.351 171.373 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.271 0 CA-C-O 121.914 0.73 . . . . 0.0 112.841 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 55.9 mt -124.63 109.62 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.501 1.52 . . . . 0.0 107.402 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -68.93 145.14 53.9 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.179 0.514 . . . . 0.0 111.139 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 60.71 21.04 11.05 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.573 1.549 . . . . 0.0 114.389 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 21.2 tptp -56.24 123.91 16.15 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.571 1.148 . . . . 0.0 111.287 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -73.41 128.87 36.7 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.968 0.907 . . . . 0.0 110.237 170.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 38.2 mm -121.73 112.61 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.187 0.995 . . . . 0.0 109.112 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.11 91.12 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.842 1.257 . . . . 0.0 109.103 -174.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 44.8 p -75.46 155.23 36.46 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.326 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -152.29 141.45 21.36 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.028 1.331 . . . . 0.0 111.399 172.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.1 mt -80.04 132.27 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.239 0.615 . . . . 0.0 109.405 175.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 . . . . . 0 N--CA 1.469 0.516 0 C-N-CA 125.082 1.353 . . . . 0.0 111.021 172.475 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 CA--C 1.536 0.436 0 CA-C-O 121.278 0.561 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -106.73 169.12 8.72 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.275 1.43 . . . . 0.0 110.444 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.0 tp -123.82 134.11 67.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 125.531 1.532 . . . . 0.0 108.283 172.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 p -121.36 153.75 37.37 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.192 0.597 . . . . 0.0 110.151 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -151.81 144.98 24.63 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.237 1.015 . . . . 0.0 111.29 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 p -77.7 116.45 18.24 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.195 1.398 . . . . 0.0 111.746 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.29 -158.67 30.21 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.575 1.56 . . . . 0.0 112.214 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.07 164.31 20.48 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 122.022 0.915 . . . . 0.0 113.422 170.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -81.61 102.59 10.75 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.175 0.99 . . . . 0.0 111.086 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.471 0.619 0 C-N-CA 123.404 0.681 . . . . 0.0 112.684 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.471 0.586 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -59.98 133.1 55.78 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 168.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -125.55 143.68 50.9 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.51 1.148 . . . . 0.0 110.473 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -131.23 169.18 16.3 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.851 1.661 . . . . 0.0 110.687 -170.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.28 130.67 19.82 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.901 0.48 . . . . 0.0 110.013 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 60.9 mt -126.24 140.54 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.883 0.873 . . . . 0.0 108.847 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.0 m -65.78 94.55 0.21 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.038 0.935 . . . . 0.0 109.772 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.68 -33.06 54.08 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.512 1.125 . . . . 0.0 111.682 175.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -66.94 -27.27 67.33 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 176.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -89.91 -29.9 18.22 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.115 0.966 . . . . 0.0 112.875 174.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 20.3 mt -59.3 -47.61 84.75 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.45 0.7 . . . . 0.0 110.643 172.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -50.89 -37.79 45.88 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.563 1.145 . . . . 0.0 113.746 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 179.735 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.0 pttm . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 120.851 0.358 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -142.26 174.28 10.76 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.146 1.378 . . . . 0.0 110.763 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -140.43 137.2 33.77 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.286 -0.884 . . . . 0.0 111.097 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.2 m -133.4 162.06 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 125.444 1.497 . . . . 0.0 111.718 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -61.75 155.14 23.65 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.443 1.097 . . . . 0.0 111.893 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.4 tp -150.94 136.16 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.789 1.236 . . . . 0.0 109.784 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -125.75 161.82 26.46 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.906 2.082 . . . . 0.0 109.488 176.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -130.8 154.58 47.87 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.162 1.385 . . . . 0.0 111.077 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -79.41 117.51 20.45 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.957 -0.464 . . . . 0.0 109.841 169.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -64.24 172.47 2.46 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 122.619 1.199 . . . . 0.0 111.176 169.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -57.0 -22.38 38.1 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.42 2.288 . . . . 0.0 113.125 173.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.4 m -83.67 -4.1 58.32 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.696 1.598 . . . . 0.0 114.15 174.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.68 34.42 66.86 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.846 1.213 . . . . 0.0 114.133 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -122.29 139.19 54.09 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.259 1.424 . . . . 0.0 110.689 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -70.93 119.96 15.82 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.645 1.178 . . . . 0.0 110.9 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -133.87 141.87 47.56 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.149 1.38 . . . . 0.0 110.138 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -59.21 140.2 56.18 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -173.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.5 tp -114.11 -47.86 2.93 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.032 0.933 . . . . 0.0 111.34 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.79 -119.02 0.81 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 123.267 0.461 . . . . 0.0 113.176 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -145.37 152.7 40.28 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.639 1.576 . . . . 0.0 110.184 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.2 tp -117.46 104.58 11.23 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.777 1.231 . . . . 0.0 110.525 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.4 t -77.82 100.37 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.507 1.123 . . . . 0.0 109.619 174.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 52.1 t -90.1 113.09 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.031 1.332 . . . . 0.0 110.36 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 . . . . . 0 N--CA 1.473 0.686 0 C-N-CA 127.044 2.138 . . . . 0.0 110.566 176.807 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.183 0 N-CA-C 113.971 0.348 . . . . 0.0 113.971 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.1 mt -119.61 143.2 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.101 0.96 . . . . 0.0 109.401 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -135.81 138.59 42.72 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.092 0.957 . . . . 0.0 110.059 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.5 p -131.54 147.63 52.55 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.488 -0.758 . . . . 0.0 111.724 -169.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.96 124.48 2.36 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-O 121.636 0.575 . . . . 0.0 112.954 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.9 137.05 51.3 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.103 1.761 . . . . 0.0 110.212 176.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.6 t30 . . . . . 0 CA--C 1.544 0.739 0 C-N-CA 126.031 1.733 . . . . 0.0 110.274 179.606 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.523 0 CA-C-O 120.772 0.32 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.2 m -55.54 132.75 49.39 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.485 -0.759 . . . . 0.0 110.146 169.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -99.89 -51.1 3.8 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.884 0.874 . . . . 0.0 109.842 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -163.98 161.57 22.81 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.12 0.968 . . . . 0.0 112.286 170.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.44 150.77 36.27 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.829 0.852 . . . . 0.0 111.512 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.413 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.8 OUTLIER -141.24 156.25 45.92 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.288 1.435 . . . . 0.0 111.845 -174.474 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -77.79 165.33 24.31 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.482 0.713 . . . . 0.0 112.601 -172.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -52.85 -34.0 52.28 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.605 1.162 . . . . 0.0 112.897 172.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -66.65 -11.81 55.5 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.87 1.268 . . . . 0.0 113.658 175.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.8 t -116.22 -5.23 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.971 1.308 . . . . 0.0 111.357 -172.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 69.6 t -50.18 -62.41 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 125.293 1.437 . . . . 0.0 111.899 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -70.25 -28.13 64.99 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -62.29 -50.48 71.52 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.446 1.498 . . . . 0.0 110.909 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -60.18 -43.84 95.52 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.996 1.318 . . . . 0.0 111.327 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 42.1 t -62.1 -34.16 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 123.705 0.802 . . . . 0.0 111.349 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -63.8 -54.56 33.19 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.459 1.104 . . . . 0.0 111.996 172.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -73.17 -2.55 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.3 ttm -114.48 1.91 14.47 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.038 1.335 . . . . 0.0 112.925 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.5 p -124.76 -12.56 7.1 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.762 1.225 . . . . 0.0 112.156 168.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -138.1 -15.14 1.32 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.79 155.09 26.81 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 124.895 1.236 . . . . 0.0 114.125 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.13 -160.1 31.35 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 123.963 0.792 . . . . 0.0 114.363 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.5 p -151.91 98.75 2.49 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -170.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -131.65 146.06 51.99 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.275 1.83 . . . . 0.0 110.132 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.23 155.75 36.47 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.461 -0.774 . . . . 0.0 110.778 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 47.0 p -114.69 158.11 22.23 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.539 1.136 . . . . 0.0 111.009 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.413 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 77.0 p -70.54 -37.87 74.12 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.387 -0.821 . . . . 0.0 110.823 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.2 mt -148.04 150.83 34.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.962 2.105 . . . . 0.0 112.171 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -143.7 107.95 4.78 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.382 1.073 . . . . 0.0 110.252 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -96.88 -40.46 8.9 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.411 1.084 . . . . 0.0 113.585 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.66 178.51 29.99 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.796 1.188 . . . . 0.0 115.616 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 33.6 t80 . . . . . 0 CA--C 1.548 0.896 0 C-N-CA 123.915 0.886 . . . . 0.0 112.075 169.446 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.577 0 N-CA-C 114.576 0.59 . . . . 0.0 114.576 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.2 mt -126.62 112.17 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.874 1.67 . . . . 0.0 108.536 174.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -70.98 145.24 50.16 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.101 0.477 . . . . 0.0 111.311 172.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 59.29 22.53 10.86 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.713 1.605 . . . . 0.0 114.137 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -54.13 127.86 28.48 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.92 1.288 . . . . 0.0 111.248 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -75.12 130.12 38.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.085 0.554 . . . . 0.0 110.544 170.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 32.8 mm -126.55 120.28 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.835 1.254 . . . . 0.0 108.668 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.68 101.55 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 125.303 1.441 . . . . 0.0 108.71 -176.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.4 p -86.29 159.3 19.47 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.485 0.714 . . . . 0.0 112.317 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -154.89 139.24 16.72 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.066 1.346 . . . . 0.0 111.736 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 26.2 mt -77.29 133.57 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.087 0.555 . . . . 0.0 109.911 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 CA--C 1.538 0.512 0 C-N-CA 125.747 1.619 . . . . 0.0 111.038 171.957 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 . . . . . 0 CA--C 1.537 0.467 0 CA-C-O 121.28 0.562 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -112.68 165.92 11.83 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.33 1.452 . . . . 0.0 110.692 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.1 tp -120.77 132.27 70.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 125.472 1.509 . . . . 0.0 108.117 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.3 p -122.45 154.76 37.34 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.571 0.748 . . . . 0.0 110.05 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -150.95 148.08 27.96 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.709 0.804 . . . . 0.0 111.844 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.4 p -80.74 125.42 30.04 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.695 1.198 . . . . 0.0 111.552 174.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.66 -151.77 26.63 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.085 1.326 . . . . 0.0 113.187 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -78.92 172.19 14.13 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.465 1.506 . . . . 0.0 110.331 168.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -82.31 119.29 23.94 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.709 -1.245 . . . . 0.0 110.805 173.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.773 0 C-N-CA 122.818 0.447 . . . . 0.0 111.36 173.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.51 117.62 7.0 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -117.96 140.23 50.02 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 122.181 0.991 . . . . 0.0 110.17 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -133.1 168.54 18.32 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.304 1.442 . . . . 0.0 111.327 -169.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.82 130.64 18.09 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.264 0.626 . . . . 0.0 109.9 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 69.6 mt -122.57 140.33 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.135 0.974 . . . . 0.0 108.536 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.9 m -64.11 95.81 0.13 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.192 0.997 . . . . 0.0 110.049 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.3 tt -55.32 -31.87 62.02 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.501 1.12 . . . . 0.0 111.757 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -69.48 -29.72 67.44 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.59 -33.51 47.52 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.292 0.951 . . . . 0.0 112.681 171.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 22.4 mt -62.28 -48.82 78.21 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.309 1.043 . . . . 0.0 110.741 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -48.81 -38.19 21.42 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.785 1.175 . . . . 0.0 113.531 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.6 mttt . . . . . 0 N--CA 1.486 1.354 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 177.885 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -140.93 165.62 27.03 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.091 0.956 . . . . 0.0 110.842 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -136.04 132.76 36.65 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.16 -0.338 . . . . 0.0 111.322 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.1 m -131.79 159.77 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.353 1.461 . . . . 0.0 111.866 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -57.98 153.75 13.79 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.747 0.819 . . . . 0.0 112.45 175.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.0 tp -149.96 137.16 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.336 1.455 . . . . 0.0 109.714 174.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -132.57 161.25 34.31 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.718 2.007 . . . . 0.0 109.674 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -134.62 160.08 39.21 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.367 1.067 . . . . 0.0 112.162 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.21 114.45 21.82 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.545 0.738 . . . . 0.0 110.625 173.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -73.59 -176.65 2.41 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.779 0.832 . . . . 0.0 112.276 175.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt -55.92 -26.65 48.62 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.489 1.916 . . . . 0.0 113.167 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.0 m -73.75 -8.25 55.28 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.342 1.457 . . . . 0.0 113.87 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.24 40.46 97.38 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.258 0.932 . . . . 0.0 112.4 -169.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -132.61 137.64 47.11 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.562 1.945 . . . . 0.0 109.097 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -67.3 130.64 43.71 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.64 0.776 . . . . 0.0 111.178 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.3 t -137.53 138.46 39.67 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.942 1.297 . . . . 0.0 110.317 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -57.17 125.88 24.71 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.443 1.097 . . . . 0.0 112.286 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.9 tp -100.73 -45.87 5.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.863 0.865 . . . . 0.0 111.092 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.86 -120.36 0.91 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.473 0.559 . . . . 0.0 113.468 -177.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -145.5 155.76 43.3 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.565 1.546 . . . . 0.0 109.575 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.5 tp -121.83 104.81 9.83 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.5 1.12 . . . . 0.0 110.698 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.2 t -77.72 98.95 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.847 1.259 . . . . 0.0 109.355 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 51.6 t -86.06 117.44 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.042 1.737 . . . . 0.0 110.197 174.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 . . . . . 0 N--CA 1.473 0.72 0 C-N-CA 126.973 2.109 . . . . 0.0 110.82 179.322 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.184 0 CA-C-O 121.182 0.323 . . . . 0.0 113.341 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.4 mt -117.31 143.96 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.074 0.95 . . . . 0.0 109.708 171.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -131.35 140.9 49.81 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.107 1.363 . . . . 0.0 109.459 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.7 p -133.15 146.92 52.01 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.134 -0.979 . . . . 0.0 112.433 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.05 126.51 3.25 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-O 121.769 0.649 . . . . 0.0 112.944 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.05 137.35 53.51 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.561 1.945 . . . . 0.0 110.128 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.9 t30 . . . . . 0 CA--C 1.547 0.838 0 C-N-CA 126.1 1.76 . . . . 0.0 110.678 -176.04 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.728 0 N-CA-C 111.413 0.153 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.3 m -58.55 136.4 57.56 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.24 -0.913 . . . . 0.0 109.262 169.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -104.45 -48.29 3.86 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.904 0.882 . . . . 0.0 110.022 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -162.38 170.5 18.7 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.416 1.086 . . . . 0.0 112.307 169.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.77 158.09 43.73 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.764 1.226 . . . . 0.0 111.62 170.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.409 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -140.5 158.38 44.09 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.926 1.29 . . . . 0.0 111.466 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -80.05 165.13 22.84 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.15 0.58 . . . . 0.0 111.834 -174.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -53.11 -33.96 54.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.602 1.161 . . . . 0.0 112.857 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -67.26 -8.44 31.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.937 1.295 . . . . 0.0 113.556 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.61 -6.69 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.586 1.154 . . . . 0.0 111.306 -172.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 79.5 t -52.12 -60.91 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 O-C-N 120.404 -1.435 . . . . 0.0 112.231 -176.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -69.0 -27.01 65.31 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.47 -52.79 59.89 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.477 1.511 . . . . 0.0 110.856 175.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.96 -46.65 89.84 Favored 'General case' 0 C--O 1.227 -0.093 0 C-N-CA 125.041 1.336 . . . . 0.0 110.484 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.74 -35.48 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.232 0.613 . . . . 0.0 111.461 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -63.07 -54.69 34.04 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.416 1.086 . . . . 0.0 112.215 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -70.25 -12.24 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 121.551 -0.718 . . . . 0.0 112.419 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -4.63 47.93 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.745 2.018 . . . . 0.0 112.186 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 34.3 p -126.39 -15.0 5.76 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 169.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -130.75 -10.55 3.93 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.942 1.297 . . . . 0.0 114.257 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.64 155.93 7.78 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.241 1.4 . . . . 0.0 113.698 -174.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.8 -170.51 32.49 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.032 0.825 . . . . 0.0 114.064 -174.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.4 p -143.44 109.4 5.25 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.927 1.291 . . . . 0.0 113.529 -168.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -138.05 148.45 45.1 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.364 1.866 . . . . 0.0 109.825 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 155.65 35.1 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.691 -0.63 . . . . 0.0 110.913 177.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 58.9 p -117.85 158.25 25.17 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.921 1.688 . . . . 0.0 110.958 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.409 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 60.0 p -74.35 -39.96 62.44 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.576 -0.703 . . . . 0.0 111.121 -177.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.3 mt -151.11 143.19 24.0 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.631 1.973 . . . . 0.0 111.919 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -138.22 98.52 3.64 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.885 0.874 . . . . 0.0 111.583 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -86.55 -40.12 15.54 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.67 178.26 7.65 Favored Glycine 0 CA--C 1.546 1.971 0 C-N-CA 124.378 0.989 . . . . 0.0 114.339 -169.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 40.5 t80 . . . . . 0 CA--C 1.55 0.947 0 C-N-CA 124.78 1.232 . . . . 0.0 112.546 169.92 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.423 0 CA-C-O 121.875 0.708 . . . . 0.0 113.199 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 62.5 mt -126.59 110.79 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.502 1.521 . . . . 0.0 108.149 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -69.7 145.27 52.46 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.305 0.574 . . . . 0.0 111.419 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 60.07 19.85 9.05 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.773 1.629 . . . . 0.0 114.466 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -54.73 124.06 15.24 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.638 1.175 . . . . 0.0 111.735 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -72.44 129.81 39.23 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.214 1.006 . . . . 0.0 110.644 171.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.0 mm -126.82 119.35 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.764 1.225 . . . . 0.0 108.922 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.75 98.32 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.274 1.43 . . . . 0.0 108.679 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.5 p -81.92 155.56 25.21 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.709 0.804 . . . . 0.0 112.125 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -151.39 140.05 20.71 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.098 1.359 . . . . 0.0 111.182 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 46.1 mt -79.95 133.06 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 . . . . . 0 N--CA 1.469 0.483 0 C-N-CA 125.188 1.395 . . . . 0.0 110.953 176.348 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 . . . . . 0 CA--C 1.54 0.57 0 CA-C-O 121.174 0.511 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -113.25 169.12 9.17 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.281 1.432 . . . . 0.0 109.91 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.9 tp -120.77 133.66 66.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.06 1.344 . . . . 0.0 108.519 169.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.1 p -121.8 155.08 36.08 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.596 0.758 . . . . 0.0 110.214 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -147.14 145.02 29.42 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.598 0.759 . . . . 0.0 112.246 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.3 p -74.91 108.71 7.82 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.982 1.313 . . . . 0.0 111.49 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.77 -162.35 33.47 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 123.83 0.729 . . . . 0.0 113.535 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -69.6 173.78 5.71 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 121.673 -0.898 . . . . 0.0 110.029 167.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -84.17 137.77 33.34 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.659 -1.276 . . . . 0.0 111.661 173.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.779 0 C-N-CA 123.174 0.589 . . . . 0.0 111.74 169.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -72.94 88.94 1.38 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.352 0.661 . . . . 0.0 109.763 173.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -76.64 147.39 37.56 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 122.113 0.959 . . . . 0.0 110.675 168.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -131.83 172.93 11.7 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.902 1.681 . . . . 0.0 111.013 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.34 131.72 18.59 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.324 0.65 . . . . 0.0 110.232 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 68.9 mt -123.6 140.76 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.185 0.994 . . . . 0.0 109.021 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.3 m -63.88 97.4 0.16 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.22 1.008 . . . . 0.0 109.865 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.6 tt -54.19 -32.43 55.62 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.218 1.007 . . . . 0.0 111.571 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.18 -28.12 69.17 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -85.88 -33.27 21.29 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.35 0.977 . . . . 0.0 112.923 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 44.8 mt -58.45 -47.47 83.9 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.261 1.024 . . . . 0.0 110.19 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -53.93 -23.61 13.48 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 175.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 93.0 mttt . . . . . 0 N--CA 1.483 1.195 0 C-N-CA 124.672 1.189 . . . . 0.0 114.163 179.786 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? . . . . . 0 N--CA 1.465 0.312 0 CA-C-O 121.624 0.726 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -143.25 170.3 16.02 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.061 1.744 . . . . 0.0 110.664 169.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.29 134.26 34.1 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.668 -0.645 . . . . 0.0 110.435 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.1 m -130.16 163.54 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.237 1.415 . . . . 0.0 111.321 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -60.35 156.35 15.97 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.969 0.908 . . . . 0.0 111.649 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.3 tp -151.3 135.09 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.695 1.198 . . . . 0.0 109.282 172.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -126.59 156.81 40.31 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.43 1.892 . . . . 0.0 108.777 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -126.03 155.09 42.05 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.67 1.188 . . . . 0.0 111.196 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -80.12 118.49 21.87 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 168.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -67.43 178.04 1.71 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 122.326 1.06 . . . . 0.0 113.119 170.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -17.19 50.63 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.923 1.289 . . . . 0.0 113.589 176.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.2 m -95.73 1.78 53.56 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.61 1.164 . . . . 0.0 112.508 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.37 21.31 79.06 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-N 119.64 1.109 . . . . 0.0 114.494 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -102.2 137.24 40.72 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.646 1.178 . . . . 0.0 110.822 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -67.84 123.96 22.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.824 0.849 . . . . 0.0 110.35 170.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -140.7 143.09 34.85 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.705 1.202 . . . . 0.0 110.453 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -58.18 139.19 55.39 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.2 tp -114.68 -46.76 2.93 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.947 0.899 . . . . 0.0 111.181 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.76 -115.01 0.61 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 122.971 0.32 . . . . 0.0 113.212 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -147.64 153.84 39.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.055 1.342 . . . . 0.0 110.148 -174.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.6 tp -121.31 105.02 10.15 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.963 1.305 . . . . 0.0 110.033 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.8 t -76.27 94.15 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.923 1.289 . . . . 0.0 109.331 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 42.8 t -81.29 99.0 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.897 1.679 . . . . 0.0 109.071 173.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 . . . . . 0 CA--C 1.54 0.57 0 C-N-CA 125.189 1.395 . . . . 0.0 111.015 174.387 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.02 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.0 mt -122.22 136.06 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.965 0.906 . . . . 0.0 110.433 173.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -123.61 141.9 51.56 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.838 2.055 . . . . 0.0 111.984 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.5 p -137.19 136.78 38.48 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.217 -0.927 . . . . 0.0 112.341 -175.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.21 127.85 5.82 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.189 0.423 . . . . 0.0 112.79 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.06 135.58 51.02 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.689 1.596 . . . . 0.0 110.22 174.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 . . . . . 0 CA--C 1.549 0.906 0 C-N-CA 125.541 1.537 . . . . 0.0 110.815 -173.74 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.678 0 CA-C-O 120.639 0.257 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 57.2 m -57.86 132.71 54.17 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.248 -0.908 . . . . 0.0 109.387 168.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -99.54 -47.49 5.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.737 0.815 . . . . 0.0 110.541 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -166.62 169.25 13.79 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.744 1.218 . . . . 0.0 112.387 171.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.53 138.51 16.36 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.43 1.092 . . . . 0.0 112.347 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.428 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -118.73 160.0 22.65 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.649 1.58 . . . . 0.0 111.767 179.063 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -83.12 167.19 18.04 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.388 0.675 . . . . 0.0 112.324 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -57.67 -32.3 67.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.073 0.949 . . . . 0.0 112.666 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -70.11 -3.8 18.34 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.436 1.094 . . . . 0.0 113.849 175.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.0 t -119.79 -3.12 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.354 1.062 . . . . 0.0 111.046 -175.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 69.5 t -55.57 -61.78 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 120.461 -1.4 . . . . 0.0 111.635 -175.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -68.24 -25.0 64.97 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -54.0 40.51 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.425 1.49 . . . . 0.0 110.584 173.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -61.96 -44.23 97.19 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.35 1.46 . . . . 0.0 111.238 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 63.3 t -53.98 -36.72 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.519 1.128 . . . . 0.0 111.003 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -70.92 -54.05 12.79 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.848 1.259 . . . . 0.0 112.379 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -70.84 -21.01 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 O-C-N 120.786 -1.196 . . . . 0.0 112.568 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -5.11 58.79 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.093 1.757 . . . . 0.0 111.703 175.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.6 p -129.66 -14.77 4.06 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -136.61 -10.05 1.87 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.186 1.794 . . . . 0.0 113.932 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.42 155.18 10.93 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.722 1.63 . . . . 0.0 113.967 -175.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.64 -170.86 33.03 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.475 1.036 . . . . 0.0 113.641 -174.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.1 p -144.03 109.87 5.29 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.748 1.219 . . . . 0.0 113.527 -169.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -138.51 145.88 41.3 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.47 1.908 . . . . 0.0 109.986 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.51 147.15 42.1 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.078 -1.014 . . . . 0.0 111.754 175.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.6 p -106.58 168.1 9.4 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.603 1.561 . . . . 0.0 111.443 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.428 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 16.5 p -74.55 -39.63 62.18 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.524 -0.735 . . . . 0.0 111.118 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.0 mt -155.85 144.2 20.07 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.406 2.282 . . . . 0.0 110.605 -174.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -138.71 105.47 5.37 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.098 0.959 . . . . 0.0 111.263 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -89.42 -40.29 12.82 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.93 179.39 15.88 Favored Glycine 0 CA--C 1.545 1.928 0 C-N-CA 124.977 1.275 . . . . 0.0 114.142 -168.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 57.8 t80 . . . . . 0 CA--C 1.55 0.967 0 C-N-CA 124.261 1.024 . . . . 0.0 112.519 169.675 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.17 0 CA-C-O 122.251 0.917 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 35.2 mt -133.04 108.48 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 125.712 1.605 . . . . 0.0 107.17 172.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -68.74 145.86 53.44 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.069 0.462 . . . . 0.0 111.201 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 59.09 25.02 13.39 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.639 1.575 . . . . 0.0 114.262 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.52 130.55 43.55 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.022 1.329 . . . . 0.0 112.108 -172.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -78.75 117.97 20.37 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.972 0.909 . . . . 0.0 112.333 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 28.5 mm -108.69 118.73 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.063 0.945 . . . . 0.0 109.66 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 mp -109.98 98.51 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.212 1.405 . . . . 0.0 108.816 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 65.8 p -80.31 157.79 26.29 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.174 174.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -154.35 142.17 20.05 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.178 1.391 . . . . 0.0 111.744 172.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.7 mt -80.86 133.32 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.652 0.781 . . . . 0.0 109.222 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 CA--C 1.536 0.439 0 C-N-CA 125.604 1.562 . . . . 0.0 110.046 171.756 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 121.278 0.561 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -110.27 168.95 9.06 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.283 1.433 . . . . 0.0 110.526 173.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.2 tp -124.97 133.44 69.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 125.498 1.519 . . . . 0.0 108.474 172.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.4 p -120.55 156.99 30.43 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.547 0.739 . . . . 0.0 109.949 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -149.02 136.91 20.61 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.695 0.798 . . . . 0.0 111.626 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.6 m -75.15 107.43 7.23 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.787 1.235 . . . . 0.0 110.896 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.61 -164.24 39.54 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.554 1.073 . . . . 0.0 114.32 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -63.63 160.97 15.69 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.912 0.885 . . . . 0.0 111.475 170.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -76.86 131.95 38.88 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.187 -0.946 . . . . 0.0 110.331 172.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.468 0.472 0 C-N-CA 124.242 1.017 . . . . 0.0 111.294 173.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 120.967 0.413 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.24 93.76 0.33 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.618 1.167 . . . . 0.0 109.852 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -99.99 144.92 28.48 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 122.413 1.101 . . . . 0.0 111.462 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -137.63 174.26 10.78 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.751 1.62 . . . . 0.0 111.211 -172.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.31 133.22 20.17 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.479 0.712 . . . . 0.0 110.127 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 64.3 mt -125.21 140.83 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.153 0.981 . . . . 0.0 108.889 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.0 m -66.17 95.37 0.29 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.041 0.936 . . . . 0.0 109.511 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.1 tt -54.75 -31.87 59.15 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.738 1.215 . . . . 0.0 111.86 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -70.3 -26.29 63.72 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -89.31 -26.72 20.97 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.833 0.853 . . . . 0.0 112.439 174.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 23.6 mt -61.55 -48.59 80.29 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.057 0.943 . . . . 0.0 110.759 169.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -51.85 -37.61 52.75 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.365 1.066 . . . . 0.0 113.636 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -178.305 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt . . . . . 0 CA--C 1.534 0.359 0 CA-C-O 121.555 0.693 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -149.15 164.48 34.62 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.168 0.987 . . . . 0.0 110.261 170.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.74 123.49 25.0 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.566 0.222 . . . . 0.0 110.658 -178.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.5 m -120.53 161.75 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.2 1.4 . . . . 0.0 111.186 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -62.14 160.36 12.94 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.793 1.237 . . . . 0.0 111.303 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.3 tp -155.96 138.21 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.576 1.15 . . . . 0.0 109.339 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -130.98 161.94 30.85 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.221 1.808 . . . . 0.0 109.729 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -134.2 159.23 41.54 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.147 1.379 . . . . 0.0 111.704 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.17 119.62 25.76 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.283 0.633 . . . . 0.0 110.535 174.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -73.7 179.94 3.92 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.238 0.615 . . . . 0.0 112.41 174.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -58.05 -24.44 58.44 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.892 1.677 . . . . 0.0 113.435 173.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.9 m -78.93 -5.49 53.86 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.848 1.259 . . . . 0.0 113.806 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.42 32.84 84.81 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.289 0.947 . . . . 0.0 113.704 -171.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -116.64 141.98 47.49 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.792 1.637 . . . . 0.0 109.854 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -69.85 133.21 47.13 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.758 0.823 . . . . 0.0 111.26 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.3 t -145.54 142.98 29.67 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.931 1.293 . . . . 0.0 110.537 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -56.98 135.89 56.22 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.284 1.034 . . . . 0.0 112.415 -174.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.1 tp -109.12 -47.76 3.37 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.591 0.756 . . . . 0.0 111.731 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.24 -130.39 2.05 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 121.712 0.618 . . . . 0.0 113.713 -175.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -137.06 152.6 50.24 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.528 1.931 . . . . 0.0 110.8 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.5 tp -119.79 104.61 10.37 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.427 1.491 . . . . 0.0 110.806 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.43 99.86 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.388 1.075 . . . . 0.0 109.544 175.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.2 t -85.11 128.06 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.161 1.385 . . . . 0.0 109.633 173.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 . . . . . 0 N--CA 1.473 0.718 0 C-N-CA 127.193 2.197 . . . . 0.0 110.137 -175.647 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.116 0 CA-C-O 121.279 0.377 . . . . 0.0 113.882 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.4 mt -112.45 139.55 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.709 0.804 . . . . 0.0 109.116 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -127.2 139.76 52.71 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.822 0.849 . . . . 0.0 110.094 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.1 p -132.09 137.27 47.68 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.59 0.756 . . . . 0.0 111.025 -173.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.29 110.48 0.83 Allowed Glycine 0 CA--C 1.52 0.387 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -170.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 32.0 tp -64.0 148.11 50.45 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.979 1.312 . . . . 0.0 110.345 175.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.3 t30 . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 126.044 1.738 . . . . 0.0 109.603 176.901 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.631 0 CA-C-O 120.692 0.282 . . . . 0.0 111.401 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.9 m -58.74 116.45 3.74 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.33 -0.856 . . . . 0.0 109.144 169.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -81.99 -52.29 7.19 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.624 0.647 . . . . 0.0 109.841 -178.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -166.19 162.44 17.55 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.94 1.296 . . . . 0.0 112.383 170.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.58 156.81 44.7 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.956 1.303 . . . . 0.0 111.399 177.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.415 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -140.97 157.93 44.65 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.104 1.362 . . . . 0.0 112.282 -177.36 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -77.09 165.34 24.72 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.535 0.734 . . . . 0.0 112.021 -173.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -57.47 -30.0 64.69 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.318 -0.864 . . . . 0.0 112.357 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -69.98 -8.31 47.98 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.549 1.54 . . . . 0.0 114.027 175.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 t -119.26 -4.38 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.777 1.231 . . . . 0.0 111.3 -173.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.3 t -50.31 -66.47 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 125.169 1.388 . . . . 0.0 111.663 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -67.69 -24.42 65.41 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.38 -51.96 63.66 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.104 1.362 . . . . 0.0 110.511 173.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -60.17 -44.13 95.29 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 124.84 1.256 . . . . 0.0 111.926 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 92.4 t -55.58 -36.25 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 122.967 0.507 . . . . 0.0 110.855 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.7 tttp -68.29 -54.94 14.04 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.534 1.133 . . . . 0.0 112.678 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -72.7 -14.6 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 121.063 -1.023 . . . . 0.0 112.518 -174.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.07 -6.41 57.95 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.544 1.537 . . . . 0.0 112.081 176.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 44.4 p -130.5 -14.89 3.65 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -131.74 -9.57 3.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.612 1.565 . . . . 0.0 113.849 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.4 156.5 7.95 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.473 1.511 . . . . 0.0 113.683 -176.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.1 -169.04 34.69 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.993 0.806 . . . . 0.0 113.966 -175.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 61.6 p -146.32 94.72 2.5 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.389 1.075 . . . . 0.0 113.488 -167.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -128.49 140.14 51.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.667 1.587 . . . . 0.0 109.885 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -69.45 153.17 43.95 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.454 0.701 . . . . 0.0 110.947 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.8 p -115.11 160.86 19.15 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.76 1.624 . . . . 0.0 110.942 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 82.4 p -76.38 -39.17 54.43 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.391 -0.818 . . . . 0.0 111.019 -177.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.3 mt -153.45 138.71 17.49 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.37 1.868 . . . . 0.0 111.694 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -137.45 101.6 4.55 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.246 1.018 . . . . 0.0 111.005 176.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -91.72 -36.87 13.35 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 174.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.42 -176.13 48.18 Favored Glycine 0 CA--C 1.544 1.86 0 CA-C-N 118.936 0.789 . . . . 0.0 113.902 -170.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.2 t80 . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -178.643 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.234 0 CA-C-O 122.088 0.826 . . . . 0.0 113.649 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.6 mt -133.47 103.24 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.31 1.444 . . . . 0.0 107.651 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -67.01 143.58 56.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.189 0.518 . . . . 0.0 110.834 173.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 61.82 19.33 10.51 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.468 1.507 . . . . 0.0 114.381 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 16.4 tptp -53.62 123.88 13.48 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.893 1.277 . . . . 0.0 111.456 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -70.86 127.48 32.76 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.952 0.901 . . . . 0.0 110.388 170.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.7 mm -124.88 116.53 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.386 1.075 . . . . 0.0 108.48 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.8 mp -110.31 92.42 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.006 1.322 . . . . 0.0 108.379 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.1 p -75.03 154.91 37.78 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.123 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -150.68 139.38 20.71 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.948 1.299 . . . . 0.0 111.135 174.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.4 mt -81.93 132.85 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 . . . . . 0 N--CA 1.466 0.353 0 C-N-CA 125.273 1.429 . . . . 0.0 110.126 174.33 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 . . . . . 0 CA--C 1.543 0.685 0 CA-C-O 121.057 0.456 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -106.38 166.15 10.75 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.271 1.428 . . . . 0.0 110.607 170.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.8 tp -118.66 138.19 50.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 125.525 1.53 . . . . 0.0 108.207 169.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.1 p -127.34 156.82 41.39 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.619 0.767 . . . . 0.0 109.933 174.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -150.79 146.14 26.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.13 0.972 . . . . 0.0 111.235 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 p -78.71 109.56 13.06 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.735 1.214 . . . . 0.0 111.402 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.43 -165.23 32.23 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 123.897 0.761 . . . . 0.0 113.204 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -65.33 164.3 13.85 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 122.254 1.026 . . . . 0.0 112.481 170.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -84.34 106.06 15.66 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.159 1.383 . . . . 0.0 111.172 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 121.413 0.625 . . . . 0.0 112.093 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.476 0.828 0 CA-C-O 120.541 0.21 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.25 94.94 0.55 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.432 0.693 . . . . 0.0 109.442 172.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -92.31 145.45 24.47 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 122.164 0.983 . . . . 0.0 111.288 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -136.25 169.99 16.75 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.739 1.616 . . . . 0.0 111.112 -172.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.86 134.6 23.53 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 122.97 0.508 . . . . 0.0 110.495 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 59.7 mt -126.75 139.19 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.807 0.843 . . . . 0.0 109.263 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.5 m -63.09 96.9 0.1 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.232 1.013 . . . . 0.0 109.791 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.35 -31.39 61.71 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.471 1.109 . . . . 0.0 111.884 177.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -67.86 -29.43 68.56 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -88.41 -18.88 27.39 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.036 0.934 . . . . 0.0 112.64 174.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 20.0 mt -70.92 -46.38 62.59 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.476 -0.765 . . . . 0.0 110.173 168.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -49.43 -48.26 47.46 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.851 1.26 . . . . 0.0 113.538 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 30.6 pttt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -177.625 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 pttm . . . . . 0 N--CA 1.475 0.807 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -154.74 170.69 21.01 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.471 1.109 . . . . 0.0 111.931 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.87 134.08 44.13 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.217 0.607 . . . . 0.0 111.261 174.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.9 m -131.13 164.19 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 125.793 1.637 . . . . 0.0 111.33 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.22 160.41 13.06 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.626 1.17 . . . . 0.0 112.111 177.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 tp -155.29 137.0 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.321 1.448 . . . . 0.0 109.963 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -127.33 159.76 33.42 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.607 1.963 . . . . 0.0 109.547 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -128.88 159.69 35.01 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.79 1.236 . . . . 0.0 111.493 176.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -87.47 118.21 26.78 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.459 0.304 . . . . 0.0 110.868 173.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -69.52 178.08 2.64 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.958 0.885 . . . . 0.0 112.712 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -60.25 -22.65 63.31 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.158 1.783 . . . . 0.0 115.035 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.8 t -85.52 -4.87 59.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.95 0.9 . . . . 0.0 112.608 174.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.4 32.35 57.99 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 121.108 -0.995 . . . . 0.0 113.299 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -109.6 142.04 41.27 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.964 1.306 . . . . 0.0 110.72 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -76.14 122.06 23.76 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.594 0.758 . . . . 0.0 110.937 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.5 t -137.43 139.39 40.64 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.135 1.374 . . . . 0.0 110.32 -175.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -57.63 141.24 48.91 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -176.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.1 tp -114.56 -47.74 2.89 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.659 0.783 . . . . 0.0 111.023 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.92 -116.27 0.64 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 123.378 0.514 . . . . 0.0 113.044 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -146.33 156.25 43.21 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.693 1.597 . . . . 0.0 109.729 -176.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.8 tp -121.16 102.27 8.2 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.153 1.381 . . . . 0.0 110.29 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.82 101.19 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.083 0.953 . . . . 0.0 109.02 171.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.9 t -88.35 127.07 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.274 1.43 . . . . 0.0 109.803 172.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 . . . . . 0 N--CA 1.475 0.782 0 C-N-CA 127.697 2.399 . . . . 0.0 110.928 -175.327 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.277 0 N-CA-C 115.096 0.799 . . . . 0.0 115.096 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 69.1 mt -113.37 142.17 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.345 1.058 . . . . 0.0 109.922 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -131.77 139.6 48.98 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.211 1.805 . . . . 0.0 109.315 -177.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.8 p -131.74 146.53 52.21 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.318 -0.864 . . . . 0.0 111.549 -171.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.45 124.0 2.41 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-O 121.699 0.61 . . . . 0.0 113.088 -177.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.72 136.18 52.47 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.434 1.894 . . . . 0.0 110.189 175.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.2 t30 . . . . . 0 CA--C 1.547 0.848 0 C-N-CA 126.367 1.867 . . . . 0.0 110.475 -175.249 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 112.278 0.474 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.2 m -55.02 135.04 49.25 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.279 -0.888 . . . . 0.0 110.468 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -102.89 -52.6 3.03 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.796 1.238 . . . . 0.0 109.89 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -163.07 162.66 25.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.824 0.85 . . . . 0.0 112.65 170.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.25 141.31 27.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.718 0.807 . . . . 0.0 111.538 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.48 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.8 OUTLIER -121.38 156.72 32.04 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.365 1.866 . . . . 0.0 111.501 -176.305 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -75.79 163.46 27.23 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.578 0.704 . . . . 0.0 112.608 -176.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -54.93 -28.03 47.91 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.038 1.335 . . . . 0.0 113.596 171.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -72.01 -15.65 62.05 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 121.104 -0.998 . . . . 0.0 113.251 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.6 t -106.32 -5.25 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.744 1.217 . . . . 0.0 110.671 -171.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.5 m -53.8 -35.03 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -96.79 -23.33 16.45 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.677 0.791 . . . . 0.0 112.307 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -68.69 -48.87 62.8 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.623 1.569 . . . . 0.0 111.318 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -60.71 -43.28 97.99 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.271 1.428 . . . . 0.0 111.338 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.7 t -53.69 -42.76 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.247 1.019 . . . . 0.0 109.914 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -60.84 -56.08 25.38 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.416 1.086 . . . . 0.0 112.313 175.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 m -72.86 -3.34 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 121.02 -1.05 . . . . 0.0 113.456 -177.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.46 -3.83 19.08 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.543 1.937 . . . . 0.0 111.902 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.7 p -129.81 -13.26 4.18 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.253 1.421 . . . . 0.0 113.29 172.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -134.03 -14.71 2.35 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.076 1.75 . . . . 0.0 114.116 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.16 154.82 11.74 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 124.797 1.189 . . . . 0.0 114.26 -176.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.28 -158.35 30.39 Favored Glycine 0 CA--C 1.533 1.162 0 O-C-N 121.58 -0.953 . . . . 0.0 114.073 -176.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.6 p -151.38 105.02 3.14 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -174.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -136.56 157.97 45.54 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.481 1.913 . . . . 0.0 110.537 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -83.58 161.57 21.12 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.16 -0.963 . . . . 0.0 111.996 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.4 p -122.96 158.59 30.12 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.853 1.661 . . . . 0.0 110.225 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.48 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 88.3 p -68.8 -36.49 78.33 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.768 -1.207 . . . . 0.0 111.139 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.4 mt -148.49 159.59 43.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.984 2.114 . . . . 0.0 111.604 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -149.93 112.47 4.73 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.475 1.11 . . . . 0.0 110.473 170.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -96.27 -47.58 5.96 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.978 0.911 . . . . 0.0 112.465 174.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.84 178.68 27.21 Favored Glycine 0 CA--C 1.544 1.856 0 C-N-CA 125.757 1.646 . . . . 0.0 113.993 -169.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 45.2 t80 . . . . . 0 CA--C 1.549 0.917 0 O-C-N 121.311 -1.111 . . . . 0.0 113.44 175.222 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.624 0 CA-C-O 121.603 0.557 . . . . 0.0 114.074 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 68.9 mt -112.38 114.61 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.721 1.608 . . . . 0.0 108.319 175.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -70.64 147.64 48.94 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.004 -0.435 . . . . 0.0 111.42 173.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 58.79 22.89 10.6 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.91 1.684 . . . . 0.0 114.465 175.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -65.8 130.7 44.2 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.297 1.439 . . . . 0.0 112.068 -171.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -79.68 122.55 26.69 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.586 1.155 . . . . 0.0 112.723 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 28.5 mm -113.93 117.66 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.419 1.088 . . . . 0.0 110.002 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mp -107.85 101.06 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.228 1.411 . . . . 0.0 107.889 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.5 p -87.08 160.61 18.51 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.585 0.707 . . . . 0.0 111.578 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -152.82 139.78 19.15 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.702 1.201 . . . . 0.0 111.191 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.9 mt -78.49 132.14 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 173.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 . . . . . 0 N--CA 1.465 0.316 0 C-N-CA 125.387 1.475 . . . . 0.0 110.088 174.183 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 CA--C 1.54 0.582 0 CA-C-O 121.192 0.52 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -106.64 167.29 9.96 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.09 1.356 . . . . 0.0 110.387 170.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.8 tp -118.77 136.92 54.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.398 1.479 . . . . 0.0 108.114 169.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.1 p -125.71 159.38 32.45 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.717 0.807 . . . . 0.0 110.151 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -149.81 144.8 26.23 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.965 0.906 . . . . 0.0 111.709 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.3 p -82.28 112.48 19.31 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.767 1.227 . . . . 0.0 111.057 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.1 -163.75 38.99 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.286 0.946 . . . . 0.0 113.158 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -72.02 168.92 17.06 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.583 0.706 . . . . 0.0 111.545 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -72.04 131.55 43.03 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.12 -0.988 . . . . 0.0 110.939 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 121.335 0.588 . . . . 0.0 112.295 172.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.476 0.863 0 CA-C-O 120.823 0.344 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.1 105.66 2.53 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.654 0.781 . . . . 0.0 109.284 175.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -109.05 144.57 36.89 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 122.087 0.946 . . . . 0.0 111.09 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -135.6 168.28 19.55 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.443 1.497 . . . . 0.0 111.536 -171.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.64 132.18 20.97 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.122 0.569 . . . . 0.0 110.004 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 66.3 mt -123.95 140.2 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.82 0.848 . . . . 0.0 108.766 176.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.2 m -65.49 95.43 0.21 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.833 0.853 . . . . 0.0 109.432 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.67 -32.64 52.41 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.577 1.151 . . . . 0.0 111.767 176.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -67.86 -25.81 65.72 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -86.35 -34.06 20.36 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.584 1.153 . . . . 0.0 112.237 171.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 22.7 mt -58.65 -43.47 89.82 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.211 -0.931 . . . . 0.0 111.277 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -53.98 -33.0 55.78 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.487 1.115 . . . . 0.0 113.816 174.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 61.2 mttm . . . . . 0 N--CA 1.48 1.058 0 C-N-CA 125.281 1.433 . . . . 0.0 114.205 179.039 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.1 pttt . . . . . 0 N--CA 1.469 0.496 0 CA-C-O 121.141 0.496 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -156.4 165.67 35.67 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.913 0.885 . . . . 0.0 110.338 170.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.56 134.33 48.6 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.2 m -132.06 161.52 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.082 1.353 . . . . 0.0 112.097 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -67.47 141.63 56.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.359 1.063 . . . . 0.0 110.268 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.2 tp -138.7 135.73 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.33 1.452 . . . . 0.0 108.751 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -128.86 161.56 29.55 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.152 1.781 . . . . 0.0 109.38 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -129.96 155.13 46.58 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.017 1.327 . . . . 0.0 111.043 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.7 118.49 22.3 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 169.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.5 p30 -68.21 178.47 1.89 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.466 1.127 . . . . 0.0 113.54 171.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -58.18 -11.83 2.99 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.355 1.862 . . . . 0.0 114.846 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.9 t -107.57 4.14 25.68 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.236 1.414 . . . . 0.0 112.514 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.69 22.35 78.41 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 120.643 -1.286 . . . . 0.0 114.505 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -105.05 138.9 40.54 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.486 1.143 . . . . 0.0 110.932 174.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -69.93 126.42 29.66 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.108 0.963 . . . . 0.0 110.538 173.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 t -142.14 143.71 33.13 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.963 1.305 . . . . 0.0 110.324 -177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -54.65 135.61 46.54 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.726 0.811 . . . . 0.0 113.048 -176.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.0 tp -111.55 -49.88 2.97 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.058 0.943 . . . . 0.0 111.075 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.57 -131.47 2.07 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 121.395 0.442 . . . . 0.0 114.108 -173.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.79 135.29 29.52 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.255 1.422 . . . . 0.0 110.123 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -106.19 108.66 20.29 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.291 1.436 . . . . 0.0 109.224 -176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.7 t -85.95 96.53 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.797 1.239 . . . . 0.0 109.295 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.6 t -71.46 110.18 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.154 0.981 . . . . 0.0 109.286 168.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 66.8 mtp85 . . . . . 0 N--CA 1.475 0.805 0 C-N-CA 127.122 2.169 . . . . 0.0 110.217 -178.624 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.701 0 N-CA-C 114.344 0.498 . . . . 0.0 114.344 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 70.1 mt -128.48 137.21 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.275 1.03 . . . . 0.0 108.919 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.07 146.32 46.04 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.336 1.454 . . . . 0.0 108.879 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 75.9 p -132.58 143.25 49.58 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.198 -0.939 . . . . 0.0 110.205 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.77 136.13 8.15 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -92.49 131.55 37.54 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.666 1.987 . . . . 0.0 109.94 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 . . . . . 0 CA--C 1.543 0.68 0 C-N-CA 125.204 1.401 . . . . 0.0 110.459 -174.208 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 51.9 m -59.48 123.42 16.77 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.403 -0.811 . . . . 0.0 109.039 168.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -87.3 -50.37 6.63 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.866 0.466 . . . . 0.0 110.124 -176.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -166.38 164.2 17.44 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.251 1.02 . . . . 0.0 112.977 172.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 p -150.32 147.48 27.68 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.859 1.314 . . . . 0.0 113.227 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.58 162.69 31.23 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.269 1.428 . . . . 0.0 111.656 -177.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -81.93 166.7 19.65 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.582 0.753 . . . . 0.0 112.368 -175.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -55.79 -34.19 65.06 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.07 -1.019 . . . . 0.0 112.423 175.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -67.98 -3.28 9.52 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.461 1.505 . . . . 0.0 113.913 175.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 t -122.09 -3.39 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.318 1.047 . . . . 0.0 111.567 -177.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.2 t -53.22 -65.44 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 120.492 -1.38 . . . . 0.0 110.863 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -64.7 -27.74 69.12 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.744 -0.597 . . . . 0.0 112.227 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.33 -53.54 53.55 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.72 1.608 . . . . 0.0 110.359 174.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -62.99 -42.39 99.84 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.475 1.11 . . . . 0.0 111.937 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 92.7 t -58.5 -37.04 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 122.885 0.474 . . . . 0.0 110.844 176.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -64.71 -55.02 22.58 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.61 1.164 . . . . 0.0 112.784 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.7 -9.6 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 121.577 -0.702 . . . . 0.0 112.28 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 20.8 ttm -95.73 -4.72 43.59 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.589 -1.319 . . . . 0.0 112.934 177.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.9 p -127.49 -13.1 5.5 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.725 0.81 . . . . 0.0 112.875 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -131.54 -12.11 3.48 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.522 1.529 . . . . 0.0 114.434 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.19 155.96 9.85 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.074 1.321 . . . . 0.0 113.662 -175.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 156.21 -168.3 33.55 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.357 0.979 . . . . 0.0 113.556 -175.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 36.0 p -146.51 105.83 3.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.483 1.113 . . . . 0.0 113.463 -168.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -136.32 143.55 44.21 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.162 1.785 . . . . 0.0 110.246 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -74.84 153.05 38.88 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.543 -0.723 . . . . 0.0 111.297 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.4 p -118.87 135.86 54.34 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.327 1.451 . . . . 0.0 110.875 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.6 t -48.15 -42.25 29.0 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.103 1.361 . . . . 0.0 113.235 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.4 mt -147.53 145.51 29.11 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.67 1.588 . . . . 0.0 112.769 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -143.89 101.18 3.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.272 1.029 . . . . 0.0 110.783 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -91.99 -37.16 12.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.157 0.983 . . . . 0.0 113.298 176.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.75 -176.95 8.42 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.414 1.483 . . . . 0.0 114.824 -172.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.0 t80 . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 174.065 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.365 0 CA-C-O 121.724 0.625 . . . . 0.0 113.356 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.3 mt -121.34 116.22 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.228 1.411 . . . . 0.0 108.078 173.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -68.34 140.56 55.9 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.977 0.418 . . . . 0.0 111.617 170.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 55.41 29.34 12.97 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.878 1.671 . . . . 0.0 114.279 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -59.52 127.75 33.62 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.804 1.242 . . . . 0.0 111.564 -175.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -75.79 119.5 19.87 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.017 0.527 . . . . 0.0 111.336 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.5 mm -112.16 116.82 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.832 1.253 . . . . 0.0 109.08 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.12 97.97 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 124.724 1.21 . . . . 0.0 108.491 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 43.0 p -76.97 159.58 29.84 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.87 174.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -153.3 142.49 21.44 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.791 1.236 . . . . 0.0 111.061 170.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mt -83.32 135.03 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.402 0.681 . . . . 0.0 109.245 174.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 . . . . . 0 N--CA 1.469 0.486 0 C-N-CA 124.887 1.275 . . . . 0.0 111.195 174.103 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 CA--C 1.541 0.619 0 CA-C-O 121.253 0.549 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -108.72 166.3 10.91 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.919 1.688 . . . . 0.0 110.62 170.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.2 tp -116.13 135.04 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.769 1.628 . . . . 0.0 108.043 169.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.1 p -125.31 155.8 39.65 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.547 0.739 . . . . 0.0 109.957 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -146.4 138.37 24.89 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.795 0.838 . . . . 0.0 111.221 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.0 p -75.69 113.38 13.07 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.325 1.05 . . . . 0.0 111.202 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.17 -156.59 26.5 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.577 1.084 . . . . 0.0 113.014 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.26 -174.05 0.34 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.04 0.936 . . . . 0.0 112.991 169.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -100.51 113.98 27.21 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.141 0.976 . . . . 0.0 111.716 169.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.766 0 C-N-CA 124.074 0.95 . . . . 0.0 112.25 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.42 86.85 1.53 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.09 0.556 . . . . 0.0 110.475 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -90.21 145.3 25.12 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.524 1.154 . . . . 0.0 112.057 172.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -138.75 169.0 18.57 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 126.359 1.863 . . . . 0.0 110.857 -173.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.44 132.26 21.33 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.079 0.551 . . . . 0.0 110.246 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 58.2 mt -125.06 139.98 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.145 0.978 . . . . 0.0 108.871 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.0 m -67.16 95.21 0.39 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.477 -0.764 . . . . 0.0 110.048 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.23 -33.52 41.78 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.574 1.15 . . . . 0.0 111.766 176.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -67.2 -29.56 69.26 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -84.82 -27.54 26.72 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.175 0.99 . . . . 0.0 111.859 172.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 40.8 mt -68.01 -43.01 79.8 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.558 0.743 . . . . 0.0 110.158 175.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 15.3 mtmt -57.32 -20.0 25.93 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.6 mttt . . . . . 0 N--CA 1.481 1.08 0 C-N-CA 124.502 1.121 . . . . 0.0 114.021 178.049 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.0 pttt . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 120.886 0.374 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -143.8 171.02 14.79 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.027 0.931 . . . . 0.0 110.786 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -142.26 122.35 13.75 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.699 -0.626 . . . . 0.0 110.77 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.6 m -123.76 161.24 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 126.351 1.86 . . . . 0.0 111.095 -176.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 160.09 13.72 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.535 0.734 . . . . 0.0 112.496 176.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.0 tp -152.72 138.5 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.712 1.605 . . . . 0.0 109.085 174.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -129.14 159.33 36.36 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.613 1.965 . . . . 0.0 109.333 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -134.86 160.94 36.63 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.731 1.213 . . . . 0.0 111.866 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.67 119.81 25.23 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.603 0.361 . . . . 0.0 110.619 172.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.9 p30 -68.81 177.08 2.71 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 122.636 1.208 . . . . 0.0 113.625 170.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.8 mtmm -58.25 -23.16 55.07 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.107 1.763 . . . . 0.0 113.337 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 m -84.03 -11.18 57.15 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.013 1.325 . . . . 0.0 113.076 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.72 33.38 42.55 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.201 1.381 . . . . 0.0 114.291 -175.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -120.72 145.65 47.28 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.363 1.465 . . . . 0.0 111.18 175.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -67.76 130.83 44.23 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.708 0.803 . . . . 0.0 111.054 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.4 t -143.12 142.84 31.61 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.824 1.249 . . . . 0.0 110.652 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -56.41 132.47 51.23 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.252 1.021 . . . . 0.0 112.342 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.9 tp -108.12 -49.87 3.13 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.571 0.749 . . . . 0.0 111.22 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.47 -119.05 0.82 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.761 0.696 . . . . 0.0 112.916 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -143.05 158.09 43.93 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.589 1.555 . . . . 0.0 111.064 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.8 tp -122.47 103.75 8.92 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.861 1.664 . . . . 0.0 110.137 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.1 t -74.73 98.85 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.572 1.149 . . . . 0.0 109.383 172.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.8 t -87.07 115.47 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.717 1.207 . . . . 0.0 110.057 173.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 . . . . . 0 N--CA 1.476 0.828 0 C-N-CA 126.906 2.083 . . . . 0.0 110.359 178.233 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.77 0 CA-C-O 121.501 0.501 . . . . 0.0 113.709 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.9 mt -117.77 142.55 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.669 0.788 . . . . 0.0 109.168 173.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -131.28 136.06 47.84 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.762 1.225 . . . . 0.0 109.138 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.6 p -129.4 150.27 50.83 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.516 0.727 . . . . 0.0 111.636 -171.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -144.32 122.73 1.85 Allowed Glycine 0 C--N 1.335 0.506 0 O-C-N 121.746 -0.596 . . . . 0.0 112.446 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -65.87 136.37 56.05 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.291 1.436 . . . . 0.0 109.621 174.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 . . . . . 0 CA--C 1.542 0.673 0 C-N-CA 126.891 2.076 . . . . 0.0 108.964 178.016 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.3 m -55.61 128.38 34.35 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 121.269 -0.895 . . . . 0.0 110.281 170.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -95.53 -51.6 4.48 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.345 0.658 . . . . 0.0 110.151 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -164.8 163.17 21.31 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.025 0.93 . . . . 0.0 112.527 170.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.05 146.79 31.08 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.005 1.322 . . . . 0.0 111.94 177.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.434 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -128.13 160.06 33.2 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.795 1.638 . . . . 0.0 111.429 -176.471 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -78.29 164.82 24.54 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.468 0.707 . . . . 0.0 112.299 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -56.67 -33.76 66.69 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.352 1.461 . . . . 0.0 114.496 174.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -69.78 -9.64 55.34 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.581 1.153 . . . . 0.0 112.957 173.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.8 t -112.51 -8.09 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.294 1.038 . . . . 0.0 111.054 -173.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.5 t -46.62 -67.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 125.623 1.569 . . . . 0.0 111.905 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -67.22 -26.97 66.87 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.501 -0.749 . . . . 0.0 112.737 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -63.56 -52.08 62.61 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.701 1.6 . . . . 0.0 110.703 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -59.47 -46.7 88.04 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 125.476 1.51 . . . . 0.0 111.031 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 82.8 t -56.19 -36.15 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.468 0.707 . . . . 0.0 110.806 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -65.87 -54.47 26.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.857 1.263 . . . . 0.0 112.659 174.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 m -71.55 -16.88 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 120.913 -1.117 . . . . 0.0 112.539 -176.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.32 -5.2 58.99 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.169 1.788 . . . . 0.0 111.693 177.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 65.0 p -128.56 -15.05 4.56 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -134.18 -10.02 2.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.493 1.517 . . . . 0.0 114.183 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.49 156.31 10.89 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.642 1.592 . . . . 0.0 113.96 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 157.66 -166.01 33.71 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.129 0.871 . . . . 0.0 113.838 -175.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 61.2 p -148.56 103.26 3.39 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -170.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -134.76 143.68 47.26 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.05 1.74 . . . . 0.0 110.137 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -71.15 162.73 28.94 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.457 -0.777 . . . . 0.0 111.636 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 81.5 p -127.43 154.12 45.43 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.441 1.497 . . . . 0.0 110.972 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.434 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 82.4 p -71.07 -38.79 72.46 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.427 -0.796 . . . . 0.0 111.103 -177.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.2 mt -152.83 140.37 19.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.71 2.004 . . . . 0.0 111.468 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -134.5 102.57 5.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.999 0.92 . . . . 0.0 110.046 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -87.49 -46.88 9.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.51 1.124 . . . . 0.0 112.76 175.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.43 173.99 34.51 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.204 1.383 . . . . 0.0 113.636 -168.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.8 t80 . . . . . 0 CA--C 1.546 0.827 0 C-N-CA 124.122 0.969 . . . . 0.0 111.922 169.568 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.366 0 CA-C-O 121.447 0.471 . . . . 0.0 113.475 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.6 mt -113.38 112.95 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.073 1.349 . . . . 0.0 108.168 176.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -74.18 147.92 42.13 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.015 0.436 . . . . 0.0 111.384 172.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 59.31 21.91 10.2 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.659 1.583 . . . . 0.0 113.976 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -63.24 126.31 26.99 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.954 1.302 . . . . 0.0 111.515 -172.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -74.88 122.36 23.28 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.36 1.464 . . . . 0.0 112.267 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.5 mm -118.48 118.02 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.184 0.993 . . . . 0.0 109.835 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.7 92.64 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.485 1.514 . . . . 0.0 109.18 -177.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.2 p -74.86 156.58 36.29 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.498 174.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -153.48 142.7 21.46 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.182 1.393 . . . . 0.0 111.646 173.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 21.8 mt -81.49 132.02 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.068 0.547 . . . . 0.0 109.721 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 CA--C 1.538 0.489 0 C-N-CA 125.694 1.598 . . . . 0.0 110.232 173.833 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -109.17 167.88 9.78 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.471 1.508 . . . . 0.0 110.447 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.4 tp -123.16 132.04 72.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 125.331 1.452 . . . . 0.0 108.31 171.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.2 p -120.25 152.64 37.46 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.588 0.755 . . . . 0.0 109.878 177.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -145.63 147.55 32.14 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.306 0.574 . . . . 0.0 111.602 178.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.5 p -73.06 109.69 6.79 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.272 1.029 . . . . 0.0 111.21 174.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.77 -166.47 30.61 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 122.139 0.855 . . . . 0.0 113.232 172.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -65.65 162.0 19.34 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.148 0.979 . . . . 0.0 113.015 170.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -84.3 101.09 11.67 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.866 1.266 . . . . 0.0 111.853 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.68 0 C-N-CA 123.458 0.703 . . . . 0.0 112.574 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.7 m . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 120.502 0.191 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.59 83.2 0.42 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.338 1.055 . . . . 0.0 110.478 176.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -81.08 141.92 33.84 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 122.157 0.979 . . . . 0.0 111.717 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -135.31 169.71 17.06 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.73 1.612 . . . . 0.0 111.534 -173.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.35 132.55 18.38 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.576 0.75 . . . . 0.0 110.446 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 68.0 mt -124.98 141.5 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.09 0.956 . . . . 0.0 108.88 177.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.3 m -66.33 93.44 0.22 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.64 1.176 . . . . 0.0 110.194 176.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.4 tt -54.98 -30.81 60.02 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.226 1.41 . . . . 0.0 112.45 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -71.65 -30.51 65.82 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -82.64 -30.7 29.2 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.01 0.924 . . . . 0.0 112.237 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 20.7 mt -57.22 -49.77 74.96 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.914 0.886 . . . . 0.0 110.779 173.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -50.45 -38.21 42.38 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.263 1.025 . . . . 0.0 113.391 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.889 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.303 0 CA-C-O 121.132 0.492 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -150.2 167.09 27.9 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.069 0.948 . . . . 0.0 110.921 173.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -131.15 131.0 43.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.855 0.462 . . . . 0.0 111.037 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 m -129.34 167.85 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 126.179 1.791 . . . . 0.0 111.026 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -65.3 166.78 9.4 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.741 1.217 . . . . 0.0 111.943 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.4 tp -161.82 135.72 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.128 1.371 . . . . 0.0 109.933 172.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -129.07 160.11 33.82 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.509 1.924 . . . . 0.0 109.324 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -127.19 160.25 31.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.337 1.455 . . . . 0.0 111.072 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -81.49 121.82 26.76 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 122.048 -0.407 . . . . 0.0 110.565 171.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -64.09 175.47 1.23 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.411 1.085 . . . . 0.0 112.105 171.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -59.76 -13.73 11.52 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.692 1.997 . . . . 0.0 114.737 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.6 m -117.05 15.55 15.06 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.932 1.293 . . . . 0.0 112.771 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.13 20.84 77.0 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 121.203 -0.936 . . . . 0.0 114.378 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -96.46 127.62 42.63 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.609 1.164 . . . . 0.0 109.485 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -69.05 125.92 28.19 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.633 -0.667 . . . . 0.0 110.639 174.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.2 t -141.78 138.32 32.19 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.851 1.26 . . . . 0.0 111.009 -172.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -57.67 137.19 56.7 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.142 0.977 . . . . 0.0 112.979 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 44.4 tp -111.03 -46.33 3.34 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.827 0.851 . . . . 0.0 111.723 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.47 -121.95 0.95 Allowed Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.351 0.501 . . . . 0.0 113.327 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -147.49 153.44 39.53 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.308 1.443 . . . . 0.0 110.482 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.8 tp -118.84 107.57 13.77 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.121 1.368 . . . . 0.0 111.005 -176.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.7 t -82.48 102.28 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.705 1.202 . . . . 0.0 108.327 173.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.07 103.25 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.769 1.628 . . . . 0.0 109.448 176.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 . . . . . 0 N--CA 1.478 0.934 0 C-N-CA 125.859 1.664 . . . . 0.0 110.965 -178.221 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.225 0 N-CA-C 115.965 1.146 . . . . 0.0 115.965 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.5 mt -121.91 136.57 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.327 1.051 . . . . 0.0 109.304 173.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.04 117.19 19.64 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 126.413 1.885 . . . . 0.0 109.411 -175.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.2 p -106.24 149.78 26.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.012 0.925 . . . . 0.0 111.32 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.09 128.32 3.84 Favored Glycine 0 C--N 1.336 0.581 0 O-C-N 121.265 -0.897 . . . . 0.0 111.876 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -85.3 127.75 34.44 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 127.157 2.183 . . . . 0.0 110.623 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 . . . . . 0 CA--C 1.538 0.509 0 C-N-CA 125.761 1.624 . . . . 0.0 109.748 -174.25 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.615 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.9 m -55.39 122.86 12.12 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.876 0.87 . . . . 0.0 110.366 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -91.15 -49.91 6.13 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.78 0.432 . . . . 0.0 110.015 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -160.36 171.12 19.68 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.764 0.792 . . . . 0.0 113.093 171.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.3 136.97 12.25 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.397 -0.815 . . . . 0.0 112.764 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.44 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -132.03 155.31 48.26 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.464 1.906 . . . . 0.0 111.188 -174.373 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -79.44 168.04 20.01 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.384 0.674 . . . . 0.0 112.598 -171.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -57.63 -34.3 69.17 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.425 1.09 . . . . 0.0 112.328 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -63.2 -16.33 59.8 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.643 1.577 . . . . 0.0 114.023 171.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.4 t -111.18 -8.25 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.603 1.161 . . . . 0.0 111.087 -173.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.7 t -47.78 -64.62 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 125.726 1.611 . . . . 0.0 111.486 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -68.93 -28.22 66.46 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -49.71 75.36 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.536 1.534 . . . . 0.0 110.367 176.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -61.88 -42.42 99.05 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.107 1.363 . . . . 0.0 112.07 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 95.3 t -56.95 -37.18 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.615 0.766 . . . . 0.0 110.679 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -68.4 -54.01 20.03 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.427 1.091 . . . . 0.0 112.447 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 m -73.5 -8.79 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 O-C-N 120.834 -1.166 . . . . 0.0 113.093 -175.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -98.58 -3.2 36.83 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.855 1.262 . . . . 0.0 112.387 176.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.9 p -129.6 -13.82 4.21 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.474 1.11 . . . . 0.0 113.041 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -135.74 -11.15 2.07 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.342 1.857 . . . . 0.0 114.1 177.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.93 154.94 11.29 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.067 1.318 . . . . 0.0 114.034 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.64 -159.51 31.4 Favored Glycine 0 CA--C 1.532 1.155 0 O-C-N 121.756 -0.849 . . . . 0.0 114.201 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 88.1 p -153.94 100.39 2.35 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -170.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -131.93 142.94 49.79 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.866 1.667 . . . . 0.0 110.091 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.4 154.61 39.95 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 121.465 -0.772 . . . . 0.0 111.106 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.7 p -118.4 156.9 28.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.231 1.412 . . . . 0.0 111.011 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.44 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 8.4 t -67.93 -41.14 83.02 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.307 1.043 . . . . 0.0 111.314 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 mt -155.56 137.69 14.67 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.243 1.817 . . . . 0.0 111.152 -177.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -134.38 103.84 5.89 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.485 1.114 . . . . 0.0 110.275 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -90.27 -39.66 12.62 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.43 175.34 6.46 Favored Glycine 0 CA--C 1.543 1.807 0 C-N-CA 124.926 1.251 . . . . 0.0 114.508 -169.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.3 t80 . . . . . 0 CA--C 1.55 0.947 0 O-C-N 121.497 -1.002 . . . . 0.0 112.272 169.386 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.177 0 CA-C-O 121.677 0.598 . . . . 0.0 113.007 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.4 mt -127.02 105.42 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.023 1.329 . . . . 0.0 107.885 169.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -67.67 146.35 53.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.074 0.464 . . . . 0.0 111.095 172.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 57.45 24.69 10.51 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.355 1.462 . . . . 0.0 113.993 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -53.95 127.51 26.58 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.077 1.351 . . . . 0.0 111.039 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -76.9 127.71 33.21 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 122.064 -0.397 . . . . 0.0 110.252 169.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 33.3 mm -122.57 115.76 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.845 1.258 . . . . 0.0 108.334 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -112.08 100.69 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 125.264 1.426 . . . . 0.0 107.875 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.7 p -83.18 159.21 22.07 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.666 0.746 . . . . 0.0 111.775 176.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -152.07 138.66 18.7 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.67 1.188 . . . . 0.0 110.863 173.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.4 mt -80.07 132.27 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 . . . . . 0 N--CA 1.465 0.31 0 C-N-CA 125.31 1.444 . . . . 0.0 110.344 175.042 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 . . . . . 0 CA--C 1.535 0.4 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -106.33 164.06 12.33 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.694 1.197 . . . . 0.0 110.485 171.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.1 tp -117.5 134.83 59.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 125.615 1.566 . . . . 0.0 107.615 169.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.1 p -124.09 155.75 37.82 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.356 0.662 . . . . 0.0 109.854 175.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -150.89 147.03 26.71 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.447 0.699 . . . . 0.0 112.179 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 55.2 p -76.24 108.17 8.98 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.059 1.344 . . . . 0.0 111.833 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.98 -160.38 17.87 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 123.999 0.809 . . . . 0.0 113.528 173.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -67.22 159.77 28.38 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.89 0.876 . . . . 0.0 112.836 171.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -78.21 106.25 9.99 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.838 1.255 . . . . 0.0 110.358 172.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 123.22 0.608 . . . . 0.0 112.326 174.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 120.915 0.388 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.26 98.67 0.83 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.392 0.677 . . . . 0.0 110.227 170.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -91.94 144.45 25.45 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.346 1.069 . . . . 0.0 111.592 172.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -134.28 169.64 16.9 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 126.106 1.763 . . . . 0.0 110.962 -173.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.07 133.44 21.79 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.184 0.594 . . . . 0.0 109.991 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 62.0 mt -126.5 138.63 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 123.736 0.815 . . . . 0.0 108.822 175.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.9 m -64.55 98.2 0.24 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.863 0.865 . . . . 0.0 109.43 177.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.83 -32.74 53.91 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.693 1.197 . . . . 0.0 111.634 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -68.32 -32.21 72.17 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -82.56 -27.74 31.4 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.335 -0.853 . . . . 0.0 112.836 173.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 18.8 mt -62.59 -51.03 68.95 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.644 0.778 . . . . 0.0 110.912 172.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -48.75 -43.36 37.61 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.853 1.261 . . . . 0.0 113.24 176.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.6 mttt . . . . . 0 N--CA 1.482 1.147 0 C-N-CA 125.542 1.537 . . . . 0.0 114.32 -178.625 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.8 pttt . . . . . 0 C--O 1.233 0.235 0 CA-C-O 121.299 0.571 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -147.39 165.86 28.93 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.297 1.439 . . . . 0.0 110.527 177.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -130.64 134.13 46.71 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.08 -0.387 . . . . 0.0 110.881 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.0 m -128.05 165.1 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.083 1.753 . . . . 0.0 109.979 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -68.55 163.39 23.66 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.56 0.744 . . . . 0.0 110.96 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.5 tp -147.01 136.12 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.078 0.951 . . . . 0.0 109.254 170.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -126.5 160.1 31.53 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.626 1.971 . . . . 0.0 109.105 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.4 161.56 35.48 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.905 0.882 . . . . 0.0 112.06 176.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.74 118.16 23.71 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.847 0.459 . . . . 0.0 110.209 173.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -72.06 178.85 3.56 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.403 0.621 . . . . 0.0 112.459 175.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -57.67 -26.37 61.57 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.87 1.668 . . . . 0.0 113.111 173.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.3 t -70.65 -17.69 62.86 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.799 1.64 . . . . 0.0 113.747 173.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.45 36.39 62.88 Favored Glycine 0 CA--C 1.534 1.233 0 O-C-N 121.072 -1.018 . . . . 0.0 113.287 -171.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -125.09 143.81 50.73 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.994 1.718 . . . . 0.0 109.85 175.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -67.64 132.83 48.25 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.814 0.846 . . . . 0.0 111.141 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 t -142.44 136.62 29.66 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.838 1.255 . . . . 0.0 110.509 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -56.98 133.14 54.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.04 0.936 . . . . 0.0 112.446 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.1 tp -111.36 -45.83 3.36 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.112 0.965 . . . . 0.0 111.212 -176.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.26 -137.89 4.02 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 122.067 0.815 . . . . 0.0 113.813 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -129.0 163.59 25.04 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.511 1.925 . . . . 0.0 110.608 173.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 16.2 tp -130.1 106.39 8.59 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.49 2.316 . . . . 0.0 110.256 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.0 t -80.31 99.44 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.659 1.184 . . . . 0.0 109.332 174.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.89 117.12 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.504 1.522 . . . . 0.0 109.587 173.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 . . . . . 0 N--CA 1.476 0.829 0 C-N-CA 127.124 2.17 . . . . 0.0 110.726 178.77 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.836 0 CA-C-O 121.656 0.587 . . . . 0.0 113.78 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.2 mt -126.22 138.84 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.899 0.879 . . . . 0.0 109.589 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -127.7 129.89 47.91 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.276 1.43 . . . . 0.0 109.036 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.9 p -121.55 137.63 54.65 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.502 -0.749 . . . . 0.0 110.207 -175.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.6 108.88 0.71 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -170.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 tt -64.04 142.24 58.48 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.771 0.828 . . . . 0.0 110.612 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.8 t30 . . . . . 0 CA--C 1.543 0.702 0 C-N-CA 126.18 1.792 . . . . 0.0 109.313 178.938 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 93.7 m -60.77 123.03 16.29 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 121.099 -1.0 . . . . 0.0 109.286 169.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -85.46 -51.4 6.56 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.442 0.697 . . . . 0.0 109.849 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -162.57 170.27 18.86 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.275 1.03 . . . . 0.0 112.744 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.99 144.01 23.01 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 122.536 1.16 . . . . 0.0 113.198 175.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.458 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -129.46 154.93 46.49 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.813 1.645 . . . . 0.0 111.845 -175.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -78.31 167.21 21.7 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.406 0.682 . . . . 0.0 112.263 -173.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -53.68 -35.67 61.32 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.017 0.927 . . . . 0.0 112.646 173.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -65.48 -8.49 19.57 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.617 1.167 . . . . 0.0 113.684 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.9 t -118.13 -4.63 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.591 1.156 . . . . 0.0 111.224 -173.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.6 t -50.87 -65.08 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 125.13 1.372 . . . . 0.0 111.334 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -68.51 -25.77 65.11 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.88 -50.92 69.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.327 1.451 . . . . 0.0 110.603 173.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -58.65 -43.79 89.91 Favored 'General case' 0 C--N 1.335 -0.064 0 C-N-CA 124.964 1.305 . . . . 0.0 111.608 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 73.3 t -56.44 -37.6 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.902 0.481 . . . . 0.0 110.867 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -66.01 -54.51 25.07 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.444 1.098 . . . . 0.0 112.513 176.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 m -74.81 -3.67 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 121.13 -0.981 . . . . 0.0 113.402 -175.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.67 -4.25 24.02 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.156 1.782 . . . . 0.0 112.008 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 43.8 p -131.84 -15.36 3.05 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.779 1.232 . . . . 0.0 113.541 174.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -131.5 -12.42 3.47 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.649 1.579 . . . . 0.0 113.847 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.34 156.14 12.45 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.678 1.132 . . . . 0.0 113.752 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.78 -159.26 31.62 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 121.742 -0.858 . . . . 0.0 113.471 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.6 p -154.21 96.82 1.98 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -131.22 143.68 50.76 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.97 1.708 . . . . 0.0 110.606 -176.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -74.08 162.74 28.69 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.831 0.852 . . . . 0.0 111.49 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.0 p -129.66 143.76 50.97 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.217 1.407 . . . . 0.0 111.365 -177.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.458 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 24.4 p -57.81 -37.03 73.04 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.321 1.448 . . . . 0.0 112.839 -178.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mt -156.4 145.58 20.5 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.07 2.148 . . . . 0.0 110.549 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -141.62 109.83 5.9 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.023 0.929 . . . . 0.0 110.246 176.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -95.59 -57.73 2.31 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.385 1.074 . . . . 0.0 112.463 175.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.46 -169.6 29.06 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.244 1.402 . . . . 0.0 113.796 -171.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 12.6 t80 . . . . . 0 CA--C 1.543 0.688 0 O-C-N 121.739 -0.859 . . . . 0.0 113.102 -179.456 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.407 0 CA-C-O 121.206 0.337 . . . . 0.0 113.105 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 62.3 mt -119.77 113.14 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.076 1.35 . . . . 0.0 108.766 174.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -72.7 147.45 45.67 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.278 0.561 . . . . 0.0 111.565 172.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 57.12 22.44 7.47 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.034 1.734 . . . . 0.0 114.06 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -56.01 123.64 15.07 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.568 1.147 . . . . 0.0 110.534 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -71.07 127.91 34.17 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.87 0.868 . . . . 0.0 110.304 171.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 36.2 mm -123.93 117.67 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.351 1.06 . . . . 0.0 108.529 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.4 100.12 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.047 1.339 . . . . 0.0 107.746 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.4 p -82.74 158.98 22.65 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.595 0.712 . . . . 0.0 111.674 175.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.2 ptpt -152.44 139.09 18.76 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.744 1.218 . . . . 0.0 111.069 175.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.5 mt -79.38 133.84 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 . . . . . 0 N--CA 1.468 0.453 0 C-N-CA 125.207 1.403 . . . . 0.0 110.622 173.593 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 . . . . . 0 CA--C 1.54 0.586 0 CA-C-O 121.261 0.553 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -105.41 168.97 8.73 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.362 1.465 . . . . 0.0 110.389 170.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.6 tp -120.38 134.85 62.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 125.597 1.559 . . . . 0.0 107.342 169.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.2 p -119.88 160.04 23.46 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.19 0.596 . . . . 0.0 109.462 171.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -148.45 142.33 25.77 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.797 0.839 . . . . 0.0 110.795 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.5 p -74.08 116.14 14.37 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.525 0.679 . . . . 0.0 110.53 173.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.74 -166.14 40.95 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.72 0.676 . . . . 0.0 112.139 174.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.29 172.16 12.94 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 121.981 0.896 . . . . 0.0 111.234 168.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -76.57 132.0 39.25 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.508 1.123 . . . . 0.0 110.43 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.905 0 O-C-N 121.472 -0.767 . . . . 0.0 111.81 171.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.472 0.635 0 CA-C-O 120.858 0.361 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -74.85 91.27 2.43 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.18 0.592 . . . . 0.0 110.517 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -77.93 151.44 33.72 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 122.32 1.057 . . . . 0.0 111.086 168.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -134.33 173.53 11.51 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.219 1.808 . . . . 0.0 110.884 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.91 138.09 24.06 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.659 0.663 . . . . 0.0 110.835 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 59.5 mt -128.8 141.53 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.05 0.94 . . . . 0.0 109.314 174.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.6 m -64.19 97.1 0.17 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.078 0.951 . . . . 0.0 109.764 175.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.95 -30.95 60.03 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.582 1.153 . . . . 0.0 112.023 175.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -67.31 -25.82 66.22 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -93.53 -15.32 25.6 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.64 1.176 . . . . 0.0 113.153 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 22.0 mt -73.87 -46.27 45.82 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.487 -0.758 . . . . 0.0 110.314 169.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -50.24 -45.12 53.76 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.704 1.202 . . . . 0.0 114.087 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 31.9 pttt . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -176.408 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.2 pttp . . . . . 0 N--CA 1.47 0.552 0 CA-C-O 120.962 0.41 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -141.21 168.32 20.06 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.68 1.192 . . . . 0.0 110.486 173.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -134.38 127.99 32.71 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.951 0.5 . . . . 0.0 110.081 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 m -126.08 158.16 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.233 1.413 . . . . 0.0 111.291 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -60.8 152.76 26.23 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.736 0.814 . . . . 0.0 111.35 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.1 tp -147.48 135.44 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.385 1.074 . . . . 0.0 109.585 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -127.68 158.72 36.81 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.465 1.906 . . . . 0.0 108.727 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -127.83 156.1 43.06 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.356 1.062 . . . . 0.0 111.106 175.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.23 119.85 22.89 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 170.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -67.66 176.33 2.5 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 122.01 0.91 . . . . 0.0 111.765 173.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -56.11 -16.13 4.67 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.91 2.084 . . . . 0.0 115.4 176.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -110.45 12.35 22.98 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.761 1.225 . . . . 0.0 113.349 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.65 20.9 79.37 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 120.973 -1.08 . . . . 0.0 114.515 176.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -102.27 144.07 31.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.529 1.132 . . . . 0.0 110.446 174.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -75.2 126.65 31.46 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.027 0.442 . . . . 0.0 110.418 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.9 t -131.57 135.18 46.8 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.317 1.447 . . . . 0.0 109.325 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -55.51 136.71 49.71 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.21 0.604 . . . . 0.0 111.816 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.3 tp -111.25 -46.38 3.31 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.799 0.84 . . . . 0.0 110.718 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.38 -111.37 0.44 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 123.103 0.382 . . . . 0.0 113.485 175.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -146.06 154.66 42.09 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.291 1.436 . . . . 0.0 110.261 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.8 tp -119.61 102.66 8.78 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.407 1.483 . . . . 0.0 109.899 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.9 t -75.46 98.12 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.07 1.348 . . . . 0.0 109.191 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.9 t -83.51 87.93 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.252 1.421 . . . . 0.0 110.062 175.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 . . . . . 0 N--CA 1.478 0.971 0 C-N-CA 124.823 1.249 . . . . 0.0 111.425 171.965 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.159 0 CA-C-O 121.284 0.38 . . . . 0.0 113.034 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.3 mt -88.9 141.0 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 121.601 -0.94 . . . . 0.0 108.899 177.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -131.26 89.7 2.76 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.061 1.344 . . . . 0.0 111.157 -174.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.6 p -83.71 152.63 24.62 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.531 -0.73 . . . . 0.0 112.778 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.76 128.22 3.4 Favored Glycine 0 CA--C 1.527 0.802 0 O-C-N 121.368 -0.833 . . . . 0.0 113.185 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.23 139.18 48.0 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.25 1.82 . . . . 0.0 110.125 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 42.0 t30 . . . . . 0 CA--C 1.543 0.697 0 C-N-CA 125.917 1.687 . . . . 0.0 111.042 -179.711 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.804 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.5 m -54.8 128.78 34.52 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.315 1.046 . . . . 0.0 110.766 171.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -96.98 -52.55 3.82 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.989 0.515 . . . . 0.0 110.376 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -164.16 154.29 14.7 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.891 0.876 . . . . 0.0 112.881 172.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.04 116.0 10.34 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 123.158 1.456 . . . . 0.0 113.343 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.94 171.61 9.46 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.967 1.307 . . . . 0.0 112.526 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -80.6 161.35 24.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.401 1.081 . . . . 0.0 112.266 176.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -55.6 -35.03 65.38 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.163 0.985 . . . . 0.0 113.055 172.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -68.07 -17.89 64.51 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 175.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.9 t -100.81 -10.58 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.831 0.852 . . . . 0.0 111.577 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 75.9 t -47.08 -51.37 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.549 1.14 . . . . 0.0 111.577 176.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -73.24 -29.07 62.51 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 177.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -76.68 -39.42 52.14 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.138 -0.976 . . . . 0.0 111.981 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -57.18 -46.06 83.17 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 124.804 1.242 . . . . 0.0 110.815 173.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 72.4 t -52.61 -42.94 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.498 1.119 . . . . 0.0 110.728 175.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -66.81 -55.01 16.77 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.507 1.523 . . . . 0.0 113.002 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 m -72.83 -5.95 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 O-C-N 121.424 -0.797 . . . . 0.0 112.983 -176.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.42 -5.77 31.9 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.727 1.611 . . . . 0.0 112.155 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.0 p -127.55 -13.16 5.45 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.934 0.894 . . . . 0.0 112.695 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -132.72 -11.21 3.08 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.656 1.582 . . . . 0.0 114.392 177.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.6 156.81 9.79 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.098 1.333 . . . . 0.0 113.821 -174.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.88 -153.93 24.95 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 121.655 -0.909 . . . . 0.0 113.106 -175.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.6 p -145.83 153.23 40.67 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.177 0.991 . . . . 0.0 112.936 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -148.73 179.55 7.75 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.317 1.847 . . . . 0.0 111.769 173.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -114.97 151.92 33.3 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.733 1.213 . . . . 0.0 110.025 168.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 62.4 p -117.28 133.58 55.81 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.766 0.827 . . . . 0.0 111.271 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.1 t -51.0 -37.85 47.62 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.308 1.043 . . . . 0.0 112.557 175.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.7 mt -146.48 147.23 30.98 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.029 1.731 . . . . 0.0 111.719 173.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -136.85 115.37 11.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 170.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -96.57 -49.01 5.3 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.8 0.84 . . . . 0.0 112.543 174.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.45 172.11 34.31 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 125.718 1.628 . . . . 0.0 113.423 -169.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 49.1 t80 . . . . . 0 CA--C 1.552 1.036 0 C-N-CA 124.131 0.972 . . . . 0.0 112.486 169.618 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.516 0 CA-C-O 121.201 0.334 . . . . 0.0 113.513 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.2 mt -122.51 119.23 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.636 1.574 . . . . 0.0 108.828 176.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -80.66 148.58 30.15 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 54.46 25.71 6.4 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.362 1.865 . . . . 0.0 113.979 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -63.08 126.57 27.8 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.283 1.433 . . . . 0.0 111.239 -172.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -78.95 130.42 35.56 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.013 0.525 . . . . 0.0 111.461 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.7 mm -126.87 120.36 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 125.862 1.665 . . . . 0.0 109.215 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.95 105.17 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.266 1.427 . . . . 0.0 108.71 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.7 p -78.69 159.88 27.77 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.725 0.774 . . . . 0.0 112.198 174.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -150.55 140.88 22.32 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.983 1.313 . . . . 0.0 110.523 171.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.4 mt -81.92 132.72 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 . . . . . 0 N--CA 1.467 0.412 0 C-N-CA 125.06 1.344 . . . . 0.0 110.563 174.019 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 CA--C 1.54 0.577 0 N-CA-C 109.56 -0.534 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -108.39 168.54 9.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.332 1.453 . . . . 0.0 110.227 171.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 tp -120.09 136.2 57.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 125.363 1.465 . . . . 0.0 108.25 170.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 p -123.25 155.64 36.77 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.337 0.655 . . . . 0.0 110.026 172.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -148.56 137.09 21.35 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.174 0.99 . . . . 0.0 111.024 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.7 p -70.52 115.55 9.82 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.168 0.987 . . . . 0.0 111.642 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.13 -163.23 38.65 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.739 1.162 . . . . 0.0 112.949 174.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -68.63 169.41 11.16 Favored 'General case' 0 CA--C 1.553 1.077 0 O-C-N 121.663 -0.904 . . . . 0.0 112.125 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -85.82 114.56 22.85 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.144 1.377 . . . . 0.0 111.265 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.748 0 C-N-CA 123.617 0.767 . . . . 0.0 111.687 174.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.8 m . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.16 93.94 0.64 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 169.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -90.55 147.8 23.11 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 122.272 1.034 . . . . 0.0 111.085 169.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -134.45 171.1 14.77 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.817 1.647 . . . . 0.0 110.932 -172.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.59 134.02 23.21 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.584 0.629 . . . . 0.0 110.5 177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 61.6 mt -127.13 140.59 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.187 0.995 . . . . 0.0 108.914 175.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.0 m -65.33 95.89 0.21 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.228 1.011 . . . . 0.0 109.914 177.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.2 tt -53.42 -33.5 54.22 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.18 0.992 . . . . 0.0 111.377 175.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -67.91 -28.87 67.86 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -79.06 -36.31 41.15 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.657 0.662 . . . . 0.0 111.807 169.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 16.1 mt -59.88 -37.32 79.04 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.554 -0.716 . . . . 0.0 111.794 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -62.14 -6.97 3.42 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 172.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 65.3 mttm . . . . . 0 N--CA 1.485 1.297 0 C-N-CA 124.985 1.314 . . . . 0.0 114.104 178.303 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.8 pttm . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 120.854 0.359 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -147.87 168.96 20.87 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.309 1.444 . . . . 0.0 110.72 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 m -136.55 134.82 37.91 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.91 0.484 . . . . 0.0 111.127 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.0 m -131.51 161.7 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.218 1.407 . . . . 0.0 112.304 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.34 153.15 23.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.742 1.217 . . . . 0.0 111.899 174.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.1 tp -152.94 136.79 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.442 1.497 . . . . 0.0 109.358 177.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -130.56 160.09 35.19 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.191 1.796 . . . . 0.0 109.759 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -132.93 158.76 41.82 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.845 1.258 . . . . 0.0 112.462 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 120.31 25.75 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.002 0.521 . . . . 0.0 110.76 173.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -72.63 179.71 3.45 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.401 0.68 . . . . 0.0 112.642 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -55.65 -29.35 59.13 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.734 1.614 . . . . 0.0 113.284 173.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.5 t -82.84 -6.8 59.6 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.127 1.371 . . . . 0.0 113.244 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.02 34.73 51.82 Favored Glycine 0 CA--C 1.533 1.219 0 O-C-N 120.855 -1.153 . . . . 0.0 114.058 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -119.05 145.39 45.93 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.362 1.465 . . . . 0.0 111.002 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -72.38 123.55 23.29 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.743 0.817 . . . . 0.0 111.181 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.0 t -139.2 141.76 37.91 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.208 1.403 . . . . 0.0 110.547 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -56.1 141.39 40.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.866 0.866 . . . . 0.0 113.054 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 tp -117.52 -47.87 2.62 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.741 0.816 . . . . 0.0 111.694 -178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.58 -117.6 0.71 Allowed Glycine 0 CA--C 1.529 0.906 0 CA-C-O 121.254 0.363 . . . . 0.0 113.663 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -145.08 156.04 43.68 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.518 1.527 . . . . 0.0 109.643 -177.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.2 tp -121.16 100.44 7.06 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.983 1.313 . . . . 0.0 110.065 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 t -76.0 96.3 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.161 1.384 . . . . 0.0 109.096 175.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.6 t -85.38 105.54 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.31 1.444 . . . . 0.0 110.031 173.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 63.3 mtt-85 . . . . . 0 N--CA 1.471 0.597 0 C-N-CA 126.482 1.913 . . . . 0.0 110.158 172.632 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.983 0 CA-C-O 121.551 0.528 . . . . 0.0 114.375 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.3 mt -122.96 145.25 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.427 1.091 . . . . 0.0 110.065 176.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -134.54 132.83 39.62 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.548 1.539 . . . . 0.0 109.763 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.6 p -126.33 147.37 49.74 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.929 -1.107 . . . . 0.0 111.883 -171.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.29 120.77 1.75 Allowed Glycine 0 CA--C 1.527 0.791 0 O-C-N 121.818 -0.551 . . . . 0.0 112.977 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.41 141.23 57.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.961 1.704 . . . . 0.0 110.036 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.553 1.074 0 C-N-CA 126.373 1.869 . . . . 0.0 111.034 -169.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.794 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.6 m -54.95 123.57 13.94 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.167 -0.958 . . . . 0.0 110.245 171.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -90.91 -51.84 5.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.599 0.76 . . . . 0.0 110.2 -177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -164.33 161.09 21.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.848 0.859 . . . . 0.0 112.613 172.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.14 153.7 43.15 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.998 1.319 . . . . 0.0 111.965 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.445 ' HA ' ' H ' ' A' ' 109' ' ' SER . 1.7 pp -140.77 154.78 46.42 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.411 1.485 . . . . 0.0 111.188 -175.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -78.52 166.96 21.97 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.602 0.715 . . . . 0.0 112.208 -172.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -59.57 -21.7 60.7 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 121.388 -0.82 . . . . 0.0 112.543 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -72.92 -12.98 61.16 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 121.045 -1.034 . . . . 0.0 113.583 173.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.7 t -112.13 -2.07 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 120.901 -1.124 . . . . 0.0 110.852 -171.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.0 m -60.96 -26.07 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -97.87 -25.57 14.97 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.693 0.679 . . . . 0.0 111.863 170.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -70.25 -53.7 15.84 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.583 1.553 . . . . 0.0 111.166 -178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -58.05 -44.58 87.5 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.571 1.148 . . . . 0.0 111.236 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 74.1 t -57.16 -36.86 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.957 0.903 . . . . 0.0 111.022 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -62.54 -57.5 10.93 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.464 1.105 . . . . 0.0 111.997 173.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -70.06 -17.16 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 O-C-N 121.331 -0.855 . . . . 0.0 112.573 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.2 -6.91 58.43 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.27 1.828 . . . . 0.0 111.91 177.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 46.2 p -128.1 -10.49 5.34 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 173.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -134.88 -9.96 2.34 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.578 1.551 . . . . 0.0 113.954 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.51 155.76 6.4 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.722 1.629 . . . . 0.0 113.824 -174.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.1 -170.8 33.3 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.267 0.937 . . . . 0.0 114.096 -175.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.8 p -143.95 103.32 4.02 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.729 1.211 . . . . 0.0 113.493 -168.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -132.86 162.02 32.65 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.423 1.889 . . . . 0.0 110.398 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.58 160.26 17.51 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.644 0.735 . . . . 0.0 111.387 177.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.9 p -126.57 153.8 44.75 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.279 1.831 . . . . 0.0 110.113 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.445 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 76.9 p -68.9 -39.74 79.55 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.527 -0.733 . . . . 0.0 111.283 -175.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.8 mt -151.61 143.27 23.64 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.904 2.082 . . . . 0.0 111.451 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -136.64 101.81 4.73 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.268 1.027 . . . . 0.0 109.299 174.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -87.52 -51.94 5.63 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.68 0.792 . . . . 0.0 111.764 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.44 178.34 49.54 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 124.526 1.06 . . . . 0.0 114.379 -173.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.5 t80 . . . . . 0 CA--C 1.545 0.769 0 C-N-CA 124.408 1.083 . . . . 0.0 111.561 170.092 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.295 0 CA-C-O 121.95 0.75 . . . . 0.0 113.702 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 36.7 mt -127.89 108.4 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.901 1.68 . . . . 0.0 107.846 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -69.21 147.64 51.0 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.176 0.512 . . . . 0.0 111.185 173.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 57.83 22.05 8.18 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.38 1.472 . . . . 0.0 114.162 178.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -56.79 123.9 16.61 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.939 1.296 . . . . 0.0 111.585 -176.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -72.01 128.97 37.39 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.545 1.138 . . . . 0.0 110.768 170.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 38.2 mm -122.94 115.78 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.734 1.214 . . . . 0.0 109.293 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.89 90.02 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.158 1.383 . . . . 0.0 108.671 -174.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.8 p -75.74 154.2 36.53 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.394 175.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -151.54 140.97 21.54 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.215 1.406 . . . . 0.0 111.099 174.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.35 133.97 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.053 0.541 . . . . 0.0 109.754 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 . . . . . 0 N--CA 1.468 0.43 0 C-N-CA 125.303 1.441 . . . . 0.0 111.107 175.368 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -107.18 168.17 9.4 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.319 1.447 . . . . 0.0 110.133 169.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.2 tp -119.04 135.03 60.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.227 1.411 . . . . 0.0 108.56 170.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.0 p -124.03 153.59 41.12 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.835 0.854 . . . . 0.0 109.955 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -151.01 145.67 25.69 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.065 0.946 . . . . 0.0 111.833 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.6 m -82.57 117.9 22.88 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.499 1.12 . . . . 0.0 111.084 176.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.86 -151.87 24.56 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.88 1.705 . . . . 0.0 113.143 177.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -72.2 173.49 8.51 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 170.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -92.4 102.29 14.76 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.084 0.954 . . . . 0.0 111.923 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.775 0 C-N-CA 124.032 0.933 . . . . 0.0 113.064 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 121.067 0.461 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.74 124.29 19.98 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 170.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -126.23 144.33 50.82 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 122.243 1.02 . . . . 0.0 111.222 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -137.91 172.14 13.37 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.493 1.517 . . . . 0.0 111.878 -168.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.68 131.48 18.01 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.507 0.723 . . . . 0.0 110.057 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 70.5 mt -124.19 139.93 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 123.959 0.904 . . . . 0.0 108.796 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.8 m -63.86 96.86 0.14 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.11 0.964 . . . . 0.0 109.601 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.1 tt -55.76 -33.0 63.91 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.072 0.949 . . . . 0.0 111.778 176.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -66.95 -27.67 67.65 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 176.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -87.06 -31.39 20.53 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.892 0.877 . . . . 0.0 112.113 174.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 19.4 mt -60.76 -44.1 97.17 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.77 0.828 . . . . 0.0 111.233 172.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -51.71 -32.7 31.3 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.547 -1.346 . . . . 0.0 113.639 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 90.4 mttt . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -179.887 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.7 pttm . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -145.96 166.21 26.69 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.112 0.965 . . . . 0.0 111.15 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 m -132.62 126.48 32.8 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.8 0.44 . . . . 0.0 110.628 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.2 m -121.91 169.12 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.839 1.656 . . . . 0.0 110.697 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -67.81 169.2 10.11 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.855 0.862 . . . . 0.0 111.622 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 tp -159.27 137.56 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.936 1.294 . . . . 0.0 109.862 171.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -129.57 158.82 38.22 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.377 2.271 . . . . 0.0 108.942 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -131.39 159.8 36.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.388 1.075 . . . . 0.0 111.766 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -88.08 119.51 28.52 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.15 0.58 . . . . 0.0 110.727 172.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -72.89 179.77 3.54 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.445 0.64 . . . . 0.0 112.191 173.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -57.55 -21.58 39.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.977 1.711 . . . . 0.0 114.428 176.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.0 m -91.56 2.38 56.49 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.045 0.938 . . . . 0.0 113.258 177.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.3 31.26 71.5 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.563 1.077 . . . . 0.0 113.8 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -109.93 140.19 44.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.992 1.317 . . . . 0.0 110.822 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -74.57 121.23 21.24 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.869 0.868 . . . . 0.0 110.77 175.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.6 t -137.42 138.62 40.02 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.915 1.286 . . . . 0.0 110.5 -176.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -58.33 143.48 44.74 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -174.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.2 tp -118.81 -46.42 2.55 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.137 0.975 . . . . 0.0 111.542 -177.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 171.87 -129.5 1.76 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-O 121.457 0.476 . . . . 0.0 113.655 -175.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -141.39 158.9 43.26 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.039 1.736 . . . . 0.0 109.461 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.4 tp -126.22 103.24 7.57 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.884 1.274 . . . . 0.0 110.497 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.1 t -76.56 96.23 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.408 1.083 . . . . 0.0 109.012 175.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.4 t -83.86 113.11 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.586 1.555 . . . . 0.0 109.697 173.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 . . . . . 0 N--CA 1.475 0.823 0 C-N-CA 126.438 1.895 . . . . 0.0 110.175 176.596 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.276 0 N-CA-C 114.761 0.664 . . . . 0.0 114.761 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.3 mt -125.08 142.06 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.237 1.015 . . . . 0.0 109.315 171.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -133.98 134.87 43.02 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.174 1.39 . . . . 0.0 108.729 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.2 p -132.72 143.21 49.46 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.676 0.79 . . . . 0.0 111.268 -173.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.66 122.77 2.69 Favored Glycine 0 C--N 1.336 0.541 0 O-C-N 121.921 -0.487 . . . . 0.0 112.695 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -66.44 126.09 27.74 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.887 1.675 . . . . 0.0 109.124 173.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 37.3 t30 . . . . . 0 CA--C 1.536 0.431 0 C-N-CA 125.864 1.666 . . . . 0.0 109.187 179.937 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.696 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.3 m -59.57 131.24 50.33 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.209 -0.932 . . . . 0.0 110.811 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -98.97 -53.63 3.21 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.168 0.987 . . . . 0.0 109.516 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -161.03 159.09 28.91 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.967 0.907 . . . . 0.0 112.557 170.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.14 149.78 33.68 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 123.052 1.406 . . . . 0.0 112.303 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 pp -142.92 152.82 42.45 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.695 1.598 . . . . 0.0 110.819 -172.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -79.43 167.81 20.32 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.476 0.711 . . . . 0.0 112.146 -170.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -52.63 -35.84 55.38 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.291 -0.881 . . . . 0.0 112.654 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.2 -8.08 22.11 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.869 1.268 . . . . 0.0 114.179 175.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 t -116.5 -5.45 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.239 1.016 . . . . 0.0 111.41 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.1 t -53.58 -61.72 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 120.476 1.489 . . . . 0.0 111.651 -177.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -69.57 -24.81 63.75 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.82 -52.42 56.85 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.695 1.598 . . . . 0.0 110.706 172.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -59.86 -44.88 93.91 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 125.222 1.409 . . . . 0.0 110.62 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.2 -36.39 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.82 0.848 . . . . 0.0 111.206 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -54.99 29.45 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.075 0.95 . . . . 0.0 111.716 173.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 m -76.0 -2.62 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -176.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 40.7 tpp -108.62 -4.22 17.3 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.426 1.49 . . . . 0.0 112.47 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 43.2 p -125.42 -11.75 6.82 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.184 0.994 . . . . 0.0 112.573 171.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -135.25 -12.4 2.13 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.3 156.58 19.15 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 124.697 1.142 . . . . 0.0 113.865 -175.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.05 -160.35 31.54 Favored Glycine 0 CA--C 1.533 1.193 0 O-C-N 121.665 -0.903 . . . . 0.0 113.894 -175.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 85.0 p -150.72 104.49 3.19 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -171.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -135.04 153.3 52.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.066 1.746 . . . . 0.0 110.369 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -80.72 159.58 25.2 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.546 -0.721 . . . . 0.0 111.145 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.2 p -124.93 149.1 47.96 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.9 1.68 . . . . 0.0 110.595 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.1 t -62.59 -44.33 96.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.824 0.85 . . . . 0.0 111.336 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mt -149.61 143.13 25.34 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.459 1.504 . . . . 0.0 111.845 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -140.87 106.08 5.02 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.891 0.876 . . . . 0.0 110.735 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -90.64 -40.26 12.0 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.054 0.942 . . . . 0.0 113.104 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.92 -178.11 40.73 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 124.658 1.123 . . . . 0.0 113.877 -170.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 22.9 t80 . . . . . 0 CA--C 1.541 0.612 0 O-C-N 121.694 -0.886 . . . . 0.0 112.511 172.412 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.546 0 CA-C-O 121.077 0.265 . . . . 0.0 113.341 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 95.3 mt -116.2 109.49 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.17 1.388 . . . . 0.0 109.318 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -69.36 146.71 51.91 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.128 0.971 . . . . 0.0 112.146 172.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 54.68 24.47 5.57 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.283 1.833 . . . . 0.0 114.586 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -55.58 123.07 12.8 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.292 1.437 . . . . 0.0 111.696 -178.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -72.37 128.45 35.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.058 0.943 . . . . 0.0 110.618 170.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.5 mm -124.14 116.33 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.819 1.248 . . . . 0.0 108.649 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.13 94.04 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.435 1.494 . . . . 0.0 108.097 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.8 p -80.14 157.61 26.57 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.859 0.838 . . . . 0.0 111.776 176.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -154.12 146.71 24.12 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.891 1.276 . . . . 0.0 111.469 174.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 16.2 mt -84.29 131.47 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.175 0.59 . . . . 0.0 110.019 173.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 . . . . . 0 CA--C 1.536 0.441 0 C-N-CA 126.291 1.836 . . . . 0.0 110.077 176.321 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 . . . . . 0 CA--C 1.539 0.537 0 CA-C-O 121.218 0.532 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -109.0 158.19 17.95 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.398 1.479 . . . . 0.0 110.735 174.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 6.8 tp -100.92 144.68 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 166.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.7 p -133.12 156.48 47.37 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.624 0.77 . . . . 0.0 109.157 169.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -151.49 145.99 25.58 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.923 0.889 . . . . 0.0 111.457 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.2 p -76.22 115.45 15.96 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.701 1.2 . . . . 0.0 110.979 174.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.66 -162.22 38.05 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.379 0.99 . . . . 0.0 112.917 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.99 161.39 26.71 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.755 0.822 . . . . 0.0 112.682 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -78.12 103.94 8.38 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.448 0.699 . . . . 0.0 110.636 172.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.54 0.569 0 C-N-CA 125.031 1.332 . . . . 0.0 112.687 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 N--CA 1.477 0.887 0 CA-C-O 120.921 0.391 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.77 100.07 0.27 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.737 0.815 . . . . 0.0 109.599 171.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -93.79 145.77 24.35 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.174 0.988 . . . . 0.0 110.974 173.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -135.14 166.85 22.12 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.697 1.599 . . . . 0.0 111.417 -172.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.88 135.51 23.26 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.894 0.477 . . . . 0.0 110.555 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 59.0 mt -130.34 142.07 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.563 1.145 . . . . 0.0 109.076 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.5 m -63.95 96.55 0.14 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.389 1.076 . . . . 0.0 110.033 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.62 -30.55 63.39 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.413 -0.804 . . . . 0.0 111.899 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -67.17 -28.04 67.78 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -90.1 -25.95 20.47 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.178 0.991 . . . . 0.0 112.247 176.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.87 -47.92 73.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.573 1.149 . . . . 0.0 111.213 171.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -49.31 -40.21 34.18 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.374 1.07 . . . . 0.0 112.765 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt . . . . . 0 N--CA 1.484 1.264 0 C-N-CA 125.447 1.499 . . . . 0.0 114.43 178.046 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.668 0.27 . . . . 0.0 110.665 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.4 tt -138.66 147.3 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.569 1.548 . . . . 0.0 110.417 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -146.79 131.66 18.08 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.492 1.117 . . . . 0.0 109.655 173.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.7 t -150.42 153.67 36.36 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.941 1.297 . . . . 0.0 110.642 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.7 t -155.11 159.0 39.88 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.982 1.313 . . . . 0.0 111.185 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -150.37 149.54 30.21 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.606 1.562 . . . . 0.0 110.783 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -160.05 136.81 9.14 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.653 1.181 . . . . 0.0 110.83 173.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -138.45 151.34 47.33 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.065 1.346 . . . . 0.0 110.926 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -150.4 144.68 25.61 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.814 1.245 . . . . 0.0 110.51 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.7 t -150.99 155.48 39.16 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.004 1.322 . . . . 0.0 110.974 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.6 t -156.04 165.86 35.18 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.194 1.398 . . . . 0.0 111.273 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -168.65 159.56 32.74 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.225 1.393 . . . . 0.0 112.371 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -150.82 130.04 12.76 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.935 1.294 . . . . 0.0 110.111 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -157.98 159.76 36.78 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.312 1.045 . . . . 0.0 111.606 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -116.39 29.79 7.74 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.158 1.783 . . . . 0.0 111.801 -174.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -101.4 91.79 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.768 2.027 . . . . 0.0 110.974 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -140.26 165.66 26.79 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.365 1.866 . . . . 0.0 111.439 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -50.94 150.44 3.01 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.604 1.962 . . . . 0.0 112.667 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.4 mm -62.53 150.47 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.858 1.263 . . . . 0.0 112.117 -172.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -51.36 -22.92 3.23 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.545 1.538 . . . . 0.0 114.714 173.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -78.77 -1.58 35.41 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.248 1.419 . . . . 0.0 114.032 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.9 m -125.62 -48.19 1.67 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.756 1.622 . . . . 0.0 111.804 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -155.07 166.13 34.56 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.424 1.49 . . . . 0.0 111.274 169.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -144.43 166.99 23.54 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.17 0.988 . . . . 0.0 110.724 171.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -134.93 135.48 41.56 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.713 0.405 . . . . 0.0 110.896 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.72 162.94 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.694 1.598 . . . . 0.0 111.457 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -64.32 159.3 21.32 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.258 1.023 . . . . 0.0 112.499 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.0 tp -153.26 136.94 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.891 1.276 . . . . 0.0 109.632 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -130.24 156.49 44.54 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.815 2.046 . . . . 0.0 108.952 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -128.78 159.52 35.46 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.527 1.131 . . . . 0.0 111.914 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.58 117.04 23.48 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.93 0.492 . . . . 0.0 110.568 173.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -71.8 -179.96 2.89 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.309 0.644 . . . . 0.0 112.298 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -56.14 -26.87 51.98 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.64 1.576 . . . . 0.0 113.424 172.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.1 m -80.07 0.59 31.27 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.668 1.587 . . . . 0.0 114.148 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.44 34.08 87.04 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.657 1.122 . . . . 0.0 114.411 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -123.49 143.2 50.32 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.75 1.62 . . . . 0.0 109.744 177.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -67.33 126.62 29.83 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.967 0.907 . . . . 0.0 110.834 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -136.72 142.05 43.08 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.437 1.495 . . . . 0.0 110.18 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -57.55 140.19 51.49 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.1 tp -118.69 -48.59 2.47 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.828 0.851 . . . . 0.0 111.623 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.85 -119.83 0.86 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 123.261 0.458 . . . . 0.0 113.236 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -144.92 159.58 42.69 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.582 1.553 . . . . 0.0 110.284 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.5 tp -124.52 104.93 9.0 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.707 1.603 . . . . 0.0 110.131 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.2 t -78.76 99.43 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.073 1.349 . . . . 0.0 109.563 175.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.4 t -85.27 101.98 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.969 1.708 . . . . 0.0 110.239 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -87.44 121.33 29.75 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.901 1.68 . . . . 0.0 110.773 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -88.54 86.48 7.03 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.127 1.371 . . . . 0.0 110.4 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -76.3 173.88 10.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.629 1.172 . . . . 0.0 112.2 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -75.25 -33.51 61.31 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.897 -1.127 . . . . 0.0 113.527 173.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -109.88 53.59 0.69 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.449 1.5 . . . . 0.0 111.106 -172.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 109.09 -160.52 13.51 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.034 0.826 . . . . 0.0 113.967 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.9 mt -122.83 141.72 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.003 0.921 . . . . 0.0 109.609 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -130.7 127.5 38.96 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.881 1.272 . . . . 0.0 109.609 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.0 p -121.44 148.54 44.28 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.7 -0.625 . . . . 0.0 111.526 -173.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.96 124.99 2.47 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 121.497 0.498 . . . . 0.0 113.081 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.77 135.44 53.97 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.029 1.731 . . . . 0.0 109.827 175.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -137.12 85.09 2.11 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.086 1.755 . . . . 0.0 110.448 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.53 177.73 6.71 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.497 1.519 . . . . 0.0 112.744 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.01 53.64 2.17 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 126.256 1.884 . . . . 0.0 114.689 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 143.72 -1.19 1.3 Allowed Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.46 1.505 . . . . 0.0 115.222 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -150.4 151.39 32.73 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.813 1.306 . . . . 0.0 112.294 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 88.2 p -151.47 146.57 26.01 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 170.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.22 162.0 28.09 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.554 1.542 . . . . 0.0 111.592 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.6 m -55.37 132.0 47.11 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.257 -0.902 . . . . 0.0 110.529 169.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -99.83 -50.86 3.89 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.032 0.933 . . . . 0.0 110.26 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -163.42 159.92 22.83 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.894 0.878 . . . . 0.0 112.349 170.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.75 148.3 30.82 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 123.151 1.453 . . . . 0.0 112.873 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.424 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -136.18 157.85 45.82 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.046 1.338 . . . . 0.0 111.527 -171.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -78.49 167.5 21.19 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.29 0.567 . . . . 0.0 112.312 -174.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -56.74 -35.61 68.8 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.324 -0.86 . . . . 0.0 112.354 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -68.52 -5.05 17.37 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.846 1.259 . . . . 0.0 113.495 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 t -117.46 -5.22 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.247 1.019 . . . . 0.0 111.292 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.7 t -49.35 -63.81 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-N 120.455 1.479 . . . . 0.0 112.006 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -69.88 -28.85 65.98 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.801 -0.562 . . . . 0.0 112.138 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -63.05 -51.09 68.05 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.881 1.672 . . . . 0.0 110.899 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -59.93 -45.34 92.9 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 125.032 1.333 . . . . 0.0 110.522 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 37.4 t -59.24 -39.87 79.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.062 0.545 . . . . 0.0 110.523 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -59.28 -52.5 65.39 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.479 1.112 . . . . 0.0 112.183 174.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.29 -10.43 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 121.509 -0.744 . . . . 0.0 112.641 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -103.41 0.12 30.79 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.445 -1.41 . . . . 0.0 112.614 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.6 p -123.42 -12.62 7.74 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.236 1.015 . . . . 0.0 112.77 169.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -137.8 -14.36 1.42 Allowed 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.23 155.74 26.85 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.111 1.339 . . . . 0.0 113.954 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.09 -169.58 32.59 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.712 1.148 . . . . 0.0 113.829 -174.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.8 p -145.25 100.71 3.51 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.213 1.405 . . . . 0.0 113.34 -168.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -129.99 146.85 51.69 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.83 1.652 . . . . 0.0 110.037 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -74.95 157.52 34.84 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.466 -0.771 . . . . 0.0 111.021 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.7 p -121.66 147.65 45.6 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.28 1.432 . . . . 0.0 110.812 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.424 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 7.6 t -60.79 -43.6 97.9 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.686 0.794 . . . . 0.0 111.407 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mt -150.27 142.4 24.06 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.454 1.502 . . . . 0.0 112.251 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -134.02 106.04 7.03 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.078 0.951 . . . . 0.0 110.14 174.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -90.45 -47.77 7.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.297 1.039 . . . . 0.0 112.571 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.32 175.46 30.09 Favored Glycine 0 CA--C 1.544 1.847 0 C-N-CA 125.679 1.609 . . . . 0.0 114.595 -170.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -58.33 163.38 3.04 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.722 1.209 . . . . 0.0 112.568 169.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -64.32 166.67 7.79 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.891 -1.131 . . . . 0.0 112.321 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 72.14 36.35 1.13 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.878 1.671 . . . . 0.0 113.228 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -133.94 174.44 10.47 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.47 1.508 . . . . 0.0 112.503 -173.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -88.01 -35.59 17.49 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.804 0.841 . . . . 0.0 111.966 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 41.8 p -72.58 -42.38 64.65 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.6 p -58.02 -21.41 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 124.851 1.26 . . . . 0.0 114.087 -170.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 66.3 mt -53.92 -39.65 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 126.552 1.941 . . . . 0.0 111.916 174.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -144.54 -38.35 0.29 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 113.13 155.86 12.05 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 127.084 2.278 . . . . 0.0 112.689 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.4 mt -110.63 115.11 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.785 1.234 . . . . 0.0 108.76 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -73.97 148.49 42.06 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.109 0.481 . . . . 0.0 111.873 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 57.43 22.35 7.86 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.224 1.81 . . . . 0.0 114.277 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -63.71 126.2 26.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.009 1.323 . . . . 0.0 111.682 -171.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -75.88 121.39 22.57 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.609 1.164 . . . . 0.0 111.907 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.7 mm -114.8 112.07 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.296 1.039 . . . . 0.0 109.537 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -105.94 104.34 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.899 1.28 . . . . 0.0 108.387 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 47.6 p -89.8 156.89 18.19 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.456 1.102 . . . . 0.0 112.006 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.4 137.74 16.65 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.093 1.357 . . . . 0.0 111.586 175.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.7 mt -77.99 132.93 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.141 0.577 . . . . 0.0 109.684 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -151.02 136.59 17.89 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.435 1.494 . . . . 0.0 110.976 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.1 157.66 34.37 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.021 -1.049 . . . . 0.0 110.908 168.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 37.0 mt -131.15 -49.88 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.165 0.986 . . . . 0.0 111.031 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -145.84 29.42 1.11 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.659 0.784 . . . . 0.0 112.548 -175.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 105.66 -18.82 40.22 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 124.735 1.159 . . . . 0.0 113.91 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 53.8 m -92.11 139.23 30.84 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.253 1.021 . . . . 0.0 108.763 169.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -71.97 126.65 30.29 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.794 -0.566 . . . . 0.0 110.025 169.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -111.3 167.83 9.99 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.939 1.295 . . . . 0.0 110.743 173.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 tp -124.75 131.46 72.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.599 1.56 . . . . 0.0 108.395 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.8 p -118.82 154.47 32.81 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.677 0.791 . . . . 0.0 110.124 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -152.83 145.07 23.92 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.431 0.692 . . . . 0.0 112.155 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.6 m -82.32 111.03 18.01 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.539 1.136 . . . . 0.0 110.443 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.17 -155.61 19.59 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.374 1.464 . . . . 0.0 113.302 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.49 170.42 2.45 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 169.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -94.9 102.16 13.99 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.596 0.758 . . . . 0.0 111.13 173.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.72 164.22 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.924 0.89 . . . . 0.0 112.163 178.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.4 tptp -113.4 12.35 18.74 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -113.78 14.45 18.68 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.785 1.634 . . . . 0.0 112.935 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 2.0 t -132.48 -47.31 0.89 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 130.74 67.18 0.1 OUTLIER Glycine 0 N--CA 1.476 1.338 0 CA-C-N 118.99 0.814 . . . . 0.0 113.939 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 55.91 28.02 11.95 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.795 1.638 . . . . 0.0 114.168 -174.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -88.48 174.79 7.9 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.445 -0.784 . . . . 0.0 108.896 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.4 m -105.8 139.26 27.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 123.386 0.674 . . . . 0.0 109.54 170.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.92 116.61 5.44 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 169.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -118.19 149.19 41.49 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 122.362 1.077 . . . . 0.0 110.297 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -137.97 174.84 10.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.106 -1.406 . . . . 0.0 111.9 -169.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.61 130.06 16.79 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.81 0.844 . . . . 0.0 109.791 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 69.8 mt -121.9 138.99 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.192 0.997 . . . . 0.0 108.807 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -63.82 95.89 0.12 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.744 0.818 . . . . 0.0 109.7 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.3 tt -53.98 -31.27 50.3 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.876 1.27 . . . . 0.0 111.879 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -69.38 -28.09 65.87 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -86.77 -26.7 24.03 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.165 0.986 . . . . 0.0 112.522 175.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 27.9 mt -62.9 -53.04 60.23 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.412 1.085 . . . . 0.0 109.796 169.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -46.53 -37.69 8.3 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -53.67 -28.4 33.2 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.033 1.333 . . . . 0.0 114.149 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -122.46 -2.14 9.01 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.96 1.704 . . . . 0.0 113.178 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.2 mp -104.23 -27.49 12.0 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.015 1.726 . . . . 0.0 112.242 -177.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 35.8 mttm . . . . . 0 C--O 1.254 1.317 0 C-N-CA 126.063 1.745 . . . . 0.0 113.235 173.345 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.1 mttp . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 120.433 0.159 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.2 pt -99.46 172.46 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.5 1.52 . . . . 0.0 111.348 173.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.0 m170 54.33 29.09 10.24 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.714 1.605 . . . . 0.0 114.384 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.8 p -94.03 155.5 17.08 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.106 1.363 . . . . 0.0 112.08 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.0 p -139.07 140.7 38.11 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.105 1.362 . . . . 0.0 110.013 169.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -146.63 149.66 33.94 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.904 1.282 . . . . 0.0 109.877 -177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -103.24 156.06 17.99 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.391 1.076 . . . . 0.0 112.318 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.4 mp0 -135.74 157.03 47.86 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.836 1.254 . . . . 0.0 111.604 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -149.57 85.63 1.44 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.767 1.227 . . . . 0.0 111.749 -174.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.7 t -151.66 -174.57 4.89 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.028 1.331 . . . . 0.0 112.253 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 p -132.06 53.87 1.97 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.825 2.05 . . . . 0.0 111.664 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.78 -133.89 2.7 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.258 1.885 . . . . 0.0 111.708 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -45.71 134.8 7.24 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.168 1.387 . . . . 0.0 112.841 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.4 m -159.69 160.9 34.67 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.153 1.381 . . . . 0.0 111.902 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -76.57 151.7 36.21 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.328 1.451 . . . . 0.0 110.904 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.28 49.34 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-O 122.608 1.194 . . . . 0.0 111.47 -170.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.28 -174.6 4.97 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.089 2.156 . . . . 0.0 111.276 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.64 116.93 3.7 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.978 1.311 . . . . 0.0 110.742 171.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 mm -105.37 153.05 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.104 0.962 . . . . 0.0 110.512 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -67.81 -12.44 60.61 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -77.26 -165.73 0.62 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.038 1.735 . . . . 0.0 113.231 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.56 -40.01 94.79 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.784 1.233 . . . . 0.0 112.699 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -65.31 148.18 52.14 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 121.622 0.725 . . . . 0.0 110.588 169.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -135.44 175.53 9.5 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.966 1.306 . . . . 0.0 110.523 171.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -141.19 145.17 35.31 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.411 -0.805 . . . . 0.0 111.172 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.4 m -139.88 152.48 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.782 0.833 . . . . 0.0 112.341 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -56.63 139.5 49.92 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.666 1.187 . . . . 0.0 110.782 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.8 tp -137.53 136.32 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.798 1.239 . . . . 0.0 109.278 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -131.15 158.61 40.0 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.485 1.914 . . . . 0.0 108.826 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -130.37 161.4 31.41 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.423 1.089 . . . . 0.0 111.707 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.38 122.52 31.97 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.186 0.594 . . . . 0.0 111.026 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.22 -176.98 5.88 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 176.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -58.07 -24.48 58.71 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.441 1.896 . . . . 0.0 114.145 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.0 m -88.12 2.64 51.57 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.394 1.078 . . . . 0.0 113.386 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.5 35.48 91.99 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.698 1.142 . . . . 0.0 113.882 -176.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -114.51 143.4 45.02 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.374 1.47 . . . . 0.0 110.392 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -73.26 119.93 18.17 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.269 0.628 . . . . 0.0 110.622 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -129.14 135.3 48.68 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.77 1.628 . . . . 0.0 109.69 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -57.39 142.18 44.68 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.1 tp -117.33 -48.01 2.63 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.777 0.831 . . . . 0.0 111.4 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.84 -109.89 0.37 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.29 0.471 . . . . 0.0 113.698 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -149.72 156.84 42.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.222 1.809 . . . . 0.0 109.819 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 tp -122.46 102.29 8.0 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.593 1.157 . . . . 0.0 110.124 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.3 t -75.76 101.62 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.56 0.744 . . . . 0.0 109.263 176.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.0 94.25 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.731 1.612 . . . . 0.0 109.159 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 47.9 mtp85 -76.25 110.84 11.08 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.258 1.423 . . . . 0.0 110.458 172.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.4 mmtp -69.26 123.03 20.07 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 168.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -113.2 170.61 8.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.533 1.133 . . . . 0.0 111.116 175.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -74.57 -26.4 59.92 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.742 -1.224 . . . . 0.0 112.708 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -115.66 32.96 5.75 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.455 1.502 . . . . 0.0 112.433 -169.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.66 -158.37 21.27 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.484 1.516 . . . . 0.0 113.469 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.5 mt -128.18 143.13 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.769 0.828 . . . . 0.0 110.168 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -131.71 125.58 32.38 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.422 1.089 . . . . 0.0 110.703 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.2 p -116.56 146.01 42.94 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.617 -0.677 . . . . 0.0 111.813 -174.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -139.99 123.67 2.5 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 123.278 0.466 . . . . 0.0 112.083 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.33 137.19 54.44 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.24 1.416 . . . . 0.0 110.179 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -132.65 95.43 3.6 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.182 2.193 . . . . 0.0 109.48 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -98.69 175.1 6.1 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.506 1.122 . . . . 0.0 111.829 173.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.56 -27.13 60.72 Favored Glycine 0 CA--C 1.538 1.512 0 N-CA-C 115.719 1.048 . . . . 0.0 115.719 -172.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -145.66 25.55 1.81 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.194 1.378 . . . . 0.0 113.687 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -154.62 149.58 26.77 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.192 0.997 . . . . 0.0 112.634 -175.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 88.8 p -155.96 149.88 25.26 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 170.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -166.19 163.45 17.87 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.966 1.706 . . . . 0.0 111.309 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.7 m -56.51 131.35 48.36 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 121.212 -0.93 . . . . 0.0 109.191 168.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -98.0 -49.65 4.69 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.503 0.592 . . . . 0.0 110.142 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -167.35 159.09 12.24 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.867 0.867 . . . . 0.0 112.503 170.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.36 149.5 32.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 122.961 1.362 . . . . 0.0 112.525 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 pp -141.04 156.12 46.06 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.363 1.465 . . . . 0.0 110.836 -170.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -83.2 167.81 17.37 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.287 0.635 . . . . 0.0 112.111 -172.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -55.67 -32.0 62.86 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.022 -1.049 . . . . 0.0 112.535 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -66.4 -6.13 13.32 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.25 1.42 . . . . 0.0 114.022 174.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.88 -3.17 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 119.451 1.023 . . . . 0.0 111.555 -175.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.3 t -52.6 -64.53 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 120.314 1.415 . . . . 0.0 111.524 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -68.38 -27.24 66.06 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.317 0.647 . . . . 0.0 112.237 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.06 -54.2 41.87 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.413 1.485 . . . . 0.0 110.43 174.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -60.58 -46.13 91.36 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 125.135 1.374 . . . . 0.0 111.373 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 87.8 t -54.46 -34.84 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.011 0.925 . . . . 0.0 110.72 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -72.69 -53.96 10.3 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.117 1.367 . . . . 0.0 113.539 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 m -68.86 -16.65 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 120.813 -1.179 . . . . 0.0 112.374 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.37 -4.55 59.19 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.247 1.819 . . . . 0.0 111.971 176.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 51.0 p -130.96 -15.76 3.33 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.34 -10.63 4.13 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.1 1.76 . . . . 0.0 113.668 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.01 156.68 7.58 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.459 1.504 . . . . 0.0 113.642 -173.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 156.33 -170.61 33.96 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.379 0.99 . . . . 0.0 113.712 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 93.7 p -146.05 95.36 2.61 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.608 1.163 . . . . 0.0 113.229 -168.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -125.97 141.13 52.11 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.751 1.62 . . . . 0.0 109.737 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -69.09 156.8 38.05 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.708 -0.62 . . . . 0.0 110.569 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.4 p -120.53 156.61 31.2 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.302 1.441 . . . . 0.0 110.804 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.9 t -70.11 -44.54 68.78 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.004 0.521 . . . . 0.0 111.169 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.6 mt -148.29 140.32 24.01 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.566 1.546 . . . . 0.0 111.352 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -134.92 103.41 5.58 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.934 0.894 . . . . 0.0 110.39 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -89.84 -44.32 10.02 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.195 0.998 . . . . 0.0 113.36 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.02 -179.94 12.81 Favored Glycine 0 CA--C 1.543 1.808 0 C-N-CA 124.986 1.279 . . . . 0.0 114.307 -169.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -57.7 160.18 4.63 Favored 'General case' 0 CA--C 1.551 1.008 0 O-C-N 121.603 -0.94 . . . . 0.0 112.03 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.3 mttp -60.47 174.32 0.58 Allowed 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 64.04 33.7 11.93 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.043 1.337 . . . . 0.0 112.667 -177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -136.45 157.43 46.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.874 1.67 . . . . 0.0 111.063 -170.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -77.73 -14.69 59.53 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.079 -1.013 . . . . 0.0 113.197 -176.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 16.5 p -92.38 -34.04 14.32 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.861 1.664 . . . . 0.0 114.195 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.0 p -67.07 -16.38 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.259 1.024 . . . . 0.0 113.52 -173.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 35.9 mm -54.52 -51.8 46.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.635 1.974 . . . . 0.0 112.237 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 51.6 m-20 -144.7 1.16 1.01 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.033 1.333 . . . . 0.0 113.587 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 81.93 170.76 45.04 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.219 1.39 . . . . 0.0 112.934 -171.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.1 mt -126.3 108.13 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.962 1.305 . . . . 0.0 109.192 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -63.98 141.26 58.83 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.7 0.8 . . . . 0.0 112.006 172.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 58.29 22.67 9.57 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.719 1.608 . . . . 0.0 114.456 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 19.0 tptp -55.21 122.94 12.17 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.352 1.061 . . . . 0.0 111.52 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -69.73 129.81 40.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.228 1.011 . . . . 0.0 110.22 169.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.7 mm -127.28 119.75 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.197 0.999 . . . . 0.0 108.661 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mp -113.13 96.45 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 125.053 1.341 . . . . 0.0 108.311 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.9 p -77.44 153.99 33.04 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.835 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -150.61 137.83 19.42 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.857 1.263 . . . . 0.0 111.115 175.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.8 mt -81.85 131.54 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -137.95 122.89 18.96 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.434 1.493 . . . . 0.0 110.644 173.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -73.84 107.58 6.15 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.193 0.997 . . . . 0.0 109.721 171.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 26.1 mt -95.25 97.81 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 175.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 59.02 16.06 4.43 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 126.475 1.91 . . . . 0.0 115.401 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 123.74 -32.32 4.28 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.149 1.357 . . . . 0.0 113.572 177.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 92.0 m -71.64 124.79 25.51 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.102 0.961 . . . . 0.0 108.92 170.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -74.71 118.49 17.73 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.735 -0.603 . . . . 0.0 109.383 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -107.59 166.13 10.9 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.991 1.316 . . . . 0.0 110.367 170.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.6 tp -119.9 133.68 65.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 125.15 1.38 . . . . 0.0 108.341 170.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.0 p -121.9 155.5 35.33 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.45 0.7 . . . . 0.0 109.909 175.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -148.11 140.85 24.64 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.889 0.875 . . . . 0.0 110.925 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.5 m -79.48 110.12 14.49 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.713 0.805 . . . . 0.0 110.197 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.02 -162.17 27.85 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.214 1.388 . . . . 0.0 112.535 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -68.26 162.88 24.09 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.641 -0.917 . . . . 0.0 112.874 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -76.26 108.19 9.03 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.293 1.037 . . . . 0.0 111.185 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.49 163.52 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.283 1.033 . . . . 0.0 112.612 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -102.94 1.85 34.32 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -108.83 13.84 24.64 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.478 1.511 . . . . 0.0 113.761 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.4 t -140.28 176.66 8.58 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.165 1.386 . . . . 0.0 112.267 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -78.95 61.36 4.1 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.998 1.761 . . . . 0.0 114.361 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 51.4 40.73 27.25 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.009 1.723 . . . . 0.0 113.145 -173.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -87.1 -177.94 6.14 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.885 0.874 . . . . 0.0 109.42 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 10.8 m -111.91 146.2 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.018 1.327 . . . . 0.0 110.308 170.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.01 114.46 3.71 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -117.5 138.85 51.6 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.309 1.052 . . . . 0.0 109.898 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -134.68 169.6 17.08 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.416 1.486 . . . . 0.0 111.199 -169.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.03 131.58 19.83 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.4 0.68 . . . . 0.0 109.909 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 59.0 mt -124.78 138.26 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.072 0.949 . . . . 0.0 108.739 177.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.2 m -63.71 94.82 0.1 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.224 1.01 . . . . 0.0 109.649 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.03 -32.2 61.68 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.325 1.05 . . . . 0.0 111.849 176.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -68.48 -29.59 68.25 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 176.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -84.19 -31.37 25.14 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.906 0.882 . . . . 0.0 112.095 174.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 17.9 mt -57.63 -49.5 76.23 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.012 0.925 . . . . 0.0 110.953 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -50.01 -40.79 45.7 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.443 1.097 . . . . 0.0 113.448 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -69.3 -17.86 63.77 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.43 1.492 . . . . 0.0 114.259 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -122.3 -3.28 8.96 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.359 1.464 . . . . 0.0 113.722 -174.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 13.1 mt -92.98 -24.09 18.48 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.042 1.337 . . . . 0.0 111.934 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.252 0 C-N-CA 126.737 2.015 . . . . 0.0 113.925 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 pp -68.91 166.1 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.621 0.768 . . . . 0.0 112.526 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -139.71 145.74 38.73 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.705 1.202 . . . . 0.0 111.307 176.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.8 p -67.23 111.54 4.02 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.619 1.167 . . . . 0.0 111.606 175.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.5 t -151.37 121.19 7.05 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.938 1.295 . . . . 0.0 110.435 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -159.23 163.34 35.96 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.084 1.754 . . . . 0.0 111.07 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -154.4 135.92 14.25 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.98 1.312 . . . . 0.0 109.928 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -114.75 99.54 7.58 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.711 1.204 . . . . 0.0 110.55 -173.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -70.51 133.54 46.88 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.938 0.895 . . . . 0.0 112.277 -173.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.8 t -86.91 75.65 9.54 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.947 1.299 . . . . 0.0 111.625 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 p -143.73 123.76 13.6 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.059 1.344 . . . . 0.0 111.327 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.95 -109.05 3.73 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.087 1.327 . . . . 0.0 112.893 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -142.03 51.34 1.5 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.36 1.464 . . . . 0.0 111.095 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.8 t -68.87 164.27 22.44 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.484 1.114 . . . . 0.0 112.702 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -64.5 136.28 56.89 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.611 1.164 . . . . 0.0 111.538 173.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.5 t -144.27 138.9 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.374 1.87 . . . . 0.0 108.327 176.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.37 173.27 7.46 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.718 1.607 . . . . 0.0 111.579 174.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -139.44 163.12 33.37 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.456 1.902 . . . . 0.0 110.403 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.1 mm -65.32 132.96 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.764 0.826 . . . . 0.0 110.577 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.21 35.6 3.02 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.606 1.562 . . . . 0.0 111.234 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -91.92 -9.4 43.27 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.065 0.946 . . . . 0.0 113.21 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.5 m -77.56 -22.06 51.57 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.791 1.637 . . . . 0.0 113.817 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -152.74 158.58 42.51 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.782 1.633 . . . . 0.0 110.788 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -143.06 168.14 20.44 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.949 0.9 . . . . 0.0 111.118 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -133.97 131.98 39.62 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.645 0.378 . . . . 0.0 111.229 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.5 162.01 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.959 1.704 . . . . 0.0 111.229 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -62.15 159.03 15.5 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.13 0.972 . . . . 0.0 111.776 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.9 tp -153.98 136.43 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.45 1.1 . . . . 0.0 109.876 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -128.82 159.49 35.56 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.105 1.762 . . . . 0.0 109.26 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -130.53 153.8 48.46 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.687 1.195 . . . . 0.0 111.03 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -81.47 119.18 23.4 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 122.152 -0.343 . . . . 0.0 110.505 174.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -71.67 -178.84 2.37 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.563 0.745 . . . . 0.0 112.752 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -54.77 -30.7 57.38 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.702 1.201 . . . . 0.0 113.552 174.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.7 m -81.09 -0.87 41.93 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.071 0.949 . . . . 0.0 113.515 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.99 29.95 73.83 Favored Glycine 0 CA--C 1.536 1.37 0 O-C-N 121.505 -0.747 . . . . 0.0 113.379 -173.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -111.3 135.46 51.81 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.415 1.486 . . . . 0.0 110.043 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -69.01 124.73 24.54 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.031 0.932 . . . . 0.0 110.8 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.2 t -137.89 137.48 38.1 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.782 1.233 . . . . 0.0 110.787 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -56.04 130.75 45.26 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.965 1.306 . . . . 0.0 112.027 -173.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.0 tp -106.54 -47.35 3.79 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.233 0.613 . . . . 0.0 111.521 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.03 -115.83 0.62 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.247 0.451 . . . . 0.0 113.267 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -146.48 157.13 43.71 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.218 1.407 . . . . 0.0 110.087 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.5 tp -121.51 102.72 8.43 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.284 1.434 . . . . 0.0 110.342 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.6 t -78.19 95.13 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.185 1.394 . . . . 0.0 109.07 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.7 t -81.84 99.48 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.735 1.614 . . . . 0.0 109.582 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.2 mtt-85 -98.42 147.19 24.97 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.007 1.323 . . . . 0.0 111.808 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -91.26 128.24 37.01 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.41 1.084 . . . . 0.0 110.353 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -102.18 177.95 4.74 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.927 1.291 . . . . 0.0 111.534 169.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -56.15 -36.82 68.72 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.462 1.105 . . . . 0.0 113.72 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -134.5 67.58 1.5 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.917 1.287 . . . . 0.0 111.901 -175.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 122.85 -158.61 17.5 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 115.337 0.895 . . . . 0.0 115.337 174.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.6 mt -119.3 137.34 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.233 1.013 . . . . 0.0 109.797 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.26 104.05 6.01 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.271 1.828 . . . . 0.0 109.364 -171.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.9 p -98.07 156.14 16.79 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.32 -1.488 . . . . 0.0 111.455 -173.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.52 122.98 1.79 Allowed Glycine 0 CA--C 1.526 0.726 0 O-C-N 121.271 -0.893 . . . . 0.0 112.16 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.87 138.39 50.16 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.002 1.721 . . . . 0.0 110.403 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -134.4 85.3 2.18 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.808 1.643 . . . . 0.0 110.482 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.82 80.92 2.21 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.062 1.745 . . . . 0.0 110.871 -176.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.04 -103.7 0.83 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.092 0.854 . . . . 0.0 112.814 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -96.97 9.72 65.79 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.152 1.358 . . . . 0.0 114.851 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -132.84 128.75 37.34 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.789 1.235 . . . . 0.0 110.919 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 54.3 p -146.68 141.58 26.98 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -176.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.89 160.41 37.62 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.147 1.379 . . . . 0.0 111.659 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.4 m -55.36 127.17 28.22 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.427 -0.795 . . . . 0.0 110.132 170.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -95.09 -48.33 6.0 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.096 0.407 . . . . 0.0 110.644 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -162.9 168.67 20.89 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 122.201 1.001 . . . . 0.0 113.162 170.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.84 139.49 18.81 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.316 -0.865 . . . . 0.0 112.381 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.46 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -129.45 156.13 44.6 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.848 1.659 . . . . 0.0 111.187 -176.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -77.48 167.46 21.61 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.433 0.635 . . . . 0.0 112.363 -174.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -55.41 -36.33 66.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.105 0.962 . . . . 0.0 112.394 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -69.4 -2.92 12.27 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.758 1.223 . . . . 0.0 114.1 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.3 t -119.59 -5.66 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 119.56 1.073 . . . . 0.0 111.453 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.4 t -48.96 -65.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 125.279 1.432 . . . . 0.0 111.85 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -68.45 -27.02 65.81 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.497 -0.752 . . . . 0.0 112.632 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -52.04 65.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.435 1.494 . . . . 0.0 110.596 175.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -60.83 -45.84 92.92 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 124.586 1.154 . . . . 0.0 111.617 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 87.6 t -56.29 -34.16 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.432 0.693 . . . . 0.0 111.25 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -66.98 -57.75 6.27 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.01 0.924 . . . . 0.0 112.278 174.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 m -69.8 -22.19 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 O-C-N 120.821 -1.175 . . . . 0.0 112.551 -175.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.61 -6.64 56.15 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.933 1.693 . . . . 0.0 111.88 175.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 81.7 p -131.4 -12.26 3.52 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -137.45 -6.03 1.78 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.668 1.587 . . . . 0.0 113.771 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.07 156.29 5.3 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 126.04 1.781 . . . . 0.0 113.843 -175.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.99 -171.37 33.27 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.165 0.888 . . . . 0.0 113.12 -174.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 85.1 p -145.1 104.04 3.92 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.507 1.123 . . . . 0.0 113.366 -168.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -134.29 143.77 47.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.179 1.792 . . . . 0.0 110.277 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -71.64 162.66 29.1 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.374 -0.829 . . . . 0.0 112.106 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.2 p -129.56 144.79 51.42 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.456 1.503 . . . . 0.0 111.023 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.46 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 6.7 t -59.07 -43.75 91.79 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.354 1.462 . . . . 0.0 112.534 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.0 mt -155.73 134.41 11.85 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.829 1.652 . . . . 0.0 111.296 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -129.54 102.1 6.23 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.643 1.177 . . . . 0.0 110.696 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -90.38 -41.81 11.28 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.613 1.165 . . . . 0.0 113.965 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 58.15 -173.53 2.97 Favored Glycine 0 CA--C 1.547 2.058 0 C-N-CA 126.222 1.867 . . . . 0.0 115.465 -169.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -62.14 167.07 4.23 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.509 1.124 . . . . 0.0 113.966 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -23.63 53.5 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -72.7 -23.76 60.91 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.538 1.135 . . . . 0.0 113.278 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -62.55 145.46 54.28 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.08 1.752 . . . . 0.0 112.075 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -73.23 -30.95 63.83 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.073 -1.017 . . . . 0.0 112.875 173.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 55.7 m -86.46 -6.76 58.83 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -174.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.2 p -51.64 -23.28 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 175.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.4 mt -62.18 -43.15 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.895 1.278 . . . . 0.0 111.969 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -135.75 -13.59 1.94 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.812 1.245 . . . . 0.0 114.245 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.91 174.51 45.16 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 126.725 2.107 . . . . 0.0 113.646 -171.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.4 mt -119.41 115.53 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.6 1.56 . . . . 0.0 108.152 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -72.96 144.39 47.29 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.097 0.475 . . . . 0.0 111.55 173.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 58.41 24.89 12.25 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 125.754 1.622 . . . . 0.0 114.042 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -62.72 122.81 16.81 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.698 1.199 . . . . 0.0 111.817 -173.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -73.22 124.16 25.1 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.322 1.049 . . . . 0.0 111.428 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.7 mm -118.3 117.79 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.809 1.244 . . . . 0.0 108.882 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.8 mp -110.09 103.37 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 124.984 1.313 . . . . 0.0 108.231 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 59.1 p -85.08 153.14 22.9 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.805 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.17 136.67 20.23 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.163 1.385 . . . . 0.0 111.15 176.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 17.3 mt -81.09 131.67 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -147.69 142.73 27.02 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.793 1.637 . . . . 0.0 110.109 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -84.39 154.85 22.59 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.441 -0.787 . . . . 0.0 109.982 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 49.2 mt -126.55 -46.47 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.989 0.916 . . . . 0.0 110.843 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -148.34 27.49 0.92 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.667 0.787 . . . . 0.0 112.78 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 110.43 -23.0 21.45 Favored Glycine 0 N--CA 1.472 1.096 0 O-C-N 121.233 -0.917 . . . . 0.0 113.71 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 52.8 m -87.58 141.45 28.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.693 0.797 . . . . 0.0 108.888 169.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.74 121.88 23.2 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.484 0.714 . . . . 0.0 109.35 170.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -107.69 165.16 11.64 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.416 1.486 . . . . 0.0 110.522 174.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.8 tp -122.21 132.22 71.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 125.327 1.451 . . . . 0.0 107.848 172.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 p -119.47 156.59 29.94 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.188 0.595 . . . . 0.0 109.794 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -152.03 141.51 21.64 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.103 0.961 . . . . 0.0 111.297 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.2 m -78.7 114.38 17.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.478 1.111 . . . . 0.0 110.484 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.33 -167.26 43.13 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.308 0.956 . . . . 0.0 112.876 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -68.08 171.47 6.87 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.749 -0.853 . . . . 0.0 112.62 168.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -81.05 136.26 35.94 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.243 -0.911 . . . . 0.0 112.114 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.46 163.11 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.815 0.846 . . . . 0.0 112.729 171.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -99.47 -14.62 19.02 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 173.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -95.46 22.5 6.92 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.38 1.472 . . . . 0.0 113.022 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.86 -34.22 0.32 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 113.79 74.72 0.65 Allowed Glycine 0 N--CA 1.476 1.328 0 CA-C-N 119.323 0.965 . . . . 0.0 113.725 170.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 57.86 29.63 17.83 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.35 1.46 . . . . 0.0 113.549 -176.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -96.04 150.71 20.17 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.607 1.163 . . . . 0.0 108.472 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.9 m -86.88 137.22 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 122.781 0.432 . . . . 0.0 110.061 171.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.09 117.16 11.31 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -106.1 148.81 27.38 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 122.009 0.909 . . . . 0.0 109.743 171.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -132.8 172.42 12.6 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.122 1.369 . . . . 0.0 111.491 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.86 133.09 23.08 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.518 0.727 . . . . 0.0 110.156 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 64.0 mt -126.47 138.66 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.133 0.973 . . . . 0.0 108.918 175.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.4 m -64.54 97.39 0.2 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.362 -0.836 . . . . 0.0 110.225 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.5 tt -54.16 -31.03 51.44 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.111 1.364 . . . . 0.0 112.179 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -72.73 -26.03 61.43 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -89.43 -26.03 21.19 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.972 -1.08 . . . . 0.0 112.053 173.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 14.5 mt -61.49 -46.55 89.52 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.849 0.86 . . . . 0.0 110.813 172.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -55.18 -36.93 66.4 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -67.91 -15.24 63.52 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -124.22 -6.04 7.76 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.094 1.358 . . . . 0.0 114.111 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 13.4 mt -93.29 -26.29 17.38 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.471 1.508 . . . . 0.0 112.396 -175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt . . . . . 0 C--O 1.252 1.217 0 C-N-CA 126.271 1.828 . . . . 0.0 112.916 175.827 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? . . . . . 0 N--CA 1.498 1.928 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.9 pt -105.63 171.04 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 125.037 1.335 . . . . 0.0 111.483 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -129.83 122.47 28.8 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.847 1.259 . . . . 0.0 109.835 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.4 t -65.15 162.69 16.53 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.432 0.693 . . . . 0.0 111.962 174.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.0 p 44.94 33.6 1.05 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.675 1.99 . . . . 0.0 115.237 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -56.61 149.74 16.99 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.033 1.333 . . . . 0.0 113.334 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.93 130.09 42.69 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.542 0.737 . . . . 0.0 111.623 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -127.25 34.24 4.75 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.856 1.662 . . . . 0.0 111.913 -174.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 65.39 50.86 1.65 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.213 1.805 . . . . 0.0 111.753 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 72.9 m -143.33 140.52 30.59 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.642 1.577 . . . . 0.0 112.168 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.3 p -76.23 116.71 17.19 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.595 1.158 . . . . 0.0 111.911 175.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 161.05 79.88 0.03 OUTLIER Glycine 0 CA--C 1.533 1.193 0 C-N-CA 123.679 0.657 . . . . 0.0 113.782 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -68.64 174.33 4.34 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.907 0.883 . . . . 0.0 113.252 173.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.7 m -58.38 167.42 1.38 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.69 1.596 . . . . 0.0 113.834 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -70.89 73.7 0.59 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.727 1.611 . . . . 0.0 112.892 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 p -158.67 148.14 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 127.628 2.371 . . . . 0.0 108.579 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.26 164.01 26.53 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.052 1.741 . . . . 0.0 110.798 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.69 160.01 31.07 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.142 0.977 . . . . 0.0 111.755 174.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.0 mm -66.94 128.19 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.371 0.668 . . . . 0.0 111.736 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -118.08 13.25 13.82 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.09 1.356 . . . . 0.0 112.772 -177.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -79.01 -7.89 58.48 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 120.857 -1.152 . . . . 0.0 113.548 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 m -87.49 15.61 6.43 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.893 2.077 . . . . 0.0 113.307 173.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.9 pttt -145.28 165.83 27.28 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.726 1.21 . . . . 0.0 111.31 172.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -144.3 169.39 17.99 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.553 1.141 . . . . 0.0 110.587 170.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -132.6 129.35 38.83 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.742 -0.599 . . . . 0.0 110.17 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.35 167.99 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.196 1.399 . . . . 0.0 110.896 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.34 164.22 7.47 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.639 1.176 . . . . 0.0 111.428 175.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.6 tp -158.72 137.26 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.774 1.229 . . . . 0.0 109.558 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -127.82 162.63 26.22 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.417 1.887 . . . . 0.0 110.073 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -132.12 156.69 45.92 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.304 1.441 . . . . 0.0 111.232 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.51 121.27 24.37 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 171.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -63.88 174.6 1.41 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.065 0.946 . . . . 0.0 111.992 171.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -57.58 -14.79 5.81 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.343 1.857 . . . . 0.0 114.857 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.2 m -115.56 14.16 16.51 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.885 1.274 . . . . 0.0 112.872 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.04 21.07 78.95 Favored Glycine 0 CA--C 1.537 1.438 0 O-C-N 121.335 -0.853 . . . . 0.0 114.393 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -96.59 125.79 41.31 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.68 1.192 . . . . 0.0 109.649 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -66.87 126.14 28.15 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.898 -0.501 . . . . 0.0 110.873 174.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.2 t -140.75 136.02 32.11 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.715 1.206 . . . . 0.0 110.81 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -55.7 131.57 46.9 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.771 1.229 . . . . 0.0 112.354 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 38.8 tp -104.87 -47.73 3.95 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.985 0.914 . . . . 0.0 111.279 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.75 -118.96 0.78 Allowed Glycine 0 CA--C 1.529 0.963 0 N-CA-C 113.978 0.351 . . . . 0.0 113.978 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -141.16 151.73 44.11 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.356 1.462 . . . . 0.0 110.366 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.4 tp -116.96 101.45 8.52 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.409 1.484 . . . . 0.0 109.878 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.1 t -77.45 97.46 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.098 1.359 . . . . 0.0 109.336 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.3 t -84.3 84.42 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.614 1.566 . . . . 0.0 110.296 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -73.9 110.7 8.4 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.795 0.838 . . . . 0.0 110.406 170.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -78.47 88.49 4.44 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.656 1.182 . . . . 0.0 109.227 169.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -67.54 172.09 5.47 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.908 1.283 . . . . 0.0 112.485 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -65.4 -39.36 92.1 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.697 -1.252 . . . . 0.0 113.383 175.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -117.6 40.66 3.03 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.407 1.483 . . . . 0.0 112.806 -169.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.06 -161.01 24.82 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.934 1.73 . . . . 0.0 114.051 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.1 mt -119.71 142.95 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.938 0.895 . . . . 0.0 109.431 169.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -132.72 92.43 3.05 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.331 1.453 . . . . 0.0 110.573 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.8 p -84.54 150.36 25.28 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.24 -0.912 . . . . 0.0 112.508 -174.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.73 120.01 1.57 Allowed Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.42 -0.8 . . . . 0.0 113.791 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -70.88 139.92 50.93 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.53 1.932 . . . . 0.0 110.588 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -134.07 78.22 1.75 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.193 1.797 . . . . 0.0 110.708 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.98 86.48 5.86 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.123 0.969 . . . . 0.0 110.939 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 62.45 -98.41 0.2 Allowed Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.566 1.079 . . . . 0.0 112.974 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.98 15.49 33.67 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.7 1.619 . . . . 0.0 114.424 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -132.72 73.14 1.51 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.803 1.241 . . . . 0.0 111.66 -174.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 77.6 p -87.35 149.74 24.3 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -167.4 157.66 11.0 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.411 1.484 . . . . 0.0 112.189 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.3 m -54.05 124.42 15.52 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.3 1.04 . . . . 0.0 110.791 171.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -92.07 -52.64 4.61 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.883 0.473 . . . . 0.0 110.426 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -163.92 153.05 13.97 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.871 0.868 . . . . 0.0 112.691 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.56 128.11 21.46 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 122.75 1.262 . . . . 0.0 112.553 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.96 163.79 16.04 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.13 1.772 . . . . 0.0 111.38 -173.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -79.72 162.05 25.41 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.404 1.082 . . . . 0.0 112.436 -175.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -55.44 -33.05 63.24 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.319 1.047 . . . . 0.0 113.055 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -70.33 -8.38 50.02 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 37.5 t -114.29 -14.56 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 121.3 -0.875 . . . . 0.0 112.028 -171.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 42.2 t -48.15 -55.81 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.502 1.121 . . . . 0.0 111.372 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -65.41 -32.87 74.72 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -69.8 -43.63 71.71 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.029 0.932 . . . . 0.0 111.343 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -58.83 -46.88 86.64 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.632 1.173 . . . . 0.0 110.736 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 92.6 t -53.94 -37.51 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.395 1.078 . . . . 0.0 111.377 175.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.87 -57.38 4.67 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.5 1.52 . . . . 0.0 112.656 176.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -71.91 -7.5 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 O-C-N 121.212 -0.93 . . . . 0.0 113.125 -175.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.58 -5.69 45.26 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.01 1.724 . . . . 0.0 111.932 176.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 47.4 p -128.89 -14.85 4.41 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.909 0.883 . . . . 0.0 112.958 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -131.97 -9.73 3.44 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.617 1.567 . . . . 0.0 114.593 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.63 157.14 7.51 Favored Glycine 0 CA--C 1.539 1.574 0 C-N-CA 125.294 1.426 . . . . 0.0 113.76 -173.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.52 -153.62 24.66 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 121.543 -0.975 . . . . 0.0 113.175 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 80.1 p -145.52 151.98 39.02 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.18 0.992 . . . . 0.0 113.148 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -148.27 -177.69 5.9 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.55 1.94 . . . . 0.0 112.177 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? -117.41 156.16 28.4 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.937 1.295 . . . . 0.0 111.657 170.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.9 p -126.17 130.81 51.73 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.977 0.911 . . . . 0.0 111.892 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.9 t -51.9 -37.55 52.85 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.409 1.084 . . . . 0.0 112.995 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.0 mt -147.62 141.31 25.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.233 1.413 . . . . 0.0 112.364 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -136.35 93.55 2.91 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.525 1.13 . . . . 0.0 110.643 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -81.7 -49.06 10.9 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.829 0.851 . . . . 0.0 113.121 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.21 177.42 43.2 Favored Glycine 0 CA--C 1.543 1.816 0 C-N-CA 125.06 1.314 . . . . 0.0 113.874 -169.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -62.93 165.4 6.85 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.085 0.954 . . . . 0.0 112.253 170.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.6 ttpp -57.93 -26.02 61.68 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.19 44.47 0.41 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.331 1.452 . . . . 0.0 113.041 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -135.0 166.02 24.01 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.053 2.141 . . . . 0.0 112.289 -173.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -88.81 -42.84 11.66 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.59 0.756 . . . . 0.0 111.409 169.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.6 t -59.01 -43.07 91.5 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.2 p -48.92 -24.67 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 115.759 1.762 . . . . 0.0 115.759 -169.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 56.8 mt -61.18 -35.17 63.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 126.721 2.008 . . . . 0.0 113.051 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -140.05 -39.01 0.45 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.575 1.55 . . . . 0.0 114.321 -171.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 104.27 166.2 24.75 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.136 1.827 . . . . 0.0 114.055 -176.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 52.7 mt -123.39 120.44 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 126.095 1.758 . . . . 0.0 108.866 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -82.31 145.01 30.2 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 57.79 24.49 10.81 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.478 1.911 . . . . 0.0 113.938 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -60.34 125.74 24.82 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.856 1.262 . . . . 0.0 111.363 -173.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -76.61 126.61 31.29 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.845 0.458 . . . . 0.0 110.925 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.3 mm -119.95 120.59 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 126.094 1.758 . . . . 0.0 109.065 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.1 mp -115.06 105.93 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.233 1.413 . . . . 0.0 108.231 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.8 p -80.97 161.63 24.21 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.777 0.799 . . . . 0.0 112.203 174.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -152.15 142.22 22.24 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.91 1.284 . . . . 0.0 110.77 171.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 52.4 mt -82.61 132.14 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -139.89 120.34 14.06 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.303 1.441 . . . . 0.0 110.273 174.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -72.19 117.89 14.38 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.85 -0.531 . . . . 0.0 109.79 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 24.6 mt -103.8 97.86 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 60.85 12.04 3.58 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.688 1.995 . . . . 0.0 115.917 -177.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 130.21 -34.9 2.62 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.997 1.284 . . . . 0.0 113.358 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 91.5 m -72.81 126.19 29.32 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.395 1.078 . . . . 0.0 109.413 171.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -74.79 118.78 18.14 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 173.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -107.93 165.9 11.11 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.821 1.248 . . . . 0.0 110.055 170.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.9 tp -117.0 137.28 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.332 1.453 . . . . 0.0 107.922 169.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 p -124.88 156.87 37.21 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.571 0.623 . . . . 0.0 110.098 172.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -149.63 135.89 19.02 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.988 0.915 . . . . 0.0 111.158 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.2 t -70.61 127.89 34.22 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.065 0.46 . . . . 0.0 110.381 172.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.59 -154.25 26.06 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.816 1.674 . . . . 0.0 112.044 175.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -69.07 169.33 12.07 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 121.936 0.874 . . . . 0.0 112.352 169.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -87.98 112.07 22.19 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.451 1.5 . . . . 0.0 111.528 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.83 162.54 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.628 0.771 . . . . 0.0 112.009 177.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -100.03 -23.19 14.96 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.703 0.801 . . . . 0.0 113.066 171.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -66.32 -8.43 25.1 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.557 1.543 . . . . 0.0 114.887 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.04 -30.56 3.48 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.012 1.325 . . . . 0.0 113.566 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 139.59 -78.42 0.3 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.179 1.371 . . . . 0.0 112.843 169.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -142.32 22.09 2.04 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.164 2.186 . . . . 0.0 110.8 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -86.04 167.58 14.88 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.497 1.119 . . . . 0.0 109.337 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.3 m -100.64 139.35 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.304 0.642 . . . . 0.0 110.288 175.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -65.94 104.28 1.08 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 171.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -104.53 145.7 29.92 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.523 1.154 . . . . 0.0 110.86 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -134.47 167.15 21.29 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.679 1.591 . . . . 0.0 110.719 -169.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.02 134.93 26.87 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.346 0.521 . . . . 0.0 110.349 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 51.3 mt -129.67 139.89 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.802 0.841 . . . . 0.0 109.334 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.7 m -63.73 95.46 0.11 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.018 0.927 . . . . 0.0 109.848 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.07 -33.32 51.55 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.602 1.161 . . . . 0.0 111.516 175.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -67.56 -27.49 66.98 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -86.73 -31.53 20.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.991 0.916 . . . . 0.0 111.949 172.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 18.9 mt -62.1 -44.1 97.4 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.847 0.859 . . . . 0.0 111.264 174.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -50.5 -41.8 53.9 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.31 1.044 . . . . 0.0 112.84 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -67.67 -20.2 65.27 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -109.42 1.98 20.29 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.897 1.679 . . . . 0.0 112.704 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 17.2 mt -112.31 -17.6 12.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.535 1.534 . . . . 0.0 113.691 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt . . . . . 0 C--O 1.253 1.261 0 C-N-CA 126.279 1.832 . . . . 0.0 113.252 173.026 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 tp -68.03 148.86 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 120.154 -1.591 . . . . 0.0 111.666 175.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -150.92 162.89 39.93 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.928 1.291 . . . . 0.0 111.828 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -154.96 164.35 39.01 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.638 1.575 . . . . 0.0 110.924 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.7 m -127.56 49.1 2.15 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.373 1.869 . . . . 0.0 110.46 -176.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 67.28 26.02 8.68 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.787 2.035 . . . . 0.0 113.96 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -85.37 149.6 25.33 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.172 1.389 . . . . 0.0 112.882 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -154.18 139.82 17.93 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.135 1.774 . . . . 0.0 110.413 175.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -103.59 73.72 1.2 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.817 1.247 . . . . 0.0 111.278 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.7 m -61.75 103.19 0.32 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.266 1.426 . . . . 0.0 112.335 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.2 p -77.04 59.35 1.66 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.776 2.03 . . . . 0.0 113.268 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.24 75.94 2.13 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 126.084 1.802 . . . . 0.0 114.181 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -101.32 158.06 16.33 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.861 1.264 . . . . 0.0 112.812 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.6 t -155.02 179.58 9.01 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.894 1.678 . . . . 0.0 111.752 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -109.15 54.72 0.65 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.692 1.997 . . . . 0.0 111.547 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 t -132.91 56.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 125.785 1.634 . . . . 0.0 110.636 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -143.72 171.27 14.43 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 126.765 2.026 . . . . 0.0 112.048 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -52.48 141.64 19.6 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.676 1.591 . . . . 0.0 111.289 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 37.0 mm -65.97 136.99 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.713 0.805 . . . . 0.0 111.33 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -116.25 -12.67 11.14 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.865 1.266 . . . . 0.0 113.393 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -91.73 -6.78 51.33 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.5 t -56.87 -34.37 67.78 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.109 1.763 . . . . 0.0 112.735 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -144.93 162.94 35.64 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.408 1.483 . . . . 0.0 111.081 169.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -145.89 165.69 28.18 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.769 1.228 . . . . 0.0 110.495 173.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -131.76 125.79 32.82 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.596 0.358 . . . . 0.0 110.464 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.9 m -118.79 165.96 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.021 1.329 . . . . 0.0 110.927 177.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -68.06 161.79 26.01 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.544 1.138 . . . . 0.0 110.995 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.2 tp -153.37 136.29 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.436 1.095 . . . . 0.0 109.667 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -127.21 161.3 28.86 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.197 1.799 . . . . 0.0 109.741 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -132.01 154.37 49.43 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 126.098 1.759 . . . . 0.0 110.749 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -76.09 124.74 27.89 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 169.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -67.43 175.68 2.67 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 122.241 1.019 . . . . 0.0 111.327 170.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -59.81 -11.73 5.92 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.234 2.213 . . . . 0.0 114.778 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.8 t -116.51 12.93 15.26 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.111 1.364 . . . . 0.0 112.821 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.31 19.71 79.38 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 121.312 -0.867 . . . . 0.0 114.615 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -95.59 129.38 42.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.778 1.231 . . . . 0.0 109.477 176.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -68.98 127.75 34.25 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.637 -0.664 . . . . 0.0 110.567 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.7 t -138.86 147.04 41.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.878 1.671 . . . . 0.0 110.241 -175.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -66.49 137.38 56.77 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.051 -1.031 . . . . 0.0 111.626 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.8 tp -110.83 -46.9 3.29 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.876 0.87 . . . . 0.0 112.291 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.27 -133.31 2.39 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 121.703 0.613 . . . . 0.0 114.612 -174.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -132.65 155.91 47.9 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.511 1.924 . . . . 0.0 110.953 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.8 tp -122.96 104.27 9.14 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.275 1.43 . . . . 0.0 110.539 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.4 t -81.57 97.48 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.48 1.512 . . . . 0.0 109.462 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.03 117.47 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.914 1.286 . . . . 0.0 109.671 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -113.77 128.24 56.33 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.925 2.09 . . . . 0.0 110.535 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -83.64 83.67 7.82 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.155 0.982 . . . . 0.0 110.629 174.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -65.77 171.66 4.13 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.073 0.949 . . . . 0.0 112.193 170.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -68.89 -31.98 71.3 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.002 -1.062 . . . . 0.0 113.746 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -126.54 47.07 2.35 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.761 1.224 . . . . 0.0 112.356 -168.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.12 -155.99 21.75 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.834 1.207 . . . . 0.0 113.964 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 68.5 mt -122.1 136.84 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.928 0.891 . . . . 0.0 109.52 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.65 142.82 47.29 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.15 1.38 . . . . 0.0 109.253 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.1 p -133.54 139.85 46.85 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.277 0.631 . . . . 0.0 110.016 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.61 107.83 0.65 Allowed Glycine 0 CA--C 1.521 0.421 0 CA-C-O 121.843 0.69 . . . . 0.0 111.61 -169.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 33.1 tp -64.09 144.56 57.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.616 1.166 . . . . 0.0 110.174 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -134.47 70.35 1.45 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.917 2.087 . . . . 0.0 109.294 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.38 77.81 9.86 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.402 1.081 . . . . 0.0 112.092 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.36 -81.51 1.08 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.506 1.527 . . . . 0.0 113.437 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -134.74 24.45 3.48 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.086 1.803 . . . . 0.0 112.993 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -135.84 50.18 2.1 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.383 1.473 . . . . 0.0 110.917 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.4 p -64.26 141.66 58.69 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.321 -0.862 . . . . 0.0 113.056 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -164.05 158.22 19.2 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.128 1.371 . . . . 0.0 111.885 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.7 m -58.82 118.34 5.63 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.024 -1.047 . . . . 0.0 109.313 169.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -82.22 -48.45 11.26 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.001 -0.437 . . . . 0.0 109.949 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -164.82 161.4 20.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.836 0.855 . . . . 0.0 113.074 170.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.87 149.41 33.2 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.985 1.374 . . . . 0.0 113.08 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.401 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.5 OUTLIER -135.92 160.31 38.99 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.31 1.444 . . . . 0.0 111.715 -175.55 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -80.13 165.99 21.92 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.3 0.64 . . . . 0.0 112.387 -175.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -54.18 -34.85 61.49 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.136 0.975 . . . . 0.0 112.771 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -67.65 -4.58 12.43 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.578 1.151 . . . . 0.0 114.086 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.84 -3.57 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.336 1.054 . . . . 0.0 111.399 -175.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.9 t -51.21 -65.38 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.261 1.424 . . . . 0.0 111.352 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -69.11 -24.06 64.07 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -50.51 68.76 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.321 1.449 . . . . 0.0 110.438 172.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -61.43 -42.56 98.95 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 124.666 1.186 . . . . 0.0 111.798 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.5 t -56.04 -35.14 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.103 0.561 . . . . 0.0 110.882 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -69.94 -54.26 14.15 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.939 1.296 . . . . 0.0 112.949 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.0 m -74.34 -6.33 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 120.933 -1.104 . . . . 0.0 112.967 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.77 -4.85 36.18 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.028 1.731 . . . . 0.0 111.742 176.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 44.7 p -132.06 -17.5 2.73 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.733 1.213 . . . . 0.0 113.496 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -131.76 -11.13 3.46 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.15 1.78 . . . . 0.0 113.667 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.21 155.8 11.62 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.977 1.275 . . . . 0.0 113.738 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 164.12 -159.43 32.25 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 121.784 -0.833 . . . . 0.0 114.299 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.6 p -154.09 89.35 1.29 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -168.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -124.42 141.71 51.87 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.769 1.628 . . . . 0.0 110.528 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -69.87 162.62 27.6 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.462 0.705 . . . . 0.0 111.54 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.2 p -130.51 147.64 52.22 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.507 1.523 . . . . 0.0 111.391 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.401 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 5.1 t -65.27 -40.36 93.82 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.874 0.87 . . . . 0.0 111.858 -178.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.8 mt -150.73 137.71 19.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.686 1.594 . . . . 0.0 111.794 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -139.03 100.54 4.05 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.642 0.777 . . . . 0.0 110.868 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -94.95 -38.59 10.62 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.13 -169.78 16.58 Favored Glycine 0 CA--C 1.543 1.815 0 C-N-CA 125.032 1.301 . . . . 0.0 115.478 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -71.15 165.9 22.61 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.169 0.988 . . . . 0.0 112.62 169.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -52.83 -28.64 23.74 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.643 1.577 . . . . 0.0 115.236 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -54.76 -35.91 64.27 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 174.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -67.16 132.48 47.89 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.964 0.906 . . . . 0.0 112.682 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -56.73 -35.14 68.21 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.602 1.161 . . . . 0.0 113.239 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.83 16.5 12.31 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -176.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.5 p -60.25 -17.36 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 55.3 mt -112.41 -47.47 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.905 0.882 . . . . 0.0 111.476 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -71.27 -20.8 62.17 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.95 0.9 . . . . 0.0 112.565 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 61.22 -174.77 5.83 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.75 1.643 . . . . 0.0 113.574 -170.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.2 mt -140.83 101.66 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.036 1.335 . . . . 0.0 107.738 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -69.32 145.07 53.3 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.191 0.519 . . . . 0.0 111.32 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 60.38 20.79 10.37 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.673 1.589 . . . . 0.0 113.821 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -55.37 123.65 14.56 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.864 1.266 . . . . 0.0 111.161 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -71.58 127.62 33.16 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.832 0.853 . . . . 0.0 110.319 170.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.3 mm -123.01 117.69 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.687 1.195 . . . . 0.0 108.56 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.37 99.01 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 125.178 1.391 . . . . 0.0 107.8 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.7 p -81.55 157.06 24.92 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.726 0.774 . . . . 0.0 111.064 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -151.52 137.56 18.22 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.467 1.107 . . . . 0.0 110.808 176.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 52.4 mt -80.6 132.67 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -139.56 121.67 15.78 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.375 1.47 . . . . 0.0 110.314 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -74.26 115.6 13.94 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.855 -0.528 . . . . 0.0 109.806 169.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.5 mt -102.02 96.68 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 60.82 13.28 4.31 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.743 2.017 . . . . 0.0 115.917 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 128.8 -33.32 3.12 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 124.955 1.264 . . . . 0.0 113.405 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 88.5 m -73.18 125.65 28.23 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.495 1.118 . . . . 0.0 109.228 171.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -75.94 117.72 17.96 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.699 -0.625 . . . . 0.0 109.646 174.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -107.02 166.18 10.8 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.154 1.382 . . . . 0.0 110.382 171.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.0 tp -118.08 137.87 50.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 125.414 1.485 . . . . 0.0 108.296 169.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.6 p -125.94 155.95 40.52 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.44 0.696 . . . . 0.0 110.024 174.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -150.51 137.47 19.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.167 0.987 . . . . 0.0 111.213 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.7 m -78.81 119.19 21.67 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.526 1.131 . . . . 0.0 110.691 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.4 -156.29 32.58 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.929 1.252 . . . . 0.0 113.256 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -66.51 161.78 22.17 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.253 1.021 . . . . 0.0 112.694 171.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -77.93 110.06 12.52 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.665 1.186 . . . . 0.0 110.506 173.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.61 157.47 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.21 0.528 . . . . 0.0 111.929 175.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.24 -27.06 15.7 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 176.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -76.28 -20.91 56.89 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.379 1.071 . . . . 0.0 113.247 -176.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.9 t -96.36 -41.07 8.81 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.66 83.89 1.5 Allowed Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.335 0.969 . . . . 0.0 113.53 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 62.23 13.98 6.33 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.151 1.78 . . . . 0.0 114.92 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -90.18 154.05 20.05 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.946 0.898 . . . . 0.0 108.885 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.3 m -91.51 143.1 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 122.712 0.405 . . . . 0.0 110.548 173.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.83 130.22 43.89 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 168.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -128.0 143.73 51.09 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.571 1.177 . . . . 0.0 111.488 173.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -135.55 169.8 16.95 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 126.093 1.757 . . . . 0.0 111.069 -169.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.83 135.22 24.3 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 122.934 0.494 . . . . 0.0 110.248 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 63.2 mt -127.32 141.24 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 123.738 0.815 . . . . 0.0 108.98 175.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.8 m -62.2 94.74 0.06 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.204 1.002 . . . . 0.0 109.753 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.05 -32.93 56.01 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.904 0.882 . . . . 0.0 111.464 174.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -66.74 -30.62 70.89 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -82.57 -32.14 28.65 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.053 0.941 . . . . 0.0 111.851 173.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 18.7 mt -60.39 -45.98 91.64 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.645 0.778 . . . . 0.0 111.39 175.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -51.29 -42.63 61.28 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 119.044 0.838 . . . . 0.0 112.833 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -64.7 -18.53 65.08 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.244 1.418 . . . . 0.0 113.996 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -116.32 -2.49 12.1 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.876 1.67 . . . . 0.0 113.287 -177.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 19.3 mt -104.01 -24.49 13.22 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.522 1.529 . . . . 0.0 113.342 -177.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 82.3 mttt . . . . . 0 C--O 1.254 1.342 0 C-N-CA 126.865 2.066 . . . . 0.0 113.245 174.835 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.4 mttm . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.6 pt -67.67 168.69 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.904 0.882 . . . . 0.0 112.494 174.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -123.44 153.8 39.94 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.301 1.441 . . . . 0.0 111.109 175.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.5 t -148.91 163.59 36.99 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.327 1.451 . . . . 0.0 111.122 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.8 m -129.4 172.87 11.08 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.728 1.611 . . . . 0.0 111.458 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -119.02 76.56 1.12 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.696 1.199 . . . . 0.0 110.869 -174.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -72.64 69.84 0.91 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.28 1.832 . . . . 0.0 112.989 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -144.09 159.15 43.11 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.58 1.552 . . . . 0.0 111.189 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -60.39 130.69 47.85 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.472 1.109 . . . . 0.0 111.948 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.7 m -151.04 159.45 44.53 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.421 1.489 . . . . 0.0 111.97 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.3 p -84.99 159.29 20.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.026 1.33 . . . . 0.0 112.525 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 135.0 -110.04 0.81 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.919 1.247 . . . . 0.0 112.344 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 54.3 27.06 7.49 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.272 1.829 . . . . 0.0 113.956 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.8 t -91.0 61.97 4.77 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.853 1.661 . . . . 0.0 111.799 -174.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.97 169.61 17.75 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.744 1.618 . . . . 0.0 112.192 175.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.6 m -124.11 41.74 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 126.341 1.856 . . . . 0.0 110.711 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -147.94 167.06 25.83 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.938 2.095 . . . . 0.0 110.853 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -36.92 117.13 0.49 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.519 1.928 . . . . 0.0 112.28 173.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.441 HG21 ' H ' ' A' ' 41' ' ' PHE . 15.8 mm -71.66 154.78 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.193 0.597 . . . . 0.0 109.739 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.0 -21.91 66.42 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 172.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.441 ' H ' HG21 ' A' ' 39' ' ' ILE . 9.5 m-85 -80.97 172.1 14.16 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.211 1.805 . . . . 0.0 112.485 174.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.0 m -75.25 -25.59 58.19 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.326 1.05 . . . . 0.0 112.872 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -97.04 161.68 13.72 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.53 1.132 . . . . 0.0 111.589 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -140.95 166.6 24.33 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.935 1.294 . . . . 0.0 111.42 170.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 m -134.74 130.35 36.06 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.591 0.357 . . . . 0.0 110.744 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.1 m -128.24 165.27 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.795 1.638 . . . . 0.0 110.853 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -63.42 163.02 11.48 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.58 1.152 . . . . 0.0 111.736 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.3 tp -159.28 137.04 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.787 1.235 . . . . 0.0 110.044 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -129.06 162.62 27.25 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.043 2.137 . . . . 0.0 109.362 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -129.3 157.9 40.59 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.152 1.381 . . . . 0.0 111.116 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -78.83 119.96 22.78 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 169.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.89 172.47 1.7 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.51 1.124 . . . . 0.0 112.154 171.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -53.29 -18.02 2.17 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.199 1.8 . . . . 0.0 115.518 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.9 m -112.07 13.53 20.68 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.322 1.049 . . . . 0.0 113.16 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.54 20.67 79.49 Favored Glycine 0 CA--C 1.537 1.45 0 O-C-N 121.213 -0.93 . . . . 0.0 114.181 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -97.4 125.87 42.29 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.797 1.239 . . . . 0.0 109.703 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -67.09 126.22 28.5 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.772 -0.58 . . . . 0.0 110.628 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.3 t -141.16 140.1 34.01 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.834 1.254 . . . . 0.0 110.842 -174.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -56.77 135.03 55.47 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.229 1.012 . . . . 0.0 112.781 -175.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.6 tp -109.18 -48.39 3.27 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.695 0.798 . . . . 0.0 111.139 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.5 -113.14 0.51 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 123.137 0.399 . . . . 0.0 113.663 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -146.61 157.56 43.74 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.439 1.495 . . . . 0.0 109.949 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.1 tp -122.9 102.19 7.87 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.504 1.521 . . . . 0.0 110.022 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.67 95.58 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.636 1.574 . . . . 0.0 109.561 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.8 t -84.18 104.57 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.211 1.804 . . . . 0.0 110.252 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -94.33 122.65 37.1 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 127.098 2.159 . . . . 0.0 111.346 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -87.69 98.64 11.55 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.105 1.362 . . . . 0.0 110.321 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -89.33 177.47 6.58 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.813 1.245 . . . . 0.0 111.764 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -71.21 -19.15 62.42 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 175.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -131.2 73.85 1.56 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.894 1.677 . . . . 0.0 110.883 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.67 -170.33 40.1 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.354 0.978 . . . . 0.0 114.026 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.3 mt -111.76 140.32 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.12 0.968 . . . . 0.0 109.404 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -128.99 130.1 46.24 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.282 1.433 . . . . 0.0 109.6 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.2 p -119.79 148.51 43.35 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.375 -0.828 . . . . 0.0 111.198 -172.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.49 125.01 2.64 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-O 121.513 0.507 . . . . 0.0 112.788 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.8 138.2 52.48 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.077 1.751 . . . . 0.0 110.402 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -136.05 75.96 1.58 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.119 1.768 . . . . 0.0 110.885 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.99 173.95 9.57 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.709 1.604 . . . . 0.0 112.237 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.12 93.56 0.07 OUTLIER Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.225 1.393 . . . . 0.0 113.255 175.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.73 14.66 77.36 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.813 1.197 . . . . 0.0 115.079 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -150.41 125.02 9.67 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.98 1.39 . . . . 0.0 111.391 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 77.3 p -145.79 142.34 28.79 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -164.88 164.27 20.9 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.706 1.603 . . . . 0.0 111.594 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.5 m -54.89 130.76 42.45 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 121.382 -0.824 . . . . 0.0 110.612 170.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -97.5 -50.91 4.33 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.897 0.879 . . . . 0.0 110.175 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -163.86 158.45 19.94 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.883 0.873 . . . . 0.0 112.728 171.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.46 133.25 27.29 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 122.092 0.948 . . . . 0.0 111.943 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.43 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -108.3 160.38 15.9 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.108 1.363 . . . . 0.0 111.669 -178.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -76.95 165.4 24.72 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.91 0.862 . . . . 0.0 112.334 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -60.04 -26.6 66.25 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.021 0.928 . . . . 0.0 112.764 172.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -74.21 -3.96 33.02 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 172.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.1 t -117.91 -2.7 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.347 1.059 . . . . 0.0 110.883 -173.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.2 m -57.14 -29.33 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -176.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -98.96 -25.91 14.43 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.281 1.033 . . . . 0.0 111.851 171.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -71.27 -49.16 45.86 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.906 1.682 . . . . 0.0 111.6 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -59.68 -45.33 92.39 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.373 1.069 . . . . 0.0 110.918 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 73.3 t -55.67 -39.4 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.724 0.81 . . . . 0.0 110.367 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -60.58 -55.22 35.93 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.533 1.533 . . . . 0.0 112.224 174.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.0 m -70.9 -14.91 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 121.12 -0.987 . . . . 0.0 112.785 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.3 -4.6 55.71 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.274 1.83 . . . . 0.0 111.824 178.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.5 p -127.84 -15.56 4.85 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.63 1.172 . . . . 0.0 114.002 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -134.24 -9.8 2.58 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.272 1.429 . . . . 0.0 114.281 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.97 156.42 9.89 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.159 1.362 . . . . 0.0 113.825 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.03 -170.61 32.64 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.65 1.119 . . . . 0.0 113.524 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 56.7 p -144.36 103.81 4.01 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.756 1.222 . . . . 0.0 113.423 -168.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -133.81 156.54 47.85 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.145 1.778 . . . . 0.0 110.289 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 165.01 20.13 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.272 -0.892 . . . . 0.0 111.288 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.6 p -131.91 146.57 52.19 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.299 1.439 . . . . 0.0 111.273 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.43 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 9.4 t -54.88 -44.33 74.0 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.96 1.304 . . . . 0.0 112.084 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.5 mt -152.67 146.49 25.2 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.366 1.867 . . . . 0.0 110.942 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -139.72 111.38 7.25 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.27 0.628 . . . . 0.0 110.253 174.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -98.19 -39.56 8.81 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.129 1.372 . . . . 0.0 114.038 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.63 178.12 7.47 Favored Glycine 0 CA--C 1.544 1.906 0 C-N-CA 125.003 1.287 . . . . 0.0 115.409 -169.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -60.99 170.48 1.55 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.894 1.278 . . . . 0.0 113.006 170.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -26.55 63.21 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 119.755 -1.841 . . . . 0.0 114.263 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -68.49 -20.58 64.6 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.116 0.966 . . . . 0.0 113.565 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.0 141.81 57.45 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.493 1.117 . . . . 0.0 112.088 176.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -71.49 -23.14 61.75 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.773 -1.205 . . . . 0.0 113.915 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 55.9 p -88.87 -12.92 40.46 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.9 p -53.36 -24.41 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -171.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.413 ' H ' HD11 ' A' ' 121' ' ' ILE . 4.9 mp -63.21 -36.46 76.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 125.537 1.535 . . . . 0.0 112.602 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -146.64 -16.85 0.42 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 -169.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.34 166.53 23.02 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.699 2.095 . . . . 0.0 114.755 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.6 mt -114.07 115.0 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.149 1.38 . . . . 0.0 108.643 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -70.7 144.28 51.06 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.028 0.442 . . . . 0.0 111.198 172.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 58.14 26.36 13.61 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.334 1.454 . . . . 0.0 113.518 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -61.79 125.66 24.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.543 1.137 . . . . 0.0 111.187 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -72.32 122.81 21.76 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.542 1.537 . . . . 0.0 111.953 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.9 mm -119.58 116.17 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.122 0.969 . . . . 0.0 109.477 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.6 mp -110.32 96.66 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.928 1.291 . . . . 0.0 108.425 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.9 p -80.62 156.46 26.38 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.983 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -151.53 139.58 20.11 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.88 1.272 . . . . 0.0 111.495 174.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.9 mt -81.07 134.08 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -141.84 123.81 15.36 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.055 1.342 . . . . 0.0 110.73 172.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -73.17 119.99 18.18 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.787 -0.571 . . . . 0.0 109.99 169.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 25.8 mt -107.86 100.6 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 176.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 58.1 15.32 3.17 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.534 1.934 . . . . 0.0 115.821 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 123.91 -25.05 6.22 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.728 1.156 . . . . 0.0 114.016 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 93.6 m -82.47 126.49 32.29 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.892 0.877 . . . . 0.0 109.506 173.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -72.86 113.27 9.71 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.545 -0.722 . . . . 0.0 110.146 173.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -103.4 167.57 9.72 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.833 1.253 . . . . 0.0 110.69 170.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.2 tp -122.09 134.02 66.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 125.634 1.574 . . . . 0.0 108.103 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 p -120.77 156.71 31.27 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.198 0.599 . . . . 0.0 109.849 173.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -150.99 140.58 21.62 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.705 0.802 . . . . 0.0 111.312 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.7 p -71.79 118.94 15.26 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.929 0.892 . . . . 0.0 110.999 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.06 -154.39 16.18 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.717 1.151 . . . . 0.0 112.19 172.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -79.98 166.55 21.48 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.659 0.783 . . . . 0.0 111.202 169.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -79.1 105.99 10.82 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.95 -1.094 . . . . 0.0 111.286 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.12 161.18 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.474 0.71 . . . . 0.0 112.06 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -100.15 -22.74 15.06 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.114 0.966 . . . . 0.0 112.628 172.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -67.87 -7.57 29.23 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.37 -16.04 5.0 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.398 1.479 . . . . 0.0 114.605 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 125.38 -86.94 0.36 Allowed Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.519 1.533 . . . . 0.0 113.002 173.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -140.22 25.21 2.28 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 127.061 2.144 . . . . 0.0 110.709 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -84.74 170.72 12.96 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.975 0.91 . . . . 0.0 108.911 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.5 m -104.37 140.96 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.128 0.571 . . . . 0.0 109.77 171.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.29 115.67 4.77 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -113.04 143.97 43.41 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.84 1.305 . . . . 0.0 111.231 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -134.65 168.06 19.68 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.202 1.801 . . . . 0.0 110.225 -169.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.89 133.46 23.54 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 69.5 mt -124.87 140.32 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.6 m -62.11 94.08 0.05 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.744 0.818 . . . . 0.0 109.226 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.54 -31.83 57.18 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.513 -0.742 . . . . 0.0 111.497 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -63.88 -27.71 69.34 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -94.78 -29.86 14.54 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.59 1.556 . . . . 0.0 111.597 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 16.9 mt -58.04 -49.66 76.11 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.435 1.094 . . . . 0.0 110.766 170.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -49.33 -37.92 26.15 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.411 1.084 . . . . 0.0 113.445 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -69.94 -18.35 63.36 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.664 1.586 . . . . 0.0 114.268 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -115.98 -9.53 11.75 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.194 1.798 . . . . 0.0 113.983 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 41.2 mt -98.02 -20.28 17.49 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.631 1.572 . . . . 0.0 112.87 -173.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 78.4 mttt . . . . . 0 C--O 1.254 1.296 0 C-N-CA 127.516 2.326 . . . . 0.0 113.584 173.327 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt . . . . . 0 N--CA 1.495 1.804 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.4 pt -61.67 162.58 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.077 0.951 . . . . 0.0 112.77 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -142.54 167.29 22.43 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.299 1.44 . . . . 0.0 111.292 175.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.5 p -128.08 137.38 52.13 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.038 1.335 . . . . 0.0 110.668 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.3 p -159.28 166.25 31.69 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.51 1.524 . . . . 0.0 111.041 -175.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -136.51 158.03 45.39 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.582 1.153 . . . . 0.0 110.833 173.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -141.28 124.43 16.42 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.077 1.351 . . . . 0.0 109.607 -177.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -62.44 124.65 21.5 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.616 0.722 . . . . 0.0 112.275 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -156.37 168.48 27.2 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.561 1.544 . . . . 0.0 111.406 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.8 t -145.54 122.97 11.66 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.808 1.243 . . . . 0.0 109.732 173.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.5 p -142.8 -40.07 0.33 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.665 1.186 . . . . 0.0 113.58 -172.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 169.23 29.97 0.02 OUTLIER Glycine 0 CA--C 1.536 1.375 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 175.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -102.41 160.36 14.62 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 118.826 1.313 . . . . 0.0 112.851 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.6 m -65.48 171.19 4.19 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.284 1.434 . . . . 0.0 113.236 173.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -134.14 154.11 51.41 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.322 1.449 . . . . 0.0 110.949 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.7 m -113.24 42.58 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.544 1.938 . . . . 0.0 111.34 -176.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -127.18 144.06 51.12 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.452 1.901 . . . . 0.0 111.654 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.4 tptm -168.01 162.96 13.57 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.822 1.649 . . . . 0.0 112.082 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.5 mm -87.36 154.14 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.478 1.111 . . . . 0.0 110.462 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -57.25 -19.73 23.26 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 172.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -78.97 -8.32 58.81 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.5 t -77.47 -4.59 46.26 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.868 1.267 . . . . 0.0 113.728 173.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -122.51 154.38 37.93 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.788 1.235 . . . . 0.0 108.9 167.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -140.0 161.29 37.96 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.158 0.983 . . . . 0.0 109.951 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -132.6 124.92 29.28 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.739 0.304 . . . . 0.0 110.595 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.4 m -122.75 162.25 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.439 1.496 . . . . 0.0 111.18 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -60.42 157.87 13.08 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.345 1.058 . . . . 0.0 111.189 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.4 tp -156.74 137.82 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.218 1.007 . . . . 0.0 109.267 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -130.52 161.97 30.28 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 126.69 1.996 . . . . 0.0 109.628 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -128.73 159.3 36.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.042 1.337 . . . . 0.0 110.899 174.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -80.08 121.44 25.53 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 122.125 -0.36 . . . . 0.0 110.319 170.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.53 171.91 2.33 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.452 1.101 . . . . 0.0 112.258 171.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -55.13 -14.76 1.77 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.425 1.89 . . . . 0.0 115.343 174.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.9 t -113.03 11.46 18.98 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.95 1.3 . . . . 0.0 112.786 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.9 21.3 78.71 Favored Glycine 0 CA--C 1.537 1.409 0 O-C-N 120.553 -1.342 . . . . 0.0 114.334 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -98.17 127.79 44.31 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.843 1.257 . . . . 0.0 109.483 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -67.15 126.83 30.44 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.783 -0.573 . . . . 0.0 110.631 173.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.6 t -140.07 140.09 36.05 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.186 1.394 . . . . 0.0 110.138 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -58.19 141.05 51.74 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.8 tp -113.11 -48.9 2.95 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.758 0.823 . . . . 0.0 110.927 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.4 -111.85 0.47 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.141 0.4 . . . . 0.0 113.32 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -147.15 146.36 29.87 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.473 1.509 . . . . 0.0 110.008 -175.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 16.5 tp -114.68 106.66 14.49 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.674 1.189 . . . . 0.0 110.513 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.8 t -77.56 100.95 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.624 1.169 . . . . 0.0 109.137 173.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.6 t -90.02 123.79 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.156 1.382 . . . . 0.0 109.603 173.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -110.94 111.98 23.49 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 127.475 2.31 . . . . 0.0 109.792 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -82.49 88.25 6.63 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.896 1.278 . . . . 0.0 110.252 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -84.31 176.1 8.95 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.616 1.166 . . . . 0.0 111.785 176.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -74.97 -42.8 56.92 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.738 -1.226 . . . . 0.0 112.541 172.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -93.37 50.34 1.49 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.003 1.321 . . . . 0.0 111.669 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.46 -163.94 14.1 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.433 1.016 . . . . 0.0 114.075 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.2 mt -117.33 142.88 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.717 0.807 . . . . 0.0 110.075 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -128.97 143.78 50.98 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.296 1.438 . . . . 0.0 109.664 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.1 p -135.31 148.83 49.61 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.299 -0.876 . . . . 0.0 112.043 -174.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.62 124.74 2.15 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-O 121.698 0.61 . . . . 0.0 112.739 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.45 139.06 43.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.147 1.779 . . . . 0.0 110.436 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -135.45 81.36 1.89 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.097 1.759 . . . . 0.0 111.106 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.91 66.12 7.81 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.243 1.817 . . . . 0.0 112.199 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.48 -87.82 0.72 Allowed Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.617 1.103 . . . . 0.0 113.634 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.6 10.59 35.51 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.789 1.661 . . . . 0.0 113.941 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -136.83 118.51 14.99 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.434 1.493 . . . . 0.0 109.845 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 77.6 p -143.81 145.58 32.45 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -173.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.8 159.88 24.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.872 1.269 . . . . 0.0 111.929 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.2 m -56.01 128.34 34.84 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.523 0.729 . . . . 0.0 110.382 169.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -93.86 -51.11 5.03 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.478 0.711 . . . . 0.0 110.218 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -167.05 164.81 15.93 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.894 1.278 . . . . 0.0 112.661 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.89 146.29 28.99 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.608 1.163 . . . . 0.0 112.563 176.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.465 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -127.53 158.27 37.87 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.417 1.487 . . . . 0.0 112.111 -176.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -77.5 165.33 24.48 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.606 0.717 . . . . 0.0 112.494 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -56.0 -35.78 67.18 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.151 0.98 . . . . 0.0 112.335 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -69.0 -8.88 49.08 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.153 0.981 . . . . 0.0 113.5 175.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.9 t -113.31 -6.58 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.494 1.118 . . . . 0.0 110.834 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 67.7 t -49.85 -67.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.609 1.164 . . . . 0.0 111.87 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -67.12 -24.86 65.96 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.697 -0.627 . . . . 0.0 112.633 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -53.56 54.47 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.527 1.531 . . . . 0.0 110.813 173.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -62.51 -43.62 98.36 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.445 1.498 . . . . 0.0 111.642 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 74.3 t -56.62 -37.83 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.471 0.708 . . . . 0.0 110.733 176.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -68.1 -53.18 27.33 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.431 1.092 . . . . 0.0 113.059 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.32 -14.51 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 O-C-N 121.003 -1.06 . . . . 0.0 112.427 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.5 ttm -92.54 -4.65 53.18 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 120.465 -1.397 . . . . 0.0 112.802 177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.5 p -126.75 -12.06 6.02 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.34 1.056 . . . . 0.0 113.114 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -136.98 -10.85 1.75 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.934 1.694 . . . . 0.0 114.415 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.27 154.64 10.02 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.728 1.632 . . . . 0.0 114.18 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.09 -168.66 33.04 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.672 1.13 . . . . 0.0 113.953 -175.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.7 p -146.24 107.38 4.18 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.873 1.269 . . . . 0.0 113.502 -168.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -136.44 149.42 48.24 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.308 1.843 . . . . 0.0 110.243 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -76.28 163.32 27.14 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.247 -0.908 . . . . 0.0 111.334 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.5 p -128.83 142.37 50.99 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.981 1.313 . . . . 0.0 111.32 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.465 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 8.4 t -53.52 -44.15 68.9 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.433 1.493 . . . . 0.0 112.256 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 mt -151.34 142.23 22.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.846 1.658 . . . . 0.0 111.691 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -136.12 102.66 5.08 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.072 0.949 . . . . 0.0 110.811 175.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -87.22 -48.53 7.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.01 0.924 . . . . 0.0 112.984 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.98 165.5 34.0 Favored Glycine 0 CA--C 1.545 1.933 0 C-N-CA 124.748 1.166 . . . . 0.0 112.584 -168.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -58.76 -65.3 0.68 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.479 1.111 . . . . 0.0 113.908 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.39 176.84 1.57 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.527 2.731 . . . . 0.0 108.357 -172.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 63.91 5.42 2.34 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.147 1.379 . . . . 0.0 113.968 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -90.39 150.83 21.7 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.95 2.1 . . . . 0.0 111.269 -172.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -73.94 -12.93 60.8 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 172.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 34.9 m -122.15 -7.14 8.85 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.8 p -57.34 -23.47 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-N 121.356 1.889 . . . . 0.0 113.452 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 33.1 mm -56.39 -36.87 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 126.407 1.883 . . . . 0.0 112.909 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -139.24 -26.1 0.84 Allowed 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.33 169.16 37.48 Favored Glycine 0 CA--C 1.539 1.56 0 C-N-CA 126.213 1.864 . . . . 0.0 113.86 -173.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.7 mt -125.72 115.83 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.807 1.643 . . . . 0.0 108.612 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -74.47 146.92 42.39 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.992 0.425 . . . . 0.0 111.836 173.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 57.47 23.36 9.01 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.136 1.774 . . . . 0.0 114.467 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -63.7 123.24 18.36 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.715 1.206 . . . . 0.0 111.727 -171.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -71.33 125.38 26.82 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.538 1.135 . . . . 0.0 111.636 177.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.7 mm -120.97 119.51 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.755 1.222 . . . . 0.0 109.169 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.3 100.27 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.88 1.272 . . . . 0.0 108.67 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 47.9 p -79.26 159.62 27.19 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.068 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.1 141.48 20.66 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.114 1.366 . . . . 0.0 111.305 171.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.5 mt -83.07 136.31 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.598 0.759 . . . . 0.0 109.275 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -142.52 127.17 18.01 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.877 1.271 . . . . 0.0 110.974 173.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -77.07 105.62 8.27 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.303 0.641 . . . . 0.0 110.311 170.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 27.2 mt -92.07 98.79 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 57.78 15.45 2.98 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.682 1.993 . . . . 0.0 115.779 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 125.73 -28.14 5.02 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.036 1.303 . . . . 0.0 113.924 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 99.6 m -78.33 126.68 31.12 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.8 0.84 . . . . 0.0 109.498 172.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -73.29 116.16 13.5 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.228 0.537 . . . . 0.0 110.322 172.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -105.42 165.25 11.26 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.486 1.514 . . . . 0.0 111.009 170.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 6.3 tp -115.7 137.04 50.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 125.743 1.617 . . . . 0.0 107.793 169.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 p -126.95 157.63 38.96 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.499 0.72 . . . . 0.0 109.772 173.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -151.27 138.63 19.42 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.015 0.926 . . . . 0.0 111.603 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.3 m -78.88 111.28 14.88 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.074 0.95 . . . . 0.0 110.821 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.71 -161.95 32.74 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.435 1.016 . . . . 0.0 113.125 175.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -63.69 170.58 3.19 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-O 121.898 0.856 . . . . 0.0 112.568 169.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -92.21 108.21 19.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.623 1.569 . . . . 0.0 111.517 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.32 159.73 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.36 0.664 . . . . 0.0 112.192 176.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.5 tttp -90.27 -31.65 16.88 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 172.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -66.89 -40.59 87.78 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -171.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.5 t -75.55 -34.76 60.74 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.242 0.617 . . . . 0.0 112.411 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 142.35 -76.37 0.31 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.81 1.672 . . . . 0.0 111.948 172.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -144.23 22.22 1.71 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.325 1.85 . . . . 0.0 111.173 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -81.49 -175.72 5.66 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.075 0.95 . . . . 0.0 109.489 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.71 144.61 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.307 0.643 . . . . 0.0 110.743 172.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.45 108.89 2.54 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 169.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -110.11 143.0 40.81 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.378 1.085 . . . . 0.0 110.675 172.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -133.39 170.15 15.89 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.97 1.708 . . . . 0.0 110.696 -170.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.31 132.26 20.23 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.532 0.333 . . . . 0.0 110.174 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 67.3 mt -125.2 138.88 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.3 m -62.88 99.2 0.15 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.735 0.698 . . . . 0.0 109.294 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.27 -30.57 62.63 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.588 0.755 . . . . 0.0 111.829 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.45 -31.57 69.96 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -87.84 -22.4 24.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.091 0.956 . . . . 0.0 112.356 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 18.1 mt -64.25 -44.02 93.1 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.94 0.896 . . . . 0.0 111.085 168.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -55.07 -40.7 70.64 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.921 0.889 . . . . 0.0 112.153 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -56.96 -19.4 17.88 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.733 1.613 . . . . 0.0 115.319 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -126.02 -5.44 6.78 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.781 1.233 . . . . 0.0 114.302 -175.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 20.7 mt -98.77 -23.37 15.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.143 1.377 . . . . 0.0 112.21 -177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm . . . . . 0 C--O 1.254 1.303 0 C-N-CA 125.895 1.678 . . . . 0.0 112.899 178.146 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 119.625 -0.226 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.7 mm -113.92 -35.71 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 124.79 1.236 . . . . 0.0 112.388 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 35.3 p80 -129.93 170.31 14.1 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.393 1.477 . . . . 0.0 111.438 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.8 t -127.33 159.27 34.9 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.372 1.069 . . . . 0.0 111.391 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.9 m -120.37 138.04 53.96 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.429 1.492 . . . . 0.0 110.366 -176.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -63.45 -24.69 67.94 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.905 0.882 . . . . 0.0 113.37 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -76.17 83.62 2.99 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.283 1.433 . . . . 0.0 112.278 173.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -151.01 147.44 27.13 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.877 1.271 . . . . 0.0 111.619 175.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -76.52 154.42 34.62 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.483 1.113 . . . . 0.0 112.34 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.1 p -63.0 168.93 3.63 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.247 1.419 . . . . 0.0 113.991 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.6 t -131.48 -35.99 1.28 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.848 1.259 . . . . 0.0 113.713 -176.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.42 -174.91 36.93 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.621 1.105 . . . . 0.0 113.36 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -134.8 173.02 12.16 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.29 1.436 . . . . 0.0 112.383 -173.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.7 m -56.64 151.85 13.11 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.893 1.277 . . . . 0.0 112.801 172.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -116.36 66.51 0.71 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.337 1.455 . . . . 0.0 112.964 -168.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.6 m -78.96 39.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 126.991 2.117 . . . . 0.0 114.518 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -93.94 -177.91 4.48 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.221 1.809 . . . . 0.0 111.773 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -57.04 153.1 11.97 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.859 1.264 . . . . 0.0 112.708 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.9 mm -71.75 140.35 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.179 0.592 . . . . 0.0 109.917 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -65.81 -8.29 20.8 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -55.48 -15.1 2.4 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 127.161 2.185 . . . . 0.0 115.584 -175.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 m -61.43 -15.9 41.57 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.618 1.567 . . . . 0.0 113.627 169.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -151.17 176.53 11.1 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.392 1.477 . . . . 0.0 111.907 169.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -147.32 155.93 42.46 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.974 0.91 . . . . 0.0 109.346 166.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 m -122.24 131.19 53.81 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.572 0.349 . . . . 0.0 110.775 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.0 m -129.27 166.09 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 125.646 1.579 . . . . 0.0 111.605 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -63.89 159.24 20.17 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.706 1.202 . . . . 0.0 111.806 177.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.0 tp -154.27 136.68 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.241 1.416 . . . . 0.0 109.571 174.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -128.89 161.93 28.71 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.498 1.919 . . . . 0.0 109.848 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -131.4 156.65 45.2 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.842 1.257 . . . . 0.0 111.338 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 119.59 20.18 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 171.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -63.27 175.51 0.95 Allowed 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 122.053 0.93 . . . . 0.0 111.728 170.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -60.36 -11.45 6.67 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.725 2.01 . . . . 0.0 114.6 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.8 m -115.64 13.49 16.3 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.169 1.388 . . . . 0.0 112.86 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.71 23.18 77.28 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 121.281 -0.887 . . . . 0.0 114.318 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -100.26 124.23 45.45 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.807 1.243 . . . . 0.0 109.674 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -64.93 123.94 20.75 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.974 0.51 . . . . 0.0 110.952 173.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.0 t -138.49 137.4 37.09 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.207 1.403 . . . . 0.0 110.402 -174.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -57.43 137.08 56.59 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.345 0.658 . . . . 0.0 112.516 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.8 tp -110.39 -47.65 3.26 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.667 0.787 . . . . 0.0 111.173 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.03 -128.98 1.55 Allowed Glycine 0 CA--C 1.528 0.86 0 CA-C-O 121.341 0.412 . . . . 0.0 113.665 -173.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -140.58 155.75 46.49 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.734 1.613 . . . . 0.0 109.621 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.8 tp -120.19 99.46 6.6 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.453 1.501 . . . . 0.0 109.662 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.3 t -76.71 101.96 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 125.321 1.448 . . . . 0.0 109.491 175.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.1 t -92.08 92.97 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.088 1.755 . . . . 0.0 109.712 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -77.28 126.33 30.76 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.814 1.645 . . . . 0.0 110.564 175.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -82.9 93.56 7.53 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.246 1.418 . . . . 0.0 109.115 175.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -78.54 165.24 23.94 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 122.074 0.94 . . . . 0.0 111.936 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -75.11 -24.6 58.1 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 120.9 -1.125 . . . . 0.0 112.937 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -126.88 47.71 2.29 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.304 1.842 . . . . 0.0 111.378 -176.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.72 -156.91 22.13 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.58 1.086 . . . . 0.0 115.36 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.4 mt -124.12 145.49 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.159 0.984 . . . . 0.0 109.657 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -137.1 128.81 28.79 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.184 0.994 . . . . 0.0 110.593 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.8 p -117.54 147.25 42.96 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.381 1.072 . . . . 0.0 111.318 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -139.16 120.83 1.97 Allowed Glycine 0 CA--C 1.522 0.497 0 O-C-N 121.909 -0.495 . . . . 0.0 112.444 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.71 121.81 17.25 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.459 1.504 . . . . 0.0 109.107 173.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -128.58 79.77 1.93 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.453 1.901 . . . . 0.0 109.112 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.64 178.05 8.56 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.462 0.649 . . . . 0.0 112.109 -178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.73 48.39 1.28 Allowed Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.877 1.703 . . . . 0.0 115.289 -175.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.47 -10.51 0.1 Allowed Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.742 1.639 . . . . 0.0 115.147 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -152.95 156.09 38.21 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.359 1.464 . . . . 0.0 112.835 -173.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 84.6 p -144.3 140.63 29.28 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 170.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -156.55 161.38 39.98 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.942 1.297 . . . . 0.0 112.245 174.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.1 m -55.4 136.21 49.66 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.05 -1.031 . . . . 0.0 110.887 171.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -106.49 -51.46 2.95 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.564 1.146 . . . . 0.0 110.417 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -164.4 154.8 14.67 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.412 0.685 . . . . 0.0 112.388 170.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.55 154.85 44.83 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.431 1.11 . . . . 0.0 111.44 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.423 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -141.34 159.75 41.56 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.967 1.307 . . . . 0.0 111.647 -174.504 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -79.83 165.71 22.44 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.592 0.757 . . . . 0.0 112.029 -175.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -55.74 -32.31 63.28 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.138 -0.976 . . . . 0.0 113.422 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.47 -14.13 62.79 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 t -106.83 -8.23 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.38 1.072 . . . . 0.0 111.262 -174.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 81.0 t -49.92 -63.38 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 125.23 1.412 . . . . 0.0 111.462 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -69.63 -25.67 64.04 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -52.08 59.19 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.217 1.407 . . . . 0.0 110.72 174.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -61.78 -43.34 99.04 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.633 1.573 . . . . 0.0 111.505 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 73.6 t -54.5 -38.27 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.252 1.021 . . . . 0.0 110.566 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -69.37 -53.75 17.93 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.585 1.154 . . . . 0.0 112.541 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.7 m -72.3 -20.6 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 121.028 -1.045 . . . . 0.0 112.248 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.46 -4.67 58.72 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.239 -1.538 . . . . 0.0 112.103 174.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 79.9 p -128.53 -12.56 4.94 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -137.68 -10.5 1.6 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.036 1.734 . . . . 0.0 114.166 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.33 155.33 11.05 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.879 1.704 . . . . 0.0 113.86 -174.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.87 -171.66 33.8 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.673 1.13 . . . . 0.0 113.292 -174.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.0 p -145.47 103.83 3.85 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.518 1.127 . . . . 0.0 113.184 -168.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -131.66 150.53 52.12 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.962 1.705 . . . . 0.0 110.152 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.71 157.22 30.19 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.265 -0.897 . . . . 0.0 111.578 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.6 p -122.94 155.84 35.93 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.162 1.785 . . . . 0.0 110.687 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.423 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 77.1 p -71.09 -38.09 72.41 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.7 -0.625 . . . . 0.0 111.568 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.8 mt -154.43 137.67 15.71 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.147 1.779 . . . . 0.0 111.809 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -134.89 102.62 5.3 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.878 0.871 . . . . 0.0 110.48 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -86.77 -45.2 11.14 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.381 1.073 . . . . 0.0 113.381 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.29 -178.77 30.14 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 124.8 1.19 . . . . 0.0 113.865 -169.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -58.16 164.78 2.21 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 125.291 1.436 . . . . 0.0 113.351 171.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -65.0 -25.9 68.05 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 119.784 -1.823 . . . . 0.0 113.805 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -87.53 51.97 2.37 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.998 1.319 . . . . 0.0 111.643 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -135.3 166.71 22.5 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.733 2.013 . . . . 0.0 111.303 -175.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -87.05 -14.48 41.41 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.8 m -126.85 3.25 6.64 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -171.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.6 p -63.41 -21.99 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 75.4 mt -66.77 -41.38 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.02 -1.05 . . . . 0.0 111.609 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -123.01 -18.3 6.44 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.536 1.134 . . . . 0.0 113.342 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.22 178.7 52.29 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.37 0.986 . . . . 0.0 112.841 -171.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 55.9 mt -124.63 109.62 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.501 1.52 . . . . 0.0 107.402 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -68.93 145.14 53.9 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.179 0.514 . . . . 0.0 111.139 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 60.71 21.04 11.05 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.573 1.549 . . . . 0.0 114.389 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 21.2 tptp -56.24 123.91 16.15 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.571 1.148 . . . . 0.0 111.287 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -73.41 128.87 36.7 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.968 0.907 . . . . 0.0 110.237 170.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 38.2 mm -121.73 112.61 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.187 0.995 . . . . 0.0 109.112 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.11 91.12 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.842 1.257 . . . . 0.0 109.103 -174.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 44.8 p -75.46 155.23 36.46 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.326 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -152.29 141.45 21.36 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.028 1.331 . . . . 0.0 111.399 172.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.1 mt -80.04 132.27 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.239 0.615 . . . . 0.0 109.405 175.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -148.41 138.03 22.16 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.082 1.353 . . . . 0.0 111.021 172.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.8 mmtm -76.39 154.38 34.94 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.34 -0.85 . . . . 0.0 110.334 169.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 44.9 mt -129.98 -47.83 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.875 0.87 . . . . 0.0 111.092 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -146.63 32.01 0.96 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.822 0.849 . . . . 0.0 112.463 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.69 -14.96 57.49 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.486 1.041 . . . . 0.0 114.109 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 65.5 m -96.23 139.41 32.41 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.614 1.166 . . . . 0.0 108.738 169.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -73.98 123.28 24.02 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.278 0.561 . . . . 0.0 109.834 171.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -106.73 169.12 8.72 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.275 1.43 . . . . 0.0 110.444 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.0 tp -123.82 134.11 67.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 125.531 1.532 . . . . 0.0 108.283 172.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 p -121.36 153.75 37.37 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.192 0.597 . . . . 0.0 110.151 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -151.81 144.98 24.63 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.237 1.015 . . . . 0.0 111.29 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 p -77.7 116.45 18.24 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.195 1.398 . . . . 0.0 111.746 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.29 -158.67 30.21 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.575 1.56 . . . . 0.0 112.214 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.07 164.31 20.48 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 122.022 0.915 . . . . 0.0 113.422 170.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -81.61 102.59 10.75 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.175 0.99 . . . . 0.0 111.086 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.03 160.99 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.404 0.681 . . . . 0.0 112.684 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -98.5 -24.9 14.95 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.159 0.983 . . . . 0.0 112.939 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -67.54 -16.15 64.04 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.64 -29.81 7.32 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.029 1.332 . . . . 0.0 113.501 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 138.42 -82.85 0.25 Allowed Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.21 1.386 . . . . 0.0 112.741 172.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -140.95 22.25 2.27 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 127.297 2.239 . . . . 0.0 110.459 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -82.14 174.17 11.45 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.6 m -106.84 139.77 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 169.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -59.98 133.1 55.78 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 168.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -125.55 143.68 50.9 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.51 1.148 . . . . 0.0 110.473 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -131.23 169.18 16.3 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.851 1.661 . . . . 0.0 110.687 -170.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.28 130.67 19.82 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.901 0.48 . . . . 0.0 110.013 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 60.9 mt -126.24 140.54 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.883 0.873 . . . . 0.0 108.847 177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.0 m -65.78 94.55 0.21 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.038 0.935 . . . . 0.0 109.772 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.68 -33.06 54.08 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.512 1.125 . . . . 0.0 111.682 175.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -66.94 -27.27 67.33 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 176.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -89.91 -29.9 18.22 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.115 0.966 . . . . 0.0 112.875 174.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 20.3 mt -59.3 -47.61 84.75 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.45 0.7 . . . . 0.0 110.643 172.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -50.89 -37.79 45.88 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.563 1.145 . . . . 0.0 113.746 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -71.55 -14.18 62.02 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -124.94 -3.64 7.62 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.882 1.273 . . . . 0.0 113.844 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 15.1 mt -96.36 -14.82 22.24 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.443 1.497 . . . . 0.0 112.968 -176.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 6.6 ptmt . . . . . 0 C--O 1.254 1.326 0 C-N-CA 126.998 2.119 . . . . 0.0 115.86 179.024 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.3 tt -107.51 155.27 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.336 1.454 . . . . 0.0 110.928 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -128.52 160.21 33.04 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.586 1.554 . . . . 0.0 110.366 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.1 m -123.66 121.05 34.54 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.695 0.798 . . . . 0.0 110.134 -171.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.1 m -67.73 -13.17 61.89 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -174.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -137.89 158.5 44.22 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.321 1.848 . . . . 0.0 110.971 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -150.96 160.84 43.67 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.668 1.187 . . . . 0.0 112.813 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 -134.58 53.18 2.01 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.48 1.512 . . . . 0.0 111.656 -171.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -58.95 103.37 0.16 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.26 1.024 . . . . 0.0 111.757 170.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.9 t -73.73 -40.37 63.6 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.081 0.952 . . . . 0.0 112.239 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.1 p -86.19 173.05 10.06 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.352 1.461 . . . . 0.0 112.346 172.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.04 95.3 0.14 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.273 0.939 . . . . 0.0 112.29 -177.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -58.42 132.41 53.62 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.657 1.183 . . . . 0.0 112.089 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.8 t -154.57 155.43 34.76 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.891 1.276 . . . . 0.0 111.707 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -154.98 127.86 8.14 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.71 1.604 . . . . 0.0 110.908 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.54 120.78 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.826 1.251 . . . . 0.0 111.134 173.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -152.47 177.72 10.32 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 127.73 2.412 . . . . 0.0 110.502 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -90.7 102.09 14.84 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.239 1.416 . . . . 0.0 110.085 169.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.97 156.5 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.606 1.562 . . . . 0.0 109.682 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -56.05 -19.65 13.77 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 172.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -78.15 -7.48 57.1 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.467 1.107 . . . . 0.0 113.8 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.99 11.34 25.47 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.498 1.919 . . . . 0.0 112.633 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -142.75 166.66 24.05 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.547 1.539 . . . . 0.0 111.441 170.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -142.26 174.28 10.76 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.146 1.378 . . . . 0.0 110.763 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -140.43 137.2 33.77 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.286 -0.884 . . . . 0.0 111.097 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.2 m -133.4 162.06 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 125.444 1.497 . . . . 0.0 111.718 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -61.75 155.14 23.65 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.443 1.097 . . . . 0.0 111.893 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.4 tp -150.94 136.16 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.789 1.236 . . . . 0.0 109.784 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -125.75 161.82 26.46 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.906 2.082 . . . . 0.0 109.488 176.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -130.8 154.58 47.87 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.162 1.385 . . . . 0.0 111.077 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -79.41 117.51 20.45 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.957 -0.464 . . . . 0.0 109.841 169.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -64.24 172.47 2.46 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 122.619 1.199 . . . . 0.0 111.176 169.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -57.0 -22.38 38.1 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.42 2.288 . . . . 0.0 113.125 173.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.4 m -83.67 -4.1 58.32 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.696 1.598 . . . . 0.0 114.15 174.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.68 34.42 66.86 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.846 1.213 . . . . 0.0 114.133 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -122.29 139.19 54.09 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.259 1.424 . . . . 0.0 110.689 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -70.93 119.96 15.82 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.645 1.178 . . . . 0.0 110.9 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -133.87 141.87 47.56 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.149 1.38 . . . . 0.0 110.138 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -59.21 140.2 56.18 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -173.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.5 tp -114.11 -47.86 2.93 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.032 0.933 . . . . 0.0 111.34 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.79 -119.02 0.81 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 123.267 0.461 . . . . 0.0 113.176 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -145.37 152.7 40.28 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.639 1.576 . . . . 0.0 110.184 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.2 tp -117.46 104.58 11.23 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.777 1.231 . . . . 0.0 110.525 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.4 t -77.82 100.37 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.507 1.123 . . . . 0.0 109.619 174.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 52.1 t -90.1 113.09 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.031 1.332 . . . . 0.0 110.36 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -95.8 125.32 40.29 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.044 2.138 . . . . 0.0 110.566 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.88 86.58 6.34 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.852 1.261 . . . . 0.0 109.722 176.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -78.33 170.26 16.92 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.922 0.868 . . . . 0.0 111.495 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.3 tp10 -73.38 -31.0 63.66 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.661 -1.275 . . . . 0.0 112.787 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -107.15 24.81 12.23 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.482 1.513 . . . . 0.0 112.805 -169.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.72 -160.68 24.34 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.964 1.745 . . . . 0.0 113.971 -176.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.1 mt -119.61 143.2 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.101 0.96 . . . . 0.0 109.401 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -135.81 138.59 42.72 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.092 0.957 . . . . 0.0 110.059 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.5 p -131.54 147.63 52.55 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.488 -0.758 . . . . 0.0 111.724 -169.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.96 124.48 2.36 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-O 121.636 0.575 . . . . 0.0 112.954 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.9 137.05 51.3 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.103 1.761 . . . . 0.0 110.212 176.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -132.2 91.92 3.02 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.031 1.733 . . . . 0.0 110.274 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -109.39 82.26 1.57 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.864 1.666 . . . . 0.0 110.885 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.0 -103.98 0.95 Allowed Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.202 0.906 . . . . 0.0 112.948 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -99.17 7.67 60.39 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.16 1.362 . . . . 0.0 114.588 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -127.29 120.79 29.45 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.966 1.306 . . . . 0.0 109.899 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.6 p -142.11 141.88 32.74 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.544 -0.722 . . . . 0.0 112.694 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -160.57 161.14 32.52 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.883 1.273 . . . . 0.0 111.614 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.2 m -55.54 132.75 49.39 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.485 -0.759 . . . . 0.0 110.146 169.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -99.89 -51.1 3.8 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.884 0.874 . . . . 0.0 109.842 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -163.98 161.57 22.81 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.12 0.968 . . . . 0.0 112.286 170.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.44 150.77 36.27 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.829 0.852 . . . . 0.0 111.512 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.413 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.8 OUTLIER -141.24 156.25 45.92 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.288 1.435 . . . . 0.0 111.845 -174.474 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -77.79 165.33 24.31 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.482 0.713 . . . . 0.0 112.601 -172.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -52.85 -34.0 52.28 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.605 1.162 . . . . 0.0 112.897 172.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -66.65 -11.81 55.5 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.87 1.268 . . . . 0.0 113.658 175.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.8 t -116.22 -5.23 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.971 1.308 . . . . 0.0 111.357 -172.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 69.6 t -50.18 -62.41 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 125.293 1.437 . . . . 0.0 111.899 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -70.25 -28.13 64.99 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -62.29 -50.48 71.52 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.446 1.498 . . . . 0.0 110.909 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -60.18 -43.84 95.52 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.996 1.318 . . . . 0.0 111.327 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 42.1 t -62.1 -34.16 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 123.705 0.802 . . . . 0.0 111.349 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -63.8 -54.56 33.19 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.459 1.104 . . . . 0.0 111.996 172.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -73.17 -2.55 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.3 ttm -114.48 1.91 14.47 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.038 1.335 . . . . 0.0 112.925 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.5 p -124.76 -12.56 7.1 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.762 1.225 . . . . 0.0 112.156 168.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -138.1 -15.14 1.32 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.79 155.09 26.81 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 124.895 1.236 . . . . 0.0 114.125 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.13 -160.1 31.35 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 123.963 0.792 . . . . 0.0 114.363 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.5 p -151.91 98.75 2.49 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -170.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -131.65 146.06 51.99 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.275 1.83 . . . . 0.0 110.132 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.23 155.75 36.47 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.461 -0.774 . . . . 0.0 110.778 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 47.0 p -114.69 158.11 22.23 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.539 1.136 . . . . 0.0 111.009 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.413 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 77.0 p -70.54 -37.87 74.12 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.387 -0.821 . . . . 0.0 110.823 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.2 mt -148.04 150.83 34.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.962 2.105 . . . . 0.0 112.171 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -143.7 107.95 4.78 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.382 1.073 . . . . 0.0 110.252 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -96.88 -40.46 8.9 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.411 1.084 . . . . 0.0 113.585 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.66 178.51 29.99 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.796 1.188 . . . . 0.0 115.616 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -65.63 170.91 4.6 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.915 0.886 . . . . 0.0 112.075 169.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -58.5 -23.99 59.39 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 120.484 -1.385 . . . . 0.0 114.653 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -67.06 -23.81 65.91 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 171.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -70.38 133.7 47.16 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.441 1.496 . . . . 0.0 111.43 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -64.56 -23.53 67.3 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 120.718 -1.239 . . . . 0.0 113.98 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.03 -7.43 45.78 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.439 1.496 . . . . 0.0 114.79 -176.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.07 -25.44 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 60.2 mt -69.99 -37.87 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 125.059 1.343 . . . . 0.0 112.468 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -133.84 -16.42 2.27 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -169.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.4 175.19 39.77 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 126.449 1.976 . . . . 0.0 114.576 -174.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.2 mt -126.62 112.17 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.874 1.67 . . . . 0.0 108.536 174.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -70.98 145.24 50.16 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.101 0.477 . . . . 0.0 111.311 172.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 59.29 22.53 10.86 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.713 1.605 . . . . 0.0 114.137 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -54.13 127.86 28.48 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.92 1.288 . . . . 0.0 111.248 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -75.12 130.12 38.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.085 0.554 . . . . 0.0 110.544 170.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 32.8 mm -126.55 120.28 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.835 1.254 . . . . 0.0 108.668 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.68 101.55 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 125.303 1.441 . . . . 0.0 108.71 -176.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.4 p -86.29 159.3 19.47 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.485 0.714 . . . . 0.0 112.317 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -154.89 139.24 16.72 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.066 1.346 . . . . 0.0 111.736 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 26.2 mt -77.29 133.57 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.087 0.555 . . . . 0.0 109.911 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -149.44 139.56 22.13 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.747 1.619 . . . . 0.0 111.038 171.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.6 mmtt -78.35 153.37 31.72 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.09 -1.006 . . . . 0.0 109.902 168.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.8 mt -128.77 -46.8 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.8 0.84 . . . . 0.0 111.261 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -144.22 20.9 1.74 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.929 0.892 . . . . 0.0 112.796 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.14 -18.74 25.66 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.789 1.185 . . . . 0.0 113.647 -177.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 53.0 m -91.28 140.53 29.7 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.742 1.217 . . . . 0.0 109.085 169.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -74.97 126.87 31.91 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.28 0.562 . . . . 0.0 110.316 170.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -112.68 165.92 11.83 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.33 1.452 . . . . 0.0 110.692 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.1 tp -120.77 132.27 70.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 125.472 1.509 . . . . 0.0 108.117 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.3 p -122.45 154.76 37.34 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.571 0.748 . . . . 0.0 110.05 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -150.95 148.08 27.96 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.709 0.804 . . . . 0.0 111.844 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.4 p -80.74 125.42 30.04 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.695 1.198 . . . . 0.0 111.552 174.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.66 -151.77 26.63 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.085 1.326 . . . . 0.0 113.187 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -78.92 172.19 14.13 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.465 1.506 . . . . 0.0 110.331 168.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -82.31 119.29 23.94 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.709 -1.245 . . . . 0.0 110.805 173.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.31 161.67 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 122.818 0.447 . . . . 0.0 111.36 173.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -93.67 -31.26 14.53 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.547 0.739 . . . . 0.0 112.689 172.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -61.37 -47.73 84.49 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.177 0.991 . . . . 0.0 112.983 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.89 -31.99 51.61 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 139.98 -76.29 0.33 Allowed Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.008 1.289 . . . . 0.0 113.497 170.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -146.44 21.07 1.35 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 127.332 2.253 . . . . 0.0 111.926 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -78.13 172.17 13.94 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.525 1.13 . . . . 0.0 108.592 172.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 16.0 m -108.19 141.12 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 122.87 0.468 . . . . 0.0 110.102 173.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.51 117.62 7.0 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -117.96 140.23 50.02 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 122.181 0.991 . . . . 0.0 110.17 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -133.1 168.54 18.32 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.304 1.442 . . . . 0.0 111.327 -169.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.82 130.64 18.09 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.264 0.626 . . . . 0.0 109.9 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 69.6 mt -122.57 140.33 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.135 0.974 . . . . 0.0 108.536 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.9 m -64.11 95.81 0.13 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.192 0.997 . . . . 0.0 110.049 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.3 tt -55.32 -31.87 62.02 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.501 1.12 . . . . 0.0 111.757 175.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -69.48 -29.72 67.44 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.59 -33.51 47.52 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.292 0.951 . . . . 0.0 112.681 171.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 22.4 mt -62.28 -48.82 78.21 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.309 1.043 . . . . 0.0 110.741 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -48.81 -38.19 21.42 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.785 1.175 . . . . 0.0 113.531 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -58.52 -24.08 59.69 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -126.84 4.44 6.62 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.004 2.121 . . . . 0.0 113.622 -177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.7 mp -106.76 -31.13 8.54 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.984 1.714 . . . . 0.0 111.933 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm . . . . . 0 C--O 1.254 1.294 0 C-N-CA 125.922 1.689 . . . . 0.0 112.558 170.535 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.2 mt -137.25 110.38 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 120.253 -1.53 . . . . 0.0 109.152 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -76.09 151.25 37.11 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.014 0.925 . . . . 0.0 112.136 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.7 p -71.05 113.34 7.99 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.473 1.109 . . . . 0.0 112.001 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.6 p -84.98 -20.61 30.29 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -72.7 138.07 46.37 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.419 1.088 . . . . 0.0 112.188 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -87.83 79.51 8.1 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.701 1.2 . . . . 0.0 112.206 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -145.29 137.59 25.82 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.821 1.248 . . . . 0.0 111.028 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.7 tm0? -148.87 109.14 4.13 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.829 1.252 . . . . 0.0 109.615 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.2 p -160.73 170.81 20.02 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.814 1.645 . . . . 0.0 111.508 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.9 m 57.25 21.32 6.54 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.657 1.583 . . . . 0.0 115.168 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.37 -31.91 1.75 Allowed Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.979 1.276 . . . . 0.0 114.56 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -72.79 150.96 42.33 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 118.646 1.223 . . . . 0.0 110.819 169.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.2 p -143.11 176.45 9.1 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.057 1.343 . . . . 0.0 112.406 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -58.9 142.69 50.04 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.995 1.318 . . . . 0.0 112.349 170.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.4 t -140.42 60.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 125.584 1.554 . . . . 0.0 109.759 -176.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -99.64 157.98 16.09 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.347 1.459 . . . . 0.0 111.542 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -138.23 103.77 5.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.925 1.69 . . . . 0.0 110.379 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.3 mp -94.5 118.78 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 125.814 1.646 . . . . 0.0 109.265 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -96.06 49.11 1.13 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.152 1.381 . . . . 0.0 110.951 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -86.48 -18.49 31.5 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 173.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.1 t -115.78 -5.86 12.1 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.757 1.623 . . . . 0.0 113.033 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -137.16 158.07 45.26 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.3 1.84 . . . . 0.0 109.558 169.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -140.93 165.62 27.03 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.091 0.956 . . . . 0.0 110.842 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -136.04 132.76 36.65 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.16 -0.338 . . . . 0.0 111.322 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.1 m -131.79 159.77 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.353 1.461 . . . . 0.0 111.866 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -57.98 153.75 13.79 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.747 0.819 . . . . 0.0 112.45 175.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.0 tp -149.96 137.16 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.336 1.455 . . . . 0.0 109.714 174.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -132.57 161.25 34.31 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.718 2.007 . . . . 0.0 109.674 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -134.62 160.08 39.21 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.367 1.067 . . . . 0.0 112.162 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.21 114.45 21.82 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.545 0.738 . . . . 0.0 110.625 173.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -73.59 -176.65 2.41 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.779 0.832 . . . . 0.0 112.276 175.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt -55.92 -26.65 48.62 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.489 1.916 . . . . 0.0 113.167 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.0 m -73.75 -8.25 55.28 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.342 1.457 . . . . 0.0 113.87 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.24 40.46 97.38 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.258 0.932 . . . . 0.0 112.4 -169.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -132.61 137.64 47.11 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.562 1.945 . . . . 0.0 109.097 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -67.3 130.64 43.71 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.64 0.776 . . . . 0.0 111.178 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.3 t -137.53 138.46 39.67 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.942 1.297 . . . . 0.0 110.317 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -57.17 125.88 24.71 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.443 1.097 . . . . 0.0 112.286 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.9 tp -100.73 -45.87 5.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.863 0.865 . . . . 0.0 111.092 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.86 -120.36 0.91 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.473 0.559 . . . . 0.0 113.468 -177.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -145.5 155.76 43.3 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.565 1.546 . . . . 0.0 109.575 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.5 tp -121.83 104.81 9.83 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.5 1.12 . . . . 0.0 110.698 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.2 t -77.72 98.95 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.847 1.259 . . . . 0.0 109.355 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 51.6 t -86.06 117.44 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.042 1.737 . . . . 0.0 110.197 174.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -104.46 122.87 46.41 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.973 2.109 . . . . 0.0 110.82 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -85.78 78.87 9.46 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.185 1.394 . . . . 0.0 110.204 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -67.6 171.49 6.22 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.443 1.097 . . . . 0.0 111.721 172.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -73.08 -38.99 66.22 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.508 -1.37 . . . . 0.0 113.93 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -109.22 30.31 6.71 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.331 1.453 . . . . 0.0 113.302 -169.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.68 -163.55 26.51 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 126.908 2.194 . . . . 0.0 113.341 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.4 mt -117.31 143.96 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.074 0.95 . . . . 0.0 109.708 171.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -131.35 140.9 49.81 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.107 1.363 . . . . 0.0 109.459 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.7 p -133.15 146.92 52.01 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.134 -0.979 . . . . 0.0 112.433 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.05 126.51 3.25 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-O 121.769 0.649 . . . . 0.0 112.944 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.05 137.35 53.51 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.561 1.945 . . . . 0.0 110.128 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -137.24 73.75 1.46 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.1 1.76 . . . . 0.0 110.678 -176.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.09 177.59 8.69 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.376 1.87 . . . . 0.0 112.596 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.24 93.71 0.02 OUTLIER Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.72 1.629 . . . . 0.0 113.903 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.64 21.68 77.84 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.855 1.217 . . . . 0.0 115.182 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -148.61 135.62 20.05 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.06 1.43 . . . . 0.0 111.973 -175.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 77.4 p -150.19 148.82 29.38 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.83 161.89 26.24 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.713 1.605 . . . . 0.0 111.413 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.3 m -58.55 136.4 57.56 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.24 -0.913 . . . . 0.0 109.262 169.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -104.45 -48.29 3.86 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.904 0.882 . . . . 0.0 110.022 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -162.38 170.5 18.7 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.416 1.086 . . . . 0.0 112.307 169.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.77 158.09 43.73 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.764 1.226 . . . . 0.0 111.62 170.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.409 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -140.5 158.38 44.09 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.926 1.29 . . . . 0.0 111.466 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -80.05 165.13 22.84 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.15 0.58 . . . . 0.0 111.834 -174.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -53.11 -33.96 54.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.602 1.161 . . . . 0.0 112.857 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -67.26 -8.44 31.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.937 1.295 . . . . 0.0 113.556 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.61 -6.69 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.586 1.154 . . . . 0.0 111.306 -172.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 79.5 t -52.12 -60.91 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 O-C-N 120.404 -1.435 . . . . 0.0 112.231 -176.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -69.0 -27.01 65.31 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.47 -52.79 59.89 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.477 1.511 . . . . 0.0 110.856 175.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.96 -46.65 89.84 Favored 'General case' 0 C--O 1.227 -0.093 0 C-N-CA 125.041 1.336 . . . . 0.0 110.484 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.74 -35.48 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.232 0.613 . . . . 0.0 111.461 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -63.07 -54.69 34.04 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.416 1.086 . . . . 0.0 112.215 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -70.25 -12.24 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 121.551 -0.718 . . . . 0.0 112.419 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -4.63 47.93 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.745 2.018 . . . . 0.0 112.186 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 34.3 p -126.39 -15.0 5.76 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 169.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -130.75 -10.55 3.93 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.942 1.297 . . . . 0.0 114.257 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.64 155.93 7.78 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.241 1.4 . . . . 0.0 113.698 -174.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.8 -170.51 32.49 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.032 0.825 . . . . 0.0 114.064 -174.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.4 p -143.44 109.4 5.25 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.927 1.291 . . . . 0.0 113.529 -168.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -138.05 148.45 45.1 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.364 1.866 . . . . 0.0 109.825 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 155.65 35.1 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.691 -0.63 . . . . 0.0 110.913 177.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 58.9 p -117.85 158.25 25.17 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.921 1.688 . . . . 0.0 110.958 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.409 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 60.0 p -74.35 -39.96 62.44 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.576 -0.703 . . . . 0.0 111.121 -177.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.3 mt -151.11 143.19 24.0 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.631 1.973 . . . . 0.0 111.919 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -138.22 98.52 3.64 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.885 0.874 . . . . 0.0 111.583 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -86.55 -40.12 15.54 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.67 178.26 7.65 Favored Glycine 0 CA--C 1.546 1.971 0 C-N-CA 124.378 0.989 . . . . 0.0 114.339 -169.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -63.7 168.05 5.26 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.78 1.232 . . . . 0.0 112.546 169.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -59.29 -21.48 59.74 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -64.45 -24.82 67.75 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 171.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -69.74 141.15 53.51 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.879 1.671 . . . . 0.0 111.862 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -69.61 -32.6 71.42 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 58.5 m -92.23 2.6 56.51 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.47 -24.86 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 120.501 1.5 . . . . 0.0 114.605 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mt -64.49 -37.85 81.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.636 1.174 . . . . 0.0 112.27 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -134.58 -12.58 2.33 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -173.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.03 177.02 35.61 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.975 1.274 . . . . 0.0 113.199 -170.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 62.5 mt -126.59 110.79 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.502 1.521 . . . . 0.0 108.149 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -69.7 145.27 52.46 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.305 0.574 . . . . 0.0 111.419 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 60.07 19.85 9.05 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.773 1.629 . . . . 0.0 114.466 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -54.73 124.06 15.24 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.638 1.175 . . . . 0.0 111.735 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -72.44 129.81 39.23 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.214 1.006 . . . . 0.0 110.644 171.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.0 mm -126.82 119.35 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.764 1.225 . . . . 0.0 108.922 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.75 98.32 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.274 1.43 . . . . 0.0 108.679 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.5 p -81.92 155.56 25.21 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.709 0.804 . . . . 0.0 112.125 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -151.39 140.05 20.71 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.098 1.359 . . . . 0.0 111.182 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 46.1 mt -79.95 133.06 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -140.34 122.94 16.22 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.188 1.395 . . . . 0.0 110.953 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -74.37 111.02 9.14 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.244 1.017 . . . . 0.0 109.971 172.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 22.7 mt -98.45 96.75 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.9 t70 61.32 17.4 8.25 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.492 1.917 . . . . 0.0 115.641 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.89 -24.03 8.52 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.539 1.066 . . . . 0.0 113.865 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 85.5 m -82.99 127.15 33.29 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.248 1.024 . . . . 0.0 109.261 171.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -73.61 123.54 24.21 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.585 -0.697 . . . . 0.0 110.091 173.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -113.25 169.12 9.17 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.281 1.432 . . . . 0.0 109.91 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.9 tp -120.77 133.66 66.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.06 1.344 . . . . 0.0 108.519 169.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.1 p -121.8 155.08 36.08 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.596 0.758 . . . . 0.0 110.214 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -147.14 145.02 29.42 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.598 0.759 . . . . 0.0 112.246 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.3 p -74.91 108.71 7.82 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.982 1.313 . . . . 0.0 111.49 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.77 -162.35 33.47 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 123.83 0.729 . . . . 0.0 113.535 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -69.6 173.78 5.71 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 121.673 -0.898 . . . . 0.0 110.029 167.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -84.17 137.77 33.34 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.659 -1.276 . . . . 0.0 111.661 173.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.26 160.11 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.174 0.589 . . . . 0.0 111.74 169.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -90.63 -32.6 16.17 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.915 0.886 . . . . 0.0 111.837 169.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -60.76 -16.57 41.64 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.45 1.9 . . . . 0.0 114.775 -177.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.13 2.61 10.41 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.436 1.494 . . . . 0.0 113.458 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 107.87 -85.41 0.41 Allowed Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.929 1.728 . . . . 0.0 113.037 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -144.31 33.92 1.2 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.578 1.951 . . . . 0.0 110.408 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -97.45 155.07 17.09 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.853 1.261 . . . . 0.0 108.968 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.1 m -89.42 141.0 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 122.53 0.332 . . . . 0.0 110.141 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -72.94 88.94 1.38 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.352 0.661 . . . . 0.0 109.763 173.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -76.64 147.39 37.56 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 122.113 0.959 . . . . 0.0 110.675 168.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -131.83 172.93 11.7 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.902 1.681 . . . . 0.0 111.013 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.34 131.72 18.59 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.324 0.65 . . . . 0.0 110.232 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 68.9 mt -123.6 140.76 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.185 0.994 . . . . 0.0 109.021 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.3 m -63.88 97.4 0.16 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.22 1.008 . . . . 0.0 109.865 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.6 tt -54.19 -32.43 55.62 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.218 1.007 . . . . 0.0 111.571 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.18 -28.12 69.17 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -85.88 -33.27 21.29 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.35 0.977 . . . . 0.0 112.923 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 44.8 mt -58.45 -47.47 83.9 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.261 1.024 . . . . 0.0 110.19 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -53.93 -23.61 13.48 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 175.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -80.73 -16.1 54.75 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.672 1.189 . . . . 0.0 114.163 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -126.85 1.79 6.66 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.961 1.304 . . . . 0.0 113.554 -174.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 3.5 mp -102.49 -17.94 15.55 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.986 1.715 . . . . 0.0 112.022 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm . . . . . 0 C--O 1.253 1.264 0 C-N-CA 125.672 1.589 . . . . 0.0 112.477 169.52 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt . . . . . 0 N--CA 1.498 1.944 0 N-CA-C 110.732 -0.099 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.19 162.42 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.661 1.185 . . . . 0.0 112.298 174.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -143.84 143.93 31.54 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.752 1.221 . . . . 0.0 111.253 171.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 m -146.54 144.08 29.35 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.908 1.683 . . . . 0.0 109.56 176.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.1 p -148.94 140.28 23.25 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.268 1.027 . . . . 0.0 112.218 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -160.1 143.36 13.85 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.609 1.564 . . . . 0.0 110.769 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -149.69 161.99 41.12 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.521 1.928 . . . . 0.0 110.034 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -120.39 141.52 50.03 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.794 1.238 . . . . 0.0 110.767 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -150.95 151.74 32.56 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.262 1.025 . . . . 0.0 112.17 -174.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.3 p -72.44 2.45 6.23 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.397 1.879 . . . . 0.0 115.14 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 t -66.98 -175.4 0.42 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.386 1.474 . . . . 0.0 112.72 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.28 -21.01 7.64 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 125.844 1.688 . . . . 0.0 115.796 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -63.74 -14.85 56.16 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 172.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.2 m -64.44 148.79 49.79 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.116 0.966 . . . . 0.0 112.785 170.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.94 160.08 24.76 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.582 1.153 . . . . 0.0 110.862 174.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -141.14 128.88 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.243 1.417 . . . . 0.0 109.369 -172.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -122.55 -169.27 1.88 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.23 1.412 . . . . 0.0 112.64 -169.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.1 mttp -62.19 128.56 36.69 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.668 1.587 . . . . 0.0 109.923 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mm -105.64 151.82 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.367 1.067 . . . . 0.0 109.806 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -73.77 -8.52 56.36 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 177.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -82.92 -168.39 2.04 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.517 1.927 . . . . 0.0 113.136 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.6 m -64.32 -31.7 73.01 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.297 1.839 . . . . 0.0 113.011 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -85.62 160.38 19.62 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.419 1.088 . . . . 0.0 111.964 173.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -143.25 170.3 16.02 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.061 1.744 . . . . 0.0 110.664 169.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.29 134.26 34.1 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.668 -0.645 . . . . 0.0 110.435 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.1 m -130.16 163.54 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.237 1.415 . . . . 0.0 111.321 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -60.35 156.35 15.97 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.969 0.908 . . . . 0.0 111.649 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.3 tp -151.3 135.09 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.695 1.198 . . . . 0.0 109.282 172.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -126.59 156.81 40.31 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.43 1.892 . . . . 0.0 108.777 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -126.03 155.09 42.05 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.67 1.188 . . . . 0.0 111.196 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -80.12 118.49 21.87 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 168.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -67.43 178.04 1.71 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 122.326 1.06 . . . . 0.0 113.119 170.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -17.19 50.63 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.923 1.289 . . . . 0.0 113.589 176.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.2 m -95.73 1.78 53.56 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.61 1.164 . . . . 0.0 112.508 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.37 21.31 79.06 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-N 119.64 1.109 . . . . 0.0 114.494 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -102.2 137.24 40.72 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.646 1.178 . . . . 0.0 110.822 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -67.84 123.96 22.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.824 0.849 . . . . 0.0 110.35 170.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -140.7 143.09 34.85 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.705 1.202 . . . . 0.0 110.453 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -58.18 139.19 55.39 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.2 tp -114.68 -46.76 2.93 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.947 0.899 . . . . 0.0 111.181 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.76 -115.01 0.61 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 122.971 0.32 . . . . 0.0 113.212 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -147.64 153.84 39.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.055 1.342 . . . . 0.0 110.148 -174.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.6 tp -121.31 105.02 10.15 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.963 1.305 . . . . 0.0 110.033 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.8 t -76.27 94.15 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.923 1.289 . . . . 0.0 109.331 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 42.8 t -81.29 99.0 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.897 1.679 . . . . 0.0 109.071 173.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -81.85 160.76 23.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.189 1.395 . . . . 0.0 111.015 174.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -116.81 80.99 1.56 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.213 1.005 . . . . 0.0 110.971 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -62.13 171.44 1.79 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 122.722 1.249 . . . . 0.0 113.344 169.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -74.36 -40.3 62.21 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.521 1.129 . . . . 0.0 113.086 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -110.88 42.23 1.65 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.917 1.287 . . . . 0.0 112.41 -171.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.88 -156.2 22.38 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.964 1.268 . . . . 0.0 114.808 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.0 mt -122.22 136.06 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.965 0.906 . . . . 0.0 110.433 173.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -123.61 141.9 51.56 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.838 2.055 . . . . 0.0 111.984 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.5 p -137.19 136.78 38.48 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.217 -0.927 . . . . 0.0 112.341 -175.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.21 127.85 5.82 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.189 0.423 . . . . 0.0 112.79 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.06 135.58 51.02 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.689 1.596 . . . . 0.0 110.22 174.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -138.81 73.8 1.45 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.541 1.537 . . . . 0.0 110.815 -173.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.13 174.5 9.98 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.497 1.519 . . . . 0.0 112.199 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.52 -47.97 67.34 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 123.828 0.727 . . . . 0.0 114.025 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.06 11.82 14.7 Favored Glycine 0 N--CA 1.473 1.133 0 CA-C-O 119.04 -0.867 . . . . 0.0 114.722 -177.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -156.18 145.65 20.83 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.753 1.276 . . . . 0.0 112.923 -171.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 80.5 p -149.58 147.97 28.79 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 170.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -164.35 162.65 22.37 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.433 1.493 . . . . 0.0 111.674 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 57.2 m -57.86 132.71 54.17 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.248 -0.908 . . . . 0.0 109.387 168.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -99.54 -47.49 5.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.737 0.815 . . . . 0.0 110.541 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -166.62 169.25 13.79 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.744 1.218 . . . . 0.0 112.387 171.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.53 138.51 16.36 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.43 1.092 . . . . 0.0 112.347 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.428 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -118.73 160.0 22.65 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.649 1.58 . . . . 0.0 111.767 179.063 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -83.12 167.19 18.04 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.388 0.675 . . . . 0.0 112.324 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -57.67 -32.3 67.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.073 0.949 . . . . 0.0 112.666 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -70.11 -3.8 18.34 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.436 1.094 . . . . 0.0 113.849 175.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.0 t -119.79 -3.12 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.354 1.062 . . . . 0.0 111.046 -175.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 69.5 t -55.57 -61.78 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 120.461 -1.4 . . . . 0.0 111.635 -175.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -68.24 -25.0 64.97 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -54.0 40.51 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.425 1.49 . . . . 0.0 110.584 173.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -61.96 -44.23 97.19 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.35 1.46 . . . . 0.0 111.238 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 63.3 t -53.98 -36.72 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.519 1.128 . . . . 0.0 111.003 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -70.92 -54.05 12.79 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.848 1.259 . . . . 0.0 112.379 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -70.84 -21.01 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 O-C-N 120.786 -1.196 . . . . 0.0 112.568 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.8 -5.11 58.79 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.093 1.757 . . . . 0.0 111.703 175.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.6 p -129.66 -14.77 4.06 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -136.61 -10.05 1.87 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.186 1.794 . . . . 0.0 113.932 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.42 155.18 10.93 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.722 1.63 . . . . 0.0 113.967 -175.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.64 -170.86 33.03 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.475 1.036 . . . . 0.0 113.641 -174.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.1 p -144.03 109.87 5.29 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.748 1.219 . . . . 0.0 113.527 -169.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -138.51 145.88 41.3 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.47 1.908 . . . . 0.0 109.986 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.51 147.15 42.1 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.078 -1.014 . . . . 0.0 111.754 175.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.6 p -106.58 168.1 9.4 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.603 1.561 . . . . 0.0 111.443 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.428 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 16.5 p -74.55 -39.63 62.18 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.524 -0.735 . . . . 0.0 111.118 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.0 mt -155.85 144.2 20.07 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.406 2.282 . . . . 0.0 110.605 -174.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -138.71 105.47 5.37 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.098 0.959 . . . . 0.0 111.263 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -89.42 -40.29 12.82 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.93 179.39 15.88 Favored Glycine 0 CA--C 1.545 1.928 0 C-N-CA 124.977 1.275 . . . . 0.0 114.142 -168.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -57.88 164.86 1.99 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.261 1.024 . . . . 0.0 112.519 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -63.47 172.42 2.04 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.23 1.012 . . . . 0.0 113.006 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 67.69 13.93 9.37 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.775 1.63 . . . . 0.0 114.107 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.77 167.66 11.5 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.929 2.092 . . . . 0.0 113.272 -177.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -77.02 -23.7 52.16 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 174.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.1 m -118.92 -1.36 11.02 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -172.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.65 -13.94 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 173.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 75.5 mt -60.62 -47.27 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.166 1.386 . . . . 0.0 111.787 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -142.63 -5.26 0.93 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.89 1.276 . . . . 0.0 114.414 -176.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 93.04 -169.52 30.93 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.456 1.503 . . . . 0.0 113.024 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 35.2 mt -133.04 108.48 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 125.712 1.605 . . . . 0.0 107.17 172.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -68.74 145.86 53.44 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.069 0.462 . . . . 0.0 111.201 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 59.09 25.02 13.39 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.639 1.575 . . . . 0.0 114.262 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.52 130.55 43.55 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.022 1.329 . . . . 0.0 112.108 -172.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -78.75 117.97 20.37 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.972 0.909 . . . . 0.0 112.333 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 28.5 mm -108.69 118.73 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.063 0.945 . . . . 0.0 109.66 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 mp -109.98 98.51 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.212 1.405 . . . . 0.0 108.816 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 65.8 p -80.31 157.79 26.29 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.174 174.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -154.35 142.17 20.05 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.178 1.391 . . . . 0.0 111.744 172.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.7 mt -80.86 133.32 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.652 0.781 . . . . 0.0 109.222 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -149.95 143.18 25.06 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.604 1.562 . . . . 0.0 110.046 171.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -82.19 158.38 23.61 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.23 -0.919 . . . . 0.0 109.801 169.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.5 mt -126.93 -46.61 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.814 0.846 . . . . 0.0 111.029 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -145.19 15.6 1.5 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -178.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 123.22 -25.11 6.42 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 124.372 0.987 . . . . 0.0 113.666 -177.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 60.8 m -86.74 142.54 28.08 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.213 1.005 . . . . 0.0 108.941 170.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -75.49 125.14 28.41 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.278 0.561 . . . . 0.0 109.855 170.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -110.27 168.95 9.06 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.283 1.433 . . . . 0.0 110.526 173.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.2 tp -124.97 133.44 69.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 125.498 1.519 . . . . 0.0 108.474 172.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.4 p -120.55 156.99 30.43 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.547 0.739 . . . . 0.0 109.949 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -149.02 136.91 20.61 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.695 0.798 . . . . 0.0 111.626 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.6 m -75.15 107.43 7.23 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.787 1.235 . . . . 0.0 110.896 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.61 -164.24 39.54 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.554 1.073 . . . . 0.0 114.32 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -63.63 160.97 15.69 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.912 0.885 . . . . 0.0 111.475 170.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -76.86 131.95 38.88 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.187 -0.946 . . . . 0.0 110.331 172.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.25 159.23 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.242 1.017 . . . . 0.0 111.294 173.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -92.53 -28.34 16.84 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.836 0.854 . . . . 0.0 112.542 172.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -67.21 -6.42 18.03 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.28 1.432 . . . . 0.0 114.569 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.42 -14.15 4.79 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 120.55 -84.35 0.37 Allowed Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.312 1.434 . . . . 0.0 113.183 172.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -137.55 24.41 2.91 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.203 1.801 . . . . 0.0 111.174 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -89.88 165.41 14.12 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.645 1.178 . . . . 0.0 109.502 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.6 m -101.55 143.18 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.289 0.635 . . . . 0.0 111.14 176.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.24 93.76 0.33 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.618 1.167 . . . . 0.0 109.852 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -99.99 144.92 28.48 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 122.413 1.101 . . . . 0.0 111.462 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -137.63 174.26 10.78 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.751 1.62 . . . . 0.0 111.211 -172.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.31 133.22 20.17 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.479 0.712 . . . . 0.0 110.127 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 64.3 mt -125.21 140.83 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.153 0.981 . . . . 0.0 108.889 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.0 m -66.17 95.37 0.29 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.041 0.936 . . . . 0.0 109.511 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.1 tt -54.75 -31.87 59.15 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.738 1.215 . . . . 0.0 111.86 177.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -70.3 -26.29 63.72 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -89.31 -26.72 20.97 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.833 0.853 . . . . 0.0 112.439 174.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 23.6 mt -61.55 -48.59 80.29 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.057 0.943 . . . . 0.0 110.759 169.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -51.85 -37.61 52.75 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.365 1.066 . . . . 0.0 113.636 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -73.11 -11.49 60.56 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -127.1 -3.63 6.33 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.2 1.4 . . . . 0.0 114.241 -175.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 26.0 mt -92.81 -21.79 19.7 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.872 1.269 . . . . 0.0 112.303 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 C--O 1.254 1.314 0 C-N-CA 126.258 1.823 . . . . 0.0 112.93 174.522 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 119.551 -0.261 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.6 pt -123.05 -8.95 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -127.53 57.63 1.5 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.27 1.428 . . . . 0.0 109.657 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.2 t -56.12 146.57 22.65 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.502 0.721 . . . . 0.0 111.695 172.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.0 p -117.31 -24.26 7.5 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.357 1.463 . . . . 0.0 112.747 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -81.33 150.33 28.51 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.951 1.3 . . . . 0.0 111.223 169.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -151.78 127.83 10.42 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.183 1.393 . . . . 0.0 110.386 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 48.57 36.64 7.83 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.604 1.562 . . . . 0.0 113.516 -174.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.99 116.06 23.65 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.919 1.688 . . . . 0.0 108.837 -177.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.7 t -134.62 148.8 50.48 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.327 1.451 . . . . 0.0 110.543 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.0 t -128.48 104.74 7.86 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.564 1.146 . . . . 0.0 110.966 -172.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.86 165.01 33.76 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.852 1.691 . . . . 0.0 111.648 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -124.02 160.2 28.17 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.835 1.254 . . . . 0.0 110.681 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.7 m -140.97 164.32 30.57 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.399 1.48 . . . . 0.0 111.049 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -109.8 145.56 36.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.383 1.473 . . . . 0.0 110.725 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -135.8 120.54 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.043 1.337 . . . . 0.0 108.796 -174.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.12 164.54 34.4 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.765 1.626 . . . . 0.0 111.676 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -137.95 114.75 10.64 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.615 1.566 . . . . 0.0 110.002 174.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.02 131.9 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.772 1.629 . . . . 0.0 108.908 177.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -74.5 -8.49 56.48 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.84 -15.4 12.33 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -178.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.5 m -67.72 -10.29 51.18 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.239 1.416 . . . . 0.0 113.322 171.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -134.38 166.94 21.68 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.794 1.638 . . . . 0.0 110.257 169.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -149.15 164.48 34.62 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.168 0.987 . . . . 0.0 110.261 170.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.74 123.49 25.0 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.566 0.222 . . . . 0.0 110.658 -178.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.5 m -120.53 161.75 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.2 1.4 . . . . 0.0 111.186 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -62.14 160.36 12.94 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.793 1.237 . . . . 0.0 111.303 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.3 tp -155.96 138.21 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.576 1.15 . . . . 0.0 109.339 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -130.98 161.94 30.85 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.221 1.808 . . . . 0.0 109.729 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -134.2 159.23 41.54 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.147 1.379 . . . . 0.0 111.704 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.17 119.62 25.76 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.283 0.633 . . . . 0.0 110.535 174.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -73.7 179.94 3.92 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.238 0.615 . . . . 0.0 112.41 174.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -58.05 -24.44 58.44 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.892 1.677 . . . . 0.0 113.435 173.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.9 m -78.93 -5.49 53.86 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.848 1.259 . . . . 0.0 113.806 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.42 32.84 84.81 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.289 0.947 . . . . 0.0 113.704 -171.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -116.64 141.98 47.49 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.792 1.637 . . . . 0.0 109.854 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -69.85 133.21 47.13 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.758 0.823 . . . . 0.0 111.26 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.3 t -145.54 142.98 29.67 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.931 1.293 . . . . 0.0 110.537 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -56.98 135.89 56.22 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.284 1.034 . . . . 0.0 112.415 -174.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.1 tp -109.12 -47.76 3.37 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.591 0.756 . . . . 0.0 111.731 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.24 -130.39 2.05 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 121.712 0.618 . . . . 0.0 113.713 -175.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -137.06 152.6 50.24 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.528 1.931 . . . . 0.0 110.8 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.5 tp -119.79 104.61 10.37 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.427 1.491 . . . . 0.0 110.806 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.43 99.86 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.388 1.075 . . . . 0.0 109.544 175.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.2 t -85.11 128.06 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.161 1.385 . . . . 0.0 109.633 173.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -119.39 118.42 31.13 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.193 2.197 . . . . 0.0 110.137 -175.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -85.54 103.76 14.69 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.15 1.38 . . . . 0.0 109.861 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -105.26 171.91 7.07 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.697 1.199 . . . . 0.0 111.694 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -76.19 -15.65 60.01 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 120.825 -1.172 . . . . 0.0 113.664 176.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -119.1 45.69 2.04 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.6 1.96 . . . . 0.0 112.053 -175.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.24 -165.39 20.58 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.002 1.286 . . . . 0.0 113.882 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.4 mt -112.45 139.55 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.709 0.804 . . . . 0.0 109.116 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -127.2 139.76 52.71 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.822 0.849 . . . . 0.0 110.094 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.1 p -132.09 137.27 47.68 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.59 0.756 . . . . 0.0 111.025 -173.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.29 110.48 0.83 Allowed Glycine 0 CA--C 1.52 0.387 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -170.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 32.0 tp -64.0 148.11 50.45 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.979 1.312 . . . . 0.0 110.345 175.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -138.35 76.99 1.6 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.044 1.738 . . . . 0.0 109.603 176.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.87 77.61 9.87 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.349 1.059 . . . . 0.0 112.338 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.42 -73.9 2.15 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.682 1.611 . . . . 0.0 113.796 174.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -137.89 18.7 3.35 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.967 1.746 . . . . 0.0 113.194 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -138.4 71.92 1.4 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.247 1.419 . . . . 0.0 110.933 -172.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.9 p -75.14 150.7 38.68 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 175.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.68 156.79 20.95 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.751 1.62 . . . . 0.0 111.401 176.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.9 m -58.74 116.45 3.74 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.33 -0.856 . . . . 0.0 109.144 169.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -81.99 -52.29 7.19 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.624 0.647 . . . . 0.0 109.841 -178.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -166.19 162.44 17.55 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.94 1.296 . . . . 0.0 112.383 170.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.58 156.81 44.7 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.956 1.303 . . . . 0.0 111.399 177.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.415 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -140.97 157.93 44.65 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.104 1.362 . . . . 0.0 112.282 -177.36 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -77.09 165.34 24.72 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.535 0.734 . . . . 0.0 112.021 -173.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -57.47 -30.0 64.69 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.318 -0.864 . . . . 0.0 112.357 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -69.98 -8.31 47.98 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.549 1.54 . . . . 0.0 114.027 175.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 t -119.26 -4.38 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.777 1.231 . . . . 0.0 111.3 -173.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.3 t -50.31 -66.47 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 125.169 1.388 . . . . 0.0 111.663 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -67.69 -24.42 65.41 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.38 -51.96 63.66 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.104 1.362 . . . . 0.0 110.511 173.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -60.17 -44.13 95.29 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 124.84 1.256 . . . . 0.0 111.926 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 92.4 t -55.58 -36.25 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 122.967 0.507 . . . . 0.0 110.855 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.7 tttp -68.29 -54.94 14.04 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.534 1.133 . . . . 0.0 112.678 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -72.7 -14.6 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 121.063 -1.023 . . . . 0.0 112.518 -174.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.07 -6.41 57.95 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.544 1.537 . . . . 0.0 112.081 176.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 44.4 p -130.5 -14.89 3.65 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -131.74 -9.57 3.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.612 1.565 . . . . 0.0 113.849 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.4 156.5 7.95 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.473 1.511 . . . . 0.0 113.683 -176.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.1 -169.04 34.69 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.993 0.806 . . . . 0.0 113.966 -175.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 61.6 p -146.32 94.72 2.5 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.389 1.075 . . . . 0.0 113.488 -167.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -128.49 140.14 51.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.667 1.587 . . . . 0.0 109.885 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -69.45 153.17 43.95 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.454 0.701 . . . . 0.0 110.947 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.8 p -115.11 160.86 19.15 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.76 1.624 . . . . 0.0 110.942 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 82.4 p -76.38 -39.17 54.43 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.391 -0.818 . . . . 0.0 111.019 -177.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.3 mt -153.45 138.71 17.49 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.37 1.868 . . . . 0.0 111.694 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -137.45 101.6 4.55 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.246 1.018 . . . . 0.0 111.005 176.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -91.72 -36.87 13.35 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 174.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.42 -176.13 48.18 Favored Glycine 0 CA--C 1.544 1.86 0 CA-C-N 118.936 0.789 . . . . 0.0 113.902 -170.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -58.12 -76.24 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -179.71 171.77 1.16 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.666 2.786 . . . . 0.0 109.211 -171.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 55.6 38.1 29.74 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 122.494 1.14 . . . . 0.0 112.213 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -130.52 147.9 52.26 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.209 1.804 . . . . 0.0 110.226 -168.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -67.23 -11.1 56.54 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -172.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.6 m -132.15 7.47 4.29 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -177.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.0 p -68.91 -14.01 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.253 -1.53 . . . . 0.0 114.253 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 66.6 mt -84.96 -38.67 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.458 1.103 . . . . 0.0 111.674 -177.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -123.7 -10.51 7.81 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.833 1.253 . . . . 0.0 113.684 -173.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.95 -178.49 43.27 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.087 1.327 . . . . 0.0 113.649 -176.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.6 mt -133.47 103.24 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.31 1.444 . . . . 0.0 107.651 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -67.01 143.58 56.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.189 0.518 . . . . 0.0 110.834 173.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 61.82 19.33 10.51 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.468 1.507 . . . . 0.0 114.381 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 16.4 tptp -53.62 123.88 13.48 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.893 1.277 . . . . 0.0 111.456 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -70.86 127.48 32.76 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.952 0.901 . . . . 0.0 110.388 170.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.7 mm -124.88 116.53 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.386 1.075 . . . . 0.0 108.48 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.8 mp -110.31 92.42 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.006 1.322 . . . . 0.0 108.379 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.1 p -75.03 154.91 37.78 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.123 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -150.68 139.38 20.71 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.948 1.299 . . . . 0.0 111.135 174.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.4 mt -81.93 132.85 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -140.45 122.45 15.61 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.273 1.429 . . . . 0.0 110.126 174.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -72.67 119.27 16.66 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 169.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.3 mt -105.37 97.09 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 175.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 61.15 11.4 3.46 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.603 1.961 . . . . 0.0 115.793 -176.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 132.84 -36.29 2.18 Favored Glycine 0 N--CA 1.473 1.117 0 C-N-CA 124.746 1.165 . . . . 0.0 113.31 176.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 88.3 m -71.85 126.74 30.52 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.472 1.109 . . . . 0.0 109.445 172.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -73.63 116.88 14.73 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.164 0.585 . . . . 0.0 109.848 173.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -106.38 166.15 10.75 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.271 1.428 . . . . 0.0 110.607 170.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.8 tp -118.66 138.19 50.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 125.525 1.53 . . . . 0.0 108.207 169.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.1 p -127.34 156.82 41.39 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.619 0.767 . . . . 0.0 109.933 174.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -150.79 146.14 26.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.13 0.972 . . . . 0.0 111.235 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 p -78.71 109.56 13.06 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.735 1.214 . . . . 0.0 111.402 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.43 -165.23 32.23 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 123.897 0.761 . . . . 0.0 113.204 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -65.33 164.3 13.85 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 122.254 1.026 . . . . 0.0 112.481 170.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -84.34 106.06 15.66 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.159 1.383 . . . . 0.0 111.172 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.89 157.38 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.413 0.625 . . . . 0.0 112.093 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -88.23 -33.07 18.24 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.215 1.006 . . . . 0.0 112.25 174.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -64.31 -42.29 96.41 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.5 -22.45 35.09 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 131.89 -80.24 0.34 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.484 1.516 . . . . 0.0 112.699 172.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -140.29 18.22 2.41 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.297 1.839 . . . . 0.0 111.424 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -79.92 -175.33 4.88 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.082 0.953 . . . . 0.0 109.674 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.9 m -117.91 142.83 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.892 0.877 . . . . 0.0 110.863 175.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.25 94.94 0.55 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.432 0.693 . . . . 0.0 109.442 172.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -92.31 145.45 24.47 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 122.164 0.983 . . . . 0.0 111.288 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -136.25 169.99 16.75 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.739 1.616 . . . . 0.0 111.112 -172.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.86 134.6 23.53 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 122.97 0.508 . . . . 0.0 110.495 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 59.7 mt -126.75 139.19 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.807 0.843 . . . . 0.0 109.263 175.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.5 m -63.09 96.9 0.1 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.232 1.013 . . . . 0.0 109.791 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.35 -31.39 61.71 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.471 1.109 . . . . 0.0 111.884 177.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -67.86 -29.43 68.56 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -88.41 -18.88 27.39 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.036 0.934 . . . . 0.0 112.64 174.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 20.0 mt -70.92 -46.38 62.59 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.476 -0.765 . . . . 0.0 110.173 168.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -49.43 -48.26 47.46 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.851 1.26 . . . . 0.0 113.538 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 30.6 pttt -62.06 -29.74 70.51 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -93.74 -18.36 22.17 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.177 1.391 . . . . 0.0 112.492 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 14.4 mt -89.4 -30.66 18.2 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.221 1.409 . . . . 0.0 112.828 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt . . . . . 0 C--O 1.253 1.289 0 C-N-CA 126.986 2.114 . . . . 0.0 113.428 169.978 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.2 mttp . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 120.443 0.163 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.8 mt -98.58 126.62 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.652 1.181 . . . . 0.0 109.153 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -155.51 154.18 31.4 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.012 1.325 . . . . 0.0 110.846 173.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.3 p -143.9 136.47 27.02 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.902 1.281 . . . . 0.0 111.668 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.3 m -65.89 161.0 22.1 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.167 0.987 . . . . 0.0 112.664 172.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -149.01 179.98 7.46 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.851 1.66 . . . . 0.0 111.28 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -127.93 147.23 50.47 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.839 1.256 . . . . 0.0 112.033 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -152.85 136.65 16.18 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.821 1.249 . . . . 0.0 110.681 -174.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -70.07 141.64 52.78 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.523 0.729 . . . . 0.0 111.61 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.2 t -150.42 90.81 1.68 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.552 1.141 . . . . 0.0 111.21 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.8 p -86.25 175.19 8.61 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.484 1.514 . . . . 0.0 112.585 174.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.76 110.66 0.46 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.366 0.984 . . . . 0.0 112.644 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -68.98 138.59 54.67 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.199 0.999 . . . . 0.0 111.453 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.3 t 52.11 26.88 4.11 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.683 1.593 . . . . 0.0 114.968 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -93.43 25.63 3.34 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.461 1.504 . . . . 0.0 113.533 -174.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.7 t -84.45 82.7 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.985 1.314 . . . . 0.0 110.209 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -141.62 163.65 32.35 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.931 1.693 . . . . 0.0 111.326 174.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -69.13 129.81 40.93 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.562 0.745 . . . . 0.0 109.609 168.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 mm -109.7 143.26 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.87 1.268 . . . . 0.0 109.01 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.2 -8.17 43.25 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -53.65 -16.64 1.7 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 127.045 2.138 . . . . 0.0 115.477 -175.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.0 t -61.38 -22.9 65.38 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.721 1.609 . . . . 0.0 113.82 170.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -145.35 162.32 37.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.253 1.021 . . . . 0.0 112.582 174.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -154.74 170.69 21.01 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.471 1.109 . . . . 0.0 111.931 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.87 134.08 44.13 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.217 0.607 . . . . 0.0 111.261 174.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.9 m -131.13 164.19 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 125.793 1.637 . . . . 0.0 111.33 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.22 160.41 13.06 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.626 1.17 . . . . 0.0 112.111 177.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 tp -155.29 137.0 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.321 1.448 . . . . 0.0 109.963 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -127.33 159.76 33.42 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.607 1.963 . . . . 0.0 109.547 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -128.88 159.69 35.01 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.79 1.236 . . . . 0.0 111.493 176.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -87.47 118.21 26.78 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.459 0.304 . . . . 0.0 110.868 173.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -69.52 178.08 2.64 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.958 0.885 . . . . 0.0 112.712 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -60.25 -22.65 63.31 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.158 1.783 . . . . 0.0 115.035 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.8 t -85.52 -4.87 59.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.95 0.9 . . . . 0.0 112.608 174.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.4 32.35 57.99 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 121.108 -0.995 . . . . 0.0 113.299 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -109.6 142.04 41.27 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.964 1.306 . . . . 0.0 110.72 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -76.14 122.06 23.76 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.594 0.758 . . . . 0.0 110.937 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.5 t -137.43 139.39 40.64 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.135 1.374 . . . . 0.0 110.32 -175.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -57.63 141.24 48.91 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -176.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.1 tp -114.56 -47.74 2.89 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.659 0.783 . . . . 0.0 111.023 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.92 -116.27 0.64 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 123.378 0.514 . . . . 0.0 113.044 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -146.33 156.25 43.21 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.693 1.597 . . . . 0.0 109.729 -176.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.8 tp -121.16 102.27 8.2 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.153 1.381 . . . . 0.0 110.29 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.82 101.19 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.083 0.953 . . . . 0.0 109.02 171.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.9 t -88.35 127.07 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.274 1.43 . . . . 0.0 109.803 172.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 -126.49 133.76 51.1 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.697 2.399 . . . . 0.0 110.928 -175.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.8 91.35 7.9 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.933 1.293 . . . . 0.0 109.766 176.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -73.06 174.45 7.89 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.721 1.208 . . . . 0.0 112.11 175.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -64.53 -31.61 72.9 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.14 -1.6 . . . . 0.0 114.017 -176.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -130.05 48.35 2.4 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.436 1.495 . . . . 0.0 112.515 -173.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.47 -164.0 23.98 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.727 1.632 . . . . 0.0 115.096 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 69.1 mt -113.37 142.17 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.345 1.058 . . . . 0.0 109.922 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -131.77 139.6 48.98 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.211 1.805 . . . . 0.0 109.315 -177.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.8 p -131.74 146.53 52.21 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.318 -0.864 . . . . 0.0 111.549 -171.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.45 124.0 2.41 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-O 121.699 0.61 . . . . 0.0 113.088 -177.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.72 136.18 52.47 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.434 1.894 . . . . 0.0 110.189 175.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -134.15 75.36 1.59 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.367 1.867 . . . . 0.0 110.475 -175.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.4 173.09 8.92 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.106 1.362 . . . . 0.0 112.075 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.68 94.44 0.04 OUTLIER Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.43 1.491 . . . . 0.0 113.648 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.63 17.2 79.04 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.855 1.216 . . . . 0.0 115.146 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -149.53 114.14 5.3 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 119.134 1.467 . . . . 0.0 111.471 -176.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.1 m -141.83 136.27 30.44 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -173.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.73 165.49 25.51 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.354 1.461 . . . . 0.0 112.278 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.2 m -55.02 135.04 49.25 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.279 -0.888 . . . . 0.0 110.468 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -102.89 -52.6 3.03 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.796 1.238 . . . . 0.0 109.89 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -163.07 162.66 25.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.824 0.85 . . . . 0.0 112.65 170.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.25 141.31 27.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.718 0.807 . . . . 0.0 111.538 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.48 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.8 OUTLIER -121.38 156.72 32.04 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.365 1.866 . . . . 0.0 111.501 -176.305 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -75.79 163.46 27.23 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.578 0.704 . . . . 0.0 112.608 -176.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -54.93 -28.03 47.91 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.038 1.335 . . . . 0.0 113.596 171.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -72.01 -15.65 62.05 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 121.104 -0.998 . . . . 0.0 113.251 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.6 t -106.32 -5.25 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.744 1.217 . . . . 0.0 110.671 -171.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.5 m -53.8 -35.03 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -96.79 -23.33 16.45 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.677 0.791 . . . . 0.0 112.307 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -68.69 -48.87 62.8 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.623 1.569 . . . . 0.0 111.318 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -60.71 -43.28 97.99 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.271 1.428 . . . . 0.0 111.338 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.7 t -53.69 -42.76 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.247 1.019 . . . . 0.0 109.914 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -60.84 -56.08 25.38 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.416 1.086 . . . . 0.0 112.313 175.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 m -72.86 -3.34 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 121.02 -1.05 . . . . 0.0 113.456 -177.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.46 -3.83 19.08 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.543 1.937 . . . . 0.0 111.902 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.7 p -129.81 -13.26 4.18 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.253 1.421 . . . . 0.0 113.29 172.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -134.03 -14.71 2.35 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.076 1.75 . . . . 0.0 114.116 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.16 154.82 11.74 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 124.797 1.189 . . . . 0.0 114.26 -176.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.28 -158.35 30.39 Favored Glycine 0 CA--C 1.533 1.162 0 O-C-N 121.58 -0.953 . . . . 0.0 114.073 -176.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.6 p -151.38 105.02 3.14 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -174.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -136.56 157.97 45.54 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.481 1.913 . . . . 0.0 110.537 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -83.58 161.57 21.12 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.16 -0.963 . . . . 0.0 111.996 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.4 p -122.96 158.59 30.12 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.853 1.661 . . . . 0.0 110.225 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.48 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 88.3 p -68.8 -36.49 78.33 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.768 -1.207 . . . . 0.0 111.139 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.4 mt -148.49 159.59 43.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.984 2.114 . . . . 0.0 111.604 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -149.93 112.47 4.73 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.475 1.11 . . . . 0.0 110.473 170.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -96.27 -47.58 5.96 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.978 0.911 . . . . 0.0 112.465 174.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.84 178.68 27.21 Favored Glycine 0 CA--C 1.544 1.856 0 C-N-CA 125.757 1.646 . . . . 0.0 113.993 -169.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -62.37 162.44 10.04 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 121.311 -1.111 . . . . 0.0 113.44 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -75.17 52.66 0.59 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.675 1.99 . . . . 0.0 112.972 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -144.67 8.62 1.32 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.712 1.605 . . . . 0.0 112.92 178.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -130.41 175.61 8.82 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.452 -1.405 . . . . 0.0 113.342 -175.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -84.86 -21.42 29.8 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 40.2 p -75.85 -25.7 56.47 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.34 -20.47 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -171.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 59.9 mt -59.51 -47.24 91.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 125.413 1.485 . . . . 0.0 111.889 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -137.34 -11.19 1.66 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.095 1.358 . . . . 0.0 114.186 -176.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.69 164.65 26.78 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.958 1.742 . . . . 0.0 114.074 -170.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 68.9 mt -112.38 114.61 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.721 1.608 . . . . 0.0 108.319 175.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -70.64 147.64 48.94 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.004 -0.435 . . . . 0.0 111.42 173.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 58.79 22.89 10.6 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.91 1.684 . . . . 0.0 114.465 175.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -65.8 130.7 44.2 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.297 1.439 . . . . 0.0 112.068 -171.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -79.68 122.55 26.69 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.586 1.155 . . . . 0.0 112.723 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 28.5 mm -113.93 117.66 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.419 1.088 . . . . 0.0 110.002 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mp -107.85 101.06 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.228 1.411 . . . . 0.0 107.889 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.5 p -87.08 160.61 18.51 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.585 0.707 . . . . 0.0 111.578 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -152.82 139.78 19.15 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.702 1.201 . . . . 0.0 111.191 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.9 mt -78.49 132.14 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 173.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -139.68 124.35 18.35 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.387 1.475 . . . . 0.0 110.088 174.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -73.79 124.67 26.5 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.707 -0.62 . . . . 0.0 109.449 169.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.2 mt -110.23 96.27 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 60.71 11.25 3.04 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.79 2.036 . . . . 0.0 115.947 -175.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 132.56 -35.46 2.33 Favored Glycine 0 N--CA 1.474 1.211 0 C-N-CA 124.977 1.275 . . . . 0.0 113.478 176.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 87.5 m -70.2 126.93 31.09 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.828 1.251 . . . . 0.0 109.424 172.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -75.33 117.01 16.67 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.668 -0.645 . . . . 0.0 109.672 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -106.64 167.29 9.96 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.09 1.356 . . . . 0.0 110.387 170.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.8 tp -118.77 136.92 54.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.398 1.479 . . . . 0.0 108.114 169.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.1 p -125.71 159.38 32.45 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.717 0.807 . . . . 0.0 110.151 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -149.81 144.8 26.23 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.965 0.906 . . . . 0.0 111.709 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.3 p -82.28 112.48 19.31 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.767 1.227 . . . . 0.0 111.057 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.1 -163.75 38.99 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.286 0.946 . . . . 0.0 113.158 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -72.02 168.92 17.06 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.583 0.706 . . . . 0.0 111.545 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -72.04 131.55 43.03 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.12 -0.988 . . . . 0.0 110.939 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -80.86 165.12 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.335 0.588 . . . . 0.0 112.295 172.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -102.72 -12.03 17.95 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.08 1.352 . . . . 0.0 114.288 173.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -88.84 11.79 16.95 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.226 1.81 . . . . 0.0 113.3 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.68 170.02 18.43 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.995 1.718 . . . . 0.0 112.358 -175.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -76.1 67.77 2.39 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.827 1.679 . . . . 0.0 114.183 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 57.8 34.47 24.44 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.78 1.632 . . . . 0.0 113.869 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -90.19 167.98 12.3 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.766 1.226 . . . . 0.0 109.794 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.6 m -101.52 145.26 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.651 1.18 . . . . 0.0 111.62 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.1 105.66 2.53 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.654 0.781 . . . . 0.0 109.284 175.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -109.05 144.57 36.89 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 122.087 0.946 . . . . 0.0 111.09 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -135.6 168.28 19.55 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.443 1.497 . . . . 0.0 111.536 -171.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.64 132.18 20.97 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.122 0.569 . . . . 0.0 110.004 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 66.3 mt -123.95 140.2 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.82 0.848 . . . . 0.0 108.766 176.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.2 m -65.49 95.43 0.21 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.833 0.853 . . . . 0.0 109.432 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.67 -32.64 52.41 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.577 1.151 . . . . 0.0 111.767 176.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -67.86 -25.81 65.72 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -86.35 -34.06 20.36 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.584 1.153 . . . . 0.0 112.237 171.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 22.7 mt -58.65 -43.47 89.82 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.211 -0.931 . . . . 0.0 111.277 176.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -53.98 -33.0 55.78 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.487 1.115 . . . . 0.0 113.816 174.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -75.48 -8.21 56.15 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.281 1.433 . . . . 0.0 114.205 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -128.83 -3.57 5.22 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.613 1.565 . . . . 0.0 114.301 -174.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 89.6 mt -109.67 1.71 19.71 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.621 1.569 . . . . 0.0 112.436 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt . . . . . 0 C--O 1.253 1.268 0 C-N-CA 128.3 2.64 . . . . 0.0 115.521 174.505 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.8 tttm . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.3 tp -147.3 147.46 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.99 1.316 . . . . 0.0 110.773 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -103.0 103.77 13.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.549 1.139 . . . . 0.0 110.213 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.3 p -69.17 163.6 24.53 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.094 0.958 . . . . 0.0 111.993 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.1 t -137.14 -50.78 0.64 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.158 0.983 . . . . 0.0 111.741 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.7 t80 47.01 37.18 4.76 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.699 1.599 . . . . 0.0 113.55 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -57.52 135.41 56.63 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.935 1.294 . . . . 0.0 113.262 -175.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -86.54 165.83 15.92 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.268 1.027 . . . . 0.0 112.515 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -142.96 165.38 27.52 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.561 1.544 . . . . 0.0 111.834 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 76.4 p -115.85 165.86 12.61 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.847 1.659 . . . . 0.0 111.481 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 43.6 p -128.38 -54.13 1.27 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.017 0.927 . . . . 0.0 113.475 -170.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.49 -167.56 28.58 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.369 0.985 . . . . 0.0 114.198 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -87.8 83.12 7.17 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.201 1.4 . . . . 0.0 111.134 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.4 m -142.78 -174.28 4.12 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.953 1.701 . . . . 0.0 110.99 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -61.06 117.63 5.75 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.22 -0.925 . . . . 0.0 110.15 172.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.95 45.74 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.862 2.065 . . . . 0.0 110.859 -175.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.09 156.07 4.22 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.443 1.097 . . . . 0.0 111.991 174.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -138.07 163.02 32.66 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.62 1.568 . . . . 0.0 111.23 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.7 mm -57.62 134.32 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.445 1.098 . . . . 0.0 110.44 174.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -130.57 -4.15 4.21 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -62.92 -14.21 44.01 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.118 1.367 . . . . 0.0 114.605 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.2 m -65.69 -12.36 52.94 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.589 1.955 . . . . 0.0 113.863 172.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -150.07 174.93 12.19 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.798 1.639 . . . . 0.0 110.756 175.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -156.4 165.67 35.67 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.913 0.885 . . . . 0.0 110.338 170.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.56 134.33 48.6 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.2 m -132.06 161.52 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.082 1.353 . . . . 0.0 112.097 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -67.47 141.63 56.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.359 1.063 . . . . 0.0 110.268 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.2 tp -138.7 135.73 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.33 1.452 . . . . 0.0 108.751 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -128.86 161.56 29.55 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.152 1.781 . . . . 0.0 109.38 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -129.96 155.13 46.58 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.017 1.327 . . . . 0.0 111.043 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.7 118.49 22.3 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 169.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.5 p30 -68.21 178.47 1.89 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.466 1.127 . . . . 0.0 113.54 171.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -58.18 -11.83 2.99 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.355 1.862 . . . . 0.0 114.846 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.9 t -107.57 4.14 25.68 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.236 1.414 . . . . 0.0 112.514 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.69 22.35 78.41 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 120.643 -1.286 . . . . 0.0 114.505 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -105.05 138.9 40.54 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.486 1.143 . . . . 0.0 110.932 174.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -69.93 126.42 29.66 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.108 0.963 . . . . 0.0 110.538 173.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 t -142.14 143.71 33.13 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.963 1.305 . . . . 0.0 110.324 -177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -54.65 135.61 46.54 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.726 0.811 . . . . 0.0 113.048 -176.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.0 tp -111.55 -49.88 2.97 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.058 0.943 . . . . 0.0 111.075 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.57 -131.47 2.07 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 121.395 0.442 . . . . 0.0 114.108 -173.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.79 135.29 29.52 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.255 1.422 . . . . 0.0 110.123 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -106.19 108.66 20.29 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.291 1.436 . . . . 0.0 109.224 -176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.7 t -85.95 96.53 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.797 1.239 . . . . 0.0 109.295 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.6 t -71.46 110.18 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.154 0.981 . . . . 0.0 109.286 168.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 66.8 mtp85 -106.43 123.88 48.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 127.122 2.169 . . . . 0.0 110.217 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -87.19 86.92 7.32 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.821 0.848 . . . . 0.0 110.785 176.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -64.66 169.25 5.14 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 122.257 1.027 . . . . 0.0 112.835 170.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.76 -36.33 78.66 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.96 1.304 . . . . 0.0 113.732 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -132.75 62.75 1.65 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.675 1.19 . . . . 0.0 112.097 -173.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.67 -155.41 21.75 Favored Glycine 0 N--CA 1.467 0.701 0 C-N-CA 124.388 0.994 . . . . 0.0 114.344 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 70.1 mt -128.48 137.21 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.275 1.03 . . . . 0.0 108.919 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.07 146.32 46.04 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.336 1.454 . . . . 0.0 108.879 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 75.9 p -132.58 143.25 49.58 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.198 -0.939 . . . . 0.0 110.205 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.77 136.13 8.15 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -92.49 131.55 37.54 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.666 1.987 . . . . 0.0 109.94 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -135.74 75.23 1.54 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.204 1.401 . . . . 0.0 110.459 -174.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.51 169.78 14.71 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.496 1.519 . . . . 0.0 113.116 178.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.98 49.91 2.21 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.856 1.693 . . . . 0.0 114.285 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.83 -6.48 0.45 Allowed Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.48 1.515 . . . . 0.0 115.251 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -153.08 154.03 34.02 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.876 1.338 . . . . 0.0 111.967 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.0 p -154.57 152.13 29.68 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -169.43 160.28 9.15 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.009 1.324 . . . . 0.0 112.611 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 51.9 m -59.48 123.42 16.77 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.403 -0.811 . . . . 0.0 109.039 168.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -87.3 -50.37 6.63 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.866 0.466 . . . . 0.0 110.124 -176.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -166.38 164.2 17.44 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.251 1.02 . . . . 0.0 112.977 172.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 p -150.32 147.48 27.68 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.859 1.314 . . . . 0.0 113.227 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.58 162.69 31.23 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.269 1.428 . . . . 0.0 111.656 -177.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -81.93 166.7 19.65 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.582 0.753 . . . . 0.0 112.368 -175.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -55.79 -34.19 65.06 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.07 -1.019 . . . . 0.0 112.423 175.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -67.98 -3.28 9.52 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.461 1.505 . . . . 0.0 113.913 175.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 t -122.09 -3.39 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.318 1.047 . . . . 0.0 111.567 -177.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.2 t -53.22 -65.44 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 120.492 -1.38 . . . . 0.0 110.863 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -64.7 -27.74 69.12 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.744 -0.597 . . . . 0.0 112.227 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.33 -53.54 53.55 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.72 1.608 . . . . 0.0 110.359 174.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -62.99 -42.39 99.84 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.475 1.11 . . . . 0.0 111.937 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 92.7 t -58.5 -37.04 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 122.885 0.474 . . . . 0.0 110.844 176.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -64.71 -55.02 22.58 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.61 1.164 . . . . 0.0 112.784 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.7 -9.6 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 121.577 -0.702 . . . . 0.0 112.28 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 20.8 ttm -95.73 -4.72 43.59 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.589 -1.319 . . . . 0.0 112.934 177.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.9 p -127.49 -13.1 5.5 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.725 0.81 . . . . 0.0 112.875 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -131.54 -12.11 3.48 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.522 1.529 . . . . 0.0 114.434 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.19 155.96 9.85 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.074 1.321 . . . . 0.0 113.662 -175.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 156.21 -168.3 33.55 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.357 0.979 . . . . 0.0 113.556 -175.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 36.0 p -146.51 105.83 3.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.483 1.113 . . . . 0.0 113.463 -168.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -136.32 143.55 44.21 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.162 1.785 . . . . 0.0 110.246 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -74.84 153.05 38.88 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.543 -0.723 . . . . 0.0 111.297 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.4 p -118.87 135.86 54.34 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.327 1.451 . . . . 0.0 110.875 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 6.6 t -48.15 -42.25 29.0 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.103 1.361 . . . . 0.0 113.235 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.4 mt -147.53 145.51 29.11 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.67 1.588 . . . . 0.0 112.769 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -143.89 101.18 3.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.272 1.029 . . . . 0.0 110.783 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -91.99 -37.16 12.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.157 0.983 . . . . 0.0 113.298 176.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.75 -176.95 8.42 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.414 1.483 . . . . 0.0 114.824 -172.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -61.7 160.43 11.69 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 174.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -77.86 52.98 1.09 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.25 1.82 . . . . 0.0 112.592 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -145.52 19.89 1.52 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.097 1.759 . . . . 0.0 111.54 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -137.2 171.55 14.32 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.831 -1.168 . . . . 0.0 114.08 -173.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -82.52 -23.3 34.65 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.731 0.812 . . . . 0.0 113.07 -175.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.7 m -92.86 -12.86 29.97 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.9 p -60.57 -14.54 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 174.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 83.8 mt -55.06 -53.33 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.814 1.645 . . . . 0.0 111.751 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -140.41 -2.2 1.44 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.405 1.482 . . . . 0.0 113.791 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 81.29 176.61 51.07 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.113 1.34 . . . . 0.0 113.356 -171.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.3 mt -121.34 116.22 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.228 1.411 . . . . 0.0 108.078 173.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -68.34 140.56 55.9 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.977 0.418 . . . . 0.0 111.617 170.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 55.41 29.34 12.97 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.878 1.671 . . . . 0.0 114.279 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -59.52 127.75 33.62 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.804 1.242 . . . . 0.0 111.564 -175.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -75.79 119.5 19.87 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.017 0.527 . . . . 0.0 111.336 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.5 mm -112.16 116.82 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.832 1.253 . . . . 0.0 109.08 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.12 97.97 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 124.724 1.21 . . . . 0.0 108.491 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 43.0 p -76.97 159.58 29.84 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.87 174.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -153.3 142.49 21.44 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.791 1.236 . . . . 0.0 111.061 170.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mt -83.32 135.03 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.402 0.681 . . . . 0.0 109.245 174.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -141.43 125.59 17.38 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.887 1.275 . . . . 0.0 111.195 174.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -75.38 104.31 5.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.359 0.664 . . . . 0.0 110.28 169.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.6 mt -90.88 99.37 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 172.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.7 t0 57.63 24.64 10.73 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.114 1.766 . . . . 0.0 115.536 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.5 -25.23 12.44 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.806 1.194 . . . . 0.0 113.703 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 97.7 m -82.41 122.99 28.71 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.046 0.923 . . . . 0.0 109.438 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -71.38 119.64 15.82 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.65 -0.656 . . . . 0.0 110.42 171.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -108.72 166.3 10.91 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.919 1.688 . . . . 0.0 110.62 170.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.2 tp -116.13 135.04 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.769 1.628 . . . . 0.0 108.043 169.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.1 p -125.31 155.8 39.65 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.547 0.739 . . . . 0.0 109.957 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -146.4 138.37 24.89 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.795 0.838 . . . . 0.0 111.221 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.0 p -75.69 113.38 13.07 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.325 1.05 . . . . 0.0 111.202 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.17 -156.59 26.5 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.577 1.084 . . . . 0.0 113.014 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.26 -174.05 0.34 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.04 0.936 . . . . 0.0 112.991 169.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -100.51 113.98 27.21 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.141 0.976 . . . . 0.0 111.716 169.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.05 160.46 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.074 0.95 . . . . 0.0 112.25 177.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -90.13 -34.62 15.8 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 172.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -59.18 -37.92 78.56 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.886 1.274 . . . . 0.0 113.941 -175.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.39 -31.34 18.91 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 133.53 -79.22 0.34 Allowed Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.161 1.362 . . . . 0.0 112.938 173.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -139.31 22.02 2.57 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.922 2.089 . . . . 0.0 110.826 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.49 179.52 6.83 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.257 1.023 . . . . 0.0 109.123 177.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.9 m -115.37 149.77 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.238 0.615 . . . . 0.0 111.852 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.42 86.85 1.53 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.09 0.556 . . . . 0.0 110.475 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -90.21 145.3 25.12 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.524 1.154 . . . . 0.0 112.057 172.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -138.75 169.0 18.57 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 126.359 1.863 . . . . 0.0 110.857 -173.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.44 132.26 21.33 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.079 0.551 . . . . 0.0 110.246 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 58.2 mt -125.06 139.98 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.145 0.978 . . . . 0.0 108.871 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.0 m -67.16 95.21 0.39 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.477 -0.764 . . . . 0.0 110.048 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.23 -33.52 41.78 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.574 1.15 . . . . 0.0 111.766 176.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -67.2 -29.56 69.26 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -84.82 -27.54 26.72 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.175 0.99 . . . . 0.0 111.859 172.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 40.8 mt -68.01 -43.01 79.8 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.558 0.743 . . . . 0.0 110.158 175.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 15.3 mtmt -57.32 -20.0 25.93 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -86.83 -15.42 39.25 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.502 1.121 . . . . 0.0 114.021 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -123.01 -3.06 8.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.385 1.474 . . . . 0.0 113.437 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 13.2 mt -92.31 -18.56 23.19 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.339 1.456 . . . . 0.0 112.639 -177.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp . . . . . 0 C--O 1.253 1.243 0 C-N-CA 126.668 1.987 . . . . 0.0 113.572 171.49 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.7 pttp . . . . . 0 N--CA 1.495 1.808 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.1 tt -66.55 -37.61 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 O-C-N 120.335 -1.478 . . . . 0.0 112.658 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -81.98 134.21 35.36 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.424 1.09 . . . . 0.0 110.886 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 46.5 p -111.22 173.37 6.37 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.766 1.627 . . . . 0.0 110.892 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.7 t -133.67 160.37 37.73 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.602 0.761 . . . . 0.0 111.965 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -141.14 161.18 38.48 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.064 1.746 . . . . 0.0 111.396 -174.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -149.92 164.47 35.33 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.749 1.62 . . . . 0.0 111.426 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.9 149.21 44.57 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.18 1.392 . . . . 0.0 110.645 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -138.85 100.15 3.97 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.961 1.304 . . . . 0.0 110.306 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.8 m -72.39 168.84 17.58 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.203 1.001 . . . . 0.0 112.117 173.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.7 p -125.77 -42.08 1.94 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.649 1.18 . . . . 0.0 112.938 175.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.72 -148.91 50.67 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-N 118.746 0.703 . . . . 0.0 113.254 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -68.72 93.64 0.54 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.742 1.217 . . . . 0.0 112.066 176.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.1 m -147.22 169.15 19.98 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.411 1.884 . . . . 0.0 111.674 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -71.71 125.47 27.2 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.014 0.926 . . . . 0.0 110.911 171.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 p -167.23 148.48 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 127.025 2.13 . . . . 0.0 108.737 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -129.86 171.59 12.57 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.292 1.437 . . . . 0.0 112.516 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.79 128.45 35.32 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.754 1.622 . . . . 0.0 110.265 173.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.0 mm -78.14 159.5 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.193 0.997 . . . . 0.0 109.538 174.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -59.4 -14.7 13.06 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.846 -1.159 . . . . 0.0 113.933 171.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -94.43 0.87 55.72 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.495 1.518 . . . . 0.0 113.953 175.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.4 t -60.76 -22.03 63.64 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.578 1.551 . . . . 0.0 113.221 176.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -140.08 161.19 38.21 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.067 1.347 . . . . 0.0 110.269 168.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -143.8 171.02 14.79 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.027 0.931 . . . . 0.0 110.786 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -142.26 122.35 13.75 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.699 -0.626 . . . . 0.0 110.77 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.6 m -123.76 161.24 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 126.351 1.86 . . . . 0.0 111.095 -176.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 160.09 13.72 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.535 0.734 . . . . 0.0 112.496 176.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.0 tp -152.72 138.5 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.712 1.605 . . . . 0.0 109.085 174.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -129.14 159.33 36.36 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.613 1.965 . . . . 0.0 109.333 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -134.86 160.94 36.63 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.731 1.213 . . . . 0.0 111.866 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.67 119.81 25.23 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.603 0.361 . . . . 0.0 110.619 172.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.9 p30 -68.81 177.08 2.71 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 122.636 1.208 . . . . 0.0 113.625 170.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.8 mtmm -58.25 -23.16 55.07 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.107 1.763 . . . . 0.0 113.337 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 m -84.03 -11.18 57.15 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.013 1.325 . . . . 0.0 113.076 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.72 33.38 42.55 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.201 1.381 . . . . 0.0 114.291 -175.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -120.72 145.65 47.28 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.363 1.465 . . . . 0.0 111.18 175.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -67.76 130.83 44.23 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.708 0.803 . . . . 0.0 111.054 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.4 t -143.12 142.84 31.61 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.824 1.249 . . . . 0.0 110.652 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -56.41 132.47 51.23 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.252 1.021 . . . . 0.0 112.342 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.9 tp -108.12 -49.87 3.13 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.571 0.749 . . . . 0.0 111.22 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.47 -119.05 0.82 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.761 0.696 . . . . 0.0 112.916 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -143.05 158.09 43.93 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.589 1.555 . . . . 0.0 111.064 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.8 tp -122.47 103.75 8.92 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.861 1.664 . . . . 0.0 110.137 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.1 t -74.73 98.85 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.572 1.149 . . . . 0.0 109.383 172.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.8 t -87.07 115.47 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.717 1.207 . . . . 0.0 110.057 173.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -104.6 116.66 32.46 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.906 2.083 . . . . 0.0 110.359 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -81.11 87.39 6.05 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.524 1.13 . . . . 0.0 110.51 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -76.97 173.5 11.7 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.31 1.044 . . . . 0.0 112.307 171.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -74.38 -33.54 63.09 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.697 -1.252 . . . . 0.0 113.543 174.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -108.76 45.14 1.06 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.284 1.434 . . . . 0.0 111.418 -170.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 113.94 -164.19 12.09 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.204 1.383 . . . . 0.0 113.709 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.9 mt -117.77 142.55 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.669 0.788 . . . . 0.0 109.168 173.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -131.28 136.06 47.84 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.762 1.225 . . . . 0.0 109.138 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.6 p -129.4 150.27 50.83 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.516 0.727 . . . . 0.0 111.636 -171.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -144.32 122.73 1.85 Allowed Glycine 0 C--N 1.335 0.506 0 O-C-N 121.746 -0.596 . . . . 0.0 112.446 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -65.87 136.37 56.05 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.291 1.436 . . . . 0.0 109.621 174.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -133.51 99.66 4.57 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.891 2.076 . . . . 0.0 108.964 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.87 100.42 7.37 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.568 1.547 . . . . 0.0 111.089 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 61.52 -113.81 6.08 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.299 0.952 . . . . 0.0 112.408 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -96.06 15.71 62.47 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.004 1.288 . . . . 0.0 114.744 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -140.56 143.54 35.38 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.02 1.41 . . . . 0.0 112.885 -174.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 46.3 m -147.0 151.27 36.69 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.064 0.946 . . . . 0.0 113.014 -175.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.79 158.36 33.41 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.292 1.437 . . . . 0.0 111.804 175.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.3 m -55.61 128.38 34.35 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 121.269 -0.895 . . . . 0.0 110.281 170.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -95.53 -51.6 4.48 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.345 0.658 . . . . 0.0 110.151 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -164.8 163.17 21.31 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.025 0.93 . . . . 0.0 112.527 170.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.05 146.79 31.08 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.005 1.322 . . . . 0.0 111.94 177.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.434 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -128.13 160.06 33.2 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.795 1.638 . . . . 0.0 111.429 -176.471 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -78.29 164.82 24.54 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.468 0.707 . . . . 0.0 112.299 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -56.67 -33.76 66.69 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.352 1.461 . . . . 0.0 114.496 174.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -69.78 -9.64 55.34 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.581 1.153 . . . . 0.0 112.957 173.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.8 t -112.51 -8.09 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.294 1.038 . . . . 0.0 111.054 -173.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.5 t -46.62 -67.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 125.623 1.569 . . . . 0.0 111.905 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -67.22 -26.97 66.87 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.501 -0.749 . . . . 0.0 112.737 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -63.56 -52.08 62.61 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.701 1.6 . . . . 0.0 110.703 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -59.47 -46.7 88.04 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 125.476 1.51 . . . . 0.0 111.031 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 82.8 t -56.19 -36.15 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.468 0.707 . . . . 0.0 110.806 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -65.87 -54.47 26.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.857 1.263 . . . . 0.0 112.659 174.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 m -71.55 -16.88 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 120.913 -1.117 . . . . 0.0 112.539 -176.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.32 -5.2 58.99 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.169 1.788 . . . . 0.0 111.693 177.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 65.0 p -128.56 -15.05 4.56 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -134.18 -10.02 2.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.493 1.517 . . . . 0.0 114.183 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.49 156.31 10.89 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.642 1.592 . . . . 0.0 113.96 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 157.66 -166.01 33.71 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.129 0.871 . . . . 0.0 113.838 -175.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 61.2 p -148.56 103.26 3.39 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -170.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -134.76 143.68 47.26 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.05 1.74 . . . . 0.0 110.137 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -71.15 162.73 28.94 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.457 -0.777 . . . . 0.0 111.636 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 81.5 p -127.43 154.12 45.43 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.441 1.497 . . . . 0.0 110.972 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.434 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 82.4 p -71.07 -38.79 72.46 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.427 -0.796 . . . . 0.0 111.103 -177.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.2 mt -152.83 140.37 19.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.71 2.004 . . . . 0.0 111.468 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -134.5 102.57 5.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.999 0.92 . . . . 0.0 110.046 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -87.49 -46.88 9.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.51 1.124 . . . . 0.0 112.76 175.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.43 173.99 34.51 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.204 1.383 . . . . 0.0 113.636 -168.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -57.39 162.87 2.57 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.122 0.969 . . . . 0.0 111.922 169.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -60.17 160.51 8.17 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.23 -0.919 . . . . 0.0 111.426 170.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 65.1 37.69 6.54 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.026 0.93 . . . . 0.0 113.075 -171.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -120.51 170.43 9.4 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.757 1.623 . . . . 0.0 111.416 170.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -86.44 -11.17 52.59 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.274 1.029 . . . . 0.0 113.763 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.8 p -103.76 -27.3 12.33 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.927 1.291 . . . . 0.0 113.96 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.9 p -60.16 -22.06 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -174.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.6 mp -59.62 -36.79 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 125.819 1.648 . . . . 0.0 112.585 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -146.76 -38.26 0.22 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -168.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 104.4 156.32 23.57 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 126.898 2.19 . . . . 0.0 113.475 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.6 mt -113.38 112.95 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.073 1.349 . . . . 0.0 108.168 176.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -74.18 147.92 42.13 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.015 0.436 . . . . 0.0 111.384 172.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 59.31 21.91 10.2 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.659 1.583 . . . . 0.0 113.976 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -63.24 126.31 26.99 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.954 1.302 . . . . 0.0 111.515 -172.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -74.88 122.36 23.28 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.36 1.464 . . . . 0.0 112.267 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.5 mm -118.48 118.02 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.184 0.993 . . . . 0.0 109.835 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.7 92.64 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.485 1.514 . . . . 0.0 109.18 -177.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.2 p -74.86 156.58 36.29 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.498 174.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -153.48 142.7 21.46 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.182 1.393 . . . . 0.0 111.646 173.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 21.8 mt -81.49 132.02 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.068 0.547 . . . . 0.0 109.721 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -149.08 141.75 24.48 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.694 1.598 . . . . 0.0 110.232 173.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -82.61 158.26 23.1 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.274 -0.892 . . . . 0.0 110.198 169.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 38.5 mt -128.36 -46.31 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.242 1.017 . . . . 0.0 110.726 178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -142.96 10.96 1.78 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 122.39 -24.37 6.92 Favored Glycine 0 N--CA 1.473 1.127 0 C-N-CA 124.226 0.917 . . . . 0.0 113.137 -174.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 62.2 m -87.07 141.3 28.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.042 0.937 . . . . 0.0 108.642 169.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -76.44 124.5 27.65 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 170.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -109.17 167.88 9.78 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.471 1.508 . . . . 0.0 110.447 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.4 tp -123.16 132.04 72.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 125.331 1.452 . . . . 0.0 108.31 171.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.2 p -120.25 152.64 37.46 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.588 0.755 . . . . 0.0 109.878 177.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -145.63 147.55 32.14 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.306 0.574 . . . . 0.0 111.602 178.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.5 p -73.06 109.69 6.79 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.272 1.029 . . . . 0.0 111.21 174.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.77 -166.47 30.61 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 122.139 0.855 . . . . 0.0 113.232 172.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -65.65 162.0 19.34 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.148 0.979 . . . . 0.0 113.015 170.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -84.3 101.09 11.67 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.866 1.266 . . . . 0.0 111.853 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.28 161.79 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.458 0.703 . . . . 0.0 112.574 178.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -109.27 8.11 25.56 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.226 1.01 . . . . 0.0 113.487 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -116.88 21.62 13.19 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.351 1.86 . . . . 0.0 112.534 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.9 t -138.05 -41.05 0.53 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.55 1.14 . . . . 0.0 113.601 173.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 124.58 69.3 0.2 Allowed Glycine 0 N--CA 1.476 1.357 0 C-N-CA 123.972 0.796 . . . . 0.0 113.954 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 57.64 25.07 11.25 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.387 1.475 . . . . 0.0 113.673 -173.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -87.44 174.61 8.41 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.236 1.014 . . . . 0.0 109.036 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.7 m -110.98 146.71 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.772 0.829 . . . . 0.0 110.848 175.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.59 83.2 0.42 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.338 1.055 . . . . 0.0 110.478 176.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -81.08 141.92 33.84 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 122.157 0.979 . . . . 0.0 111.717 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -135.31 169.71 17.06 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.73 1.612 . . . . 0.0 111.534 -173.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.35 132.55 18.38 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.576 0.75 . . . . 0.0 110.446 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 68.0 mt -124.98 141.5 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.09 0.956 . . . . 0.0 108.88 177.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.3 m -66.33 93.44 0.22 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.64 1.176 . . . . 0.0 110.194 176.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.4 tt -54.98 -30.81 60.02 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.226 1.41 . . . . 0.0 112.45 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -71.65 -30.51 65.82 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -82.64 -30.7 29.2 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.01 0.924 . . . . 0.0 112.237 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 20.7 mt -57.22 -49.77 74.96 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.914 0.886 . . . . 0.0 110.779 173.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -50.45 -38.21 42.38 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.263 1.025 . . . . 0.0 113.391 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -64.29 -21.14 66.49 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -120.82 -4.29 9.68 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.534 1.533 . . . . 0.0 113.421 -174.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 15.3 mt -98.09 -22.33 16.29 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.596 1.558 . . . . 0.0 112.736 -175.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp . . . . . 0 C--O 1.254 1.309 0 C-N-CA 125.951 1.7 . . . . 0.0 113.363 175.023 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.005 0.431 . . . . 0.0 112.125 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.2 pt -136.6 172.6 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.788 2.035 . . . . 0.0 110.642 173.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -58.83 162.45 4.08 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.636 0.775 . . . . 0.0 112.741 171.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 54.0 p -130.88 159.39 37.54 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.809 1.243 . . . . 0.0 111.636 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 58.1 m -140.04 162.97 33.94 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.467 1.507 . . . . 0.0 110.863 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -141.19 150.01 42.18 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.151 1.381 . . . . 0.0 110.883 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -90.85 127.62 36.43 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.993 0.917 . . . . 0.0 110.357 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.55 150.79 48.46 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.494 -0.754 . . . . 0.0 111.575 169.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 53.42 24.31 3.88 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.47 1.508 . . . . 0.0 114.481 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.4 t -64.11 163.17 12.94 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.018 1.327 . . . . 0.0 112.962 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.0 t -114.96 163.29 15.79 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.379 1.472 . . . . 0.0 112.292 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.75 -148.95 18.63 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.54 1.543 . . . . 0.0 112.853 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -143.21 148.01 35.78 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.684 1.194 . . . . 0.0 111.354 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.7 m -62.83 153.27 33.64 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.627 1.171 . . . . 0.0 112.958 177.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -91.91 100.58 13.22 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.38 1.072 . . . . 0.0 110.429 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.9 p -155.24 145.39 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.077 1.751 . . . . 0.0 109.6 174.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -143.35 155.4 44.42 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.521 1.528 . . . . 0.0 111.441 172.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -149.96 166.57 29.23 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.198 2.199 . . . . 0.0 110.321 175.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 44.2 mm -66.36 135.99 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.864 0.866 . . . . 0.0 110.279 170.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -128.72 8.77 5.84 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.668 1.187 . . . . 0.0 113.217 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -68.82 -4.25 15.48 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.973 1.309 . . . . 0.0 114.445 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.4 m -58.76 -25.08 62.68 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 127.24 2.216 . . . . 0.0 114.086 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.88 166.96 23.23 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.652 1.181 . . . . 0.0 110.168 166.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -150.2 167.09 27.9 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.069 0.948 . . . . 0.0 110.921 173.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -131.15 131.0 43.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.855 0.462 . . . . 0.0 111.037 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 m -129.34 167.85 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 126.179 1.791 . . . . 0.0 111.026 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -65.3 166.78 9.4 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.741 1.217 . . . . 0.0 111.943 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.4 tp -161.82 135.72 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.128 1.371 . . . . 0.0 109.933 172.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -129.07 160.11 33.82 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.509 1.924 . . . . 0.0 109.324 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -127.19 160.25 31.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.337 1.455 . . . . 0.0 111.072 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -81.49 121.82 26.76 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 122.048 -0.407 . . . . 0.0 110.565 171.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -64.09 175.47 1.23 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.411 1.085 . . . . 0.0 112.105 171.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -59.76 -13.73 11.52 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.692 1.997 . . . . 0.0 114.737 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.6 m -117.05 15.55 15.06 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.932 1.293 . . . . 0.0 112.771 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.13 20.84 77.0 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 121.203 -0.936 . . . . 0.0 114.378 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -96.46 127.62 42.63 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.609 1.164 . . . . 0.0 109.485 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -69.05 125.92 28.19 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.633 -0.667 . . . . 0.0 110.639 174.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.2 t -141.78 138.32 32.19 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.851 1.26 . . . . 0.0 111.009 -172.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -57.67 137.19 56.7 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.142 0.977 . . . . 0.0 112.979 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 44.4 tp -111.03 -46.33 3.34 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.827 0.851 . . . . 0.0 111.723 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.47 -121.95 0.95 Allowed Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.351 0.501 . . . . 0.0 113.327 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -147.49 153.44 39.53 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.308 1.443 . . . . 0.0 110.482 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.8 tp -118.84 107.57 13.77 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.121 1.368 . . . . 0.0 111.005 -176.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.7 t -82.48 102.28 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.705 1.202 . . . . 0.0 108.327 173.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.07 103.25 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.769 1.628 . . . . 0.0 109.448 176.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -98.19 140.51 32.38 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.859 1.664 . . . . 0.0 110.965 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -99.68 90.79 4.59 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.06 1.344 . . . . 0.0 109.844 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -68.78 171.38 7.92 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 122.406 1.098 . . . . 0.0 113.278 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -62.17 -28.06 69.39 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.275 1.03 . . . . 0.0 113.224 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -137.19 40.32 2.48 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.941 1.696 . . . . 0.0 112.778 -171.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.85 -157.95 27.53 Favored Glycine 0 CA--C 1.534 1.225 0 N-CA-C 115.965 1.146 . . . . 0.0 115.965 175.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 35.5 mt -121.91 136.57 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.327 1.051 . . . . 0.0 109.304 173.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.04 117.19 19.64 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 126.413 1.885 . . . . 0.0 109.411 -175.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.2 p -106.24 149.78 26.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.012 0.925 . . . . 0.0 111.32 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.09 128.32 3.84 Favored Glycine 0 C--N 1.336 0.581 0 O-C-N 121.265 -0.897 . . . . 0.0 111.876 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -85.3 127.75 34.44 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 127.157 2.183 . . . . 0.0 110.623 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -122.79 86.88 2.65 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.761 1.624 . . . . 0.0 109.748 -174.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -97.49 122.5 40.62 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.328 1.051 . . . . 0.0 110.054 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 50.89 -94.2 0.01 OUTLIER Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.39 1.471 . . . . 0.0 114.479 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -125.89 15.85 6.95 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 126.002 1.763 . . . . 0.0 114.62 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.81 157.51 21.28 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.565 1.546 . . . . 0.0 110.857 171.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.3 p -146.05 136.66 24.16 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.385 0.674 . . . . 0.0 112.623 169.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -147.92 152.61 37.84 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.059 0.944 . . . . 0.0 112.385 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.9 m -55.39 122.86 12.12 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.876 0.87 . . . . 0.0 110.366 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -91.15 -49.91 6.13 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.78 0.432 . . . . 0.0 110.015 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -160.36 171.12 19.68 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.764 0.792 . . . . 0.0 113.093 171.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.3 136.97 12.25 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.397 -0.815 . . . . 0.0 112.764 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.44 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -132.03 155.31 48.26 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.464 1.906 . . . . 0.0 111.188 -174.373 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -79.44 168.04 20.01 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.384 0.674 . . . . 0.0 112.598 -171.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -57.63 -34.3 69.17 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.425 1.09 . . . . 0.0 112.328 176.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -63.2 -16.33 59.8 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.643 1.577 . . . . 0.0 114.023 171.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.4 t -111.18 -8.25 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.603 1.161 . . . . 0.0 111.087 -173.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.7 t -47.78 -64.62 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 125.726 1.611 . . . . 0.0 111.486 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -68.93 -28.22 66.46 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -49.71 75.36 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.536 1.534 . . . . 0.0 110.367 176.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -61.88 -42.42 99.05 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.107 1.363 . . . . 0.0 112.07 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 95.3 t -56.95 -37.18 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.615 0.766 . . . . 0.0 110.679 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -68.4 -54.01 20.03 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.427 1.091 . . . . 0.0 112.447 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 m -73.5 -8.79 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 O-C-N 120.834 -1.166 . . . . 0.0 113.093 -175.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -98.58 -3.2 36.83 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.855 1.262 . . . . 0.0 112.387 176.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.9 p -129.6 -13.82 4.21 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.474 1.11 . . . . 0.0 113.041 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -135.74 -11.15 2.07 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.342 1.857 . . . . 0.0 114.1 177.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.93 154.94 11.29 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.067 1.318 . . . . 0.0 114.034 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.64 -159.51 31.4 Favored Glycine 0 CA--C 1.532 1.155 0 O-C-N 121.756 -0.849 . . . . 0.0 114.201 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 88.1 p -153.94 100.39 2.35 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -170.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -131.93 142.94 49.79 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.866 1.667 . . . . 0.0 110.091 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.4 154.61 39.95 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 121.465 -0.772 . . . . 0.0 111.106 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.7 p -118.4 156.9 28.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.231 1.412 . . . . 0.0 111.011 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.44 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 8.4 t -67.93 -41.14 83.02 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.307 1.043 . . . . 0.0 111.314 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 mt -155.56 137.69 14.67 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.243 1.817 . . . . 0.0 111.152 -177.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -134.38 103.84 5.89 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.485 1.114 . . . . 0.0 110.275 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -90.27 -39.66 12.62 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.43 175.34 6.46 Favored Glycine 0 CA--C 1.543 1.807 0 C-N-CA 124.926 1.251 . . . . 0.0 114.508 -169.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -61.5 159.09 13.52 Favored 'General case' 0 CA--C 1.55 0.947 0 O-C-N 121.497 -1.002 . . . . 0.0 112.272 169.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -52.65 166.77 0.17 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.385 1.874 . . . . 0.0 113.324 174.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 69.9 37.49 1.77 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.349 1.46 . . . . 0.0 112.167 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -147.06 144.43 29.09 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.848 1.259 . . . . 0.0 112.087 -169.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -68.42 -15.79 63.68 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -173.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.4 p -87.73 -18.43 29.48 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.8 t -67.15 -25.38 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-N 120.738 1.608 . . . . 0.0 111.644 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 74.9 mt -53.15 -47.22 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.816 1.647 . . . . 0.0 112.211 -176.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -147.68 -7.15 0.44 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 92.59 176.92 41.48 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.156 1.836 . . . . 0.0 113.007 -172.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.4 mt -127.02 105.42 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.023 1.329 . . . . 0.0 107.885 169.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -67.67 146.35 53.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.074 0.464 . . . . 0.0 111.095 172.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 57.45 24.69 10.51 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.355 1.462 . . . . 0.0 113.993 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -53.95 127.51 26.58 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.077 1.351 . . . . 0.0 111.039 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -76.9 127.71 33.21 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 122.064 -0.397 . . . . 0.0 110.252 169.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 33.3 mm -122.57 115.76 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.845 1.258 . . . . 0.0 108.334 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -112.08 100.69 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 125.264 1.426 . . . . 0.0 107.875 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.7 p -83.18 159.21 22.07 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.666 0.746 . . . . 0.0 111.775 176.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -152.07 138.66 18.7 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.67 1.188 . . . . 0.0 110.863 173.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.4 mt -80.07 132.27 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -139.91 123.0 16.79 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.31 1.444 . . . . 0.0 110.344 175.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -74.32 114.98 13.31 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 169.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 27.3 mt -101.67 98.07 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 58.87 15.03 3.6 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.695 1.998 . . . . 0.0 115.764 -176.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 124.3 -26.66 5.74 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.028 1.299 . . . . 0.0 114.07 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.0 m -77.8 128.61 34.27 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.587 1.155 . . . . 0.0 108.74 171.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -78.79 116.12 18.92 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.555 -0.715 . . . . 0.0 109.285 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -106.33 164.06 12.33 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.694 1.197 . . . . 0.0 110.485 171.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.1 tp -117.5 134.83 59.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 125.615 1.566 . . . . 0.0 107.615 169.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.1 p -124.09 155.75 37.82 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.356 0.662 . . . . 0.0 109.854 175.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -150.89 147.03 26.71 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.447 0.699 . . . . 0.0 112.179 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 55.2 p -76.24 108.17 8.98 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.059 1.344 . . . . 0.0 111.833 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.98 -160.38 17.87 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 123.999 0.809 . . . . 0.0 113.528 173.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -67.22 159.77 28.38 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.89 0.876 . . . . 0.0 112.836 171.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -78.21 106.25 9.99 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.838 1.255 . . . . 0.0 110.358 172.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -61.3 161.38 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.22 0.608 . . . . 0.0 112.326 174.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -92.26 -31.78 15.28 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -71.82 -37.66 70.29 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.7 t -80.87 169.34 17.68 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.401 0.68 . . . . 0.0 112.086 176.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -77.27 65.9 2.98 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.642 1.591 . . . . 0.0 114.106 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 55.37 36.63 27.49 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.14 1.776 . . . . 0.0 113.47 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -92.59 170.03 10.06 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.379 1.072 . . . . 0.0 109.393 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.3 m -104.56 148.23 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.824 0.85 . . . . 0.0 111.255 174.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.26 98.67 0.83 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.392 0.677 . . . . 0.0 110.227 170.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -91.94 144.45 25.45 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.346 1.069 . . . . 0.0 111.592 172.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -134.28 169.64 16.9 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 126.106 1.763 . . . . 0.0 110.962 -173.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.07 133.44 21.79 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.184 0.594 . . . . 0.0 109.991 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 62.0 mt -126.5 138.63 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 123.736 0.815 . . . . 0.0 108.822 175.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.9 m -64.55 98.2 0.24 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.863 0.865 . . . . 0.0 109.43 177.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.83 -32.74 53.91 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.693 1.197 . . . . 0.0 111.634 177.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -68.32 -32.21 72.17 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -82.56 -27.74 31.4 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.335 -0.853 . . . . 0.0 112.836 173.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 18.8 mt -62.59 -51.03 68.95 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.644 0.778 . . . . 0.0 110.912 172.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -48.75 -43.36 37.61 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.853 1.261 . . . . 0.0 113.24 176.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -64.28 -21.01 66.44 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.542 1.537 . . . . 0.0 114.32 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -119.77 -8.91 9.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.138 1.375 . . . . 0.0 113.918 -176.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 13.0 mt -87.21 -28.66 22.26 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.506 1.523 . . . . 0.0 112.231 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.393 1.877 . . . . 0.0 113.231 176.48 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.9 tttm . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.7 mm -74.69 124.85 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 120.15 -1.594 . . . . 0.0 109.207 175.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -126.77 135.64 51.34 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.11 1.364 . . . . 0.0 109.532 174.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 67.3 p -136.64 164.08 29.05 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.483 1.513 . . . . 0.0 110.482 -176.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.1 t -148.48 154.2 39.51 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.394 1.077 . . . . 0.0 110.972 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -150.13 166.15 30.67 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.796 1.238 . . . . 0.0 111.604 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.5 143.76 51.09 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.397 1.479 . . . . 0.0 111.301 -173.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -151.01 167.94 26.12 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.87 1.268 . . . . 0.0 111.257 -173.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -58.69 149.87 24.97 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.276 1.03 . . . . 0.0 113.428 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.5 t -87.23 152.3 22.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.855 1.262 . . . . 0.0 111.642 174.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 65.4 m -139.73 174.16 10.79 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.106 1.763 . . . . 0.0 111.739 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.97 -162.37 3.66 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 124.806 1.193 . . . . 0.0 114.227 172.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 60.04 31.59 20.68 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.341 1.456 . . . . 0.0 113.376 -176.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.6 p -62.35 163.36 8.63 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.321 1.448 . . . . 0.0 113.632 174.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -134.85 163.49 29.7 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.321 1.849 . . . . 0.0 110.712 -171.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.8 t -121.79 58.46 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 125.056 1.342 . . . . 0.0 109.908 -174.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.78 172.03 13.61 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.872 2.069 . . . . 0.0 111.378 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -77.29 52.95 0.97 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.897 2.079 . . . . 0.0 113.24 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 mm -68.97 160.67 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.599 1.16 . . . . 0.0 110.998 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -57.1 -14.62 4.09 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.352 1.461 . . . . 0.0 114.812 174.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -107.44 -4.54 18.39 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 175.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.0 t -55.88 -33.62 64.75 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.213 1.405 . . . . 0.0 112.194 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -111.5 154.47 24.7 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.273 1.029 . . . . 0.0 110.556 168.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -147.39 165.86 28.93 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.297 1.439 . . . . 0.0 110.527 177.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -130.64 134.13 46.71 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.08 -0.387 . . . . 0.0 110.881 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.0 m -128.05 165.1 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.083 1.753 . . . . 0.0 109.979 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -68.55 163.39 23.66 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.56 0.744 . . . . 0.0 110.96 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.5 tp -147.01 136.12 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.078 0.951 . . . . 0.0 109.254 170.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -126.5 160.1 31.53 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.626 1.971 . . . . 0.0 109.105 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.4 161.56 35.48 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.905 0.882 . . . . 0.0 112.06 176.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.74 118.16 23.71 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.847 0.459 . . . . 0.0 110.209 173.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -72.06 178.85 3.56 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.403 0.621 . . . . 0.0 112.459 175.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -57.67 -26.37 61.57 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.87 1.668 . . . . 0.0 113.111 173.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.3 t -70.65 -17.69 62.86 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.799 1.64 . . . . 0.0 113.747 173.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.45 36.39 62.88 Favored Glycine 0 CA--C 1.534 1.233 0 O-C-N 121.072 -1.018 . . . . 0.0 113.287 -171.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -125.09 143.81 50.73 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.994 1.718 . . . . 0.0 109.85 175.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -67.64 132.83 48.25 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.814 0.846 . . . . 0.0 111.141 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 t -142.44 136.62 29.66 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.838 1.255 . . . . 0.0 110.509 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -56.98 133.14 54.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.04 0.936 . . . . 0.0 112.446 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.1 tp -111.36 -45.83 3.36 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.112 0.965 . . . . 0.0 111.212 -176.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.26 -137.89 4.02 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 122.067 0.815 . . . . 0.0 113.813 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -129.0 163.59 25.04 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.511 1.925 . . . . 0.0 110.608 173.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 16.2 tp -130.1 106.39 8.59 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.49 2.316 . . . . 0.0 110.256 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.0 t -80.31 99.44 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.659 1.184 . . . . 0.0 109.332 174.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.89 117.12 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.504 1.522 . . . . 0.0 109.587 173.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 -112.22 118.21 34.69 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.124 2.17 . . . . 0.0 110.726 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -74.19 95.89 2.68 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.542 1.137 . . . . 0.0 109.61 169.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -72.63 171.94 11.54 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.922 0.868 . . . . 0.0 111.831 171.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -60.9 -35.73 77.43 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.018 -1.051 . . . . 0.0 112.999 174.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -133.27 57.35 1.81 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.262 1.425 . . . . 0.0 111.26 -169.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 128.44 -163.82 21.84 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.431 1.491 . . . . 0.0 113.78 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.2 mt -126.22 138.84 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.899 0.879 . . . . 0.0 109.589 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -127.7 129.89 47.91 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.276 1.43 . . . . 0.0 109.036 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.9 p -121.55 137.63 54.65 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.502 -0.749 . . . . 0.0 110.207 -175.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.6 108.88 0.71 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -170.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 tt -64.04 142.24 58.48 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.771 0.828 . . . . 0.0 110.612 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -138.1 75.79 1.54 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.18 1.792 . . . . 0.0 109.313 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.88 171.32 4.49 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.12 0.968 . . . . 0.0 112.041 173.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.48 -22.66 32.21 Favored Glycine 0 CA--C 1.54 1.611 0 N-CA-C 116.203 1.241 . . . . 0.0 116.203 -174.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -153.55 23.97 0.74 Allowed Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.748 1.166 . . . . 0.0 114.73 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -153.96 135.56 14.34 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.472 1.109 . . . . 0.0 110.879 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -141.93 134.32 28.0 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.36 -0.838 . . . . 0.0 111.657 -174.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.89 160.86 34.1 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.107 1.363 . . . . 0.0 112.13 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 93.7 m -60.77 123.03 16.29 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 121.099 -1.0 . . . . 0.0 109.286 169.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -85.46 -51.4 6.56 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.442 0.697 . . . . 0.0 109.849 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -162.57 170.27 18.86 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.275 1.03 . . . . 0.0 112.744 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.99 144.01 23.01 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 122.536 1.16 . . . . 0.0 113.198 175.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.458 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -129.46 154.93 46.49 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.813 1.645 . . . . 0.0 111.845 -175.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -78.31 167.21 21.7 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.406 0.682 . . . . 0.0 112.263 -173.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -53.68 -35.67 61.32 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.017 0.927 . . . . 0.0 112.646 173.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -65.48 -8.49 19.57 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.617 1.167 . . . . 0.0 113.684 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.9 t -118.13 -4.63 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.591 1.156 . . . . 0.0 111.224 -173.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.6 t -50.87 -65.08 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 125.13 1.372 . . . . 0.0 111.334 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -68.51 -25.77 65.11 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.88 -50.92 69.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.327 1.451 . . . . 0.0 110.603 173.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -58.65 -43.79 89.91 Favored 'General case' 0 C--N 1.335 -0.064 0 C-N-CA 124.964 1.305 . . . . 0.0 111.608 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 73.3 t -56.44 -37.6 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.902 0.481 . . . . 0.0 110.867 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -66.01 -54.51 25.07 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.444 1.098 . . . . 0.0 112.513 176.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 m -74.81 -3.67 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 121.13 -0.981 . . . . 0.0 113.402 -175.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.67 -4.25 24.02 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.156 1.782 . . . . 0.0 112.008 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 43.8 p -131.84 -15.36 3.05 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.779 1.232 . . . . 0.0 113.541 174.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -131.5 -12.42 3.47 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.649 1.579 . . . . 0.0 113.847 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.34 156.14 12.45 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.678 1.132 . . . . 0.0 113.752 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.78 -159.26 31.62 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 121.742 -0.858 . . . . 0.0 113.471 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.6 p -154.21 96.82 1.98 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -131.22 143.68 50.76 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.97 1.708 . . . . 0.0 110.606 -176.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -74.08 162.74 28.69 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.831 0.852 . . . . 0.0 111.49 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.0 p -129.66 143.76 50.97 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.217 1.407 . . . . 0.0 111.365 -177.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.458 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 24.4 p -57.81 -37.03 73.04 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.321 1.448 . . . . 0.0 112.839 -178.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mt -156.4 145.58 20.5 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.07 2.148 . . . . 0.0 110.549 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -141.62 109.83 5.9 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.023 0.929 . . . . 0.0 110.246 176.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -95.59 -57.73 2.31 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.385 1.074 . . . . 0.0 112.463 175.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.46 -169.6 29.06 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.244 1.402 . . . . 0.0 113.796 -171.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -67.17 -75.08 0.1 Allowed 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.739 -0.859 . . . . 0.0 113.102 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.06 172.29 1.28 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 128.532 2.733 . . . . 0.0 108.879 -171.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 53.73 35.12 20.53 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.083 1.353 . . . . 0.0 113.853 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -131.89 156.89 45.32 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.266 1.826 . . . . 0.0 110.991 -169.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -80.55 -19.72 45.06 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 120.689 -1.257 . . . . 0.0 113.171 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 43.8 p -79.42 -39.22 32.93 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.361 1.065 . . . . 0.0 113.599 172.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.3 p -66.05 -14.86 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -170.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.12 -47.09 95.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.556 1.543 . . . . 0.0 112.063 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -136.94 -11.98 1.72 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.889 1.275 . . . . 0.0 114.16 -175.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.99 158.67 29.78 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.89 1.709 . . . . 0.0 113.105 -170.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 62.3 mt -119.77 113.14 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.076 1.35 . . . . 0.0 108.766 174.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -72.7 147.45 45.67 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.278 0.561 . . . . 0.0 111.565 172.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 57.12 22.44 7.47 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.034 1.734 . . . . 0.0 114.06 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -56.01 123.64 15.07 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.568 1.147 . . . . 0.0 110.534 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -71.07 127.91 34.17 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.87 0.868 . . . . 0.0 110.304 171.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 36.2 mm -123.93 117.67 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.351 1.06 . . . . 0.0 108.529 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -111.4 100.12 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.047 1.339 . . . . 0.0 107.746 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.4 p -82.74 158.98 22.65 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.595 0.712 . . . . 0.0 111.674 175.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.2 ptpt -152.44 139.09 18.76 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.744 1.218 . . . . 0.0 111.069 175.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.5 mt -79.38 133.84 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -140.04 124.55 18.06 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.207 1.403 . . . . 0.0 110.622 173.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -74.62 115.72 14.49 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.809 -0.557 . . . . 0.0 109.747 169.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.0 mt -102.74 98.43 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 60.0 12.91 3.4 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.77 2.028 . . . . 0.0 115.78 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 128.78 -34.46 2.86 Favored Glycine 0 N--CA 1.473 1.122 0 C-N-CA 124.919 1.247 . . . . 0.0 113.445 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 88.6 m -72.01 127.63 33.16 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.371 1.068 . . . . 0.0 109.549 171.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -75.5 116.44 16.22 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.741 -0.599 . . . . 0.0 109.889 173.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -105.41 168.97 8.73 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.362 1.465 . . . . 0.0 110.389 170.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.6 tp -120.38 134.85 62.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 125.597 1.559 . . . . 0.0 107.342 169.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.2 p -119.88 160.04 23.46 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.19 0.596 . . . . 0.0 109.462 171.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -148.45 142.33 25.77 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.797 0.839 . . . . 0.0 110.795 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.5 p -74.08 116.14 14.37 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.525 0.679 . . . . 0.0 110.53 173.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.74 -166.14 40.95 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.72 0.676 . . . . 0.0 112.139 174.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.29 172.16 12.94 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 121.981 0.896 . . . . 0.0 111.234 168.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -76.57 132.0 39.25 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.508 1.123 . . . . 0.0 110.43 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.15 162.0 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.472 -0.767 . . . . 0.0 111.81 171.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -96.99 -24.94 15.57 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -69.26 -19.04 63.92 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.453 1.501 . . . . 0.0 113.625 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.02 61.31 1.58 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.491 1.916 . . . . 0.0 110.059 176.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 57.9 -91.11 0.03 OUTLIER Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.659 2.076 . . . . 0.0 115.473 171.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -146.93 25.41 1.15 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.928 2.091 . . . . 0.0 112.374 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -85.99 155.82 20.71 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.928 1.291 . . . . 0.0 108.893 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.6 m -89.2 140.2 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 122.713 0.405 . . . . 0.0 110.799 176.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -74.85 91.27 2.43 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.18 0.592 . . . . 0.0 110.517 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -77.93 151.44 33.72 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 122.32 1.057 . . . . 0.0 111.086 168.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -134.33 173.53 11.51 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.219 1.808 . . . . 0.0 110.884 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.91 138.09 24.06 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.659 0.663 . . . . 0.0 110.835 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 59.5 mt -128.8 141.53 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.05 0.94 . . . . 0.0 109.314 174.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.6 m -64.19 97.1 0.17 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.078 0.951 . . . . 0.0 109.764 175.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.95 -30.95 60.03 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.582 1.153 . . . . 0.0 112.023 175.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -67.31 -25.82 66.22 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -93.53 -15.32 25.6 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.64 1.176 . . . . 0.0 113.153 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 22.0 mt -73.87 -46.27 45.82 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.487 -0.758 . . . . 0.0 110.314 169.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -50.24 -45.12 53.76 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.704 1.202 . . . . 0.0 114.087 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -60.53 -29.19 68.97 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -176.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -98.34 -11.62 22.33 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.025 1.33 . . . . 0.0 112.905 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 17.1 mt -97.95 -24.4 15.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.132 1.373 . . . . 0.0 112.986 -174.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt . . . . . 0 C--O 1.253 1.272 0 C-N-CA 126.108 1.763 . . . . 0.0 113.17 169.503 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.3 tt -61.56 149.73 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.764 0.826 . . . . 0.0 111.56 170.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -144.94 150.96 37.9 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.218 1.407 . . . . 0.0 111.148 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.8 p -116.66 73.31 0.85 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.742 1.617 . . . . 0.0 110.348 -173.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.2 m 56.52 43.81 25.2 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.496 1.518 . . . . 0.0 113.308 -175.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -127.36 131.53 50.36 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.462 1.505 . . . . 0.0 111.156 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -81.75 113.24 19.59 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.361 1.064 . . . . 0.0 110.874 176.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.99 166.56 5.63 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 170.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -60.71 139.09 58.0 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.604 -0.685 . . . . 0.0 111.564 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.5 m -125.43 177.67 6.05 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.73 1.612 . . . . 0.0 111.494 -176.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.4 t -52.67 -50.63 62.86 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.925 0.89 . . . . 0.0 112.912 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 49.2 -135.69 22.12 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 124.879 1.228 . . . . 0.0 114.536 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.39 161.55 16.75 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.204 1.002 . . . . 0.0 112.649 170.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 62.6 p -58.87 168.34 1.3 Allowed 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.241 -0.912 . . . . 0.0 113.22 170.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -51.43 124.18 11.4 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.46 1.104 . . . . 0.0 111.889 169.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 m -126.69 44.16 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 127.008 2.123 . . . . 0.0 111.102 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -57.45 160.54 4.05 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.018 1.327 . . . . 0.0 113.042 175.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.47 153.41 43.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.553 1.141 . . . . 0.0 111.252 175.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.5 mm -71.54 156.77 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.769 1.228 . . . . 0.0 111.01 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -59.65 -12.99 7.89 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.267 1.427 . . . . 0.0 114.249 171.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -95.65 -4.12 44.95 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.289 1.436 . . . . 0.0 113.33 173.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.3 m -114.66 -28.51 7.1 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.697 1.999 . . . . 0.0 112.246 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -138.52 158.74 43.67 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.796 1.238 . . . . 0.0 110.84 168.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -141.21 168.32 20.06 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.68 1.192 . . . . 0.0 110.486 173.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -134.38 127.99 32.71 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.951 0.5 . . . . 0.0 110.081 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 m -126.08 158.16 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.233 1.413 . . . . 0.0 111.291 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -60.8 152.76 26.23 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.736 0.814 . . . . 0.0 111.35 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.1 tp -147.48 135.44 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.385 1.074 . . . . 0.0 109.585 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -127.68 158.72 36.81 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.465 1.906 . . . . 0.0 108.727 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -127.83 156.1 43.06 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.356 1.062 . . . . 0.0 111.106 175.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.23 119.85 22.89 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 170.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -67.66 176.33 2.5 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 122.01 0.91 . . . . 0.0 111.765 173.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -56.11 -16.13 4.67 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.91 2.084 . . . . 0.0 115.4 176.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -110.45 12.35 22.98 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.761 1.225 . . . . 0.0 113.349 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.65 20.9 79.37 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 120.973 -1.08 . . . . 0.0 114.515 176.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -102.27 144.07 31.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.529 1.132 . . . . 0.0 110.446 174.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -75.2 126.65 31.46 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.027 0.442 . . . . 0.0 110.418 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.9 t -131.57 135.18 46.8 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.317 1.447 . . . . 0.0 109.325 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -55.51 136.71 49.71 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.21 0.604 . . . . 0.0 111.816 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.3 tp -111.25 -46.38 3.31 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.799 0.84 . . . . 0.0 110.718 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.38 -111.37 0.44 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 123.103 0.382 . . . . 0.0 113.485 175.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -146.06 154.66 42.09 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.291 1.436 . . . . 0.0 110.261 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.8 tp -119.61 102.66 8.78 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.407 1.483 . . . . 0.0 109.899 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.9 t -75.46 98.12 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.07 1.348 . . . . 0.0 109.191 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.9 t -83.51 87.93 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.252 1.421 . . . . 0.0 110.062 175.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -82.9 125.71 31.67 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.823 1.249 . . . . 0.0 111.425 171.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -78.05 137.9 38.49 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.786 0.834 . . . . 0.0 109.932 167.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -135.36 171.52 14.32 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.602 1.561 . . . . 0.0 110.837 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -67.98 -33.88 75.49 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.602 -1.311 . . . . 0.0 113.025 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -89.94 22.47 3.17 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.171 1.388 . . . . 0.0 112.975 -177.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 109.36 -168.71 13.4 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.804 1.668 . . . . 0.0 113.034 -175.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.3 mt -88.9 141.0 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 121.601 -0.94 . . . . 0.0 108.899 177.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -131.26 89.7 2.76 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.061 1.344 . . . . 0.0 111.157 -174.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.6 p -83.71 152.63 24.62 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.531 -0.73 . . . . 0.0 112.778 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.76 128.22 3.4 Favored Glycine 0 CA--C 1.527 0.802 0 O-C-N 121.368 -0.833 . . . . 0.0 113.185 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.23 139.18 48.0 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.25 1.82 . . . . 0.0 110.125 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -136.9 87.11 2.26 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.917 1.687 . . . . 0.0 111.042 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.92 5.0 46.05 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.51 62.24 1.41 Allowed Glycine 0 CA--C 1.53 1.028 0 O-C-N 121.413 -0.804 . . . . 0.0 113.2 174.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.67 -4.92 22.84 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.28 1.419 . . . . 0.0 113.7 -174.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -141.71 64.83 1.39 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.371 1.468 . . . . 0.0 110.717 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.9 p -94.84 144.12 25.91 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.204 1.002 . . . . 0.0 112.955 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.98 160.78 25.09 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.336 1.454 . . . . 0.0 112.15 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.5 m -54.8 128.78 34.52 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.315 1.046 . . . . 0.0 110.766 171.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -96.98 -52.55 3.82 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.989 0.515 . . . . 0.0 110.376 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -164.16 154.29 14.7 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.891 0.876 . . . . 0.0 112.881 172.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.04 116.0 10.34 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 123.158 1.456 . . . . 0.0 113.343 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.94 171.61 9.46 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.967 1.307 . . . . 0.0 112.526 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -80.6 161.35 24.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.401 1.081 . . . . 0.0 112.266 176.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -55.6 -35.03 65.38 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.163 0.985 . . . . 0.0 113.055 172.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -68.07 -17.89 64.51 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 175.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.9 t -100.81 -10.58 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.831 0.852 . . . . 0.0 111.577 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 75.9 t -47.08 -51.37 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.549 1.14 . . . . 0.0 111.577 176.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -73.24 -29.07 62.51 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 177.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -76.68 -39.42 52.14 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.138 -0.976 . . . . 0.0 111.981 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -57.18 -46.06 83.17 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 124.804 1.242 . . . . 0.0 110.815 173.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 72.4 t -52.61 -42.94 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.498 1.119 . . . . 0.0 110.728 175.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -66.81 -55.01 16.77 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.507 1.523 . . . . 0.0 113.002 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 m -72.83 -5.95 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 O-C-N 121.424 -0.797 . . . . 0.0 112.983 -176.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.42 -5.77 31.9 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.727 1.611 . . . . 0.0 112.155 178.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.0 p -127.55 -13.16 5.45 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.934 0.894 . . . . 0.0 112.695 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -132.72 -11.21 3.08 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.656 1.582 . . . . 0.0 114.392 177.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.6 156.81 9.79 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.098 1.333 . . . . 0.0 113.821 -174.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.88 -153.93 24.95 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 121.655 -0.909 . . . . 0.0 113.106 -175.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.6 p -145.83 153.23 40.67 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.177 0.991 . . . . 0.0 112.936 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -148.73 179.55 7.75 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.317 1.847 . . . . 0.0 111.769 173.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -114.97 151.92 33.3 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.733 1.213 . . . . 0.0 110.025 168.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 62.4 p -117.28 133.58 55.81 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.766 0.827 . . . . 0.0 111.271 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.1 t -51.0 -37.85 47.62 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.308 1.043 . . . . 0.0 112.557 175.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.7 mt -146.48 147.23 30.98 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.029 1.731 . . . . 0.0 111.719 173.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -136.85 115.37 11.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 170.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -96.57 -49.01 5.3 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.8 0.84 . . . . 0.0 112.543 174.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.45 172.11 34.31 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 125.718 1.628 . . . . 0.0 113.423 -169.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -58.21 165.82 1.84 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.131 0.972 . . . . 0.0 112.486 169.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -56.35 -30.34 62.51 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 120.728 -1.232 . . . . 0.0 114.152 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.67 58.25 1.06 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.707 1.203 . . . . 0.0 112.031 173.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.497 ' HG3' ' H ' ' A' ' 119' ' ' SER . 6.3 tp10 -148.67 149.03 30.77 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.893 1.277 . . . . 0.0 111.382 -175.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -74.95 -22.16 58.75 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.356 -0.84 . . . . 0.0 112.98 172.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.497 ' H ' ' HG3' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -83.44 -41.77 17.7 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.815 1.646 . . . . 0.0 114.174 -177.104 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.6 p -50.38 -25.32 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 126.274 1.83 . . . . 0.0 115.689 -169.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 53.0 mt -59.46 -35.8 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 126.221 1.808 . . . . 0.0 112.306 175.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -135.74 -38.82 0.72 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.471 1.508 . . . . 0.0 113.83 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.28 166.35 29.98 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 127.162 2.315 . . . . 0.0 113.513 -175.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.2 mt -122.51 119.23 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.636 1.574 . . . . 0.0 108.828 176.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -80.66 148.58 30.15 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 54.46 25.71 6.4 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.362 1.865 . . . . 0.0 113.979 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -63.08 126.57 27.8 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.283 1.433 . . . . 0.0 111.239 -172.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -78.95 130.42 35.56 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.013 0.525 . . . . 0.0 111.461 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.7 mm -126.87 120.36 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 125.862 1.665 . . . . 0.0 109.215 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.95 105.17 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.266 1.427 . . . . 0.0 108.71 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.7 p -78.69 159.88 27.77 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.725 0.774 . . . . 0.0 112.198 174.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -150.55 140.88 22.32 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.983 1.313 . . . . 0.0 110.523 171.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.4 mt -81.92 132.72 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -140.06 121.56 15.14 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.06 1.344 . . . . 0.0 110.563 174.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -72.1 120.01 17.1 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.738 -0.602 . . . . 0.0 109.742 169.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 24.3 mt -106.79 97.19 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 175.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 60.86 12.22 3.7 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.774 2.03 . . . . 0.0 115.816 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 130.22 -34.98 2.6 Favored Glycine 0 N--CA 1.473 1.106 0 C-N-CA 125.071 1.32 . . . . 0.0 113.316 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 73.0 m -71.81 125.26 26.7 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.382 1.073 . . . . 0.0 109.47 171.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -74.97 119.23 18.87 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.72 -0.613 . . . . 0.0 109.56 173.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -108.39 168.54 9.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.332 1.453 . . . . 0.0 110.227 171.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 tp -120.09 136.2 57.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 125.363 1.465 . . . . 0.0 108.25 170.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 p -123.25 155.64 36.77 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.337 0.655 . . . . 0.0 110.026 172.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -148.56 137.09 21.35 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.174 0.99 . . . . 0.0 111.024 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.7 p -70.52 115.55 9.82 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.168 0.987 . . . . 0.0 111.642 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.13 -163.23 38.65 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.739 1.162 . . . . 0.0 112.949 174.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -68.63 169.41 11.16 Favored 'General case' 0 CA--C 1.553 1.077 0 O-C-N 121.663 -0.904 . . . . 0.0 112.125 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -85.82 114.56 22.85 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.144 1.377 . . . . 0.0 111.265 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.29 162.36 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.617 0.767 . . . . 0.0 111.687 174.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.7 tptt -101.85 -13.43 17.67 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 171.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -78.06 6.59 7.6 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.696 1.598 . . . . 0.0 113.799 176.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.78 171.08 14.54 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.03 1.332 . . . . 0.0 111.97 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -80.29 74.77 2.29 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.472 1.51 . . . . 0.0 113.698 -176.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . 0.253 4.1 p30 48.1 41.22 15.08 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.289 1.836 . . . . 0.0 115.109 -175.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -92.16 175.65 6.78 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.022 0.929 . . . . 0.0 110.004 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.8 m -111.33 146.52 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.17 0.988 . . . . 0.0 109.833 173.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.16 93.94 0.64 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 169.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -90.55 147.8 23.11 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 122.272 1.034 . . . . 0.0 111.085 169.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -134.45 171.1 14.77 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.817 1.647 . . . . 0.0 110.932 -172.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.59 134.02 23.21 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.584 0.629 . . . . 0.0 110.5 177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 61.6 mt -127.13 140.59 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.187 0.995 . . . . 0.0 108.914 175.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.0 m -65.33 95.89 0.21 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.228 1.011 . . . . 0.0 109.914 177.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.2 tt -53.42 -33.5 54.22 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.18 0.992 . . . . 0.0 111.377 175.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -67.91 -28.87 67.86 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -79.06 -36.31 41.15 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.657 0.662 . . . . 0.0 111.807 169.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 16.1 mt -59.88 -37.32 79.04 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.554 -0.716 . . . . 0.0 111.794 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -62.14 -6.97 3.42 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 172.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -98.43 -15.31 19.7 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.985 1.314 . . . . 0.0 114.104 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -122.59 1.94 9.52 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.781 1.632 . . . . 0.0 113.408 -178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 53.0 mt -103.57 -17.86 15.0 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.146 0.978 . . . . 0.0 113.14 176.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm . . . . . 0 C--O 1.253 1.245 0 C-N-CA 125.858 1.663 . . . . 0.0 112.769 169.509 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.3 mm 46.43 73.26 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 126.851 2.06 . . . . 0.0 112.617 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -126.1 57.59 1.38 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.013 1.325 . . . . 0.0 111.627 -174.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.5 m -132.22 143.23 49.79 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.355 1.862 . . . . 0.0 109.223 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.8 m 54.42 32.87 17.44 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.018 1.327 . . . . 0.0 114.0 -173.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -63.63 166.65 6.64 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.548 1.139 . . . . 0.0 112.799 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -146.37 150.83 36.43 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.86 1.264 . . . . 0.0 111.477 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -66.51 143.94 56.76 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.899 0.88 . . . . 0.0 112.46 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -65.89 148.42 51.82 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.49 0.716 . . . . 0.0 111.951 171.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.9 m -63.87 132.91 52.27 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.493 1.117 . . . . 0.0 112.005 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 m -66.45 161.83 21.9 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.249 1.02 . . . . 0.0 112.137 170.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.75 -75.63 0.74 Allowed Glycine 0 CA--C 1.534 1.278 0 O-C-N 121.712 -0.618 . . . . 0.0 112.558 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -161.35 142.57 11.42 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.463 1.505 . . . . 0.0 111.633 173.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -163.61 170.36 17.27 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.387 1.475 . . . . 0.0 111.658 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -69.29 96.49 0.86 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.036 1.734 . . . . 0.0 111.081 172.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.2 m -99.6 42.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 126.125 1.77 . . . . 0.0 112.116 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -63.03 169.37 3.39 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.496 1.518 . . . . 0.0 112.237 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -139.1 155.23 48.06 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.917 1.687 . . . . 0.0 111.069 -173.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.5 mp -122.66 156.5 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.016 1.726 . . . . 0.0 109.493 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -60.1 -14.59 17.61 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -79.77 -8.62 59.36 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.532 1.133 . . . . 0.0 113.831 172.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.4 t -88.85 11.23 18.5 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.298 1.839 . . . . 0.0 112.899 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -143.69 165.87 26.44 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.764 1.626 . . . . 0.0 111.639 174.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -147.87 168.96 20.87 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.309 1.444 . . . . 0.0 110.72 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 m -136.55 134.82 37.91 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.91 0.484 . . . . 0.0 111.127 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.0 m -131.51 161.7 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.218 1.407 . . . . 0.0 112.304 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.34 153.15 23.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.742 1.217 . . . . 0.0 111.899 174.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.1 tp -152.94 136.79 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.442 1.497 . . . . 0.0 109.358 177.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -130.56 160.09 35.19 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.191 1.796 . . . . 0.0 109.759 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -132.93 158.76 41.82 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.845 1.258 . . . . 0.0 112.462 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 120.31 25.75 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.002 0.521 . . . . 0.0 110.76 173.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -72.63 179.71 3.45 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.401 0.68 . . . . 0.0 112.642 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -55.65 -29.35 59.13 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.734 1.614 . . . . 0.0 113.284 173.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.5 t -82.84 -6.8 59.6 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.127 1.371 . . . . 0.0 113.244 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.02 34.73 51.82 Favored Glycine 0 CA--C 1.533 1.219 0 O-C-N 120.855 -1.153 . . . . 0.0 114.058 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -119.05 145.39 45.93 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.362 1.465 . . . . 0.0 111.002 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -72.38 123.55 23.29 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.743 0.817 . . . . 0.0 111.181 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.0 t -139.2 141.76 37.91 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.208 1.403 . . . . 0.0 110.547 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -56.1 141.39 40.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.866 0.866 . . . . 0.0 113.054 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 tp -117.52 -47.87 2.62 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.741 0.816 . . . . 0.0 111.694 -178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.58 -117.6 0.71 Allowed Glycine 0 CA--C 1.529 0.906 0 CA-C-O 121.254 0.363 . . . . 0.0 113.663 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -145.08 156.04 43.68 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.518 1.527 . . . . 0.0 109.643 -177.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.2 tp -121.16 100.44 7.06 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.983 1.313 . . . . 0.0 110.065 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 t -76.0 96.3 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.161 1.384 . . . . 0.0 109.096 175.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.6 t -85.38 105.54 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.31 1.444 . . . . 0.0 110.031 173.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 63.3 mtt-85 -91.12 121.16 32.67 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.482 1.913 . . . . 0.0 110.158 172.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -83.89 91.27 7.53 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.52 0.728 . . . . 0.0 109.288 170.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -71.05 171.9 10.06 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.82 1.248 . . . . 0.0 112.776 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -63.87 -32.87 74.54 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.444 1.098 . . . . 0.0 113.734 176.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -125.58 86.91 2.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.413 1.485 . . . . 0.0 109.787 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.57 -157.95 24.07 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.878 0.751 . . . . 0.0 114.375 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.3 mt -122.96 145.25 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.427 1.091 . . . . 0.0 110.065 176.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -134.54 132.83 39.62 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.548 1.539 . . . . 0.0 109.763 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.6 p -126.33 147.37 49.74 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.929 -1.107 . . . . 0.0 111.883 -171.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.29 120.77 1.75 Allowed Glycine 0 CA--C 1.527 0.791 0 O-C-N 121.818 -0.551 . . . . 0.0 112.977 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.41 141.23 57.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.961 1.704 . . . . 0.0 110.036 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.93 60.81 1.69 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.373 1.869 . . . . 0.0 111.034 -169.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.37 66.44 3.93 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.128 1.371 . . . . 0.0 113.768 -174.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.68 -58.51 4.48 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.615 1.578 . . . . 0.0 114.15 172.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.46 24.27 0.58 Allowed Glycine 0 CA--C 1.536 1.393 0 C-N-CA 126.499 2.0 . . . . 0.0 113.383 177.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -135.72 44.48 2.5 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.764 1.625 . . . . 0.0 110.806 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.3 p -66.21 141.77 57.94 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.35 152.88 26.47 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.154 1.382 . . . . 0.0 112.482 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.6 m -54.95 123.57 13.94 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.167 -0.958 . . . . 0.0 110.245 171.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -90.91 -51.84 5.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.599 0.76 . . . . 0.0 110.2 -177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -164.33 161.09 21.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.848 0.859 . . . . 0.0 112.613 172.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.14 153.7 43.15 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.998 1.319 . . . . 0.0 111.965 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.445 ' HA ' ' H ' ' A' ' 109' ' ' SER . 1.7 pp -140.77 154.78 46.42 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.411 1.485 . . . . 0.0 111.188 -175.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -78.52 166.96 21.97 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.602 0.715 . . . . 0.0 112.208 -172.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -59.57 -21.7 60.7 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 121.388 -0.82 . . . . 0.0 112.543 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -72.92 -12.98 61.16 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 121.045 -1.034 . . . . 0.0 113.583 173.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.7 t -112.13 -2.07 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 120.901 -1.124 . . . . 0.0 110.852 -171.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.0 m -60.96 -26.07 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -97.87 -25.57 14.97 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.693 0.679 . . . . 0.0 111.863 170.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -70.25 -53.7 15.84 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.583 1.553 . . . . 0.0 111.166 -178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -58.05 -44.58 87.5 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.571 1.148 . . . . 0.0 111.236 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 74.1 t -57.16 -36.86 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.957 0.903 . . . . 0.0 111.022 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -62.54 -57.5 10.93 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.464 1.105 . . . . 0.0 111.997 173.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -70.06 -17.16 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 O-C-N 121.331 -0.855 . . . . 0.0 112.573 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.2 -6.91 58.43 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.27 1.828 . . . . 0.0 111.91 177.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 46.2 p -128.1 -10.49 5.34 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 173.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -134.88 -9.96 2.34 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.578 1.551 . . . . 0.0 113.954 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.51 155.76 6.4 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.722 1.629 . . . . 0.0 113.824 -174.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.1 -170.8 33.3 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.267 0.937 . . . . 0.0 114.096 -175.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.8 p -143.95 103.32 4.02 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.729 1.211 . . . . 0.0 113.493 -168.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -132.86 162.02 32.65 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.423 1.889 . . . . 0.0 110.398 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.58 160.26 17.51 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.644 0.735 . . . . 0.0 111.387 177.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.9 p -126.57 153.8 44.75 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.279 1.831 . . . . 0.0 110.113 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.445 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 76.9 p -68.9 -39.74 79.55 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.527 -0.733 . . . . 0.0 111.283 -175.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.8 mt -151.61 143.27 23.64 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.904 2.082 . . . . 0.0 111.451 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -136.64 101.81 4.73 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.268 1.027 . . . . 0.0 109.299 174.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -87.52 -51.94 5.63 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.68 0.792 . . . . 0.0 111.764 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.44 178.34 49.54 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 124.526 1.06 . . . . 0.0 114.379 -173.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -61.98 155.14 24.54 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.408 1.083 . . . . 0.0 111.561 170.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -58.44 -26.65 63.56 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.945 1.298 . . . . 0.0 114.0 -176.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -78.65 -12.06 60.0 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 174.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -72.14 174.76 6.7 Favored 'General case' 0 CA--C 1.552 1.044 0 O-C-N 120.711 -1.243 . . . . 0.0 112.483 170.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.44 -26.6 14.4 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -167.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.9 m -102.86 -1.26 29.95 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.355 1.062 . . . . 0.0 113.058 -177.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.7 p -54.81 -24.41 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 126.524 1.929 . . . . 0.0 115.543 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.8 mp -69.07 -39.92 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.259 1.023 . . . . 0.0 112.134 -178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -123.45 -18.75 6.1 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.647 1.179 . . . . 0.0 113.661 -173.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.0 173.48 38.56 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.439 1.495 . . . . 0.0 113.702 -171.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 36.7 mt -127.89 108.4 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.901 1.68 . . . . 0.0 107.846 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -69.21 147.64 51.0 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.176 0.512 . . . . 0.0 111.185 173.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 57.83 22.05 8.18 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.38 1.472 . . . . 0.0 114.162 178.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -56.79 123.9 16.61 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.939 1.296 . . . . 0.0 111.585 -176.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -72.01 128.97 37.39 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.545 1.138 . . . . 0.0 110.768 170.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 38.2 mm -122.94 115.78 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.734 1.214 . . . . 0.0 109.293 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.89 90.02 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.158 1.383 . . . . 0.0 108.671 -174.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.8 p -75.74 154.2 36.53 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.394 175.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -151.54 140.97 21.54 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.215 1.406 . . . . 0.0 111.099 174.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.35 133.97 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.053 0.541 . . . . 0.0 109.754 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -139.13 122.42 17.06 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.303 1.441 . . . . 0.0 111.107 175.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -72.57 105.26 4.15 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.693 1.197 . . . . 0.0 110.357 170.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 25.6 mt -95.18 99.11 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 174.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 57.0 19.53 4.69 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.583 1.953 . . . . 0.0 115.696 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.03 -22.35 9.82 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.555 1.074 . . . . 0.0 114.291 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 89.6 m -82.9 128.09 34.12 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 117.942 0.871 . . . . 0.0 109.016 170.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.74 117.85 17.03 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.629 -0.669 . . . . 0.0 109.525 172.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -107.18 168.17 9.4 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.319 1.447 . . . . 0.0 110.133 169.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.2 tp -119.04 135.03 60.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.227 1.411 . . . . 0.0 108.56 170.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.0 p -124.03 153.59 41.12 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.835 0.854 . . . . 0.0 109.955 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -151.01 145.67 25.69 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.065 0.946 . . . . 0.0 111.833 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.6 m -82.57 117.9 22.88 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.499 1.12 . . . . 0.0 111.084 176.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.86 -151.87 24.56 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.88 1.705 . . . . 0.0 113.143 177.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -72.2 173.49 8.51 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 170.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -92.4 102.29 14.76 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.084 0.954 . . . . 0.0 111.923 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -61.61 156.43 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.032 0.933 . . . . 0.0 113.064 -178.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.41 ' HE3' ' HA ' ' A' ' 150' ' ' LYS . 0.4 OUTLIER -91.12 -27.4 18.58 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.754 0.821 . . . . 0.0 112.491 177.275 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -64.27 -47.81 78.11 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.903 1.281 . . . . 0.0 113.083 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.82 -36.18 37.27 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -176.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 142.19 -74.79 0.33 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.852 1.215 . . . . 0.0 113.111 171.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -146.07 20.16 1.42 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.654 1.982 . . . . 0.0 112.46 177.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -77.87 178.59 7.3 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.035 0.934 . . . . 0.0 108.885 174.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 19.5 m -110.89 142.33 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.291 0.637 . . . . 0.0 110.78 173.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.74 124.29 19.98 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 170.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -126.23 144.33 50.82 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 122.243 1.02 . . . . 0.0 111.222 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -137.91 172.14 13.37 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.493 1.517 . . . . 0.0 111.878 -168.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.68 131.48 18.01 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.507 0.723 . . . . 0.0 110.057 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 70.5 mt -124.19 139.93 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 123.959 0.904 . . . . 0.0 108.796 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.8 m -63.86 96.86 0.14 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.11 0.964 . . . . 0.0 109.601 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.1 tt -55.76 -33.0 63.91 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.072 0.949 . . . . 0.0 111.778 176.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -66.95 -27.67 67.65 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 176.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -87.06 -31.39 20.53 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.892 0.877 . . . . 0.0 112.113 174.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 19.4 mt -60.76 -44.1 97.17 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.77 0.828 . . . . 0.0 111.233 172.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -51.71 -32.7 31.3 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.547 -1.346 . . . . 0.0 113.639 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -68.22 -18.48 64.58 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -126.66 0.25 6.79 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.769 1.628 . . . . 0.0 114.134 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 29.1 mt -102.78 -21.49 14.05 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.697 1.599 . . . . 0.0 112.444 176.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm . . . . . 0 C--O 1.255 1.382 0 C-N-CA 127.033 2.133 . . . . 0.0 112.092 173.39 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.3 pttt . . . . . 0 N--CA 1.496 1.843 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.74 7.93 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 121.094 1.77 . . . . 0.0 114.52 -173.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -64.78 158.42 24.97 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.387 -0.821 . . . . 0.0 112.564 174.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 t -150.54 143.84 24.94 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.869 1.267 . . . . 0.0 110.875 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.2 m -148.01 110.5 4.68 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.385 1.474 . . . . 0.0 110.136 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -64.15 137.68 58.08 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.255 0.55 . . . . 0.0 111.759 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -68.97 169.97 10.68 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.297 1.039 . . . . 0.0 112.711 171.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -130.23 146.44 51.85 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.897 1.279 . . . . 0.0 110.711 178.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -117.87 152.64 34.99 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.185 1.394 . . . . 0.0 110.902 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.5 p -149.53 133.73 17.29 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.773 1.229 . . . . 0.0 111.119 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.1 p -79.83 166.18 21.97 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.58 1.152 . . . . 0.0 111.962 172.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -120.37 162.09 14.44 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.895 1.236 . . . . 0.0 112.624 175.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.92 151.46 31.7 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.75 0.82 . . . . 0.0 112.767 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.5 t -159.96 148.73 17.4 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.906 1.283 . . . . 0.0 111.343 173.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -78.7 99.2 6.53 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.39 1.476 . . . . 0.0 110.09 174.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.6 t -125.88 68.89 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 125.785 1.634 . . . . 0.0 109.585 -176.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -69.47 157.12 37.74 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.071 0.948 . . . . 0.0 111.898 172.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm -149.73 156.7 42.3 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.575 1.95 . . . . 0.0 111.045 175.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.0 mm -67.84 155.79 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.449 1.5 . . . . 0.0 110.523 177.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -61.98 -6.01 2.57 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 173.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -96.96 -1.12 46.3 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.602 1.561 . . . . 0.0 113.554 171.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.0 t -130.83 0.13 4.29 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.853 2.061 . . . . 0.0 113.15 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -149.7 153.84 37.59 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.122 1.769 . . . . 0.0 109.534 169.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -145.96 166.21 26.69 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.112 0.965 . . . . 0.0 111.15 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 m -132.62 126.48 32.8 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.8 0.44 . . . . 0.0 110.628 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.2 m -121.91 169.12 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.839 1.656 . . . . 0.0 110.697 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -67.81 169.2 10.11 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.855 0.862 . . . . 0.0 111.622 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 tp -159.27 137.56 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.936 1.294 . . . . 0.0 109.862 171.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -129.57 158.82 38.22 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.377 2.271 . . . . 0.0 108.942 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -131.39 159.8 36.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.388 1.075 . . . . 0.0 111.766 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -88.08 119.51 28.52 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.15 0.58 . . . . 0.0 110.727 172.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -72.89 179.77 3.54 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.445 0.64 . . . . 0.0 112.191 173.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -57.55 -21.58 39.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.977 1.711 . . . . 0.0 114.428 176.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.0 m -91.56 2.38 56.49 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.045 0.938 . . . . 0.0 113.258 177.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.3 31.26 71.5 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.563 1.077 . . . . 0.0 113.8 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -109.93 140.19 44.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.992 1.317 . . . . 0.0 110.822 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -74.57 121.23 21.24 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.869 0.868 . . . . 0.0 110.77 175.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.6 t -137.42 138.62 40.02 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.915 1.286 . . . . 0.0 110.5 -176.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -58.33 143.48 44.74 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -174.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.2 tp -118.81 -46.42 2.55 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.137 0.975 . . . . 0.0 111.542 -177.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 171.87 -129.5 1.76 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-O 121.457 0.476 . . . . 0.0 113.655 -175.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -141.39 158.9 43.26 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.039 1.736 . . . . 0.0 109.461 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.4 tp -126.22 103.24 7.57 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.884 1.274 . . . . 0.0 110.497 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.1 t -76.56 96.23 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.408 1.083 . . . . 0.0 109.012 175.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.4 t -83.86 113.11 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.586 1.555 . . . . 0.0 109.697 173.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -103.65 123.05 46.27 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.438 1.895 . . . . 0.0 110.175 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -82.15 84.5 7.02 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.553 1.141 . . . . 0.0 109.626 172.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -66.13 166.95 10.85 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.282 1.039 . . . . 0.0 111.961 173.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -72.81 -23.39 60.78 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.137 -0.977 . . . . 0.0 113.306 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -131.46 42.62 3.17 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.812 1.645 . . . . 0.0 112.903 -173.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.08 -157.73 25.55 Favored Glycine 0 N--CA 1.475 1.276 0 C-N-CA 125.667 1.603 . . . . 0.0 114.761 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.3 mt -125.08 142.06 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.237 1.015 . . . . 0.0 109.315 171.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -133.98 134.87 43.02 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.174 1.39 . . . . 0.0 108.729 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.2 p -132.72 143.21 49.46 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.676 0.79 . . . . 0.0 111.268 -173.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.66 122.77 2.69 Favored Glycine 0 C--N 1.336 0.541 0 O-C-N 121.921 -0.487 . . . . 0.0 112.695 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -66.44 126.09 27.74 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.887 1.675 . . . . 0.0 109.124 173.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -129.88 91.36 3.12 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.864 1.666 . . . . 0.0 109.187 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.14 1.27 48.67 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 104.9 -48.99 0.93 Allowed Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.706 1.622 . . . . 0.0 112.982 172.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.59 -13.8 66.85 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.399 1.0 . . . . 0.0 113.621 171.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.52 153.73 40.73 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.781 2.032 . . . . 0.0 111.557 177.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 52.3 p -147.56 124.06 11.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.529 1.131 . . . . 0.0 111.8 174.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -150.0 161.44 42.31 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.823 0.849 . . . . 0.0 112.453 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.3 m -59.57 131.24 50.33 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.209 -0.932 . . . . 0.0 110.811 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -98.97 -53.63 3.21 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.168 0.987 . . . . 0.0 109.516 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -161.03 159.09 28.91 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.967 0.907 . . . . 0.0 112.557 170.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.14 149.78 33.68 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 123.052 1.406 . . . . 0.0 112.303 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 pp -142.92 152.82 42.45 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.695 1.598 . . . . 0.0 110.819 -172.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -79.43 167.81 20.32 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.476 0.711 . . . . 0.0 112.146 -170.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -52.63 -35.84 55.38 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.291 -0.881 . . . . 0.0 112.654 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.2 -8.08 22.11 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.869 1.268 . . . . 0.0 114.179 175.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 t -116.5 -5.45 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.239 1.016 . . . . 0.0 111.41 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.1 t -53.58 -61.72 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 120.476 1.489 . . . . 0.0 111.651 -177.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -69.57 -24.81 63.75 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.82 -52.42 56.85 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.695 1.598 . . . . 0.0 110.706 172.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -59.86 -44.88 93.91 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 125.222 1.409 . . . . 0.0 110.62 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.2 -36.39 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.82 0.848 . . . . 0.0 111.206 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -54.99 29.45 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.075 0.95 . . . . 0.0 111.716 173.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 m -76.0 -2.62 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -176.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 40.7 tpp -108.62 -4.22 17.3 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.426 1.49 . . . . 0.0 112.47 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 43.2 p -125.42 -11.75 6.82 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.184 0.994 . . . . 0.0 112.573 171.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -135.25 -12.4 2.13 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.3 156.58 19.15 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 124.697 1.142 . . . . 0.0 113.865 -175.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.05 -160.35 31.54 Favored Glycine 0 CA--C 1.533 1.193 0 O-C-N 121.665 -0.903 . . . . 0.0 113.894 -175.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 85.0 p -150.72 104.49 3.19 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -171.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -135.04 153.3 52.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.066 1.746 . . . . 0.0 110.369 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -80.72 159.58 25.2 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.546 -0.721 . . . . 0.0 111.145 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.2 p -124.93 149.1 47.96 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.9 1.68 . . . . 0.0 110.595 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.1 t -62.59 -44.33 96.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.824 0.85 . . . . 0.0 111.336 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mt -149.61 143.13 25.34 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.459 1.504 . . . . 0.0 111.845 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -140.87 106.08 5.02 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.891 0.876 . . . . 0.0 110.735 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -90.64 -40.26 12.0 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.054 0.942 . . . . 0.0 113.104 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.92 -178.11 40.73 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 124.658 1.123 . . . . 0.0 113.877 -170.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -57.77 147.65 27.4 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.694 -0.886 . . . . 0.0 112.511 172.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -53.79 158.86 1.82 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.119 1.768 . . . . 0.0 112.634 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 65.6 52.64 1.31 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.265 1.426 . . . . 0.0 112.334 -175.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -148.92 156.5 42.38 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.034 1.334 . . . . 0.0 112.211 -172.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -66.07 -29.01 69.27 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -170.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 27.8 t -74.6 -41.18 60.92 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.082 0.855 . . . . 0.0 112.966 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 78.5 t -48.58 -29.87 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 126.102 1.761 . . . . 0.0 113.809 -171.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 41.0 mm -43.22 -46.62 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 126.853 2.061 . . . . 0.0 113.389 170.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -147.41 -16.83 0.38 Allowed 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -176.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.02 163.01 38.84 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 126.044 1.783 . . . . 0.0 113.341 -171.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 95.3 mt -116.2 109.49 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.17 1.388 . . . . 0.0 109.318 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -69.36 146.71 51.91 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.128 0.971 . . . . 0.0 112.146 172.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 54.68 24.47 5.57 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.283 1.833 . . . . 0.0 114.586 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -55.58 123.07 12.8 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.292 1.437 . . . . 0.0 111.696 -178.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -72.37 128.45 35.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.058 0.943 . . . . 0.0 110.618 170.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.5 mm -124.14 116.33 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.819 1.248 . . . . 0.0 108.649 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.13 94.04 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.435 1.494 . . . . 0.0 108.097 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.8 p -80.14 157.61 26.57 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.859 0.838 . . . . 0.0 111.776 176.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -154.12 146.71 24.12 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.891 1.276 . . . . 0.0 111.469 174.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 16.2 mt -84.29 131.47 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.175 0.59 . . . . 0.0 110.019 173.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -147.34 140.44 25.16 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.291 1.836 . . . . 0.0 110.077 176.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -83.84 154.87 23.24 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.158 -0.964 . . . . 0.0 110.243 169.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 42.0 mt -128.51 -45.15 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.175 0.99 . . . . 0.0 110.944 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -145.29 19.96 1.56 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.897 0.879 . . . . 0.0 112.885 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.63 -22.25 15.24 Favored Glycine 0 N--CA 1.474 1.226 0 O-C-N 121.244 -0.91 . . . . 0.0 113.582 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 53.8 m -88.96 143.2 27.03 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.089 0.956 . . . . 0.0 109.067 169.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -76.26 123.96 26.73 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.737 0.815 . . . . 0.0 110.264 171.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -109.0 158.19 17.95 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.398 1.479 . . . . 0.0 110.735 174.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 6.8 tp -100.92 144.68 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 166.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.7 p -133.12 156.48 47.37 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.624 0.77 . . . . 0.0 109.157 169.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -151.49 145.99 25.58 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.923 0.889 . . . . 0.0 111.457 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.2 p -76.22 115.45 15.96 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.701 1.2 . . . . 0.0 110.979 174.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.66 -162.22 38.05 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.379 0.99 . . . . 0.0 112.917 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.99 161.39 26.71 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.755 0.822 . . . . 0.0 112.682 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -78.12 103.94 8.38 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.448 0.699 . . . . 0.0 110.636 172.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.75 157.91 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.031 1.332 . . . . 0.0 112.687 179.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -92.49 -22.28 19.67 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -78.19 3.56 14.89 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.76 -32.26 1.0 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -178.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 139.79 -80.31 0.27 Allowed Glycine 0 N--CA 1.472 1.074 0 C-N-CA 124.718 1.152 . . . . 0.0 112.71 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -142.43 19.06 2.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 127.056 2.142 . . . . 0.0 110.665 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -80.95 165.03 22.13 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.681 1.192 . . . . 0.0 108.756 176.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.7 m -102.03 141.82 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 120.921 0.391 . . . . 0.0 110.316 171.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.77 100.07 0.27 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.737 0.815 . . . . 0.0 109.599 171.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -93.79 145.77 24.35 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.174 0.988 . . . . 0.0 110.974 173.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -135.14 166.85 22.12 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.697 1.599 . . . . 0.0 111.417 -172.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.88 135.51 23.26 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.894 0.477 . . . . 0.0 110.555 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 59.0 mt -130.34 142.07 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.563 1.145 . . . . 0.0 109.076 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.5 m -63.95 96.55 0.14 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.389 1.076 . . . . 0.0 110.033 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.62 -30.55 63.39 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.413 -0.804 . . . . 0.0 111.899 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -67.17 -28.04 67.78 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -90.1 -25.95 20.47 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.178 0.991 . . . . 0.0 112.247 176.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 12.6 mt -65.87 -47.92 73.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.573 1.149 . . . . 0.0 111.213 171.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -49.31 -40.21 34.18 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.374 1.07 . . . . 0.0 112.765 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -52.38 -24.27 7.4 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.447 1.499 . . . . 0.0 114.43 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -122.51 -1.53 9.06 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.698 1.599 . . . . 0.0 113.671 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 72.4 mt -118.39 -13.6 9.78 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.292 1.437 . . . . 0.0 113.692 -176.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp . . . . . 0 C--O 1.256 1.4 0 C-N-CA 125.721 1.609 . . . . 0.0 112.94 168.38 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.7 pttm . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 120.813 0.34 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -144.43 166.99 23.54 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.17 0.988 . . . . 0.0 110.724 171.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -134.93 135.48 41.56 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.713 0.405 . . . . 0.0 110.896 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.72 162.94 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.694 1.598 . . . . 0.0 111.457 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -64.32 159.3 21.32 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.258 1.023 . . . . 0.0 112.499 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.0 tp -153.26 136.94 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.891 1.276 . . . . 0.0 109.632 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -130.24 156.49 44.54 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.815 2.046 . . . . 0.0 108.952 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -128.78 159.52 35.46 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.527 1.131 . . . . 0.0 111.914 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.58 117.04 23.48 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.93 0.492 . . . . 0.0 110.568 173.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -71.8 -179.96 2.89 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.309 0.644 . . . . 0.0 112.298 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -56.14 -26.87 51.98 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.64 1.576 . . . . 0.0 113.424 172.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.1 m -80.07 0.59 31.27 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.668 1.587 . . . . 0.0 114.148 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.44 34.08 87.04 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.657 1.122 . . . . 0.0 114.411 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -123.49 143.2 50.32 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.75 1.62 . . . . 0.0 109.744 177.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -67.33 126.62 29.83 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.967 0.907 . . . . 0.0 110.834 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -136.72 142.05 43.08 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.437 1.495 . . . . 0.0 110.18 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -57.55 140.19 51.49 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.1 tp -118.69 -48.59 2.47 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.828 0.851 . . . . 0.0 111.623 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.85 -119.83 0.86 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 123.261 0.458 . . . . 0.0 113.236 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -144.92 159.58 42.69 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.582 1.553 . . . . 0.0 110.284 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.5 tp -124.52 104.93 9.0 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.707 1.603 . . . . 0.0 110.131 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.2 t -78.76 99.43 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.073 1.349 . . . . 0.0 109.563 175.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.4 t -85.27 101.98 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.969 1.708 . . . . 0.0 110.239 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 . . . . . 0 N--CA 1.475 0.807 0 C-N-CA 125.901 1.68 . . . . 0.0 110.773 174.978 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.81 0 CA-C-O 121.432 0.462 . . . . 0.0 113.967 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.9 mt -122.83 141.72 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.003 0.921 . . . . 0.0 109.609 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -130.7 127.5 38.96 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.881 1.272 . . . . 0.0 109.609 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.0 p -121.44 148.54 44.28 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.7 -0.625 . . . . 0.0 111.526 -173.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.96 124.99 2.47 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 121.497 0.498 . . . . 0.0 113.081 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.77 135.44 53.97 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.029 1.731 . . . . 0.0 109.827 175.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.4 t30 . . . . . 0 CA--C 1.544 0.748 0 C-N-CA 126.086 1.755 . . . . 0.0 110.448 -177.038 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.728 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.6 m -55.37 132.0 47.11 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.257 -0.902 . . . . 0.0 110.529 169.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -99.83 -50.86 3.89 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.032 0.933 . . . . 0.0 110.26 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -163.42 159.92 22.83 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.894 0.878 . . . . 0.0 112.349 170.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.75 148.3 30.82 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 123.151 1.453 . . . . 0.0 112.873 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.449 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -136.18 157.85 45.82 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.046 1.338 . . . . 0.0 111.527 -171.833 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -78.49 167.5 21.19 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.29 0.567 . . . . 0.0 112.312 -174.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -56.74 -35.61 68.8 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.324 -0.86 . . . . 0.0 112.354 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -68.52 -5.05 17.37 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.846 1.259 . . . . 0.0 113.495 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 t -117.46 -5.22 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.247 1.019 . . . . 0.0 111.292 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.7 t -49.35 -63.81 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-N 120.455 1.479 . . . . 0.0 112.006 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -69.88 -28.85 65.98 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.801 -0.562 . . . . 0.0 112.138 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -63.05 -51.09 68.05 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.881 1.672 . . . . 0.0 110.899 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -59.93 -45.34 92.9 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 125.032 1.333 . . . . 0.0 110.522 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 37.4 t -59.24 -39.87 79.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.062 0.545 . . . . 0.0 110.523 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -59.28 -52.5 65.39 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.479 1.112 . . . . 0.0 112.183 174.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.29 -10.43 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 121.509 -0.744 . . . . 0.0 112.641 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.597 ' CG ' HD13 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -103.41 0.12 30.79 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.445 -1.41 . . . . 0.0 112.614 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.6 p -123.42 -12.62 7.74 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.236 1.015 . . . . 0.0 112.77 169.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -137.8 -14.36 1.42 Allowed 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.23 155.74 26.85 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.111 1.339 . . . . 0.0 113.954 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.09 -169.58 32.59 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.712 1.148 . . . . 0.0 113.829 -174.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.8 p -145.25 100.71 3.51 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.213 1.405 . . . . 0.0 113.34 -168.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -129.99 146.85 51.69 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.83 1.652 . . . . 0.0 110.037 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -74.95 157.52 34.84 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.466 -0.771 . . . . 0.0 111.021 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.7 p -121.66 147.65 45.6 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.28 1.432 . . . . 0.0 110.812 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.449 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 7.6 t -60.79 -43.6 97.9 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.686 0.794 . . . . 0.0 111.407 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mt -150.27 142.4 24.06 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.454 1.502 . . . . 0.0 112.251 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -134.02 106.04 7.03 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.078 0.951 . . . . 0.0 110.14 174.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -90.45 -47.77 7.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.297 1.039 . . . . 0.0 112.571 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.32 175.46 30.09 Favored Glycine 0 CA--C 1.544 1.847 0 C-N-CA 125.679 1.609 . . . . 0.0 114.595 -170.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 49.7 t80 . . . . . 0 CA--C 1.551 1.006 0 C-N-CA 124.722 1.209 . . . . 0.0 112.568 169.783 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.456 0 N-CA-C 112.689 -0.165 . . . . 0.0 112.689 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.4 mt -110.63 115.11 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.785 1.234 . . . . 0.0 108.76 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -73.97 148.49 42.06 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.109 0.481 . . . . 0.0 111.873 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 57.43 22.35 7.86 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.224 1.81 . . . . 0.0 114.277 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -63.71 126.2 26.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.009 1.323 . . . . 0.0 111.682 -171.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -75.88 121.39 22.57 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.609 1.164 . . . . 0.0 111.907 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.7 mm -114.8 112.07 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.296 1.039 . . . . 0.0 109.537 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -105.94 104.34 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.899 1.28 . . . . 0.0 108.387 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 47.6 p -89.8 156.89 18.19 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.456 1.102 . . . . 0.0 112.006 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.4 137.74 16.65 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.093 1.357 . . . . 0.0 111.586 175.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.7 mt -77.99 132.93 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.141 0.577 . . . . 0.0 109.684 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 . . . . . 0 CA--C 1.539 0.544 0 C-N-CA 125.435 1.494 . . . . 0.0 110.976 171.326 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 121.053 0.454 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -111.3 167.83 9.99 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.939 1.295 . . . . 0.0 110.743 173.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 tp -124.75 131.46 72.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.599 1.56 . . . . 0.0 108.395 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.8 p -118.82 154.47 32.81 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.677 0.791 . . . . 0.0 110.124 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -152.83 145.07 23.92 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.431 0.692 . . . . 0.0 112.155 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.6 m -82.32 111.03 18.01 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.539 1.136 . . . . 0.0 110.443 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.17 -155.61 19.59 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.374 1.464 . . . . 0.0 113.302 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.49 170.42 2.45 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 169.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -94.9 102.16 13.99 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.596 0.758 . . . . 0.0 111.13 173.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.73 0 C-N-CA 123.924 0.89 . . . . 0.0 112.163 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.468 0.448 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.92 116.61 5.44 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 169.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -118.19 149.19 41.49 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 122.362 1.077 . . . . 0.0 110.297 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -137.97 174.84 10.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.106 -1.406 . . . . 0.0 111.9 -169.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.61 130.06 16.79 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.81 0.844 . . . . 0.0 109.791 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.45 ' CG2' HD11 ' A' ' 166' ' ' LEU . 69.8 mt -121.9 138.99 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.192 0.997 . . . . 0.0 108.807 176.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -63.82 95.89 0.12 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.744 0.818 . . . . 0.0 109.7 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.602 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.3 tt -53.98 -31.27 50.3 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.876 1.27 . . . . 0.0 111.879 175.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -69.38 -28.09 65.87 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -86.77 -26.7 24.03 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.165 0.986 . . . . 0.0 112.522 175.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 163' ' ' LEU . 27.9 mt -62.9 -53.04 60.23 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.412 1.085 . . . . 0.0 109.796 169.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -46.53 -37.69 8.3 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt . . . . . 0 N--CA 1.485 1.299 0 C-N-CA 125.033 1.333 . . . . 0.0 114.149 177.028 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 121.622 0.725 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -135.44 175.53 9.5 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.966 1.306 . . . . 0.0 110.523 171.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -141.19 145.17 35.31 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.411 -0.805 . . . . 0.0 111.172 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.4 m -139.88 152.48 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.782 0.833 . . . . 0.0 112.341 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -56.63 139.5 49.92 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.666 1.187 . . . . 0.0 110.782 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.8 tp -137.53 136.32 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.798 1.239 . . . . 0.0 109.278 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -131.15 158.61 40.0 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.485 1.914 . . . . 0.0 108.826 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -130.37 161.4 31.41 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.423 1.089 . . . . 0.0 111.707 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.38 122.52 31.97 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.186 0.594 . . . . 0.0 111.026 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.22 -176.98 5.88 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 176.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -58.07 -24.48 58.71 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.441 1.896 . . . . 0.0 114.145 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.0 m -88.12 2.64 51.57 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.394 1.078 . . . . 0.0 113.386 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.5 35.48 91.99 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.698 1.142 . . . . 0.0 113.882 -176.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -114.51 143.4 45.02 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.374 1.47 . . . . 0.0 110.392 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -73.26 119.93 18.17 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.269 0.628 . . . . 0.0 110.622 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -129.14 135.3 48.68 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.77 1.628 . . . . 0.0 109.69 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -57.39 142.18 44.68 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.1 tp -117.33 -48.01 2.63 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.777 0.831 . . . . 0.0 111.4 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.84 -109.89 0.37 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.29 0.471 . . . . 0.0 113.698 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -149.72 156.84 42.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.222 1.809 . . . . 0.0 109.819 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 tp -122.46 102.29 8.0 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.593 1.157 . . . . 0.0 110.124 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.3 t -75.76 101.62 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.56 0.744 . . . . 0.0 109.263 176.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.0 94.25 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.731 1.612 . . . . 0.0 109.159 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 47.9 mtp85 . . . . . 0 N--CA 1.473 0.72 0 C-N-CA 125.258 1.423 . . . . 0.0 110.458 172.555 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.949 0 CA-C-O 121.457 0.476 . . . . 0.0 113.469 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.5 mt -128.18 143.13 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.769 0.828 . . . . 0.0 110.168 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -131.71 125.58 32.38 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.422 1.089 . . . . 0.0 110.703 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.2 p -116.56 146.01 42.94 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.617 -0.677 . . . . 0.0 111.813 -174.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -139.99 123.67 2.5 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 123.278 0.466 . . . . 0.0 112.083 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.33 137.19 54.44 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.24 1.416 . . . . 0.0 110.179 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.0 t30 . . . . . 0 CA--C 1.543 0.675 0 C-N-CA 127.182 2.193 . . . . 0.0 109.48 179.564 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.739 0 CA-C-O 120.478 0.18 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.7 m -56.51 131.35 48.36 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 121.212 -0.93 . . . . 0.0 109.191 168.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -98.0 -49.65 4.69 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.503 0.592 . . . . 0.0 110.142 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -167.35 159.09 12.24 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.867 0.867 . . . . 0.0 112.503 170.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.36 149.5 32.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 122.961 1.362 . . . . 0.0 112.525 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.427 ' HA ' ' H ' ' A' ' 109' ' ' SER . 2.4 pp -141.04 156.12 46.06 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.363 1.465 . . . . 0.0 110.836 -170.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -83.2 167.81 17.37 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.287 0.635 . . . . 0.0 112.111 -172.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -55.67 -32.0 62.86 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.022 -1.049 . . . . 0.0 112.535 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -66.4 -6.13 13.32 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.25 1.42 . . . . 0.0 114.022 174.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.88 -3.17 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 119.451 1.023 . . . . 0.0 111.555 -175.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.517 ' O ' HG23 ' A' ' 97' ' ' VAL . 71.3 t -52.6 -64.53 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 120.314 1.415 . . . . 0.0 111.524 -177.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -68.38 -27.24 66.06 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.317 0.647 . . . . 0.0 112.237 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.06 -54.2 41.87 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.413 1.485 . . . . 0.0 110.43 174.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -60.58 -46.13 91.36 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 125.135 1.374 . . . . 0.0 111.373 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 93' ' ' VAL . 87.8 t -54.46 -34.84 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.011 0.925 . . . . 0.0 110.72 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -72.69 -53.96 10.3 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.117 1.367 . . . . 0.0 113.539 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 m -68.86 -16.65 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 120.813 -1.179 . . . . 0.0 112.374 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.653 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -86.37 -4.55 59.19 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.247 1.819 . . . . 0.0 111.971 176.736 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 51.0 p -130.96 -15.76 3.33 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.34 -10.63 4.13 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.1 1.76 . . . . 0.0 113.668 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.01 156.68 7.58 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.459 1.504 . . . . 0.0 113.642 -173.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 156.33 -170.61 33.96 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.379 0.99 . . . . 0.0 113.712 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 93.7 p -146.05 95.36 2.61 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.608 1.163 . . . . 0.0 113.229 -168.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -125.97 141.13 52.11 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.751 1.62 . . . . 0.0 109.737 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -69.09 156.8 38.05 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.708 -0.62 . . . . 0.0 110.569 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.4 p -120.53 156.61 31.2 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.302 1.441 . . . . 0.0 110.804 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.427 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 7.9 t -70.11 -44.54 68.78 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.004 0.521 . . . . 0.0 111.169 -178.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.6 mt -148.29 140.32 24.01 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.566 1.546 . . . . 0.0 111.352 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -134.92 103.41 5.58 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.934 0.894 . . . . 0.0 110.39 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -89.84 -44.32 10.02 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.195 0.998 . . . . 0.0 113.36 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.02 -179.94 12.81 Favored Glycine 0 CA--C 1.543 1.808 0 C-N-CA 124.986 1.279 . . . . 0.0 114.307 -169.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 67.1 t80 . . . . . 0 CA--C 1.551 1.008 0 O-C-N 121.603 -0.94 . . . . 0.0 112.03 169.407 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.275 0 CA-C-O 121.59 0.55 . . . . 0.0 112.934 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.1 mt -126.3 108.13 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.962 1.305 . . . . 0.0 109.192 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -63.98 141.26 58.83 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.7 0.8 . . . . 0.0 112.006 172.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 58.29 22.67 9.57 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.719 1.608 . . . . 0.0 114.456 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 19.0 tptp -55.21 122.94 12.17 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.352 1.061 . . . . 0.0 111.52 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -69.73 129.81 40.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.228 1.011 . . . . 0.0 110.22 169.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.7 mm -127.28 119.75 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.197 0.999 . . . . 0.0 108.661 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mp -113.13 96.45 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 125.053 1.341 . . . . 0.0 108.311 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.9 p -77.44 153.99 33.04 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.835 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -150.61 137.83 19.42 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.857 1.263 . . . . 0.0 111.115 175.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.8 mt -81.85 131.54 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 . . . . . 0 CA--C 1.537 0.474 0 C-N-CA 125.434 1.493 . . . . 0.0 110.644 173.991 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 CA--C 1.538 0.504 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -107.59 166.13 10.9 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.991 1.316 . . . . 0.0 110.367 170.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.6 tp -119.9 133.68 65.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 125.15 1.38 . . . . 0.0 108.341 170.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.0 p -121.9 155.5 35.33 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.45 0.7 . . . . 0.0 109.909 175.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -148.11 140.85 24.64 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.889 0.875 . . . . 0.0 110.925 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.5 m -79.48 110.12 14.49 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.713 0.805 . . . . 0.0 110.197 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.02 -162.17 27.85 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.214 1.388 . . . . 0.0 112.535 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -68.26 162.88 24.09 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.641 -0.917 . . . . 0.0 112.874 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -76.26 108.19 9.03 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.293 1.037 . . . . 0.0 111.185 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.856 0 C-N-CA 124.283 1.033 . . . . 0.0 112.612 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 10.8 m . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.01 114.46 3.71 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -117.5 138.85 51.6 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.309 1.052 . . . . 0.0 109.898 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -134.68 169.6 17.08 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.416 1.486 . . . . 0.0 111.199 -169.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.03 131.58 19.83 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.4 0.68 . . . . 0.0 109.909 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.425 ' CG2' HD11 ' A' ' 166' ' ' LEU . 59.0 mt -124.78 138.26 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.072 0.949 . . . . 0.0 108.739 177.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.2 m -63.71 94.82 0.1 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.224 1.01 . . . . 0.0 109.649 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.592 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.4 tt -55.03 -32.2 61.68 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.325 1.05 . . . . 0.0 111.849 176.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -68.48 -29.59 68.25 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 176.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -84.19 -31.37 25.14 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.906 0.882 . . . . 0.0 112.095 174.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.653 HD13 ' HG3' ' A' ' 100' ' ' MET . 17.9 mt -57.63 -49.5 76.23 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.012 0.925 . . . . 0.0 110.953 173.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -50.01 -40.79 45.7 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.443 1.097 . . . . 0.0 113.448 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 60.9 mttm . . . . . 0 N--CA 1.48 1.026 0 C-N-CA 125.43 1.492 . . . . 0.0 114.259 -178.336 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.9 pttt . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 110.788 -0.079 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -143.06 168.14 20.44 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.949 0.9 . . . . 0.0 111.118 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -133.97 131.98 39.62 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.645 0.378 . . . . 0.0 111.229 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.5 162.01 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.959 1.704 . . . . 0.0 111.229 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -62.15 159.03 15.5 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.13 0.972 . . . . 0.0 111.776 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.9 tp -153.98 136.43 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.45 1.1 . . . . 0.0 109.876 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -128.82 159.49 35.56 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.105 1.762 . . . . 0.0 109.26 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -130.53 153.8 48.46 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.687 1.195 . . . . 0.0 111.03 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -81.47 119.18 23.4 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 122.152 -0.343 . . . . 0.0 110.505 174.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -71.67 -178.84 2.37 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.563 0.745 . . . . 0.0 112.752 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -54.77 -30.7 57.38 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.702 1.201 . . . . 0.0 113.552 174.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.7 m -81.09 -0.87 41.93 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.071 0.949 . . . . 0.0 113.515 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.99 29.95 73.83 Favored Glycine 0 CA--C 1.536 1.37 0 O-C-N 121.505 -0.747 . . . . 0.0 113.379 -173.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -111.3 135.46 51.81 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.415 1.486 . . . . 0.0 110.043 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -69.01 124.73 24.54 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.031 0.932 . . . . 0.0 110.8 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.2 t -137.89 137.48 38.1 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.782 1.233 . . . . 0.0 110.787 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -56.04 130.75 45.26 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.965 1.306 . . . . 0.0 112.027 -173.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.0 tp -106.54 -47.35 3.79 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.233 0.613 . . . . 0.0 111.521 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.03 -115.83 0.62 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.247 0.451 . . . . 0.0 113.267 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -146.48 157.13 43.71 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.218 1.407 . . . . 0.0 110.087 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.5 tp -121.51 102.72 8.43 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.284 1.434 . . . . 0.0 110.342 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.6 t -78.19 95.13 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.185 1.394 . . . . 0.0 109.07 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.7 t -81.84 99.48 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.735 1.614 . . . . 0.0 109.582 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.2 mtt-85 . . . . . 0 N--CA 1.479 1.001 0 C-N-CA 125.007 1.323 . . . . 0.0 111.808 177.395 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.086 0 N-CA-C 115.337 0.895 . . . . 0.0 115.337 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.6 mt -119.3 137.34 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.233 1.013 . . . . 0.0 109.797 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.26 104.05 6.01 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.271 1.828 . . . . 0.0 109.364 -171.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.9 p -98.07 156.14 16.79 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.32 -1.488 . . . . 0.0 111.455 -173.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.52 122.98 1.79 Allowed Glycine 0 CA--C 1.526 0.726 0 O-C-N 121.271 -0.893 . . . . 0.0 112.16 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.87 138.39 50.16 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.002 1.721 . . . . 0.0 110.403 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.6 t30 . . . . . 0 CA--C 1.546 0.809 0 C-N-CA 125.808 1.643 . . . . 0.0 110.482 -178.632 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.4 m -55.36 127.17 28.22 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.427 -0.795 . . . . 0.0 110.132 170.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -95.09 -48.33 6.0 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.096 0.407 . . . . 0.0 110.644 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -162.9 168.67 20.89 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 122.201 1.001 . . . . 0.0 113.162 170.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.84 139.49 18.81 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.316 -0.865 . . . . 0.0 112.381 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.481 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -129.45 156.13 44.6 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.848 1.659 . . . . 0.0 111.187 -176.789 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -77.48 167.46 21.61 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.433 0.635 . . . . 0.0 112.363 -174.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -55.41 -36.33 66.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.105 0.962 . . . . 0.0 112.394 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -69.4 -2.92 12.27 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.758 1.223 . . . . 0.0 114.1 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.3 t -119.59 -5.66 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 119.56 1.073 . . . . 0.0 111.453 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.4 t -48.96 -65.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 125.279 1.432 . . . . 0.0 111.85 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -68.45 -27.02 65.81 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.497 -0.752 . . . . 0.0 112.632 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -52.04 65.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.435 1.494 . . . . 0.0 110.596 175.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -60.83 -45.84 92.92 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 124.586 1.154 . . . . 0.0 111.617 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 87.6 t -56.29 -34.16 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.432 0.693 . . . . 0.0 111.25 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -66.98 -57.75 6.27 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.01 0.924 . . . . 0.0 112.278 174.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 m -69.8 -22.19 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 O-C-N 120.821 -1.175 . . . . 0.0 112.551 -175.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.648 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -78.61 -6.64 56.15 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.933 1.693 . . . . 0.0 111.88 175.108 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 81.7 p -131.4 -12.26 3.52 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -137.45 -6.03 1.78 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.668 1.587 . . . . 0.0 113.771 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.07 156.29 5.3 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 126.04 1.781 . . . . 0.0 113.843 -175.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.99 -171.37 33.27 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.165 0.888 . . . . 0.0 113.12 -174.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 85.1 p -145.1 104.04 3.92 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.507 1.123 . . . . 0.0 113.366 -168.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -134.29 143.77 47.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.179 1.792 . . . . 0.0 110.277 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -71.64 162.66 29.1 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.374 -0.829 . . . . 0.0 112.106 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.2 p -129.56 144.79 51.42 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.456 1.503 . . . . 0.0 111.023 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.481 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 6.7 t -59.07 -43.75 91.79 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.354 1.462 . . . . 0.0 112.534 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.0 mt -155.73 134.41 11.85 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.829 1.652 . . . . 0.0 111.296 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -129.54 102.1 6.23 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.643 1.177 . . . . 0.0 110.696 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -90.38 -41.81 11.28 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.613 1.165 . . . . 0.0 113.965 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 58.15 -173.53 2.97 Favored Glycine 0 CA--C 1.547 2.058 0 C-N-CA 126.222 1.867 . . . . 0.0 115.465 -169.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 19.8 t80 . . . . . 0 N--CA 1.476 0.85 0 C-N-CA 124.509 1.124 . . . . 0.0 113.966 177.254 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.434 0 CA-C-O 121.749 0.638 . . . . 0.0 113.646 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.4 mt -119.41 115.53 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.6 1.56 . . . . 0.0 108.152 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -72.96 144.39 47.29 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.097 0.475 . . . . 0.0 111.55 173.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 58.41 24.89 12.25 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 125.754 1.622 . . . . 0.0 114.042 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -62.72 122.81 16.81 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.698 1.199 . . . . 0.0 111.817 -173.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -73.22 124.16 25.1 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.322 1.049 . . . . 0.0 111.428 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.7 mm -118.3 117.79 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.809 1.244 . . . . 0.0 108.882 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.8 mp -110.09 103.37 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 124.984 1.313 . . . . 0.0 108.231 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 59.1 p -85.08 153.14 22.9 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.805 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.17 136.67 20.23 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.163 1.385 . . . . 0.0 111.15 176.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 17.3 mt -81.09 131.67 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 . . . . . 0 N--CA 1.466 0.372 0 C-N-CA 125.793 1.637 . . . . 0.0 110.109 175.37 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -107.69 165.16 11.64 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.416 1.486 . . . . 0.0 110.522 174.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.8 tp -122.21 132.22 71.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 125.327 1.451 . . . . 0.0 107.848 172.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 p -119.47 156.59 29.94 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.188 0.595 . . . . 0.0 109.794 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -152.03 141.51 21.64 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.103 0.961 . . . . 0.0 111.297 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.2 m -78.7 114.38 17.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.478 1.111 . . . . 0.0 110.484 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.33 -167.26 43.13 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.308 0.956 . . . . 0.0 112.876 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -68.08 171.47 6.87 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.749 -0.853 . . . . 0.0 112.62 168.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -81.05 136.26 35.94 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.243 -0.911 . . . . 0.0 112.114 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.779 0 C-N-CA 123.815 0.846 . . . . 0.0 112.729 171.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.09 117.16 11.31 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -106.1 148.81 27.38 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 122.009 0.909 . . . . 0.0 109.743 171.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -132.8 172.42 12.6 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.122 1.369 . . . . 0.0 111.491 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.86 133.09 23.08 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.518 0.727 . . . . 0.0 110.156 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.409 ' CG2' HD11 ' A' ' 166' ' ' LEU . 64.0 mt -126.47 138.66 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.133 0.973 . . . . 0.0 108.918 175.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.4 m -64.54 97.39 0.2 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.362 -0.836 . . . . 0.0 110.225 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.5 tt -54.16 -31.03 51.44 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.111 1.364 . . . . 0.0 112.179 175.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -72.73 -26.03 61.43 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -89.43 -26.03 21.19 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.972 -1.08 . . . . 0.0 112.053 173.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.648 HD13 ' HG3' ' A' ' 100' ' ' MET . 14.5 mt -61.49 -46.55 89.52 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.849 0.86 . . . . 0.0 110.813 172.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -55.18 -36.93 66.4 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 177.825 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.9 pttt . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 121.069 0.461 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -144.3 169.39 17.99 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.553 1.141 . . . . 0.0 110.587 170.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -132.6 129.35 38.83 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.742 -0.599 . . . . 0.0 110.17 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.35 167.99 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.196 1.399 . . . . 0.0 110.896 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.34 164.22 7.47 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.639 1.176 . . . . 0.0 111.428 175.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.6 tp -158.72 137.26 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.774 1.229 . . . . 0.0 109.558 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -127.82 162.63 26.22 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.417 1.887 . . . . 0.0 110.073 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -132.12 156.69 45.92 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.304 1.441 . . . . 0.0 111.232 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.51 121.27 24.37 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 171.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -63.88 174.6 1.41 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.065 0.946 . . . . 0.0 111.992 171.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -57.58 -14.79 5.81 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.343 1.857 . . . . 0.0 114.857 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.2 m -115.56 14.16 16.51 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.885 1.274 . . . . 0.0 112.872 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.04 21.07 78.95 Favored Glycine 0 CA--C 1.537 1.438 0 O-C-N 121.335 -0.853 . . . . 0.0 114.393 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -96.59 125.79 41.31 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.68 1.192 . . . . 0.0 109.649 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -66.87 126.14 28.15 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.898 -0.501 . . . . 0.0 110.873 174.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.2 t -140.75 136.02 32.11 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.715 1.206 . . . . 0.0 110.81 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -55.7 131.57 46.9 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.771 1.229 . . . . 0.0 112.354 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 38.8 tp -104.87 -47.73 3.95 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.985 0.914 . . . . 0.0 111.279 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.75 -118.96 0.78 Allowed Glycine 0 CA--C 1.529 0.963 0 N-CA-C 113.978 0.351 . . . . 0.0 113.978 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -141.16 151.73 44.11 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.356 1.462 . . . . 0.0 110.366 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.4 tp -116.96 101.45 8.52 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.409 1.484 . . . . 0.0 109.878 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.1 t -77.45 97.46 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.098 1.359 . . . . 0.0 109.336 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.3 t -84.3 84.42 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.614 1.566 . . . . 0.0 110.296 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 . . . . . 0 N--CA 1.478 0.938 0 C-N-CA 123.795 0.838 . . . . 0.0 110.406 170.319 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.115 0 N-CA-C 114.051 0.38 . . . . 0.0 114.051 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.445 HD11 HG13 ' A' ' 93' ' ' VAL . 45.1 mt -119.71 142.95 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.938 0.895 . . . . 0.0 109.431 169.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -132.72 92.43 3.05 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.331 1.453 . . . . 0.0 110.573 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.8 p -84.54 150.36 25.28 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.24 -0.912 . . . . 0.0 112.508 -174.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.73 120.01 1.57 Allowed Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.42 -0.8 . . . . 0.0 113.791 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -70.88 139.92 50.93 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.53 1.932 . . . . 0.0 110.588 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 . . . . . 0 CA--C 1.543 0.696 0 C-N-CA 126.193 1.797 . . . . 0.0 110.708 -178.775 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.879 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.3 m -54.05 124.42 15.52 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.3 1.04 . . . . 0.0 110.791 171.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -92.07 -52.64 4.61 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.883 0.473 . . . . 0.0 110.426 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -163.92 153.05 13.97 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.871 0.868 . . . . 0.0 112.691 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.56 128.11 21.46 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 122.75 1.262 . . . . 0.0 112.553 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.96 163.79 16.04 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.13 1.772 . . . . 0.0 111.38 -173.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -79.72 162.05 25.41 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.404 1.082 . . . . 0.0 112.436 -175.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -55.44 -33.05 63.24 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.319 1.047 . . . . 0.0 113.055 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -70.33 -8.38 50.02 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 37.5 t -114.29 -14.56 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 121.3 -0.875 . . . . 0.0 112.028 -171.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.55 ' O ' HG23 ' A' ' 97' ' ' VAL . 42.2 t -48.15 -55.81 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.502 1.121 . . . . 0.0 111.372 177.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -65.41 -32.87 74.72 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -69.8 -43.63 71.71 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.029 0.932 . . . . 0.0 111.343 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -58.83 -46.88 86.64 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.632 1.173 . . . . 0.0 110.736 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 93' ' ' VAL . 92.6 t -53.94 -37.51 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.395 1.078 . . . . 0.0 111.377 175.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.87 -57.38 4.67 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.5 1.52 . . . . 0.0 112.656 176.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -71.91 -7.5 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 O-C-N 121.212 -0.93 . . . . 0.0 113.125 -175.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.408 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -94.58 -5.69 45.26 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.01 1.724 . . . . 0.0 111.932 176.635 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 47.4 p -128.89 -14.85 4.41 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.909 0.883 . . . . 0.0 112.958 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -131.97 -9.73 3.44 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.617 1.567 . . . . 0.0 114.593 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.63 157.14 7.51 Favored Glycine 0 CA--C 1.539 1.574 0 C-N-CA 125.294 1.426 . . . . 0.0 113.76 -173.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.52 -153.62 24.66 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 121.543 -0.975 . . . . 0.0 113.175 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 80.1 p -145.52 151.98 39.02 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.18 0.992 . . . . 0.0 113.148 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -148.27 -177.69 5.9 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.55 1.94 . . . . 0.0 112.177 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? -117.41 156.16 28.4 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.937 1.295 . . . . 0.0 111.657 170.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.9 p -126.17 130.81 51.73 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.977 0.911 . . . . 0.0 111.892 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.9 t -51.9 -37.55 52.85 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.409 1.084 . . . . 0.0 112.995 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.0 mt -147.62 141.31 25.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.233 1.413 . . . . 0.0 112.364 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -136.35 93.55 2.91 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.525 1.13 . . . . 0.0 110.643 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -81.7 -49.06 10.9 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.829 0.851 . . . . 0.0 113.121 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.21 177.42 43.2 Favored Glycine 0 CA--C 1.543 1.816 0 C-N-CA 125.06 1.314 . . . . 0.0 113.874 -169.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 44.9 t80 . . . . . 0 CA--C 1.551 0.986 0 C-N-CA 124.085 0.954 . . . . 0.0 112.253 170.382 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.626 0 CA-C-O 121.317 0.399 . . . . 0.0 114.055 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 52.7 mt -123.39 120.44 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 126.095 1.758 . . . . 0.0 108.866 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -82.31 145.01 30.2 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 57.79 24.49 10.81 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.478 1.911 . . . . 0.0 113.938 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -60.34 125.74 24.82 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.856 1.262 . . . . 0.0 111.363 -173.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -76.61 126.61 31.29 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.845 0.458 . . . . 0.0 110.925 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.3 mm -119.95 120.59 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 126.094 1.758 . . . . 0.0 109.065 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.1 mp -115.06 105.93 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.233 1.413 . . . . 0.0 108.231 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.8 p -80.97 161.63 24.21 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.777 0.799 . . . . 0.0 112.203 174.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -152.15 142.22 22.24 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.91 1.284 . . . . 0.0 110.77 171.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 52.4 mt -82.61 132.14 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 . . . . . 0 N--CA 1.467 0.388 0 C-N-CA 125.303 1.441 . . . . 0.0 110.273 174.28 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 . . . . . 0 CA--C 1.538 0.514 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -107.93 165.9 11.11 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.821 1.248 . . . . 0.0 110.055 170.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.9 tp -117.0 137.28 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.332 1.453 . . . . 0.0 107.922 169.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 p -124.88 156.87 37.21 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.571 0.623 . . . . 0.0 110.098 172.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -149.63 135.89 19.02 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.988 0.915 . . . . 0.0 111.158 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.2 t -70.61 127.89 34.22 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.065 0.46 . . . . 0.0 110.381 172.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.59 -154.25 26.06 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.816 1.674 . . . . 0.0 112.044 175.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -69.07 169.33 12.07 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 121.936 0.874 . . . . 0.0 112.352 169.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -87.98 112.07 22.19 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.451 1.5 . . . . 0.0 111.528 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.414 ' CG2' ' HB2' ' A' ' 157' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.477 0.892 0 C-N-CA 123.628 0.771 . . . . 0.0 112.009 177.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.414 ' HB2' ' CG2' ' A' ' 149' ' ' ILE . . . -65.94 104.28 1.08 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 171.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -104.53 145.7 29.92 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.523 1.154 . . . . 0.0 110.86 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -134.47 167.15 21.29 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.679 1.591 . . . . 0.0 110.719 -169.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.02 134.93 26.87 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.346 0.521 . . . . 0.0 110.349 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.501 ' CG2' HD11 ' A' ' 166' ' ' LEU . 51.3 mt -129.67 139.89 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.802 0.841 . . . . 0.0 109.334 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.7 m -63.73 95.46 0.11 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.018 0.927 . . . . 0.0 109.848 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.444 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.0 OUTLIER -53.07 -33.32 51.55 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.602 1.161 . . . . 0.0 111.516 175.459 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -67.56 -27.49 66.98 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -86.73 -31.53 20.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.991 0.916 . . . . 0.0 111.949 172.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.501 HD11 ' CG2' ' A' ' 161' ' ' ILE . 18.9 mt -62.1 -44.1 97.4 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.847 0.859 . . . . 0.0 111.264 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -50.5 -41.8 53.9 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.31 1.044 . . . . 0.0 112.84 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 81.1 mttt . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.92 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.1 pttp . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 120.919 0.39 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -145.89 165.69 28.18 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.769 1.228 . . . . 0.0 110.495 173.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -131.76 125.79 32.82 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.596 0.358 . . . . 0.0 110.464 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.9 m -118.79 165.96 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.021 1.329 . . . . 0.0 110.927 177.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -68.06 161.79 26.01 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.544 1.138 . . . . 0.0 110.995 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.2 tp -153.37 136.29 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.436 1.095 . . . . 0.0 109.667 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -127.21 161.3 28.86 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.197 1.799 . . . . 0.0 109.741 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -132.01 154.37 49.43 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 126.098 1.759 . . . . 0.0 110.749 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -76.09 124.74 27.89 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 169.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -67.43 175.68 2.67 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 122.241 1.019 . . . . 0.0 111.327 170.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -59.81 -11.73 5.92 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.234 2.213 . . . . 0.0 114.778 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.8 t -116.51 12.93 15.26 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.111 1.364 . . . . 0.0 112.821 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.31 19.71 79.38 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 121.312 -0.867 . . . . 0.0 114.615 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -95.59 129.38 42.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.778 1.231 . . . . 0.0 109.477 176.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -68.98 127.75 34.25 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.637 -0.664 . . . . 0.0 110.567 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.7 t -138.86 147.04 41.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.878 1.671 . . . . 0.0 110.241 -175.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -66.49 137.38 56.77 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.051 -1.031 . . . . 0.0 111.626 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.8 tp -110.83 -46.9 3.29 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.876 0.87 . . . . 0.0 112.291 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.27 -133.31 2.39 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 121.703 0.613 . . . . 0.0 114.612 -174.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -132.65 155.91 47.9 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.511 1.924 . . . . 0.0 110.953 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.8 tp -122.96 104.27 9.14 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.275 1.43 . . . . 0.0 110.539 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.4 t -81.57 97.48 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.48 1.512 . . . . 0.0 109.462 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.03 117.47 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.914 1.286 . . . . 0.0 109.671 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 . . . . . 0 N--CA 1.475 0.822 0 C-N-CA 126.925 2.09 . . . . 0.0 110.535 -179.342 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.838 0 N-CA-C 113.964 0.346 . . . . 0.0 113.964 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 68.5 mt -122.1 136.84 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.928 0.891 . . . . 0.0 109.52 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.65 142.82 47.29 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.15 1.38 . . . . 0.0 109.253 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.1 p -133.54 139.85 46.85 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.277 0.631 . . . . 0.0 110.016 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.61 107.83 0.65 Allowed Glycine 0 CA--C 1.521 0.421 0 CA-C-O 121.843 0.69 . . . . 0.0 111.61 -169.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 33.1 tp -64.09 144.56 57.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.616 1.166 . . . . 0.0 110.174 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 . . . . . 0 CA--C 1.542 0.661 0 C-N-CA 126.917 2.087 . . . . 0.0 109.294 179.144 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.7 m -58.82 118.34 5.63 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.024 -1.047 . . . . 0.0 109.313 169.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -82.22 -48.45 11.26 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.001 -0.437 . . . . 0.0 109.949 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -164.82 161.4 20.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.836 0.855 . . . . 0.0 113.074 170.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.87 149.41 33.2 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.985 1.374 . . . . 0.0 113.08 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.424 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.5 OUTLIER -135.92 160.31 38.99 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.31 1.444 . . . . 0.0 111.715 -175.55 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -80.13 165.99 21.92 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.3 0.64 . . . . 0.0 112.387 -175.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -54.18 -34.85 61.49 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.136 0.975 . . . . 0.0 112.771 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -67.65 -4.58 12.43 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.578 1.151 . . . . 0.0 114.086 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.84 -3.57 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.336 1.054 . . . . 0.0 111.399 -175.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.9 t -51.21 -65.38 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.261 1.424 . . . . 0.0 111.352 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -69.11 -24.06 64.07 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -50.51 68.76 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.321 1.449 . . . . 0.0 110.438 172.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -61.43 -42.56 98.95 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 124.666 1.186 . . . . 0.0 111.798 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.5 t -56.04 -35.14 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.103 0.561 . . . . 0.0 110.882 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -69.94 -54.26 14.15 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.939 1.296 . . . . 0.0 112.949 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.0 m -74.34 -6.33 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 120.933 -1.104 . . . . 0.0 112.967 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.527 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -97.77 -4.85 36.18 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.028 1.731 . . . . 0.0 111.742 176.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 44.7 p -132.06 -17.5 2.73 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.733 1.213 . . . . 0.0 113.496 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -131.76 -11.13 3.46 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.15 1.78 . . . . 0.0 113.667 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.21 155.8 11.62 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.977 1.275 . . . . 0.0 113.738 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 164.12 -159.43 32.25 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 121.784 -0.833 . . . . 0.0 114.299 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.6 p -154.09 89.35 1.29 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -168.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -124.42 141.71 51.87 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.769 1.628 . . . . 0.0 110.528 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -69.87 162.62 27.6 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.462 0.705 . . . . 0.0 111.54 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.2 p -130.51 147.64 52.22 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.507 1.523 . . . . 0.0 111.391 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.424 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 5.1 t -65.27 -40.36 93.82 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.874 0.87 . . . . 0.0 111.858 -178.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.8 mt -150.73 137.71 19.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.686 1.594 . . . . 0.0 111.794 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -139.03 100.54 4.05 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.642 0.777 . . . . 0.0 110.868 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -94.95 -38.59 10.62 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.13 -169.78 16.58 Favored Glycine 0 CA--C 1.543 1.815 0 C-N-CA 125.032 1.301 . . . . 0.0 115.478 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 31.5 t80 . . . . . 0 CA--C 1.549 0.936 0 C-N-CA 124.169 0.988 . . . . 0.0 112.62 169.73 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.003 0 CA-C-O 121.626 0.57 . . . . 0.0 113.574 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.2 mt -140.83 101.66 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.036 1.335 . . . . 0.0 107.738 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -69.32 145.07 53.3 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.191 0.519 . . . . 0.0 111.32 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 60.38 20.79 10.37 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.673 1.589 . . . . 0.0 113.821 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -55.37 123.65 14.56 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.864 1.266 . . . . 0.0 111.161 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -71.58 127.62 33.16 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.832 0.853 . . . . 0.0 110.319 170.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.3 mm -123.01 117.69 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.687 1.195 . . . . 0.0 108.56 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.37 99.01 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 125.178 1.391 . . . . 0.0 107.8 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.7 p -81.55 157.06 24.92 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.726 0.774 . . . . 0.0 111.064 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -151.52 137.56 18.22 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.467 1.107 . . . . 0.0 110.808 176.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 52.4 mt -80.6 132.67 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 . . . . . 0 N--CA 1.466 0.333 0 C-N-CA 125.375 1.47 . . . . 0.0 110.314 175.156 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -107.02 166.18 10.8 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.154 1.382 . . . . 0.0 110.382 171.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.0 tp -118.08 137.87 50.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 125.414 1.485 . . . . 0.0 108.296 169.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.6 p -125.94 155.95 40.52 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.44 0.696 . . . . 0.0 110.024 174.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -150.51 137.47 19.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.167 0.987 . . . . 0.0 111.213 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.7 m -78.81 119.19 21.67 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.526 1.131 . . . . 0.0 110.691 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.4 -156.29 32.58 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.929 1.252 . . . . 0.0 113.256 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -66.51 161.78 22.17 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.253 1.021 . . . . 0.0 112.694 171.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -77.93 110.06 12.52 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.665 1.186 . . . . 0.0 110.506 173.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 121.21 0.528 . . . . 0.0 111.929 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.472 0.655 0 CA-C-O 120.845 0.355 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.83 130.22 43.89 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 168.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -128.0 143.73 51.09 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.571 1.177 . . . . 0.0 111.488 173.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -135.55 169.8 16.95 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 126.093 1.757 . . . . 0.0 111.069 -169.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.83 135.22 24.3 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 122.934 0.494 . . . . 0.0 110.248 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.457 ' CG2' HD11 ' A' ' 166' ' ' LEU . 63.2 mt -127.32 141.24 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 123.738 0.815 . . . . 0.0 108.98 175.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.8 m -62.2 94.74 0.06 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.204 1.002 . . . . 0.0 109.753 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.504 ' HA ' HD12 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -54.05 -32.93 56.01 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.904 0.882 . . . . 0.0 111.464 174.774 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -66.74 -30.62 70.89 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -82.57 -32.14 28.65 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.053 0.941 . . . . 0.0 111.851 173.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.527 HD13 ' HG3' ' A' ' 100' ' ' MET . 18.7 mt -60.39 -45.98 91.64 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.645 0.778 . . . . 0.0 111.39 175.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.431 ' HE3' HD21 ' A' ' 163' ' ' LEU . 77.0 mttt -51.29 -42.63 61.28 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 119.044 0.838 . . . . 0.0 112.833 175.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 86.8 mttt . . . . . 0 N--CA 1.484 1.23 0 C-N-CA 125.244 1.418 . . . . 0.0 113.996 -178.439 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.3 pttp . . . . . 0 N--CA 1.467 0.411 0 CA-C-O 121.287 0.565 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -140.95 166.6 24.33 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.935 1.294 . . . . 0.0 111.42 170.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 m -134.74 130.35 36.06 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.591 0.357 . . . . 0.0 110.744 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.1 m -128.24 165.27 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.795 1.638 . . . . 0.0 110.853 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -63.42 163.02 11.48 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.58 1.152 . . . . 0.0 111.736 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.3 tp -159.28 137.04 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.787 1.235 . . . . 0.0 110.044 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -129.06 162.62 27.25 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.043 2.137 . . . . 0.0 109.362 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -129.3 157.9 40.59 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.152 1.381 . . . . 0.0 111.116 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -78.83 119.96 22.78 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 169.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.89 172.47 1.7 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.51 1.124 . . . . 0.0 112.154 171.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -53.29 -18.02 2.17 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.199 1.8 . . . . 0.0 115.518 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.9 m -112.07 13.53 20.68 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.322 1.049 . . . . 0.0 113.16 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.54 20.67 79.49 Favored Glycine 0 CA--C 1.537 1.45 0 O-C-N 121.213 -0.93 . . . . 0.0 114.181 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -97.4 125.87 42.29 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.797 1.239 . . . . 0.0 109.703 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -67.09 126.22 28.5 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.772 -0.58 . . . . 0.0 110.628 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.3 t -141.16 140.1 34.01 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.834 1.254 . . . . 0.0 110.842 -174.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -56.77 135.03 55.47 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.229 1.012 . . . . 0.0 112.781 -175.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.6 tp -109.18 -48.39 3.27 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.695 0.798 . . . . 0.0 111.139 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.5 -113.14 0.51 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 123.137 0.399 . . . . 0.0 113.663 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -146.61 157.56 43.74 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.439 1.495 . . . . 0.0 109.949 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.1 tp -122.9 102.19 7.87 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.504 1.521 . . . . 0.0 110.022 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.67 95.58 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.636 1.574 . . . . 0.0 109.561 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.8 t -84.18 104.57 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.211 1.804 . . . . 0.0 110.252 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 . . . . . 0 N--CA 1.476 0.858 0 C-N-CA 127.098 2.159 . . . . 0.0 111.346 176.556 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.056 0 CA-C-O 122.056 0.809 . . . . 0.0 114.026 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.3 mt -111.76 140.32 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.12 0.968 . . . . 0.0 109.404 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -128.99 130.1 46.24 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.282 1.433 . . . . 0.0 109.6 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.2 p -119.79 148.51 43.35 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.375 -0.828 . . . . 0.0 111.198 -172.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.49 125.01 2.64 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-O 121.513 0.507 . . . . 0.0 112.788 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.8 138.2 52.48 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.077 1.751 . . . . 0.0 110.402 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.2 t30 . . . . . 0 CA--C 1.546 0.808 0 C-N-CA 126.119 1.768 . . . . 0.0 110.885 -176.254 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.695 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.5 m -54.89 130.76 42.45 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 121.382 -0.824 . . . . 0.0 110.612 170.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -97.5 -50.91 4.33 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.897 0.879 . . . . 0.0 110.175 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -163.86 158.45 19.94 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.883 0.873 . . . . 0.0 112.728 171.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.46 133.25 27.29 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 122.092 0.948 . . . . 0.0 111.943 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.442 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -108.3 160.38 15.9 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.108 1.363 . . . . 0.0 111.669 -178.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -76.95 165.4 24.72 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.91 0.862 . . . . 0.0 112.334 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -60.04 -26.6 66.25 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.021 0.928 . . . . 0.0 112.764 172.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -74.21 -3.96 33.02 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 172.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.1 t -117.91 -2.7 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.347 1.059 . . . . 0.0 110.883 -173.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.2 m -57.14 -29.33 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -176.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -98.96 -25.91 14.43 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.281 1.033 . . . . 0.0 111.851 171.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -71.27 -49.16 45.86 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.906 1.682 . . . . 0.0 111.6 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -59.68 -45.33 92.39 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.373 1.069 . . . . 0.0 110.918 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 73.3 t -55.67 -39.4 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.724 0.81 . . . . 0.0 110.367 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -60.58 -55.22 35.93 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.533 1.533 . . . . 0.0 112.224 174.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.0 m -70.9 -14.91 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 121.12 -0.987 . . . . 0.0 112.785 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.456 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -91.3 -4.6 55.71 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.274 1.83 . . . . 0.0 111.824 178.57 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.5 p -127.84 -15.56 4.85 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.63 1.172 . . . . 0.0 114.002 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -134.24 -9.8 2.58 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.272 1.429 . . . . 0.0 114.281 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.97 156.42 9.89 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.159 1.362 . . . . 0.0 113.825 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.03 -170.61 32.64 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.65 1.119 . . . . 0.0 113.524 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.503 ' HB3' HG23 ' A' ' 130' ' ' ILE . 56.7 p -144.36 103.81 4.01 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.756 1.222 . . . . 0.0 113.423 -168.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -133.81 156.54 47.85 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.145 1.778 . . . . 0.0 110.289 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 165.01 20.13 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.272 -0.892 . . . . 0.0 111.288 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.6 p -131.91 146.57 52.19 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.299 1.439 . . . . 0.0 111.273 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.442 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 9.4 t -54.88 -44.33 74.0 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.96 1.304 . . . . 0.0 112.084 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.5 mt -152.67 146.49 25.2 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.366 1.867 . . . . 0.0 110.942 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.431 ' CD2' HD11 ' A' ' 129' ' ' ILE . 39.6 t80 -139.72 111.38 7.25 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.27 0.628 . . . . 0.0 110.253 174.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -98.19 -39.56 8.81 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.129 1.372 . . . . 0.0 114.038 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.63 178.12 7.47 Favored Glycine 0 CA--C 1.544 1.906 0 C-N-CA 125.003 1.287 . . . . 0.0 115.409 -169.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 41.2 t80 . . . . . 0 CA--C 1.551 0.988 0 C-N-CA 124.894 1.278 . . . . 0.0 113.006 170.22 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.509 0 CA-C-O 122.046 0.804 . . . . 0.0 114.755 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.6 mt -114.07 115.0 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.149 1.38 . . . . 0.0 108.643 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -70.7 144.28 51.06 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.028 0.442 . . . . 0.0 111.198 172.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 58.14 26.36 13.61 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.334 1.454 . . . . 0.0 113.518 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -61.79 125.66 24.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.543 1.137 . . . . 0.0 111.187 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -72.32 122.81 21.76 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.542 1.537 . . . . 0.0 111.953 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.431 HD11 ' CD2' ' A' ' 111' ' ' TYR . 34.9 mm -119.58 116.17 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.122 0.969 . . . . 0.0 109.477 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.503 HG23 ' HB3' ' A' ' 105' ' ' SER . 3.6 mp -110.32 96.66 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.928 1.291 . . . . 0.0 108.425 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.9 p -80.62 156.46 26.38 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.983 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -151.53 139.58 20.11 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.88 1.272 . . . . 0.0 111.495 174.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.9 mt -81.07 134.08 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 . . . . . 0 N--CA 1.466 0.36 0 C-N-CA 125.055 1.342 . . . . 0.0 110.73 172.736 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 CA--C 1.543 0.696 0 CA-C-O 121.22 0.534 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -103.4 167.57 9.72 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.833 1.253 . . . . 0.0 110.69 170.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.2 tp -122.09 134.02 66.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 125.634 1.574 . . . . 0.0 108.103 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 p -120.77 156.71 31.27 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.198 0.599 . . . . 0.0 109.849 173.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -150.99 140.58 21.62 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.705 0.802 . . . . 0.0 111.312 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.7 p -71.79 118.94 15.26 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.929 0.892 . . . . 0.0 110.999 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.06 -154.39 16.18 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.717 1.151 . . . . 0.0 112.19 172.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -79.98 166.55 21.48 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.659 0.783 . . . . 0.0 111.202 169.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -79.1 105.99 10.82 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.95 -1.094 . . . . 0.0 111.286 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.434 ' CG2' ' HB2' ' A' ' 157' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.701 0 C-N-CA 123.474 0.71 . . . . 0.0 112.06 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.434 ' HB2' ' CG2' ' A' ' 149' ' ' ILE . . . -63.29 115.67 4.77 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -113.04 143.97 43.41 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.84 1.305 . . . . 0.0 111.231 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -134.65 168.06 19.68 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.202 1.801 . . . . 0.0 110.225 -169.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.89 133.46 23.54 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 69.5 mt -124.87 140.32 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.6 m -62.11 94.08 0.05 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.744 0.818 . . . . 0.0 109.226 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.54 -31.83 57.18 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.513 -0.742 . . . . 0.0 111.497 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -63.88 -27.71 69.34 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -94.78 -29.86 14.54 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.59 1.556 . . . . 0.0 111.597 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.456 HD13 ' HG3' ' A' ' 100' ' ' MET . 16.9 mt -58.04 -49.66 76.11 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.435 1.094 . . . . 0.0 110.766 170.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -49.33 -37.92 26.15 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.411 1.084 . . . . 0.0 113.445 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 48.6 mttm . . . . . 0 N--CA 1.48 1.053 0 C-N-CA 125.664 1.586 . . . . 0.0 114.268 -178.451 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt . . . . . 0 C--O 1.234 0.273 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -140.0 161.29 37.96 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.158 0.983 . . . . 0.0 109.951 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -132.6 124.92 29.28 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.739 0.304 . . . . 0.0 110.595 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.4 m -122.75 162.25 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.439 1.496 . . . . 0.0 111.18 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -60.42 157.87 13.08 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.345 1.058 . . . . 0.0 111.189 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.4 tp -156.74 137.82 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.218 1.007 . . . . 0.0 109.267 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -130.52 161.97 30.28 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 126.69 1.996 . . . . 0.0 109.628 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -128.73 159.3 36.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.042 1.337 . . . . 0.0 110.899 174.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -80.08 121.44 25.53 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 122.125 -0.36 . . . . 0.0 110.319 170.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.53 171.91 2.33 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.452 1.101 . . . . 0.0 112.258 171.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -55.13 -14.76 1.77 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.425 1.89 . . . . 0.0 115.343 174.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.9 t -113.03 11.46 18.98 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.95 1.3 . . . . 0.0 112.786 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.9 21.3 78.71 Favored Glycine 0 CA--C 1.537 1.409 0 O-C-N 120.553 -1.342 . . . . 0.0 114.334 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -98.17 127.79 44.31 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.843 1.257 . . . . 0.0 109.483 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -67.15 126.83 30.44 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.783 -0.573 . . . . 0.0 110.631 173.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.6 t -140.07 140.09 36.05 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.186 1.394 . . . . 0.0 110.138 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -58.19 141.05 51.74 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.8 tp -113.11 -48.9 2.95 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.758 0.823 . . . . 0.0 110.927 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.4 -111.85 0.47 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.141 0.4 . . . . 0.0 113.32 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -147.15 146.36 29.87 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.473 1.509 . . . . 0.0 110.008 -175.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 16.5 tp -114.68 106.66 14.49 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.674 1.189 . . . . 0.0 110.513 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.8 t -77.56 100.95 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.624 1.169 . . . . 0.0 109.137 173.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.6 t -90.02 123.79 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.156 1.382 . . . . 0.0 109.603 173.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 . . . . . 0 N--CA 1.473 0.677 0 C-N-CA 127.475 2.31 . . . . 0.0 109.792 -178.266 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.934 0 CA-C-O 121.362 0.423 . . . . 0.0 114.075 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.2 mt -117.33 142.88 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.717 0.807 . . . . 0.0 110.075 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -128.97 143.78 50.98 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.296 1.438 . . . . 0.0 109.664 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.1 p -135.31 148.83 49.61 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.299 -0.876 . . . . 0.0 112.043 -174.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.62 124.74 2.15 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-O 121.698 0.61 . . . . 0.0 112.739 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.46 HD12 ' CD1' ' A' ' 114' ' ' TYR . 3.2 tm? -74.45 139.06 43.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.147 1.779 . . . . 0.0 110.436 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.411 ' N ' HD13 ' A' ' 76' ' ' LEU . 48.4 t30 . . . . . 0 CA--C 1.547 0.849 0 C-N-CA 126.097 1.759 . . . . 0.0 111.106 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.708 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.2 m -56.01 128.34 34.84 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.523 0.729 . . . . 0.0 110.382 169.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -93.86 -51.11 5.03 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.478 0.711 . . . . 0.0 110.218 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -167.05 164.81 15.93 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.894 1.278 . . . . 0.0 112.661 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.89 146.29 28.99 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.608 1.163 . . . . 0.0 112.563 176.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.494 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -127.53 158.27 37.87 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.417 1.487 . . . . 0.0 112.111 -176.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -77.5 165.33 24.48 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.606 0.717 . . . . 0.0 112.494 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -56.0 -35.78 67.18 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.151 0.98 . . . . 0.0 112.335 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -69.0 -8.88 49.08 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.153 0.981 . . . . 0.0 113.5 175.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.9 t -113.31 -6.58 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.494 1.118 . . . . 0.0 110.834 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 67.7 t -49.85 -67.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.609 1.164 . . . . 0.0 111.87 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -67.12 -24.86 65.96 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.697 -0.627 . . . . 0.0 112.633 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -53.56 54.47 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.527 1.531 . . . . 0.0 110.813 173.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -62.51 -43.62 98.36 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.445 1.498 . . . . 0.0 111.642 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 74.3 t -56.62 -37.83 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.471 0.708 . . . . 0.0 110.733 176.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -68.1 -53.18 27.33 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.431 1.092 . . . . 0.0 113.059 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.32 -14.51 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 O-C-N 121.003 -1.06 . . . . 0.0 112.427 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.532 ' CG ' HD13 ' A' ' 166' ' ' LEU . 6.5 ttm -92.54 -4.65 53.18 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 120.465 -1.397 . . . . 0.0 112.802 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.5 p -126.75 -12.06 6.02 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.34 1.056 . . . . 0.0 113.114 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -136.98 -10.85 1.75 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.934 1.694 . . . . 0.0 114.415 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.27 154.64 10.02 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.728 1.632 . . . . 0.0 114.18 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.09 -168.66 33.04 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.672 1.13 . . . . 0.0 113.953 -175.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.7 p -146.24 107.38 4.18 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.873 1.269 . . . . 0.0 113.502 -168.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -136.44 149.42 48.24 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.308 1.843 . . . . 0.0 110.243 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -76.28 163.32 27.14 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.247 -0.908 . . . . 0.0 111.334 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.5 p -128.83 142.37 50.99 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.981 1.313 . . . . 0.0 111.32 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.494 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 8.4 t -53.52 -44.15 68.9 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.433 1.493 . . . . 0.0 112.256 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 mt -151.34 142.23 22.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.846 1.658 . . . . 0.0 111.691 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -136.12 102.66 5.08 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.072 0.949 . . . . 0.0 110.811 175.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -87.22 -48.53 7.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.01 0.924 . . . . 0.0 112.984 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.98 165.5 34.0 Favored Glycine 0 CA--C 1.545 1.933 0 C-N-CA 124.748 1.166 . . . . 0.0 112.584 -168.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.46 ' CD1' HD12 ' A' ' 76' ' ' LEU . 5.6 t80 . . . . . 0 N--CA 1.474 0.773 0 C-N-CA 124.479 1.111 . . . . 0.0 113.908 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.56 0 CA-C-O 121.312 0.396 . . . . 0.0 113.86 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.7 mt -125.72 115.83 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.807 1.643 . . . . 0.0 108.612 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -74.47 146.92 42.39 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.992 0.425 . . . . 0.0 111.836 173.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 57.47 23.36 9.01 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.136 1.774 . . . . 0.0 114.467 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -63.7 123.24 18.36 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.715 1.206 . . . . 0.0 111.727 -171.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -71.33 125.38 26.82 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.538 1.135 . . . . 0.0 111.636 177.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.7 mm -120.97 119.51 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.755 1.222 . . . . 0.0 109.169 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.3 100.27 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.88 1.272 . . . . 0.0 108.67 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 47.9 p -79.26 159.62 27.19 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.068 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.1 141.48 20.66 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.114 1.366 . . . . 0.0 111.305 171.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.5 mt -83.07 136.31 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.598 0.759 . . . . 0.0 109.275 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 . . . . . 0 N--CA 1.469 0.514 0 C-N-CA 124.877 1.271 . . . . 0.0 110.974 173.964 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 121.228 0.537 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -105.42 165.25 11.26 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.486 1.514 . . . . 0.0 111.009 170.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 6.3 tp -115.7 137.04 50.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 125.743 1.617 . . . . 0.0 107.793 169.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 p -126.95 157.63 38.96 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.499 0.72 . . . . 0.0 109.772 173.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -151.27 138.63 19.42 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.015 0.926 . . . . 0.0 111.603 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.3 m -78.88 111.28 14.88 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.074 0.95 . . . . 0.0 110.821 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.71 -161.95 32.74 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.435 1.016 . . . . 0.0 113.125 175.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -63.69 170.58 3.19 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-O 121.898 0.856 . . . . 0.0 112.568 169.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -92.21 108.21 19.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.623 1.569 . . . . 0.0 111.517 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.477 0.876 0 C-N-CA 123.36 0.664 . . . . 0.0 112.192 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 120.47 0.176 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.45 108.89 2.54 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 169.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -110.11 143.0 40.81 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.378 1.085 . . . . 0.0 110.675 172.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -133.39 170.15 15.89 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.97 1.708 . . . . 0.0 110.696 -170.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.31 132.26 20.23 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.532 0.333 . . . . 0.0 110.174 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 67.3 mt -125.2 138.88 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.3 m -62.88 99.2 0.15 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.735 0.698 . . . . 0.0 109.294 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.508 ' HA ' HD12 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -56.27 -30.57 62.63 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.588 0.755 . . . . 0.0 111.829 177.782 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.45 -31.57 69.96 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -87.84 -22.4 24.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.091 0.956 . . . . 0.0 112.356 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.532 HD13 ' CG ' ' A' ' 100' ' ' MET . 18.1 mt -64.25 -44.02 93.1 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.94 0.896 . . . . 0.0 111.085 168.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -55.07 -40.7 70.64 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.921 0.889 . . . . 0.0 112.153 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp . . . . . 0 N--CA 1.48 1.037 0 C-N-CA 125.733 1.613 . . . . 0.0 115.319 175.379 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 121.736 0.779 . . . . 0.0 111.907 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -147.32 155.93 42.46 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.974 0.91 . . . . 0.0 109.346 166.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 m -122.24 131.19 53.81 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.572 0.349 . . . . 0.0 110.775 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.0 m -129.27 166.09 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 125.646 1.579 . . . . 0.0 111.605 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -63.89 159.24 20.17 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.706 1.202 . . . . 0.0 111.806 177.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.0 tp -154.27 136.68 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.241 1.416 . . . . 0.0 109.571 174.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -128.89 161.93 28.71 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.498 1.919 . . . . 0.0 109.848 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -131.4 156.65 45.2 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.842 1.257 . . . . 0.0 111.338 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 119.59 20.18 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 171.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -63.27 175.51 0.95 Allowed 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 122.053 0.93 . . . . 0.0 111.728 170.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -60.36 -11.45 6.67 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.725 2.01 . . . . 0.0 114.6 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.8 m -115.64 13.49 16.3 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.169 1.388 . . . . 0.0 112.86 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.71 23.18 77.28 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 121.281 -0.887 . . . . 0.0 114.318 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -100.26 124.23 45.45 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.807 1.243 . . . . 0.0 109.674 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -64.93 123.94 20.75 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.974 0.51 . . . . 0.0 110.952 173.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.0 t -138.49 137.4 37.09 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.207 1.403 . . . . 0.0 110.402 -174.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -57.43 137.08 56.59 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.345 0.658 . . . . 0.0 112.516 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.8 tp -110.39 -47.65 3.26 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.667 0.787 . . . . 0.0 111.173 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.03 -128.98 1.55 Allowed Glycine 0 CA--C 1.528 0.86 0 CA-C-O 121.341 0.412 . . . . 0.0 113.665 -173.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -140.58 155.75 46.49 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.734 1.613 . . . . 0.0 109.621 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.8 tp -120.19 99.46 6.6 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.453 1.501 . . . . 0.0 109.662 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.3 t -76.71 101.96 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 125.321 1.448 . . . . 0.0 109.491 175.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.1 t -92.08 92.97 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.088 1.755 . . . . 0.0 109.712 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 . . . . . 0 N--CA 1.471 0.606 0 C-N-CA 125.814 1.645 . . . . 0.0 110.564 175.277 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.996 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.4 mt -124.12 145.49 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.159 0.984 . . . . 0.0 109.657 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -137.1 128.81 28.79 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.184 0.994 . . . . 0.0 110.593 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.8 p -117.54 147.25 42.96 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.381 1.072 . . . . 0.0 111.318 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -139.16 120.83 1.97 Allowed Glycine 0 CA--C 1.522 0.497 0 O-C-N 121.909 -0.495 . . . . 0.0 112.444 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.71 121.81 17.25 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.459 1.504 . . . . 0.0 109.107 173.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.1 t30 . . . . . 0 CA--C 1.538 0.516 0 C-N-CA 126.453 1.901 . . . . 0.0 109.112 -177.085 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.738 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.1 m -55.4 136.21 49.66 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.05 -1.031 . . . . 0.0 110.887 171.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -106.49 -51.46 2.95 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.564 1.146 . . . . 0.0 110.417 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -164.4 154.8 14.67 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.412 0.685 . . . . 0.0 112.388 170.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.55 154.85 44.83 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.431 1.11 . . . . 0.0 111.44 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.476 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -141.34 159.75 41.56 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.967 1.307 . . . . 0.0 111.647 -174.504 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -79.83 165.71 22.44 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.592 0.757 . . . . 0.0 112.029 -175.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -55.74 -32.31 63.28 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.138 -0.976 . . . . 0.0 113.422 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.47 -14.13 62.79 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 t -106.83 -8.23 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.38 1.072 . . . . 0.0 111.262 -174.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 97' ' ' VAL . 81.0 t -49.92 -63.38 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 125.23 1.412 . . . . 0.0 111.462 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -69.63 -25.67 64.04 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -52.08 59.19 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.217 1.407 . . . . 0.0 110.72 174.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -61.78 -43.34 99.04 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.633 1.573 . . . . 0.0 111.505 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 93' ' ' VAL . 73.6 t -54.5 -38.27 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.252 1.021 . . . . 0.0 110.566 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -69.37 -53.75 17.93 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.585 1.154 . . . . 0.0 112.541 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.7 m -72.3 -20.6 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 121.028 -1.045 . . . . 0.0 112.248 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.58 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -83.46 -4.67 58.72 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.239 -1.538 . . . . 0.0 112.103 174.778 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 79.9 p -128.53 -12.56 4.94 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -137.68 -10.5 1.6 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.036 1.734 . . . . 0.0 114.166 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.33 155.33 11.05 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.879 1.704 . . . . 0.0 113.86 -174.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.87 -171.66 33.8 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.673 1.13 . . . . 0.0 113.292 -174.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.0 p -145.47 103.83 3.85 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.518 1.127 . . . . 0.0 113.184 -168.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -131.66 150.53 52.12 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.962 1.705 . . . . 0.0 110.152 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.71 157.22 30.19 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.265 -0.897 . . . . 0.0 111.578 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.6 p -122.94 155.84 35.93 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.162 1.785 . . . . 0.0 110.687 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.476 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 77.1 p -71.09 -38.09 72.41 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.7 -0.625 . . . . 0.0 111.568 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.8 mt -154.43 137.67 15.71 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.147 1.779 . . . . 0.0 111.809 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -134.89 102.62 5.3 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.878 0.871 . . . . 0.0 110.48 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -86.77 -45.2 11.14 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.381 1.073 . . . . 0.0 113.381 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.29 -178.77 30.14 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 124.8 1.19 . . . . 0.0 113.865 -169.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 24.4 t80 . . . . . 0 CA--C 1.554 1.13 0 C-N-CA 125.291 1.436 . . . . 0.0 113.351 171.373 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.271 0 CA-C-O 121.914 0.73 . . . . 0.0 112.841 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 55.9 mt -124.63 109.62 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.501 1.52 . . . . 0.0 107.402 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -68.93 145.14 53.9 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.179 0.514 . . . . 0.0 111.139 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 60.71 21.04 11.05 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.573 1.549 . . . . 0.0 114.389 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 21.2 tptp -56.24 123.91 16.15 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.571 1.148 . . . . 0.0 111.287 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -73.41 128.87 36.7 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.968 0.907 . . . . 0.0 110.237 170.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 38.2 mm -121.73 112.61 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.187 0.995 . . . . 0.0 109.112 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.11 91.12 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.842 1.257 . . . . 0.0 109.103 -174.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 44.8 p -75.46 155.23 36.46 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.326 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -152.29 141.45 21.36 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.028 1.331 . . . . 0.0 111.399 172.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.1 mt -80.04 132.27 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.239 0.615 . . . . 0.0 109.405 175.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 . . . . . 0 N--CA 1.469 0.516 0 C-N-CA 125.082 1.353 . . . . 0.0 111.021 172.475 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 CA--C 1.536 0.436 0 CA-C-O 121.278 0.561 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -106.73 169.12 8.72 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.275 1.43 . . . . 0.0 110.444 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.0 tp -123.82 134.11 67.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 125.531 1.532 . . . . 0.0 108.283 172.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 p -121.36 153.75 37.37 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.192 0.597 . . . . 0.0 110.151 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -151.81 144.98 24.63 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.237 1.015 . . . . 0.0 111.29 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 p -77.7 116.45 18.24 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.195 1.398 . . . . 0.0 111.746 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.29 -158.67 30.21 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.575 1.56 . . . . 0.0 112.214 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.07 164.31 20.48 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 122.022 0.915 . . . . 0.0 113.422 170.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -81.61 102.59 10.75 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.175 0.99 . . . . 0.0 111.086 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.471 0.619 0 C-N-CA 123.404 0.681 . . . . 0.0 112.684 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.471 0.586 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -59.98 133.1 55.78 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 168.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -125.55 143.68 50.9 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.51 1.148 . . . . 0.0 110.473 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -131.23 169.18 16.3 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.851 1.661 . . . . 0.0 110.687 -170.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.28 130.67 19.82 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.901 0.48 . . . . 0.0 110.013 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.476 ' CG2' HD11 ' A' ' 166' ' ' LEU . 60.9 mt -126.24 140.54 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.883 0.873 . . . . 0.0 108.847 177.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.0 m -65.78 94.55 0.21 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.038 0.935 . . . . 0.0 109.772 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.553 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.0 OUTLIER -53.68 -33.06 54.08 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.512 1.125 . . . . 0.0 111.682 175.857 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -66.94 -27.27 67.33 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 176.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -89.91 -29.9 18.22 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.115 0.966 . . . . 0.0 112.875 174.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.58 HD13 ' HG3' ' A' ' 100' ' ' MET . 20.3 mt -59.3 -47.61 84.75 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.45 0.7 . . . . 0.0 110.643 172.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -50.89 -37.79 45.88 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.563 1.145 . . . . 0.0 113.746 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 179.735 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.0 pttm . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 120.851 0.358 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -142.26 174.28 10.76 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.146 1.378 . . . . 0.0 110.763 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -140.43 137.2 33.77 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.286 -0.884 . . . . 0.0 111.097 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.2 m -133.4 162.06 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 125.444 1.497 . . . . 0.0 111.718 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -61.75 155.14 23.65 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.443 1.097 . . . . 0.0 111.893 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.4 tp -150.94 136.16 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.789 1.236 . . . . 0.0 109.784 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -125.75 161.82 26.46 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.906 2.082 . . . . 0.0 109.488 176.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -130.8 154.58 47.87 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.162 1.385 . . . . 0.0 111.077 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -79.41 117.51 20.45 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.957 -0.464 . . . . 0.0 109.841 169.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -64.24 172.47 2.46 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 122.619 1.199 . . . . 0.0 111.176 169.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -57.0 -22.38 38.1 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.42 2.288 . . . . 0.0 113.125 173.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.4 m -83.67 -4.1 58.32 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.696 1.598 . . . . 0.0 114.15 174.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.68 34.42 66.86 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.846 1.213 . . . . 0.0 114.133 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -122.29 139.19 54.09 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.259 1.424 . . . . 0.0 110.689 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -70.93 119.96 15.82 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.645 1.178 . . . . 0.0 110.9 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -133.87 141.87 47.56 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.149 1.38 . . . . 0.0 110.138 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -59.21 140.2 56.18 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -173.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.5 tp -114.11 -47.86 2.93 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.032 0.933 . . . . 0.0 111.34 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.79 -119.02 0.81 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 123.267 0.461 . . . . 0.0 113.176 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -145.37 152.7 40.28 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.639 1.576 . . . . 0.0 110.184 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.2 tp -117.46 104.58 11.23 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.777 1.231 . . . . 0.0 110.525 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.4 t -77.82 100.37 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.507 1.123 . . . . 0.0 109.619 174.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 52.1 t -90.1 113.09 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.031 1.332 . . . . 0.0 110.36 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 . . . . . 0 N--CA 1.473 0.686 0 C-N-CA 127.044 2.138 . . . . 0.0 110.566 176.807 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.183 0 N-CA-C 113.971 0.348 . . . . 0.0 113.971 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.1 mt -119.61 143.2 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.101 0.96 . . . . 0.0 109.401 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -135.81 138.59 42.72 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.092 0.957 . . . . 0.0 110.059 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.5 p -131.54 147.63 52.55 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.488 -0.758 . . . . 0.0 111.724 -169.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.96 124.48 2.36 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-O 121.636 0.575 . . . . 0.0 112.954 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.9 137.05 51.3 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.103 1.761 . . . . 0.0 110.212 176.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.6 t30 . . . . . 0 CA--C 1.544 0.739 0 C-N-CA 126.031 1.733 . . . . 0.0 110.274 179.606 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.523 0 CA-C-O 120.772 0.32 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.2 m -55.54 132.75 49.39 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.485 -0.759 . . . . 0.0 110.146 169.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -99.89 -51.1 3.8 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.884 0.874 . . . . 0.0 109.842 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -163.98 161.57 22.81 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.12 0.968 . . . . 0.0 112.286 170.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.44 150.77 36.27 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.829 0.852 . . . . 0.0 111.512 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.51 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.8 OUTLIER -141.24 156.25 45.92 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.288 1.435 . . . . 0.0 111.845 -174.474 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -77.79 165.33 24.31 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.482 0.713 . . . . 0.0 112.601 -172.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -52.85 -34.0 52.28 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.605 1.162 . . . . 0.0 112.897 172.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -66.65 -11.81 55.5 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.87 1.268 . . . . 0.0 113.658 175.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.8 t -116.22 -5.23 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.971 1.308 . . . . 0.0 111.357 -172.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 69.6 t -50.18 -62.41 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 125.293 1.437 . . . . 0.0 111.899 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -70.25 -28.13 64.99 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -62.29 -50.48 71.52 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.446 1.498 . . . . 0.0 110.909 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -60.18 -43.84 95.52 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.996 1.318 . . . . 0.0 111.327 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 42.1 t -62.1 -34.16 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 123.705 0.802 . . . . 0.0 111.349 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -63.8 -54.56 33.19 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.459 1.104 . . . . 0.0 111.996 172.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -73.17 -2.55 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.587 ' CG ' HD13 ' A' ' 166' ' ' LEU . 2.3 ttm -114.48 1.91 14.47 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.038 1.335 . . . . 0.0 112.925 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.5 p -124.76 -12.56 7.1 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.762 1.225 . . . . 0.0 112.156 168.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -138.1 -15.14 1.32 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.79 155.09 26.81 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 124.895 1.236 . . . . 0.0 114.125 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.13 -160.1 31.35 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 123.963 0.792 . . . . 0.0 114.363 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.5 p -151.91 98.75 2.49 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -170.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -131.65 146.06 51.99 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.275 1.83 . . . . 0.0 110.132 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.23 155.75 36.47 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.461 -0.774 . . . . 0.0 110.778 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 47.0 p -114.69 158.11 22.23 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.539 1.136 . . . . 0.0 111.009 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.51 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 77.0 p -70.54 -37.87 74.12 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.387 -0.821 . . . . 0.0 110.823 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.2 mt -148.04 150.83 34.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.962 2.105 . . . . 0.0 112.171 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -143.7 107.95 4.78 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.382 1.073 . . . . 0.0 110.252 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -96.88 -40.46 8.9 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.411 1.084 . . . . 0.0 113.585 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.66 178.51 29.99 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.796 1.188 . . . . 0.0 115.616 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 33.6 t80 . . . . . 0 CA--C 1.548 0.896 0 C-N-CA 123.915 0.886 . . . . 0.0 112.075 169.446 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.577 0 N-CA-C 114.576 0.59 . . . . 0.0 114.576 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.2 mt -126.62 112.17 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.874 1.67 . . . . 0.0 108.536 174.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -70.98 145.24 50.16 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.101 0.477 . . . . 0.0 111.311 172.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 59.29 22.53 10.86 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.713 1.605 . . . . 0.0 114.137 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -54.13 127.86 28.48 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.92 1.288 . . . . 0.0 111.248 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -75.12 130.12 38.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.085 0.554 . . . . 0.0 110.544 170.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 32.8 mm -126.55 120.28 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.835 1.254 . . . . 0.0 108.668 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.68 101.55 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 125.303 1.441 . . . . 0.0 108.71 -176.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.4 p -86.29 159.3 19.47 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.485 0.714 . . . . 0.0 112.317 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -154.89 139.24 16.72 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.066 1.346 . . . . 0.0 111.736 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 26.2 mt -77.29 133.57 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.087 0.555 . . . . 0.0 109.911 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 CA--C 1.538 0.512 0 C-N-CA 125.747 1.619 . . . . 0.0 111.038 171.957 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 . . . . . 0 CA--C 1.537 0.467 0 CA-C-O 121.28 0.562 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -112.68 165.92 11.83 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.33 1.452 . . . . 0.0 110.692 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.1 tp -120.77 132.27 70.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 125.472 1.509 . . . . 0.0 108.117 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.3 p -122.45 154.76 37.34 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.571 0.748 . . . . 0.0 110.05 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -150.95 148.08 27.96 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.709 0.804 . . . . 0.0 111.844 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.4 p -80.74 125.42 30.04 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.695 1.198 . . . . 0.0 111.552 174.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.66 -151.77 26.63 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.085 1.326 . . . . 0.0 113.187 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -78.92 172.19 14.13 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.465 1.506 . . . . 0.0 110.331 168.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -82.31 119.29 23.94 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.709 -1.245 . . . . 0.0 110.805 173.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.773 0 C-N-CA 122.818 0.447 . . . . 0.0 111.36 173.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.51 117.62 7.0 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -117.96 140.23 50.02 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 122.181 0.991 . . . . 0.0 110.17 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -133.1 168.54 18.32 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.304 1.442 . . . . 0.0 111.327 -169.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.82 130.64 18.09 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.264 0.626 . . . . 0.0 109.9 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.42 ' CG2' HD11 ' A' ' 166' ' ' LEU . 69.6 mt -122.57 140.33 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.135 0.974 . . . . 0.0 108.536 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.9 m -64.11 95.81 0.13 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.192 0.997 . . . . 0.0 110.049 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.531 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.3 tt -55.32 -31.87 62.02 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.501 1.12 . . . . 0.0 111.757 175.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -69.48 -29.72 67.44 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.59 -33.51 47.52 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.292 0.951 . . . . 0.0 112.681 171.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.587 HD13 ' CG ' ' A' ' 100' ' ' MET . 22.4 mt -62.28 -48.82 78.21 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.309 1.043 . . . . 0.0 110.741 175.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -48.81 -38.19 21.42 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.785 1.175 . . . . 0.0 113.531 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.6 mttt . . . . . 0 N--CA 1.486 1.354 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 177.885 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -140.93 165.62 27.03 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.091 0.956 . . . . 0.0 110.842 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -136.04 132.76 36.65 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.16 -0.338 . . . . 0.0 111.322 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.1 m -131.79 159.77 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.353 1.461 . . . . 0.0 111.866 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -57.98 153.75 13.79 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.747 0.819 . . . . 0.0 112.45 175.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.0 tp -149.96 137.16 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.336 1.455 . . . . 0.0 109.714 174.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -132.57 161.25 34.31 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.718 2.007 . . . . 0.0 109.674 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -134.62 160.08 39.21 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.367 1.067 . . . . 0.0 112.162 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.21 114.45 21.82 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.545 0.738 . . . . 0.0 110.625 173.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -73.59 -176.65 2.41 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.779 0.832 . . . . 0.0 112.276 175.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt -55.92 -26.65 48.62 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.489 1.916 . . . . 0.0 113.167 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.0 m -73.75 -8.25 55.28 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.342 1.457 . . . . 0.0 113.87 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.24 40.46 97.38 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.258 0.932 . . . . 0.0 112.4 -169.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -132.61 137.64 47.11 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.562 1.945 . . . . 0.0 109.097 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -67.3 130.64 43.71 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.64 0.776 . . . . 0.0 111.178 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.3 t -137.53 138.46 39.67 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.942 1.297 . . . . 0.0 110.317 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -57.17 125.88 24.71 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.443 1.097 . . . . 0.0 112.286 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.9 tp -100.73 -45.87 5.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.863 0.865 . . . . 0.0 111.092 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.86 -120.36 0.91 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.473 0.559 . . . . 0.0 113.468 -177.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -145.5 155.76 43.3 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.565 1.546 . . . . 0.0 109.575 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.5 tp -121.83 104.81 9.83 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.5 1.12 . . . . 0.0 110.698 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.2 t -77.72 98.95 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.847 1.259 . . . . 0.0 109.355 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 51.6 t -86.06 117.44 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.042 1.737 . . . . 0.0 110.197 174.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 . . . . . 0 N--CA 1.473 0.72 0 C-N-CA 126.973 2.109 . . . . 0.0 110.82 179.322 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.184 0 CA-C-O 121.182 0.323 . . . . 0.0 113.341 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.4 mt -117.31 143.96 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.074 0.95 . . . . 0.0 109.708 171.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -131.35 140.9 49.81 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.107 1.363 . . . . 0.0 109.459 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.7 p -133.15 146.92 52.01 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.134 -0.979 . . . . 0.0 112.433 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.05 126.51 3.25 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-O 121.769 0.649 . . . . 0.0 112.944 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.05 137.35 53.51 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.561 1.945 . . . . 0.0 110.128 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.9 t30 . . . . . 0 CA--C 1.547 0.838 0 C-N-CA 126.1 1.76 . . . . 0.0 110.678 -176.04 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.728 0 N-CA-C 111.413 0.153 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.3 m -58.55 136.4 57.56 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.24 -0.913 . . . . 0.0 109.262 169.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -104.45 -48.29 3.86 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.904 0.882 . . . . 0.0 110.022 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -162.38 170.5 18.7 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.416 1.086 . . . . 0.0 112.307 169.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.77 158.09 43.73 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.764 1.226 . . . . 0.0 111.62 170.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.521 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -140.5 158.38 44.09 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.926 1.29 . . . . 0.0 111.466 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -80.05 165.13 22.84 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.15 0.58 . . . . 0.0 111.834 -174.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -53.11 -33.96 54.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.602 1.161 . . . . 0.0 112.857 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -67.26 -8.44 31.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.937 1.295 . . . . 0.0 113.556 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.61 -6.69 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.586 1.154 . . . . 0.0 111.306 -172.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 79.5 t -52.12 -60.91 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 O-C-N 120.404 -1.435 . . . . 0.0 112.231 -176.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -69.0 -27.01 65.31 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.47 -52.79 59.89 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.477 1.511 . . . . 0.0 110.856 175.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.96 -46.65 89.84 Favored 'General case' 0 C--O 1.227 -0.093 0 C-N-CA 125.041 1.336 . . . . 0.0 110.484 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.74 -35.48 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.232 0.613 . . . . 0.0 111.461 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -63.07 -54.69 34.04 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.416 1.086 . . . . 0.0 112.215 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -70.25 -12.24 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 121.551 -0.718 . . . . 0.0 112.419 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.56 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -94.44 -4.63 47.93 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.745 2.018 . . . . 0.0 112.186 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 34.3 p -126.39 -15.0 5.76 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 169.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -130.75 -10.55 3.93 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.942 1.297 . . . . 0.0 114.257 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.64 155.93 7.78 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.241 1.4 . . . . 0.0 113.698 -174.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.8 -170.51 32.49 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.032 0.825 . . . . 0.0 114.064 -174.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.4 p -143.44 109.4 5.25 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.927 1.291 . . . . 0.0 113.529 -168.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -138.05 148.45 45.1 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.364 1.866 . . . . 0.0 109.825 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 155.65 35.1 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.691 -0.63 . . . . 0.0 110.913 177.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 58.9 p -117.85 158.25 25.17 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.921 1.688 . . . . 0.0 110.958 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.521 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 60.0 p -74.35 -39.96 62.44 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.576 -0.703 . . . . 0.0 111.121 -177.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.3 mt -151.11 143.19 24.0 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.631 1.973 . . . . 0.0 111.919 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -138.22 98.52 3.64 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.885 0.874 . . . . 0.0 111.583 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -86.55 -40.12 15.54 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.67 178.26 7.65 Favored Glycine 0 CA--C 1.546 1.971 0 C-N-CA 124.378 0.989 . . . . 0.0 114.339 -169.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 40.5 t80 . . . . . 0 CA--C 1.55 0.947 0 C-N-CA 124.78 1.232 . . . . 0.0 112.546 169.92 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.423 0 CA-C-O 121.875 0.708 . . . . 0.0 113.199 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 62.5 mt -126.59 110.79 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.502 1.521 . . . . 0.0 108.149 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -69.7 145.27 52.46 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.305 0.574 . . . . 0.0 111.419 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 60.07 19.85 9.05 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.773 1.629 . . . . 0.0 114.466 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -54.73 124.06 15.24 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.638 1.175 . . . . 0.0 111.735 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -72.44 129.81 39.23 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.214 1.006 . . . . 0.0 110.644 171.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.0 mm -126.82 119.35 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.764 1.225 . . . . 0.0 108.922 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.75 98.32 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.274 1.43 . . . . 0.0 108.679 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.5 p -81.92 155.56 25.21 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.709 0.804 . . . . 0.0 112.125 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -151.39 140.05 20.71 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.098 1.359 . . . . 0.0 111.182 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 46.1 mt -79.95 133.06 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 . . . . . 0 N--CA 1.469 0.483 0 C-N-CA 125.188 1.395 . . . . 0.0 110.953 176.348 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 . . . . . 0 CA--C 1.54 0.57 0 CA-C-O 121.174 0.511 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -113.25 169.12 9.17 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.281 1.432 . . . . 0.0 109.91 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.9 tp -120.77 133.66 66.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.06 1.344 . . . . 0.0 108.519 169.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.1 p -121.8 155.08 36.08 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.596 0.758 . . . . 0.0 110.214 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -147.14 145.02 29.42 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.598 0.759 . . . . 0.0 112.246 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.3 p -74.91 108.71 7.82 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.982 1.313 . . . . 0.0 111.49 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.77 -162.35 33.47 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 123.83 0.729 . . . . 0.0 113.535 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -69.6 173.78 5.71 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 121.673 -0.898 . . . . 0.0 110.029 167.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -84.17 137.77 33.34 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.659 -1.276 . . . . 0.0 111.661 173.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.779 0 C-N-CA 123.174 0.589 . . . . 0.0 111.74 169.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -72.94 88.94 1.38 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.352 0.661 . . . . 0.0 109.763 173.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -76.64 147.39 37.56 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 122.113 0.959 . . . . 0.0 110.675 168.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -131.83 172.93 11.7 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.902 1.681 . . . . 0.0 111.013 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.34 131.72 18.59 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.324 0.65 . . . . 0.0 110.232 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 68.9 mt -123.6 140.76 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.185 0.994 . . . . 0.0 109.021 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.3 m -63.88 97.4 0.16 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.22 1.008 . . . . 0.0 109.865 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.6 tt -54.19 -32.43 55.62 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.218 1.007 . . . . 0.0 111.571 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.18 -28.12 69.17 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -85.88 -33.27 21.29 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.35 0.977 . . . . 0.0 112.923 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.56 HD13 ' HG3' ' A' ' 100' ' ' MET . 44.8 mt -58.45 -47.47 83.9 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.261 1.024 . . . . 0.0 110.19 175.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -53.93 -23.61 13.48 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 175.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 93.0 mttt . . . . . 0 N--CA 1.483 1.195 0 C-N-CA 124.672 1.189 . . . . 0.0 114.163 179.786 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? . . . . . 0 N--CA 1.465 0.312 0 CA-C-O 121.624 0.726 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -143.25 170.3 16.02 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.061 1.744 . . . . 0.0 110.664 169.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.29 134.26 34.1 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.668 -0.645 . . . . 0.0 110.435 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.1 m -130.16 163.54 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.237 1.415 . . . . 0.0 111.321 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -60.35 156.35 15.97 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.969 0.908 . . . . 0.0 111.649 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.3 tp -151.3 135.09 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.695 1.198 . . . . 0.0 109.282 172.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -126.59 156.81 40.31 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.43 1.892 . . . . 0.0 108.777 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -126.03 155.09 42.05 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.67 1.188 . . . . 0.0 111.196 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -80.12 118.49 21.87 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 168.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -67.43 178.04 1.71 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 122.326 1.06 . . . . 0.0 113.119 170.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -17.19 50.63 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.923 1.289 . . . . 0.0 113.589 176.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.2 m -95.73 1.78 53.56 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.61 1.164 . . . . 0.0 112.508 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.37 21.31 79.06 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-N 119.64 1.109 . . . . 0.0 114.494 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -102.2 137.24 40.72 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.646 1.178 . . . . 0.0 110.822 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -67.84 123.96 22.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.824 0.849 . . . . 0.0 110.35 170.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -140.7 143.09 34.85 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.705 1.202 . . . . 0.0 110.453 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -58.18 139.19 55.39 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.2 tp -114.68 -46.76 2.93 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.947 0.899 . . . . 0.0 111.181 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.76 -115.01 0.61 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 122.971 0.32 . . . . 0.0 113.212 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -147.64 153.84 39.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.055 1.342 . . . . 0.0 110.148 -174.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.6 tp -121.31 105.02 10.15 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.963 1.305 . . . . 0.0 110.033 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.8 t -76.27 94.15 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.923 1.289 . . . . 0.0 109.331 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 42.8 t -81.29 99.0 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.897 1.679 . . . . 0.0 109.071 173.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 . . . . . 0 CA--C 1.54 0.57 0 C-N-CA 125.189 1.395 . . . . 0.0 111.015 174.387 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.02 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.0 mt -122.22 136.06 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.965 0.906 . . . . 0.0 110.433 173.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -123.61 141.9 51.56 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.838 2.055 . . . . 0.0 111.984 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.5 p -137.19 136.78 38.48 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.217 -0.927 . . . . 0.0 112.341 -175.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.21 127.85 5.82 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.189 0.423 . . . . 0.0 112.79 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.06 135.58 51.02 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.689 1.596 . . . . 0.0 110.22 174.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 . . . . . 0 CA--C 1.549 0.906 0 C-N-CA 125.541 1.537 . . . . 0.0 110.815 -173.74 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.678 0 CA-C-O 120.639 0.257 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 57.2 m -57.86 132.71 54.17 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.248 -0.908 . . . . 0.0 109.387 168.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -99.54 -47.49 5.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.737 0.815 . . . . 0.0 110.541 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -166.62 169.25 13.79 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.744 1.218 . . . . 0.0 112.387 171.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.53 138.51 16.36 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.43 1.092 . . . . 0.0 112.347 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.511 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -118.73 160.0 22.65 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.649 1.58 . . . . 0.0 111.767 179.063 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -83.12 167.19 18.04 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.388 0.675 . . . . 0.0 112.324 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -57.67 -32.3 67.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.073 0.949 . . . . 0.0 112.666 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -70.11 -3.8 18.34 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.436 1.094 . . . . 0.0 113.849 175.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.0 t -119.79 -3.12 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.354 1.062 . . . . 0.0 111.046 -175.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 97' ' ' VAL . 69.5 t -55.57 -61.78 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 120.461 -1.4 . . . . 0.0 111.635 -175.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -68.24 -25.0 64.97 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -54.0 40.51 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.425 1.49 . . . . 0.0 110.584 173.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -61.96 -44.23 97.19 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.35 1.46 . . . . 0.0 111.238 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 93' ' ' VAL . 63.3 t -53.98 -36.72 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.519 1.128 . . . . 0.0 111.003 177.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -70.92 -54.05 12.79 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.848 1.259 . . . . 0.0 112.379 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -70.84 -21.01 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 O-C-N 120.786 -1.196 . . . . 0.0 112.568 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.599 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -82.8 -5.11 58.79 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.093 1.757 . . . . 0.0 111.703 175.502 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.6 p -129.66 -14.77 4.06 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -136.61 -10.05 1.87 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.186 1.794 . . . . 0.0 113.932 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.42 155.18 10.93 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.722 1.63 . . . . 0.0 113.967 -175.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.64 -170.86 33.03 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.475 1.036 . . . . 0.0 113.641 -174.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.1 p -144.03 109.87 5.29 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.748 1.219 . . . . 0.0 113.527 -169.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -138.51 145.88 41.3 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.47 1.908 . . . . 0.0 109.986 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.51 147.15 42.1 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.078 -1.014 . . . . 0.0 111.754 175.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.6 p -106.58 168.1 9.4 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.603 1.561 . . . . 0.0 111.443 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.511 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 16.5 p -74.55 -39.63 62.18 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.524 -0.735 . . . . 0.0 111.118 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.0 mt -155.85 144.2 20.07 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.406 2.282 . . . . 0.0 110.605 -174.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -138.71 105.47 5.37 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.098 0.959 . . . . 0.0 111.263 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -89.42 -40.29 12.82 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.93 179.39 15.88 Favored Glycine 0 CA--C 1.545 1.928 0 C-N-CA 124.977 1.275 . . . . 0.0 114.142 -168.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 57.8 t80 . . . . . 0 CA--C 1.55 0.967 0 C-N-CA 124.261 1.024 . . . . 0.0 112.519 169.675 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.17 0 CA-C-O 122.251 0.917 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 35.2 mt -133.04 108.48 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 125.712 1.605 . . . . 0.0 107.17 172.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -68.74 145.86 53.44 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.069 0.462 . . . . 0.0 111.201 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 59.09 25.02 13.39 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.639 1.575 . . . . 0.0 114.262 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.52 130.55 43.55 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.022 1.329 . . . . 0.0 112.108 -172.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -78.75 117.97 20.37 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.972 0.909 . . . . 0.0 112.333 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 28.5 mm -108.69 118.73 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.063 0.945 . . . . 0.0 109.66 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 mp -109.98 98.51 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.212 1.405 . . . . 0.0 108.816 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 65.8 p -80.31 157.79 26.29 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.174 174.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -154.35 142.17 20.05 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.178 1.391 . . . . 0.0 111.744 172.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.7 mt -80.86 133.32 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.652 0.781 . . . . 0.0 109.222 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 CA--C 1.536 0.439 0 C-N-CA 125.604 1.562 . . . . 0.0 110.046 171.756 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 121.278 0.561 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -110.27 168.95 9.06 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.283 1.433 . . . . 0.0 110.526 173.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.2 tp -124.97 133.44 69.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 125.498 1.519 . . . . 0.0 108.474 172.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.4 p -120.55 156.99 30.43 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.547 0.739 . . . . 0.0 109.949 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -149.02 136.91 20.61 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.695 0.798 . . . . 0.0 111.626 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.6 m -75.15 107.43 7.23 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.787 1.235 . . . . 0.0 110.896 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.61 -164.24 39.54 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.554 1.073 . . . . 0.0 114.32 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -63.63 160.97 15.69 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.912 0.885 . . . . 0.0 111.475 170.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -76.86 131.95 38.88 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.187 -0.946 . . . . 0.0 110.331 172.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.468 0.472 0 C-N-CA 124.242 1.017 . . . . 0.0 111.294 173.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 120.967 0.413 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.24 93.76 0.33 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.618 1.167 . . . . 0.0 109.852 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -99.99 144.92 28.48 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 122.413 1.101 . . . . 0.0 111.462 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -137.63 174.26 10.78 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.751 1.62 . . . . 0.0 111.211 -172.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.31 133.22 20.17 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.479 0.712 . . . . 0.0 110.127 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.43 ' CG2' HD11 ' A' ' 166' ' ' LEU . 64.3 mt -125.21 140.83 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.153 0.981 . . . . 0.0 108.889 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.0 m -66.17 95.37 0.29 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.041 0.936 . . . . 0.0 109.511 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.54 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.1 tt -54.75 -31.87 59.15 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.738 1.215 . . . . 0.0 111.86 177.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -70.3 -26.29 63.72 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -89.31 -26.72 20.97 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.833 0.853 . . . . 0.0 112.439 174.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.599 HD13 ' HG3' ' A' ' 100' ' ' MET . 23.6 mt -61.55 -48.59 80.29 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.057 0.943 . . . . 0.0 110.759 169.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -51.85 -37.61 52.75 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.365 1.066 . . . . 0.0 113.636 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -178.305 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt . . . . . 0 CA--C 1.534 0.359 0 CA-C-O 121.555 0.693 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -149.15 164.48 34.62 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.168 0.987 . . . . 0.0 110.261 170.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.74 123.49 25.0 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.566 0.222 . . . . 0.0 110.658 -178.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.5 m -120.53 161.75 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.2 1.4 . . . . 0.0 111.186 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -62.14 160.36 12.94 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.793 1.237 . . . . 0.0 111.303 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.3 tp -155.96 138.21 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.576 1.15 . . . . 0.0 109.339 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -130.98 161.94 30.85 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.221 1.808 . . . . 0.0 109.729 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -134.2 159.23 41.54 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.147 1.379 . . . . 0.0 111.704 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.17 119.62 25.76 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.283 0.633 . . . . 0.0 110.535 174.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -73.7 179.94 3.92 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.238 0.615 . . . . 0.0 112.41 174.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -58.05 -24.44 58.44 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.892 1.677 . . . . 0.0 113.435 173.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.9 m -78.93 -5.49 53.86 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.848 1.259 . . . . 0.0 113.806 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.42 32.84 84.81 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.289 0.947 . . . . 0.0 113.704 -171.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -116.64 141.98 47.49 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.792 1.637 . . . . 0.0 109.854 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -69.85 133.21 47.13 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.758 0.823 . . . . 0.0 111.26 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.3 t -145.54 142.98 29.67 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.931 1.293 . . . . 0.0 110.537 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -56.98 135.89 56.22 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.284 1.034 . . . . 0.0 112.415 -174.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.1 tp -109.12 -47.76 3.37 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.591 0.756 . . . . 0.0 111.731 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.24 -130.39 2.05 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 121.712 0.618 . . . . 0.0 113.713 -175.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -137.06 152.6 50.24 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.528 1.931 . . . . 0.0 110.8 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.5 tp -119.79 104.61 10.37 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.427 1.491 . . . . 0.0 110.806 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.43 99.86 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.388 1.075 . . . . 0.0 109.544 175.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.2 t -85.11 128.06 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.161 1.385 . . . . 0.0 109.633 173.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 . . . . . 0 N--CA 1.473 0.718 0 C-N-CA 127.193 2.197 . . . . 0.0 110.137 -175.647 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.116 0 CA-C-O 121.279 0.377 . . . . 0.0 113.882 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.4 mt -112.45 139.55 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.709 0.804 . . . . 0.0 109.116 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -127.2 139.76 52.71 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.822 0.849 . . . . 0.0 110.094 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.1 p -132.09 137.27 47.68 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.59 0.756 . . . . 0.0 111.025 -173.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.29 110.48 0.83 Allowed Glycine 0 CA--C 1.52 0.387 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -170.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 32.0 tp -64.0 148.11 50.45 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.979 1.312 . . . . 0.0 110.345 175.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.3 t30 . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 126.044 1.738 . . . . 0.0 109.603 176.901 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.631 0 CA-C-O 120.692 0.282 . . . . 0.0 111.401 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.9 m -58.74 116.45 3.74 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.33 -0.856 . . . . 0.0 109.144 169.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -81.99 -52.29 7.19 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.624 0.647 . . . . 0.0 109.841 -178.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -166.19 162.44 17.55 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.94 1.296 . . . . 0.0 112.383 170.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.58 156.81 44.7 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.956 1.303 . . . . 0.0 111.399 177.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.535 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -140.97 157.93 44.65 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.104 1.362 . . . . 0.0 112.282 -177.36 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -77.09 165.34 24.72 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.535 0.734 . . . . 0.0 112.021 -173.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -57.47 -30.0 64.69 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.318 -0.864 . . . . 0.0 112.357 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -69.98 -8.31 47.98 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.549 1.54 . . . . 0.0 114.027 175.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 t -119.26 -4.38 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.777 1.231 . . . . 0.0 111.3 -173.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.3 t -50.31 -66.47 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 125.169 1.388 . . . . 0.0 111.663 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -67.69 -24.42 65.41 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.38 -51.96 63.66 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.104 1.362 . . . . 0.0 110.511 173.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -60.17 -44.13 95.29 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 124.84 1.256 . . . . 0.0 111.926 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 92.4 t -55.58 -36.25 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 122.967 0.507 . . . . 0.0 110.855 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.7 tttp -68.29 -54.94 14.04 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.534 1.133 . . . . 0.0 112.678 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -72.7 -14.6 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 121.063 -1.023 . . . . 0.0 112.518 -174.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.505 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -88.07 -6.41 57.95 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.544 1.537 . . . . 0.0 112.081 176.938 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 44.4 p -130.5 -14.89 3.65 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -131.74 -9.57 3.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.612 1.565 . . . . 0.0 113.849 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.4 156.5 7.95 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.473 1.511 . . . . 0.0 113.683 -176.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.1 -169.04 34.69 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.993 0.806 . . . . 0.0 113.966 -175.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 61.6 p -146.32 94.72 2.5 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.389 1.075 . . . . 0.0 113.488 -167.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -128.49 140.14 51.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.667 1.587 . . . . 0.0 109.885 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -69.45 153.17 43.95 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.454 0.701 . . . . 0.0 110.947 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.8 p -115.11 160.86 19.15 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.76 1.624 . . . . 0.0 110.942 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.535 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 82.4 p -76.38 -39.17 54.43 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.391 -0.818 . . . . 0.0 111.019 -177.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.3 mt -153.45 138.71 17.49 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.37 1.868 . . . . 0.0 111.694 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -137.45 101.6 4.55 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.246 1.018 . . . . 0.0 111.005 176.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -91.72 -36.87 13.35 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 174.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.42 -176.13 48.18 Favored Glycine 0 CA--C 1.544 1.86 0 CA-C-N 118.936 0.789 . . . . 0.0 113.902 -170.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.2 t80 . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -178.643 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.234 0 CA-C-O 122.088 0.826 . . . . 0.0 113.649 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.6 mt -133.47 103.24 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.31 1.444 . . . . 0.0 107.651 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -67.01 143.58 56.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.189 0.518 . . . . 0.0 110.834 173.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 61.82 19.33 10.51 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.468 1.507 . . . . 0.0 114.381 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 16.4 tptp -53.62 123.88 13.48 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.893 1.277 . . . . 0.0 111.456 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -70.86 127.48 32.76 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.952 0.901 . . . . 0.0 110.388 170.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.7 mm -124.88 116.53 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.386 1.075 . . . . 0.0 108.48 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.8 mp -110.31 92.42 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.006 1.322 . . . . 0.0 108.379 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.1 p -75.03 154.91 37.78 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.123 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -150.68 139.38 20.71 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.948 1.299 . . . . 0.0 111.135 174.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.4 mt -81.93 132.85 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 . . . . . 0 N--CA 1.466 0.353 0 C-N-CA 125.273 1.429 . . . . 0.0 110.126 174.33 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 . . . . . 0 CA--C 1.543 0.685 0 CA-C-O 121.057 0.456 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -106.38 166.15 10.75 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.271 1.428 . . . . 0.0 110.607 170.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.8 tp -118.66 138.19 50.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 125.525 1.53 . . . . 0.0 108.207 169.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.1 p -127.34 156.82 41.39 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.619 0.767 . . . . 0.0 109.933 174.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -150.79 146.14 26.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.13 0.972 . . . . 0.0 111.235 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 p -78.71 109.56 13.06 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.735 1.214 . . . . 0.0 111.402 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.43 -165.23 32.23 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 123.897 0.761 . . . . 0.0 113.204 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -65.33 164.3 13.85 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 122.254 1.026 . . . . 0.0 112.481 170.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -84.34 106.06 15.66 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.159 1.383 . . . . 0.0 111.172 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 121.413 0.625 . . . . 0.0 112.093 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.476 0.828 0 CA-C-O 120.541 0.21 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.25 94.94 0.55 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.432 0.693 . . . . 0.0 109.442 172.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -92.31 145.45 24.47 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 122.164 0.983 . . . . 0.0 111.288 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -136.25 169.99 16.75 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.739 1.616 . . . . 0.0 111.112 -172.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.86 134.6 23.53 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 122.97 0.508 . . . . 0.0 110.495 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.466 ' CG2' HD11 ' A' ' 166' ' ' LEU . 59.7 mt -126.75 139.19 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.807 0.843 . . . . 0.0 109.263 175.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.5 m -63.09 96.9 0.1 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.232 1.013 . . . . 0.0 109.791 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.553 ' HA ' HD12 ' A' ' 166' ' ' LEU . 0.8 OUTLIER -55.35 -31.39 61.71 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.471 1.109 . . . . 0.0 111.884 177.067 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -67.86 -29.43 68.56 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -88.41 -18.88 27.39 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.036 0.934 . . . . 0.0 112.64 174.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.553 HD12 ' HA ' ' A' ' 163' ' ' LEU . 20.0 mt -70.92 -46.38 62.59 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.476 -0.765 . . . . 0.0 110.173 168.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -49.43 -48.26 47.46 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.851 1.26 . . . . 0.0 113.538 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 30.6 pttt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -177.625 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 pttm . . . . . 0 N--CA 1.475 0.807 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -154.74 170.69 21.01 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.471 1.109 . . . . 0.0 111.931 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.87 134.08 44.13 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.217 0.607 . . . . 0.0 111.261 174.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.9 m -131.13 164.19 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 125.793 1.637 . . . . 0.0 111.33 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.22 160.41 13.06 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.626 1.17 . . . . 0.0 112.111 177.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 tp -155.29 137.0 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.321 1.448 . . . . 0.0 109.963 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -127.33 159.76 33.42 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.607 1.963 . . . . 0.0 109.547 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -128.88 159.69 35.01 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.79 1.236 . . . . 0.0 111.493 176.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -87.47 118.21 26.78 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.459 0.304 . . . . 0.0 110.868 173.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -69.52 178.08 2.64 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.958 0.885 . . . . 0.0 112.712 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -60.25 -22.65 63.31 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.158 1.783 . . . . 0.0 115.035 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.8 t -85.52 -4.87 59.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.95 0.9 . . . . 0.0 112.608 174.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.4 32.35 57.99 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 121.108 -0.995 . . . . 0.0 113.299 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.6 142.04 41.27 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.964 1.306 . . . . 0.0 110.72 178.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -76.14 122.06 23.76 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.594 0.758 . . . . 0.0 110.937 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.5 t -137.43 139.39 40.64 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.135 1.374 . . . . 0.0 110.32 -175.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -57.63 141.24 48.91 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -176.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.1 tp -114.56 -47.74 2.89 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.659 0.783 . . . . 0.0 111.023 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.92 -116.27 0.64 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 123.378 0.514 . . . . 0.0 113.044 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -146.33 156.25 43.21 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.693 1.597 . . . . 0.0 109.729 -176.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.8 tp -121.16 102.27 8.2 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.153 1.381 . . . . 0.0 110.29 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.82 101.19 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.083 0.953 . . . . 0.0 109.02 171.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.9 t -88.35 127.07 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.274 1.43 . . . . 0.0 109.803 172.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 . . . . . 0 N--CA 1.475 0.782 0 C-N-CA 127.697 2.399 . . . . 0.0 110.928 -175.327 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.277 0 N-CA-C 115.096 0.799 . . . . 0.0 115.096 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 69.1 mt -113.37 142.17 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.345 1.058 . . . . 0.0 109.922 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -131.77 139.6 48.98 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.211 1.805 . . . . 0.0 109.315 -177.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.8 p -131.74 146.53 52.21 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.318 -0.864 . . . . 0.0 111.549 -171.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.45 124.0 2.41 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-O 121.699 0.61 . . . . 0.0 113.088 -177.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.72 136.18 52.47 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.434 1.894 . . . . 0.0 110.189 175.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.2 t30 . . . . . 0 CA--C 1.547 0.848 0 C-N-CA 126.367 1.867 . . . . 0.0 110.475 -175.249 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 112.278 0.474 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.2 m -55.02 135.04 49.25 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.279 -0.888 . . . . 0.0 110.468 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -102.89 -52.6 3.03 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.796 1.238 . . . . 0.0 109.89 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -163.07 162.66 25.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.824 0.85 . . . . 0.0 112.65 170.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.25 141.31 27.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.718 0.807 . . . . 0.0 111.538 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.557 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.8 OUTLIER -121.38 156.72 32.04 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.365 1.866 . . . . 0.0 111.501 -176.305 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -75.79 163.46 27.23 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.578 0.704 . . . . 0.0 112.608 -176.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -54.93 -28.03 47.91 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.038 1.335 . . . . 0.0 113.596 171.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -72.01 -15.65 62.05 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 121.104 -0.998 . . . . 0.0 113.251 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.6 t -106.32 -5.25 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.744 1.217 . . . . 0.0 110.671 -171.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.5 m -53.8 -35.03 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -96.79 -23.33 16.45 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.677 0.791 . . . . 0.0 112.307 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -68.69 -48.87 62.8 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.623 1.569 . . . . 0.0 111.318 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -60.71 -43.28 97.99 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.271 1.428 . . . . 0.0 111.338 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.7 t -53.69 -42.76 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.247 1.019 . . . . 0.0 109.914 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -60.84 -56.08 25.38 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.416 1.086 . . . . 0.0 112.313 175.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 m -72.86 -3.34 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 121.02 -1.05 . . . . 0.0 113.456 -177.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.497 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -107.46 -3.83 19.08 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.543 1.937 . . . . 0.0 111.902 179.723 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.7 p -129.81 -13.26 4.18 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.253 1.421 . . . . 0.0 113.29 172.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -134.03 -14.71 2.35 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.076 1.75 . . . . 0.0 114.116 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.16 154.82 11.74 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 124.797 1.189 . . . . 0.0 114.26 -176.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.28 -158.35 30.39 Favored Glycine 0 CA--C 1.533 1.162 0 O-C-N 121.58 -0.953 . . . . 0.0 114.073 -176.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.6 p -151.38 105.02 3.14 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -174.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -136.56 157.97 45.54 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.481 1.913 . . . . 0.0 110.537 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -83.58 161.57 21.12 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.16 -0.963 . . . . 0.0 111.996 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.4 p -122.96 158.59 30.12 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.853 1.661 . . . . 0.0 110.225 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.557 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 88.3 p -68.8 -36.49 78.33 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.768 -1.207 . . . . 0.0 111.139 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.4 mt -148.49 159.59 43.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.984 2.114 . . . . 0.0 111.604 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -149.93 112.47 4.73 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.475 1.11 . . . . 0.0 110.473 170.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -96.27 -47.58 5.96 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.978 0.911 . . . . 0.0 112.465 174.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.84 178.68 27.21 Favored Glycine 0 CA--C 1.544 1.856 0 C-N-CA 125.757 1.646 . . . . 0.0 113.993 -169.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 45.2 t80 . . . . . 0 CA--C 1.549 0.917 0 O-C-N 121.311 -1.111 . . . . 0.0 113.44 175.222 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.624 0 CA-C-O 121.603 0.557 . . . . 0.0 114.074 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 68.9 mt -112.38 114.61 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.721 1.608 . . . . 0.0 108.319 175.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -70.64 147.64 48.94 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.004 -0.435 . . . . 0.0 111.42 173.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 58.79 22.89 10.6 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.91 1.684 . . . . 0.0 114.465 175.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -65.8 130.7 44.2 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.297 1.439 . . . . 0.0 112.068 -171.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -79.68 122.55 26.69 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.586 1.155 . . . . 0.0 112.723 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 28.5 mm -113.93 117.66 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.419 1.088 . . . . 0.0 110.002 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mp -107.85 101.06 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.228 1.411 . . . . 0.0 107.889 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.5 p -87.08 160.61 18.51 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.585 0.707 . . . . 0.0 111.578 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -152.82 139.78 19.15 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.702 1.201 . . . . 0.0 111.191 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.9 mt -78.49 132.14 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 173.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 . . . . . 0 N--CA 1.465 0.316 0 C-N-CA 125.387 1.475 . . . . 0.0 110.088 174.183 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 CA--C 1.54 0.582 0 CA-C-O 121.192 0.52 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -106.64 167.29 9.96 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.09 1.356 . . . . 0.0 110.387 170.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.8 tp -118.77 136.92 54.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.398 1.479 . . . . 0.0 108.114 169.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.1 p -125.71 159.38 32.45 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.717 0.807 . . . . 0.0 110.151 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -149.81 144.8 26.23 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.965 0.906 . . . . 0.0 111.709 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.3 p -82.28 112.48 19.31 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.767 1.227 . . . . 0.0 111.057 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.1 -163.75 38.99 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.286 0.946 . . . . 0.0 113.158 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -72.02 168.92 17.06 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.583 0.706 . . . . 0.0 111.545 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -72.04 131.55 43.03 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.12 -0.988 . . . . 0.0 110.939 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 121.335 0.588 . . . . 0.0 112.295 172.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.476 0.863 0 CA-C-O 120.823 0.344 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.1 105.66 2.53 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.654 0.781 . . . . 0.0 109.284 175.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -109.05 144.57 36.89 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 122.087 0.946 . . . . 0.0 111.09 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -135.6 168.28 19.55 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.443 1.497 . . . . 0.0 111.536 -171.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.64 132.18 20.97 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.122 0.569 . . . . 0.0 110.004 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.4 ' CG2' HD11 ' A' ' 166' ' ' LEU . 66.3 mt -123.95 140.2 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.82 0.848 . . . . 0.0 108.766 176.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.2 m -65.49 95.43 0.21 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.833 0.853 . . . . 0.0 109.432 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.415 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.0 OUTLIER -53.67 -32.64 52.41 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.577 1.151 . . . . 0.0 111.767 176.299 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -67.86 -25.81 65.72 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -86.35 -34.06 20.36 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.584 1.153 . . . . 0.0 112.237 171.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.497 HD13 ' HG3' ' A' ' 100' ' ' MET . 22.7 mt -58.65 -43.47 89.82 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.211 -0.931 . . . . 0.0 111.277 176.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -53.98 -33.0 55.78 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.487 1.115 . . . . 0.0 113.816 174.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 61.2 mttm . . . . . 0 N--CA 1.48 1.058 0 C-N-CA 125.281 1.433 . . . . 0.0 114.205 179.039 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.1 pttt . . . . . 0 N--CA 1.469 0.496 0 CA-C-O 121.141 0.496 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -156.4 165.67 35.67 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.913 0.885 . . . . 0.0 110.338 170.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.56 134.33 48.6 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.2 m -132.06 161.52 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.082 1.353 . . . . 0.0 112.097 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -67.47 141.63 56.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.359 1.063 . . . . 0.0 110.268 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.2 tp -138.7 135.73 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.33 1.452 . . . . 0.0 108.751 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -128.86 161.56 29.55 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.152 1.781 . . . . 0.0 109.38 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -129.96 155.13 46.58 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.017 1.327 . . . . 0.0 111.043 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.7 118.49 22.3 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 169.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.5 p30 -68.21 178.47 1.89 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.466 1.127 . . . . 0.0 113.54 171.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -58.18 -11.83 2.99 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.355 1.862 . . . . 0.0 114.846 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.9 t -107.57 4.14 25.68 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.236 1.414 . . . . 0.0 112.514 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.69 22.35 78.41 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 120.643 -1.286 . . . . 0.0 114.505 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -105.05 138.9 40.54 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.486 1.143 . . . . 0.0 110.932 174.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -69.93 126.42 29.66 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.108 0.963 . . . . 0.0 110.538 173.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 t -142.14 143.71 33.13 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.963 1.305 . . . . 0.0 110.324 -177.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -54.65 135.61 46.54 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.726 0.811 . . . . 0.0 113.048 -176.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.0 tp -111.55 -49.88 2.97 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.058 0.943 . . . . 0.0 111.075 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.57 -131.47 2.07 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 121.395 0.442 . . . . 0.0 114.108 -173.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.79 135.29 29.52 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.255 1.422 . . . . 0.0 110.123 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.454 HD11 ' HB ' ' A' ' 74' ' ' THR . 1.2 tm? -106.19 108.66 20.29 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.291 1.436 . . . . 0.0 109.224 -176.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.463 HG12 ' HG3' ' A' ' 66' ' ' ARG . 60.7 t -85.95 96.53 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.797 1.239 . . . . 0.0 109.295 174.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.6 t -71.46 110.18 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.154 0.981 . . . . 0.0 109.286 168.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.463 ' HG3' HG12 ' A' ' 64' ' ' VAL . 66.8 mtp85 . . . . . 0 N--CA 1.475 0.805 0 C-N-CA 127.122 2.169 . . . . 0.0 110.217 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.701 0 N-CA-C 114.344 0.498 . . . . 0.0 114.344 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 70.1 mt -128.48 137.21 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.275 1.03 . . . . 0.0 108.919 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.07 146.32 46.04 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.336 1.454 . . . . 0.0 108.879 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.454 ' HB ' HD11 ' A' ' 63' ' ' LEU . 75.9 p -132.58 143.25 49.58 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.198 -0.939 . . . . 0.0 110.205 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.77 136.13 8.15 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -92.49 131.55 37.54 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.666 1.987 . . . . 0.0 109.94 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.0 m120 . . . . . 0 CA--C 1.543 0.68 0 C-N-CA 125.204 1.401 . . . . 0.0 110.459 -174.208 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 51.9 m -59.48 123.42 16.77 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.403 -0.811 . . . . 0.0 109.039 168.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -87.3 -50.37 6.63 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.866 0.466 . . . . 0.0 110.124 -176.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -166.38 164.2 17.44 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.251 1.02 . . . . 0.0 112.977 172.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 p -150.32 147.48 27.68 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.859 1.314 . . . . 0.0 113.227 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.413 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.5 OUTLIER -133.58 162.69 31.23 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.269 1.428 . . . . 0.0 111.656 -177.042 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -81.93 166.7 19.65 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.582 0.753 . . . . 0.0 112.368 -175.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -55.79 -34.19 65.06 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.07 -1.019 . . . . 0.0 112.423 175.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -67.98 -3.28 9.52 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.461 1.505 . . . . 0.0 113.913 175.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 t -122.09 -3.39 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.318 1.047 . . . . 0.0 111.567 -177.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.2 t -53.22 -65.44 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 120.492 -1.38 . . . . 0.0 110.863 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -64.7 -27.74 69.12 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.744 -0.597 . . . . 0.0 112.227 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.33 -53.54 53.55 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.72 1.608 . . . . 0.0 110.359 174.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -62.99 -42.39 99.84 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.475 1.11 . . . . 0.0 111.937 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 92.7 t -58.5 -37.04 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 122.885 0.474 . . . . 0.0 110.844 176.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -64.71 -55.02 22.58 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.61 1.164 . . . . 0.0 112.784 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.7 -9.6 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 121.577 -0.702 . . . . 0.0 112.28 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.466 ' CG ' HD13 ' A' ' 166' ' ' LEU . 20.8 ttm -95.73 -4.72 43.59 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.589 -1.319 . . . . 0.0 112.934 177.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.9 p -127.49 -13.1 5.5 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.725 0.81 . . . . 0.0 112.875 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -131.54 -12.11 3.48 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.522 1.529 . . . . 0.0 114.434 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.19 155.96 9.85 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.074 1.321 . . . . 0.0 113.662 -175.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 156.21 -168.3 33.55 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.357 0.979 . . . . 0.0 113.556 -175.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 36.0 p -146.51 105.83 3.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.483 1.113 . . . . 0.0 113.463 -168.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -136.32 143.55 44.21 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.162 1.785 . . . . 0.0 110.246 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -74.84 153.05 38.88 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.543 -0.723 . . . . 0.0 111.297 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.4 p -118.87 135.86 54.34 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.327 1.451 . . . . 0.0 110.875 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.413 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 6.6 t -48.15 -42.25 29.0 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.103 1.361 . . . . 0.0 113.235 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.4 mt -147.53 145.51 29.11 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.67 1.588 . . . . 0.0 112.769 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -143.89 101.18 3.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.272 1.029 . . . . 0.0 110.783 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -91.99 -37.16 12.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.157 0.983 . . . . 0.0 113.298 176.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.75 -176.95 8.42 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.414 1.483 . . . . 0.0 114.824 -172.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.0 t80 . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 174.065 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.365 0 CA-C-O 121.724 0.625 . . . . 0.0 113.356 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.3 mt -121.34 116.22 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.228 1.411 . . . . 0.0 108.078 173.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -68.34 140.56 55.9 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.977 0.418 . . . . 0.0 111.617 170.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 55.41 29.34 12.97 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.878 1.671 . . . . 0.0 114.279 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -59.52 127.75 33.62 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.804 1.242 . . . . 0.0 111.564 -175.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -75.79 119.5 19.87 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.017 0.527 . . . . 0.0 111.336 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.5 mm -112.16 116.82 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.832 1.253 . . . . 0.0 109.08 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.12 97.97 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 124.724 1.21 . . . . 0.0 108.491 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 43.0 p -76.97 159.58 29.84 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.87 174.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -153.3 142.49 21.44 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.791 1.236 . . . . 0.0 111.061 170.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mt -83.32 135.03 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.402 0.681 . . . . 0.0 109.245 174.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 . . . . . 0 N--CA 1.469 0.486 0 C-N-CA 124.887 1.275 . . . . 0.0 111.195 174.103 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 CA--C 1.541 0.619 0 CA-C-O 121.253 0.549 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -108.72 166.3 10.91 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.919 1.688 . . . . 0.0 110.62 170.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.2 tp -116.13 135.04 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.769 1.628 . . . . 0.0 108.043 169.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.1 p -125.31 155.8 39.65 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.547 0.739 . . . . 0.0 109.957 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -146.4 138.37 24.89 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.795 0.838 . . . . 0.0 111.221 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.0 p -75.69 113.38 13.07 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.325 1.05 . . . . 0.0 111.202 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.17 -156.59 26.5 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.577 1.084 . . . . 0.0 113.014 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.26 -174.05 0.34 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.04 0.936 . . . . 0.0 112.991 169.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -100.51 113.98 27.21 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.141 0.976 . . . . 0.0 111.716 169.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.766 0 C-N-CA 124.074 0.95 . . . . 0.0 112.25 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.42 86.85 1.53 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.09 0.556 . . . . 0.0 110.475 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -90.21 145.3 25.12 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.524 1.154 . . . . 0.0 112.057 172.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -138.75 169.0 18.57 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 126.359 1.863 . . . . 0.0 110.857 -173.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.44 132.26 21.33 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.079 0.551 . . . . 0.0 110.246 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.458 ' CG2' HD11 ' A' ' 166' ' ' LEU . 58.2 mt -125.06 139.98 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.145 0.978 . . . . 0.0 108.871 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.0 m -67.16 95.21 0.39 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.477 -0.764 . . . . 0.0 110.048 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.556 HD21 ' HE2' ' A' ' 167' ' ' LYS . 1.0 OUTLIER -52.23 -33.52 41.78 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.574 1.15 . . . . 0.0 111.766 176.164 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -67.2 -29.56 69.26 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -84.82 -27.54 26.72 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.175 0.99 . . . . 0.0 111.859 172.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 163' ' ' LEU . 40.8 mt -68.01 -43.01 79.8 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.558 0.743 . . . . 0.0 110.158 175.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.556 ' HE2' HD21 ' A' ' 163' ' ' LEU . 15.3 mtmt -57.32 -20.0 25.93 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.6 mttt . . . . . 0 N--CA 1.481 1.08 0 C-N-CA 124.502 1.121 . . . . 0.0 114.021 178.049 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.0 pttt . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 120.886 0.374 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -143.8 171.02 14.79 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.027 0.931 . . . . 0.0 110.786 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -142.26 122.35 13.75 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.699 -0.626 . . . . 0.0 110.77 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.6 m -123.76 161.24 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 126.351 1.86 . . . . 0.0 111.095 -176.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 160.09 13.72 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.535 0.734 . . . . 0.0 112.496 176.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.0 tp -152.72 138.5 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.712 1.605 . . . . 0.0 109.085 174.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -129.14 159.33 36.36 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.613 1.965 . . . . 0.0 109.333 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -134.86 160.94 36.63 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.731 1.213 . . . . 0.0 111.866 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.67 119.81 25.23 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.603 0.361 . . . . 0.0 110.619 172.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.9 p30 -68.81 177.08 2.71 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 122.636 1.208 . . . . 0.0 113.625 170.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.8 mtmm -58.25 -23.16 55.07 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.107 1.763 . . . . 0.0 113.337 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 m -84.03 -11.18 57.15 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.013 1.325 . . . . 0.0 113.076 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.72 33.38 42.55 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.201 1.381 . . . . 0.0 114.291 -175.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -120.72 145.65 47.28 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.363 1.465 . . . . 0.0 111.18 175.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -67.76 130.83 44.23 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.708 0.803 . . . . 0.0 111.054 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.4 t -143.12 142.84 31.61 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.824 1.249 . . . . 0.0 110.652 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -56.41 132.47 51.23 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.252 1.021 . . . . 0.0 112.342 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.9 tp -108.12 -49.87 3.13 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.571 0.749 . . . . 0.0 111.22 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.47 -119.05 0.82 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.761 0.696 . . . . 0.0 112.916 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -143.05 158.09 43.93 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.589 1.555 . . . . 0.0 111.064 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.8 tp -122.47 103.75 8.92 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.861 1.664 . . . . 0.0 110.137 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.1 t -74.73 98.85 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.572 1.149 . . . . 0.0 109.383 172.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.8 t -87.07 115.47 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.717 1.207 . . . . 0.0 110.057 173.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 . . . . . 0 N--CA 1.476 0.828 0 C-N-CA 126.906 2.083 . . . . 0.0 110.359 178.233 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.77 0 CA-C-O 121.501 0.501 . . . . 0.0 113.709 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.9 mt -117.77 142.55 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.669 0.788 . . . . 0.0 109.168 173.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -131.28 136.06 47.84 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.762 1.225 . . . . 0.0 109.138 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.6 p -129.4 150.27 50.83 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.516 0.727 . . . . 0.0 111.636 -171.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -144.32 122.73 1.85 Allowed Glycine 0 C--N 1.335 0.506 0 O-C-N 121.746 -0.596 . . . . 0.0 112.446 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -65.87 136.37 56.05 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.291 1.436 . . . . 0.0 109.621 174.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 . . . . . 0 CA--C 1.542 0.673 0 C-N-CA 126.891 2.076 . . . . 0.0 108.964 178.016 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.3 m -55.61 128.38 34.35 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 121.269 -0.895 . . . . 0.0 110.281 170.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -95.53 -51.6 4.48 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.345 0.658 . . . . 0.0 110.151 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -164.8 163.17 21.31 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.025 0.93 . . . . 0.0 112.527 170.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.05 146.79 31.08 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.005 1.322 . . . . 0.0 111.94 177.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.523 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -128.13 160.06 33.2 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.795 1.638 . . . . 0.0 111.429 -176.471 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -78.29 164.82 24.54 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.468 0.707 . . . . 0.0 112.299 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -56.67 -33.76 66.69 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.352 1.461 . . . . 0.0 114.496 174.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -69.78 -9.64 55.34 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.581 1.153 . . . . 0.0 112.957 173.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.8 t -112.51 -8.09 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.294 1.038 . . . . 0.0 111.054 -173.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.5 t -46.62 -67.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 125.623 1.569 . . . . 0.0 111.905 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -67.22 -26.97 66.87 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.501 -0.749 . . . . 0.0 112.737 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -63.56 -52.08 62.61 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.701 1.6 . . . . 0.0 110.703 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -59.47 -46.7 88.04 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 125.476 1.51 . . . . 0.0 111.031 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 82.8 t -56.19 -36.15 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.468 0.707 . . . . 0.0 110.806 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -65.87 -54.47 26.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.857 1.263 . . . . 0.0 112.659 174.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 m -71.55 -16.88 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 120.913 -1.117 . . . . 0.0 112.539 -176.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.644 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -87.32 -5.2 58.99 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.169 1.788 . . . . 0.0 111.693 177.042 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 65.0 p -128.56 -15.05 4.56 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -134.18 -10.02 2.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.493 1.517 . . . . 0.0 114.183 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.49 156.31 10.89 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.642 1.592 . . . . 0.0 113.96 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 157.66 -166.01 33.71 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.129 0.871 . . . . 0.0 113.838 -175.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 61.2 p -148.56 103.26 3.39 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -170.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -134.76 143.68 47.26 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.05 1.74 . . . . 0.0 110.137 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -71.15 162.73 28.94 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.457 -0.777 . . . . 0.0 111.636 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 81.5 p -127.43 154.12 45.43 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.441 1.497 . . . . 0.0 110.972 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.523 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 82.4 p -71.07 -38.79 72.46 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.427 -0.796 . . . . 0.0 111.103 -177.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.2 mt -152.83 140.37 19.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.71 2.004 . . . . 0.0 111.468 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -134.5 102.57 5.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.999 0.92 . . . . 0.0 110.046 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -87.49 -46.88 9.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.51 1.124 . . . . 0.0 112.76 175.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.43 173.99 34.51 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.204 1.383 . . . . 0.0 113.636 -168.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.8 t80 . . . . . 0 CA--C 1.546 0.827 0 C-N-CA 124.122 0.969 . . . . 0.0 111.922 169.568 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.366 0 CA-C-O 121.447 0.471 . . . . 0.0 113.475 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.6 mt -113.38 112.95 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.073 1.349 . . . . 0.0 108.168 176.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -74.18 147.92 42.13 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.015 0.436 . . . . 0.0 111.384 172.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 59.31 21.91 10.2 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.659 1.583 . . . . 0.0 113.976 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -63.24 126.31 26.99 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.954 1.302 . . . . 0.0 111.515 -172.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -74.88 122.36 23.28 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.36 1.464 . . . . 0.0 112.267 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.5 mm -118.48 118.02 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.184 0.993 . . . . 0.0 109.835 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.7 92.64 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.485 1.514 . . . . 0.0 109.18 -177.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.2 p -74.86 156.58 36.29 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.498 174.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -153.48 142.7 21.46 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.182 1.393 . . . . 0.0 111.646 173.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 21.8 mt -81.49 132.02 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.068 0.547 . . . . 0.0 109.721 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 CA--C 1.538 0.489 0 C-N-CA 125.694 1.598 . . . . 0.0 110.232 173.833 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -109.17 167.88 9.78 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.471 1.508 . . . . 0.0 110.447 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.4 tp -123.16 132.04 72.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 125.331 1.452 . . . . 0.0 108.31 171.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.2 p -120.25 152.64 37.46 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.588 0.755 . . . . 0.0 109.878 177.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -145.63 147.55 32.14 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.306 0.574 . . . . 0.0 111.602 178.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.5 p -73.06 109.69 6.79 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.272 1.029 . . . . 0.0 111.21 174.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.77 -166.47 30.61 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 122.139 0.855 . . . . 0.0 113.232 172.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -65.65 162.0 19.34 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.148 0.979 . . . . 0.0 113.015 170.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -84.3 101.09 11.67 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.866 1.266 . . . . 0.0 111.853 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.68 0 C-N-CA 123.458 0.703 . . . . 0.0 112.574 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.7 m . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 120.502 0.191 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.59 83.2 0.42 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.338 1.055 . . . . 0.0 110.478 176.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -81.08 141.92 33.84 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 122.157 0.979 . . . . 0.0 111.717 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -135.31 169.71 17.06 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.73 1.612 . . . . 0.0 111.534 -173.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.35 132.55 18.38 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.576 0.75 . . . . 0.0 110.446 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.46 ' CG2' HD11 ' A' ' 166' ' ' LEU . 68.0 mt -124.98 141.5 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.09 0.956 . . . . 0.0 108.88 177.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.3 m -66.33 93.44 0.22 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.64 1.176 . . . . 0.0 110.194 176.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.59 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.4 tt -54.98 -30.81 60.02 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.226 1.41 . . . . 0.0 112.45 178.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -71.65 -30.51 65.82 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -82.64 -30.7 29.2 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.01 0.924 . . . . 0.0 112.237 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.644 HD13 ' HG3' ' A' ' 100' ' ' MET . 20.7 mt -57.22 -49.77 74.96 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.914 0.886 . . . . 0.0 110.779 173.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -50.45 -38.21 42.38 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.263 1.025 . . . . 0.0 113.391 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.889 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.303 0 CA-C-O 121.132 0.492 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -150.2 167.09 27.9 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.069 0.948 . . . . 0.0 110.921 173.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -131.15 131.0 43.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.855 0.462 . . . . 0.0 111.037 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 m -129.34 167.85 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 126.179 1.791 . . . . 0.0 111.026 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -65.3 166.78 9.4 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.741 1.217 . . . . 0.0 111.943 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.422 HG21 ' CD2' ' A' ' 76' ' ' LEU . 5.4 tp -161.82 135.72 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.128 1.371 . . . . 0.0 109.933 172.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -129.07 160.11 33.82 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.509 1.924 . . . . 0.0 109.324 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -127.19 160.25 31.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.337 1.455 . . . . 0.0 111.072 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -81.49 121.82 26.76 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 122.048 -0.407 . . . . 0.0 110.565 171.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -64.09 175.47 1.23 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.411 1.085 . . . . 0.0 112.105 171.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -59.76 -13.73 11.52 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.692 1.997 . . . . 0.0 114.737 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.6 m -117.05 15.55 15.06 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.932 1.293 . . . . 0.0 112.771 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.13 20.84 77.0 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 121.203 -0.936 . . . . 0.0 114.378 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -96.46 127.62 42.63 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.609 1.164 . . . . 0.0 109.485 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -69.05 125.92 28.19 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.633 -0.667 . . . . 0.0 110.639 174.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.2 t -141.78 138.32 32.19 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.851 1.26 . . . . 0.0 111.009 -172.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -57.67 137.19 56.7 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.142 0.977 . . . . 0.0 112.979 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 44.4 tp -111.03 -46.33 3.34 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.827 0.851 . . . . 0.0 111.723 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.47 -121.95 0.95 Allowed Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.351 0.501 . . . . 0.0 113.327 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -147.49 153.44 39.53 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.308 1.443 . . . . 0.0 110.482 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.8 tp -118.84 107.57 13.77 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.121 1.368 . . . . 0.0 111.005 -176.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.7 t -82.48 102.28 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.705 1.202 . . . . 0.0 108.327 173.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.07 103.25 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.769 1.628 . . . . 0.0 109.448 176.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 . . . . . 0 N--CA 1.478 0.934 0 C-N-CA 125.859 1.664 . . . . 0.0 110.965 -178.221 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.225 0 N-CA-C 115.965 1.146 . . . . 0.0 115.965 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.439 HG13 HG22 ' A' ' 93' ' ' VAL . 35.5 mt -121.91 136.57 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.327 1.051 . . . . 0.0 109.304 173.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.04 117.19 19.64 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 126.413 1.885 . . . . 0.0 109.411 -175.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.2 p -106.24 149.78 26.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.012 0.925 . . . . 0.0 111.32 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.09 128.32 3.84 Favored Glycine 0 C--N 1.336 0.581 0 O-C-N 121.265 -0.897 . . . . 0.0 111.876 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.422 ' CD2' HG21 ' A' ' 48' ' ' ILE . 3.2 tm? -85.3 127.75 34.44 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 127.157 2.183 . . . . 0.0 110.623 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.2 m120 . . . . . 0 CA--C 1.538 0.509 0 C-N-CA 125.761 1.624 . . . . 0.0 109.748 -174.25 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.615 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.9 m -55.39 122.86 12.12 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.876 0.87 . . . . 0.0 110.366 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -91.15 -49.91 6.13 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.78 0.432 . . . . 0.0 110.015 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -160.36 171.12 19.68 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.764 0.792 . . . . 0.0 113.093 171.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.3 136.97 12.25 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.397 -0.815 . . . . 0.0 112.764 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.484 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -132.03 155.31 48.26 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.464 1.906 . . . . 0.0 111.188 -174.373 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -79.44 168.04 20.01 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.384 0.674 . . . . 0.0 112.598 -171.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.457 ' HA ' HG23 ' A' ' 93' ' ' VAL . 2.7 tm-20 -57.63 -34.3 69.17 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.425 1.09 . . . . 0.0 112.328 176.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -63.2 -16.33 59.8 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.643 1.577 . . . . 0.0 114.023 171.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.4 t -111.18 -8.25 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.603 1.161 . . . . 0.0 111.087 -173.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.457 HG23 ' HA ' ' A' ' 90' ' ' GLU . 54.7 t -47.78 -64.62 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 125.726 1.611 . . . . 0.0 111.486 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -68.93 -28.22 66.46 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -49.71 75.36 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.536 1.534 . . . . 0.0 110.367 176.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -61.88 -42.42 99.05 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.107 1.363 . . . . 0.0 112.07 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 95.3 t -56.95 -37.18 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.615 0.766 . . . . 0.0 110.679 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -68.4 -54.01 20.03 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.427 1.091 . . . . 0.0 112.447 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 m -73.5 -8.79 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 O-C-N 120.834 -1.166 . . . . 0.0 113.093 -175.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.561 ' CG ' HD13 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -98.58 -3.2 36.83 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.855 1.262 . . . . 0.0 112.387 176.473 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.9 p -129.6 -13.82 4.21 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.474 1.11 . . . . 0.0 113.041 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -135.74 -11.15 2.07 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.342 1.857 . . . . 0.0 114.1 177.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.93 154.94 11.29 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.067 1.318 . . . . 0.0 114.034 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.64 -159.51 31.4 Favored Glycine 0 CA--C 1.532 1.155 0 O-C-N 121.756 -0.849 . . . . 0.0 114.201 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 88.1 p -153.94 100.39 2.35 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -170.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -131.93 142.94 49.79 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.866 1.667 . . . . 0.0 110.091 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.4 154.61 39.95 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 121.465 -0.772 . . . . 0.0 111.106 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.7 p -118.4 156.9 28.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.231 1.412 . . . . 0.0 111.011 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.484 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 8.4 t -67.93 -41.14 83.02 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.307 1.043 . . . . 0.0 111.314 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 mt -155.56 137.69 14.67 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.243 1.817 . . . . 0.0 111.152 -177.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -134.38 103.84 5.89 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.485 1.114 . . . . 0.0 110.275 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -90.27 -39.66 12.62 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.43 175.34 6.46 Favored Glycine 0 CA--C 1.543 1.807 0 C-N-CA 124.926 1.251 . . . . 0.0 114.508 -169.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.3 t80 . . . . . 0 CA--C 1.55 0.947 0 O-C-N 121.497 -1.002 . . . . 0.0 112.272 169.386 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.177 0 CA-C-O 121.677 0.598 . . . . 0.0 113.007 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.4 mt -127.02 105.42 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.023 1.329 . . . . 0.0 107.885 169.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -67.67 146.35 53.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.074 0.464 . . . . 0.0 111.095 172.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 57.45 24.69 10.51 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.355 1.462 . . . . 0.0 113.993 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -53.95 127.51 26.58 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.077 1.351 . . . . 0.0 111.039 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -76.9 127.71 33.21 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 122.064 -0.397 . . . . 0.0 110.252 169.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 33.3 mm -122.57 115.76 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.845 1.258 . . . . 0.0 108.334 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -112.08 100.69 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 125.264 1.426 . . . . 0.0 107.875 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.7 p -83.18 159.21 22.07 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.666 0.746 . . . . 0.0 111.775 176.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -152.07 138.66 18.7 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.67 1.188 . . . . 0.0 110.863 173.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.4 mt -80.07 132.27 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 . . . . . 0 N--CA 1.465 0.31 0 C-N-CA 125.31 1.444 . . . . 0.0 110.344 175.042 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 . . . . . 0 CA--C 1.535 0.4 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -106.33 164.06 12.33 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.694 1.197 . . . . 0.0 110.485 171.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.1 tp -117.5 134.83 59.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 125.615 1.566 . . . . 0.0 107.615 169.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.1 p -124.09 155.75 37.82 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.356 0.662 . . . . 0.0 109.854 175.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -150.89 147.03 26.71 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.447 0.699 . . . . 0.0 112.179 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 55.2 p -76.24 108.17 8.98 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.059 1.344 . . . . 0.0 111.833 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.98 -160.38 17.87 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 123.999 0.809 . . . . 0.0 113.528 173.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -67.22 159.77 28.38 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.89 0.876 . . . . 0.0 112.836 171.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -78.21 106.25 9.99 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.838 1.255 . . . . 0.0 110.358 172.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 123.22 0.608 . . . . 0.0 112.326 174.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 120.915 0.388 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.26 98.67 0.83 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.392 0.677 . . . . 0.0 110.227 170.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -91.94 144.45 25.45 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.346 1.069 . . . . 0.0 111.592 172.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -134.28 169.64 16.9 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 126.106 1.763 . . . . 0.0 110.962 -173.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.07 133.44 21.79 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.184 0.594 . . . . 0.0 109.991 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.434 ' CG2' HD11 ' A' ' 166' ' ' LEU . 62.0 mt -126.5 138.63 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 123.736 0.815 . . . . 0.0 108.822 175.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.9 m -64.55 98.2 0.24 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.863 0.865 . . . . 0.0 109.43 177.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.559 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.0 OUTLIER -53.83 -32.74 53.91 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.693 1.197 . . . . 0.0 111.634 177.829 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -68.32 -32.21 72.17 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -82.56 -27.74 31.4 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.335 -0.853 . . . . 0.0 112.836 173.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.561 HD13 ' CG ' ' A' ' 100' ' ' MET . 18.8 mt -62.59 -51.03 68.95 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.644 0.778 . . . . 0.0 110.912 172.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -48.75 -43.36 37.61 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.853 1.261 . . . . 0.0 113.24 176.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.6 mttt . . . . . 0 N--CA 1.482 1.147 0 C-N-CA 125.542 1.537 . . . . 0.0 114.32 -178.625 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.8 pttt . . . . . 0 C--O 1.233 0.235 0 CA-C-O 121.299 0.571 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -147.39 165.86 28.93 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.297 1.439 . . . . 0.0 110.527 177.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -130.64 134.13 46.71 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.08 -0.387 . . . . 0.0 110.881 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.0 m -128.05 165.1 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.083 1.753 . . . . 0.0 109.979 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -68.55 163.39 23.66 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.56 0.744 . . . . 0.0 110.96 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.5 tp -147.01 136.12 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.078 0.951 . . . . 0.0 109.254 170.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -126.5 160.1 31.53 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.626 1.971 . . . . 0.0 109.105 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.4 161.56 35.48 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.905 0.882 . . . . 0.0 112.06 176.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.74 118.16 23.71 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.847 0.459 . . . . 0.0 110.209 173.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -72.06 178.85 3.56 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.403 0.621 . . . . 0.0 112.459 175.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -57.67 -26.37 61.57 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.87 1.668 . . . . 0.0 113.111 173.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.3 t -70.65 -17.69 62.86 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.799 1.64 . . . . 0.0 113.747 173.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.45 36.39 62.88 Favored Glycine 0 CA--C 1.534 1.233 0 O-C-N 121.072 -1.018 . . . . 0.0 113.287 -171.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -125.09 143.81 50.73 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.994 1.718 . . . . 0.0 109.85 175.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -67.64 132.83 48.25 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.814 0.846 . . . . 0.0 111.141 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 t -142.44 136.62 29.66 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.838 1.255 . . . . 0.0 110.509 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -56.98 133.14 54.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.04 0.936 . . . . 0.0 112.446 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.1 tp -111.36 -45.83 3.36 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.112 0.965 . . . . 0.0 111.212 -176.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.26 -137.89 4.02 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 122.067 0.815 . . . . 0.0 113.813 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -129.0 163.59 25.04 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.511 1.925 . . . . 0.0 110.608 173.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 16.2 tp -130.1 106.39 8.59 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.49 2.316 . . . . 0.0 110.256 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.0 t -80.31 99.44 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.659 1.184 . . . . 0.0 109.332 174.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.89 117.12 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.504 1.522 . . . . 0.0 109.587 173.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 . . . . . 0 N--CA 1.476 0.829 0 C-N-CA 127.124 2.17 . . . . 0.0 110.726 178.77 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.836 0 CA-C-O 121.656 0.587 . . . . 0.0 113.78 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.2 mt -126.22 138.84 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.899 0.879 . . . . 0.0 109.589 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -127.7 129.89 47.91 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.276 1.43 . . . . 0.0 109.036 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.9 p -121.55 137.63 54.65 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.502 -0.749 . . . . 0.0 110.207 -175.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.6 108.88 0.71 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -170.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 tt -64.04 142.24 58.48 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.771 0.828 . . . . 0.0 110.612 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.8 t30 . . . . . 0 CA--C 1.543 0.702 0 C-N-CA 126.18 1.792 . . . . 0.0 109.313 178.938 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 93.7 m -60.77 123.03 16.29 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 121.099 -1.0 . . . . 0.0 109.286 169.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -85.46 -51.4 6.56 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.442 0.697 . . . . 0.0 109.849 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -162.57 170.27 18.86 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.275 1.03 . . . . 0.0 112.744 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.99 144.01 23.01 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 122.536 1.16 . . . . 0.0 113.198 175.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.482 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -129.46 154.93 46.49 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.813 1.645 . . . . 0.0 111.845 -175.677 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -78.31 167.21 21.7 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.406 0.682 . . . . 0.0 112.263 -173.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -53.68 -35.67 61.32 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.017 0.927 . . . . 0.0 112.646 173.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -65.48 -8.49 19.57 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.617 1.167 . . . . 0.0 113.684 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.9 t -118.13 -4.63 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.591 1.156 . . . . 0.0 111.224 -173.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.6 t -50.87 -65.08 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 125.13 1.372 . . . . 0.0 111.334 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -68.51 -25.77 65.11 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.88 -50.92 69.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.327 1.451 . . . . 0.0 110.603 173.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -58.65 -43.79 89.91 Favored 'General case' 0 C--N 1.335 -0.064 0 C-N-CA 124.964 1.305 . . . . 0.0 111.608 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 73.3 t -56.44 -37.6 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.902 0.481 . . . . 0.0 110.867 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -66.01 -54.51 25.07 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.444 1.098 . . . . 0.0 112.513 176.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 m -74.81 -3.67 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 121.13 -0.981 . . . . 0.0 113.402 -175.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.475 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -103.67 -4.25 24.02 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.156 1.782 . . . . 0.0 112.008 179.128 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 43.8 p -131.84 -15.36 3.05 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.779 1.232 . . . . 0.0 113.541 174.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -131.5 -12.42 3.47 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.649 1.579 . . . . 0.0 113.847 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.34 156.14 12.45 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.678 1.132 . . . . 0.0 113.752 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.78 -159.26 31.62 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 121.742 -0.858 . . . . 0.0 113.471 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.486 ' HB3' HG23 ' A' ' 130' ' ' ILE . 31.6 p -154.21 96.82 1.98 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -131.22 143.68 50.76 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.97 1.708 . . . . 0.0 110.606 -176.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -74.08 162.74 28.69 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.831 0.852 . . . . 0.0 111.49 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.0 p -129.66 143.76 50.97 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.217 1.407 . . . . 0.0 111.365 -177.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.482 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 24.4 p -57.81 -37.03 73.04 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.321 1.448 . . . . 0.0 112.839 -178.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mt -156.4 145.58 20.5 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.07 2.148 . . . . 0.0 110.549 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -141.62 109.83 5.9 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.023 0.929 . . . . 0.0 110.246 176.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -95.59 -57.73 2.31 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.385 1.074 . . . . 0.0 112.463 175.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.46 -169.6 29.06 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.244 1.402 . . . . 0.0 113.796 -171.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 12.6 t80 . . . . . 0 CA--C 1.543 0.688 0 O-C-N 121.739 -0.859 . . . . 0.0 113.102 -179.456 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.407 0 CA-C-O 121.206 0.337 . . . . 0.0 113.105 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 62.3 mt -119.77 113.14 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.076 1.35 . . . . 0.0 108.766 174.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -72.7 147.45 45.67 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.278 0.561 . . . . 0.0 111.565 172.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 57.12 22.44 7.47 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.034 1.734 . . . . 0.0 114.06 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -56.01 123.64 15.07 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.568 1.147 . . . . 0.0 110.534 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -71.07 127.91 34.17 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.87 0.868 . . . . 0.0 110.304 171.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 36.2 mm -123.93 117.67 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.351 1.06 . . . . 0.0 108.529 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.486 HG23 ' HB3' ' A' ' 105' ' ' SER . 3.9 mp -111.4 100.12 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.047 1.339 . . . . 0.0 107.746 -177.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.4 p -82.74 158.98 22.65 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.595 0.712 . . . . 0.0 111.674 175.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.2 ptpt -152.44 139.09 18.76 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.744 1.218 . . . . 0.0 111.069 175.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.5 mt -79.38 133.84 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 . . . . . 0 N--CA 1.468 0.453 0 C-N-CA 125.207 1.403 . . . . 0.0 110.622 173.593 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 . . . . . 0 CA--C 1.54 0.586 0 CA-C-O 121.261 0.553 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -105.41 168.97 8.73 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.362 1.465 . . . . 0.0 110.389 170.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.6 tp -120.38 134.85 62.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 125.597 1.559 . . . . 0.0 107.342 169.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.2 p -119.88 160.04 23.46 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.19 0.596 . . . . 0.0 109.462 171.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -148.45 142.33 25.77 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.797 0.839 . . . . 0.0 110.795 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.5 p -74.08 116.14 14.37 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.525 0.679 . . . . 0.0 110.53 173.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.74 -166.14 40.95 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.72 0.676 . . . . 0.0 112.139 174.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.29 172.16 12.94 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 121.981 0.896 . . . . 0.0 111.234 168.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -76.57 132.0 39.25 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.508 1.123 . . . . 0.0 110.43 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.905 0 O-C-N 121.472 -0.767 . . . . 0.0 111.81 171.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.472 0.635 0 CA-C-O 120.858 0.361 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -74.85 91.27 2.43 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.18 0.592 . . . . 0.0 110.517 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -77.93 151.44 33.72 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 122.32 1.057 . . . . 0.0 111.086 168.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -134.33 173.53 11.51 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.219 1.808 . . . . 0.0 110.884 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.91 138.09 24.06 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.659 0.663 . . . . 0.0 110.835 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 59.5 mt -128.8 141.53 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.05 0.94 . . . . 0.0 109.314 174.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.6 m -64.19 97.1 0.17 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.078 0.951 . . . . 0.0 109.764 175.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.519 ' HA ' HD12 ' A' ' 166' ' ' LEU . 0.8 OUTLIER -54.95 -30.95 60.03 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.582 1.153 . . . . 0.0 112.023 175.941 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -67.31 -25.82 66.22 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -93.53 -15.32 25.6 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.64 1.176 . . . . 0.0 113.153 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 163' ' ' LEU . 22.0 mt -73.87 -46.27 45.82 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.487 -0.758 . . . . 0.0 110.314 169.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -50.24 -45.12 53.76 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.704 1.202 . . . . 0.0 114.087 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 31.9 pttt . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -176.408 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.2 pttp . . . . . 0 N--CA 1.47 0.552 0 CA-C-O 120.962 0.41 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -141.21 168.32 20.06 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.68 1.192 . . . . 0.0 110.486 173.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -134.38 127.99 32.71 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.951 0.5 . . . . 0.0 110.081 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 m -126.08 158.16 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.233 1.413 . . . . 0.0 111.291 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -60.8 152.76 26.23 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.736 0.814 . . . . 0.0 111.35 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.1 tp -147.48 135.44 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.385 1.074 . . . . 0.0 109.585 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -127.68 158.72 36.81 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.465 1.906 . . . . 0.0 108.727 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -127.83 156.1 43.06 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.356 1.062 . . . . 0.0 111.106 175.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.23 119.85 22.89 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 170.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -67.66 176.33 2.5 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 122.01 0.91 . . . . 0.0 111.765 173.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -56.11 -16.13 4.67 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.91 2.084 . . . . 0.0 115.4 176.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -110.45 12.35 22.98 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.761 1.225 . . . . 0.0 113.349 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.65 20.9 79.37 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 120.973 -1.08 . . . . 0.0 114.515 176.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -102.27 144.07 31.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.529 1.132 . . . . 0.0 110.446 174.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -75.2 126.65 31.46 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.027 0.442 . . . . 0.0 110.418 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.9 t -131.57 135.18 46.8 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.317 1.447 . . . . 0.0 109.325 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -55.51 136.71 49.71 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.21 0.604 . . . . 0.0 111.816 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.3 tp -111.25 -46.38 3.31 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.799 0.84 . . . . 0.0 110.718 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.38 -111.37 0.44 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 123.103 0.382 . . . . 0.0 113.485 175.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -146.06 154.66 42.09 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.291 1.436 . . . . 0.0 110.261 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.8 tp -119.61 102.66 8.78 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.407 1.483 . . . . 0.0 109.899 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.9 t -75.46 98.12 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.07 1.348 . . . . 0.0 109.191 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.9 t -83.51 87.93 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.252 1.421 . . . . 0.0 110.062 175.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 . . . . . 0 N--CA 1.478 0.971 0 C-N-CA 124.823 1.249 . . . . 0.0 111.425 171.965 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.159 0 CA-C-O 121.284 0.38 . . . . 0.0 113.034 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.3 mt -88.9 141.0 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 121.601 -0.94 . . . . 0.0 108.899 177.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -131.26 89.7 2.76 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.061 1.344 . . . . 0.0 111.157 -174.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.6 p -83.71 152.63 24.62 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.531 -0.73 . . . . 0.0 112.778 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.76 128.22 3.4 Favored Glycine 0 CA--C 1.527 0.802 0 O-C-N 121.368 -0.833 . . . . 0.0 113.185 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.23 139.18 48.0 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.25 1.82 . . . . 0.0 110.125 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 42.0 t30 . . . . . 0 CA--C 1.543 0.697 0 C-N-CA 125.917 1.687 . . . . 0.0 111.042 -179.711 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.804 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.5 m -54.8 128.78 34.52 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.315 1.046 . . . . 0.0 110.766 171.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -96.98 -52.55 3.82 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.989 0.515 . . . . 0.0 110.376 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -164.16 154.29 14.7 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.891 0.876 . . . . 0.0 112.881 172.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.04 116.0 10.34 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 123.158 1.456 . . . . 0.0 113.343 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.94 171.61 9.46 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.967 1.307 . . . . 0.0 112.526 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -80.6 161.35 24.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.401 1.081 . . . . 0.0 112.266 176.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -55.6 -35.03 65.38 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.163 0.985 . . . . 0.0 113.055 172.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -68.07 -17.89 64.51 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 175.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.9 t -100.81 -10.58 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.831 0.852 . . . . 0.0 111.577 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 97' ' ' VAL . 75.9 t -47.08 -51.37 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.549 1.14 . . . . 0.0 111.577 176.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -73.24 -29.07 62.51 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 177.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -76.68 -39.42 52.14 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.138 -0.976 . . . . 0.0 111.981 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -57.18 -46.06 83.17 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 124.804 1.242 . . . . 0.0 110.815 173.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 93' ' ' VAL . 72.4 t -52.61 -42.94 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.498 1.119 . . . . 0.0 110.728 175.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -66.81 -55.01 16.77 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.507 1.523 . . . . 0.0 113.002 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 m -72.83 -5.95 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 O-C-N 121.424 -0.797 . . . . 0.0 112.983 -176.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.44 ' CG ' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -98.42 -5.77 31.9 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.727 1.611 . . . . 0.0 112.155 178.425 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.403 ' HB ' ' HE2' ' A' ' 167' ' ' LYS . 32.0 p -127.55 -13.16 5.45 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.934 0.894 . . . . 0.0 112.695 176.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -132.72 -11.21 3.08 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.656 1.582 . . . . 0.0 114.392 177.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.6 156.81 9.79 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.098 1.333 . . . . 0.0 113.821 -174.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.88 -153.93 24.95 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 121.655 -0.909 . . . . 0.0 113.106 -175.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.6 p -145.83 153.23 40.67 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.177 0.991 . . . . 0.0 112.936 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -148.73 179.55 7.75 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.317 1.847 . . . . 0.0 111.769 173.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -114.97 151.92 33.3 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.733 1.213 . . . . 0.0 110.025 168.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 62.4 p -117.28 133.58 55.81 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.766 0.827 . . . . 0.0 111.271 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.1 t -51.0 -37.85 47.62 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.308 1.043 . . . . 0.0 112.557 175.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.7 mt -146.48 147.23 30.98 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.029 1.731 . . . . 0.0 111.719 173.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -136.85 115.37 11.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 170.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -96.57 -49.01 5.3 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.8 0.84 . . . . 0.0 112.543 174.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.45 172.11 34.31 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 125.718 1.628 . . . . 0.0 113.423 -169.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 49.1 t80 . . . . . 0 CA--C 1.552 1.036 0 C-N-CA 124.131 0.972 . . . . 0.0 112.486 169.618 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.516 0 CA-C-O 121.201 0.334 . . . . 0.0 113.513 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.2 mt -122.51 119.23 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.636 1.574 . . . . 0.0 108.828 176.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -80.66 148.58 30.15 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 54.46 25.71 6.4 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.362 1.865 . . . . 0.0 113.979 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -63.08 126.57 27.8 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.283 1.433 . . . . 0.0 111.239 -172.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -78.95 130.42 35.56 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.013 0.525 . . . . 0.0 111.461 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.7 mm -126.87 120.36 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 125.862 1.665 . . . . 0.0 109.215 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.95 105.17 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.266 1.427 . . . . 0.0 108.71 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.7 p -78.69 159.88 27.77 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.725 0.774 . . . . 0.0 112.198 174.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -150.55 140.88 22.32 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.983 1.313 . . . . 0.0 110.523 171.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.4 mt -81.92 132.72 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 . . . . . 0 N--CA 1.467 0.412 0 C-N-CA 125.06 1.344 . . . . 0.0 110.563 174.019 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 CA--C 1.54 0.577 0 N-CA-C 109.56 -0.534 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -108.39 168.54 9.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.332 1.453 . . . . 0.0 110.227 171.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 tp -120.09 136.2 57.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 125.363 1.465 . . . . 0.0 108.25 170.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 p -123.25 155.64 36.77 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.337 0.655 . . . . 0.0 110.026 172.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -148.56 137.09 21.35 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.174 0.99 . . . . 0.0 111.024 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.7 p -70.52 115.55 9.82 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.168 0.987 . . . . 0.0 111.642 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.13 -163.23 38.65 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.739 1.162 . . . . 0.0 112.949 174.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -68.63 169.41 11.16 Favored 'General case' 0 CA--C 1.553 1.077 0 O-C-N 121.663 -0.904 . . . . 0.0 112.125 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -85.82 114.56 22.85 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.144 1.377 . . . . 0.0 111.265 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.748 0 C-N-CA 123.617 0.767 . . . . 0.0 111.687 174.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.8 m . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.16 93.94 0.64 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 169.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -90.55 147.8 23.11 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 122.272 1.034 . . . . 0.0 111.085 169.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -134.45 171.1 14.77 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.817 1.647 . . . . 0.0 110.932 -172.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.59 134.02 23.21 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.584 0.629 . . . . 0.0 110.5 177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.476 ' CG2' HD11 ' A' ' 166' ' ' LEU . 61.6 mt -127.13 140.59 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.187 0.995 . . . . 0.0 108.914 175.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.0 m -65.33 95.89 0.21 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.228 1.011 . . . . 0.0 109.914 177.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.553 HD21 ' HE3' ' A' ' 167' ' ' LYS . 1.2 tt -53.42 -33.5 54.22 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.18 0.992 . . . . 0.0 111.377 175.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -67.91 -28.87 67.86 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -79.06 -36.31 41.15 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.657 0.662 . . . . 0.0 111.807 169.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.476 HD11 ' CG2' ' A' ' 161' ' ' ILE . 16.1 mt -59.88 -37.32 79.04 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.554 -0.716 . . . . 0.0 111.794 176.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.553 ' HE3' HD21 ' A' ' 163' ' ' LEU . 73.6 mttt -62.14 -6.97 3.42 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 172.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 65.3 mttm . . . . . 0 N--CA 1.485 1.297 0 C-N-CA 124.985 1.314 . . . . 0.0 114.104 178.303 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.8 pttm . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 120.854 0.359 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -147.87 168.96 20.87 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.309 1.444 . . . . 0.0 110.72 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 m -136.55 134.82 37.91 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.91 0.484 . . . . 0.0 111.127 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.0 m -131.51 161.7 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.218 1.407 . . . . 0.0 112.304 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.34 153.15 23.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.742 1.217 . . . . 0.0 111.899 174.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.1 tp -152.94 136.79 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.442 1.497 . . . . 0.0 109.358 177.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -130.56 160.09 35.19 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.191 1.796 . . . . 0.0 109.759 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -132.93 158.76 41.82 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.845 1.258 . . . . 0.0 112.462 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 120.31 25.75 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.002 0.521 . . . . 0.0 110.76 173.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -72.63 179.71 3.45 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.401 0.68 . . . . 0.0 112.642 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -55.65 -29.35 59.13 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.734 1.614 . . . . 0.0 113.284 173.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.5 t -82.84 -6.8 59.6 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.127 1.371 . . . . 0.0 113.244 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.02 34.73 51.82 Favored Glycine 0 CA--C 1.533 1.219 0 O-C-N 120.855 -1.153 . . . . 0.0 114.058 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.05 145.39 45.93 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.362 1.465 . . . . 0.0 111.002 176.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -72.38 123.55 23.29 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.743 0.817 . . . . 0.0 111.181 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.0 t -139.2 141.76 37.91 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.208 1.403 . . . . 0.0 110.547 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -56.1 141.39 40.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.866 0.866 . . . . 0.0 113.054 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 tp -117.52 -47.87 2.62 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.741 0.816 . . . . 0.0 111.694 -178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.58 -117.6 0.71 Allowed Glycine 0 CA--C 1.529 0.906 0 CA-C-O 121.254 0.363 . . . . 0.0 113.663 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -145.08 156.04 43.68 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.518 1.527 . . . . 0.0 109.643 -177.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.2 tp -121.16 100.44 7.06 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.983 1.313 . . . . 0.0 110.065 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 t -76.0 96.3 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.161 1.384 . . . . 0.0 109.096 175.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.6 t -85.38 105.54 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.31 1.444 . . . . 0.0 110.031 173.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 63.3 mtt-85 . . . . . 0 N--CA 1.471 0.597 0 C-N-CA 126.482 1.913 . . . . 0.0 110.158 172.632 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.983 0 CA-C-O 121.551 0.528 . . . . 0.0 114.375 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.3 mt -122.96 145.25 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.427 1.091 . . . . 0.0 110.065 176.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -134.54 132.83 39.62 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.548 1.539 . . . . 0.0 109.763 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.6 p -126.33 147.37 49.74 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.929 -1.107 . . . . 0.0 111.883 -171.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.29 120.77 1.75 Allowed Glycine 0 CA--C 1.527 0.791 0 O-C-N 121.818 -0.551 . . . . 0.0 112.977 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.41 141.23 57.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.961 1.704 . . . . 0.0 110.036 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.553 1.074 0 C-N-CA 126.373 1.869 . . . . 0.0 111.034 -169.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.794 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.6 m -54.95 123.57 13.94 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.167 -0.958 . . . . 0.0 110.245 171.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -90.91 -51.84 5.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.599 0.76 . . . . 0.0 110.2 -177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -164.33 161.09 21.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.848 0.859 . . . . 0.0 112.613 172.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.14 153.7 43.15 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.998 1.319 . . . . 0.0 111.965 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.516 ' HA ' ' H ' ' A' ' 109' ' ' SER . 1.7 pp -140.77 154.78 46.42 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.411 1.485 . . . . 0.0 111.188 -175.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -78.52 166.96 21.97 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.602 0.715 . . . . 0.0 112.208 -172.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -59.57 -21.7 60.7 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 121.388 -0.82 . . . . 0.0 112.543 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -72.92 -12.98 61.16 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 121.045 -1.034 . . . . 0.0 113.583 173.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.7 t -112.13 -2.07 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 120.901 -1.124 . . . . 0.0 110.852 -171.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.0 m -60.96 -26.07 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -97.87 -25.57 14.97 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.693 0.679 . . . . 0.0 111.863 170.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -70.25 -53.7 15.84 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.583 1.553 . . . . 0.0 111.166 -178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -58.05 -44.58 87.5 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.571 1.148 . . . . 0.0 111.236 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 74.1 t -57.16 -36.86 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.957 0.903 . . . . 0.0 111.022 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -62.54 -57.5 10.93 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.464 1.105 . . . . 0.0 111.997 173.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -70.06 -17.16 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 O-C-N 121.331 -0.855 . . . . 0.0 112.573 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.483 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -87.2 -6.91 58.43 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.27 1.828 . . . . 0.0 111.91 177.637 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 46.2 p -128.1 -10.49 5.34 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 173.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -134.88 -9.96 2.34 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.578 1.551 . . . . 0.0 113.954 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.51 155.76 6.4 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.722 1.629 . . . . 0.0 113.824 -174.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.1 -170.8 33.3 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.267 0.937 . . . . 0.0 114.096 -175.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.8 p -143.95 103.32 4.02 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.729 1.211 . . . . 0.0 113.493 -168.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -132.86 162.02 32.65 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.423 1.889 . . . . 0.0 110.398 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.58 160.26 17.51 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.644 0.735 . . . . 0.0 111.387 177.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.9 p -126.57 153.8 44.75 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.279 1.831 . . . . 0.0 110.113 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.516 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 76.9 p -68.9 -39.74 79.55 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.527 -0.733 . . . . 0.0 111.283 -175.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.8 mt -151.61 143.27 23.64 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.904 2.082 . . . . 0.0 111.451 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.41 ' CD2' HD11 ' A' ' 129' ' ' ILE . 39.7 t80 -136.64 101.81 4.73 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.268 1.027 . . . . 0.0 109.299 174.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -87.52 -51.94 5.63 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.68 0.792 . . . . 0.0 111.764 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.44 178.34 49.54 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 124.526 1.06 . . . . 0.0 114.379 -173.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.5 t80 . . . . . 0 CA--C 1.545 0.769 0 C-N-CA 124.408 1.083 . . . . 0.0 111.561 170.092 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.295 0 CA-C-O 121.95 0.75 . . . . 0.0 113.702 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 36.7 mt -127.89 108.4 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.901 1.68 . . . . 0.0 107.846 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -69.21 147.64 51.0 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.176 0.512 . . . . 0.0 111.185 173.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 57.83 22.05 8.18 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.38 1.472 . . . . 0.0 114.162 178.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -56.79 123.9 16.61 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.939 1.296 . . . . 0.0 111.585 -176.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -72.01 128.97 37.39 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.545 1.138 . . . . 0.0 110.768 170.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.41 HD11 ' CD2' ' A' ' 111' ' ' TYR . 38.2 mm -122.94 115.78 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.734 1.214 . . . . 0.0 109.293 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.89 90.02 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.158 1.383 . . . . 0.0 108.671 -174.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.8 p -75.74 154.2 36.53 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.394 175.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -151.54 140.97 21.54 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.215 1.406 . . . . 0.0 111.099 174.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.35 133.97 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.053 0.541 . . . . 0.0 109.754 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 . . . . . 0 N--CA 1.468 0.43 0 C-N-CA 125.303 1.441 . . . . 0.0 111.107 175.368 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -107.18 168.17 9.4 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.319 1.447 . . . . 0.0 110.133 169.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.2 tp -119.04 135.03 60.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.227 1.411 . . . . 0.0 108.56 170.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.0 p -124.03 153.59 41.12 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.835 0.854 . . . . 0.0 109.955 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -151.01 145.67 25.69 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.065 0.946 . . . . 0.0 111.833 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.6 m -82.57 117.9 22.88 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.499 1.12 . . . . 0.0 111.084 176.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.86 -151.87 24.56 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.88 1.705 . . . . 0.0 113.143 177.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -72.2 173.49 8.51 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 170.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -92.4 102.29 14.76 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.084 0.954 . . . . 0.0 111.923 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.775 0 C-N-CA 124.032 0.933 . . . . 0.0 113.064 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 121.067 0.461 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.74 124.29 19.98 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 170.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -126.23 144.33 50.82 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 122.243 1.02 . . . . 0.0 111.222 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -137.91 172.14 13.37 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.493 1.517 . . . . 0.0 111.878 -168.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.68 131.48 18.01 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.507 0.723 . . . . 0.0 110.057 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 70.5 mt -124.19 139.93 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 123.959 0.904 . . . . 0.0 108.796 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.8 m -63.86 96.86 0.14 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.11 0.964 . . . . 0.0 109.601 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.43 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.1 tt -55.76 -33.0 63.91 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.072 0.949 . . . . 0.0 111.778 176.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -66.95 -27.67 67.65 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 176.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -87.06 -31.39 20.53 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.892 0.877 . . . . 0.0 112.113 174.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.483 HD13 ' HG3' ' A' ' 100' ' ' MET . 19.4 mt -60.76 -44.1 97.17 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.77 0.828 . . . . 0.0 111.233 172.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -51.71 -32.7 31.3 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.547 -1.346 . . . . 0.0 113.639 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 90.4 mttt . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -179.887 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.7 pttm . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -145.96 166.21 26.69 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.112 0.965 . . . . 0.0 111.15 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 m -132.62 126.48 32.8 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.8 0.44 . . . . 0.0 110.628 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.2 m -121.91 169.12 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.839 1.656 . . . . 0.0 110.697 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -67.81 169.2 10.11 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.855 0.862 . . . . 0.0 111.622 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 tp -159.27 137.56 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.936 1.294 . . . . 0.0 109.862 171.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -129.57 158.82 38.22 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.377 2.271 . . . . 0.0 108.942 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -131.39 159.8 36.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.388 1.075 . . . . 0.0 111.766 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -88.08 119.51 28.52 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.15 0.58 . . . . 0.0 110.727 172.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -72.89 179.77 3.54 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.445 0.64 . . . . 0.0 112.191 173.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -57.55 -21.58 39.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.977 1.711 . . . . 0.0 114.428 176.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.0 m -91.56 2.38 56.49 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.045 0.938 . . . . 0.0 113.258 177.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.3 31.26 71.5 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.563 1.077 . . . . 0.0 113.8 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -109.93 140.19 44.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.992 1.317 . . . . 0.0 110.822 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -74.57 121.23 21.24 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.869 0.868 . . . . 0.0 110.77 175.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.6 t -137.42 138.62 40.02 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.915 1.286 . . . . 0.0 110.5 -176.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -58.33 143.48 44.74 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -174.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.2 tp -118.81 -46.42 2.55 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.137 0.975 . . . . 0.0 111.542 -177.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 171.87 -129.5 1.76 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-O 121.457 0.476 . . . . 0.0 113.655 -175.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -141.39 158.9 43.26 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.039 1.736 . . . . 0.0 109.461 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.4 tp -126.22 103.24 7.57 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.884 1.274 . . . . 0.0 110.497 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.1 t -76.56 96.23 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.408 1.083 . . . . 0.0 109.012 175.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.4 t -83.86 113.11 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.586 1.555 . . . . 0.0 109.697 173.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 . . . . . 0 N--CA 1.475 0.823 0 C-N-CA 126.438 1.895 . . . . 0.0 110.175 176.596 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.276 0 N-CA-C 114.761 0.664 . . . . 0.0 114.761 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.3 mt -125.08 142.06 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.237 1.015 . . . . 0.0 109.315 171.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -133.98 134.87 43.02 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.174 1.39 . . . . 0.0 108.729 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.2 p -132.72 143.21 49.46 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.676 0.79 . . . . 0.0 111.268 -173.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.66 122.77 2.69 Favored Glycine 0 C--N 1.336 0.541 0 O-C-N 121.921 -0.487 . . . . 0.0 112.695 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -66.44 126.09 27.74 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.887 1.675 . . . . 0.0 109.124 173.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 37.3 t30 . . . . . 0 CA--C 1.536 0.431 0 C-N-CA 125.864 1.666 . . . . 0.0 109.187 179.937 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.696 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.3 m -59.57 131.24 50.33 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.209 -0.932 . . . . 0.0 110.811 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -98.97 -53.63 3.21 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.168 0.987 . . . . 0.0 109.516 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -161.03 159.09 28.91 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.967 0.907 . . . . 0.0 112.557 170.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.14 149.78 33.68 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 123.052 1.406 . . . . 0.0 112.303 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.434 ' HA ' ' H ' ' A' ' 109' ' ' SER . 2.1 pp -142.92 152.82 42.45 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.695 1.598 . . . . 0.0 110.819 -172.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -79.43 167.81 20.32 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.476 0.711 . . . . 0.0 112.146 -170.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -52.63 -35.84 55.38 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.291 -0.881 . . . . 0.0 112.654 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.2 -8.08 22.11 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.869 1.268 . . . . 0.0 114.179 175.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 t -116.5 -5.45 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.239 1.016 . . . . 0.0 111.41 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.1 t -53.58 -61.72 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 120.476 1.489 . . . . 0.0 111.651 -177.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -69.57 -24.81 63.75 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.82 -52.42 56.85 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.695 1.598 . . . . 0.0 110.706 172.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -59.86 -44.88 93.91 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 125.222 1.409 . . . . 0.0 110.62 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.2 -36.39 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.82 0.848 . . . . 0.0 111.206 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -54.99 29.45 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.075 0.95 . . . . 0.0 111.716 173.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 m -76.0 -2.62 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -176.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.637 ' SD ' HD13 ' A' ' 166' ' ' LEU . 40.7 tpp -108.62 -4.22 17.3 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.426 1.49 . . . . 0.0 112.47 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 43.2 p -125.42 -11.75 6.82 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.184 0.994 . . . . 0.0 112.573 171.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -135.25 -12.4 2.13 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.3 156.58 19.15 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 124.697 1.142 . . . . 0.0 113.865 -175.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.05 -160.35 31.54 Favored Glycine 0 CA--C 1.533 1.193 0 O-C-N 121.665 -0.903 . . . . 0.0 113.894 -175.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 85.0 p -150.72 104.49 3.19 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -171.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -135.04 153.3 52.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.066 1.746 . . . . 0.0 110.369 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -80.72 159.58 25.2 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.546 -0.721 . . . . 0.0 111.145 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.2 p -124.93 149.1 47.96 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.9 1.68 . . . . 0.0 110.595 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.434 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 8.1 t -62.59 -44.33 96.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.824 0.85 . . . . 0.0 111.336 -177.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mt -149.61 143.13 25.34 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.459 1.504 . . . . 0.0 111.845 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -140.87 106.08 5.02 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.891 0.876 . . . . 0.0 110.735 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -90.64 -40.26 12.0 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.054 0.942 . . . . 0.0 113.104 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.92 -178.11 40.73 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 124.658 1.123 . . . . 0.0 113.877 -170.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 22.9 t80 . . . . . 0 CA--C 1.541 0.612 0 O-C-N 121.694 -0.886 . . . . 0.0 112.511 172.412 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.546 0 CA-C-O 121.077 0.265 . . . . 0.0 113.341 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 95.3 mt -116.2 109.49 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.17 1.388 . . . . 0.0 109.318 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -69.36 146.71 51.91 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.128 0.971 . . . . 0.0 112.146 172.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 54.68 24.47 5.57 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.283 1.833 . . . . 0.0 114.586 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -55.58 123.07 12.8 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.292 1.437 . . . . 0.0 111.696 -178.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -72.37 128.45 35.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.058 0.943 . . . . 0.0 110.618 170.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.5 mm -124.14 116.33 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.819 1.248 . . . . 0.0 108.649 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.13 94.04 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.435 1.494 . . . . 0.0 108.097 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.8 p -80.14 157.61 26.57 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.859 0.838 . . . . 0.0 111.776 176.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -154.12 146.71 24.12 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.891 1.276 . . . . 0.0 111.469 174.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 16.2 mt -84.29 131.47 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.175 0.59 . . . . 0.0 110.019 173.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 . . . . . 0 CA--C 1.536 0.441 0 C-N-CA 126.291 1.836 . . . . 0.0 110.077 176.321 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 . . . . . 0 CA--C 1.539 0.537 0 CA-C-O 121.218 0.532 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -109.0 158.19 17.95 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.398 1.479 . . . . 0.0 110.735 174.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 6.8 tp -100.92 144.68 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 166.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.7 p -133.12 156.48 47.37 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.624 0.77 . . . . 0.0 109.157 169.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -151.49 145.99 25.58 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.923 0.889 . . . . 0.0 111.457 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.2 p -76.22 115.45 15.96 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.701 1.2 . . . . 0.0 110.979 174.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.66 -162.22 38.05 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.379 0.99 . . . . 0.0 112.917 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.99 161.39 26.71 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.755 0.822 . . . . 0.0 112.682 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -78.12 103.94 8.38 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.448 0.699 . . . . 0.0 110.636 172.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.556 ' CG2' ' HB2' ' A' ' 157' ' ' ALA . 0.2 OUTLIER . . . . . 0 CA--C 1.54 0.569 0 C-N-CA 125.031 1.332 . . . . 0.0 112.687 179.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 N--CA 1.477 0.887 0 CA-C-O 120.921 0.391 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.556 ' HB2' ' CG2' ' A' ' 149' ' ' ILE . . . -63.77 100.07 0.27 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.737 0.815 . . . . 0.0 109.599 171.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -93.79 145.77 24.35 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.174 0.988 . . . . 0.0 110.974 173.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -135.14 166.85 22.12 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.697 1.599 . . . . 0.0 111.417 -172.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.88 135.51 23.26 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.894 0.477 . . . . 0.0 110.555 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 59.0 mt -130.34 142.07 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.563 1.145 . . . . 0.0 109.076 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.5 m -63.95 96.55 0.14 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.389 1.076 . . . . 0.0 110.033 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -56.62 -30.55 63.39 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.413 -0.804 . . . . 0.0 111.899 176.25 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -67.17 -28.04 67.78 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -90.1 -25.95 20.47 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.178 0.991 . . . . 0.0 112.247 176.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.637 HD13 ' SD ' ' A' ' 100' ' ' MET . 12.6 mt -65.87 -47.92 73.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.573 1.149 . . . . 0.0 111.213 171.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -49.31 -40.21 34.18 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.374 1.07 . . . . 0.0 112.765 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt . . . . . 0 N--CA 1.484 1.264 0 C-N-CA 125.447 1.499 . . . . 0.0 114.43 178.046 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.668 0.27 . . . . 0.0 110.665 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.4 tt -138.66 147.3 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.569 1.548 . . . . 0.0 110.417 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -146.79 131.66 18.08 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.492 1.117 . . . . 0.0 109.655 173.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.7 t -150.42 153.67 36.36 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.941 1.297 . . . . 0.0 110.642 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.7 t -155.11 159.0 39.88 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.982 1.313 . . . . 0.0 111.185 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -150.37 149.54 30.21 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.606 1.562 . . . . 0.0 110.783 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -160.05 136.81 9.14 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.653 1.181 . . . . 0.0 110.83 173.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -138.45 151.34 47.33 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.065 1.346 . . . . 0.0 110.926 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -150.4 144.68 25.61 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.814 1.245 . . . . 0.0 110.51 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.7 t -150.99 155.48 39.16 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.004 1.322 . . . . 0.0 110.974 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.6 t -156.04 165.86 35.18 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.194 1.398 . . . . 0.0 111.273 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -168.65 159.56 32.74 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.225 1.393 . . . . 0.0 112.371 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -150.82 130.04 12.76 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.935 1.294 . . . . 0.0 110.111 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -157.98 159.76 36.78 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.312 1.045 . . . . 0.0 111.606 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -116.39 29.79 7.74 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.158 1.783 . . . . 0.0 111.801 -174.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -101.4 91.79 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.768 2.027 . . . . 0.0 110.974 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -140.26 165.66 26.79 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.365 1.866 . . . . 0.0 111.439 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -50.94 150.44 3.01 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.604 1.962 . . . . 0.0 112.667 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.4 mm -62.53 150.47 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.858 1.263 . . . . 0.0 112.117 -172.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -51.36 -22.92 3.23 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.545 1.538 . . . . 0.0 114.714 173.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -78.77 -1.58 35.41 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.248 1.419 . . . . 0.0 114.032 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.9 m -125.62 -48.19 1.67 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.756 1.622 . . . . 0.0 111.804 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -155.07 166.13 34.56 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.424 1.49 . . . . 0.0 111.274 169.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -144.43 166.99 23.54 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.17 0.988 . . . . 0.0 110.724 171.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -134.93 135.48 41.56 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.713 0.405 . . . . 0.0 110.896 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.72 162.94 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.694 1.598 . . . . 0.0 111.457 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -64.32 159.3 21.32 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.258 1.023 . . . . 0.0 112.499 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.0 tp -153.26 136.94 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.891 1.276 . . . . 0.0 109.632 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -130.24 156.49 44.54 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.815 2.046 . . . . 0.0 108.952 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -128.78 159.52 35.46 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.527 1.131 . . . . 0.0 111.914 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.58 117.04 23.48 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.93 0.492 . . . . 0.0 110.568 173.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -71.8 -179.96 2.89 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.309 0.644 . . . . 0.0 112.298 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -56.14 -26.87 51.98 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.64 1.576 . . . . 0.0 113.424 172.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.1 m -80.07 0.59 31.27 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.668 1.587 . . . . 0.0 114.148 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.44 34.08 87.04 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.657 1.122 . . . . 0.0 114.411 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -123.49 143.2 50.32 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.75 1.62 . . . . 0.0 109.744 177.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -67.33 126.62 29.83 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.967 0.907 . . . . 0.0 110.834 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -136.72 142.05 43.08 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.437 1.495 . . . . 0.0 110.18 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -57.55 140.19 51.49 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.1 tp -118.69 -48.59 2.47 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.828 0.851 . . . . 0.0 111.623 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.85 -119.83 0.86 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 123.261 0.458 . . . . 0.0 113.236 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -144.92 159.58 42.69 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.582 1.553 . . . . 0.0 110.284 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.5 tp -124.52 104.93 9.0 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.707 1.603 . . . . 0.0 110.131 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.2 t -78.76 99.43 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.073 1.349 . . . . 0.0 109.563 175.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.4 t -85.27 101.98 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.969 1.708 . . . . 0.0 110.239 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -87.44 121.33 29.75 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.901 1.68 . . . . 0.0 110.773 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -88.54 86.48 7.03 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.127 1.371 . . . . 0.0 110.4 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -76.3 173.88 10.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.629 1.172 . . . . 0.0 112.2 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -75.25 -33.51 61.31 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.897 -1.127 . . . . 0.0 113.527 173.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -109.88 53.59 0.69 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.449 1.5 . . . . 0.0 111.106 -172.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 109.09 -160.52 13.51 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.034 0.826 . . . . 0.0 113.967 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.9 mt -122.83 141.72 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.003 0.921 . . . . 0.0 109.609 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -130.7 127.5 38.96 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.881 1.272 . . . . 0.0 109.609 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.0 p -121.44 148.54 44.28 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.7 -0.625 . . . . 0.0 111.526 -173.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.96 124.99 2.47 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 121.497 0.498 . . . . 0.0 113.081 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.77 135.44 53.97 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.029 1.731 . . . . 0.0 109.827 175.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -137.12 85.09 2.11 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.086 1.755 . . . . 0.0 110.448 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.53 177.73 6.71 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.497 1.519 . . . . 0.0 112.744 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.01 53.64 2.17 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 126.256 1.884 . . . . 0.0 114.689 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 143.72 -1.19 1.3 Allowed Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.46 1.505 . . . . 0.0 115.222 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -150.4 151.39 32.73 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.813 1.306 . . . . 0.0 112.294 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 88.2 p -151.47 146.57 26.01 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 170.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.22 162.0 28.09 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.554 1.542 . . . . 0.0 111.592 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.6 m -55.37 132.0 47.11 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.257 -0.902 . . . . 0.0 110.529 169.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -99.83 -50.86 3.89 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.032 0.933 . . . . 0.0 110.26 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -163.42 159.92 22.83 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.894 0.878 . . . . 0.0 112.349 170.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.75 148.3 30.82 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 123.151 1.453 . . . . 0.0 112.873 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.449 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -136.18 157.85 45.82 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.046 1.338 . . . . 0.0 111.527 -171.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -78.49 167.5 21.19 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.29 0.567 . . . . 0.0 112.312 -174.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -56.74 -35.61 68.8 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.324 -0.86 . . . . 0.0 112.354 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -68.52 -5.05 17.37 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.846 1.259 . . . . 0.0 113.495 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 t -117.46 -5.22 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.247 1.019 . . . . 0.0 111.292 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.7 t -49.35 -63.81 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-N 120.455 1.479 . . . . 0.0 112.006 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -69.88 -28.85 65.98 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.801 -0.562 . . . . 0.0 112.138 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -63.05 -51.09 68.05 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.881 1.672 . . . . 0.0 110.899 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -59.93 -45.34 92.9 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 125.032 1.333 . . . . 0.0 110.522 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 37.4 t -59.24 -39.87 79.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.062 0.545 . . . . 0.0 110.523 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -59.28 -52.5 65.39 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.479 1.112 . . . . 0.0 112.183 174.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.29 -10.43 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 121.509 -0.744 . . . . 0.0 112.641 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.597 ' CG ' HD13 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -103.41 0.12 30.79 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.445 -1.41 . . . . 0.0 112.614 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.6 p -123.42 -12.62 7.74 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.236 1.015 . . . . 0.0 112.77 169.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -137.8 -14.36 1.42 Allowed 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.23 155.74 26.85 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.111 1.339 . . . . 0.0 113.954 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.09 -169.58 32.59 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.712 1.148 . . . . 0.0 113.829 -174.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.8 p -145.25 100.71 3.51 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.213 1.405 . . . . 0.0 113.34 -168.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -129.99 146.85 51.69 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.83 1.652 . . . . 0.0 110.037 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -74.95 157.52 34.84 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.466 -0.771 . . . . 0.0 111.021 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.7 p -121.66 147.65 45.6 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.28 1.432 . . . . 0.0 110.812 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.449 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 7.6 t -60.79 -43.6 97.9 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.686 0.794 . . . . 0.0 111.407 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mt -150.27 142.4 24.06 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.454 1.502 . . . . 0.0 112.251 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -134.02 106.04 7.03 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.078 0.951 . . . . 0.0 110.14 174.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -90.45 -47.77 7.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.297 1.039 . . . . 0.0 112.571 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.32 175.46 30.09 Favored Glycine 0 CA--C 1.544 1.847 0 C-N-CA 125.679 1.609 . . . . 0.0 114.595 -170.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -58.33 163.38 3.04 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.722 1.209 . . . . 0.0 112.568 169.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -64.32 166.67 7.79 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.891 -1.131 . . . . 0.0 112.321 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 72.14 36.35 1.13 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.878 1.671 . . . . 0.0 113.228 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -133.94 174.44 10.47 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.47 1.508 . . . . 0.0 112.503 -173.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -88.01 -35.59 17.49 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.804 0.841 . . . . 0.0 111.966 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 41.8 p -72.58 -42.38 64.65 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.6 p -58.02 -21.41 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 124.851 1.26 . . . . 0.0 114.087 -170.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 66.3 mt -53.92 -39.65 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 126.552 1.941 . . . . 0.0 111.916 174.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -144.54 -38.35 0.29 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 113.13 155.86 12.05 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 127.084 2.278 . . . . 0.0 112.689 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.4 mt -110.63 115.11 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.785 1.234 . . . . 0.0 108.76 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -73.97 148.49 42.06 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.109 0.481 . . . . 0.0 111.873 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 57.43 22.35 7.86 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.224 1.81 . . . . 0.0 114.277 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -63.71 126.2 26.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.009 1.323 . . . . 0.0 111.682 -171.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -75.88 121.39 22.57 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.609 1.164 . . . . 0.0 111.907 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.7 mm -114.8 112.07 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.296 1.039 . . . . 0.0 109.537 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -105.94 104.34 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.899 1.28 . . . . 0.0 108.387 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 47.6 p -89.8 156.89 18.19 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.456 1.102 . . . . 0.0 112.006 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.4 137.74 16.65 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.093 1.357 . . . . 0.0 111.586 175.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.7 mt -77.99 132.93 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.141 0.577 . . . . 0.0 109.684 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -151.02 136.59 17.89 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.435 1.494 . . . . 0.0 110.976 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.1 157.66 34.37 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.021 -1.049 . . . . 0.0 110.908 168.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 37.0 mt -131.15 -49.88 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.165 0.986 . . . . 0.0 111.031 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -145.84 29.42 1.11 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.659 0.784 . . . . 0.0 112.548 -175.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 105.66 -18.82 40.22 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 124.735 1.159 . . . . 0.0 113.91 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 53.8 m -92.11 139.23 30.84 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.253 1.021 . . . . 0.0 108.763 169.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -71.97 126.65 30.29 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.794 -0.566 . . . . 0.0 110.025 169.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -111.3 167.83 9.99 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.939 1.295 . . . . 0.0 110.743 173.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 tp -124.75 131.46 72.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.599 1.56 . . . . 0.0 108.395 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.8 p -118.82 154.47 32.81 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.677 0.791 . . . . 0.0 110.124 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -152.83 145.07 23.92 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.431 0.692 . . . . 0.0 112.155 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.6 m -82.32 111.03 18.01 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.539 1.136 . . . . 0.0 110.443 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.17 -155.61 19.59 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.374 1.464 . . . . 0.0 113.302 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.49 170.42 2.45 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 169.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -94.9 102.16 13.99 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.596 0.758 . . . . 0.0 111.13 173.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.72 164.22 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.924 0.89 . . . . 0.0 112.163 178.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.4 tptp -113.4 12.35 18.74 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -113.78 14.45 18.68 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.785 1.634 . . . . 0.0 112.935 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 2.0 t -132.48 -47.31 0.89 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 130.74 67.18 0.1 OUTLIER Glycine 0 N--CA 1.476 1.338 0 CA-C-N 118.99 0.814 . . . . 0.0 113.939 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 55.91 28.02 11.95 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.795 1.638 . . . . 0.0 114.168 -174.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -88.48 174.79 7.9 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.445 -0.784 . . . . 0.0 108.896 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.4 m -105.8 139.26 27.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 123.386 0.674 . . . . 0.0 109.54 170.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.92 116.61 5.44 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 169.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -118.19 149.19 41.49 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 122.362 1.077 . . . . 0.0 110.297 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -137.97 174.84 10.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.106 -1.406 . . . . 0.0 111.9 -169.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.61 130.06 16.79 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.81 0.844 . . . . 0.0 109.791 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.45 ' CG2' HD11 ' A' ' 166' ' ' LEU . 69.8 mt -121.9 138.99 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.192 0.997 . . . . 0.0 108.807 176.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -63.82 95.89 0.12 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.744 0.818 . . . . 0.0 109.7 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.602 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.3 tt -53.98 -31.27 50.3 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.876 1.27 . . . . 0.0 111.879 175.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -69.38 -28.09 65.87 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -86.77 -26.7 24.03 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.165 0.986 . . . . 0.0 112.522 175.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 163' ' ' LEU . 27.9 mt -62.9 -53.04 60.23 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.412 1.085 . . . . 0.0 109.796 169.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -46.53 -37.69 8.3 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -53.67 -28.4 33.2 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.033 1.333 . . . . 0.0 114.149 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -122.46 -2.14 9.01 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.96 1.704 . . . . 0.0 113.178 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.2 mp -104.23 -27.49 12.0 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.015 1.726 . . . . 0.0 112.242 -177.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 35.8 mttm . . . . . 0 C--O 1.254 1.317 0 C-N-CA 126.063 1.745 . . . . 0.0 113.235 173.345 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.1 mttp . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 120.433 0.159 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.2 pt -99.46 172.46 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.5 1.52 . . . . 0.0 111.348 173.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.0 m170 54.33 29.09 10.24 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.714 1.605 . . . . 0.0 114.384 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.8 p -94.03 155.5 17.08 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.106 1.363 . . . . 0.0 112.08 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.0 p -139.07 140.7 38.11 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.105 1.362 . . . . 0.0 110.013 169.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -146.63 149.66 33.94 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.904 1.282 . . . . 0.0 109.877 -177.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -103.24 156.06 17.99 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.391 1.076 . . . . 0.0 112.318 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.4 mp0 -135.74 157.03 47.86 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.836 1.254 . . . . 0.0 111.604 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -149.57 85.63 1.44 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.767 1.227 . . . . 0.0 111.749 -174.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.7 t -151.66 -174.57 4.89 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.028 1.331 . . . . 0.0 112.253 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 p -132.06 53.87 1.97 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.825 2.05 . . . . 0.0 111.664 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.78 -133.89 2.7 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.258 1.885 . . . . 0.0 111.708 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -45.71 134.8 7.24 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.168 1.387 . . . . 0.0 112.841 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.4 m -159.69 160.9 34.67 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.153 1.381 . . . . 0.0 111.902 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -76.57 151.7 36.21 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.328 1.451 . . . . 0.0 110.904 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.28 49.34 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-O 122.608 1.194 . . . . 0.0 111.47 -170.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.28 -174.6 4.97 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.089 2.156 . . . . 0.0 111.276 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.64 116.93 3.7 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.978 1.311 . . . . 0.0 110.742 171.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 mm -105.37 153.05 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.104 0.962 . . . . 0.0 110.512 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -67.81 -12.44 60.61 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -77.26 -165.73 0.62 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.038 1.735 . . . . 0.0 113.231 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.56 -40.01 94.79 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.784 1.233 . . . . 0.0 112.699 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -65.31 148.18 52.14 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 121.622 0.725 . . . . 0.0 110.588 169.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -135.44 175.53 9.5 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.966 1.306 . . . . 0.0 110.523 171.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -141.19 145.17 35.31 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.411 -0.805 . . . . 0.0 111.172 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.4 m -139.88 152.48 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.782 0.833 . . . . 0.0 112.341 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -56.63 139.5 49.92 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.666 1.187 . . . . 0.0 110.782 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.8 tp -137.53 136.32 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.798 1.239 . . . . 0.0 109.278 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -131.15 158.61 40.0 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.485 1.914 . . . . 0.0 108.826 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -130.37 161.4 31.41 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.423 1.089 . . . . 0.0 111.707 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.38 122.52 31.97 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.186 0.594 . . . . 0.0 111.026 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.22 -176.98 5.88 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 176.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -58.07 -24.48 58.71 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.441 1.896 . . . . 0.0 114.145 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.0 m -88.12 2.64 51.57 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.394 1.078 . . . . 0.0 113.386 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.5 35.48 91.99 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.698 1.142 . . . . 0.0 113.882 -176.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -114.51 143.4 45.02 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.374 1.47 . . . . 0.0 110.392 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -73.26 119.93 18.17 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.269 0.628 . . . . 0.0 110.622 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -129.14 135.3 48.68 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.77 1.628 . . . . 0.0 109.69 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -57.39 142.18 44.68 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.1 tp -117.33 -48.01 2.63 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.777 0.831 . . . . 0.0 111.4 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.84 -109.89 0.37 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.29 0.471 . . . . 0.0 113.698 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -149.72 156.84 42.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.222 1.809 . . . . 0.0 109.819 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 tp -122.46 102.29 8.0 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.593 1.157 . . . . 0.0 110.124 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.3 t -75.76 101.62 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.56 0.744 . . . . 0.0 109.263 176.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.0 94.25 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.731 1.612 . . . . 0.0 109.159 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 47.9 mtp85 -76.25 110.84 11.08 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.258 1.423 . . . . 0.0 110.458 172.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.4 mmtp -69.26 123.03 20.07 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 168.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -113.2 170.61 8.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.533 1.133 . . . . 0.0 111.116 175.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -74.57 -26.4 59.92 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.742 -1.224 . . . . 0.0 112.708 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -115.66 32.96 5.75 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.455 1.502 . . . . 0.0 112.433 -169.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.66 -158.37 21.27 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.484 1.516 . . . . 0.0 113.469 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.5 mt -128.18 143.13 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.769 0.828 . . . . 0.0 110.168 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -131.71 125.58 32.38 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.422 1.089 . . . . 0.0 110.703 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.2 p -116.56 146.01 42.94 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.617 -0.677 . . . . 0.0 111.813 -174.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -139.99 123.67 2.5 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 123.278 0.466 . . . . 0.0 112.083 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.33 137.19 54.44 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.24 1.416 . . . . 0.0 110.179 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -132.65 95.43 3.6 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.182 2.193 . . . . 0.0 109.48 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -98.69 175.1 6.1 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.506 1.122 . . . . 0.0 111.829 173.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.56 -27.13 60.72 Favored Glycine 0 CA--C 1.538 1.512 0 N-CA-C 115.719 1.048 . . . . 0.0 115.719 -172.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -145.66 25.55 1.81 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.194 1.378 . . . . 0.0 113.687 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -154.62 149.58 26.77 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.192 0.997 . . . . 0.0 112.634 -175.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 88.8 p -155.96 149.88 25.26 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 170.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -166.19 163.45 17.87 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.966 1.706 . . . . 0.0 111.309 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.7 m -56.51 131.35 48.36 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 121.212 -0.93 . . . . 0.0 109.191 168.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -98.0 -49.65 4.69 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.503 0.592 . . . . 0.0 110.142 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -167.35 159.09 12.24 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.867 0.867 . . . . 0.0 112.503 170.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.36 149.5 32.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 122.961 1.362 . . . . 0.0 112.525 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.427 ' HA ' ' H ' ' A' ' 109' ' ' SER . 2.4 pp -141.04 156.12 46.06 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.363 1.465 . . . . 0.0 110.836 -170.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -83.2 167.81 17.37 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.287 0.635 . . . . 0.0 112.111 -172.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -55.67 -32.0 62.86 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.022 -1.049 . . . . 0.0 112.535 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -66.4 -6.13 13.32 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.25 1.42 . . . . 0.0 114.022 174.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.88 -3.17 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 119.451 1.023 . . . . 0.0 111.555 -175.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.517 ' O ' HG23 ' A' ' 97' ' ' VAL . 71.3 t -52.6 -64.53 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 120.314 1.415 . . . . 0.0 111.524 -177.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -68.38 -27.24 66.06 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.317 0.647 . . . . 0.0 112.237 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.06 -54.2 41.87 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.413 1.485 . . . . 0.0 110.43 174.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -60.58 -46.13 91.36 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 125.135 1.374 . . . . 0.0 111.373 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 93' ' ' VAL . 87.8 t -54.46 -34.84 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.011 0.925 . . . . 0.0 110.72 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -72.69 -53.96 10.3 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.117 1.367 . . . . 0.0 113.539 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 m -68.86 -16.65 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 120.813 -1.179 . . . . 0.0 112.374 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.653 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -86.37 -4.55 59.19 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.247 1.819 . . . . 0.0 111.971 176.736 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 51.0 p -130.96 -15.76 3.33 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.34 -10.63 4.13 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.1 1.76 . . . . 0.0 113.668 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.01 156.68 7.58 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.459 1.504 . . . . 0.0 113.642 -173.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 156.33 -170.61 33.96 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.379 0.99 . . . . 0.0 113.712 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 93.7 p -146.05 95.36 2.61 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.608 1.163 . . . . 0.0 113.229 -168.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -125.97 141.13 52.11 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.751 1.62 . . . . 0.0 109.737 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -69.09 156.8 38.05 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.708 -0.62 . . . . 0.0 110.569 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.4 p -120.53 156.61 31.2 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.302 1.441 . . . . 0.0 110.804 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.427 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 7.9 t -70.11 -44.54 68.78 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.004 0.521 . . . . 0.0 111.169 -178.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.6 mt -148.29 140.32 24.01 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.566 1.546 . . . . 0.0 111.352 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -134.92 103.41 5.58 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.934 0.894 . . . . 0.0 110.39 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -89.84 -44.32 10.02 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.195 0.998 . . . . 0.0 113.36 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.02 -179.94 12.81 Favored Glycine 0 CA--C 1.543 1.808 0 C-N-CA 124.986 1.279 . . . . 0.0 114.307 -169.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -57.7 160.18 4.63 Favored 'General case' 0 CA--C 1.551 1.008 0 O-C-N 121.603 -0.94 . . . . 0.0 112.03 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.617 ' HA ' HG11 ' A' ' 120' ' ' VAL . 26.3 mttp -60.47 174.32 0.58 Allowed 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 173.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 64.04 33.7 11.93 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.043 1.337 . . . . 0.0 112.667 -177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.587 ' HG3' HG22 ' A' ' 149' ' ' ILE . 12.0 tt0 -136.45 157.43 46.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.874 1.67 . . . . 0.0 111.063 -170.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -77.73 -14.69 59.53 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.079 -1.013 . . . . 0.0 113.197 -176.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 16.5 p -92.38 -34.04 14.32 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.861 1.664 . . . . 0.0 114.195 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.617 HG11 ' HA ' ' A' ' 115' ' ' LYS . 10.0 p -67.07 -16.38 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.259 1.024 . . . . 0.0 113.52 -173.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 35.9 mm -54.52 -51.8 46.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.635 1.974 . . . . 0.0 112.237 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 51.6 m-20 -144.7 1.16 1.01 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.033 1.333 . . . . 0.0 113.587 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 81.93 170.76 45.04 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.219 1.39 . . . . 0.0 112.934 -171.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.1 mt -126.3 108.13 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.962 1.305 . . . . 0.0 109.192 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -63.98 141.26 58.83 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.7 0.8 . . . . 0.0 112.006 172.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 58.29 22.67 9.57 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.719 1.608 . . . . 0.0 114.456 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 19.0 tptp -55.21 122.94 12.17 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.352 1.061 . . . . 0.0 111.52 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -69.73 129.81 40.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.228 1.011 . . . . 0.0 110.22 169.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.7 mm -127.28 119.75 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.197 0.999 . . . . 0.0 108.661 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mp -113.13 96.45 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 125.053 1.341 . . . . 0.0 108.311 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.9 p -77.44 153.99 33.04 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.835 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -150.61 137.83 19.42 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.857 1.263 . . . . 0.0 111.115 175.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.8 mt -81.85 131.54 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -137.95 122.89 18.96 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.434 1.493 . . . . 0.0 110.644 173.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -73.84 107.58 6.15 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.193 0.997 . . . . 0.0 109.721 171.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 26.1 mt -95.25 97.81 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 175.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 59.02 16.06 4.43 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 126.475 1.91 . . . . 0.0 115.401 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 123.74 -32.32 4.28 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.149 1.357 . . . . 0.0 113.572 177.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 92.0 m -71.64 124.79 25.51 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.102 0.961 . . . . 0.0 108.92 170.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -74.71 118.49 17.73 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.735 -0.603 . . . . 0.0 109.383 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -107.59 166.13 10.9 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.991 1.316 . . . . 0.0 110.367 170.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.6 tp -119.9 133.68 65.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 125.15 1.38 . . . . 0.0 108.341 170.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.0 p -121.9 155.5 35.33 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.45 0.7 . . . . 0.0 109.909 175.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -148.11 140.85 24.64 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.889 0.875 . . . . 0.0 110.925 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.5 m -79.48 110.12 14.49 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.713 0.805 . . . . 0.0 110.197 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.02 -162.17 27.85 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.214 1.388 . . . . 0.0 112.535 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -68.26 162.88 24.09 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.641 -0.917 . . . . 0.0 112.874 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -76.26 108.19 9.03 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.293 1.037 . . . . 0.0 111.185 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.587 HG22 ' HG3' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -62.49 163.52 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.283 1.033 . . . . 0.0 112.612 177.283 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -102.94 1.85 34.32 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -108.83 13.84 24.64 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.478 1.511 . . . . 0.0 113.761 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.435 ' HB3' HD11 ' A' ' 149' ' ' ILE . 1.4 t -140.28 176.66 8.58 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.165 1.386 . . . . 0.0 112.267 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -78.95 61.36 4.1 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.998 1.761 . . . . 0.0 114.361 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 51.4 40.73 27.25 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.009 1.723 . . . . 0.0 113.145 -173.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -87.1 -177.94 6.14 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.885 0.874 . . . . 0.0 109.42 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 10.8 m -111.91 146.2 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.018 1.327 . . . . 0.0 110.308 170.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.01 114.46 3.71 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -117.5 138.85 51.6 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.309 1.052 . . . . 0.0 109.898 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -134.68 169.6 17.08 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.416 1.486 . . . . 0.0 111.199 -169.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.03 131.58 19.83 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.4 0.68 . . . . 0.0 109.909 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.425 ' CG2' HD11 ' A' ' 166' ' ' LEU . 59.0 mt -124.78 138.26 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.072 0.949 . . . . 0.0 108.739 177.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.2 m -63.71 94.82 0.1 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.224 1.01 . . . . 0.0 109.649 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.592 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.4 tt -55.03 -32.2 61.68 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.325 1.05 . . . . 0.0 111.849 176.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -68.48 -29.59 68.25 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 176.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -84.19 -31.37 25.14 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.906 0.882 . . . . 0.0 112.095 174.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.653 HD13 ' HG3' ' A' ' 100' ' ' MET . 17.9 mt -57.63 -49.5 76.23 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.012 0.925 . . . . 0.0 110.953 173.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -50.01 -40.79 45.7 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.443 1.097 . . . . 0.0 113.448 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -69.3 -17.86 63.77 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.43 1.492 . . . . 0.0 114.259 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -122.3 -3.28 8.96 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.359 1.464 . . . . 0.0 113.722 -174.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 13.1 mt -92.98 -24.09 18.48 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.042 1.337 . . . . 0.0 111.934 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.252 0 C-N-CA 126.737 2.015 . . . . 0.0 113.925 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 pp -68.91 166.1 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.621 0.768 . . . . 0.0 112.526 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -139.71 145.74 38.73 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.705 1.202 . . . . 0.0 111.307 176.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.8 p -67.23 111.54 4.02 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.619 1.167 . . . . 0.0 111.606 175.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.5 t -151.37 121.19 7.05 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.938 1.295 . . . . 0.0 110.435 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -159.23 163.34 35.96 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.084 1.754 . . . . 0.0 111.07 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -154.4 135.92 14.25 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.98 1.312 . . . . 0.0 109.928 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -114.75 99.54 7.58 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.711 1.204 . . . . 0.0 110.55 -173.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -70.51 133.54 46.88 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.938 0.895 . . . . 0.0 112.277 -173.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.8 t -86.91 75.65 9.54 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.947 1.299 . . . . 0.0 111.625 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 p -143.73 123.76 13.6 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.059 1.344 . . . . 0.0 111.327 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.95 -109.05 3.73 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.087 1.327 . . . . 0.0 112.893 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -142.03 51.34 1.5 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.36 1.464 . . . . 0.0 111.095 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.8 t -68.87 164.27 22.44 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.484 1.114 . . . . 0.0 112.702 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -64.5 136.28 56.89 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.611 1.164 . . . . 0.0 111.538 173.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.5 t -144.27 138.9 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.374 1.87 . . . . 0.0 108.327 176.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.37 173.27 7.46 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.718 1.607 . . . . 0.0 111.579 174.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -139.44 163.12 33.37 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.456 1.902 . . . . 0.0 110.403 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.1 mm -65.32 132.96 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.764 0.826 . . . . 0.0 110.577 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.21 35.6 3.02 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.606 1.562 . . . . 0.0 111.234 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -91.92 -9.4 43.27 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.065 0.946 . . . . 0.0 113.21 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.5 m -77.56 -22.06 51.57 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.791 1.637 . . . . 0.0 113.817 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -152.74 158.58 42.51 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.782 1.633 . . . . 0.0 110.788 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -143.06 168.14 20.44 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.949 0.9 . . . . 0.0 111.118 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -133.97 131.98 39.62 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.645 0.378 . . . . 0.0 111.229 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.5 162.01 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.959 1.704 . . . . 0.0 111.229 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -62.15 159.03 15.5 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.13 0.972 . . . . 0.0 111.776 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.9 tp -153.98 136.43 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.45 1.1 . . . . 0.0 109.876 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -128.82 159.49 35.56 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.105 1.762 . . . . 0.0 109.26 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -130.53 153.8 48.46 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.687 1.195 . . . . 0.0 111.03 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -81.47 119.18 23.4 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 122.152 -0.343 . . . . 0.0 110.505 174.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -71.67 -178.84 2.37 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.563 0.745 . . . . 0.0 112.752 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -54.77 -30.7 57.38 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.702 1.201 . . . . 0.0 113.552 174.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.7 m -81.09 -0.87 41.93 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.071 0.949 . . . . 0.0 113.515 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.99 29.95 73.83 Favored Glycine 0 CA--C 1.536 1.37 0 O-C-N 121.505 -0.747 . . . . 0.0 113.379 -173.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -111.3 135.46 51.81 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.415 1.486 . . . . 0.0 110.043 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -69.01 124.73 24.54 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.031 0.932 . . . . 0.0 110.8 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.2 t -137.89 137.48 38.1 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.782 1.233 . . . . 0.0 110.787 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -56.04 130.75 45.26 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.965 1.306 . . . . 0.0 112.027 -173.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.0 tp -106.54 -47.35 3.79 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.233 0.613 . . . . 0.0 111.521 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.03 -115.83 0.62 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.247 0.451 . . . . 0.0 113.267 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -146.48 157.13 43.71 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.218 1.407 . . . . 0.0 110.087 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.5 tp -121.51 102.72 8.43 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.284 1.434 . . . . 0.0 110.342 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.6 t -78.19 95.13 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.185 1.394 . . . . 0.0 109.07 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.7 t -81.84 99.48 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.735 1.614 . . . . 0.0 109.582 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.2 mtt-85 -98.42 147.19 24.97 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.007 1.323 . . . . 0.0 111.808 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -91.26 128.24 37.01 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.41 1.084 . . . . 0.0 110.353 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -102.18 177.95 4.74 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.927 1.291 . . . . 0.0 111.534 169.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -56.15 -36.82 68.72 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.462 1.105 . . . . 0.0 113.72 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -134.5 67.58 1.5 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.917 1.287 . . . . 0.0 111.901 -175.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 122.85 -158.61 17.5 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 115.337 0.895 . . . . 0.0 115.337 174.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.6 mt -119.3 137.34 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.233 1.013 . . . . 0.0 109.797 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.26 104.05 6.01 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.271 1.828 . . . . 0.0 109.364 -171.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.9 p -98.07 156.14 16.79 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.32 -1.488 . . . . 0.0 111.455 -173.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.52 122.98 1.79 Allowed Glycine 0 CA--C 1.526 0.726 0 O-C-N 121.271 -0.893 . . . . 0.0 112.16 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.87 138.39 50.16 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.002 1.721 . . . . 0.0 110.403 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -134.4 85.3 2.18 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.808 1.643 . . . . 0.0 110.482 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.82 80.92 2.21 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.062 1.745 . . . . 0.0 110.871 -176.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.04 -103.7 0.83 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.092 0.854 . . . . 0.0 112.814 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -96.97 9.72 65.79 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.152 1.358 . . . . 0.0 114.851 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -132.84 128.75 37.34 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.789 1.235 . . . . 0.0 110.919 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 54.3 p -146.68 141.58 26.98 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -176.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.89 160.41 37.62 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.147 1.379 . . . . 0.0 111.659 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.4 m -55.36 127.17 28.22 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.427 -0.795 . . . . 0.0 110.132 170.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -95.09 -48.33 6.0 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.096 0.407 . . . . 0.0 110.644 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -162.9 168.67 20.89 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 122.201 1.001 . . . . 0.0 113.162 170.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.84 139.49 18.81 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.316 -0.865 . . . . 0.0 112.381 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.481 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -129.45 156.13 44.6 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.848 1.659 . . . . 0.0 111.187 -176.789 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -77.48 167.46 21.61 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.433 0.635 . . . . 0.0 112.363 -174.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -55.41 -36.33 66.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.105 0.962 . . . . 0.0 112.394 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -69.4 -2.92 12.27 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.758 1.223 . . . . 0.0 114.1 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.3 t -119.59 -5.66 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 119.56 1.073 . . . . 0.0 111.453 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.4 t -48.96 -65.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 125.279 1.432 . . . . 0.0 111.85 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -68.45 -27.02 65.81 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.497 -0.752 . . . . 0.0 112.632 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -52.04 65.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.435 1.494 . . . . 0.0 110.596 175.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -60.83 -45.84 92.92 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 124.586 1.154 . . . . 0.0 111.617 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.582 HG22 HD22 ' A' ' 170' ' ' LEU . 87.6 t -56.29 -34.16 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.432 0.693 . . . . 0.0 111.25 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -66.98 -57.75 6.27 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.01 0.924 . . . . 0.0 112.278 174.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 m -69.8 -22.19 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 O-C-N 120.821 -1.175 . . . . 0.0 112.551 -175.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.648 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -78.61 -6.64 56.15 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.933 1.693 . . . . 0.0 111.88 175.108 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 81.7 p -131.4 -12.26 3.52 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -137.45 -6.03 1.78 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.668 1.587 . . . . 0.0 113.771 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.07 156.29 5.3 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 126.04 1.781 . . . . 0.0 113.843 -175.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.99 -171.37 33.27 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.165 0.888 . . . . 0.0 113.12 -174.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 85.1 p -145.1 104.04 3.92 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.507 1.123 . . . . 0.0 113.366 -168.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -134.29 143.77 47.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.179 1.792 . . . . 0.0 110.277 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -71.64 162.66 29.1 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.374 -0.829 . . . . 0.0 112.106 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.2 p -129.56 144.79 51.42 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.456 1.503 . . . . 0.0 111.023 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.481 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 6.7 t -59.07 -43.75 91.79 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.354 1.462 . . . . 0.0 112.534 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.0 mt -155.73 134.41 11.85 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.829 1.652 . . . . 0.0 111.296 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -129.54 102.1 6.23 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.643 1.177 . . . . 0.0 110.696 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -90.38 -41.81 11.28 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.613 1.165 . . . . 0.0 113.965 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 58.15 -173.53 2.97 Favored Glycine 0 CA--C 1.547 2.058 0 C-N-CA 126.222 1.867 . . . . 0.0 115.465 -169.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -62.14 167.07 4.23 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.509 1.124 . . . . 0.0 113.966 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -23.63 53.5 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -72.7 -23.76 60.91 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.538 1.135 . . . . 0.0 113.278 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -62.55 145.46 54.28 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.08 1.752 . . . . 0.0 112.075 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -73.23 -30.95 63.83 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.073 -1.017 . . . . 0.0 112.875 173.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 55.7 m -86.46 -6.76 58.83 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -174.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.2 p -51.64 -23.28 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 175.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.4 mt -62.18 -43.15 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.895 1.278 . . . . 0.0 111.969 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -135.75 -13.59 1.94 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.812 1.245 . . . . 0.0 114.245 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.91 174.51 45.16 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 126.725 2.107 . . . . 0.0 113.646 -171.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.4 mt -119.41 115.53 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.6 1.56 . . . . 0.0 108.152 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -72.96 144.39 47.29 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.097 0.475 . . . . 0.0 111.55 173.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 58.41 24.89 12.25 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 125.754 1.622 . . . . 0.0 114.042 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -62.72 122.81 16.81 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.698 1.199 . . . . 0.0 111.817 -173.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -73.22 124.16 25.1 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.322 1.049 . . . . 0.0 111.428 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.7 mm -118.3 117.79 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.809 1.244 . . . . 0.0 108.882 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.8 mp -110.09 103.37 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 124.984 1.313 . . . . 0.0 108.231 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 59.1 p -85.08 153.14 22.9 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.805 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.17 136.67 20.23 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.163 1.385 . . . . 0.0 111.15 176.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 17.3 mt -81.09 131.67 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -147.69 142.73 27.02 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.793 1.637 . . . . 0.0 110.109 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -84.39 154.85 22.59 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.441 -0.787 . . . . 0.0 109.982 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 49.2 mt -126.55 -46.47 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.989 0.916 . . . . 0.0 110.843 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -148.34 27.49 0.92 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.667 0.787 . . . . 0.0 112.78 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 110.43 -23.0 21.45 Favored Glycine 0 N--CA 1.472 1.096 0 O-C-N 121.233 -0.917 . . . . 0.0 113.71 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 52.8 m -87.58 141.45 28.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.693 0.797 . . . . 0.0 108.888 169.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.74 121.88 23.2 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.484 0.714 . . . . 0.0 109.35 170.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -107.69 165.16 11.64 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.416 1.486 . . . . 0.0 110.522 174.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.8 tp -122.21 132.22 71.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 125.327 1.451 . . . . 0.0 107.848 172.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 p -119.47 156.59 29.94 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.188 0.595 . . . . 0.0 109.794 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -152.03 141.51 21.64 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.103 0.961 . . . . 0.0 111.297 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.2 m -78.7 114.38 17.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.478 1.111 . . . . 0.0 110.484 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.33 -167.26 43.13 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.308 0.956 . . . . 0.0 112.876 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -68.08 171.47 6.87 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.749 -0.853 . . . . 0.0 112.62 168.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -81.05 136.26 35.94 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.243 -0.911 . . . . 0.0 112.114 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.46 163.11 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.815 0.846 . . . . 0.0 112.729 171.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -99.47 -14.62 19.02 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 173.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -95.46 22.5 6.92 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.38 1.472 . . . . 0.0 113.022 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.86 -34.22 0.32 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 113.79 74.72 0.65 Allowed Glycine 0 N--CA 1.476 1.328 0 CA-C-N 119.323 0.965 . . . . 0.0 113.725 170.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 57.86 29.63 17.83 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.35 1.46 . . . . 0.0 113.549 -176.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -96.04 150.71 20.17 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.607 1.163 . . . . 0.0 108.472 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.9 m -86.88 137.22 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 122.781 0.432 . . . . 0.0 110.061 171.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.09 117.16 11.31 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -106.1 148.81 27.38 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 122.009 0.909 . . . . 0.0 109.743 171.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -132.8 172.42 12.6 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.122 1.369 . . . . 0.0 111.491 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.86 133.09 23.08 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.518 0.727 . . . . 0.0 110.156 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.409 ' CG2' HD11 ' A' ' 166' ' ' LEU . 64.0 mt -126.47 138.66 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.133 0.973 . . . . 0.0 108.918 175.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.4 m -64.54 97.39 0.2 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.362 -0.836 . . . . 0.0 110.225 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.5 tt -54.16 -31.03 51.44 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.111 1.364 . . . . 0.0 112.179 175.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -72.73 -26.03 61.43 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -89.43 -26.03 21.19 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.972 -1.08 . . . . 0.0 112.053 173.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.648 HD13 ' HG3' ' A' ' 100' ' ' MET . 14.5 mt -61.49 -46.55 89.52 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.849 0.86 . . . . 0.0 110.813 172.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -55.18 -36.93 66.4 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -67.91 -15.24 63.52 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -124.22 -6.04 7.76 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.094 1.358 . . . . 0.0 114.111 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.582 HD22 HG22 ' A' ' 97' ' ' VAL . 13.4 mt -93.29 -26.29 17.38 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.471 1.508 . . . . 0.0 112.396 -175.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt . . . . . 0 C--O 1.252 1.217 0 C-N-CA 126.271 1.828 . . . . 0.0 112.916 175.827 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? . . . . . 0 N--CA 1.498 1.928 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.9 pt -105.63 171.04 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 125.037 1.335 . . . . 0.0 111.483 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -129.83 122.47 28.8 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.847 1.259 . . . . 0.0 109.835 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.4 t -65.15 162.69 16.53 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.432 0.693 . . . . 0.0 111.962 174.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.0 p 44.94 33.6 1.05 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.675 1.99 . . . . 0.0 115.237 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -56.61 149.74 16.99 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.033 1.333 . . . . 0.0 113.334 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.93 130.09 42.69 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.542 0.737 . . . . 0.0 111.623 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -127.25 34.24 4.75 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.856 1.662 . . . . 0.0 111.913 -174.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 65.39 50.86 1.65 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.213 1.805 . . . . 0.0 111.753 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 72.9 m -143.33 140.52 30.59 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.642 1.577 . . . . 0.0 112.168 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.3 p -76.23 116.71 17.19 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.595 1.158 . . . . 0.0 111.911 175.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 161.05 79.88 0.03 OUTLIER Glycine 0 CA--C 1.533 1.193 0 C-N-CA 123.679 0.657 . . . . 0.0 113.782 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -68.64 174.33 4.34 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.907 0.883 . . . . 0.0 113.252 173.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.7 m -58.38 167.42 1.38 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.69 1.596 . . . . 0.0 113.834 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -70.89 73.7 0.59 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.727 1.611 . . . . 0.0 112.892 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 p -158.67 148.14 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 127.628 2.371 . . . . 0.0 108.579 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.26 164.01 26.53 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.052 1.741 . . . . 0.0 110.798 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.69 160.01 31.07 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.142 0.977 . . . . 0.0 111.755 174.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.0 mm -66.94 128.19 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.371 0.668 . . . . 0.0 111.736 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -118.08 13.25 13.82 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.09 1.356 . . . . 0.0 112.772 -177.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -79.01 -7.89 58.48 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 120.857 -1.152 . . . . 0.0 113.548 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 m -87.49 15.61 6.43 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.893 2.077 . . . . 0.0 113.307 173.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.9 pttt -145.28 165.83 27.28 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.726 1.21 . . . . 0.0 111.31 172.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -144.3 169.39 17.99 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.553 1.141 . . . . 0.0 110.587 170.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -132.6 129.35 38.83 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.742 -0.599 . . . . 0.0 110.17 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.35 167.99 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.196 1.399 . . . . 0.0 110.896 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.34 164.22 7.47 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.639 1.176 . . . . 0.0 111.428 175.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.6 tp -158.72 137.26 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.774 1.229 . . . . 0.0 109.558 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -127.82 162.63 26.22 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.417 1.887 . . . . 0.0 110.073 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -132.12 156.69 45.92 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.304 1.441 . . . . 0.0 111.232 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.51 121.27 24.37 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 171.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -63.88 174.6 1.41 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.065 0.946 . . . . 0.0 111.992 171.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -57.58 -14.79 5.81 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.343 1.857 . . . . 0.0 114.857 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.2 m -115.56 14.16 16.51 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.885 1.274 . . . . 0.0 112.872 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.04 21.07 78.95 Favored Glycine 0 CA--C 1.537 1.438 0 O-C-N 121.335 -0.853 . . . . 0.0 114.393 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -96.59 125.79 41.31 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.68 1.192 . . . . 0.0 109.649 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -66.87 126.14 28.15 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.898 -0.501 . . . . 0.0 110.873 174.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.2 t -140.75 136.02 32.11 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.715 1.206 . . . . 0.0 110.81 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -55.7 131.57 46.9 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.771 1.229 . . . . 0.0 112.354 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 38.8 tp -104.87 -47.73 3.95 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.985 0.914 . . . . 0.0 111.279 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.75 -118.96 0.78 Allowed Glycine 0 CA--C 1.529 0.963 0 N-CA-C 113.978 0.351 . . . . 0.0 113.978 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -141.16 151.73 44.11 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.356 1.462 . . . . 0.0 110.366 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.4 tp -116.96 101.45 8.52 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.409 1.484 . . . . 0.0 109.878 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.1 t -77.45 97.46 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.098 1.359 . . . . 0.0 109.336 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.3 t -84.3 84.42 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.614 1.566 . . . . 0.0 110.296 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -73.9 110.7 8.4 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.795 0.838 . . . . 0.0 110.406 170.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.57 ' HE2' HG11 ' A' ' 93' ' ' VAL . 26.1 tptp -78.47 88.49 4.44 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.656 1.182 . . . . 0.0 109.227 169.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -67.54 172.09 5.47 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.908 1.283 . . . . 0.0 112.485 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -65.4 -39.36 92.1 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.697 -1.252 . . . . 0.0 113.383 175.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -117.6 40.66 3.03 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.407 1.483 . . . . 0.0 112.806 -169.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.06 -161.01 24.82 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.934 1.73 . . . . 0.0 114.051 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.445 HD11 HG13 ' A' ' 93' ' ' VAL . 45.1 mt -119.71 142.95 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.938 0.895 . . . . 0.0 109.431 169.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -132.72 92.43 3.05 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.331 1.453 . . . . 0.0 110.573 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.8 p -84.54 150.36 25.28 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.24 -0.912 . . . . 0.0 112.508 -174.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.73 120.01 1.57 Allowed Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.42 -0.8 . . . . 0.0 113.791 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -70.88 139.92 50.93 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.53 1.932 . . . . 0.0 110.588 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -134.07 78.22 1.75 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.193 1.797 . . . . 0.0 110.708 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.98 86.48 5.86 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.123 0.969 . . . . 0.0 110.939 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 62.45 -98.41 0.2 Allowed Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.566 1.079 . . . . 0.0 112.974 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.98 15.49 33.67 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.7 1.619 . . . . 0.0 114.424 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -132.72 73.14 1.51 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.803 1.241 . . . . 0.0 111.66 -174.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 77.6 p -87.35 149.74 24.3 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -167.4 157.66 11.0 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.411 1.484 . . . . 0.0 112.189 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.3 m -54.05 124.42 15.52 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.3 1.04 . . . . 0.0 110.791 171.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -92.07 -52.64 4.61 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.883 0.473 . . . . 0.0 110.426 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -163.92 153.05 13.97 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.871 0.868 . . . . 0.0 112.691 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.56 128.11 21.46 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 122.75 1.262 . . . . 0.0 112.553 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.96 163.79 16.04 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.13 1.772 . . . . 0.0 111.38 -173.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -79.72 162.05 25.41 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.404 1.082 . . . . 0.0 112.436 -175.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -55.44 -33.05 63.24 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.319 1.047 . . . . 0.0 113.055 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -70.33 -8.38 50.02 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 37.5 t -114.29 -14.56 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 121.3 -0.875 . . . . 0.0 112.028 -171.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.57 HG11 ' HE2' ' A' ' 67' ' ' LYS . 42.2 t -48.15 -55.81 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.502 1.121 . . . . 0.0 111.372 177.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -65.41 -32.87 74.72 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -69.8 -43.63 71.71 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.029 0.932 . . . . 0.0 111.343 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -58.83 -46.88 86.64 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.632 1.173 . . . . 0.0 110.736 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 93' ' ' VAL . 92.6 t -53.94 -37.51 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.395 1.078 . . . . 0.0 111.377 175.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.87 -57.38 4.67 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.5 1.52 . . . . 0.0 112.656 176.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -71.91 -7.5 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 O-C-N 121.212 -0.93 . . . . 0.0 113.125 -175.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.408 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -94.58 -5.69 45.26 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.01 1.724 . . . . 0.0 111.932 176.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 47.4 p -128.89 -14.85 4.41 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.909 0.883 . . . . 0.0 112.958 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -131.97 -9.73 3.44 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.617 1.567 . . . . 0.0 114.593 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.63 157.14 7.51 Favored Glycine 0 CA--C 1.539 1.574 0 C-N-CA 125.294 1.426 . . . . 0.0 113.76 -173.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.52 -153.62 24.66 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 121.543 -0.975 . . . . 0.0 113.175 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 80.1 p -145.52 151.98 39.02 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.18 0.992 . . . . 0.0 113.148 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -148.27 -177.69 5.9 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.55 1.94 . . . . 0.0 112.177 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? -117.41 156.16 28.4 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.937 1.295 . . . . 0.0 111.657 170.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.9 p -126.17 130.81 51.73 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.977 0.911 . . . . 0.0 111.892 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.9 t -51.9 -37.55 52.85 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.409 1.084 . . . . 0.0 112.995 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.0 mt -147.62 141.31 25.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.233 1.413 . . . . 0.0 112.364 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -136.35 93.55 2.91 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.525 1.13 . . . . 0.0 110.643 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -81.7 -49.06 10.9 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.829 0.851 . . . . 0.0 113.121 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.21 177.42 43.2 Favored Glycine 0 CA--C 1.543 1.816 0 C-N-CA 125.06 1.314 . . . . 0.0 113.874 -169.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -62.93 165.4 6.85 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.085 0.954 . . . . 0.0 112.253 170.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.6 ttpp -57.93 -26.02 61.68 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.19 44.47 0.41 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.331 1.452 . . . . 0.0 113.041 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -135.0 166.02 24.01 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.053 2.141 . . . . 0.0 112.289 -173.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -88.81 -42.84 11.66 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.59 0.756 . . . . 0.0 111.409 169.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.6 t -59.01 -43.07 91.5 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.2 p -48.92 -24.67 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 115.759 1.762 . . . . 0.0 115.759 -169.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 56.8 mt -61.18 -35.17 63.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 126.721 2.008 . . . . 0.0 113.051 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -140.05 -39.01 0.45 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.575 1.55 . . . . 0.0 114.321 -171.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 104.27 166.2 24.75 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.136 1.827 . . . . 0.0 114.055 -176.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 52.7 mt -123.39 120.44 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 126.095 1.758 . . . . 0.0 108.866 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -82.31 145.01 30.2 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 57.79 24.49 10.81 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.478 1.911 . . . . 0.0 113.938 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -60.34 125.74 24.82 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.856 1.262 . . . . 0.0 111.363 -173.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -76.61 126.61 31.29 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.845 0.458 . . . . 0.0 110.925 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.3 mm -119.95 120.59 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 126.094 1.758 . . . . 0.0 109.065 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.1 mp -115.06 105.93 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.233 1.413 . . . . 0.0 108.231 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.8 p -80.97 161.63 24.21 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.777 0.799 . . . . 0.0 112.203 174.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -152.15 142.22 22.24 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.91 1.284 . . . . 0.0 110.77 171.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 52.4 mt -82.61 132.14 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -139.89 120.34 14.06 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.303 1.441 . . . . 0.0 110.273 174.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -72.19 117.89 14.38 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.85 -0.531 . . . . 0.0 109.79 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 24.6 mt -103.8 97.86 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 60.85 12.04 3.58 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.688 1.995 . . . . 0.0 115.917 -177.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 130.21 -34.9 2.62 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.997 1.284 . . . . 0.0 113.358 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 91.5 m -72.81 126.19 29.32 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.395 1.078 . . . . 0.0 109.413 171.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -74.79 118.78 18.14 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 173.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -107.93 165.9 11.11 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.821 1.248 . . . . 0.0 110.055 170.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.9 tp -117.0 137.28 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.332 1.453 . . . . 0.0 107.922 169.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 p -124.88 156.87 37.21 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.571 0.623 . . . . 0.0 110.098 172.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -149.63 135.89 19.02 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.988 0.915 . . . . 0.0 111.158 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.2 t -70.61 127.89 34.22 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.065 0.46 . . . . 0.0 110.381 172.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.59 -154.25 26.06 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.816 1.674 . . . . 0.0 112.044 175.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -69.07 169.33 12.07 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 121.936 0.874 . . . . 0.0 112.352 169.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -87.98 112.07 22.19 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.451 1.5 . . . . 0.0 111.528 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.414 ' CG2' ' HB2' ' A' ' 157' ' ' ALA . 0.2 OUTLIER -69.83 162.54 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.628 0.771 . . . . 0.0 112.009 177.596 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -100.03 -23.19 14.96 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.703 0.801 . . . . 0.0 113.066 171.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -66.32 -8.43 25.1 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.557 1.543 . . . . 0.0 114.887 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.04 -30.56 3.48 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.012 1.325 . . . . 0.0 113.566 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 139.59 -78.42 0.3 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.179 1.371 . . . . 0.0 112.843 169.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -142.32 22.09 2.04 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.164 2.186 . . . . 0.0 110.8 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -86.04 167.58 14.88 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.497 1.119 . . . . 0.0 109.337 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.3 m -100.64 139.35 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.304 0.642 . . . . 0.0 110.288 175.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.414 ' HB2' ' CG2' ' A' ' 149' ' ' ILE . . . -65.94 104.28 1.08 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 171.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -104.53 145.7 29.92 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.523 1.154 . . . . 0.0 110.86 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -134.47 167.15 21.29 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.679 1.591 . . . . 0.0 110.719 -169.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.02 134.93 26.87 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.346 0.521 . . . . 0.0 110.349 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.501 ' CG2' HD11 ' A' ' 166' ' ' LEU . 51.3 mt -129.67 139.89 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.802 0.841 . . . . 0.0 109.334 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.7 m -63.73 95.46 0.11 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.018 0.927 . . . . 0.0 109.848 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.444 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.0 OUTLIER -53.07 -33.32 51.55 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.602 1.161 . . . . 0.0 111.516 175.459 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -67.56 -27.49 66.98 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -86.73 -31.53 20.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.991 0.916 . . . . 0.0 111.949 172.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.501 HD11 ' CG2' ' A' ' 161' ' ' ILE . 18.9 mt -62.1 -44.1 97.4 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.847 0.859 . . . . 0.0 111.264 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -50.5 -41.8 53.9 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.31 1.044 . . . . 0.0 112.84 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -67.67 -20.2 65.27 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -109.42 1.98 20.29 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.897 1.679 . . . . 0.0 112.704 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.508 HD22 HG22 ' A' ' 97' ' ' VAL . 17.2 mt -112.31 -17.6 12.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.535 1.534 . . . . 0.0 113.691 -176.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt . . . . . 0 C--O 1.253 1.261 0 C-N-CA 126.279 1.832 . . . . 0.0 113.252 173.026 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 tp -68.03 148.86 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 120.154 -1.591 . . . . 0.0 111.666 175.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -150.92 162.89 39.93 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.928 1.291 . . . . 0.0 111.828 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -154.96 164.35 39.01 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.638 1.575 . . . . 0.0 110.924 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.7 m -127.56 49.1 2.15 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.373 1.869 . . . . 0.0 110.46 -176.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 67.28 26.02 8.68 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.787 2.035 . . . . 0.0 113.96 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -85.37 149.6 25.33 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.172 1.389 . . . . 0.0 112.882 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -154.18 139.82 17.93 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.135 1.774 . . . . 0.0 110.413 175.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -103.59 73.72 1.2 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.817 1.247 . . . . 0.0 111.278 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.7 m -61.75 103.19 0.32 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.266 1.426 . . . . 0.0 112.335 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.2 p -77.04 59.35 1.66 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.776 2.03 . . . . 0.0 113.268 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.24 75.94 2.13 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 126.084 1.802 . . . . 0.0 114.181 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -101.32 158.06 16.33 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.861 1.264 . . . . 0.0 112.812 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.6 t -155.02 179.58 9.01 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.894 1.678 . . . . 0.0 111.752 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -109.15 54.72 0.65 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.692 1.997 . . . . 0.0 111.547 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 t -132.91 56.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 125.785 1.634 . . . . 0.0 110.636 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -143.72 171.27 14.43 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 126.765 2.026 . . . . 0.0 112.048 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -52.48 141.64 19.6 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.676 1.591 . . . . 0.0 111.289 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 37.0 mm -65.97 136.99 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.713 0.805 . . . . 0.0 111.33 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -116.25 -12.67 11.14 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.865 1.266 . . . . 0.0 113.393 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -91.73 -6.78 51.33 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.5 t -56.87 -34.37 67.78 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.109 1.763 . . . . 0.0 112.735 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -144.93 162.94 35.64 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.408 1.483 . . . . 0.0 111.081 169.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -145.89 165.69 28.18 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.769 1.228 . . . . 0.0 110.495 173.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -131.76 125.79 32.82 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.596 0.358 . . . . 0.0 110.464 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.9 m -118.79 165.96 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.021 1.329 . . . . 0.0 110.927 177.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -68.06 161.79 26.01 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.544 1.138 . . . . 0.0 110.995 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.2 tp -153.37 136.29 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.436 1.095 . . . . 0.0 109.667 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -127.21 161.3 28.86 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.197 1.799 . . . . 0.0 109.741 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -132.01 154.37 49.43 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 126.098 1.759 . . . . 0.0 110.749 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -76.09 124.74 27.89 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 169.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -67.43 175.68 2.67 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 122.241 1.019 . . . . 0.0 111.327 170.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -59.81 -11.73 5.92 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.234 2.213 . . . . 0.0 114.778 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.8 t -116.51 12.93 15.26 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.111 1.364 . . . . 0.0 112.821 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.31 19.71 79.38 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 121.312 -0.867 . . . . 0.0 114.615 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -95.59 129.38 42.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.778 1.231 . . . . 0.0 109.477 176.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -68.98 127.75 34.25 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.637 -0.664 . . . . 0.0 110.567 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.7 t -138.86 147.04 41.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.878 1.671 . . . . 0.0 110.241 -175.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -66.49 137.38 56.77 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.051 -1.031 . . . . 0.0 111.626 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.8 tp -110.83 -46.9 3.29 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.876 0.87 . . . . 0.0 112.291 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.27 -133.31 2.39 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 121.703 0.613 . . . . 0.0 114.612 -174.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -132.65 155.91 47.9 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.511 1.924 . . . . 0.0 110.953 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.8 tp -122.96 104.27 9.14 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.275 1.43 . . . . 0.0 110.539 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.4 t -81.57 97.48 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.48 1.512 . . . . 0.0 109.462 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.03 117.47 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.914 1.286 . . . . 0.0 109.671 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -113.77 128.24 56.33 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.925 2.09 . . . . 0.0 110.535 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -83.64 83.67 7.82 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.155 0.982 . . . . 0.0 110.629 174.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -65.77 171.66 4.13 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.073 0.949 . . . . 0.0 112.193 170.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -68.89 -31.98 71.3 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.002 -1.062 . . . . 0.0 113.746 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -126.54 47.07 2.35 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.761 1.224 . . . . 0.0 112.356 -168.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.12 -155.99 21.75 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.834 1.207 . . . . 0.0 113.964 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 68.5 mt -122.1 136.84 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.928 0.891 . . . . 0.0 109.52 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.65 142.82 47.29 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.15 1.38 . . . . 0.0 109.253 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.1 p -133.54 139.85 46.85 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.277 0.631 . . . . 0.0 110.016 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.61 107.83 0.65 Allowed Glycine 0 CA--C 1.521 0.421 0 CA-C-O 121.843 0.69 . . . . 0.0 111.61 -169.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 33.1 tp -64.09 144.56 57.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.616 1.166 . . . . 0.0 110.174 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -134.47 70.35 1.45 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.917 2.087 . . . . 0.0 109.294 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.38 77.81 9.86 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.402 1.081 . . . . 0.0 112.092 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.36 -81.51 1.08 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.506 1.527 . . . . 0.0 113.437 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -134.74 24.45 3.48 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.086 1.803 . . . . 0.0 112.993 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -135.84 50.18 2.1 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.383 1.473 . . . . 0.0 110.917 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.4 p -64.26 141.66 58.69 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.321 -0.862 . . . . 0.0 113.056 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -164.05 158.22 19.2 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.128 1.371 . . . . 0.0 111.885 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.7 m -58.82 118.34 5.63 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.024 -1.047 . . . . 0.0 109.313 169.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -82.22 -48.45 11.26 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.001 -0.437 . . . . 0.0 109.949 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -164.82 161.4 20.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.836 0.855 . . . . 0.0 113.074 170.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.87 149.41 33.2 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.985 1.374 . . . . 0.0 113.08 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.424 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.5 OUTLIER -135.92 160.31 38.99 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.31 1.444 . . . . 0.0 111.715 -175.55 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -80.13 165.99 21.92 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.3 0.64 . . . . 0.0 112.387 -175.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -54.18 -34.85 61.49 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.136 0.975 . . . . 0.0 112.771 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -67.65 -4.58 12.43 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.578 1.151 . . . . 0.0 114.086 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.84 -3.57 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.336 1.054 . . . . 0.0 111.399 -175.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.9 t -51.21 -65.38 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.261 1.424 . . . . 0.0 111.352 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -69.11 -24.06 64.07 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -50.51 68.76 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.321 1.449 . . . . 0.0 110.438 172.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -61.43 -42.56 98.95 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 124.666 1.186 . . . . 0.0 111.798 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.507 HG22 HD22 ' A' ' 170' ' ' LEU . 89.5 t -56.04 -35.14 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.103 0.561 . . . . 0.0 110.882 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -69.94 -54.26 14.15 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.939 1.296 . . . . 0.0 112.949 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.0 m -74.34 -6.33 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 120.933 -1.104 . . . . 0.0 112.967 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.527 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -97.77 -4.85 36.18 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.028 1.731 . . . . 0.0 111.742 176.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 44.7 p -132.06 -17.5 2.73 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.733 1.213 . . . . 0.0 113.496 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -131.76 -11.13 3.46 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.15 1.78 . . . . 0.0 113.667 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.21 155.8 11.62 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.977 1.275 . . . . 0.0 113.738 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 164.12 -159.43 32.25 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 121.784 -0.833 . . . . 0.0 114.299 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.6 p -154.09 89.35 1.29 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -168.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -124.42 141.71 51.87 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.769 1.628 . . . . 0.0 110.528 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -69.87 162.62 27.6 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.462 0.705 . . . . 0.0 111.54 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.2 p -130.51 147.64 52.22 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.507 1.523 . . . . 0.0 111.391 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.424 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 5.1 t -65.27 -40.36 93.82 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.874 0.87 . . . . 0.0 111.858 -178.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.8 mt -150.73 137.71 19.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.686 1.594 . . . . 0.0 111.794 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -139.03 100.54 4.05 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.642 0.777 . . . . 0.0 110.868 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -94.95 -38.59 10.62 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.13 -169.78 16.58 Favored Glycine 0 CA--C 1.543 1.815 0 C-N-CA 125.032 1.301 . . . . 0.0 115.478 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -71.15 165.9 22.61 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.169 0.988 . . . . 0.0 112.62 169.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -52.83 -28.64 23.74 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.643 1.577 . . . . 0.0 115.236 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -54.76 -35.91 64.27 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 174.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -67.16 132.48 47.89 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.964 0.906 . . . . 0.0 112.682 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -56.73 -35.14 68.21 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.602 1.161 . . . . 0.0 113.239 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.83 16.5 12.31 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -176.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.5 p -60.25 -17.36 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 55.3 mt -112.41 -47.47 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.905 0.882 . . . . 0.0 111.476 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -71.27 -20.8 62.17 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.95 0.9 . . . . 0.0 112.565 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 61.22 -174.77 5.83 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.75 1.643 . . . . 0.0 113.574 -170.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.2 mt -140.83 101.66 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.036 1.335 . . . . 0.0 107.738 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -69.32 145.07 53.3 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.191 0.519 . . . . 0.0 111.32 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 60.38 20.79 10.37 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.673 1.589 . . . . 0.0 113.821 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -55.37 123.65 14.56 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.864 1.266 . . . . 0.0 111.161 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -71.58 127.62 33.16 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.832 0.853 . . . . 0.0 110.319 170.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.3 mm -123.01 117.69 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.687 1.195 . . . . 0.0 108.56 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.37 99.01 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 125.178 1.391 . . . . 0.0 107.8 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.7 p -81.55 157.06 24.92 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.726 0.774 . . . . 0.0 111.064 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -151.52 137.56 18.22 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.467 1.107 . . . . 0.0 110.808 176.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 52.4 mt -80.6 132.67 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -139.56 121.67 15.78 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.375 1.47 . . . . 0.0 110.314 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -74.26 115.6 13.94 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.855 -0.528 . . . . 0.0 109.806 169.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.5 mt -102.02 96.68 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 60.82 13.28 4.31 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.743 2.017 . . . . 0.0 115.917 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 128.8 -33.32 3.12 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 124.955 1.264 . . . . 0.0 113.405 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 88.5 m -73.18 125.65 28.23 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.495 1.118 . . . . 0.0 109.228 171.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -75.94 117.72 17.96 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.699 -0.625 . . . . 0.0 109.646 174.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -107.02 166.18 10.8 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.154 1.382 . . . . 0.0 110.382 171.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.0 tp -118.08 137.87 50.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 125.414 1.485 . . . . 0.0 108.296 169.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.6 p -125.94 155.95 40.52 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.44 0.696 . . . . 0.0 110.024 174.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -150.51 137.47 19.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.167 0.987 . . . . 0.0 111.213 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.7 m -78.81 119.19 21.67 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.526 1.131 . . . . 0.0 110.691 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.4 -156.29 32.58 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.929 1.252 . . . . 0.0 113.256 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -66.51 161.78 22.17 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.253 1.021 . . . . 0.0 112.694 171.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -77.93 110.06 12.52 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.665 1.186 . . . . 0.0 110.506 173.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.61 157.47 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.21 0.528 . . . . 0.0 111.929 175.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.24 -27.06 15.7 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 176.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -76.28 -20.91 56.89 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.379 1.071 . . . . 0.0 113.247 -176.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.9 t -96.36 -41.07 8.81 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.66 83.89 1.5 Allowed Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.335 0.969 . . . . 0.0 113.53 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 62.23 13.98 6.33 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.151 1.78 . . . . 0.0 114.92 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -90.18 154.05 20.05 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.946 0.898 . . . . 0.0 108.885 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.3 m -91.51 143.1 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 122.712 0.405 . . . . 0.0 110.548 173.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.83 130.22 43.89 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 168.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -128.0 143.73 51.09 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.571 1.177 . . . . 0.0 111.488 173.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -135.55 169.8 16.95 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 126.093 1.757 . . . . 0.0 111.069 -169.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.83 135.22 24.3 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 122.934 0.494 . . . . 0.0 110.248 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.457 ' CG2' HD11 ' A' ' 166' ' ' LEU . 63.2 mt -127.32 141.24 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 123.738 0.815 . . . . 0.0 108.98 175.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.8 m -62.2 94.74 0.06 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.204 1.002 . . . . 0.0 109.753 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.504 ' HA ' HD12 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -54.05 -32.93 56.01 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.904 0.882 . . . . 0.0 111.464 174.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -66.74 -30.62 70.89 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -82.57 -32.14 28.65 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.053 0.941 . . . . 0.0 111.851 173.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.527 HD13 ' HG3' ' A' ' 100' ' ' MET . 18.7 mt -60.39 -45.98 91.64 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.645 0.778 . . . . 0.0 111.39 175.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.431 ' HE3' HD21 ' A' ' 163' ' ' LEU . 77.0 mttt -51.29 -42.63 61.28 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 119.044 0.838 . . . . 0.0 112.833 175.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -64.7 -18.53 65.08 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.244 1.418 . . . . 0.0 113.996 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -116.32 -2.49 12.1 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.876 1.67 . . . . 0.0 113.287 -177.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.507 HD22 HG22 ' A' ' 97' ' ' VAL . 19.3 mt -104.01 -24.49 13.22 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.522 1.529 . . . . 0.0 113.342 -177.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 82.3 mttt . . . . . 0 C--O 1.254 1.342 0 C-N-CA 126.865 2.066 . . . . 0.0 113.245 174.835 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.4 mttm . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.6 pt -67.67 168.69 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.904 0.882 . . . . 0.0 112.494 174.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -123.44 153.8 39.94 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.301 1.441 . . . . 0.0 111.109 175.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.5 t -148.91 163.59 36.99 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.327 1.451 . . . . 0.0 111.122 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.8 m -129.4 172.87 11.08 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.728 1.611 . . . . 0.0 111.458 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -119.02 76.56 1.12 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.696 1.199 . . . . 0.0 110.869 -174.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -72.64 69.84 0.91 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.28 1.832 . . . . 0.0 112.989 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -144.09 159.15 43.11 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.58 1.552 . . . . 0.0 111.189 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -60.39 130.69 47.85 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.472 1.109 . . . . 0.0 111.948 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.7 m -151.04 159.45 44.53 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.421 1.489 . . . . 0.0 111.97 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.3 p -84.99 159.29 20.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.026 1.33 . . . . 0.0 112.525 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 135.0 -110.04 0.81 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.919 1.247 . . . . 0.0 112.344 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 54.3 27.06 7.49 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.272 1.829 . . . . 0.0 113.956 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.8 t -91.0 61.97 4.77 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.853 1.661 . . . . 0.0 111.799 -174.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.97 169.61 17.75 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.744 1.618 . . . . 0.0 112.192 175.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.6 m -124.11 41.74 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 126.341 1.856 . . . . 0.0 110.711 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -147.94 167.06 25.83 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.938 2.095 . . . . 0.0 110.853 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -36.92 117.13 0.49 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.519 1.928 . . . . 0.0 112.28 173.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.409 HG22 ' H ' ' A' ' 41' ' ' PHE . 15.8 mm -71.66 154.78 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.193 0.597 . . . . 0.0 109.739 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.0 -21.91 66.42 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 172.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.409 ' H ' HG22 ' A' ' 39' ' ' ILE . 9.5 m-85 -80.97 172.1 14.16 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.211 1.805 . . . . 0.0 112.485 174.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.0 m -75.25 -25.59 58.19 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.326 1.05 . . . . 0.0 112.872 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -97.04 161.68 13.72 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.53 1.132 . . . . 0.0 111.589 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -140.95 166.6 24.33 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.935 1.294 . . . . 0.0 111.42 170.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 m -134.74 130.35 36.06 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.591 0.357 . . . . 0.0 110.744 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.1 m -128.24 165.27 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.795 1.638 . . . . 0.0 110.853 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -63.42 163.02 11.48 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.58 1.152 . . . . 0.0 111.736 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.3 tp -159.28 137.04 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.787 1.235 . . . . 0.0 110.044 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -129.06 162.62 27.25 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.043 2.137 . . . . 0.0 109.362 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -129.3 157.9 40.59 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.152 1.381 . . . . 0.0 111.116 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -78.83 119.96 22.78 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 169.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.89 172.47 1.7 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.51 1.124 . . . . 0.0 112.154 171.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -53.29 -18.02 2.17 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.199 1.8 . . . . 0.0 115.518 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.9 m -112.07 13.53 20.68 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.322 1.049 . . . . 0.0 113.16 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.54 20.67 79.49 Favored Glycine 0 CA--C 1.537 1.45 0 O-C-N 121.213 -0.93 . . . . 0.0 114.181 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -97.4 125.87 42.29 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.797 1.239 . . . . 0.0 109.703 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -67.09 126.22 28.5 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.772 -0.58 . . . . 0.0 110.628 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.3 t -141.16 140.1 34.01 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.834 1.254 . . . . 0.0 110.842 -174.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -56.77 135.03 55.47 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.229 1.012 . . . . 0.0 112.781 -175.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.6 tp -109.18 -48.39 3.27 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.695 0.798 . . . . 0.0 111.139 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.5 -113.14 0.51 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 123.137 0.399 . . . . 0.0 113.663 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -146.61 157.56 43.74 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.439 1.495 . . . . 0.0 109.949 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.1 tp -122.9 102.19 7.87 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.504 1.521 . . . . 0.0 110.022 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.67 95.58 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.636 1.574 . . . . 0.0 109.561 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.8 t -84.18 104.57 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.211 1.804 . . . . 0.0 110.252 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -94.33 122.65 37.1 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 127.098 2.159 . . . . 0.0 111.346 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -87.69 98.64 11.55 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.105 1.362 . . . . 0.0 110.321 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -89.33 177.47 6.58 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.813 1.245 . . . . 0.0 111.764 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -71.21 -19.15 62.42 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 175.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -131.2 73.85 1.56 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.894 1.677 . . . . 0.0 110.883 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.67 -170.33 40.1 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.354 0.978 . . . . 0.0 114.026 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.3 mt -111.76 140.32 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.12 0.968 . . . . 0.0 109.404 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -128.99 130.1 46.24 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.282 1.433 . . . . 0.0 109.6 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.2 p -119.79 148.51 43.35 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.375 -0.828 . . . . 0.0 111.198 -172.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.49 125.01 2.64 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-O 121.513 0.507 . . . . 0.0 112.788 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.8 138.2 52.48 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.077 1.751 . . . . 0.0 110.402 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -136.05 75.96 1.58 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.119 1.768 . . . . 0.0 110.885 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.99 173.95 9.57 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.709 1.604 . . . . 0.0 112.237 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.12 93.56 0.07 OUTLIER Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.225 1.393 . . . . 0.0 113.255 175.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.73 14.66 77.36 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.813 1.197 . . . . 0.0 115.079 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -150.41 125.02 9.67 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.98 1.39 . . . . 0.0 111.391 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 77.3 p -145.79 142.34 28.79 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -164.88 164.27 20.9 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.706 1.603 . . . . 0.0 111.594 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.5 m -54.89 130.76 42.45 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 121.382 -0.824 . . . . 0.0 110.612 170.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -97.5 -50.91 4.33 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.897 0.879 . . . . 0.0 110.175 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -163.86 158.45 19.94 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.883 0.873 . . . . 0.0 112.728 171.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.46 133.25 27.29 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 122.092 0.948 . . . . 0.0 111.943 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.442 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -108.3 160.38 15.9 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.108 1.363 . . . . 0.0 111.669 -178.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -76.95 165.4 24.72 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.91 0.862 . . . . 0.0 112.334 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -60.04 -26.6 66.25 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.021 0.928 . . . . 0.0 112.764 172.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -74.21 -3.96 33.02 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 172.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.1 t -117.91 -2.7 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.347 1.059 . . . . 0.0 110.883 -173.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.2 m -57.14 -29.33 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -176.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -98.96 -25.91 14.43 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.281 1.033 . . . . 0.0 111.851 171.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -71.27 -49.16 45.86 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.906 1.682 . . . . 0.0 111.6 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -59.68 -45.33 92.39 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.373 1.069 . . . . 0.0 110.918 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 73.3 t -55.67 -39.4 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.724 0.81 . . . . 0.0 110.367 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -60.58 -55.22 35.93 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.533 1.533 . . . . 0.0 112.224 174.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.0 m -70.9 -14.91 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 121.12 -0.987 . . . . 0.0 112.785 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.456 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -91.3 -4.6 55.71 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.274 1.83 . . . . 0.0 111.824 178.57 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.5 p -127.84 -15.56 4.85 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.63 1.172 . . . . 0.0 114.002 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -134.24 -9.8 2.58 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.272 1.429 . . . . 0.0 114.281 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.97 156.42 9.89 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.159 1.362 . . . . 0.0 113.825 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.03 -170.61 32.64 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.65 1.119 . . . . 0.0 113.524 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.503 ' HB3' HG23 ' A' ' 130' ' ' ILE . 56.7 p -144.36 103.81 4.01 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.756 1.222 . . . . 0.0 113.423 -168.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -133.81 156.54 47.85 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.145 1.778 . . . . 0.0 110.289 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 165.01 20.13 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.272 -0.892 . . . . 0.0 111.288 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.6 p -131.91 146.57 52.19 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.299 1.439 . . . . 0.0 111.273 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.442 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 9.4 t -54.88 -44.33 74.0 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.96 1.304 . . . . 0.0 112.084 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.5 mt -152.67 146.49 25.2 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.366 1.867 . . . . 0.0 110.942 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.431 ' CD2' HD11 ' A' ' 129' ' ' ILE . 39.6 t80 -139.72 111.38 7.25 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.27 0.628 . . . . 0.0 110.253 174.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -98.19 -39.56 8.81 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.129 1.372 . . . . 0.0 114.038 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.63 178.12 7.47 Favored Glycine 0 CA--C 1.544 1.906 0 C-N-CA 125.003 1.287 . . . . 0.0 115.409 -169.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -60.99 170.48 1.55 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.894 1.278 . . . . 0.0 113.006 170.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -26.55 63.21 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 119.755 -1.841 . . . . 0.0 114.263 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -68.49 -20.58 64.6 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.116 0.966 . . . . 0.0 113.565 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.0 141.81 57.45 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.493 1.117 . . . . 0.0 112.088 176.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -71.49 -23.14 61.75 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.773 -1.205 . . . . 0.0 113.915 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 55.9 p -88.87 -12.92 40.46 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.9 p -53.36 -24.41 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -171.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.507 HD12 ' H ' ' A' ' 121' ' ' ILE . 4.9 mp -63.21 -36.46 76.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 125.537 1.535 . . . . 0.0 112.602 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -146.64 -16.85 0.42 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 -169.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.34 166.53 23.02 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.699 2.095 . . . . 0.0 114.755 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.6 mt -114.07 115.0 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.149 1.38 . . . . 0.0 108.643 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -70.7 144.28 51.06 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.028 0.442 . . . . 0.0 111.198 172.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 58.14 26.36 13.61 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.334 1.454 . . . . 0.0 113.518 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -61.79 125.66 24.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.543 1.137 . . . . 0.0 111.187 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -72.32 122.81 21.76 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.542 1.537 . . . . 0.0 111.953 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.431 HD11 ' CD2' ' A' ' 111' ' ' TYR . 34.9 mm -119.58 116.17 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.122 0.969 . . . . 0.0 109.477 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.503 HG23 ' HB3' ' A' ' 105' ' ' SER . 3.6 mp -110.32 96.66 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.928 1.291 . . . . 0.0 108.425 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.9 p -80.62 156.46 26.38 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.983 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -151.53 139.58 20.11 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.88 1.272 . . . . 0.0 111.495 174.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.9 mt -81.07 134.08 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -141.84 123.81 15.36 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.055 1.342 . . . . 0.0 110.73 172.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -73.17 119.99 18.18 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.787 -0.571 . . . . 0.0 109.99 169.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 25.8 mt -107.86 100.6 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 176.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 58.1 15.32 3.17 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.534 1.934 . . . . 0.0 115.821 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 123.91 -25.05 6.22 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.728 1.156 . . . . 0.0 114.016 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 93.6 m -82.47 126.49 32.29 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.892 0.877 . . . . 0.0 109.506 173.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -72.86 113.27 9.71 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.545 -0.722 . . . . 0.0 110.146 173.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -103.4 167.57 9.72 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.833 1.253 . . . . 0.0 110.69 170.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.2 tp -122.09 134.02 66.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 125.634 1.574 . . . . 0.0 108.103 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 p -120.77 156.71 31.27 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.198 0.599 . . . . 0.0 109.849 173.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -150.99 140.58 21.62 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.705 0.802 . . . . 0.0 111.312 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.7 p -71.79 118.94 15.26 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.929 0.892 . . . . 0.0 110.999 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.06 -154.39 16.18 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.717 1.151 . . . . 0.0 112.19 172.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -79.98 166.55 21.48 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.659 0.783 . . . . 0.0 111.202 169.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -79.1 105.99 10.82 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.95 -1.094 . . . . 0.0 111.286 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.434 ' CG2' ' HB2' ' A' ' 157' ' ' ALA . 0.2 OUTLIER -68.12 161.18 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.474 0.71 . . . . 0.0 112.06 178.397 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -100.15 -22.74 15.06 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.114 0.966 . . . . 0.0 112.628 172.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -67.87 -7.57 29.23 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.37 -16.04 5.0 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.398 1.479 . . . . 0.0 114.605 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 125.38 -86.94 0.36 Allowed Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.519 1.533 . . . . 0.0 113.002 173.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -140.22 25.21 2.28 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 127.061 2.144 . . . . 0.0 110.709 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -84.74 170.72 12.96 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.975 0.91 . . . . 0.0 108.911 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.5 m -104.37 140.96 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.128 0.571 . . . . 0.0 109.77 171.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.434 ' HB2' ' CG2' ' A' ' 149' ' ' ILE . . . -63.29 115.67 4.77 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -113.04 143.97 43.41 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.84 1.305 . . . . 0.0 111.231 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -134.65 168.06 19.68 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.202 1.801 . . . . 0.0 110.225 -169.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.89 133.46 23.54 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 69.5 mt -124.87 140.32 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.6 m -62.11 94.08 0.05 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.744 0.818 . . . . 0.0 109.226 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.54 -31.83 57.18 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.513 -0.742 . . . . 0.0 111.497 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -63.88 -27.71 69.34 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -94.78 -29.86 14.54 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.59 1.556 . . . . 0.0 111.597 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.456 HD13 ' HG3' ' A' ' 100' ' ' MET . 16.9 mt -58.04 -49.66 76.11 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.435 1.094 . . . . 0.0 110.766 170.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -49.33 -37.92 26.15 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.411 1.084 . . . . 0.0 113.445 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -69.94 -18.35 63.36 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.664 1.586 . . . . 0.0 114.268 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -115.98 -9.53 11.75 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.194 1.798 . . . . 0.0 113.983 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 41.2 mt -98.02 -20.28 17.49 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.631 1.572 . . . . 0.0 112.87 -173.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 78.4 mttt . . . . . 0 C--O 1.254 1.296 0 C-N-CA 127.516 2.326 . . . . 0.0 113.584 173.327 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt . . . . . 0 N--CA 1.495 1.804 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.4 pt -61.67 162.58 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.077 0.951 . . . . 0.0 112.77 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -142.54 167.29 22.43 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.299 1.44 . . . . 0.0 111.292 175.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.5 p -128.08 137.38 52.13 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.038 1.335 . . . . 0.0 110.668 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.3 p -159.28 166.25 31.69 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.51 1.524 . . . . 0.0 111.041 -175.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -136.51 158.03 45.39 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.582 1.153 . . . . 0.0 110.833 173.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -141.28 124.43 16.42 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.077 1.351 . . . . 0.0 109.607 -177.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -62.44 124.65 21.5 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.616 0.722 . . . . 0.0 112.275 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -156.37 168.48 27.2 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.561 1.544 . . . . 0.0 111.406 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.8 t -145.54 122.97 11.66 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.808 1.243 . . . . 0.0 109.732 173.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.5 p -142.8 -40.07 0.33 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.665 1.186 . . . . 0.0 113.58 -172.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 169.23 29.97 0.02 OUTLIER Glycine 0 CA--C 1.536 1.375 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 175.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -102.41 160.36 14.62 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 118.826 1.313 . . . . 0.0 112.851 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.6 m -65.48 171.19 4.19 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.284 1.434 . . . . 0.0 113.236 173.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -134.14 154.11 51.41 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.322 1.449 . . . . 0.0 110.949 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.7 m -113.24 42.58 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.544 1.938 . . . . 0.0 111.34 -176.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -127.18 144.06 51.12 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.452 1.901 . . . . 0.0 111.654 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.4 tptm -168.01 162.96 13.57 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.822 1.649 . . . . 0.0 112.082 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.5 mm -87.36 154.14 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.478 1.111 . . . . 0.0 110.462 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -57.25 -19.73 23.26 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 172.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -78.97 -8.32 58.81 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.5 t -77.47 -4.59 46.26 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.868 1.267 . . . . 0.0 113.728 173.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -122.51 154.38 37.93 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.788 1.235 . . . . 0.0 108.9 167.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -140.0 161.29 37.96 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.158 0.983 . . . . 0.0 109.951 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -132.6 124.92 29.28 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.739 0.304 . . . . 0.0 110.595 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.4 m -122.75 162.25 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.439 1.496 . . . . 0.0 111.18 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -60.42 157.87 13.08 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.345 1.058 . . . . 0.0 111.189 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.4 tp -156.74 137.82 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.218 1.007 . . . . 0.0 109.267 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -130.52 161.97 30.28 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 126.69 1.996 . . . . 0.0 109.628 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -128.73 159.3 36.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.042 1.337 . . . . 0.0 110.899 174.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -80.08 121.44 25.53 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 122.125 -0.36 . . . . 0.0 110.319 170.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.53 171.91 2.33 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.452 1.101 . . . . 0.0 112.258 171.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -55.13 -14.76 1.77 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.425 1.89 . . . . 0.0 115.343 174.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.9 t -113.03 11.46 18.98 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.95 1.3 . . . . 0.0 112.786 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.9 21.3 78.71 Favored Glycine 0 CA--C 1.537 1.409 0 O-C-N 120.553 -1.342 . . . . 0.0 114.334 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -98.17 127.79 44.31 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.843 1.257 . . . . 0.0 109.483 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -67.15 126.83 30.44 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.783 -0.573 . . . . 0.0 110.631 173.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.6 t -140.07 140.09 36.05 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.186 1.394 . . . . 0.0 110.138 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -58.19 141.05 51.74 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.8 tp -113.11 -48.9 2.95 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.758 0.823 . . . . 0.0 110.927 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.4 -111.85 0.47 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.141 0.4 . . . . 0.0 113.32 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -147.15 146.36 29.87 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.473 1.509 . . . . 0.0 110.008 -175.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 16.5 tp -114.68 106.66 14.49 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.674 1.189 . . . . 0.0 110.513 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.8 t -77.56 100.95 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.624 1.169 . . . . 0.0 109.137 173.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.6 t -90.02 123.79 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.156 1.382 . . . . 0.0 109.603 173.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -110.94 111.98 23.49 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 127.475 2.31 . . . . 0.0 109.792 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -82.49 88.25 6.63 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.896 1.278 . . . . 0.0 110.252 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -84.31 176.1 8.95 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.616 1.166 . . . . 0.0 111.785 176.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -74.97 -42.8 56.92 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.738 -1.226 . . . . 0.0 112.541 172.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -93.37 50.34 1.49 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.003 1.321 . . . . 0.0 111.669 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.46 -163.94 14.1 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.433 1.016 . . . . 0.0 114.075 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.2 mt -117.33 142.88 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.717 0.807 . . . . 0.0 110.075 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -128.97 143.78 50.98 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.296 1.438 . . . . 0.0 109.664 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.1 p -135.31 148.83 49.61 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.299 -0.876 . . . . 0.0 112.043 -174.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.62 124.74 2.15 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-O 121.698 0.61 . . . . 0.0 112.739 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.46 HD12 ' CD1' ' A' ' 114' ' ' TYR . 3.2 tm? -74.45 139.06 43.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.147 1.779 . . . . 0.0 110.436 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.411 ' N ' HD13 ' A' ' 76' ' ' LEU . 48.4 t30 -135.45 81.36 1.89 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.097 1.759 . . . . 0.0 111.106 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.91 66.12 7.81 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.243 1.817 . . . . 0.0 112.199 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.48 -87.82 0.72 Allowed Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.617 1.103 . . . . 0.0 113.634 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.6 10.59 35.51 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.789 1.661 . . . . 0.0 113.941 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -136.83 118.51 14.99 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.434 1.493 . . . . 0.0 109.845 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 77.6 p -143.81 145.58 32.45 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -173.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.8 159.88 24.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.872 1.269 . . . . 0.0 111.929 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.2 m -56.01 128.34 34.84 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.523 0.729 . . . . 0.0 110.382 169.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -93.86 -51.11 5.03 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.478 0.711 . . . . 0.0 110.218 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -167.05 164.81 15.93 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.894 1.278 . . . . 0.0 112.661 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.89 146.29 28.99 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.608 1.163 . . . . 0.0 112.563 176.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.494 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -127.53 158.27 37.87 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.417 1.487 . . . . 0.0 112.111 -176.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -77.5 165.33 24.48 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.606 0.717 . . . . 0.0 112.494 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -56.0 -35.78 67.18 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.151 0.98 . . . . 0.0 112.335 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -69.0 -8.88 49.08 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.153 0.981 . . . . 0.0 113.5 175.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.9 t -113.31 -6.58 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.494 1.118 . . . . 0.0 110.834 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 67.7 t -49.85 -67.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.609 1.164 . . . . 0.0 111.87 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -67.12 -24.86 65.96 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.697 -0.627 . . . . 0.0 112.633 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -53.56 54.47 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.527 1.531 . . . . 0.0 110.813 173.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -62.51 -43.62 98.36 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.445 1.498 . . . . 0.0 111.642 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.479 HG22 HD22 ' A' ' 170' ' ' LEU . 74.3 t -56.62 -37.83 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.471 0.708 . . . . 0.0 110.733 176.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -68.1 -53.18 27.33 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.431 1.092 . . . . 0.0 113.059 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.32 -14.51 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 O-C-N 121.003 -1.06 . . . . 0.0 112.427 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.532 ' CG ' HD13 ' A' ' 166' ' ' LEU . 6.5 ttm -92.54 -4.65 53.18 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 120.465 -1.397 . . . . 0.0 112.802 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.5 p -126.75 -12.06 6.02 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.34 1.056 . . . . 0.0 113.114 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -136.98 -10.85 1.75 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.934 1.694 . . . . 0.0 114.415 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.27 154.64 10.02 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.728 1.632 . . . . 0.0 114.18 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.09 -168.66 33.04 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.672 1.13 . . . . 0.0 113.953 -175.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.7 p -146.24 107.38 4.18 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.873 1.269 . . . . 0.0 113.502 -168.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -136.44 149.42 48.24 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.308 1.843 . . . . 0.0 110.243 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -76.28 163.32 27.14 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.247 -0.908 . . . . 0.0 111.334 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.5 p -128.83 142.37 50.99 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.981 1.313 . . . . 0.0 111.32 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.494 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 8.4 t -53.52 -44.15 68.9 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.433 1.493 . . . . 0.0 112.256 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 mt -151.34 142.23 22.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.846 1.658 . . . . 0.0 111.691 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -136.12 102.66 5.08 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.072 0.949 . . . . 0.0 110.811 175.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -87.22 -48.53 7.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.01 0.924 . . . . 0.0 112.984 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.98 165.5 34.0 Favored Glycine 0 CA--C 1.545 1.933 0 C-N-CA 124.748 1.166 . . . . 0.0 112.584 -168.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.46 ' CD1' HD12 ' A' ' 76' ' ' LEU . 5.6 t80 -58.76 -65.3 0.68 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.479 1.111 . . . . 0.0 113.908 -178.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.39 176.84 1.57 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.527 2.731 . . . . 0.0 108.357 -172.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 63.91 5.42 2.34 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.147 1.379 . . . . 0.0 113.968 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -90.39 150.83 21.7 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.95 2.1 . . . . 0.0 111.269 -172.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -73.94 -12.93 60.8 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 172.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 34.9 m -122.15 -7.14 8.85 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.8 p -57.34 -23.47 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-N 121.356 1.889 . . . . 0.0 113.452 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 33.1 mm -56.39 -36.87 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 126.407 1.883 . . . . 0.0 112.909 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -139.24 -26.1 0.84 Allowed 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.33 169.16 37.48 Favored Glycine 0 CA--C 1.539 1.56 0 C-N-CA 126.213 1.864 . . . . 0.0 113.86 -173.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.7 mt -125.72 115.83 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.807 1.643 . . . . 0.0 108.612 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -74.47 146.92 42.39 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.992 0.425 . . . . 0.0 111.836 173.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 57.47 23.36 9.01 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.136 1.774 . . . . 0.0 114.467 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -63.7 123.24 18.36 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.715 1.206 . . . . 0.0 111.727 -171.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -71.33 125.38 26.82 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.538 1.135 . . . . 0.0 111.636 177.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.7 mm -120.97 119.51 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.755 1.222 . . . . 0.0 109.169 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.3 100.27 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.88 1.272 . . . . 0.0 108.67 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 47.9 p -79.26 159.62 27.19 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.068 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.1 141.48 20.66 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.114 1.366 . . . . 0.0 111.305 171.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.5 mt -83.07 136.31 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.598 0.759 . . . . 0.0 109.275 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -142.52 127.17 18.01 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.877 1.271 . . . . 0.0 110.974 173.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -77.07 105.62 8.27 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.303 0.641 . . . . 0.0 110.311 170.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 27.2 mt -92.07 98.79 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 57.78 15.45 2.98 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.682 1.993 . . . . 0.0 115.779 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 125.73 -28.14 5.02 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.036 1.303 . . . . 0.0 113.924 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 99.6 m -78.33 126.68 31.12 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.8 0.84 . . . . 0.0 109.498 172.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -73.29 116.16 13.5 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.228 0.537 . . . . 0.0 110.322 172.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -105.42 165.25 11.26 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.486 1.514 . . . . 0.0 111.009 170.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 6.3 tp -115.7 137.04 50.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 125.743 1.617 . . . . 0.0 107.793 169.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 p -126.95 157.63 38.96 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.499 0.72 . . . . 0.0 109.772 173.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -151.27 138.63 19.42 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.015 0.926 . . . . 0.0 111.603 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.3 m -78.88 111.28 14.88 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.074 0.95 . . . . 0.0 110.821 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.71 -161.95 32.74 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.435 1.016 . . . . 0.0 113.125 175.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -63.69 170.58 3.19 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-O 121.898 0.856 . . . . 0.0 112.568 169.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -92.21 108.21 19.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.623 1.569 . . . . 0.0 111.517 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.32 159.73 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.36 0.664 . . . . 0.0 112.192 176.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.5 tttp -90.27 -31.65 16.88 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 172.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -66.89 -40.59 87.78 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -171.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.5 t -75.55 -34.76 60.74 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.242 0.617 . . . . 0.0 112.411 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 142.35 -76.37 0.31 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.81 1.672 . . . . 0.0 111.948 172.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -144.23 22.22 1.71 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.325 1.85 . . . . 0.0 111.173 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -81.49 -175.72 5.66 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.075 0.95 . . . . 0.0 109.489 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.71 144.61 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.307 0.643 . . . . 0.0 110.743 172.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.45 108.89 2.54 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 169.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -110.11 143.0 40.81 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.378 1.085 . . . . 0.0 110.675 172.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -133.39 170.15 15.89 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.97 1.708 . . . . 0.0 110.696 -170.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.31 132.26 20.23 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.532 0.333 . . . . 0.0 110.174 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 67.3 mt -125.2 138.88 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.3 m -62.88 99.2 0.15 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.735 0.698 . . . . 0.0 109.294 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.508 ' HA ' HD12 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -56.27 -30.57 62.63 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.588 0.755 . . . . 0.0 111.829 177.782 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.45 -31.57 69.96 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -87.84 -22.4 24.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.091 0.956 . . . . 0.0 112.356 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.532 HD13 ' CG ' ' A' ' 100' ' ' MET . 18.1 mt -64.25 -44.02 93.1 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.94 0.896 . . . . 0.0 111.085 168.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -55.07 -40.7 70.64 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.921 0.889 . . . . 0.0 112.153 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -56.96 -19.4 17.88 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.733 1.613 . . . . 0.0 115.319 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -126.02 -5.44 6.78 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.781 1.233 . . . . 0.0 114.302 -175.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.479 HD22 HG22 ' A' ' 97' ' ' VAL . 20.7 mt -98.77 -23.37 15.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.143 1.377 . . . . 0.0 112.21 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm . . . . . 0 C--O 1.254 1.303 0 C-N-CA 125.895 1.678 . . . . 0.0 112.899 178.146 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 119.625 -0.226 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.7 mm -113.92 -35.71 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 124.79 1.236 . . . . 0.0 112.388 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 35.3 p80 -129.93 170.31 14.1 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.393 1.477 . . . . 0.0 111.438 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.8 t -127.33 159.27 34.9 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.372 1.069 . . . . 0.0 111.391 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.9 m -120.37 138.04 53.96 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.429 1.492 . . . . 0.0 110.366 -176.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -63.45 -24.69 67.94 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.905 0.882 . . . . 0.0 113.37 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -76.17 83.62 2.99 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.283 1.433 . . . . 0.0 112.278 173.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -151.01 147.44 27.13 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.877 1.271 . . . . 0.0 111.619 175.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -76.52 154.42 34.62 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.483 1.113 . . . . 0.0 112.34 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.1 p -63.0 168.93 3.63 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.247 1.419 . . . . 0.0 113.991 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.6 t -131.48 -35.99 1.28 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.848 1.259 . . . . 0.0 113.713 -176.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.42 -174.91 36.93 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.621 1.105 . . . . 0.0 113.36 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -134.8 173.02 12.16 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.29 1.436 . . . . 0.0 112.383 -173.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.7 m -56.64 151.85 13.11 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.893 1.277 . . . . 0.0 112.801 172.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -116.36 66.51 0.71 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.337 1.455 . . . . 0.0 112.964 -168.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.6 m -78.96 39.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 126.991 2.117 . . . . 0.0 114.518 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -93.94 -177.91 4.48 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.221 1.809 . . . . 0.0 111.773 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -57.04 153.1 11.97 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.859 1.264 . . . . 0.0 112.708 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.9 mm -71.75 140.35 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.179 0.592 . . . . 0.0 109.917 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -65.81 -8.29 20.8 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -55.48 -15.1 2.4 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 127.161 2.185 . . . . 0.0 115.584 -175.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 m -61.43 -15.9 41.57 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.618 1.567 . . . . 0.0 113.627 169.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -151.17 176.53 11.1 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.392 1.477 . . . . 0.0 111.907 169.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -147.32 155.93 42.46 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.974 0.91 . . . . 0.0 109.346 166.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 m -122.24 131.19 53.81 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.572 0.349 . . . . 0.0 110.775 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.0 m -129.27 166.09 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 125.646 1.579 . . . . 0.0 111.605 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -63.89 159.24 20.17 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.706 1.202 . . . . 0.0 111.806 177.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.0 tp -154.27 136.68 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.241 1.416 . . . . 0.0 109.571 174.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -128.89 161.93 28.71 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.498 1.919 . . . . 0.0 109.848 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -131.4 156.65 45.2 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.842 1.257 . . . . 0.0 111.338 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 119.59 20.18 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 171.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -63.27 175.51 0.95 Allowed 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 122.053 0.93 . . . . 0.0 111.728 170.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -60.36 -11.45 6.67 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.725 2.01 . . . . 0.0 114.6 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.8 m -115.64 13.49 16.3 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.169 1.388 . . . . 0.0 112.86 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.71 23.18 77.28 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 121.281 -0.887 . . . . 0.0 114.318 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -100.26 124.23 45.45 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.807 1.243 . . . . 0.0 109.674 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -64.93 123.94 20.75 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.974 0.51 . . . . 0.0 110.952 173.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.0 t -138.49 137.4 37.09 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.207 1.403 . . . . 0.0 110.402 -174.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -57.43 137.08 56.59 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.345 0.658 . . . . 0.0 112.516 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.8 tp -110.39 -47.65 3.26 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.667 0.787 . . . . 0.0 111.173 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.03 -128.98 1.55 Allowed Glycine 0 CA--C 1.528 0.86 0 CA-C-O 121.341 0.412 . . . . 0.0 113.665 -173.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -140.58 155.75 46.49 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.734 1.613 . . . . 0.0 109.621 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.8 tp -120.19 99.46 6.6 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.453 1.501 . . . . 0.0 109.662 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.3 t -76.71 101.96 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 125.321 1.448 . . . . 0.0 109.491 175.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.1 t -92.08 92.97 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.088 1.755 . . . . 0.0 109.712 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -77.28 126.33 30.76 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.814 1.645 . . . . 0.0 110.564 175.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -82.9 93.56 7.53 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.246 1.418 . . . . 0.0 109.115 175.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -78.54 165.24 23.94 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 122.074 0.94 . . . . 0.0 111.936 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -75.11 -24.6 58.1 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 120.9 -1.125 . . . . 0.0 112.937 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -126.88 47.71 2.29 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.304 1.842 . . . . 0.0 111.378 -176.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.72 -156.91 22.13 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.58 1.086 . . . . 0.0 115.36 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.4 mt -124.12 145.49 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.159 0.984 . . . . 0.0 109.657 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -137.1 128.81 28.79 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.184 0.994 . . . . 0.0 110.593 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.8 p -117.54 147.25 42.96 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.381 1.072 . . . . 0.0 111.318 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -139.16 120.83 1.97 Allowed Glycine 0 CA--C 1.522 0.497 0 O-C-N 121.909 -0.495 . . . . 0.0 112.444 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.71 121.81 17.25 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.459 1.504 . . . . 0.0 109.107 173.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -128.58 79.77 1.93 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.453 1.901 . . . . 0.0 109.112 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.64 178.05 8.56 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.462 0.649 . . . . 0.0 112.109 -178.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.73 48.39 1.28 Allowed Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.877 1.703 . . . . 0.0 115.289 -175.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.47 -10.51 0.1 Allowed Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.742 1.639 . . . . 0.0 115.147 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -152.95 156.09 38.21 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.359 1.464 . . . . 0.0 112.835 -173.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 84.6 p -144.3 140.63 29.28 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 170.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -156.55 161.38 39.98 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.942 1.297 . . . . 0.0 112.245 174.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.1 m -55.4 136.21 49.66 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.05 -1.031 . . . . 0.0 110.887 171.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -106.49 -51.46 2.95 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.564 1.146 . . . . 0.0 110.417 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -164.4 154.8 14.67 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.412 0.685 . . . . 0.0 112.388 170.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.55 154.85 44.83 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.431 1.11 . . . . 0.0 111.44 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.476 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -141.34 159.75 41.56 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.967 1.307 . . . . 0.0 111.647 -174.504 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -79.83 165.71 22.44 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.592 0.757 . . . . 0.0 112.029 -175.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -55.74 -32.31 63.28 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.138 -0.976 . . . . 0.0 113.422 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.47 -14.13 62.79 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 t -106.83 -8.23 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.38 1.072 . . . . 0.0 111.262 -174.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 97' ' ' VAL . 81.0 t -49.92 -63.38 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 125.23 1.412 . . . . 0.0 111.462 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -69.63 -25.67 64.04 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -52.08 59.19 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.217 1.407 . . . . 0.0 110.72 174.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -61.78 -43.34 99.04 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.633 1.573 . . . . 0.0 111.505 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 93' ' ' VAL . 73.6 t -54.5 -38.27 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.252 1.021 . . . . 0.0 110.566 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -69.37 -53.75 17.93 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.585 1.154 . . . . 0.0 112.541 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.7 m -72.3 -20.6 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 121.028 -1.045 . . . . 0.0 112.248 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.58 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -83.46 -4.67 58.72 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.239 -1.538 . . . . 0.0 112.103 174.778 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 79.9 p -128.53 -12.56 4.94 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -137.68 -10.5 1.6 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.036 1.734 . . . . 0.0 114.166 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.33 155.33 11.05 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.879 1.704 . . . . 0.0 113.86 -174.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.87 -171.66 33.8 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.673 1.13 . . . . 0.0 113.292 -174.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.0 p -145.47 103.83 3.85 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.518 1.127 . . . . 0.0 113.184 -168.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -131.66 150.53 52.12 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.962 1.705 . . . . 0.0 110.152 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.71 157.22 30.19 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.265 -0.897 . . . . 0.0 111.578 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.6 p -122.94 155.84 35.93 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.162 1.785 . . . . 0.0 110.687 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.476 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 77.1 p -71.09 -38.09 72.41 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.7 -0.625 . . . . 0.0 111.568 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.8 mt -154.43 137.67 15.71 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.147 1.779 . . . . 0.0 111.809 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -134.89 102.62 5.3 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.878 0.871 . . . . 0.0 110.48 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -86.77 -45.2 11.14 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.381 1.073 . . . . 0.0 113.381 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.29 -178.77 30.14 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 124.8 1.19 . . . . 0.0 113.865 -169.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -58.16 164.78 2.21 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 125.291 1.436 . . . . 0.0 113.351 171.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -65.0 -25.9 68.05 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 119.784 -1.823 . . . . 0.0 113.805 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -87.53 51.97 2.37 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.998 1.319 . . . . 0.0 111.643 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -135.3 166.71 22.5 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.733 2.013 . . . . 0.0 111.303 -175.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -87.05 -14.48 41.41 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.8 m -126.85 3.25 6.64 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -171.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.6 p -63.41 -21.99 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 75.4 mt -66.77 -41.38 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.02 -1.05 . . . . 0.0 111.609 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -123.01 -18.3 6.44 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.536 1.134 . . . . 0.0 113.342 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.22 178.7 52.29 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.37 0.986 . . . . 0.0 112.841 -171.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 55.9 mt -124.63 109.62 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.501 1.52 . . . . 0.0 107.402 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -68.93 145.14 53.9 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.179 0.514 . . . . 0.0 111.139 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 60.71 21.04 11.05 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.573 1.549 . . . . 0.0 114.389 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 21.2 tptp -56.24 123.91 16.15 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.571 1.148 . . . . 0.0 111.287 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -73.41 128.87 36.7 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.968 0.907 . . . . 0.0 110.237 170.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 38.2 mm -121.73 112.61 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.187 0.995 . . . . 0.0 109.112 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.11 91.12 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.842 1.257 . . . . 0.0 109.103 -174.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 44.8 p -75.46 155.23 36.46 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.326 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -152.29 141.45 21.36 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.028 1.331 . . . . 0.0 111.399 172.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.1 mt -80.04 132.27 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.239 0.615 . . . . 0.0 109.405 175.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -148.41 138.03 22.16 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.082 1.353 . . . . 0.0 111.021 172.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.8 mmtm -76.39 154.38 34.94 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.34 -0.85 . . . . 0.0 110.334 169.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 44.9 mt -129.98 -47.83 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.875 0.87 . . . . 0.0 111.092 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -146.63 32.01 0.96 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.822 0.849 . . . . 0.0 112.463 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.69 -14.96 57.49 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.486 1.041 . . . . 0.0 114.109 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 65.5 m -96.23 139.41 32.41 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.614 1.166 . . . . 0.0 108.738 169.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -73.98 123.28 24.02 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.278 0.561 . . . . 0.0 109.834 171.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -106.73 169.12 8.72 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.275 1.43 . . . . 0.0 110.444 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.0 tp -123.82 134.11 67.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 125.531 1.532 . . . . 0.0 108.283 172.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 p -121.36 153.75 37.37 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.192 0.597 . . . . 0.0 110.151 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -151.81 144.98 24.63 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.237 1.015 . . . . 0.0 111.29 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 p -77.7 116.45 18.24 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.195 1.398 . . . . 0.0 111.746 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.29 -158.67 30.21 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.575 1.56 . . . . 0.0 112.214 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.07 164.31 20.48 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 122.022 0.915 . . . . 0.0 113.422 170.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -81.61 102.59 10.75 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.175 0.99 . . . . 0.0 111.086 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.03 160.99 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.404 0.681 . . . . 0.0 112.684 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -98.5 -24.9 14.95 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.159 0.983 . . . . 0.0 112.939 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -67.54 -16.15 64.04 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.64 -29.81 7.32 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.029 1.332 . . . . 0.0 113.501 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 138.42 -82.85 0.25 Allowed Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.21 1.386 . . . . 0.0 112.741 172.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -140.95 22.25 2.27 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 127.297 2.239 . . . . 0.0 110.459 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -82.14 174.17 11.45 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.6 m -106.84 139.77 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 169.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -59.98 133.1 55.78 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 168.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -125.55 143.68 50.9 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.51 1.148 . . . . 0.0 110.473 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -131.23 169.18 16.3 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.851 1.661 . . . . 0.0 110.687 -170.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.28 130.67 19.82 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.901 0.48 . . . . 0.0 110.013 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.476 ' CG2' HD11 ' A' ' 166' ' ' LEU . 60.9 mt -126.24 140.54 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.883 0.873 . . . . 0.0 108.847 177.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.0 m -65.78 94.55 0.21 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.038 0.935 . . . . 0.0 109.772 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.553 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.0 OUTLIER -53.68 -33.06 54.08 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.512 1.125 . . . . 0.0 111.682 175.857 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -66.94 -27.27 67.33 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 176.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -89.91 -29.9 18.22 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.115 0.966 . . . . 0.0 112.875 174.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.58 HD13 ' HG3' ' A' ' 100' ' ' MET . 20.3 mt -59.3 -47.61 84.75 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.45 0.7 . . . . 0.0 110.643 172.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -50.89 -37.79 45.88 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.563 1.145 . . . . 0.0 113.746 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -71.55 -14.18 62.02 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -124.94 -3.64 7.62 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.882 1.273 . . . . 0.0 113.844 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 15.1 mt -96.36 -14.82 22.24 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.443 1.497 . . . . 0.0 112.968 -176.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 6.6 ptmt . . . . . 0 C--O 1.254 1.326 0 C-N-CA 126.998 2.119 . . . . 0.0 115.86 179.024 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.3 tt -107.51 155.27 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.336 1.454 . . . . 0.0 110.928 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -128.52 160.21 33.04 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.586 1.554 . . . . 0.0 110.366 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.1 m -123.66 121.05 34.54 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.695 0.798 . . . . 0.0 110.134 -171.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.1 m -67.73 -13.17 61.89 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -174.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -137.89 158.5 44.22 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.321 1.848 . . . . 0.0 110.971 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -150.96 160.84 43.67 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.668 1.187 . . . . 0.0 112.813 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 -134.58 53.18 2.01 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.48 1.512 . . . . 0.0 111.656 -171.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -58.95 103.37 0.16 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.26 1.024 . . . . 0.0 111.757 170.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.9 t -73.73 -40.37 63.6 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.081 0.952 . . . . 0.0 112.239 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.1 p -86.19 173.05 10.06 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.352 1.461 . . . . 0.0 112.346 172.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.04 95.3 0.14 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.273 0.939 . . . . 0.0 112.29 -177.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -58.42 132.41 53.62 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.657 1.183 . . . . 0.0 112.089 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.8 t -154.57 155.43 34.76 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.891 1.276 . . . . 0.0 111.707 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -154.98 127.86 8.14 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.71 1.604 . . . . 0.0 110.908 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.54 120.78 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.826 1.251 . . . . 0.0 111.134 173.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -152.47 177.72 10.32 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 127.73 2.412 . . . . 0.0 110.502 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -90.7 102.09 14.84 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.239 1.416 . . . . 0.0 110.085 169.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.97 156.5 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.606 1.562 . . . . 0.0 109.682 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -56.05 -19.65 13.77 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 172.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -78.15 -7.48 57.1 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.467 1.107 . . . . 0.0 113.8 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.99 11.34 25.47 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.498 1.919 . . . . 0.0 112.633 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -142.75 166.66 24.05 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.547 1.539 . . . . 0.0 111.441 170.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -142.26 174.28 10.76 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.146 1.378 . . . . 0.0 110.763 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -140.43 137.2 33.77 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.286 -0.884 . . . . 0.0 111.097 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.2 m -133.4 162.06 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 125.444 1.497 . . . . 0.0 111.718 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -61.75 155.14 23.65 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.443 1.097 . . . . 0.0 111.893 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.4 tp -150.94 136.16 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.789 1.236 . . . . 0.0 109.784 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -125.75 161.82 26.46 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.906 2.082 . . . . 0.0 109.488 176.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -130.8 154.58 47.87 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.162 1.385 . . . . 0.0 111.077 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -79.41 117.51 20.45 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.957 -0.464 . . . . 0.0 109.841 169.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -64.24 172.47 2.46 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 122.619 1.199 . . . . 0.0 111.176 169.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -57.0 -22.38 38.1 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.42 2.288 . . . . 0.0 113.125 173.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.4 m -83.67 -4.1 58.32 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.696 1.598 . . . . 0.0 114.15 174.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.68 34.42 66.86 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.846 1.213 . . . . 0.0 114.133 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -122.29 139.19 54.09 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.259 1.424 . . . . 0.0 110.689 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -70.93 119.96 15.82 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.645 1.178 . . . . 0.0 110.9 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -133.87 141.87 47.56 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.149 1.38 . . . . 0.0 110.138 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -59.21 140.2 56.18 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -173.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.5 tp -114.11 -47.86 2.93 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.032 0.933 . . . . 0.0 111.34 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.79 -119.02 0.81 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 123.267 0.461 . . . . 0.0 113.176 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -145.37 152.7 40.28 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.639 1.576 . . . . 0.0 110.184 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.2 tp -117.46 104.58 11.23 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.777 1.231 . . . . 0.0 110.525 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.4 t -77.82 100.37 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.507 1.123 . . . . 0.0 109.619 174.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 52.1 t -90.1 113.09 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.031 1.332 . . . . 0.0 110.36 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -95.8 125.32 40.29 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.044 2.138 . . . . 0.0 110.566 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.88 86.58 6.34 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.852 1.261 . . . . 0.0 109.722 176.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -78.33 170.26 16.92 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.922 0.868 . . . . 0.0 111.495 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.3 tp10 -73.38 -31.0 63.66 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.661 -1.275 . . . . 0.0 112.787 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -107.15 24.81 12.23 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.482 1.513 . . . . 0.0 112.805 -169.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.72 -160.68 24.34 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.964 1.745 . . . . 0.0 113.971 -176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.1 mt -119.61 143.2 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.101 0.96 . . . . 0.0 109.401 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -135.81 138.59 42.72 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.092 0.957 . . . . 0.0 110.059 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.5 p -131.54 147.63 52.55 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.488 -0.758 . . . . 0.0 111.724 -169.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.96 124.48 2.36 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-O 121.636 0.575 . . . . 0.0 112.954 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.9 137.05 51.3 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.103 1.761 . . . . 0.0 110.212 176.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -132.2 91.92 3.02 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.031 1.733 . . . . 0.0 110.274 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -109.39 82.26 1.57 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.864 1.666 . . . . 0.0 110.885 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.0 -103.98 0.95 Allowed Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.202 0.906 . . . . 0.0 112.948 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -99.17 7.67 60.39 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.16 1.362 . . . . 0.0 114.588 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -127.29 120.79 29.45 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.966 1.306 . . . . 0.0 109.899 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.6 p -142.11 141.88 32.74 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.544 -0.722 . . . . 0.0 112.694 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -160.57 161.14 32.52 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.883 1.273 . . . . 0.0 111.614 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.2 m -55.54 132.75 49.39 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.485 -0.759 . . . . 0.0 110.146 169.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -99.89 -51.1 3.8 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.884 0.874 . . . . 0.0 109.842 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -163.98 161.57 22.81 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.12 0.968 . . . . 0.0 112.286 170.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.44 150.77 36.27 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.829 0.852 . . . . 0.0 111.512 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.51 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.8 OUTLIER -141.24 156.25 45.92 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.288 1.435 . . . . 0.0 111.845 -174.474 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -77.79 165.33 24.31 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.482 0.713 . . . . 0.0 112.601 -172.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -52.85 -34.0 52.28 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.605 1.162 . . . . 0.0 112.897 172.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -66.65 -11.81 55.5 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.87 1.268 . . . . 0.0 113.658 175.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.8 t -116.22 -5.23 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.971 1.308 . . . . 0.0 111.357 -172.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 69.6 t -50.18 -62.41 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 125.293 1.437 . . . . 0.0 111.899 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -70.25 -28.13 64.99 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -62.29 -50.48 71.52 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.446 1.498 . . . . 0.0 110.909 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -60.18 -43.84 95.52 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.996 1.318 . . . . 0.0 111.327 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 42.1 t -62.1 -34.16 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 123.705 0.802 . . . . 0.0 111.349 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -63.8 -54.56 33.19 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.459 1.104 . . . . 0.0 111.996 172.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -73.17 -2.55 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.587 ' CG ' HD13 ' A' ' 166' ' ' LEU . 2.3 ttm -114.48 1.91 14.47 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.038 1.335 . . . . 0.0 112.925 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.5 p -124.76 -12.56 7.1 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.762 1.225 . . . . 0.0 112.156 168.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -138.1 -15.14 1.32 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.79 155.09 26.81 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 124.895 1.236 . . . . 0.0 114.125 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.13 -160.1 31.35 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 123.963 0.792 . . . . 0.0 114.363 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.5 p -151.91 98.75 2.49 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -170.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -131.65 146.06 51.99 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.275 1.83 . . . . 0.0 110.132 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.23 155.75 36.47 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.461 -0.774 . . . . 0.0 110.778 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 47.0 p -114.69 158.11 22.23 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.539 1.136 . . . . 0.0 111.009 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.51 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 77.0 p -70.54 -37.87 74.12 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.387 -0.821 . . . . 0.0 110.823 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.2 mt -148.04 150.83 34.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.962 2.105 . . . . 0.0 112.171 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -143.7 107.95 4.78 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.382 1.073 . . . . 0.0 110.252 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -96.88 -40.46 8.9 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.411 1.084 . . . . 0.0 113.585 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.66 178.51 29.99 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.796 1.188 . . . . 0.0 115.616 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -65.63 170.91 4.6 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.915 0.886 . . . . 0.0 112.075 169.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -58.5 -23.99 59.39 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 120.484 -1.385 . . . . 0.0 114.653 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -67.06 -23.81 65.91 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 171.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -70.38 133.7 47.16 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.441 1.496 . . . . 0.0 111.43 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -64.56 -23.53 67.3 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 120.718 -1.239 . . . . 0.0 113.98 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.03 -7.43 45.78 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.439 1.496 . . . . 0.0 114.79 -176.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.07 -25.44 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 60.2 mt -69.99 -37.87 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 125.059 1.343 . . . . 0.0 112.468 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -133.84 -16.42 2.27 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -169.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.4 175.19 39.77 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 126.449 1.976 . . . . 0.0 114.576 -174.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.2 mt -126.62 112.17 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.874 1.67 . . . . 0.0 108.536 174.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -70.98 145.24 50.16 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.101 0.477 . . . . 0.0 111.311 172.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 59.29 22.53 10.86 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.713 1.605 . . . . 0.0 114.137 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -54.13 127.86 28.48 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.92 1.288 . . . . 0.0 111.248 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -75.12 130.12 38.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.085 0.554 . . . . 0.0 110.544 170.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 32.8 mm -126.55 120.28 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.835 1.254 . . . . 0.0 108.668 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.68 101.55 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 125.303 1.441 . . . . 0.0 108.71 -176.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.4 p -86.29 159.3 19.47 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.485 0.714 . . . . 0.0 112.317 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -154.89 139.24 16.72 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.066 1.346 . . . . 0.0 111.736 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 26.2 mt -77.29 133.57 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.087 0.555 . . . . 0.0 109.911 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -149.44 139.56 22.13 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.747 1.619 . . . . 0.0 111.038 171.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.6 mmtt -78.35 153.37 31.72 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.09 -1.006 . . . . 0.0 109.902 168.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.8 mt -128.77 -46.8 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.8 0.84 . . . . 0.0 111.261 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -144.22 20.9 1.74 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.929 0.892 . . . . 0.0 112.796 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.14 -18.74 25.66 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.789 1.185 . . . . 0.0 113.647 -177.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 53.0 m -91.28 140.53 29.7 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.742 1.217 . . . . 0.0 109.085 169.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -74.97 126.87 31.91 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.28 0.562 . . . . 0.0 110.316 170.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -112.68 165.92 11.83 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.33 1.452 . . . . 0.0 110.692 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.1 tp -120.77 132.27 70.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 125.472 1.509 . . . . 0.0 108.117 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.3 p -122.45 154.76 37.34 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.571 0.748 . . . . 0.0 110.05 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -150.95 148.08 27.96 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.709 0.804 . . . . 0.0 111.844 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.4 p -80.74 125.42 30.04 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.695 1.198 . . . . 0.0 111.552 174.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.66 -151.77 26.63 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.085 1.326 . . . . 0.0 113.187 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -78.92 172.19 14.13 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.465 1.506 . . . . 0.0 110.331 168.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -82.31 119.29 23.94 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.709 -1.245 . . . . 0.0 110.805 173.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.31 161.67 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 122.818 0.447 . . . . 0.0 111.36 173.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -93.67 -31.26 14.53 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.547 0.739 . . . . 0.0 112.689 172.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -61.37 -47.73 84.49 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.177 0.991 . . . . 0.0 112.983 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.89 -31.99 51.61 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 139.98 -76.29 0.33 Allowed Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.008 1.289 . . . . 0.0 113.497 170.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -146.44 21.07 1.35 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 127.332 2.253 . . . . 0.0 111.926 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -78.13 172.17 13.94 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.525 1.13 . . . . 0.0 108.592 172.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 16.0 m -108.19 141.12 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 122.87 0.468 . . . . 0.0 110.102 173.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.51 117.62 7.0 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -117.96 140.23 50.02 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 122.181 0.991 . . . . 0.0 110.17 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -133.1 168.54 18.32 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.304 1.442 . . . . 0.0 111.327 -169.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.82 130.64 18.09 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.264 0.626 . . . . 0.0 109.9 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.42 ' CG2' HD11 ' A' ' 166' ' ' LEU . 69.6 mt -122.57 140.33 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.135 0.974 . . . . 0.0 108.536 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.9 m -64.11 95.81 0.13 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.192 0.997 . . . . 0.0 110.049 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.531 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.3 tt -55.32 -31.87 62.02 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.501 1.12 . . . . 0.0 111.757 175.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -69.48 -29.72 67.44 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.59 -33.51 47.52 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.292 0.951 . . . . 0.0 112.681 171.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.587 HD13 ' CG ' ' A' ' 100' ' ' MET . 22.4 mt -62.28 -48.82 78.21 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.309 1.043 . . . . 0.0 110.741 175.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -48.81 -38.19 21.42 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.785 1.175 . . . . 0.0 113.531 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -58.52 -24.08 59.69 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -126.84 4.44 6.62 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.004 2.121 . . . . 0.0 113.622 -177.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.7 mp -106.76 -31.13 8.54 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.984 1.714 . . . . 0.0 111.933 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm . . . . . 0 C--O 1.254 1.294 0 C-N-CA 125.922 1.689 . . . . 0.0 112.558 170.535 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.2 mt -137.25 110.38 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 120.253 -1.53 . . . . 0.0 109.152 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -76.09 151.25 37.11 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.014 0.925 . . . . 0.0 112.136 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.7 p -71.05 113.34 7.99 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.473 1.109 . . . . 0.0 112.001 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.6 p -84.98 -20.61 30.29 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -72.7 138.07 46.37 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.419 1.088 . . . . 0.0 112.188 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -87.83 79.51 8.1 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.701 1.2 . . . . 0.0 112.206 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -145.29 137.59 25.82 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.821 1.248 . . . . 0.0 111.028 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.7 tm0? -148.87 109.14 4.13 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.829 1.252 . . . . 0.0 109.615 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.2 p -160.73 170.81 20.02 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.814 1.645 . . . . 0.0 111.508 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.9 m 57.25 21.32 6.54 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.657 1.583 . . . . 0.0 115.168 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.37 -31.91 1.75 Allowed Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.979 1.276 . . . . 0.0 114.56 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -72.79 150.96 42.33 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 118.646 1.223 . . . . 0.0 110.819 169.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.2 p -143.11 176.45 9.1 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.057 1.343 . . . . 0.0 112.406 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -58.9 142.69 50.04 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.995 1.318 . . . . 0.0 112.349 170.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.4 t -140.42 60.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 125.584 1.554 . . . . 0.0 109.759 -176.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -99.64 157.98 16.09 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.347 1.459 . . . . 0.0 111.542 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -138.23 103.77 5.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.925 1.69 . . . . 0.0 110.379 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.3 mp -94.5 118.78 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 125.814 1.646 . . . . 0.0 109.265 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -96.06 49.11 1.13 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.152 1.381 . . . . 0.0 110.951 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -86.48 -18.49 31.5 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 173.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.1 t -115.78 -5.86 12.1 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.757 1.623 . . . . 0.0 113.033 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -137.16 158.07 45.26 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.3 1.84 . . . . 0.0 109.558 169.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -140.93 165.62 27.03 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.091 0.956 . . . . 0.0 110.842 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -136.04 132.76 36.65 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.16 -0.338 . . . . 0.0 111.322 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.1 m -131.79 159.77 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.353 1.461 . . . . 0.0 111.866 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -57.98 153.75 13.79 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.747 0.819 . . . . 0.0 112.45 175.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.0 tp -149.96 137.16 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.336 1.455 . . . . 0.0 109.714 174.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -132.57 161.25 34.31 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.718 2.007 . . . . 0.0 109.674 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -134.62 160.08 39.21 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.367 1.067 . . . . 0.0 112.162 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.21 114.45 21.82 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.545 0.738 . . . . 0.0 110.625 173.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -73.59 -176.65 2.41 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.779 0.832 . . . . 0.0 112.276 175.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt -55.92 -26.65 48.62 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.489 1.916 . . . . 0.0 113.167 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.0 m -73.75 -8.25 55.28 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.342 1.457 . . . . 0.0 113.87 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.24 40.46 97.38 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.258 0.932 . . . . 0.0 112.4 -169.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -132.61 137.64 47.11 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.562 1.945 . . . . 0.0 109.097 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -67.3 130.64 43.71 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.64 0.776 . . . . 0.0 111.178 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.3 t -137.53 138.46 39.67 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.942 1.297 . . . . 0.0 110.317 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -57.17 125.88 24.71 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.443 1.097 . . . . 0.0 112.286 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.9 tp -100.73 -45.87 5.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.863 0.865 . . . . 0.0 111.092 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.86 -120.36 0.91 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.473 0.559 . . . . 0.0 113.468 -177.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -145.5 155.76 43.3 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.565 1.546 . . . . 0.0 109.575 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.5 tp -121.83 104.81 9.83 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.5 1.12 . . . . 0.0 110.698 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.2 t -77.72 98.95 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.847 1.259 . . . . 0.0 109.355 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 51.6 t -86.06 117.44 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.042 1.737 . . . . 0.0 110.197 174.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -104.46 122.87 46.41 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.973 2.109 . . . . 0.0 110.82 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -85.78 78.87 9.46 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.185 1.394 . . . . 0.0 110.204 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -67.6 171.49 6.22 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.443 1.097 . . . . 0.0 111.721 172.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -73.08 -38.99 66.22 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.508 -1.37 . . . . 0.0 113.93 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -109.22 30.31 6.71 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.331 1.453 . . . . 0.0 113.302 -169.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.68 -163.55 26.51 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 126.908 2.194 . . . . 0.0 113.341 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.4 mt -117.31 143.96 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.074 0.95 . . . . 0.0 109.708 171.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -131.35 140.9 49.81 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.107 1.363 . . . . 0.0 109.459 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.7 p -133.15 146.92 52.01 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.134 -0.979 . . . . 0.0 112.433 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.05 126.51 3.25 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-O 121.769 0.649 . . . . 0.0 112.944 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.05 137.35 53.51 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.561 1.945 . . . . 0.0 110.128 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -137.24 73.75 1.46 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.1 1.76 . . . . 0.0 110.678 -176.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.09 177.59 8.69 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.376 1.87 . . . . 0.0 112.596 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.24 93.71 0.02 OUTLIER Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.72 1.629 . . . . 0.0 113.903 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.64 21.68 77.84 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.855 1.217 . . . . 0.0 115.182 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -148.61 135.62 20.05 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.06 1.43 . . . . 0.0 111.973 -175.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 77.4 p -150.19 148.82 29.38 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.83 161.89 26.24 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.713 1.605 . . . . 0.0 111.413 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.3 m -58.55 136.4 57.56 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.24 -0.913 . . . . 0.0 109.262 169.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -104.45 -48.29 3.86 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.904 0.882 . . . . 0.0 110.022 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -162.38 170.5 18.7 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.416 1.086 . . . . 0.0 112.307 169.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.77 158.09 43.73 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.764 1.226 . . . . 0.0 111.62 170.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.521 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -140.5 158.38 44.09 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.926 1.29 . . . . 0.0 111.466 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -80.05 165.13 22.84 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.15 0.58 . . . . 0.0 111.834 -174.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -53.11 -33.96 54.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.602 1.161 . . . . 0.0 112.857 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -67.26 -8.44 31.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.937 1.295 . . . . 0.0 113.556 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.61 -6.69 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.586 1.154 . . . . 0.0 111.306 -172.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 79.5 t -52.12 -60.91 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 O-C-N 120.404 -1.435 . . . . 0.0 112.231 -176.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -69.0 -27.01 65.31 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.47 -52.79 59.89 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.477 1.511 . . . . 0.0 110.856 175.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.96 -46.65 89.84 Favored 'General case' 0 C--O 1.227 -0.093 0 C-N-CA 125.041 1.336 . . . . 0.0 110.484 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.74 -35.48 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.232 0.613 . . . . 0.0 111.461 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -63.07 -54.69 34.04 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.416 1.086 . . . . 0.0 112.215 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -70.25 -12.24 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 121.551 -0.718 . . . . 0.0 112.419 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.56 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -94.44 -4.63 47.93 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.745 2.018 . . . . 0.0 112.186 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.404 HG23 HD23 ' A' ' 170' ' ' LEU . 34.3 p -126.39 -15.0 5.76 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 169.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -130.75 -10.55 3.93 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.942 1.297 . . . . 0.0 114.257 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.64 155.93 7.78 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.241 1.4 . . . . 0.0 113.698 -174.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.8 -170.51 32.49 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.032 0.825 . . . . 0.0 114.064 -174.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.4 p -143.44 109.4 5.25 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.927 1.291 . . . . 0.0 113.529 -168.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -138.05 148.45 45.1 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.364 1.866 . . . . 0.0 109.825 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 155.65 35.1 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.691 -0.63 . . . . 0.0 110.913 177.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 58.9 p -117.85 158.25 25.17 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.921 1.688 . . . . 0.0 110.958 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.521 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 60.0 p -74.35 -39.96 62.44 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.576 -0.703 . . . . 0.0 111.121 -177.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.3 mt -151.11 143.19 24.0 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.631 1.973 . . . . 0.0 111.919 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -138.22 98.52 3.64 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.885 0.874 . . . . 0.0 111.583 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -86.55 -40.12 15.54 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.67 178.26 7.65 Favored Glycine 0 CA--C 1.546 1.971 0 C-N-CA 124.378 0.989 . . . . 0.0 114.339 -169.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -63.7 168.05 5.26 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.78 1.232 . . . . 0.0 112.546 169.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -59.29 -21.48 59.74 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -64.45 -24.82 67.75 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 171.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -69.74 141.15 53.51 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.879 1.671 . . . . 0.0 111.862 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -69.61 -32.6 71.42 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 58.5 m -92.23 2.6 56.51 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.47 -24.86 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 120.501 1.5 . . . . 0.0 114.605 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mt -64.49 -37.85 81.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.636 1.174 . . . . 0.0 112.27 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -134.58 -12.58 2.33 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -173.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.03 177.02 35.61 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.975 1.274 . . . . 0.0 113.199 -170.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 62.5 mt -126.59 110.79 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.502 1.521 . . . . 0.0 108.149 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -69.7 145.27 52.46 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.305 0.574 . . . . 0.0 111.419 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 60.07 19.85 9.05 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.773 1.629 . . . . 0.0 114.466 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -54.73 124.06 15.24 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.638 1.175 . . . . 0.0 111.735 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -72.44 129.81 39.23 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.214 1.006 . . . . 0.0 110.644 171.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.0 mm -126.82 119.35 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.764 1.225 . . . . 0.0 108.922 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.75 98.32 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.274 1.43 . . . . 0.0 108.679 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.5 p -81.92 155.56 25.21 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.709 0.804 . . . . 0.0 112.125 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -151.39 140.05 20.71 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.098 1.359 . . . . 0.0 111.182 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 46.1 mt -79.95 133.06 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -140.34 122.94 16.22 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.188 1.395 . . . . 0.0 110.953 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -74.37 111.02 9.14 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.244 1.017 . . . . 0.0 109.971 172.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 22.7 mt -98.45 96.75 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.9 t70 61.32 17.4 8.25 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.492 1.917 . . . . 0.0 115.641 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.89 -24.03 8.52 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.539 1.066 . . . . 0.0 113.865 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 85.5 m -82.99 127.15 33.29 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.248 1.024 . . . . 0.0 109.261 171.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -73.61 123.54 24.21 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.585 -0.697 . . . . 0.0 110.091 173.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -113.25 169.12 9.17 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.281 1.432 . . . . 0.0 109.91 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.9 tp -120.77 133.66 66.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.06 1.344 . . . . 0.0 108.519 169.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.1 p -121.8 155.08 36.08 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.596 0.758 . . . . 0.0 110.214 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -147.14 145.02 29.42 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.598 0.759 . . . . 0.0 112.246 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.3 p -74.91 108.71 7.82 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.982 1.313 . . . . 0.0 111.49 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.77 -162.35 33.47 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 123.83 0.729 . . . . 0.0 113.535 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -69.6 173.78 5.71 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 121.673 -0.898 . . . . 0.0 110.029 167.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -84.17 137.77 33.34 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.659 -1.276 . . . . 0.0 111.661 173.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.26 160.11 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.174 0.589 . . . . 0.0 111.74 169.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -90.63 -32.6 16.17 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.915 0.886 . . . . 0.0 111.837 169.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -60.76 -16.57 41.64 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.45 1.9 . . . . 0.0 114.775 -177.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.13 2.61 10.41 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.436 1.494 . . . . 0.0 113.458 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 107.87 -85.41 0.41 Allowed Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.929 1.728 . . . . 0.0 113.037 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -144.31 33.92 1.2 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.578 1.951 . . . . 0.0 110.408 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -97.45 155.07 17.09 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.853 1.261 . . . . 0.0 108.968 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.1 m -89.42 141.0 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 122.53 0.332 . . . . 0.0 110.141 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -72.94 88.94 1.38 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.352 0.661 . . . . 0.0 109.763 173.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -76.64 147.39 37.56 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 122.113 0.959 . . . . 0.0 110.675 168.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -131.83 172.93 11.7 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.902 1.681 . . . . 0.0 111.013 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.34 131.72 18.59 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.324 0.65 . . . . 0.0 110.232 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 68.9 mt -123.6 140.76 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.185 0.994 . . . . 0.0 109.021 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.3 m -63.88 97.4 0.16 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.22 1.008 . . . . 0.0 109.865 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.6 tt -54.19 -32.43 55.62 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.218 1.007 . . . . 0.0 111.571 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.18 -28.12 69.17 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -85.88 -33.27 21.29 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.35 0.977 . . . . 0.0 112.923 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.56 HD13 ' HG3' ' A' ' 100' ' ' MET . 44.8 mt -58.45 -47.47 83.9 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.261 1.024 . . . . 0.0 110.19 175.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -53.93 -23.61 13.48 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 175.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -80.73 -16.1 54.75 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.672 1.189 . . . . 0.0 114.163 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -126.85 1.79 6.66 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.961 1.304 . . . . 0.0 113.554 -174.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.404 HD23 HG23 ' A' ' 101' ' ' THR . 3.5 mp -102.49 -17.94 15.55 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.986 1.715 . . . . 0.0 112.022 -176.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm . . . . . 0 C--O 1.253 1.264 0 C-N-CA 125.672 1.589 . . . . 0.0 112.477 169.52 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt . . . . . 0 N--CA 1.498 1.944 0 N-CA-C 110.732 -0.099 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.19 162.42 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.661 1.185 . . . . 0.0 112.298 174.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -143.84 143.93 31.54 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.752 1.221 . . . . 0.0 111.253 171.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 m -146.54 144.08 29.35 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.908 1.683 . . . . 0.0 109.56 176.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.1 p -148.94 140.28 23.25 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.268 1.027 . . . . 0.0 112.218 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -160.1 143.36 13.85 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.609 1.564 . . . . 0.0 110.769 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -149.69 161.99 41.12 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.521 1.928 . . . . 0.0 110.034 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -120.39 141.52 50.03 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.794 1.238 . . . . 0.0 110.767 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -150.95 151.74 32.56 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.262 1.025 . . . . 0.0 112.17 -174.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.3 p -72.44 2.45 6.23 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.397 1.879 . . . . 0.0 115.14 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 t -66.98 -175.4 0.42 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.386 1.474 . . . . 0.0 112.72 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.28 -21.01 7.64 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 125.844 1.688 . . . . 0.0 115.796 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -63.74 -14.85 56.16 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 172.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.2 m -64.44 148.79 49.79 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.116 0.966 . . . . 0.0 112.785 170.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.94 160.08 24.76 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.582 1.153 . . . . 0.0 110.862 174.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -141.14 128.88 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.243 1.417 . . . . 0.0 109.369 -172.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -122.55 -169.27 1.88 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.23 1.412 . . . . 0.0 112.64 -169.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.1 mttp -62.19 128.56 36.69 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.668 1.587 . . . . 0.0 109.923 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mm -105.64 151.82 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.367 1.067 . . . . 0.0 109.806 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -73.77 -8.52 56.36 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 177.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -82.92 -168.39 2.04 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.517 1.927 . . . . 0.0 113.136 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.6 m -64.32 -31.7 73.01 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.297 1.839 . . . . 0.0 113.011 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -85.62 160.38 19.62 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.419 1.088 . . . . 0.0 111.964 173.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -143.25 170.3 16.02 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.061 1.744 . . . . 0.0 110.664 169.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.29 134.26 34.1 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.668 -0.645 . . . . 0.0 110.435 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.1 m -130.16 163.54 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.237 1.415 . . . . 0.0 111.321 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -60.35 156.35 15.97 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.969 0.908 . . . . 0.0 111.649 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.3 tp -151.3 135.09 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.695 1.198 . . . . 0.0 109.282 172.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -126.59 156.81 40.31 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.43 1.892 . . . . 0.0 108.777 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -126.03 155.09 42.05 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.67 1.188 . . . . 0.0 111.196 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -80.12 118.49 21.87 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 168.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -67.43 178.04 1.71 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 122.326 1.06 . . . . 0.0 113.119 170.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -17.19 50.63 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.923 1.289 . . . . 0.0 113.589 176.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.2 m -95.73 1.78 53.56 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.61 1.164 . . . . 0.0 112.508 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.37 21.31 79.06 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-N 119.64 1.109 . . . . 0.0 114.494 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -102.2 137.24 40.72 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.646 1.178 . . . . 0.0 110.822 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -67.84 123.96 22.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.824 0.849 . . . . 0.0 110.35 170.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -140.7 143.09 34.85 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.705 1.202 . . . . 0.0 110.453 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -58.18 139.19 55.39 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.2 tp -114.68 -46.76 2.93 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.947 0.899 . . . . 0.0 111.181 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.76 -115.01 0.61 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 122.971 0.32 . . . . 0.0 113.212 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -147.64 153.84 39.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.055 1.342 . . . . 0.0 110.148 -174.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.6 tp -121.31 105.02 10.15 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.963 1.305 . . . . 0.0 110.033 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.8 t -76.27 94.15 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.923 1.289 . . . . 0.0 109.331 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 42.8 t -81.29 99.0 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.897 1.679 . . . . 0.0 109.071 173.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -81.85 160.76 23.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.189 1.395 . . . . 0.0 111.015 174.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -116.81 80.99 1.56 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.213 1.005 . . . . 0.0 110.971 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -62.13 171.44 1.79 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 122.722 1.249 . . . . 0.0 113.344 169.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -74.36 -40.3 62.21 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.521 1.129 . . . . 0.0 113.086 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -110.88 42.23 1.65 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.917 1.287 . . . . 0.0 112.41 -171.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.88 -156.2 22.38 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.964 1.268 . . . . 0.0 114.808 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.0 mt -122.22 136.06 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.965 0.906 . . . . 0.0 110.433 173.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -123.61 141.9 51.56 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.838 2.055 . . . . 0.0 111.984 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.5 p -137.19 136.78 38.48 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.217 -0.927 . . . . 0.0 112.341 -175.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.21 127.85 5.82 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.189 0.423 . . . . 0.0 112.79 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.06 135.58 51.02 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.689 1.596 . . . . 0.0 110.22 174.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -138.81 73.8 1.45 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.541 1.537 . . . . 0.0 110.815 -173.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.13 174.5 9.98 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.497 1.519 . . . . 0.0 112.199 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.52 -47.97 67.34 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 123.828 0.727 . . . . 0.0 114.025 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.06 11.82 14.7 Favored Glycine 0 N--CA 1.473 1.133 0 CA-C-O 119.04 -0.867 . . . . 0.0 114.722 -177.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -156.18 145.65 20.83 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.753 1.276 . . . . 0.0 112.923 -171.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 80.5 p -149.58 147.97 28.79 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 170.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -164.35 162.65 22.37 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.433 1.493 . . . . 0.0 111.674 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 57.2 m -57.86 132.71 54.17 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.248 -0.908 . . . . 0.0 109.387 168.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -99.54 -47.49 5.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.737 0.815 . . . . 0.0 110.541 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -166.62 169.25 13.79 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.744 1.218 . . . . 0.0 112.387 171.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.53 138.51 16.36 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.43 1.092 . . . . 0.0 112.347 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.511 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -118.73 160.0 22.65 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.649 1.58 . . . . 0.0 111.767 179.063 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -83.12 167.19 18.04 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.388 0.675 . . . . 0.0 112.324 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -57.67 -32.3 67.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.073 0.949 . . . . 0.0 112.666 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -70.11 -3.8 18.34 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.436 1.094 . . . . 0.0 113.849 175.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.0 t -119.79 -3.12 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.354 1.062 . . . . 0.0 111.046 -175.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 97' ' ' VAL . 69.5 t -55.57 -61.78 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 120.461 -1.4 . . . . 0.0 111.635 -175.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -68.24 -25.0 64.97 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -54.0 40.51 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.425 1.49 . . . . 0.0 110.584 173.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -61.96 -44.23 97.19 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.35 1.46 . . . . 0.0 111.238 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 93' ' ' VAL . 63.3 t -53.98 -36.72 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.519 1.128 . . . . 0.0 111.003 177.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -70.92 -54.05 12.79 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.848 1.259 . . . . 0.0 112.379 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -70.84 -21.01 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 O-C-N 120.786 -1.196 . . . . 0.0 112.568 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.599 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -82.8 -5.11 58.79 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.093 1.757 . . . . 0.0 111.703 175.502 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.6 p -129.66 -14.77 4.06 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -136.61 -10.05 1.87 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.186 1.794 . . . . 0.0 113.932 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.42 155.18 10.93 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.722 1.63 . . . . 0.0 113.967 -175.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.64 -170.86 33.03 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.475 1.036 . . . . 0.0 113.641 -174.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.1 p -144.03 109.87 5.29 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.748 1.219 . . . . 0.0 113.527 -169.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -138.51 145.88 41.3 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.47 1.908 . . . . 0.0 109.986 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.51 147.15 42.1 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.078 -1.014 . . . . 0.0 111.754 175.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.6 p -106.58 168.1 9.4 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.603 1.561 . . . . 0.0 111.443 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.511 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 16.5 p -74.55 -39.63 62.18 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.524 -0.735 . . . . 0.0 111.118 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.0 mt -155.85 144.2 20.07 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.406 2.282 . . . . 0.0 110.605 -174.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -138.71 105.47 5.37 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.098 0.959 . . . . 0.0 111.263 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -89.42 -40.29 12.82 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.93 179.39 15.88 Favored Glycine 0 CA--C 1.545 1.928 0 C-N-CA 124.977 1.275 . . . . 0.0 114.142 -168.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -57.88 164.86 1.99 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.261 1.024 . . . . 0.0 112.519 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -63.47 172.42 2.04 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.23 1.012 . . . . 0.0 113.006 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 67.69 13.93 9.37 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.775 1.63 . . . . 0.0 114.107 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.77 167.66 11.5 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.929 2.092 . . . . 0.0 113.272 -177.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -77.02 -23.7 52.16 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 174.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.1 m -118.92 -1.36 11.02 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -172.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.65 -13.94 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 173.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 75.5 mt -60.62 -47.27 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.166 1.386 . . . . 0.0 111.787 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -142.63 -5.26 0.93 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.89 1.276 . . . . 0.0 114.414 -176.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 93.04 -169.52 30.93 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.456 1.503 . . . . 0.0 113.024 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 35.2 mt -133.04 108.48 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 125.712 1.605 . . . . 0.0 107.17 172.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -68.74 145.86 53.44 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.069 0.462 . . . . 0.0 111.201 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 59.09 25.02 13.39 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.639 1.575 . . . . 0.0 114.262 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.52 130.55 43.55 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.022 1.329 . . . . 0.0 112.108 -172.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -78.75 117.97 20.37 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.972 0.909 . . . . 0.0 112.333 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 28.5 mm -108.69 118.73 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.063 0.945 . . . . 0.0 109.66 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 mp -109.98 98.51 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.212 1.405 . . . . 0.0 108.816 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 65.8 p -80.31 157.79 26.29 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.174 174.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -154.35 142.17 20.05 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.178 1.391 . . . . 0.0 111.744 172.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.7 mt -80.86 133.32 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.652 0.781 . . . . 0.0 109.222 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -149.95 143.18 25.06 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.604 1.562 . . . . 0.0 110.046 171.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -82.19 158.38 23.61 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.23 -0.919 . . . . 0.0 109.801 169.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.5 mt -126.93 -46.61 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.814 0.846 . . . . 0.0 111.029 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -145.19 15.6 1.5 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -178.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 123.22 -25.11 6.42 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 124.372 0.987 . . . . 0.0 113.666 -177.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 60.8 m -86.74 142.54 28.08 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.213 1.005 . . . . 0.0 108.941 170.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -75.49 125.14 28.41 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.278 0.561 . . . . 0.0 109.855 170.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -110.27 168.95 9.06 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.283 1.433 . . . . 0.0 110.526 173.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.2 tp -124.97 133.44 69.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 125.498 1.519 . . . . 0.0 108.474 172.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.4 p -120.55 156.99 30.43 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.547 0.739 . . . . 0.0 109.949 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -149.02 136.91 20.61 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.695 0.798 . . . . 0.0 111.626 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.6 m -75.15 107.43 7.23 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.787 1.235 . . . . 0.0 110.896 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.61 -164.24 39.54 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.554 1.073 . . . . 0.0 114.32 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -63.63 160.97 15.69 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.912 0.885 . . . . 0.0 111.475 170.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -76.86 131.95 38.88 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.187 -0.946 . . . . 0.0 110.331 172.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.436 HD11 ' HB3' ' A' ' 152' ' ' SER . 0.2 OUTLIER -87.25 159.23 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.242 1.017 . . . . 0.0 111.294 173.352 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -92.53 -28.34 16.84 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.836 0.854 . . . . 0.0 112.542 172.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -67.21 -6.42 18.03 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.28 1.432 . . . . 0.0 114.569 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.436 ' HB3' HD11 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -128.42 -14.15 4.79 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -179.491 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 120.55 -84.35 0.37 Allowed Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.312 1.434 . . . . 0.0 113.183 172.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -137.55 24.41 2.91 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.203 1.801 . . . . 0.0 111.174 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -89.88 165.41 14.12 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.645 1.178 . . . . 0.0 109.502 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.6 m -101.55 143.18 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.289 0.635 . . . . 0.0 111.14 176.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.24 93.76 0.33 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.618 1.167 . . . . 0.0 109.852 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -99.99 144.92 28.48 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 122.413 1.101 . . . . 0.0 111.462 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -137.63 174.26 10.78 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.751 1.62 . . . . 0.0 111.211 -172.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.31 133.22 20.17 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.479 0.712 . . . . 0.0 110.127 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.43 ' CG2' HD11 ' A' ' 166' ' ' LEU . 64.3 mt -125.21 140.83 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.153 0.981 . . . . 0.0 108.889 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.0 m -66.17 95.37 0.29 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.041 0.936 . . . . 0.0 109.511 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.54 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.1 tt -54.75 -31.87 59.15 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.738 1.215 . . . . 0.0 111.86 177.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -70.3 -26.29 63.72 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -89.31 -26.72 20.97 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.833 0.853 . . . . 0.0 112.439 174.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.599 HD13 ' HG3' ' A' ' 100' ' ' MET . 23.6 mt -61.55 -48.59 80.29 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.057 0.943 . . . . 0.0 110.759 169.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -51.85 -37.61 52.75 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.365 1.066 . . . . 0.0 113.636 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -73.11 -11.49 60.56 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -127.1 -3.63 6.33 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.2 1.4 . . . . 0.0 114.241 -175.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 26.0 mt -92.81 -21.79 19.7 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.872 1.269 . . . . 0.0 112.303 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 C--O 1.254 1.314 0 C-N-CA 126.258 1.823 . . . . 0.0 112.93 174.522 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 119.551 -0.261 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.6 pt -123.05 -8.95 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -127.53 57.63 1.5 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.27 1.428 . . . . 0.0 109.657 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.2 t -56.12 146.57 22.65 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.502 0.721 . . . . 0.0 111.695 172.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.0 p -117.31 -24.26 7.5 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.357 1.463 . . . . 0.0 112.747 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -81.33 150.33 28.51 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.951 1.3 . . . . 0.0 111.223 169.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -151.78 127.83 10.42 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.183 1.393 . . . . 0.0 110.386 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 48.57 36.64 7.83 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.604 1.562 . . . . 0.0 113.516 -174.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.99 116.06 23.65 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.919 1.688 . . . . 0.0 108.837 -177.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.7 t -134.62 148.8 50.48 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.327 1.451 . . . . 0.0 110.543 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.0 t -128.48 104.74 7.86 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.564 1.146 . . . . 0.0 110.966 -172.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.86 165.01 33.76 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.852 1.691 . . . . 0.0 111.648 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -124.02 160.2 28.17 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.835 1.254 . . . . 0.0 110.681 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.7 m -140.97 164.32 30.57 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.399 1.48 . . . . 0.0 111.049 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -109.8 145.56 36.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.383 1.473 . . . . 0.0 110.725 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -135.8 120.54 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.043 1.337 . . . . 0.0 108.796 -174.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.12 164.54 34.4 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.765 1.626 . . . . 0.0 111.676 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -137.95 114.75 10.64 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.615 1.566 . . . . 0.0 110.002 174.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.452 HG22 ' H ' ' A' ' 41' ' ' PHE . 3.0 mp -117.02 131.9 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.772 1.629 . . . . 0.0 108.908 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -74.5 -8.49 56.48 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.452 ' H ' HG22 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -58.84 -15.4 12.33 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -178.285 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.5 m -67.72 -10.29 51.18 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.239 1.416 . . . . 0.0 113.322 171.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -134.38 166.94 21.68 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.794 1.638 . . . . 0.0 110.257 169.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -149.15 164.48 34.62 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.168 0.987 . . . . 0.0 110.261 170.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.74 123.49 25.0 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.566 0.222 . . . . 0.0 110.658 -178.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.5 m -120.53 161.75 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.2 1.4 . . . . 0.0 111.186 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -62.14 160.36 12.94 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.793 1.237 . . . . 0.0 111.303 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.3 tp -155.96 138.21 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.576 1.15 . . . . 0.0 109.339 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -130.98 161.94 30.85 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.221 1.808 . . . . 0.0 109.729 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -134.2 159.23 41.54 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.147 1.379 . . . . 0.0 111.704 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.17 119.62 25.76 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.283 0.633 . . . . 0.0 110.535 174.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -73.7 179.94 3.92 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.238 0.615 . . . . 0.0 112.41 174.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -58.05 -24.44 58.44 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.892 1.677 . . . . 0.0 113.435 173.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.9 m -78.93 -5.49 53.86 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.848 1.259 . . . . 0.0 113.806 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.42 32.84 84.81 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.289 0.947 . . . . 0.0 113.704 -171.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -116.64 141.98 47.49 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.792 1.637 . . . . 0.0 109.854 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -69.85 133.21 47.13 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.758 0.823 . . . . 0.0 111.26 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.3 t -145.54 142.98 29.67 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.931 1.293 . . . . 0.0 110.537 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -56.98 135.89 56.22 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.284 1.034 . . . . 0.0 112.415 -174.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.1 tp -109.12 -47.76 3.37 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.591 0.756 . . . . 0.0 111.731 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.24 -130.39 2.05 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 121.712 0.618 . . . . 0.0 113.713 -175.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -137.06 152.6 50.24 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.528 1.931 . . . . 0.0 110.8 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.5 tp -119.79 104.61 10.37 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.427 1.491 . . . . 0.0 110.806 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.43 99.86 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.388 1.075 . . . . 0.0 109.544 175.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.2 t -85.11 128.06 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.161 1.385 . . . . 0.0 109.633 173.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -119.39 118.42 31.13 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.193 2.197 . . . . 0.0 110.137 -175.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -85.54 103.76 14.69 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.15 1.38 . . . . 0.0 109.861 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -105.26 171.91 7.07 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.697 1.199 . . . . 0.0 111.694 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -76.19 -15.65 60.01 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 120.825 -1.172 . . . . 0.0 113.664 176.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -119.1 45.69 2.04 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.6 1.96 . . . . 0.0 112.053 -175.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.24 -165.39 20.58 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.002 1.286 . . . . 0.0 113.882 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.4 mt -112.45 139.55 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.709 0.804 . . . . 0.0 109.116 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -127.2 139.76 52.71 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.822 0.849 . . . . 0.0 110.094 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.1 p -132.09 137.27 47.68 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.59 0.756 . . . . 0.0 111.025 -173.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.29 110.48 0.83 Allowed Glycine 0 CA--C 1.52 0.387 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -170.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 32.0 tp -64.0 148.11 50.45 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.979 1.312 . . . . 0.0 110.345 175.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -138.35 76.99 1.6 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.044 1.738 . . . . 0.0 109.603 176.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.87 77.61 9.87 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.349 1.059 . . . . 0.0 112.338 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.42 -73.9 2.15 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.682 1.611 . . . . 0.0 113.796 174.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -137.89 18.7 3.35 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.967 1.746 . . . . 0.0 113.194 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -138.4 71.92 1.4 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.247 1.419 . . . . 0.0 110.933 -172.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.9 p -75.14 150.7 38.68 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 175.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.68 156.79 20.95 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.751 1.62 . . . . 0.0 111.401 176.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.9 m -58.74 116.45 3.74 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.33 -0.856 . . . . 0.0 109.144 169.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -81.99 -52.29 7.19 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.624 0.647 . . . . 0.0 109.841 -178.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -166.19 162.44 17.55 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.94 1.296 . . . . 0.0 112.383 170.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.58 156.81 44.7 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.956 1.303 . . . . 0.0 111.399 177.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.535 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -140.97 157.93 44.65 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.104 1.362 . . . . 0.0 112.282 -177.36 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -77.09 165.34 24.72 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.535 0.734 . . . . 0.0 112.021 -173.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -57.47 -30.0 64.69 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.318 -0.864 . . . . 0.0 112.357 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -69.98 -8.31 47.98 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.549 1.54 . . . . 0.0 114.027 175.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 t -119.26 -4.38 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.777 1.231 . . . . 0.0 111.3 -173.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.3 t -50.31 -66.47 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 125.169 1.388 . . . . 0.0 111.663 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -67.69 -24.42 65.41 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.38 -51.96 63.66 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.104 1.362 . . . . 0.0 110.511 173.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -60.17 -44.13 95.29 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 124.84 1.256 . . . . 0.0 111.926 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.543 HG22 HD22 ' A' ' 170' ' ' LEU . 92.4 t -55.58 -36.25 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 122.967 0.507 . . . . 0.0 110.855 178.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.7 tttp -68.29 -54.94 14.04 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.534 1.133 . . . . 0.0 112.678 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -72.7 -14.6 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 121.063 -1.023 . . . . 0.0 112.518 -174.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.505 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -88.07 -6.41 57.95 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.544 1.537 . . . . 0.0 112.081 176.938 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 44.4 p -130.5 -14.89 3.65 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -131.74 -9.57 3.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.612 1.565 . . . . 0.0 113.849 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.4 156.5 7.95 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.473 1.511 . . . . 0.0 113.683 -176.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.1 -169.04 34.69 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.993 0.806 . . . . 0.0 113.966 -175.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 61.6 p -146.32 94.72 2.5 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.389 1.075 . . . . 0.0 113.488 -167.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -128.49 140.14 51.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.667 1.587 . . . . 0.0 109.885 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -69.45 153.17 43.95 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.454 0.701 . . . . 0.0 110.947 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.8 p -115.11 160.86 19.15 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.76 1.624 . . . . 0.0 110.942 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.535 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 82.4 p -76.38 -39.17 54.43 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.391 -0.818 . . . . 0.0 111.019 -177.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.3 mt -153.45 138.71 17.49 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.37 1.868 . . . . 0.0 111.694 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -137.45 101.6 4.55 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.246 1.018 . . . . 0.0 111.005 176.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -91.72 -36.87 13.35 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 174.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.42 -176.13 48.18 Favored Glycine 0 CA--C 1.544 1.86 0 CA-C-N 118.936 0.789 . . . . 0.0 113.902 -170.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -58.12 -76.24 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -179.71 171.77 1.16 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.666 2.786 . . . . 0.0 109.211 -171.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 55.6 38.1 29.74 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 122.494 1.14 . . . . 0.0 112.213 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -130.52 147.9 52.26 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.209 1.804 . . . . 0.0 110.226 -168.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -67.23 -11.1 56.54 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -172.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.6 m -132.15 7.47 4.29 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -177.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.0 p -68.91 -14.01 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.253 -1.53 . . . . 0.0 114.253 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 66.6 mt -84.96 -38.67 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.458 1.103 . . . . 0.0 111.674 -177.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -123.7 -10.51 7.81 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.833 1.253 . . . . 0.0 113.684 -173.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.95 -178.49 43.27 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.087 1.327 . . . . 0.0 113.649 -176.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.6 mt -133.47 103.24 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.31 1.444 . . . . 0.0 107.651 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -67.01 143.58 56.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.189 0.518 . . . . 0.0 110.834 173.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 61.82 19.33 10.51 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.468 1.507 . . . . 0.0 114.381 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 16.4 tptp -53.62 123.88 13.48 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.893 1.277 . . . . 0.0 111.456 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -70.86 127.48 32.76 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.952 0.901 . . . . 0.0 110.388 170.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.7 mm -124.88 116.53 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.386 1.075 . . . . 0.0 108.48 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.8 mp -110.31 92.42 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.006 1.322 . . . . 0.0 108.379 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.1 p -75.03 154.91 37.78 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.123 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -150.68 139.38 20.71 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.948 1.299 . . . . 0.0 111.135 174.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.4 mt -81.93 132.85 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -140.45 122.45 15.61 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.273 1.429 . . . . 0.0 110.126 174.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -72.67 119.27 16.66 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 169.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.3 mt -105.37 97.09 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 175.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 61.15 11.4 3.46 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.603 1.961 . . . . 0.0 115.793 -176.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 132.84 -36.29 2.18 Favored Glycine 0 N--CA 1.473 1.117 0 C-N-CA 124.746 1.165 . . . . 0.0 113.31 176.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 88.3 m -71.85 126.74 30.52 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.472 1.109 . . . . 0.0 109.445 172.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -73.63 116.88 14.73 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.164 0.585 . . . . 0.0 109.848 173.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -106.38 166.15 10.75 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.271 1.428 . . . . 0.0 110.607 170.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.8 tp -118.66 138.19 50.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 125.525 1.53 . . . . 0.0 108.207 169.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.1 p -127.34 156.82 41.39 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.619 0.767 . . . . 0.0 109.933 174.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -150.79 146.14 26.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.13 0.972 . . . . 0.0 111.235 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 p -78.71 109.56 13.06 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.735 1.214 . . . . 0.0 111.402 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.43 -165.23 32.23 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 123.897 0.761 . . . . 0.0 113.204 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -65.33 164.3 13.85 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 122.254 1.026 . . . . 0.0 112.481 170.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -84.34 106.06 15.66 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.159 1.383 . . . . 0.0 111.172 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.89 157.38 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.413 0.625 . . . . 0.0 112.093 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -88.23 -33.07 18.24 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.215 1.006 . . . . 0.0 112.25 174.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -64.31 -42.29 96.41 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.5 -22.45 35.09 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 131.89 -80.24 0.34 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.484 1.516 . . . . 0.0 112.699 172.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -140.29 18.22 2.41 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.297 1.839 . . . . 0.0 111.424 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -79.92 -175.33 4.88 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.082 0.953 . . . . 0.0 109.674 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.9 m -117.91 142.83 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.892 0.877 . . . . 0.0 110.863 175.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.25 94.94 0.55 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.432 0.693 . . . . 0.0 109.442 172.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -92.31 145.45 24.47 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 122.164 0.983 . . . . 0.0 111.288 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -136.25 169.99 16.75 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.739 1.616 . . . . 0.0 111.112 -172.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.86 134.6 23.53 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 122.97 0.508 . . . . 0.0 110.495 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.466 ' CG2' HD11 ' A' ' 166' ' ' LEU . 59.7 mt -126.75 139.19 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.807 0.843 . . . . 0.0 109.263 175.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.5 m -63.09 96.9 0.1 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.232 1.013 . . . . 0.0 109.791 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.553 ' HA ' HD12 ' A' ' 166' ' ' LEU . 0.8 OUTLIER -55.35 -31.39 61.71 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.471 1.109 . . . . 0.0 111.884 177.067 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -67.86 -29.43 68.56 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -88.41 -18.88 27.39 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.036 0.934 . . . . 0.0 112.64 174.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.553 HD12 ' HA ' ' A' ' 163' ' ' LEU . 20.0 mt -70.92 -46.38 62.59 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.476 -0.765 . . . . 0.0 110.173 168.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -49.43 -48.26 47.46 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.851 1.26 . . . . 0.0 113.538 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 30.6 pttt -62.06 -29.74 70.51 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -93.74 -18.36 22.17 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.177 1.391 . . . . 0.0 112.492 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.543 HD22 HG22 ' A' ' 97' ' ' VAL . 14.4 mt -89.4 -30.66 18.2 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.221 1.409 . . . . 0.0 112.828 -177.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt . . . . . 0 C--O 1.253 1.289 0 C-N-CA 126.986 2.114 . . . . 0.0 113.428 169.978 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.2 mttp . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 120.443 0.163 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.8 mt -98.58 126.62 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.652 1.181 . . . . 0.0 109.153 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -155.51 154.18 31.4 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.012 1.325 . . . . 0.0 110.846 173.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.3 p -143.9 136.47 27.02 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.902 1.281 . . . . 0.0 111.668 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.3 m -65.89 161.0 22.1 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.167 0.987 . . . . 0.0 112.664 172.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -149.01 179.98 7.46 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.851 1.66 . . . . 0.0 111.28 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -127.93 147.23 50.47 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.839 1.256 . . . . 0.0 112.033 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -152.85 136.65 16.18 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.821 1.249 . . . . 0.0 110.681 -174.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -70.07 141.64 52.78 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.523 0.729 . . . . 0.0 111.61 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.2 t -150.42 90.81 1.68 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.552 1.141 . . . . 0.0 111.21 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.8 p -86.25 175.19 8.61 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.484 1.514 . . . . 0.0 112.585 174.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.76 110.66 0.46 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.366 0.984 . . . . 0.0 112.644 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -68.98 138.59 54.67 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.199 0.999 . . . . 0.0 111.453 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.3 t 52.11 26.88 4.11 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.683 1.593 . . . . 0.0 114.968 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -93.43 25.63 3.34 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.461 1.504 . . . . 0.0 113.533 -174.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.7 t -84.45 82.7 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.985 1.314 . . . . 0.0 110.209 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -141.62 163.65 32.35 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.931 1.693 . . . . 0.0 111.326 174.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -69.13 129.81 40.93 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.562 0.745 . . . . 0.0 109.609 168.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 mm -109.7 143.26 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.87 1.268 . . . . 0.0 109.01 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.2 -8.17 43.25 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -53.65 -16.64 1.7 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 127.045 2.138 . . . . 0.0 115.477 -175.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.0 t -61.38 -22.9 65.38 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.721 1.609 . . . . 0.0 113.82 170.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -145.35 162.32 37.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.253 1.021 . . . . 0.0 112.582 174.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -154.74 170.69 21.01 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.471 1.109 . . . . 0.0 111.931 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.87 134.08 44.13 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.217 0.607 . . . . 0.0 111.261 174.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.9 m -131.13 164.19 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 125.793 1.637 . . . . 0.0 111.33 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.22 160.41 13.06 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.626 1.17 . . . . 0.0 112.111 177.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 tp -155.29 137.0 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.321 1.448 . . . . 0.0 109.963 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -127.33 159.76 33.42 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.607 1.963 . . . . 0.0 109.547 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -128.88 159.69 35.01 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.79 1.236 . . . . 0.0 111.493 176.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -87.47 118.21 26.78 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.459 0.304 . . . . 0.0 110.868 173.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -69.52 178.08 2.64 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.958 0.885 . . . . 0.0 112.712 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -60.25 -22.65 63.31 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.158 1.783 . . . . 0.0 115.035 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.8 t -85.52 -4.87 59.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.95 0.9 . . . . 0.0 112.608 174.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.4 32.35 57.99 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 121.108 -0.995 . . . . 0.0 113.299 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.6 142.04 41.27 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.964 1.306 . . . . 0.0 110.72 178.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -76.14 122.06 23.76 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.594 0.758 . . . . 0.0 110.937 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.5 t -137.43 139.39 40.64 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.135 1.374 . . . . 0.0 110.32 -175.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -57.63 141.24 48.91 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -176.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.1 tp -114.56 -47.74 2.89 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.659 0.783 . . . . 0.0 111.023 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.92 -116.27 0.64 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 123.378 0.514 . . . . 0.0 113.044 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -146.33 156.25 43.21 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.693 1.597 . . . . 0.0 109.729 -176.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.8 tp -121.16 102.27 8.2 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.153 1.381 . . . . 0.0 110.29 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.82 101.19 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.083 0.953 . . . . 0.0 109.02 171.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.9 t -88.35 127.07 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.274 1.43 . . . . 0.0 109.803 172.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 -126.49 133.76 51.1 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.697 2.399 . . . . 0.0 110.928 -175.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.8 91.35 7.9 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.933 1.293 . . . . 0.0 109.766 176.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -73.06 174.45 7.89 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.721 1.208 . . . . 0.0 112.11 175.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -64.53 -31.61 72.9 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.14 -1.6 . . . . 0.0 114.017 -176.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -130.05 48.35 2.4 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.436 1.495 . . . . 0.0 112.515 -173.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.47 -164.0 23.98 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.727 1.632 . . . . 0.0 115.096 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 69.1 mt -113.37 142.17 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.345 1.058 . . . . 0.0 109.922 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -131.77 139.6 48.98 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.211 1.805 . . . . 0.0 109.315 -177.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.8 p -131.74 146.53 52.21 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.318 -0.864 . . . . 0.0 111.549 -171.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.45 124.0 2.41 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-O 121.699 0.61 . . . . 0.0 113.088 -177.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.72 136.18 52.47 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.434 1.894 . . . . 0.0 110.189 175.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -134.15 75.36 1.59 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.367 1.867 . . . . 0.0 110.475 -175.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.4 173.09 8.92 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.106 1.362 . . . . 0.0 112.075 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.68 94.44 0.04 OUTLIER Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.43 1.491 . . . . 0.0 113.648 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.63 17.2 79.04 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.855 1.216 . . . . 0.0 115.146 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -149.53 114.14 5.3 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 119.134 1.467 . . . . 0.0 111.471 -176.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.1 m -141.83 136.27 30.44 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -173.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.73 165.49 25.51 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.354 1.461 . . . . 0.0 112.278 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.2 m -55.02 135.04 49.25 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.279 -0.888 . . . . 0.0 110.468 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -102.89 -52.6 3.03 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.796 1.238 . . . . 0.0 109.89 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -163.07 162.66 25.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.824 0.85 . . . . 0.0 112.65 170.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.25 141.31 27.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.718 0.807 . . . . 0.0 111.538 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.557 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.8 OUTLIER -121.38 156.72 32.04 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.365 1.866 . . . . 0.0 111.501 -176.305 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -75.79 163.46 27.23 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.578 0.704 . . . . 0.0 112.608 -176.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -54.93 -28.03 47.91 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.038 1.335 . . . . 0.0 113.596 171.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -72.01 -15.65 62.05 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 121.104 -0.998 . . . . 0.0 113.251 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.6 t -106.32 -5.25 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.744 1.217 . . . . 0.0 110.671 -171.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.5 m -53.8 -35.03 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -96.79 -23.33 16.45 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.677 0.791 . . . . 0.0 112.307 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -68.69 -48.87 62.8 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.623 1.569 . . . . 0.0 111.318 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -60.71 -43.28 97.99 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.271 1.428 . . . . 0.0 111.338 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.7 t -53.69 -42.76 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.247 1.019 . . . . 0.0 109.914 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -60.84 -56.08 25.38 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.416 1.086 . . . . 0.0 112.313 175.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 m -72.86 -3.34 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 121.02 -1.05 . . . . 0.0 113.456 -177.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.497 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -107.46 -3.83 19.08 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.543 1.937 . . . . 0.0 111.902 179.723 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.7 p -129.81 -13.26 4.18 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.253 1.421 . . . . 0.0 113.29 172.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -134.03 -14.71 2.35 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.076 1.75 . . . . 0.0 114.116 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.16 154.82 11.74 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 124.797 1.189 . . . . 0.0 114.26 -176.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.28 -158.35 30.39 Favored Glycine 0 CA--C 1.533 1.162 0 O-C-N 121.58 -0.953 . . . . 0.0 114.073 -176.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.6 p -151.38 105.02 3.14 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -174.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -136.56 157.97 45.54 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.481 1.913 . . . . 0.0 110.537 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -83.58 161.57 21.12 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.16 -0.963 . . . . 0.0 111.996 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.4 p -122.96 158.59 30.12 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.853 1.661 . . . . 0.0 110.225 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.557 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 88.3 p -68.8 -36.49 78.33 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.768 -1.207 . . . . 0.0 111.139 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.4 mt -148.49 159.59 43.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.984 2.114 . . . . 0.0 111.604 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -149.93 112.47 4.73 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.475 1.11 . . . . 0.0 110.473 170.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -96.27 -47.58 5.96 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.978 0.911 . . . . 0.0 112.465 174.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.84 178.68 27.21 Favored Glycine 0 CA--C 1.544 1.856 0 C-N-CA 125.757 1.646 . . . . 0.0 113.993 -169.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -62.37 162.44 10.04 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 121.311 -1.111 . . . . 0.0 113.44 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -75.17 52.66 0.59 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.675 1.99 . . . . 0.0 112.972 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -144.67 8.62 1.32 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.712 1.605 . . . . 0.0 112.92 178.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -130.41 175.61 8.82 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.452 -1.405 . . . . 0.0 113.342 -175.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -84.86 -21.42 29.8 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 40.2 p -75.85 -25.7 56.47 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.34 -20.47 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -171.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 59.9 mt -59.51 -47.24 91.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 125.413 1.485 . . . . 0.0 111.889 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -137.34 -11.19 1.66 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.095 1.358 . . . . 0.0 114.186 -176.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.69 164.65 26.78 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.958 1.742 . . . . 0.0 114.074 -170.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 68.9 mt -112.38 114.61 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.721 1.608 . . . . 0.0 108.319 175.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -70.64 147.64 48.94 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.004 -0.435 . . . . 0.0 111.42 173.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 58.79 22.89 10.6 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.91 1.684 . . . . 0.0 114.465 175.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -65.8 130.7 44.2 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.297 1.439 . . . . 0.0 112.068 -171.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -79.68 122.55 26.69 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.586 1.155 . . . . 0.0 112.723 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 28.5 mm -113.93 117.66 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.419 1.088 . . . . 0.0 110.002 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mp -107.85 101.06 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.228 1.411 . . . . 0.0 107.889 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.5 p -87.08 160.61 18.51 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.585 0.707 . . . . 0.0 111.578 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -152.82 139.78 19.15 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.702 1.201 . . . . 0.0 111.191 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.9 mt -78.49 132.14 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 173.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -139.68 124.35 18.35 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.387 1.475 . . . . 0.0 110.088 174.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -73.79 124.67 26.5 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.707 -0.62 . . . . 0.0 109.449 169.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.2 mt -110.23 96.27 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 60.71 11.25 3.04 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.79 2.036 . . . . 0.0 115.947 -175.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 132.56 -35.46 2.33 Favored Glycine 0 N--CA 1.474 1.211 0 C-N-CA 124.977 1.275 . . . . 0.0 113.478 176.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 87.5 m -70.2 126.93 31.09 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.828 1.251 . . . . 0.0 109.424 172.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -75.33 117.01 16.67 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.668 -0.645 . . . . 0.0 109.672 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -106.64 167.29 9.96 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.09 1.356 . . . . 0.0 110.387 170.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.8 tp -118.77 136.92 54.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.398 1.479 . . . . 0.0 108.114 169.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.1 p -125.71 159.38 32.45 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.717 0.807 . . . . 0.0 110.151 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -149.81 144.8 26.23 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.965 0.906 . . . . 0.0 111.709 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.3 p -82.28 112.48 19.31 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.767 1.227 . . . . 0.0 111.057 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.1 -163.75 38.99 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.286 0.946 . . . . 0.0 113.158 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -72.02 168.92 17.06 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.583 0.706 . . . . 0.0 111.545 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -72.04 131.55 43.03 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.12 -0.988 . . . . 0.0 110.939 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -80.86 165.12 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.335 0.588 . . . . 0.0 112.295 172.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -102.72 -12.03 17.95 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.08 1.352 . . . . 0.0 114.288 173.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -88.84 11.79 16.95 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.226 1.81 . . . . 0.0 113.3 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.68 170.02 18.43 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.995 1.718 . . . . 0.0 112.358 -175.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -76.1 67.77 2.39 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.827 1.679 . . . . 0.0 114.183 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 57.8 34.47 24.44 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.78 1.632 . . . . 0.0 113.869 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -90.19 167.98 12.3 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.766 1.226 . . . . 0.0 109.794 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.6 m -101.52 145.26 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.651 1.18 . . . . 0.0 111.62 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.1 105.66 2.53 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.654 0.781 . . . . 0.0 109.284 175.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -109.05 144.57 36.89 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 122.087 0.946 . . . . 0.0 111.09 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -135.6 168.28 19.55 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.443 1.497 . . . . 0.0 111.536 -171.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.64 132.18 20.97 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.122 0.569 . . . . 0.0 110.004 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.4 ' CG2' HD11 ' A' ' 166' ' ' LEU . 66.3 mt -123.95 140.2 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.82 0.848 . . . . 0.0 108.766 176.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.2 m -65.49 95.43 0.21 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.833 0.853 . . . . 0.0 109.432 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.415 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.0 OUTLIER -53.67 -32.64 52.41 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.577 1.151 . . . . 0.0 111.767 176.299 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -67.86 -25.81 65.72 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -86.35 -34.06 20.36 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.584 1.153 . . . . 0.0 112.237 171.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.497 HD13 ' HG3' ' A' ' 100' ' ' MET . 22.7 mt -58.65 -43.47 89.82 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.211 -0.931 . . . . 0.0 111.277 176.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -53.98 -33.0 55.78 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.487 1.115 . . . . 0.0 113.816 174.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -75.48 -8.21 56.15 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.281 1.433 . . . . 0.0 114.205 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -128.83 -3.57 5.22 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.613 1.565 . . . . 0.0 114.301 -174.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 89.6 mt -109.67 1.71 19.71 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.621 1.569 . . . . 0.0 112.436 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt . . . . . 0 C--O 1.253 1.268 0 C-N-CA 128.3 2.64 . . . . 0.0 115.521 174.505 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.8 tttm . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.3 tp -147.3 147.46 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.99 1.316 . . . . 0.0 110.773 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -103.0 103.77 13.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.549 1.139 . . . . 0.0 110.213 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.3 p -69.17 163.6 24.53 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.094 0.958 . . . . 0.0 111.993 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.1 t -137.14 -50.78 0.64 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.158 0.983 . . . . 0.0 111.741 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.7 t80 47.01 37.18 4.76 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.699 1.599 . . . . 0.0 113.55 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -57.52 135.41 56.63 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.935 1.294 . . . . 0.0 113.262 -175.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -86.54 165.83 15.92 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.268 1.027 . . . . 0.0 112.515 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -142.96 165.38 27.52 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.561 1.544 . . . . 0.0 111.834 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 76.4 p -115.85 165.86 12.61 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.847 1.659 . . . . 0.0 111.481 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 43.6 p -128.38 -54.13 1.27 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.017 0.927 . . . . 0.0 113.475 -170.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.49 -167.56 28.58 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.369 0.985 . . . . 0.0 114.198 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -87.8 83.12 7.17 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.201 1.4 . . . . 0.0 111.134 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.4 m -142.78 -174.28 4.12 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.953 1.701 . . . . 0.0 110.99 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -61.06 117.63 5.75 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.22 -0.925 . . . . 0.0 110.15 172.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.95 45.74 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.862 2.065 . . . . 0.0 110.859 -175.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.09 156.07 4.22 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.443 1.097 . . . . 0.0 111.991 174.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -138.07 163.02 32.66 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.62 1.568 . . . . 0.0 111.23 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.7 mm -57.62 134.32 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.445 1.098 . . . . 0.0 110.44 174.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -130.57 -4.15 4.21 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -62.92 -14.21 44.01 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.118 1.367 . . . . 0.0 114.605 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.2 m -65.69 -12.36 52.94 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.589 1.955 . . . . 0.0 113.863 172.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -150.07 174.93 12.19 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.798 1.639 . . . . 0.0 110.756 175.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -156.4 165.67 35.67 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.913 0.885 . . . . 0.0 110.338 170.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.56 134.33 48.6 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.2 m -132.06 161.52 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.082 1.353 . . . . 0.0 112.097 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -67.47 141.63 56.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.359 1.063 . . . . 0.0 110.268 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.2 tp -138.7 135.73 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.33 1.452 . . . . 0.0 108.751 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -128.86 161.56 29.55 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.152 1.781 . . . . 0.0 109.38 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -129.96 155.13 46.58 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.017 1.327 . . . . 0.0 111.043 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.7 118.49 22.3 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 169.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.5 p30 -68.21 178.47 1.89 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.466 1.127 . . . . 0.0 113.54 171.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -58.18 -11.83 2.99 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.355 1.862 . . . . 0.0 114.846 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.9 t -107.57 4.14 25.68 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.236 1.414 . . . . 0.0 112.514 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.69 22.35 78.41 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 120.643 -1.286 . . . . 0.0 114.505 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -105.05 138.9 40.54 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.486 1.143 . . . . 0.0 110.932 174.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -69.93 126.42 29.66 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.108 0.963 . . . . 0.0 110.538 173.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 t -142.14 143.71 33.13 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.963 1.305 . . . . 0.0 110.324 -177.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -54.65 135.61 46.54 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.726 0.811 . . . . 0.0 113.048 -176.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.0 tp -111.55 -49.88 2.97 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.058 0.943 . . . . 0.0 111.075 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.57 -131.47 2.07 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 121.395 0.442 . . . . 0.0 114.108 -173.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.79 135.29 29.52 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.255 1.422 . . . . 0.0 110.123 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.454 HD11 ' HB ' ' A' ' 74' ' ' THR . 1.2 tm? -106.19 108.66 20.29 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.291 1.436 . . . . 0.0 109.224 -176.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.463 HG12 ' HG3' ' A' ' 66' ' ' ARG . 60.7 t -85.95 96.53 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.797 1.239 . . . . 0.0 109.295 174.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.6 t -71.46 110.18 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.154 0.981 . . . . 0.0 109.286 168.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.463 ' HG3' HG12 ' A' ' 64' ' ' VAL . 66.8 mtp85 -106.43 123.88 48.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 127.122 2.169 . . . . 0.0 110.217 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -87.19 86.92 7.32 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.821 0.848 . . . . 0.0 110.785 176.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -64.66 169.25 5.14 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 122.257 1.027 . . . . 0.0 112.835 170.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.76 -36.33 78.66 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.96 1.304 . . . . 0.0 113.732 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -132.75 62.75 1.65 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.675 1.19 . . . . 0.0 112.097 -173.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.67 -155.41 21.75 Favored Glycine 0 N--CA 1.467 0.701 0 C-N-CA 124.388 0.994 . . . . 0.0 114.344 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 70.1 mt -128.48 137.21 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.275 1.03 . . . . 0.0 108.919 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.07 146.32 46.04 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.336 1.454 . . . . 0.0 108.879 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.454 ' HB ' HD11 ' A' ' 63' ' ' LEU . 75.9 p -132.58 143.25 49.58 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.198 -0.939 . . . . 0.0 110.205 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.77 136.13 8.15 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -92.49 131.55 37.54 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.666 1.987 . . . . 0.0 109.94 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -135.74 75.23 1.54 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.204 1.401 . . . . 0.0 110.459 -174.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.51 169.78 14.71 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.496 1.519 . . . . 0.0 113.116 178.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.98 49.91 2.21 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.856 1.693 . . . . 0.0 114.285 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.83 -6.48 0.45 Allowed Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.48 1.515 . . . . 0.0 115.251 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -153.08 154.03 34.02 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.876 1.338 . . . . 0.0 111.967 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.0 p -154.57 152.13 29.68 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -169.43 160.28 9.15 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.009 1.324 . . . . 0.0 112.611 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 51.9 m -59.48 123.42 16.77 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.403 -0.811 . . . . 0.0 109.039 168.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -87.3 -50.37 6.63 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.866 0.466 . . . . 0.0 110.124 -176.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -166.38 164.2 17.44 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.251 1.02 . . . . 0.0 112.977 172.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 p -150.32 147.48 27.68 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.859 1.314 . . . . 0.0 113.227 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.413 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.5 OUTLIER -133.58 162.69 31.23 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.269 1.428 . . . . 0.0 111.656 -177.042 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -81.93 166.7 19.65 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.582 0.753 . . . . 0.0 112.368 -175.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -55.79 -34.19 65.06 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.07 -1.019 . . . . 0.0 112.423 175.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -67.98 -3.28 9.52 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.461 1.505 . . . . 0.0 113.913 175.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 t -122.09 -3.39 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.318 1.047 . . . . 0.0 111.567 -177.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.2 t -53.22 -65.44 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 120.492 -1.38 . . . . 0.0 110.863 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -64.7 -27.74 69.12 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.744 -0.597 . . . . 0.0 112.227 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.33 -53.54 53.55 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.72 1.608 . . . . 0.0 110.359 174.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -62.99 -42.39 99.84 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.475 1.11 . . . . 0.0 111.937 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.527 HG22 HD22 ' A' ' 170' ' ' LEU . 92.7 t -58.5 -37.04 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 122.885 0.474 . . . . 0.0 110.844 176.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -64.71 -55.02 22.58 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.61 1.164 . . . . 0.0 112.784 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.7 -9.6 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 121.577 -0.702 . . . . 0.0 112.28 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.466 ' CG ' HD13 ' A' ' 166' ' ' LEU . 20.8 ttm -95.73 -4.72 43.59 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.589 -1.319 . . . . 0.0 112.934 177.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.9 p -127.49 -13.1 5.5 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.725 0.81 . . . . 0.0 112.875 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -131.54 -12.11 3.48 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.522 1.529 . . . . 0.0 114.434 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.19 155.96 9.85 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.074 1.321 . . . . 0.0 113.662 -175.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 156.21 -168.3 33.55 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.357 0.979 . . . . 0.0 113.556 -175.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 36.0 p -146.51 105.83 3.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.483 1.113 . . . . 0.0 113.463 -168.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -136.32 143.55 44.21 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.162 1.785 . . . . 0.0 110.246 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -74.84 153.05 38.88 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.543 -0.723 . . . . 0.0 111.297 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.4 p -118.87 135.86 54.34 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.327 1.451 . . . . 0.0 110.875 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.413 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 6.6 t -48.15 -42.25 29.0 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.103 1.361 . . . . 0.0 113.235 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.4 mt -147.53 145.51 29.11 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.67 1.588 . . . . 0.0 112.769 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -143.89 101.18 3.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.272 1.029 . . . . 0.0 110.783 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -91.99 -37.16 12.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.157 0.983 . . . . 0.0 113.298 176.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.75 -176.95 8.42 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.414 1.483 . . . . 0.0 114.824 -172.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -61.7 160.43 11.69 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 174.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -77.86 52.98 1.09 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.25 1.82 . . . . 0.0 112.592 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -145.52 19.89 1.52 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.097 1.759 . . . . 0.0 111.54 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -137.2 171.55 14.32 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.831 -1.168 . . . . 0.0 114.08 -173.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -82.52 -23.3 34.65 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.731 0.812 . . . . 0.0 113.07 -175.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.7 m -92.86 -12.86 29.97 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.9 p -60.57 -14.54 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 174.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 83.8 mt -55.06 -53.33 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.814 1.645 . . . . 0.0 111.751 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -140.41 -2.2 1.44 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.405 1.482 . . . . 0.0 113.791 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 81.29 176.61 51.07 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.113 1.34 . . . . 0.0 113.356 -171.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.3 mt -121.34 116.22 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.228 1.411 . . . . 0.0 108.078 173.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -68.34 140.56 55.9 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.977 0.418 . . . . 0.0 111.617 170.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 55.41 29.34 12.97 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.878 1.671 . . . . 0.0 114.279 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -59.52 127.75 33.62 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.804 1.242 . . . . 0.0 111.564 -175.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -75.79 119.5 19.87 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.017 0.527 . . . . 0.0 111.336 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.5 mm -112.16 116.82 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.832 1.253 . . . . 0.0 109.08 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.12 97.97 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 124.724 1.21 . . . . 0.0 108.491 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 43.0 p -76.97 159.58 29.84 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.87 174.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -153.3 142.49 21.44 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.791 1.236 . . . . 0.0 111.061 170.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mt -83.32 135.03 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.402 0.681 . . . . 0.0 109.245 174.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -141.43 125.59 17.38 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.887 1.275 . . . . 0.0 111.195 174.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -75.38 104.31 5.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.359 0.664 . . . . 0.0 110.28 169.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.6 mt -90.88 99.37 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 172.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.7 t0 57.63 24.64 10.73 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.114 1.766 . . . . 0.0 115.536 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.5 -25.23 12.44 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.806 1.194 . . . . 0.0 113.703 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 97.7 m -82.41 122.99 28.71 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.046 0.923 . . . . 0.0 109.438 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -71.38 119.64 15.82 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.65 -0.656 . . . . 0.0 110.42 171.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -108.72 166.3 10.91 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.919 1.688 . . . . 0.0 110.62 170.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.2 tp -116.13 135.04 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.769 1.628 . . . . 0.0 108.043 169.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.1 p -125.31 155.8 39.65 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.547 0.739 . . . . 0.0 109.957 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -146.4 138.37 24.89 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.795 0.838 . . . . 0.0 111.221 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.0 p -75.69 113.38 13.07 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.325 1.05 . . . . 0.0 111.202 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.17 -156.59 26.5 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.577 1.084 . . . . 0.0 113.014 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.26 -174.05 0.34 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.04 0.936 . . . . 0.0 112.991 169.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -100.51 113.98 27.21 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.141 0.976 . . . . 0.0 111.716 169.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.405 HD11 ' HB3' ' A' ' 152' ' ' SER . 0.2 OUTLIER -70.05 160.46 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.074 0.95 . . . . 0.0 112.25 177.015 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -90.13 -34.62 15.8 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 172.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -59.18 -37.92 78.56 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.886 1.274 . . . . 0.0 113.941 -175.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.405 ' HB3' HD11 ' A' ' 149' ' ' ILE . 1.0 OUTLIER -88.39 -31.34 18.91 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -179.683 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 133.53 -79.22 0.34 Allowed Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.161 1.362 . . . . 0.0 112.938 173.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -139.31 22.02 2.57 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.922 2.089 . . . . 0.0 110.826 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.49 179.52 6.83 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.257 1.023 . . . . 0.0 109.123 177.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.9 m -115.37 149.77 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.238 0.615 . . . . 0.0 111.852 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.42 86.85 1.53 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.09 0.556 . . . . 0.0 110.475 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -90.21 145.3 25.12 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.524 1.154 . . . . 0.0 112.057 172.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -138.75 169.0 18.57 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 126.359 1.863 . . . . 0.0 110.857 -173.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.44 132.26 21.33 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.079 0.551 . . . . 0.0 110.246 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.458 ' CG2' HD11 ' A' ' 166' ' ' LEU . 58.2 mt -125.06 139.98 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.145 0.978 . . . . 0.0 108.871 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.0 m -67.16 95.21 0.39 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.477 -0.764 . . . . 0.0 110.048 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.556 HD21 ' HE2' ' A' ' 167' ' ' LYS . 1.0 OUTLIER -52.23 -33.52 41.78 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.574 1.15 . . . . 0.0 111.766 176.164 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -67.2 -29.56 69.26 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -84.82 -27.54 26.72 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.175 0.99 . . . . 0.0 111.859 172.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 163' ' ' LEU . 40.8 mt -68.01 -43.01 79.8 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.558 0.743 . . . . 0.0 110.158 175.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.556 ' HE2' HD21 ' A' ' 163' ' ' LEU . 15.3 mtmt -57.32 -20.0 25.93 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -86.83 -15.42 39.25 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.502 1.121 . . . . 0.0 114.021 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -123.01 -3.06 8.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.385 1.474 . . . . 0.0 113.437 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.527 HD22 HG22 ' A' ' 97' ' ' VAL . 13.2 mt -92.31 -18.56 23.19 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.339 1.456 . . . . 0.0 112.639 -177.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp . . . . . 0 C--O 1.253 1.243 0 C-N-CA 126.668 1.987 . . . . 0.0 113.572 171.49 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.7 pttp . . . . . 0 N--CA 1.495 1.808 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.1 tt -66.55 -37.61 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 O-C-N 120.335 -1.478 . . . . 0.0 112.658 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -81.98 134.21 35.36 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.424 1.09 . . . . 0.0 110.886 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 46.5 p -111.22 173.37 6.37 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.766 1.627 . . . . 0.0 110.892 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.7 t -133.67 160.37 37.73 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.602 0.761 . . . . 0.0 111.965 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -141.14 161.18 38.48 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.064 1.746 . . . . 0.0 111.396 -174.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -149.92 164.47 35.33 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.749 1.62 . . . . 0.0 111.426 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.9 149.21 44.57 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.18 1.392 . . . . 0.0 110.645 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -138.85 100.15 3.97 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.961 1.304 . . . . 0.0 110.306 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.8 m -72.39 168.84 17.58 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.203 1.001 . . . . 0.0 112.117 173.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.7 p -125.77 -42.08 1.94 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.649 1.18 . . . . 0.0 112.938 175.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.72 -148.91 50.67 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-N 118.746 0.703 . . . . 0.0 113.254 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -68.72 93.64 0.54 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.742 1.217 . . . . 0.0 112.066 176.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.1 m -147.22 169.15 19.98 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.411 1.884 . . . . 0.0 111.674 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -71.71 125.47 27.2 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.014 0.926 . . . . 0.0 110.911 171.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 p -167.23 148.48 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 127.025 2.13 . . . . 0.0 108.737 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -129.86 171.59 12.57 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.292 1.437 . . . . 0.0 112.516 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.79 128.45 35.32 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.754 1.622 . . . . 0.0 110.265 173.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.0 mm -78.14 159.5 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.193 0.997 . . . . 0.0 109.538 174.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -59.4 -14.7 13.06 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.846 -1.159 . . . . 0.0 113.933 171.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -94.43 0.87 55.72 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.495 1.518 . . . . 0.0 113.953 175.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.4 t -60.76 -22.03 63.64 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.578 1.551 . . . . 0.0 113.221 176.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -140.08 161.19 38.21 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.067 1.347 . . . . 0.0 110.269 168.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -143.8 171.02 14.79 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.027 0.931 . . . . 0.0 110.786 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -142.26 122.35 13.75 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.699 -0.626 . . . . 0.0 110.77 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.6 m -123.76 161.24 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 126.351 1.86 . . . . 0.0 111.095 -176.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 160.09 13.72 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.535 0.734 . . . . 0.0 112.496 176.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.0 tp -152.72 138.5 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.712 1.605 . . . . 0.0 109.085 174.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -129.14 159.33 36.36 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.613 1.965 . . . . 0.0 109.333 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -134.86 160.94 36.63 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.731 1.213 . . . . 0.0 111.866 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.67 119.81 25.23 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.603 0.361 . . . . 0.0 110.619 172.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.9 p30 -68.81 177.08 2.71 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 122.636 1.208 . . . . 0.0 113.625 170.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.8 mtmm -58.25 -23.16 55.07 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.107 1.763 . . . . 0.0 113.337 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 m -84.03 -11.18 57.15 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.013 1.325 . . . . 0.0 113.076 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.72 33.38 42.55 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.201 1.381 . . . . 0.0 114.291 -175.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -120.72 145.65 47.28 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.363 1.465 . . . . 0.0 111.18 175.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -67.76 130.83 44.23 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.708 0.803 . . . . 0.0 111.054 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.4 t -143.12 142.84 31.61 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.824 1.249 . . . . 0.0 110.652 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -56.41 132.47 51.23 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.252 1.021 . . . . 0.0 112.342 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.9 tp -108.12 -49.87 3.13 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.571 0.749 . . . . 0.0 111.22 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.47 -119.05 0.82 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.761 0.696 . . . . 0.0 112.916 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -143.05 158.09 43.93 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.589 1.555 . . . . 0.0 111.064 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.8 tp -122.47 103.75 8.92 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.861 1.664 . . . . 0.0 110.137 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.1 t -74.73 98.85 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.572 1.149 . . . . 0.0 109.383 172.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.8 t -87.07 115.47 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.717 1.207 . . . . 0.0 110.057 173.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -104.6 116.66 32.46 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.906 2.083 . . . . 0.0 110.359 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -81.11 87.39 6.05 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.524 1.13 . . . . 0.0 110.51 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -76.97 173.5 11.7 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.31 1.044 . . . . 0.0 112.307 171.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -74.38 -33.54 63.09 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.697 -1.252 . . . . 0.0 113.543 174.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -108.76 45.14 1.06 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.284 1.434 . . . . 0.0 111.418 -170.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 113.94 -164.19 12.09 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.204 1.383 . . . . 0.0 113.709 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.9 mt -117.77 142.55 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.669 0.788 . . . . 0.0 109.168 173.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -131.28 136.06 47.84 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.762 1.225 . . . . 0.0 109.138 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.6 p -129.4 150.27 50.83 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.516 0.727 . . . . 0.0 111.636 -171.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -144.32 122.73 1.85 Allowed Glycine 0 C--N 1.335 0.506 0 O-C-N 121.746 -0.596 . . . . 0.0 112.446 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -65.87 136.37 56.05 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.291 1.436 . . . . 0.0 109.621 174.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -133.51 99.66 4.57 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.891 2.076 . . . . 0.0 108.964 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.87 100.42 7.37 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.568 1.547 . . . . 0.0 111.089 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 61.52 -113.81 6.08 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.299 0.952 . . . . 0.0 112.408 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -96.06 15.71 62.47 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.004 1.288 . . . . 0.0 114.744 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -140.56 143.54 35.38 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.02 1.41 . . . . 0.0 112.885 -174.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 46.3 m -147.0 151.27 36.69 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.064 0.946 . . . . 0.0 113.014 -175.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.79 158.36 33.41 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.292 1.437 . . . . 0.0 111.804 175.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.3 m -55.61 128.38 34.35 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 121.269 -0.895 . . . . 0.0 110.281 170.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -95.53 -51.6 4.48 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.345 0.658 . . . . 0.0 110.151 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -164.8 163.17 21.31 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.025 0.93 . . . . 0.0 112.527 170.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.05 146.79 31.08 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.005 1.322 . . . . 0.0 111.94 177.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.523 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -128.13 160.06 33.2 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.795 1.638 . . . . 0.0 111.429 -176.471 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -78.29 164.82 24.54 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.468 0.707 . . . . 0.0 112.299 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -56.67 -33.76 66.69 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.352 1.461 . . . . 0.0 114.496 174.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -69.78 -9.64 55.34 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.581 1.153 . . . . 0.0 112.957 173.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.8 t -112.51 -8.09 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.294 1.038 . . . . 0.0 111.054 -173.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.5 t -46.62 -67.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 125.623 1.569 . . . . 0.0 111.905 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -67.22 -26.97 66.87 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.501 -0.749 . . . . 0.0 112.737 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -63.56 -52.08 62.61 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.701 1.6 . . . . 0.0 110.703 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -59.47 -46.7 88.04 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 125.476 1.51 . . . . 0.0 111.031 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.516 HG22 HD22 ' A' ' 170' ' ' LEU . 82.8 t -56.19 -36.15 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.468 0.707 . . . . 0.0 110.806 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -65.87 -54.47 26.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.857 1.263 . . . . 0.0 112.659 174.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 m -71.55 -16.88 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 120.913 -1.117 . . . . 0.0 112.539 -176.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.644 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -87.32 -5.2 58.99 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.169 1.788 . . . . 0.0 111.693 177.042 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 65.0 p -128.56 -15.05 4.56 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -134.18 -10.02 2.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.493 1.517 . . . . 0.0 114.183 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.49 156.31 10.89 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.642 1.592 . . . . 0.0 113.96 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 157.66 -166.01 33.71 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.129 0.871 . . . . 0.0 113.838 -175.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 61.2 p -148.56 103.26 3.39 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -170.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -134.76 143.68 47.26 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.05 1.74 . . . . 0.0 110.137 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -71.15 162.73 28.94 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.457 -0.777 . . . . 0.0 111.636 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 81.5 p -127.43 154.12 45.43 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.441 1.497 . . . . 0.0 110.972 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.523 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 82.4 p -71.07 -38.79 72.46 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.427 -0.796 . . . . 0.0 111.103 -177.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.2 mt -152.83 140.37 19.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.71 2.004 . . . . 0.0 111.468 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -134.5 102.57 5.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.999 0.92 . . . . 0.0 110.046 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -87.49 -46.88 9.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.51 1.124 . . . . 0.0 112.76 175.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.43 173.99 34.51 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.204 1.383 . . . . 0.0 113.636 -168.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -57.39 162.87 2.57 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.122 0.969 . . . . 0.0 111.922 169.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -60.17 160.51 8.17 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.23 -0.919 . . . . 0.0 111.426 170.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 65.1 37.69 6.54 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.026 0.93 . . . . 0.0 113.075 -171.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -120.51 170.43 9.4 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.757 1.623 . . . . 0.0 111.416 170.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -86.44 -11.17 52.59 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.274 1.029 . . . . 0.0 113.763 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.8 p -103.76 -27.3 12.33 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.927 1.291 . . . . 0.0 113.96 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.9 p -60.16 -22.06 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -174.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.6 mp -59.62 -36.79 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 125.819 1.648 . . . . 0.0 112.585 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -146.76 -38.26 0.22 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -168.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 104.4 156.32 23.57 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 126.898 2.19 . . . . 0.0 113.475 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.6 mt -113.38 112.95 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.073 1.349 . . . . 0.0 108.168 176.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -74.18 147.92 42.13 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.015 0.436 . . . . 0.0 111.384 172.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 59.31 21.91 10.2 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.659 1.583 . . . . 0.0 113.976 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -63.24 126.31 26.99 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.954 1.302 . . . . 0.0 111.515 -172.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -74.88 122.36 23.28 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.36 1.464 . . . . 0.0 112.267 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.5 mm -118.48 118.02 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.184 0.993 . . . . 0.0 109.835 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.7 92.64 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.485 1.514 . . . . 0.0 109.18 -177.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.2 p -74.86 156.58 36.29 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.498 174.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -153.48 142.7 21.46 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.182 1.393 . . . . 0.0 111.646 173.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 21.8 mt -81.49 132.02 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.068 0.547 . . . . 0.0 109.721 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -149.08 141.75 24.48 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.694 1.598 . . . . 0.0 110.232 173.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -82.61 158.26 23.1 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.274 -0.892 . . . . 0.0 110.198 169.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 38.5 mt -128.36 -46.31 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.242 1.017 . . . . 0.0 110.726 178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -142.96 10.96 1.78 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 122.39 -24.37 6.92 Favored Glycine 0 N--CA 1.473 1.127 0 C-N-CA 124.226 0.917 . . . . 0.0 113.137 -174.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 62.2 m -87.07 141.3 28.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.042 0.937 . . . . 0.0 108.642 169.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -76.44 124.5 27.65 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 170.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -109.17 167.88 9.78 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.471 1.508 . . . . 0.0 110.447 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.4 tp -123.16 132.04 72.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 125.331 1.452 . . . . 0.0 108.31 171.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.2 p -120.25 152.64 37.46 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.588 0.755 . . . . 0.0 109.878 177.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -145.63 147.55 32.14 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.306 0.574 . . . . 0.0 111.602 178.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.5 p -73.06 109.69 6.79 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.272 1.029 . . . . 0.0 111.21 174.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.77 -166.47 30.61 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 122.139 0.855 . . . . 0.0 113.232 172.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -65.65 162.0 19.34 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.148 0.979 . . . . 0.0 113.015 170.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -84.3 101.09 11.67 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.866 1.266 . . . . 0.0 111.853 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.417 HD11 ' HB3' ' A' ' 152' ' ' SER . 0.2 OUTLIER -66.28 161.79 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.458 0.703 . . . . 0.0 112.574 178.51 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -109.27 8.11 25.56 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.226 1.01 . . . . 0.0 113.487 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -116.88 21.62 13.19 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.351 1.86 . . . . 0.0 112.534 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.417 ' HB3' HD11 ' A' ' 149' ' ' ILE . 1.9 t -138.05 -41.05 0.53 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.55 1.14 . . . . 0.0 113.601 173.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 124.58 69.3 0.2 Allowed Glycine 0 N--CA 1.476 1.357 0 C-N-CA 123.972 0.796 . . . . 0.0 113.954 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 57.64 25.07 11.25 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.387 1.475 . . . . 0.0 113.673 -173.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -87.44 174.61 8.41 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.236 1.014 . . . . 0.0 109.036 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.7 m -110.98 146.71 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.772 0.829 . . . . 0.0 110.848 175.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.59 83.2 0.42 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.338 1.055 . . . . 0.0 110.478 176.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -81.08 141.92 33.84 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 122.157 0.979 . . . . 0.0 111.717 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -135.31 169.71 17.06 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.73 1.612 . . . . 0.0 111.534 -173.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.35 132.55 18.38 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.576 0.75 . . . . 0.0 110.446 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.46 ' CG2' HD11 ' A' ' 166' ' ' LEU . 68.0 mt -124.98 141.5 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.09 0.956 . . . . 0.0 108.88 177.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.3 m -66.33 93.44 0.22 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.64 1.176 . . . . 0.0 110.194 176.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.59 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.4 tt -54.98 -30.81 60.02 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.226 1.41 . . . . 0.0 112.45 178.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -71.65 -30.51 65.82 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -82.64 -30.7 29.2 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.01 0.924 . . . . 0.0 112.237 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.644 HD13 ' HG3' ' A' ' 100' ' ' MET . 20.7 mt -57.22 -49.77 74.96 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.914 0.886 . . . . 0.0 110.779 173.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -50.45 -38.21 42.38 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.263 1.025 . . . . 0.0 113.391 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -64.29 -21.14 66.49 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -120.82 -4.29 9.68 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.534 1.533 . . . . 0.0 113.421 -174.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.516 HD22 HG22 ' A' ' 97' ' ' VAL . 15.3 mt -98.09 -22.33 16.29 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.596 1.558 . . . . 0.0 112.736 -175.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp . . . . . 0 C--O 1.254 1.309 0 C-N-CA 125.951 1.7 . . . . 0.0 113.363 175.023 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.005 0.431 . . . . 0.0 112.125 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.2 pt -136.6 172.6 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.788 2.035 . . . . 0.0 110.642 173.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -58.83 162.45 4.08 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.636 0.775 . . . . 0.0 112.741 171.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 54.0 p -130.88 159.39 37.54 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.809 1.243 . . . . 0.0 111.636 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 58.1 m -140.04 162.97 33.94 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.467 1.507 . . . . 0.0 110.863 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -141.19 150.01 42.18 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.151 1.381 . . . . 0.0 110.883 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -90.85 127.62 36.43 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.993 0.917 . . . . 0.0 110.357 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.55 150.79 48.46 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.494 -0.754 . . . . 0.0 111.575 169.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 53.42 24.31 3.88 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.47 1.508 . . . . 0.0 114.481 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.4 t -64.11 163.17 12.94 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.018 1.327 . . . . 0.0 112.962 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.0 t -114.96 163.29 15.79 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.379 1.472 . . . . 0.0 112.292 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.75 -148.95 18.63 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.54 1.543 . . . . 0.0 112.853 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -143.21 148.01 35.78 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.684 1.194 . . . . 0.0 111.354 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.7 m -62.83 153.27 33.64 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.627 1.171 . . . . 0.0 112.958 177.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -91.91 100.58 13.22 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.38 1.072 . . . . 0.0 110.429 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.9 p -155.24 145.39 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.077 1.751 . . . . 0.0 109.6 174.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -143.35 155.4 44.42 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.521 1.528 . . . . 0.0 111.441 172.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -149.96 166.57 29.23 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.198 2.199 . . . . 0.0 110.321 175.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 44.2 mm -66.36 135.99 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.864 0.866 . . . . 0.0 110.279 170.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -128.72 8.77 5.84 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.668 1.187 . . . . 0.0 113.217 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -68.82 -4.25 15.48 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.973 1.309 . . . . 0.0 114.445 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.4 m -58.76 -25.08 62.68 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 127.24 2.216 . . . . 0.0 114.086 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.88 166.96 23.23 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.652 1.181 . . . . 0.0 110.168 166.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -150.2 167.09 27.9 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.069 0.948 . . . . 0.0 110.921 173.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -131.15 131.0 43.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.855 0.462 . . . . 0.0 111.037 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 m -129.34 167.85 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 126.179 1.791 . . . . 0.0 111.026 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -65.3 166.78 9.4 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.741 1.217 . . . . 0.0 111.943 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.422 HG21 ' CD2' ' A' ' 76' ' ' LEU . 5.4 tp -161.82 135.72 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.128 1.371 . . . . 0.0 109.933 172.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -129.07 160.11 33.82 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.509 1.924 . . . . 0.0 109.324 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -127.19 160.25 31.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.337 1.455 . . . . 0.0 111.072 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -81.49 121.82 26.76 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 122.048 -0.407 . . . . 0.0 110.565 171.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -64.09 175.47 1.23 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.411 1.085 . . . . 0.0 112.105 171.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -59.76 -13.73 11.52 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.692 1.997 . . . . 0.0 114.737 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.6 m -117.05 15.55 15.06 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.932 1.293 . . . . 0.0 112.771 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.13 20.84 77.0 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 121.203 -0.936 . . . . 0.0 114.378 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -96.46 127.62 42.63 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.609 1.164 . . . . 0.0 109.485 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -69.05 125.92 28.19 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.633 -0.667 . . . . 0.0 110.639 174.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.2 t -141.78 138.32 32.19 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.851 1.26 . . . . 0.0 111.009 -172.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -57.67 137.19 56.7 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.142 0.977 . . . . 0.0 112.979 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 44.4 tp -111.03 -46.33 3.34 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.827 0.851 . . . . 0.0 111.723 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.47 -121.95 0.95 Allowed Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.351 0.501 . . . . 0.0 113.327 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -147.49 153.44 39.53 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.308 1.443 . . . . 0.0 110.482 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.8 tp -118.84 107.57 13.77 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.121 1.368 . . . . 0.0 111.005 -176.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.7 t -82.48 102.28 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.705 1.202 . . . . 0.0 108.327 173.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.07 103.25 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.769 1.628 . . . . 0.0 109.448 176.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -98.19 140.51 32.38 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.859 1.664 . . . . 0.0 110.965 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -99.68 90.79 4.59 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.06 1.344 . . . . 0.0 109.844 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -68.78 171.38 7.92 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 122.406 1.098 . . . . 0.0 113.278 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -62.17 -28.06 69.39 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.275 1.03 . . . . 0.0 113.224 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -137.19 40.32 2.48 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.941 1.696 . . . . 0.0 112.778 -171.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.85 -157.95 27.53 Favored Glycine 0 CA--C 1.534 1.225 0 N-CA-C 115.965 1.146 . . . . 0.0 115.965 175.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.439 HG13 HG22 ' A' ' 93' ' ' VAL . 35.5 mt -121.91 136.57 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.327 1.051 . . . . 0.0 109.304 173.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.04 117.19 19.64 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 126.413 1.885 . . . . 0.0 109.411 -175.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.2 p -106.24 149.78 26.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.012 0.925 . . . . 0.0 111.32 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.09 128.32 3.84 Favored Glycine 0 C--N 1.336 0.581 0 O-C-N 121.265 -0.897 . . . . 0.0 111.876 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.422 ' CD2' HG21 ' A' ' 48' ' ' ILE . 3.2 tm? -85.3 127.75 34.44 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 127.157 2.183 . . . . 0.0 110.623 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -122.79 86.88 2.65 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.761 1.624 . . . . 0.0 109.748 -174.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -97.49 122.5 40.62 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.328 1.051 . . . . 0.0 110.054 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 50.89 -94.2 0.01 OUTLIER Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.39 1.471 . . . . 0.0 114.479 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -125.89 15.85 6.95 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 126.002 1.763 . . . . 0.0 114.62 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.81 157.51 21.28 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.565 1.546 . . . . 0.0 110.857 171.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.3 p -146.05 136.66 24.16 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.385 0.674 . . . . 0.0 112.623 169.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -147.92 152.61 37.84 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.059 0.944 . . . . 0.0 112.385 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.9 m -55.39 122.86 12.12 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.876 0.87 . . . . 0.0 110.366 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -91.15 -49.91 6.13 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.78 0.432 . . . . 0.0 110.015 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -160.36 171.12 19.68 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.764 0.792 . . . . 0.0 113.093 171.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.3 136.97 12.25 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.397 -0.815 . . . . 0.0 112.764 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.484 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -132.03 155.31 48.26 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.464 1.906 . . . . 0.0 111.188 -174.373 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -79.44 168.04 20.01 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.384 0.674 . . . . 0.0 112.598 -171.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.457 ' HA ' HG23 ' A' ' 93' ' ' VAL . 2.7 tm-20 -57.63 -34.3 69.17 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.425 1.09 . . . . 0.0 112.328 176.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -63.2 -16.33 59.8 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.643 1.577 . . . . 0.0 114.023 171.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.4 t -111.18 -8.25 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.603 1.161 . . . . 0.0 111.087 -173.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.457 HG23 ' HA ' ' A' ' 90' ' ' GLU . 54.7 t -47.78 -64.62 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 125.726 1.611 . . . . 0.0 111.486 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -68.93 -28.22 66.46 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -49.71 75.36 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.536 1.534 . . . . 0.0 110.367 176.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -61.88 -42.42 99.05 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.107 1.363 . . . . 0.0 112.07 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.581 HG22 HD22 ' A' ' 170' ' ' LEU . 95.3 t -56.95 -37.18 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.615 0.766 . . . . 0.0 110.679 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -68.4 -54.01 20.03 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.427 1.091 . . . . 0.0 112.447 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 m -73.5 -8.79 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 O-C-N 120.834 -1.166 . . . . 0.0 113.093 -175.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.561 ' CG ' HD13 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -98.58 -3.2 36.83 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.855 1.262 . . . . 0.0 112.387 176.473 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.9 p -129.6 -13.82 4.21 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.474 1.11 . . . . 0.0 113.041 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -135.74 -11.15 2.07 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.342 1.857 . . . . 0.0 114.1 177.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.93 154.94 11.29 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.067 1.318 . . . . 0.0 114.034 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.64 -159.51 31.4 Favored Glycine 0 CA--C 1.532 1.155 0 O-C-N 121.756 -0.849 . . . . 0.0 114.201 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 88.1 p -153.94 100.39 2.35 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -170.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -131.93 142.94 49.79 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.866 1.667 . . . . 0.0 110.091 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.4 154.61 39.95 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 121.465 -0.772 . . . . 0.0 111.106 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.7 p -118.4 156.9 28.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.231 1.412 . . . . 0.0 111.011 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.484 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 8.4 t -67.93 -41.14 83.02 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.307 1.043 . . . . 0.0 111.314 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 mt -155.56 137.69 14.67 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.243 1.817 . . . . 0.0 111.152 -177.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -134.38 103.84 5.89 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.485 1.114 . . . . 0.0 110.275 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -90.27 -39.66 12.62 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.43 175.34 6.46 Favored Glycine 0 CA--C 1.543 1.807 0 C-N-CA 124.926 1.251 . . . . 0.0 114.508 -169.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -61.5 159.09 13.52 Favored 'General case' 0 CA--C 1.55 0.947 0 O-C-N 121.497 -1.002 . . . . 0.0 112.272 169.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.535 ' HA ' HG21 ' A' ' 120' ' ' VAL . 24.6 mmtp -52.65 166.77 0.17 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.385 1.874 . . . . 0.0 113.324 174.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 69.9 37.49 1.77 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.349 1.46 . . . . 0.0 112.167 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -147.06 144.43 29.09 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.848 1.259 . . . . 0.0 112.087 -169.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -68.42 -15.79 63.68 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -173.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.4 p -87.73 -18.43 29.48 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.535 HG21 ' HA ' ' A' ' 115' ' ' LYS . 11.8 t -67.15 -25.38 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-N 120.738 1.608 . . . . 0.0 111.644 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 74.9 mt -53.15 -47.22 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.816 1.647 . . . . 0.0 112.211 -176.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -147.68 -7.15 0.44 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 92.59 176.92 41.48 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.156 1.836 . . . . 0.0 113.007 -172.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.4 mt -127.02 105.42 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.023 1.329 . . . . 0.0 107.885 169.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -67.67 146.35 53.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.074 0.464 . . . . 0.0 111.095 172.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 57.45 24.69 10.51 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.355 1.462 . . . . 0.0 113.993 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -53.95 127.51 26.58 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.077 1.351 . . . . 0.0 111.039 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -76.9 127.71 33.21 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 122.064 -0.397 . . . . 0.0 110.252 169.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 33.3 mm -122.57 115.76 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.845 1.258 . . . . 0.0 108.334 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -112.08 100.69 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 125.264 1.426 . . . . 0.0 107.875 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.7 p -83.18 159.21 22.07 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.666 0.746 . . . . 0.0 111.775 176.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -152.07 138.66 18.7 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.67 1.188 . . . . 0.0 110.863 173.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.4 mt -80.07 132.27 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -139.91 123.0 16.79 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.31 1.444 . . . . 0.0 110.344 175.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -74.32 114.98 13.31 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 169.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 27.3 mt -101.67 98.07 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 58.87 15.03 3.6 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.695 1.998 . . . . 0.0 115.764 -176.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 124.3 -26.66 5.74 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.028 1.299 . . . . 0.0 114.07 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.0 m -77.8 128.61 34.27 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.587 1.155 . . . . 0.0 108.74 171.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -78.79 116.12 18.92 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.555 -0.715 . . . . 0.0 109.285 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -106.33 164.06 12.33 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.694 1.197 . . . . 0.0 110.485 171.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.1 tp -117.5 134.83 59.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 125.615 1.566 . . . . 0.0 107.615 169.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.1 p -124.09 155.75 37.82 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.356 0.662 . . . . 0.0 109.854 175.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -150.89 147.03 26.71 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.447 0.699 . . . . 0.0 112.179 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 55.2 p -76.24 108.17 8.98 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.059 1.344 . . . . 0.0 111.833 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.98 -160.38 17.87 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 123.999 0.809 . . . . 0.0 113.528 173.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -67.22 159.77 28.38 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.89 0.876 . . . . 0.0 112.836 171.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -78.21 106.25 9.99 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.838 1.255 . . . . 0.0 110.358 172.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -61.3 161.38 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.22 0.608 . . . . 0.0 112.326 174.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -92.26 -31.78 15.28 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -71.82 -37.66 70.29 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.7 t -80.87 169.34 17.68 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.401 0.68 . . . . 0.0 112.086 176.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -77.27 65.9 2.98 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.642 1.591 . . . . 0.0 114.106 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 55.37 36.63 27.49 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.14 1.776 . . . . 0.0 113.47 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -92.59 170.03 10.06 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.379 1.072 . . . . 0.0 109.393 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.3 m -104.56 148.23 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.824 0.85 . . . . 0.0 111.255 174.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.26 98.67 0.83 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.392 0.677 . . . . 0.0 110.227 170.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -91.94 144.45 25.45 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.346 1.069 . . . . 0.0 111.592 172.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -134.28 169.64 16.9 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 126.106 1.763 . . . . 0.0 110.962 -173.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.07 133.44 21.79 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.184 0.594 . . . . 0.0 109.991 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.434 ' CG2' HD11 ' A' ' 166' ' ' LEU . 62.0 mt -126.5 138.63 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 123.736 0.815 . . . . 0.0 108.822 175.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.9 m -64.55 98.2 0.24 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.863 0.865 . . . . 0.0 109.43 177.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.559 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.0 OUTLIER -53.83 -32.74 53.91 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.693 1.197 . . . . 0.0 111.634 177.829 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -68.32 -32.21 72.17 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -82.56 -27.74 31.4 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.335 -0.853 . . . . 0.0 112.836 173.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.561 HD13 ' CG ' ' A' ' 100' ' ' MET . 18.8 mt -62.59 -51.03 68.95 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.644 0.778 . . . . 0.0 110.912 172.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -48.75 -43.36 37.61 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.853 1.261 . . . . 0.0 113.24 176.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -64.28 -21.01 66.44 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.542 1.537 . . . . 0.0 114.32 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -119.77 -8.91 9.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.138 1.375 . . . . 0.0 113.918 -176.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.581 HD22 HG22 ' A' ' 97' ' ' VAL . 13.0 mt -87.21 -28.66 22.26 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.506 1.523 . . . . 0.0 112.231 -178.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.393 1.877 . . . . 0.0 113.231 176.48 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.9 tttm . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.7 mm -74.69 124.85 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 120.15 -1.594 . . . . 0.0 109.207 175.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -126.77 135.64 51.34 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.11 1.364 . . . . 0.0 109.532 174.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 67.3 p -136.64 164.08 29.05 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.483 1.513 . . . . 0.0 110.482 -176.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.1 t -148.48 154.2 39.51 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.394 1.077 . . . . 0.0 110.972 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -150.13 166.15 30.67 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.796 1.238 . . . . 0.0 111.604 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.5 143.76 51.09 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.397 1.479 . . . . 0.0 111.301 -173.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -151.01 167.94 26.12 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.87 1.268 . . . . 0.0 111.257 -173.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -58.69 149.87 24.97 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.276 1.03 . . . . 0.0 113.428 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.5 t -87.23 152.3 22.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.855 1.262 . . . . 0.0 111.642 174.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 65.4 m -139.73 174.16 10.79 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.106 1.763 . . . . 0.0 111.739 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.97 -162.37 3.66 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 124.806 1.193 . . . . 0.0 114.227 172.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 60.04 31.59 20.68 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.341 1.456 . . . . 0.0 113.376 -176.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.6 p -62.35 163.36 8.63 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.321 1.448 . . . . 0.0 113.632 174.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -134.85 163.49 29.7 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.321 1.849 . . . . 0.0 110.712 -171.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.8 t -121.79 58.46 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 125.056 1.342 . . . . 0.0 109.908 -174.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.78 172.03 13.61 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.872 2.069 . . . . 0.0 111.378 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -77.29 52.95 0.97 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.897 2.079 . . . . 0.0 113.24 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 mm -68.97 160.67 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.599 1.16 . . . . 0.0 110.998 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -57.1 -14.62 4.09 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.352 1.461 . . . . 0.0 114.812 174.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -107.44 -4.54 18.39 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 175.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.0 t -55.88 -33.62 64.75 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.213 1.405 . . . . 0.0 112.194 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -111.5 154.47 24.7 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.273 1.029 . . . . 0.0 110.556 168.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -147.39 165.86 28.93 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.297 1.439 . . . . 0.0 110.527 177.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -130.64 134.13 46.71 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.08 -0.387 . . . . 0.0 110.881 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.0 m -128.05 165.1 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.083 1.753 . . . . 0.0 109.979 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -68.55 163.39 23.66 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.56 0.744 . . . . 0.0 110.96 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.5 tp -147.01 136.12 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.078 0.951 . . . . 0.0 109.254 170.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -126.5 160.1 31.53 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.626 1.971 . . . . 0.0 109.105 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.4 161.56 35.48 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.905 0.882 . . . . 0.0 112.06 176.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.74 118.16 23.71 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.847 0.459 . . . . 0.0 110.209 173.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -72.06 178.85 3.56 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.403 0.621 . . . . 0.0 112.459 175.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -57.67 -26.37 61.57 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.87 1.668 . . . . 0.0 113.111 173.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.3 t -70.65 -17.69 62.86 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.799 1.64 . . . . 0.0 113.747 173.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.45 36.39 62.88 Favored Glycine 0 CA--C 1.534 1.233 0 O-C-N 121.072 -1.018 . . . . 0.0 113.287 -171.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -125.09 143.81 50.73 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.994 1.718 . . . . 0.0 109.85 175.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -67.64 132.83 48.25 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.814 0.846 . . . . 0.0 111.141 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 t -142.44 136.62 29.66 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.838 1.255 . . . . 0.0 110.509 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -56.98 133.14 54.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.04 0.936 . . . . 0.0 112.446 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.1 tp -111.36 -45.83 3.36 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.112 0.965 . . . . 0.0 111.212 -176.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.26 -137.89 4.02 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 122.067 0.815 . . . . 0.0 113.813 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -129.0 163.59 25.04 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.511 1.925 . . . . 0.0 110.608 173.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 16.2 tp -130.1 106.39 8.59 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.49 2.316 . . . . 0.0 110.256 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.0 t -80.31 99.44 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.659 1.184 . . . . 0.0 109.332 174.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.89 117.12 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.504 1.522 . . . . 0.0 109.587 173.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 -112.22 118.21 34.69 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.124 2.17 . . . . 0.0 110.726 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -74.19 95.89 2.68 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.542 1.137 . . . . 0.0 109.61 169.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -72.63 171.94 11.54 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.922 0.868 . . . . 0.0 111.831 171.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -60.9 -35.73 77.43 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.018 -1.051 . . . . 0.0 112.999 174.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -133.27 57.35 1.81 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.262 1.425 . . . . 0.0 111.26 -169.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 128.44 -163.82 21.84 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.431 1.491 . . . . 0.0 113.78 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.2 mt -126.22 138.84 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.899 0.879 . . . . 0.0 109.589 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -127.7 129.89 47.91 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.276 1.43 . . . . 0.0 109.036 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.9 p -121.55 137.63 54.65 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.502 -0.749 . . . . 0.0 110.207 -175.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.6 108.88 0.71 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -170.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 tt -64.04 142.24 58.48 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.771 0.828 . . . . 0.0 110.612 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -138.1 75.79 1.54 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.18 1.792 . . . . 0.0 109.313 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.88 171.32 4.49 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.12 0.968 . . . . 0.0 112.041 173.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.48 -22.66 32.21 Favored Glycine 0 CA--C 1.54 1.611 0 N-CA-C 116.203 1.241 . . . . 0.0 116.203 -174.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -153.55 23.97 0.74 Allowed Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.748 1.166 . . . . 0.0 114.73 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -153.96 135.56 14.34 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.472 1.109 . . . . 0.0 110.879 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -141.93 134.32 28.0 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.36 -0.838 . . . . 0.0 111.657 -174.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.89 160.86 34.1 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.107 1.363 . . . . 0.0 112.13 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 93.7 m -60.77 123.03 16.29 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 121.099 -1.0 . . . . 0.0 109.286 169.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -85.46 -51.4 6.56 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.442 0.697 . . . . 0.0 109.849 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -162.57 170.27 18.86 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.275 1.03 . . . . 0.0 112.744 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.99 144.01 23.01 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 122.536 1.16 . . . . 0.0 113.198 175.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.482 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -129.46 154.93 46.49 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.813 1.645 . . . . 0.0 111.845 -175.677 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -78.31 167.21 21.7 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.406 0.682 . . . . 0.0 112.263 -173.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -53.68 -35.67 61.32 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.017 0.927 . . . . 0.0 112.646 173.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -65.48 -8.49 19.57 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.617 1.167 . . . . 0.0 113.684 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.9 t -118.13 -4.63 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.591 1.156 . . . . 0.0 111.224 -173.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.6 t -50.87 -65.08 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 125.13 1.372 . . . . 0.0 111.334 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -68.51 -25.77 65.11 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.88 -50.92 69.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.327 1.451 . . . . 0.0 110.603 173.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -58.65 -43.79 89.91 Favored 'General case' 0 C--N 1.335 -0.064 0 C-N-CA 124.964 1.305 . . . . 0.0 111.608 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.541 HG22 HD22 ' A' ' 170' ' ' LEU . 73.3 t -56.44 -37.6 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.902 0.481 . . . . 0.0 110.867 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -66.01 -54.51 25.07 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.444 1.098 . . . . 0.0 112.513 176.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 m -74.81 -3.67 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 121.13 -0.981 . . . . 0.0 113.402 -175.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.475 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -103.67 -4.25 24.02 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.156 1.782 . . . . 0.0 112.008 179.128 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 43.8 p -131.84 -15.36 3.05 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.779 1.232 . . . . 0.0 113.541 174.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -131.5 -12.42 3.47 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.649 1.579 . . . . 0.0 113.847 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.34 156.14 12.45 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.678 1.132 . . . . 0.0 113.752 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.78 -159.26 31.62 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 121.742 -0.858 . . . . 0.0 113.471 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.486 ' HB3' HG23 ' A' ' 130' ' ' ILE . 31.6 p -154.21 96.82 1.98 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -131.22 143.68 50.76 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.97 1.708 . . . . 0.0 110.606 -176.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -74.08 162.74 28.69 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.831 0.852 . . . . 0.0 111.49 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.0 p -129.66 143.76 50.97 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.217 1.407 . . . . 0.0 111.365 -177.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.482 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 24.4 p -57.81 -37.03 73.04 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.321 1.448 . . . . 0.0 112.839 -178.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mt -156.4 145.58 20.5 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.07 2.148 . . . . 0.0 110.549 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -141.62 109.83 5.9 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.023 0.929 . . . . 0.0 110.246 176.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -95.59 -57.73 2.31 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.385 1.074 . . . . 0.0 112.463 175.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.46 -169.6 29.06 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.244 1.402 . . . . 0.0 113.796 -171.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -67.17 -75.08 0.1 Allowed 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.739 -0.859 . . . . 0.0 113.102 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.06 172.29 1.28 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 128.532 2.733 . . . . 0.0 108.879 -171.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 53.73 35.12 20.53 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.083 1.353 . . . . 0.0 113.853 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -131.89 156.89 45.32 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.266 1.826 . . . . 0.0 110.991 -169.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -80.55 -19.72 45.06 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 120.689 -1.257 . . . . 0.0 113.171 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 43.8 p -79.42 -39.22 32.93 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.361 1.065 . . . . 0.0 113.599 172.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.3 p -66.05 -14.86 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -170.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.12 -47.09 95.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.556 1.543 . . . . 0.0 112.063 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -136.94 -11.98 1.72 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.889 1.275 . . . . 0.0 114.16 -175.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.99 158.67 29.78 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.89 1.709 . . . . 0.0 113.105 -170.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 62.3 mt -119.77 113.14 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.076 1.35 . . . . 0.0 108.766 174.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -72.7 147.45 45.67 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.278 0.561 . . . . 0.0 111.565 172.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 57.12 22.44 7.47 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.034 1.734 . . . . 0.0 114.06 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -56.01 123.64 15.07 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.568 1.147 . . . . 0.0 110.534 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -71.07 127.91 34.17 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.87 0.868 . . . . 0.0 110.304 171.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 36.2 mm -123.93 117.67 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.351 1.06 . . . . 0.0 108.529 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.486 HG23 ' HB3' ' A' ' 105' ' ' SER . 3.9 mp -111.4 100.12 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.047 1.339 . . . . 0.0 107.746 -177.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.4 p -82.74 158.98 22.65 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.595 0.712 . . . . 0.0 111.674 175.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.2 ptpt -152.44 139.09 18.76 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.744 1.218 . . . . 0.0 111.069 175.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.5 mt -79.38 133.84 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -140.04 124.55 18.06 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.207 1.403 . . . . 0.0 110.622 173.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -74.62 115.72 14.49 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.809 -0.557 . . . . 0.0 109.747 169.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.0 mt -102.74 98.43 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 60.0 12.91 3.4 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.77 2.028 . . . . 0.0 115.78 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 128.78 -34.46 2.86 Favored Glycine 0 N--CA 1.473 1.122 0 C-N-CA 124.919 1.247 . . . . 0.0 113.445 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 88.6 m -72.01 127.63 33.16 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.371 1.068 . . . . 0.0 109.549 171.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -75.5 116.44 16.22 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.741 -0.599 . . . . 0.0 109.889 173.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -105.41 168.97 8.73 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.362 1.465 . . . . 0.0 110.389 170.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.6 tp -120.38 134.85 62.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 125.597 1.559 . . . . 0.0 107.342 169.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.2 p -119.88 160.04 23.46 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.19 0.596 . . . . 0.0 109.462 171.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -148.45 142.33 25.77 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.797 0.839 . . . . 0.0 110.795 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.5 p -74.08 116.14 14.37 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.525 0.679 . . . . 0.0 110.53 173.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.74 -166.14 40.95 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.72 0.676 . . . . 0.0 112.139 174.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.29 172.16 12.94 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 121.981 0.896 . . . . 0.0 111.234 168.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -76.57 132.0 39.25 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.508 1.123 . . . . 0.0 110.43 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.15 162.0 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.472 -0.767 . . . . 0.0 111.81 171.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -96.99 -24.94 15.57 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -69.26 -19.04 63.92 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.453 1.501 . . . . 0.0 113.625 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.02 61.31 1.58 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.491 1.916 . . . . 0.0 110.059 176.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 57.9 -91.11 0.03 OUTLIER Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.659 2.076 . . . . 0.0 115.473 171.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -146.93 25.41 1.15 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.928 2.091 . . . . 0.0 112.374 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -85.99 155.82 20.71 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.928 1.291 . . . . 0.0 108.893 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.6 m -89.2 140.2 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 122.713 0.405 . . . . 0.0 110.799 176.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -74.85 91.27 2.43 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.18 0.592 . . . . 0.0 110.517 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -77.93 151.44 33.72 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 122.32 1.057 . . . . 0.0 111.086 168.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -134.33 173.53 11.51 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.219 1.808 . . . . 0.0 110.884 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.91 138.09 24.06 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.659 0.663 . . . . 0.0 110.835 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 59.5 mt -128.8 141.53 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.05 0.94 . . . . 0.0 109.314 174.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.6 m -64.19 97.1 0.17 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.078 0.951 . . . . 0.0 109.764 175.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.519 ' HA ' HD12 ' A' ' 166' ' ' LEU . 0.8 OUTLIER -54.95 -30.95 60.03 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.582 1.153 . . . . 0.0 112.023 175.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -67.31 -25.82 66.22 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -93.53 -15.32 25.6 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.64 1.176 . . . . 0.0 113.153 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 163' ' ' LEU . 22.0 mt -73.87 -46.27 45.82 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.487 -0.758 . . . . 0.0 110.314 169.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -50.24 -45.12 53.76 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.704 1.202 . . . . 0.0 114.087 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -60.53 -29.19 68.97 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -176.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -98.34 -11.62 22.33 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.025 1.33 . . . . 0.0 112.905 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.541 HD22 HG22 ' A' ' 97' ' ' VAL . 17.1 mt -97.95 -24.4 15.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.132 1.373 . . . . 0.0 112.986 -174.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt . . . . . 0 C--O 1.253 1.272 0 C-N-CA 126.108 1.763 . . . . 0.0 113.17 169.503 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.3 tt -61.56 149.73 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.764 0.826 . . . . 0.0 111.56 170.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -144.94 150.96 37.9 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.218 1.407 . . . . 0.0 111.148 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.8 p -116.66 73.31 0.85 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.742 1.617 . . . . 0.0 110.348 -173.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.2 m 56.52 43.81 25.2 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.496 1.518 . . . . 0.0 113.308 -175.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -127.36 131.53 50.36 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.462 1.505 . . . . 0.0 111.156 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -81.75 113.24 19.59 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.361 1.064 . . . . 0.0 110.874 176.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.99 166.56 5.63 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 170.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -60.71 139.09 58.0 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.604 -0.685 . . . . 0.0 111.564 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.5 m -125.43 177.67 6.05 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.73 1.612 . . . . 0.0 111.494 -176.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.4 t -52.67 -50.63 62.86 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.925 0.89 . . . . 0.0 112.912 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 49.2 -135.69 22.12 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 124.879 1.228 . . . . 0.0 114.536 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.39 161.55 16.75 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.204 1.002 . . . . 0.0 112.649 170.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 62.6 p -58.87 168.34 1.3 Allowed 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.241 -0.912 . . . . 0.0 113.22 170.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -51.43 124.18 11.4 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.46 1.104 . . . . 0.0 111.889 169.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 m -126.69 44.16 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 127.008 2.123 . . . . 0.0 111.102 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -57.45 160.54 4.05 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.018 1.327 . . . . 0.0 113.042 175.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.47 153.41 43.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.553 1.141 . . . . 0.0 111.252 175.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.5 mm -71.54 156.77 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.769 1.228 . . . . 0.0 111.01 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -59.65 -12.99 7.89 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.267 1.427 . . . . 0.0 114.249 171.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -95.65 -4.12 44.95 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.289 1.436 . . . . 0.0 113.33 173.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.3 m -114.66 -28.51 7.1 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.697 1.999 . . . . 0.0 112.246 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -138.52 158.74 43.67 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.796 1.238 . . . . 0.0 110.84 168.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -141.21 168.32 20.06 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.68 1.192 . . . . 0.0 110.486 173.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -134.38 127.99 32.71 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.951 0.5 . . . . 0.0 110.081 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 m -126.08 158.16 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.233 1.413 . . . . 0.0 111.291 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -60.8 152.76 26.23 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.736 0.814 . . . . 0.0 111.35 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.1 tp -147.48 135.44 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.385 1.074 . . . . 0.0 109.585 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -127.68 158.72 36.81 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.465 1.906 . . . . 0.0 108.727 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -127.83 156.1 43.06 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.356 1.062 . . . . 0.0 111.106 175.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.23 119.85 22.89 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 170.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -67.66 176.33 2.5 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 122.01 0.91 . . . . 0.0 111.765 173.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -56.11 -16.13 4.67 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.91 2.084 . . . . 0.0 115.4 176.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -110.45 12.35 22.98 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.761 1.225 . . . . 0.0 113.349 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.65 20.9 79.37 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 120.973 -1.08 . . . . 0.0 114.515 176.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -102.27 144.07 31.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.529 1.132 . . . . 0.0 110.446 174.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -75.2 126.65 31.46 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.027 0.442 . . . . 0.0 110.418 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.9 t -131.57 135.18 46.8 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.317 1.447 . . . . 0.0 109.325 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -55.51 136.71 49.71 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.21 0.604 . . . . 0.0 111.816 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.3 tp -111.25 -46.38 3.31 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.799 0.84 . . . . 0.0 110.718 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.38 -111.37 0.44 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 123.103 0.382 . . . . 0.0 113.485 175.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -146.06 154.66 42.09 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.291 1.436 . . . . 0.0 110.261 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.8 tp -119.61 102.66 8.78 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.407 1.483 . . . . 0.0 109.899 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.9 t -75.46 98.12 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.07 1.348 . . . . 0.0 109.191 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.9 t -83.51 87.93 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.252 1.421 . . . . 0.0 110.062 175.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -82.9 125.71 31.67 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.823 1.249 . . . . 0.0 111.425 171.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -78.05 137.9 38.49 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.786 0.834 . . . . 0.0 109.932 167.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -135.36 171.52 14.32 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.602 1.561 . . . . 0.0 110.837 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -67.98 -33.88 75.49 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.602 -1.311 . . . . 0.0 113.025 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -89.94 22.47 3.17 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.171 1.388 . . . . 0.0 112.975 -177.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 109.36 -168.71 13.4 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.804 1.668 . . . . 0.0 113.034 -175.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.3 mt -88.9 141.0 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 121.601 -0.94 . . . . 0.0 108.899 177.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -131.26 89.7 2.76 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.061 1.344 . . . . 0.0 111.157 -174.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.6 p -83.71 152.63 24.62 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.531 -0.73 . . . . 0.0 112.778 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.76 128.22 3.4 Favored Glycine 0 CA--C 1.527 0.802 0 O-C-N 121.368 -0.833 . . . . 0.0 113.185 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.23 139.18 48.0 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.25 1.82 . . . . 0.0 110.125 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -136.9 87.11 2.26 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.917 1.687 . . . . 0.0 111.042 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.92 5.0 46.05 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.51 62.24 1.41 Allowed Glycine 0 CA--C 1.53 1.028 0 O-C-N 121.413 -0.804 . . . . 0.0 113.2 174.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.67 -4.92 22.84 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.28 1.419 . . . . 0.0 113.7 -174.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -141.71 64.83 1.39 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.371 1.468 . . . . 0.0 110.717 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.9 p -94.84 144.12 25.91 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.204 1.002 . . . . 0.0 112.955 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.98 160.78 25.09 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.336 1.454 . . . . 0.0 112.15 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.5 m -54.8 128.78 34.52 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.315 1.046 . . . . 0.0 110.766 171.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -96.98 -52.55 3.82 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.989 0.515 . . . . 0.0 110.376 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -164.16 154.29 14.7 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.891 0.876 . . . . 0.0 112.881 172.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.04 116.0 10.34 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 123.158 1.456 . . . . 0.0 113.343 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.94 171.61 9.46 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.967 1.307 . . . . 0.0 112.526 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -80.6 161.35 24.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.401 1.081 . . . . 0.0 112.266 176.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -55.6 -35.03 65.38 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.163 0.985 . . . . 0.0 113.055 172.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -68.07 -17.89 64.51 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 175.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.9 t -100.81 -10.58 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.831 0.852 . . . . 0.0 111.577 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 97' ' ' VAL . 75.9 t -47.08 -51.37 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.549 1.14 . . . . 0.0 111.577 176.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -73.24 -29.07 62.51 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 177.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -76.68 -39.42 52.14 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.138 -0.976 . . . . 0.0 111.981 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -57.18 -46.06 83.17 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 124.804 1.242 . . . . 0.0 110.815 173.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.66 HG22 HD22 ' A' ' 170' ' ' LEU . 72.4 t -52.61 -42.94 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.498 1.119 . . . . 0.0 110.728 175.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -66.81 -55.01 16.77 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.507 1.523 . . . . 0.0 113.002 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 m -72.83 -5.95 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 O-C-N 121.424 -0.797 . . . . 0.0 112.983 -176.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.44 ' CG ' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -98.42 -5.77 31.9 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.727 1.611 . . . . 0.0 112.155 178.425 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.403 ' HB ' ' HE2' ' A' ' 167' ' ' LYS . 32.0 p -127.55 -13.16 5.45 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.934 0.894 . . . . 0.0 112.695 176.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -132.72 -11.21 3.08 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.656 1.582 . . . . 0.0 114.392 177.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.6 156.81 9.79 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.098 1.333 . . . . 0.0 113.821 -174.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.88 -153.93 24.95 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 121.655 -0.909 . . . . 0.0 113.106 -175.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.6 p -145.83 153.23 40.67 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.177 0.991 . . . . 0.0 112.936 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -148.73 179.55 7.75 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.317 1.847 . . . . 0.0 111.769 173.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -114.97 151.92 33.3 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.733 1.213 . . . . 0.0 110.025 168.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 62.4 p -117.28 133.58 55.81 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.766 0.827 . . . . 0.0 111.271 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.1 t -51.0 -37.85 47.62 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.308 1.043 . . . . 0.0 112.557 175.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.7 mt -146.48 147.23 30.98 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.029 1.731 . . . . 0.0 111.719 173.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -136.85 115.37 11.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 170.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -96.57 -49.01 5.3 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.8 0.84 . . . . 0.0 112.543 174.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.45 172.11 34.31 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 125.718 1.628 . . . . 0.0 113.423 -169.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -58.21 165.82 1.84 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.131 0.972 . . . . 0.0 112.486 169.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -56.35 -30.34 62.51 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 120.728 -1.232 . . . . 0.0 114.152 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.67 58.25 1.06 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.707 1.203 . . . . 0.0 112.031 173.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.55 ' HG3' ' H ' ' A' ' 119' ' ' SER . 6.3 tp10 -148.67 149.03 30.77 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.893 1.277 . . . . 0.0 111.382 -175.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -74.95 -22.16 58.75 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.356 -0.84 . . . . 0.0 112.98 172.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.55 ' H ' ' HG3' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -83.44 -41.77 17.7 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.815 1.646 . . . . 0.0 114.174 -177.104 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.6 p -50.38 -25.32 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 126.274 1.83 . . . . 0.0 115.689 -169.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 53.0 mt -59.46 -35.8 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 126.221 1.808 . . . . 0.0 112.306 175.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -135.74 -38.82 0.72 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.471 1.508 . . . . 0.0 113.83 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.28 166.35 29.98 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 127.162 2.315 . . . . 0.0 113.513 -175.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.2 mt -122.51 119.23 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.636 1.574 . . . . 0.0 108.828 176.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -80.66 148.58 30.15 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 54.46 25.71 6.4 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.362 1.865 . . . . 0.0 113.979 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -63.08 126.57 27.8 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.283 1.433 . . . . 0.0 111.239 -172.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -78.95 130.42 35.56 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.013 0.525 . . . . 0.0 111.461 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.7 mm -126.87 120.36 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 125.862 1.665 . . . . 0.0 109.215 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.95 105.17 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.266 1.427 . . . . 0.0 108.71 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.7 p -78.69 159.88 27.77 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.725 0.774 . . . . 0.0 112.198 174.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -150.55 140.88 22.32 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.983 1.313 . . . . 0.0 110.523 171.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.4 mt -81.92 132.72 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -140.06 121.56 15.14 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.06 1.344 . . . . 0.0 110.563 174.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -72.1 120.01 17.1 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.738 -0.602 . . . . 0.0 109.742 169.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 24.3 mt -106.79 97.19 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 175.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 60.86 12.22 3.7 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.774 2.03 . . . . 0.0 115.816 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 130.22 -34.98 2.6 Favored Glycine 0 N--CA 1.473 1.106 0 C-N-CA 125.071 1.32 . . . . 0.0 113.316 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 73.0 m -71.81 125.26 26.7 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.382 1.073 . . . . 0.0 109.47 171.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -74.97 119.23 18.87 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.72 -0.613 . . . . 0.0 109.56 173.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -108.39 168.54 9.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.332 1.453 . . . . 0.0 110.227 171.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 tp -120.09 136.2 57.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 125.363 1.465 . . . . 0.0 108.25 170.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 p -123.25 155.64 36.77 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.337 0.655 . . . . 0.0 110.026 172.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -148.56 137.09 21.35 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.174 0.99 . . . . 0.0 111.024 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.7 p -70.52 115.55 9.82 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.168 0.987 . . . . 0.0 111.642 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.13 -163.23 38.65 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.739 1.162 . . . . 0.0 112.949 174.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -68.63 169.41 11.16 Favored 'General case' 0 CA--C 1.553 1.077 0 O-C-N 121.663 -0.904 . . . . 0.0 112.125 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -85.82 114.56 22.85 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.144 1.377 . . . . 0.0 111.265 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.29 162.36 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.617 0.767 . . . . 0.0 111.687 174.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.7 tptt -101.85 -13.43 17.67 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 171.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -78.06 6.59 7.6 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.696 1.598 . . . . 0.0 113.799 176.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.78 171.08 14.54 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.03 1.332 . . . . 0.0 111.97 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -80.29 74.77 2.29 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.472 1.51 . . . . 0.0 113.698 -176.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . 0.253 4.1 p30 48.1 41.22 15.08 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.289 1.836 . . . . 0.0 115.109 -175.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -92.16 175.65 6.78 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.022 0.929 . . . . 0.0 110.004 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.8 m -111.33 146.52 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.17 0.988 . . . . 0.0 109.833 173.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.16 93.94 0.64 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 169.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -90.55 147.8 23.11 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 122.272 1.034 . . . . 0.0 111.085 169.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -134.45 171.1 14.77 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.817 1.647 . . . . 0.0 110.932 -172.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.59 134.02 23.21 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.584 0.629 . . . . 0.0 110.5 177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.476 ' CG2' HD11 ' A' ' 166' ' ' LEU . 61.6 mt -127.13 140.59 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.187 0.995 . . . . 0.0 108.914 175.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.0 m -65.33 95.89 0.21 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.228 1.011 . . . . 0.0 109.914 177.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.553 HD21 ' HE3' ' A' ' 167' ' ' LYS . 1.2 tt -53.42 -33.5 54.22 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.18 0.992 . . . . 0.0 111.377 175.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -67.91 -28.87 67.86 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -79.06 -36.31 41.15 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.657 0.662 . . . . 0.0 111.807 169.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.476 HD11 ' CG2' ' A' ' 161' ' ' ILE . 16.1 mt -59.88 -37.32 79.04 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.554 -0.716 . . . . 0.0 111.794 176.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.553 ' HE3' HD21 ' A' ' 163' ' ' LEU . 73.6 mttt -62.14 -6.97 3.42 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 172.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -98.43 -15.31 19.7 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.985 1.314 . . . . 0.0 114.104 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -122.59 1.94 9.52 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.781 1.632 . . . . 0.0 113.408 -178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.66 HD22 HG22 ' A' ' 97' ' ' VAL . 53.0 mt -103.57 -17.86 15.0 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.146 0.978 . . . . 0.0 113.14 176.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm . . . . . 0 C--O 1.253 1.245 0 C-N-CA 125.858 1.663 . . . . 0.0 112.769 169.509 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.3 mm 46.43 73.26 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 126.851 2.06 . . . . 0.0 112.617 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -126.1 57.59 1.38 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.013 1.325 . . . . 0.0 111.627 -174.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.5 m -132.22 143.23 49.79 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.355 1.862 . . . . 0.0 109.223 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.8 m 54.42 32.87 17.44 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.018 1.327 . . . . 0.0 114.0 -173.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -63.63 166.65 6.64 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.548 1.139 . . . . 0.0 112.799 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -146.37 150.83 36.43 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.86 1.264 . . . . 0.0 111.477 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -66.51 143.94 56.76 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.899 0.88 . . . . 0.0 112.46 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -65.89 148.42 51.82 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.49 0.716 . . . . 0.0 111.951 171.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.9 m -63.87 132.91 52.27 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.493 1.117 . . . . 0.0 112.005 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 m -66.45 161.83 21.9 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.249 1.02 . . . . 0.0 112.137 170.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.75 -75.63 0.74 Allowed Glycine 0 CA--C 1.534 1.278 0 O-C-N 121.712 -0.618 . . . . 0.0 112.558 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -161.35 142.57 11.42 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.463 1.505 . . . . 0.0 111.633 173.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -163.61 170.36 17.27 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.387 1.475 . . . . 0.0 111.658 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -69.29 96.49 0.86 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.036 1.734 . . . . 0.0 111.081 172.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.2 m -99.6 42.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 126.125 1.77 . . . . 0.0 112.116 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -63.03 169.37 3.39 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.496 1.518 . . . . 0.0 112.237 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -139.1 155.23 48.06 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.917 1.687 . . . . 0.0 111.069 -173.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.5 mp -122.66 156.5 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.016 1.726 . . . . 0.0 109.493 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -60.1 -14.59 17.61 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -79.77 -8.62 59.36 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.532 1.133 . . . . 0.0 113.831 172.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.4 t -88.85 11.23 18.5 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.298 1.839 . . . . 0.0 112.899 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -143.69 165.87 26.44 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.764 1.626 . . . . 0.0 111.639 174.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -147.87 168.96 20.87 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.309 1.444 . . . . 0.0 110.72 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 m -136.55 134.82 37.91 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.91 0.484 . . . . 0.0 111.127 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.0 m -131.51 161.7 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.218 1.407 . . . . 0.0 112.304 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.34 153.15 23.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.742 1.217 . . . . 0.0 111.899 174.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.1 tp -152.94 136.79 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.442 1.497 . . . . 0.0 109.358 177.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -130.56 160.09 35.19 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.191 1.796 . . . . 0.0 109.759 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -132.93 158.76 41.82 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.845 1.258 . . . . 0.0 112.462 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 120.31 25.75 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.002 0.521 . . . . 0.0 110.76 173.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -72.63 179.71 3.45 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.401 0.68 . . . . 0.0 112.642 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -55.65 -29.35 59.13 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.734 1.614 . . . . 0.0 113.284 173.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.5 t -82.84 -6.8 59.6 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.127 1.371 . . . . 0.0 113.244 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.02 34.73 51.82 Favored Glycine 0 CA--C 1.533 1.219 0 O-C-N 120.855 -1.153 . . . . 0.0 114.058 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.05 145.39 45.93 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.362 1.465 . . . . 0.0 111.002 176.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -72.38 123.55 23.29 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.743 0.817 . . . . 0.0 111.181 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.0 t -139.2 141.76 37.91 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.208 1.403 . . . . 0.0 110.547 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -56.1 141.39 40.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.866 0.866 . . . . 0.0 113.054 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 tp -117.52 -47.87 2.62 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.741 0.816 . . . . 0.0 111.694 -178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.58 -117.6 0.71 Allowed Glycine 0 CA--C 1.529 0.906 0 CA-C-O 121.254 0.363 . . . . 0.0 113.663 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -145.08 156.04 43.68 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.518 1.527 . . . . 0.0 109.643 -177.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.2 tp -121.16 100.44 7.06 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.983 1.313 . . . . 0.0 110.065 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 t -76.0 96.3 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.161 1.384 . . . . 0.0 109.096 175.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.6 t -85.38 105.54 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.31 1.444 . . . . 0.0 110.031 173.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 63.3 mtt-85 -91.12 121.16 32.67 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.482 1.913 . . . . 0.0 110.158 172.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -83.89 91.27 7.53 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.52 0.728 . . . . 0.0 109.288 170.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -71.05 171.9 10.06 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.82 1.248 . . . . 0.0 112.776 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -63.87 -32.87 74.54 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.444 1.098 . . . . 0.0 113.734 176.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -125.58 86.91 2.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.413 1.485 . . . . 0.0 109.787 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.57 -157.95 24.07 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.878 0.751 . . . . 0.0 114.375 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.3 mt -122.96 145.25 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.427 1.091 . . . . 0.0 110.065 176.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -134.54 132.83 39.62 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.548 1.539 . . . . 0.0 109.763 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.6 p -126.33 147.37 49.74 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.929 -1.107 . . . . 0.0 111.883 -171.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.29 120.77 1.75 Allowed Glycine 0 CA--C 1.527 0.791 0 O-C-N 121.818 -0.551 . . . . 0.0 112.977 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.41 141.23 57.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.961 1.704 . . . . 0.0 110.036 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.93 60.81 1.69 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.373 1.869 . . . . 0.0 111.034 -169.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.37 66.44 3.93 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.128 1.371 . . . . 0.0 113.768 -174.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.68 -58.51 4.48 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.615 1.578 . . . . 0.0 114.15 172.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.46 24.27 0.58 Allowed Glycine 0 CA--C 1.536 1.393 0 C-N-CA 126.499 2.0 . . . . 0.0 113.383 177.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -135.72 44.48 2.5 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.764 1.625 . . . . 0.0 110.806 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.3 p -66.21 141.77 57.94 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.35 152.88 26.47 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.154 1.382 . . . . 0.0 112.482 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.6 m -54.95 123.57 13.94 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.167 -0.958 . . . . 0.0 110.245 171.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -90.91 -51.84 5.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.599 0.76 . . . . 0.0 110.2 -177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -164.33 161.09 21.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.848 0.859 . . . . 0.0 112.613 172.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.14 153.7 43.15 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.998 1.319 . . . . 0.0 111.965 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.516 ' HA ' ' H ' ' A' ' 109' ' ' SER . 1.7 pp -140.77 154.78 46.42 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.411 1.485 . . . . 0.0 111.188 -175.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -78.52 166.96 21.97 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.602 0.715 . . . . 0.0 112.208 -172.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -59.57 -21.7 60.7 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 121.388 -0.82 . . . . 0.0 112.543 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -72.92 -12.98 61.16 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 121.045 -1.034 . . . . 0.0 113.583 173.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.7 t -112.13 -2.07 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 120.901 -1.124 . . . . 0.0 110.852 -171.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.0 m -60.96 -26.07 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -97.87 -25.57 14.97 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.693 0.679 . . . . 0.0 111.863 170.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -70.25 -53.7 15.84 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.583 1.553 . . . . 0.0 111.166 -178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -58.05 -44.58 87.5 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.571 1.148 . . . . 0.0 111.236 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.501 HG22 HD22 ' A' ' 170' ' ' LEU . 74.1 t -57.16 -36.86 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.957 0.903 . . . . 0.0 111.022 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -62.54 -57.5 10.93 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.464 1.105 . . . . 0.0 111.997 173.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -70.06 -17.16 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 O-C-N 121.331 -0.855 . . . . 0.0 112.573 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.483 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -87.2 -6.91 58.43 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.27 1.828 . . . . 0.0 111.91 177.637 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 46.2 p -128.1 -10.49 5.34 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 173.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -134.88 -9.96 2.34 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.578 1.551 . . . . 0.0 113.954 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.51 155.76 6.4 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.722 1.629 . . . . 0.0 113.824 -174.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.1 -170.8 33.3 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.267 0.937 . . . . 0.0 114.096 -175.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.8 p -143.95 103.32 4.02 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.729 1.211 . . . . 0.0 113.493 -168.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -132.86 162.02 32.65 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.423 1.889 . . . . 0.0 110.398 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.58 160.26 17.51 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.644 0.735 . . . . 0.0 111.387 177.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.9 p -126.57 153.8 44.75 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.279 1.831 . . . . 0.0 110.113 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.516 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 76.9 p -68.9 -39.74 79.55 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.527 -0.733 . . . . 0.0 111.283 -175.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.8 mt -151.61 143.27 23.64 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.904 2.082 . . . . 0.0 111.451 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.41 ' CD2' HD11 ' A' ' 129' ' ' ILE . 39.7 t80 -136.64 101.81 4.73 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.268 1.027 . . . . 0.0 109.299 174.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -87.52 -51.94 5.63 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.68 0.792 . . . . 0.0 111.764 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.44 178.34 49.54 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 124.526 1.06 . . . . 0.0 114.379 -173.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -61.98 155.14 24.54 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.408 1.083 . . . . 0.0 111.561 170.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -58.44 -26.65 63.56 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.945 1.298 . . . . 0.0 114.0 -176.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -78.65 -12.06 60.0 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 174.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -72.14 174.76 6.7 Favored 'General case' 0 CA--C 1.552 1.044 0 O-C-N 120.711 -1.243 . . . . 0.0 112.483 170.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.44 -26.6 14.4 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -167.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.9 m -102.86 -1.26 29.95 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.355 1.062 . . . . 0.0 113.058 -177.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.7 p -54.81 -24.41 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 126.524 1.929 . . . . 0.0 115.543 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.419 HD12 ' H ' ' A' ' 121' ' ' ILE . 4.8 mp -69.07 -39.92 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.259 1.023 . . . . 0.0 112.134 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -123.45 -18.75 6.1 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.647 1.179 . . . . 0.0 113.661 -173.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.0 173.48 38.56 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.439 1.495 . . . . 0.0 113.702 -171.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 36.7 mt -127.89 108.4 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.901 1.68 . . . . 0.0 107.846 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -69.21 147.64 51.0 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.176 0.512 . . . . 0.0 111.185 173.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 57.83 22.05 8.18 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.38 1.472 . . . . 0.0 114.162 178.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -56.79 123.9 16.61 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.939 1.296 . . . . 0.0 111.585 -176.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -72.01 128.97 37.39 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.545 1.138 . . . . 0.0 110.768 170.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.41 HD11 ' CD2' ' A' ' 111' ' ' TYR . 38.2 mm -122.94 115.78 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.734 1.214 . . . . 0.0 109.293 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.89 90.02 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.158 1.383 . . . . 0.0 108.671 -174.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.8 p -75.74 154.2 36.53 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.394 175.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -151.54 140.97 21.54 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.215 1.406 . . . . 0.0 111.099 174.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.35 133.97 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.053 0.541 . . . . 0.0 109.754 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -139.13 122.42 17.06 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.303 1.441 . . . . 0.0 111.107 175.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -72.57 105.26 4.15 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.693 1.197 . . . . 0.0 110.357 170.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 25.6 mt -95.18 99.11 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 174.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 57.0 19.53 4.69 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.583 1.953 . . . . 0.0 115.696 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.03 -22.35 9.82 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.555 1.074 . . . . 0.0 114.291 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 89.6 m -82.9 128.09 34.12 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 117.942 0.871 . . . . 0.0 109.016 170.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.74 117.85 17.03 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.629 -0.669 . . . . 0.0 109.525 172.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -107.18 168.17 9.4 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.319 1.447 . . . . 0.0 110.133 169.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.2 tp -119.04 135.03 60.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.227 1.411 . . . . 0.0 108.56 170.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.0 p -124.03 153.59 41.12 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.835 0.854 . . . . 0.0 109.955 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -151.01 145.67 25.69 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.065 0.946 . . . . 0.0 111.833 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.6 m -82.57 117.9 22.88 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.499 1.12 . . . . 0.0 111.084 176.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.86 -151.87 24.56 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.88 1.705 . . . . 0.0 113.143 177.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -72.2 173.49 8.51 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 170.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -92.4 102.29 14.76 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.084 0.954 . . . . 0.0 111.923 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -61.61 156.43 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.032 0.933 . . . . 0.0 113.064 -178.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 150' ' ' LYS . 0.4 OUTLIER -91.12 -27.4 18.58 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.754 0.821 . . . . 0.0 112.491 177.275 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -64.27 -47.81 78.11 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.903 1.281 . . . . 0.0 113.083 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.82 -36.18 37.27 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -176.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 142.19 -74.79 0.33 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.852 1.215 . . . . 0.0 113.111 171.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -146.07 20.16 1.42 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.654 1.982 . . . . 0.0 112.46 177.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -77.87 178.59 7.3 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.035 0.934 . . . . 0.0 108.885 174.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 19.5 m -110.89 142.33 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.291 0.637 . . . . 0.0 110.78 173.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.74 124.29 19.98 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 170.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -126.23 144.33 50.82 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 122.243 1.02 . . . . 0.0 111.222 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -137.91 172.14 13.37 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.493 1.517 . . . . 0.0 111.878 -168.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.68 131.48 18.01 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.507 0.723 . . . . 0.0 110.057 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 70.5 mt -124.19 139.93 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 123.959 0.904 . . . . 0.0 108.796 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.8 m -63.86 96.86 0.14 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.11 0.964 . . . . 0.0 109.601 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.43 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.1 tt -55.76 -33.0 63.91 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.072 0.949 . . . . 0.0 111.778 176.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -66.95 -27.67 67.65 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 176.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -87.06 -31.39 20.53 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.892 0.877 . . . . 0.0 112.113 174.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.483 HD13 ' HG3' ' A' ' 100' ' ' MET . 19.4 mt -60.76 -44.1 97.17 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.77 0.828 . . . . 0.0 111.233 172.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -51.71 -32.7 31.3 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.547 -1.346 . . . . 0.0 113.639 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -68.22 -18.48 64.58 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -126.66 0.25 6.79 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.769 1.628 . . . . 0.0 114.134 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.501 HD22 HG22 ' A' ' 97' ' ' VAL . 29.1 mt -102.78 -21.49 14.05 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.697 1.599 . . . . 0.0 112.444 176.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm . . . . . 0 C--O 1.255 1.382 0 C-N-CA 127.033 2.133 . . . . 0.0 112.092 173.39 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.3 pttt . . . . . 0 N--CA 1.496 1.843 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.74 7.93 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 121.094 1.77 . . . . 0.0 114.52 -173.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -64.78 158.42 24.97 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.387 -0.821 . . . . 0.0 112.564 174.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 t -150.54 143.84 24.94 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.869 1.267 . . . . 0.0 110.875 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.2 m -148.01 110.5 4.68 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.385 1.474 . . . . 0.0 110.136 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -64.15 137.68 58.08 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.255 0.55 . . . . 0.0 111.759 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -68.97 169.97 10.68 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.297 1.039 . . . . 0.0 112.711 171.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -130.23 146.44 51.85 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.897 1.279 . . . . 0.0 110.711 178.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -117.87 152.64 34.99 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.185 1.394 . . . . 0.0 110.902 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.5 p -149.53 133.73 17.29 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.773 1.229 . . . . 0.0 111.119 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.1 p -79.83 166.18 21.97 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.58 1.152 . . . . 0.0 111.962 172.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -120.37 162.09 14.44 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.895 1.236 . . . . 0.0 112.624 175.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.92 151.46 31.7 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.75 0.82 . . . . 0.0 112.767 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.5 t -159.96 148.73 17.4 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.906 1.283 . . . . 0.0 111.343 173.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -78.7 99.2 6.53 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.39 1.476 . . . . 0.0 110.09 174.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.6 t -125.88 68.89 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 125.785 1.634 . . . . 0.0 109.585 -176.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -69.47 157.12 37.74 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.071 0.948 . . . . 0.0 111.898 172.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm -149.73 156.7 42.3 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.575 1.95 . . . . 0.0 111.045 175.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.0 mm -67.84 155.79 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.449 1.5 . . . . 0.0 110.523 177.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -61.98 -6.01 2.57 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 173.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -96.96 -1.12 46.3 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.602 1.561 . . . . 0.0 113.554 171.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.0 t -130.83 0.13 4.29 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.853 2.061 . . . . 0.0 113.15 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -149.7 153.84 37.59 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.122 1.769 . . . . 0.0 109.534 169.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -145.96 166.21 26.69 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.112 0.965 . . . . 0.0 111.15 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 m -132.62 126.48 32.8 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.8 0.44 . . . . 0.0 110.628 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.2 m -121.91 169.12 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.839 1.656 . . . . 0.0 110.697 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -67.81 169.2 10.11 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.855 0.862 . . . . 0.0 111.622 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 tp -159.27 137.56 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.936 1.294 . . . . 0.0 109.862 171.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -129.57 158.82 38.22 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.377 2.271 . . . . 0.0 108.942 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -131.39 159.8 36.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.388 1.075 . . . . 0.0 111.766 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -88.08 119.51 28.52 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.15 0.58 . . . . 0.0 110.727 172.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -72.89 179.77 3.54 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.445 0.64 . . . . 0.0 112.191 173.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -57.55 -21.58 39.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.977 1.711 . . . . 0.0 114.428 176.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.0 m -91.56 2.38 56.49 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.045 0.938 . . . . 0.0 113.258 177.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.3 31.26 71.5 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.563 1.077 . . . . 0.0 113.8 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -109.93 140.19 44.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.992 1.317 . . . . 0.0 110.822 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -74.57 121.23 21.24 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.869 0.868 . . . . 0.0 110.77 175.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.6 t -137.42 138.62 40.02 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.915 1.286 . . . . 0.0 110.5 -176.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -58.33 143.48 44.74 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -174.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.2 tp -118.81 -46.42 2.55 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.137 0.975 . . . . 0.0 111.542 -177.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 171.87 -129.5 1.76 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-O 121.457 0.476 . . . . 0.0 113.655 -175.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -141.39 158.9 43.26 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.039 1.736 . . . . 0.0 109.461 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.4 tp -126.22 103.24 7.57 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.884 1.274 . . . . 0.0 110.497 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.1 t -76.56 96.23 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.408 1.083 . . . . 0.0 109.012 175.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.4 t -83.86 113.11 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.586 1.555 . . . . 0.0 109.697 173.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -103.65 123.05 46.27 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.438 1.895 . . . . 0.0 110.175 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -82.15 84.5 7.02 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.553 1.141 . . . . 0.0 109.626 172.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -66.13 166.95 10.85 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.282 1.039 . . . . 0.0 111.961 173.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -72.81 -23.39 60.78 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.137 -0.977 . . . . 0.0 113.306 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -131.46 42.62 3.17 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.812 1.645 . . . . 0.0 112.903 -173.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.08 -157.73 25.55 Favored Glycine 0 N--CA 1.475 1.276 0 C-N-CA 125.667 1.603 . . . . 0.0 114.761 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.3 mt -125.08 142.06 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.237 1.015 . . . . 0.0 109.315 171.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -133.98 134.87 43.02 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.174 1.39 . . . . 0.0 108.729 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.2 p -132.72 143.21 49.46 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.676 0.79 . . . . 0.0 111.268 -173.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.66 122.77 2.69 Favored Glycine 0 C--N 1.336 0.541 0 O-C-N 121.921 -0.487 . . . . 0.0 112.695 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -66.44 126.09 27.74 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.887 1.675 . . . . 0.0 109.124 173.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -129.88 91.36 3.12 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.864 1.666 . . . . 0.0 109.187 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.14 1.27 48.67 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 104.9 -48.99 0.93 Allowed Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.706 1.622 . . . . 0.0 112.982 172.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.59 -13.8 66.85 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.399 1.0 . . . . 0.0 113.621 171.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.52 153.73 40.73 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.781 2.032 . . . . 0.0 111.557 177.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 52.3 p -147.56 124.06 11.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.529 1.131 . . . . 0.0 111.8 174.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -150.0 161.44 42.31 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.823 0.849 . . . . 0.0 112.453 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.3 m -59.57 131.24 50.33 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.209 -0.932 . . . . 0.0 110.811 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -98.97 -53.63 3.21 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.168 0.987 . . . . 0.0 109.516 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -161.03 159.09 28.91 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.967 0.907 . . . . 0.0 112.557 170.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.14 149.78 33.68 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 123.052 1.406 . . . . 0.0 112.303 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.434 ' HA ' ' H ' ' A' ' 109' ' ' SER . 2.1 pp -142.92 152.82 42.45 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.695 1.598 . . . . 0.0 110.819 -172.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -79.43 167.81 20.32 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.476 0.711 . . . . 0.0 112.146 -170.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -52.63 -35.84 55.38 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.291 -0.881 . . . . 0.0 112.654 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.2 -8.08 22.11 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.869 1.268 . . . . 0.0 114.179 175.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 t -116.5 -5.45 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.239 1.016 . . . . 0.0 111.41 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.1 t -53.58 -61.72 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 120.476 1.489 . . . . 0.0 111.651 -177.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -69.57 -24.81 63.75 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.82 -52.42 56.85 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.695 1.598 . . . . 0.0 110.706 172.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -59.86 -44.88 93.91 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 125.222 1.409 . . . . 0.0 110.62 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.2 -36.39 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.82 0.848 . . . . 0.0 111.206 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -54.99 29.45 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.075 0.95 . . . . 0.0 111.716 173.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 m -76.0 -2.62 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -176.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.637 ' SD ' HD13 ' A' ' 166' ' ' LEU . 40.7 tpp -108.62 -4.22 17.3 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.426 1.49 . . . . 0.0 112.47 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 43.2 p -125.42 -11.75 6.82 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.184 0.994 . . . . 0.0 112.573 171.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -135.25 -12.4 2.13 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.3 156.58 19.15 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 124.697 1.142 . . . . 0.0 113.865 -175.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.05 -160.35 31.54 Favored Glycine 0 CA--C 1.533 1.193 0 O-C-N 121.665 -0.903 . . . . 0.0 113.894 -175.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 85.0 p -150.72 104.49 3.19 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -171.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -135.04 153.3 52.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.066 1.746 . . . . 0.0 110.369 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -80.72 159.58 25.2 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.546 -0.721 . . . . 0.0 111.145 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.2 p -124.93 149.1 47.96 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.9 1.68 . . . . 0.0 110.595 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.434 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 8.1 t -62.59 -44.33 96.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.824 0.85 . . . . 0.0 111.336 -177.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mt -149.61 143.13 25.34 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.459 1.504 . . . . 0.0 111.845 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -140.87 106.08 5.02 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.891 0.876 . . . . 0.0 110.735 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -90.64 -40.26 12.0 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.054 0.942 . . . . 0.0 113.104 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.92 -178.11 40.73 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 124.658 1.123 . . . . 0.0 113.877 -170.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -57.77 147.65 27.4 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.694 -0.886 . . . . 0.0 112.511 172.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -53.79 158.86 1.82 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.119 1.768 . . . . 0.0 112.634 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 65.6 52.64 1.31 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.265 1.426 . . . . 0.0 112.334 -175.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -148.92 156.5 42.38 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.034 1.334 . . . . 0.0 112.211 -172.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -66.07 -29.01 69.27 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -170.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 27.8 t -74.6 -41.18 60.92 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.082 0.855 . . . . 0.0 112.966 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 78.5 t -48.58 -29.87 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 126.102 1.761 . . . . 0.0 113.809 -171.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 41.0 mm -43.22 -46.62 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 126.853 2.061 . . . . 0.0 113.389 170.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -147.41 -16.83 0.38 Allowed 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -176.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.02 163.01 38.84 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 126.044 1.783 . . . . 0.0 113.341 -171.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 95.3 mt -116.2 109.49 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.17 1.388 . . . . 0.0 109.318 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -69.36 146.71 51.91 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.128 0.971 . . . . 0.0 112.146 172.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 54.68 24.47 5.57 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.283 1.833 . . . . 0.0 114.586 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -55.58 123.07 12.8 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.292 1.437 . . . . 0.0 111.696 -178.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -72.37 128.45 35.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.058 0.943 . . . . 0.0 110.618 170.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.5 mm -124.14 116.33 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.819 1.248 . . . . 0.0 108.649 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.13 94.04 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.435 1.494 . . . . 0.0 108.097 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.8 p -80.14 157.61 26.57 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.859 0.838 . . . . 0.0 111.776 176.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -154.12 146.71 24.12 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.891 1.276 . . . . 0.0 111.469 174.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 16.2 mt -84.29 131.47 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.175 0.59 . . . . 0.0 110.019 173.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -147.34 140.44 25.16 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.291 1.836 . . . . 0.0 110.077 176.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -83.84 154.87 23.24 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.158 -0.964 . . . . 0.0 110.243 169.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 42.0 mt -128.51 -45.15 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.175 0.99 . . . . 0.0 110.944 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -145.29 19.96 1.56 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.897 0.879 . . . . 0.0 112.885 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.63 -22.25 15.24 Favored Glycine 0 N--CA 1.474 1.226 0 O-C-N 121.244 -0.91 . . . . 0.0 113.582 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 53.8 m -88.96 143.2 27.03 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.089 0.956 . . . . 0.0 109.067 169.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -76.26 123.96 26.73 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.737 0.815 . . . . 0.0 110.264 171.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -109.0 158.19 17.95 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.398 1.479 . . . . 0.0 110.735 174.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 6.8 tp -100.92 144.68 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 166.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.7 p -133.12 156.48 47.37 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.624 0.77 . . . . 0.0 109.157 169.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -151.49 145.99 25.58 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.923 0.889 . . . . 0.0 111.457 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.2 p -76.22 115.45 15.96 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.701 1.2 . . . . 0.0 110.979 174.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.66 -162.22 38.05 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.379 0.99 . . . . 0.0 112.917 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.99 161.39 26.71 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.755 0.822 . . . . 0.0 112.682 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -78.12 103.94 8.38 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.448 0.699 . . . . 0.0 110.636 172.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.556 ' CG2' ' HB2' ' A' ' 157' ' ' ALA . 0.2 OUTLIER -65.75 157.91 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.031 1.332 . . . . 0.0 112.687 179.013 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -92.49 -22.28 19.67 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -78.19 3.56 14.89 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.418 ' HB3' HD11 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -134.76 -32.26 1.0 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -178.619 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 139.79 -80.31 0.27 Allowed Glycine 0 N--CA 1.472 1.074 0 C-N-CA 124.718 1.152 . . . . 0.0 112.71 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -142.43 19.06 2.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 127.056 2.142 . . . . 0.0 110.665 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -80.95 165.03 22.13 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.681 1.192 . . . . 0.0 108.756 176.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.7 m -102.03 141.82 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 120.921 0.391 . . . . 0.0 110.316 171.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.556 ' HB2' ' CG2' ' A' ' 149' ' ' ILE . . . -63.77 100.07 0.27 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.737 0.815 . . . . 0.0 109.599 171.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -93.79 145.77 24.35 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.174 0.988 . . . . 0.0 110.974 173.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -135.14 166.85 22.12 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.697 1.599 . . . . 0.0 111.417 -172.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.88 135.51 23.26 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.894 0.477 . . . . 0.0 110.555 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 59.0 mt -130.34 142.07 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.563 1.145 . . . . 0.0 109.076 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.5 m -63.95 96.55 0.14 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.389 1.076 . . . . 0.0 110.033 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -56.62 -30.55 63.39 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.413 -0.804 . . . . 0.0 111.899 176.25 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -67.17 -28.04 67.78 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -90.1 -25.95 20.47 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.178 0.991 . . . . 0.0 112.247 176.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.637 HD13 ' SD ' ' A' ' 100' ' ' MET . 12.6 mt -65.87 -47.92 73.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.573 1.149 . . . . 0.0 111.213 171.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -49.31 -40.21 34.18 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.374 1.07 . . . . 0.0 112.765 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -52.38 -24.27 7.4 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.447 1.499 . . . . 0.0 114.43 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -122.51 -1.53 9.06 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.698 1.599 . . . . 0.0 113.671 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 72.4 mt -118.39 -13.6 9.78 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.292 1.437 . . . . 0.0 113.692 -176.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp . . . . . 0 C--O 1.256 1.4 0 C-N-CA 125.721 1.609 . . . . 0.0 112.94 168.38 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.7 pttm . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 120.813 0.34 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -144.43 166.99 23.54 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.17 0.988 . . . . 0.0 110.724 171.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -134.93 135.48 41.56 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.713 0.405 . . . . 0.0 110.896 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.72 162.94 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.694 1.598 . . . . 0.0 111.457 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -64.32 159.3 21.32 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.258 1.023 . . . . 0.0 112.499 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.0 tp -153.26 136.94 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.891 1.276 . . . . 0.0 109.632 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -130.24 156.49 44.54 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.815 2.046 . . . . 0.0 108.952 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -128.78 159.52 35.46 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.527 1.131 . . . . 0.0 111.914 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.58 117.04 23.48 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.93 0.492 . . . . 0.0 110.568 173.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -71.8 -179.96 2.89 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.309 0.644 . . . . 0.0 112.298 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -56.14 -26.87 51.98 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.64 1.576 . . . . 0.0 113.424 172.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.1 m -80.07 0.59 31.27 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.668 1.587 . . . . 0.0 114.148 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.44 34.08 87.04 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.657 1.122 . . . . 0.0 114.411 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -123.49 143.2 50.32 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.75 1.62 . . . . 0.0 109.744 177.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -67.33 126.62 29.83 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.967 0.907 . . . . 0.0 110.834 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -136.72 142.05 43.08 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.437 1.495 . . . . 0.0 110.18 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -57.55 140.19 51.49 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.1 tp -118.69 -48.59 2.47 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.828 0.851 . . . . 0.0 111.623 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.85 -119.83 0.86 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 123.261 0.458 . . . . 0.0 113.236 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -144.92 159.58 42.69 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.582 1.553 . . . . 0.0 110.284 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.5 tp -124.52 104.93 9.0 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.707 1.603 . . . . 0.0 110.131 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.2 t -78.76 99.43 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.073 1.349 . . . . 0.0 109.563 175.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.4 t -85.27 101.98 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.969 1.708 . . . . 0.0 110.239 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 . . . . . 0 N--CA 1.475 0.807 0 C-N-CA 125.901 1.68 . . . . 0.0 110.773 174.978 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.81 0 CA-C-O 121.432 0.462 . . . . 0.0 113.967 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.9 mt -122.83 141.72 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.003 0.921 . . . . 0.0 109.609 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -130.7 127.5 38.96 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.881 1.272 . . . . 0.0 109.609 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.0 p -121.44 148.54 44.28 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.7 -0.625 . . . . 0.0 111.526 -173.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.96 124.99 2.47 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 121.497 0.498 . . . . 0.0 113.081 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.77 135.44 53.97 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.029 1.731 . . . . 0.0 109.827 175.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.4 t30 . . . . . 0 CA--C 1.544 0.748 0 C-N-CA 126.086 1.755 . . . . 0.0 110.448 -177.038 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.728 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.6 m -55.37 132.0 47.11 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.257 -0.902 . . . . 0.0 110.529 169.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -99.83 -50.86 3.89 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.032 0.933 . . . . 0.0 110.26 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -163.42 159.92 22.83 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.894 0.878 . . . . 0.0 112.349 170.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.75 148.3 30.82 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 123.151 1.453 . . . . 0.0 112.873 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.449 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -136.18 157.85 45.82 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.046 1.338 . . . . 0.0 111.527 -171.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -78.49 167.5 21.19 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.29 0.567 . . . . 0.0 112.312 -174.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -56.74 -35.61 68.8 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.324 -0.86 . . . . 0.0 112.354 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -68.52 -5.05 17.37 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.846 1.259 . . . . 0.0 113.495 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 t -117.46 -5.22 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.247 1.019 . . . . 0.0 111.292 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.7 t -49.35 -63.81 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-N 120.455 1.479 . . . . 0.0 112.006 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -69.88 -28.85 65.98 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.801 -0.562 . . . . 0.0 112.138 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -63.05 -51.09 68.05 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.881 1.672 . . . . 0.0 110.899 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -59.93 -45.34 92.9 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 125.032 1.333 . . . . 0.0 110.522 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 37.4 t -59.24 -39.87 79.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.062 0.545 . . . . 0.0 110.523 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -59.28 -52.5 65.39 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.479 1.112 . . . . 0.0 112.183 174.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.29 -10.43 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 121.509 -0.744 . . . . 0.0 112.641 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.597 ' CG ' HD13 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -103.41 0.12 30.79 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.445 -1.41 . . . . 0.0 112.614 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.6 p -123.42 -12.62 7.74 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.236 1.015 . . . . 0.0 112.77 169.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -137.8 -14.36 1.42 Allowed 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.23 155.74 26.85 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.111 1.339 . . . . 0.0 113.954 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.09 -169.58 32.59 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.712 1.148 . . . . 0.0 113.829 -174.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.8 p -145.25 100.71 3.51 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.213 1.405 . . . . 0.0 113.34 -168.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -129.99 146.85 51.69 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.83 1.652 . . . . 0.0 110.037 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -74.95 157.52 34.84 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.466 -0.771 . . . . 0.0 111.021 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.7 p -121.66 147.65 45.6 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.28 1.432 . . . . 0.0 110.812 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.449 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 7.6 t -60.79 -43.6 97.9 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.686 0.794 . . . . 0.0 111.407 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mt -150.27 142.4 24.06 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.454 1.502 . . . . 0.0 112.251 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -134.02 106.04 7.03 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.078 0.951 . . . . 0.0 110.14 174.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -90.45 -47.77 7.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.297 1.039 . . . . 0.0 112.571 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.32 175.46 30.09 Favored Glycine 0 CA--C 1.544 1.847 0 C-N-CA 125.679 1.609 . . . . 0.0 114.595 -170.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 49.7 t80 . . . . . 0 CA--C 1.551 1.006 0 C-N-CA 124.722 1.209 . . . . 0.0 112.568 169.783 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.456 0 N-CA-C 112.689 -0.165 . . . . 0.0 112.689 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.4 mt -110.63 115.11 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.785 1.234 . . . . 0.0 108.76 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -73.97 148.49 42.06 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.109 0.481 . . . . 0.0 111.873 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 57.43 22.35 7.86 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.224 1.81 . . . . 0.0 114.277 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -63.71 126.2 26.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.009 1.323 . . . . 0.0 111.682 -171.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -75.88 121.39 22.57 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.609 1.164 . . . . 0.0 111.907 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.7 mm -114.8 112.07 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.296 1.039 . . . . 0.0 109.537 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -105.94 104.34 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.899 1.28 . . . . 0.0 108.387 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 47.6 p -89.8 156.89 18.19 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.456 1.102 . . . . 0.0 112.006 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.4 137.74 16.65 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.093 1.357 . . . . 0.0 111.586 175.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.7 mt -77.99 132.93 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.141 0.577 . . . . 0.0 109.684 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 . . . . . 0 CA--C 1.539 0.544 0 C-N-CA 125.435 1.494 . . . . 0.0 110.976 171.326 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 121.053 0.454 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -111.3 167.83 9.99 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.939 1.295 . . . . 0.0 110.743 173.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 tp -124.75 131.46 72.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.599 1.56 . . . . 0.0 108.395 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.8 p -118.82 154.47 32.81 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.677 0.791 . . . . 0.0 110.124 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -152.83 145.07 23.92 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.431 0.692 . . . . 0.0 112.155 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.6 m -82.32 111.03 18.01 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.539 1.136 . . . . 0.0 110.443 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.17 -155.61 19.59 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.374 1.464 . . . . 0.0 113.302 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.49 170.42 2.45 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 169.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -94.9 102.16 13.99 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.596 0.758 . . . . 0.0 111.13 173.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.73 0 C-N-CA 123.924 0.89 . . . . 0.0 112.163 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.468 0.448 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.92 116.61 5.44 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 169.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -118.19 149.19 41.49 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 122.362 1.077 . . . . 0.0 110.297 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -137.97 174.84 10.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.106 -1.406 . . . . 0.0 111.9 -169.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.61 130.06 16.79 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.81 0.844 . . . . 0.0 109.791 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.45 ' CG2' HD11 ' A' ' 166' ' ' LEU . 69.8 mt -121.9 138.99 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.192 0.997 . . . . 0.0 108.807 176.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -63.82 95.89 0.12 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.744 0.818 . . . . 0.0 109.7 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.602 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.3 tt -53.98 -31.27 50.3 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.876 1.27 . . . . 0.0 111.879 175.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -69.38 -28.09 65.87 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -86.77 -26.7 24.03 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.165 0.986 . . . . 0.0 112.522 175.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 163' ' ' LEU . 27.9 mt -62.9 -53.04 60.23 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.412 1.085 . . . . 0.0 109.796 169.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -46.53 -37.69 8.3 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt . . . . . 0 N--CA 1.485 1.299 0 C-N-CA 125.033 1.333 . . . . 0.0 114.149 177.028 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? . . . . . 0 CA--C 1.53 0.174 0 CA-C-O 121.622 0.725 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -135.44 175.53 9.5 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.966 1.306 . . . . 0.0 110.523 171.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -141.19 145.17 35.31 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.411 -0.805 . . . . 0.0 111.172 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.4 m -139.88 152.48 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.782 0.833 . . . . 0.0 112.341 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -56.63 139.5 49.92 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.666 1.187 . . . . 0.0 110.782 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.8 tp -137.53 136.32 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.798 1.239 . . . . 0.0 109.278 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -131.15 158.61 40.0 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.485 1.914 . . . . 0.0 108.826 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -130.37 161.4 31.41 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.423 1.089 . . . . 0.0 111.707 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.38 122.52 31.97 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.186 0.594 . . . . 0.0 111.026 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.22 -176.98 5.88 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 176.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -58.07 -24.48 58.71 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.441 1.896 . . . . 0.0 114.145 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.0 m -88.12 2.64 51.57 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.394 1.078 . . . . 0.0 113.386 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.5 35.48 91.99 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.698 1.142 . . . . 0.0 113.882 -176.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -114.51 143.4 45.02 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.374 1.47 . . . . 0.0 110.392 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -73.26 119.93 18.17 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.269 0.628 . . . . 0.0 110.622 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -129.14 135.3 48.68 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.77 1.628 . . . . 0.0 109.69 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -57.39 142.18 44.68 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.1 tp -117.33 -48.01 2.63 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.777 0.831 . . . . 0.0 111.4 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.84 -109.89 0.37 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.29 0.471 . . . . 0.0 113.698 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -149.72 156.84 42.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.222 1.809 . . . . 0.0 109.819 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 tp -122.46 102.29 8.0 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.593 1.157 . . . . 0.0 110.124 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.3 t -75.76 101.62 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.56 0.744 . . . . 0.0 109.263 176.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.0 94.25 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.731 1.612 . . . . 0.0 109.159 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 47.9 mtp85 . . . . . 0 N--CA 1.473 0.72 0 C-N-CA 125.258 1.423 . . . . 0.0 110.458 172.555 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.949 0 CA-C-O 121.457 0.476 . . . . 0.0 113.469 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.5 mt -128.18 143.13 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.769 0.828 . . . . 0.0 110.168 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -131.71 125.58 32.38 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.422 1.089 . . . . 0.0 110.703 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.2 p -116.56 146.01 42.94 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.617 -0.677 . . . . 0.0 111.813 -174.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -139.99 123.67 2.5 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 123.278 0.466 . . . . 0.0 112.083 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.33 137.19 54.44 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.24 1.416 . . . . 0.0 110.179 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.0 t30 . . . . . 0 CA--C 1.543 0.675 0 C-N-CA 127.182 2.193 . . . . 0.0 109.48 179.564 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.739 0 CA-C-O 120.478 0.18 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.7 m -56.51 131.35 48.36 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 121.212 -0.93 . . . . 0.0 109.191 168.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -98.0 -49.65 4.69 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.503 0.592 . . . . 0.0 110.142 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -167.35 159.09 12.24 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.867 0.867 . . . . 0.0 112.503 170.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.36 149.5 32.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 122.961 1.362 . . . . 0.0 112.525 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.427 ' HA ' ' H ' ' A' ' 109' ' ' SER . 2.4 pp -141.04 156.12 46.06 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.363 1.465 . . . . 0.0 110.836 -170.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -83.2 167.81 17.37 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.287 0.635 . . . . 0.0 112.111 -172.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -55.67 -32.0 62.86 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.022 -1.049 . . . . 0.0 112.535 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -66.4 -6.13 13.32 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.25 1.42 . . . . 0.0 114.022 174.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.88 -3.17 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 119.451 1.023 . . . . 0.0 111.555 -175.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.517 ' O ' HG23 ' A' ' 97' ' ' VAL . 71.3 t -52.6 -64.53 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 120.314 1.415 . . . . 0.0 111.524 -177.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -68.38 -27.24 66.06 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.317 0.647 . . . . 0.0 112.237 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.06 -54.2 41.87 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.413 1.485 . . . . 0.0 110.43 174.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -60.58 -46.13 91.36 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 125.135 1.374 . . . . 0.0 111.373 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 93' ' ' VAL . 87.8 t -54.46 -34.84 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.011 0.925 . . . . 0.0 110.72 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -72.69 -53.96 10.3 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.117 1.367 . . . . 0.0 113.539 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 m -68.86 -16.65 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 120.813 -1.179 . . . . 0.0 112.374 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.653 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -86.37 -4.55 59.19 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.247 1.819 . . . . 0.0 111.971 176.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 51.0 p -130.96 -15.76 3.33 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.34 -10.63 4.13 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.1 1.76 . . . . 0.0 113.668 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.01 156.68 7.58 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.459 1.504 . . . . 0.0 113.642 -173.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 156.33 -170.61 33.96 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.379 0.99 . . . . 0.0 113.712 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 93.7 p -146.05 95.36 2.61 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.608 1.163 . . . . 0.0 113.229 -168.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -125.97 141.13 52.11 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.751 1.62 . . . . 0.0 109.737 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -69.09 156.8 38.05 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.708 -0.62 . . . . 0.0 110.569 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.4 p -120.53 156.61 31.2 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.302 1.441 . . . . 0.0 110.804 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.427 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 7.9 t -70.11 -44.54 68.78 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.004 0.521 . . . . 0.0 111.169 -178.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.6 mt -148.29 140.32 24.01 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.566 1.546 . . . . 0.0 111.352 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -134.92 103.41 5.58 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.934 0.894 . . . . 0.0 110.39 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -89.84 -44.32 10.02 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.195 0.998 . . . . 0.0 113.36 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.02 -179.94 12.81 Favored Glycine 0 CA--C 1.543 1.808 0 C-N-CA 124.986 1.279 . . . . 0.0 114.307 -169.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 67.1 t80 . . . . . 0 CA--C 1.551 1.008 0 O-C-N 121.603 -0.94 . . . . 0.0 112.03 169.407 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.275 0 CA-C-O 121.59 0.55 . . . . 0.0 112.934 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.1 mt -126.3 108.13 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.962 1.305 . . . . 0.0 109.192 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -63.98 141.26 58.83 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.7 0.8 . . . . 0.0 112.006 172.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 58.29 22.67 9.57 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.719 1.608 . . . . 0.0 114.456 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 19.0 tptp -55.21 122.94 12.17 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.352 1.061 . . . . 0.0 111.52 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -69.73 129.81 40.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.228 1.011 . . . . 0.0 110.22 169.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.7 mm -127.28 119.75 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.197 0.999 . . . . 0.0 108.661 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mp -113.13 96.45 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 125.053 1.341 . . . . 0.0 108.311 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.9 p -77.44 153.99 33.04 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.835 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -150.61 137.83 19.42 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.857 1.263 . . . . 0.0 111.115 175.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.8 mt -81.85 131.54 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 . . . . . 0 CA--C 1.537 0.474 0 C-N-CA 125.434 1.493 . . . . 0.0 110.644 173.991 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 CA--C 1.538 0.504 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -107.59 166.13 10.9 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.991 1.316 . . . . 0.0 110.367 170.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.6 tp -119.9 133.68 65.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 125.15 1.38 . . . . 0.0 108.341 170.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.0 p -121.9 155.5 35.33 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.45 0.7 . . . . 0.0 109.909 175.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -148.11 140.85 24.64 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.889 0.875 . . . . 0.0 110.925 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.5 m -79.48 110.12 14.49 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.713 0.805 . . . . 0.0 110.197 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.02 -162.17 27.85 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.214 1.388 . . . . 0.0 112.535 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -68.26 162.88 24.09 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.641 -0.917 . . . . 0.0 112.874 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -76.26 108.19 9.03 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.293 1.037 . . . . 0.0 111.185 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.856 0 C-N-CA 124.283 1.033 . . . . 0.0 112.612 177.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 10.8 m . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.01 114.46 3.71 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -117.5 138.85 51.6 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.309 1.052 . . . . 0.0 109.898 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -134.68 169.6 17.08 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.416 1.486 . . . . 0.0 111.199 -169.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.03 131.58 19.83 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.4 0.68 . . . . 0.0 109.909 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.425 ' CG2' HD11 ' A' ' 166' ' ' LEU . 59.0 mt -124.78 138.26 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.072 0.949 . . . . 0.0 108.739 177.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.2 m -63.71 94.82 0.1 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.224 1.01 . . . . 0.0 109.649 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.592 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.4 tt -55.03 -32.2 61.68 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.325 1.05 . . . . 0.0 111.849 176.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -68.48 -29.59 68.25 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 176.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -84.19 -31.37 25.14 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.906 0.882 . . . . 0.0 112.095 174.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.653 HD13 ' HG3' ' A' ' 100' ' ' MET . 17.9 mt -57.63 -49.5 76.23 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.012 0.925 . . . . 0.0 110.953 173.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -50.01 -40.79 45.7 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.443 1.097 . . . . 0.0 113.448 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 60.9 mttm . . . . . 0 N--CA 1.48 1.026 0 C-N-CA 125.43 1.492 . . . . 0.0 114.259 -178.336 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.9 pttt . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 110.788 -0.079 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -143.06 168.14 20.44 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.949 0.9 . . . . 0.0 111.118 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -133.97 131.98 39.62 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.645 0.378 . . . . 0.0 111.229 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.5 162.01 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.959 1.704 . . . . 0.0 111.229 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -62.15 159.03 15.5 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.13 0.972 . . . . 0.0 111.776 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.9 tp -153.98 136.43 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.45 1.1 . . . . 0.0 109.876 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -128.82 159.49 35.56 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.105 1.762 . . . . 0.0 109.26 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -130.53 153.8 48.46 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.687 1.195 . . . . 0.0 111.03 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -81.47 119.18 23.4 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 122.152 -0.343 . . . . 0.0 110.505 174.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -71.67 -178.84 2.37 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.563 0.745 . . . . 0.0 112.752 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -54.77 -30.7 57.38 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.702 1.201 . . . . 0.0 113.552 174.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.7 m -81.09 -0.87 41.93 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.071 0.949 . . . . 0.0 113.515 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.99 29.95 73.83 Favored Glycine 0 CA--C 1.536 1.37 0 O-C-N 121.505 -0.747 . . . . 0.0 113.379 -173.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -111.3 135.46 51.81 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.415 1.486 . . . . 0.0 110.043 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -69.01 124.73 24.54 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.031 0.932 . . . . 0.0 110.8 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.2 t -137.89 137.48 38.1 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.782 1.233 . . . . 0.0 110.787 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -56.04 130.75 45.26 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.965 1.306 . . . . 0.0 112.027 -173.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.0 tp -106.54 -47.35 3.79 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.233 0.613 . . . . 0.0 111.521 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.03 -115.83 0.62 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.247 0.451 . . . . 0.0 113.267 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -146.48 157.13 43.71 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.218 1.407 . . . . 0.0 110.087 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.5 tp -121.51 102.72 8.43 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.284 1.434 . . . . 0.0 110.342 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.6 t -78.19 95.13 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.185 1.394 . . . . 0.0 109.07 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.7 t -81.84 99.48 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.735 1.614 . . . . 0.0 109.582 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.2 mtt-85 . . . . . 0 N--CA 1.479 1.001 0 C-N-CA 125.007 1.323 . . . . 0.0 111.808 177.395 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.086 0 N-CA-C 115.337 0.895 . . . . 0.0 115.337 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.6 mt -119.3 137.34 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.233 1.013 . . . . 0.0 109.797 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.26 104.05 6.01 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.271 1.828 . . . . 0.0 109.364 -171.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.9 p -98.07 156.14 16.79 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.32 -1.488 . . . . 0.0 111.455 -173.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.52 122.98 1.79 Allowed Glycine 0 CA--C 1.526 0.726 0 O-C-N 121.271 -0.893 . . . . 0.0 112.16 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.87 138.39 50.16 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.002 1.721 . . . . 0.0 110.403 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.6 t30 . . . . . 0 CA--C 1.546 0.809 0 C-N-CA 125.808 1.643 . . . . 0.0 110.482 -178.632 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.4 m -55.36 127.17 28.22 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.427 -0.795 . . . . 0.0 110.132 170.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -95.09 -48.33 6.0 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.096 0.407 . . . . 0.0 110.644 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -162.9 168.67 20.89 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 122.201 1.001 . . . . 0.0 113.162 170.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.84 139.49 18.81 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.316 -0.865 . . . . 0.0 112.381 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.481 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -129.45 156.13 44.6 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.848 1.659 . . . . 0.0 111.187 -176.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -77.48 167.46 21.61 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.433 0.635 . . . . 0.0 112.363 -174.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -55.41 -36.33 66.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.105 0.962 . . . . 0.0 112.394 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -69.4 -2.92 12.27 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.758 1.223 . . . . 0.0 114.1 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.3 t -119.59 -5.66 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 119.56 1.073 . . . . 0.0 111.453 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.4 t -48.96 -65.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 125.279 1.432 . . . . 0.0 111.85 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -68.45 -27.02 65.81 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.497 -0.752 . . . . 0.0 112.632 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -52.04 65.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.435 1.494 . . . . 0.0 110.596 175.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -60.83 -45.84 92.92 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 124.586 1.154 . . . . 0.0 111.617 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 87.6 t -56.29 -34.16 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.432 0.693 . . . . 0.0 111.25 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -66.98 -57.75 6.27 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.01 0.924 . . . . 0.0 112.278 174.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 m -69.8 -22.19 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 O-C-N 120.821 -1.175 . . . . 0.0 112.551 -175.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.648 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -78.61 -6.64 56.15 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.933 1.693 . . . . 0.0 111.88 175.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 81.7 p -131.4 -12.26 3.52 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -137.45 -6.03 1.78 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.668 1.587 . . . . 0.0 113.771 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.07 156.29 5.3 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 126.04 1.781 . . . . 0.0 113.843 -175.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.99 -171.37 33.27 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.165 0.888 . . . . 0.0 113.12 -174.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 85.1 p -145.1 104.04 3.92 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.507 1.123 . . . . 0.0 113.366 -168.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -134.29 143.77 47.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.179 1.792 . . . . 0.0 110.277 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -71.64 162.66 29.1 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.374 -0.829 . . . . 0.0 112.106 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.2 p -129.56 144.79 51.42 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.456 1.503 . . . . 0.0 111.023 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.481 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 6.7 t -59.07 -43.75 91.79 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.354 1.462 . . . . 0.0 112.534 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.0 mt -155.73 134.41 11.85 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.829 1.652 . . . . 0.0 111.296 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -129.54 102.1 6.23 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.643 1.177 . . . . 0.0 110.696 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -90.38 -41.81 11.28 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.613 1.165 . . . . 0.0 113.965 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 58.15 -173.53 2.97 Favored Glycine 0 CA--C 1.547 2.058 0 C-N-CA 126.222 1.867 . . . . 0.0 115.465 -169.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 19.8 t80 . . . . . 0 N--CA 1.476 0.85 0 C-N-CA 124.509 1.124 . . . . 0.0 113.966 177.254 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.434 0 CA-C-O 121.749 0.638 . . . . 0.0 113.646 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.4 mt -119.41 115.53 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.6 1.56 . . . . 0.0 108.152 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -72.96 144.39 47.29 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.097 0.475 . . . . 0.0 111.55 173.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 58.41 24.89 12.25 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 125.754 1.622 . . . . 0.0 114.042 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -62.72 122.81 16.81 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.698 1.199 . . . . 0.0 111.817 -173.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -73.22 124.16 25.1 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.322 1.049 . . . . 0.0 111.428 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.7 mm -118.3 117.79 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.809 1.244 . . . . 0.0 108.882 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.8 mp -110.09 103.37 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 124.984 1.313 . . . . 0.0 108.231 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 59.1 p -85.08 153.14 22.9 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.805 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.17 136.67 20.23 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.163 1.385 . . . . 0.0 111.15 176.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 17.3 mt -81.09 131.67 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 . . . . . 0 N--CA 1.466 0.372 0 C-N-CA 125.793 1.637 . . . . 0.0 110.109 175.37 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -107.69 165.16 11.64 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.416 1.486 . . . . 0.0 110.522 174.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.8 tp -122.21 132.22 71.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 125.327 1.451 . . . . 0.0 107.848 172.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 p -119.47 156.59 29.94 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.188 0.595 . . . . 0.0 109.794 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -152.03 141.51 21.64 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.103 0.961 . . . . 0.0 111.297 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.2 m -78.7 114.38 17.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.478 1.111 . . . . 0.0 110.484 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.33 -167.26 43.13 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.308 0.956 . . . . 0.0 112.876 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -68.08 171.47 6.87 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.749 -0.853 . . . . 0.0 112.62 168.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -81.05 136.26 35.94 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.243 -0.911 . . . . 0.0 112.114 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.779 0 C-N-CA 123.815 0.846 . . . . 0.0 112.729 171.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.09 117.16 11.31 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -106.1 148.81 27.38 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 122.009 0.909 . . . . 0.0 109.743 171.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -132.8 172.42 12.6 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.122 1.369 . . . . 0.0 111.491 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.86 133.09 23.08 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.518 0.727 . . . . 0.0 110.156 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.409 ' CG2' HD11 ' A' ' 166' ' ' LEU . 64.0 mt -126.47 138.66 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.133 0.973 . . . . 0.0 108.918 175.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.4 m -64.54 97.39 0.2 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.362 -0.836 . . . . 0.0 110.225 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.5 tt -54.16 -31.03 51.44 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.111 1.364 . . . . 0.0 112.179 175.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -72.73 -26.03 61.43 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -89.43 -26.03 21.19 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.972 -1.08 . . . . 0.0 112.053 173.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.648 HD13 ' HG3' ' A' ' 100' ' ' MET . 14.5 mt -61.49 -46.55 89.52 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.849 0.86 . . . . 0.0 110.813 172.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -55.18 -36.93 66.4 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 177.825 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.9 pttt . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 121.069 0.461 . . . . 0.0 111.31 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -144.3 169.39 17.99 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.553 1.141 . . . . 0.0 110.587 170.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -132.6 129.35 38.83 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.742 -0.599 . . . . 0.0 110.17 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.35 167.99 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.196 1.399 . . . . 0.0 110.896 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.34 164.22 7.47 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.639 1.176 . . . . 0.0 111.428 175.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.6 tp -158.72 137.26 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.774 1.229 . . . . 0.0 109.558 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -127.82 162.63 26.22 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.417 1.887 . . . . 0.0 110.073 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -132.12 156.69 45.92 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.304 1.441 . . . . 0.0 111.232 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.51 121.27 24.37 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 171.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -63.88 174.6 1.41 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.065 0.946 . . . . 0.0 111.992 171.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -57.58 -14.79 5.81 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.343 1.857 . . . . 0.0 114.857 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.2 m -115.56 14.16 16.51 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.885 1.274 . . . . 0.0 112.872 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.04 21.07 78.95 Favored Glycine 0 CA--C 1.537 1.438 0 O-C-N 121.335 -0.853 . . . . 0.0 114.393 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -96.59 125.79 41.31 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.68 1.192 . . . . 0.0 109.649 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -66.87 126.14 28.15 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.898 -0.501 . . . . 0.0 110.873 174.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.2 t -140.75 136.02 32.11 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.715 1.206 . . . . 0.0 110.81 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -55.7 131.57 46.9 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.771 1.229 . . . . 0.0 112.354 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 38.8 tp -104.87 -47.73 3.95 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.985 0.914 . . . . 0.0 111.279 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.75 -118.96 0.78 Allowed Glycine 0 CA--C 1.529 0.963 0 N-CA-C 113.978 0.351 . . . . 0.0 113.978 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -141.16 151.73 44.11 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.356 1.462 . . . . 0.0 110.366 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.4 tp -116.96 101.45 8.52 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.409 1.484 . . . . 0.0 109.878 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.1 t -77.45 97.46 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.098 1.359 . . . . 0.0 109.336 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.3 t -84.3 84.42 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.614 1.566 . . . . 0.0 110.296 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 . . . . . 0 N--CA 1.478 0.938 0 C-N-CA 123.795 0.838 . . . . 0.0 110.406 170.319 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.115 0 N-CA-C 114.051 0.38 . . . . 0.0 114.051 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.445 HD11 HG13 ' A' ' 93' ' ' VAL . 45.1 mt -119.71 142.95 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.938 0.895 . . . . 0.0 109.431 169.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -132.72 92.43 3.05 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.331 1.453 . . . . 0.0 110.573 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.8 p -84.54 150.36 25.28 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.24 -0.912 . . . . 0.0 112.508 -174.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.73 120.01 1.57 Allowed Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.42 -0.8 . . . . 0.0 113.791 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -70.88 139.92 50.93 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.53 1.932 . . . . 0.0 110.588 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 . . . . . 0 CA--C 1.543 0.696 0 C-N-CA 126.193 1.797 . . . . 0.0 110.708 -178.775 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.879 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.3 m -54.05 124.42 15.52 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.3 1.04 . . . . 0.0 110.791 171.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -92.07 -52.64 4.61 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.883 0.473 . . . . 0.0 110.426 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -163.92 153.05 13.97 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.871 0.868 . . . . 0.0 112.691 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.56 128.11 21.46 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 122.75 1.262 . . . . 0.0 112.553 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.96 163.79 16.04 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.13 1.772 . . . . 0.0 111.38 -173.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -79.72 162.05 25.41 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.404 1.082 . . . . 0.0 112.436 -175.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -55.44 -33.05 63.24 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.319 1.047 . . . . 0.0 113.055 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -70.33 -8.38 50.02 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 37.5 t -114.29 -14.56 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 121.3 -0.875 . . . . 0.0 112.028 -171.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.55 ' O ' HG23 ' A' ' 97' ' ' VAL . 42.2 t -48.15 -55.81 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.502 1.121 . . . . 0.0 111.372 177.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -65.41 -32.87 74.72 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -69.8 -43.63 71.71 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.029 0.932 . . . . 0.0 111.343 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -58.83 -46.88 86.64 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.632 1.173 . . . . 0.0 110.736 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 93' ' ' VAL . 92.6 t -53.94 -37.51 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.395 1.078 . . . . 0.0 111.377 175.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.87 -57.38 4.67 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.5 1.52 . . . . 0.0 112.656 176.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -71.91 -7.5 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 O-C-N 121.212 -0.93 . . . . 0.0 113.125 -175.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.408 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -94.58 -5.69 45.26 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.01 1.724 . . . . 0.0 111.932 176.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 47.4 p -128.89 -14.85 4.41 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.909 0.883 . . . . 0.0 112.958 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -131.97 -9.73 3.44 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.617 1.567 . . . . 0.0 114.593 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.63 157.14 7.51 Favored Glycine 0 CA--C 1.539 1.574 0 C-N-CA 125.294 1.426 . . . . 0.0 113.76 -173.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.52 -153.62 24.66 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 121.543 -0.975 . . . . 0.0 113.175 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 80.1 p -145.52 151.98 39.02 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.18 0.992 . . . . 0.0 113.148 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -148.27 -177.69 5.9 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.55 1.94 . . . . 0.0 112.177 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? -117.41 156.16 28.4 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.937 1.295 . . . . 0.0 111.657 170.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.9 p -126.17 130.81 51.73 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.977 0.911 . . . . 0.0 111.892 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.9 t -51.9 -37.55 52.85 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.409 1.084 . . . . 0.0 112.995 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.0 mt -147.62 141.31 25.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.233 1.413 . . . . 0.0 112.364 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -136.35 93.55 2.91 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.525 1.13 . . . . 0.0 110.643 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -81.7 -49.06 10.9 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.829 0.851 . . . . 0.0 113.121 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.21 177.42 43.2 Favored Glycine 0 CA--C 1.543 1.816 0 C-N-CA 125.06 1.314 . . . . 0.0 113.874 -169.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 44.9 t80 . . . . . 0 CA--C 1.551 0.986 0 C-N-CA 124.085 0.954 . . . . 0.0 112.253 170.382 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.626 0 CA-C-O 121.317 0.399 . . . . 0.0 114.055 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 52.7 mt -123.39 120.44 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 126.095 1.758 . . . . 0.0 108.866 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -82.31 145.01 30.2 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 57.79 24.49 10.81 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.478 1.911 . . . . 0.0 113.938 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -60.34 125.74 24.82 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.856 1.262 . . . . 0.0 111.363 -173.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -76.61 126.61 31.29 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.845 0.458 . . . . 0.0 110.925 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.3 mm -119.95 120.59 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 126.094 1.758 . . . . 0.0 109.065 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.1 mp -115.06 105.93 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.233 1.413 . . . . 0.0 108.231 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.8 p -80.97 161.63 24.21 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.777 0.799 . . . . 0.0 112.203 174.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -152.15 142.22 22.24 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.91 1.284 . . . . 0.0 110.77 171.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 52.4 mt -82.61 132.14 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 . . . . . 0 N--CA 1.467 0.388 0 C-N-CA 125.303 1.441 . . . . 0.0 110.273 174.28 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 . . . . . 0 CA--C 1.538 0.514 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -107.93 165.9 11.11 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.821 1.248 . . . . 0.0 110.055 170.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.9 tp -117.0 137.28 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.332 1.453 . . . . 0.0 107.922 169.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 p -124.88 156.87 37.21 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.571 0.623 . . . . 0.0 110.098 172.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -149.63 135.89 19.02 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.988 0.915 . . . . 0.0 111.158 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.2 t -70.61 127.89 34.22 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.065 0.46 . . . . 0.0 110.381 172.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.59 -154.25 26.06 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.816 1.674 . . . . 0.0 112.044 175.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -69.07 169.33 12.07 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 121.936 0.874 . . . . 0.0 112.352 169.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -87.98 112.07 22.19 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.451 1.5 . . . . 0.0 111.528 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.414 ' CG2' ' HB2' ' A' ' 157' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.477 0.892 0 C-N-CA 123.628 0.771 . . . . 0.0 112.009 177.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.414 ' HB2' ' CG2' ' A' ' 149' ' ' ILE . . . -65.94 104.28 1.08 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 171.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -104.53 145.7 29.92 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.523 1.154 . . . . 0.0 110.86 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -134.47 167.15 21.29 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.679 1.591 . . . . 0.0 110.719 -169.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.02 134.93 26.87 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.346 0.521 . . . . 0.0 110.349 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.501 ' CG2' HD11 ' A' ' 166' ' ' LEU . 51.3 mt -129.67 139.89 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.802 0.841 . . . . 0.0 109.334 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.7 m -63.73 95.46 0.11 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.018 0.927 . . . . 0.0 109.848 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.444 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.0 OUTLIER -53.07 -33.32 51.55 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.602 1.161 . . . . 0.0 111.516 175.459 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -67.56 -27.49 66.98 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -86.73 -31.53 20.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.991 0.916 . . . . 0.0 111.949 172.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.501 HD11 ' CG2' ' A' ' 161' ' ' ILE . 18.9 mt -62.1 -44.1 97.4 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.847 0.859 . . . . 0.0 111.264 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -50.5 -41.8 53.9 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.31 1.044 . . . . 0.0 112.84 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 81.1 mttt . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.92 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.1 pttp . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 120.919 0.39 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -145.89 165.69 28.18 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.769 1.228 . . . . 0.0 110.495 173.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -131.76 125.79 32.82 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.596 0.358 . . . . 0.0 110.464 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.9 m -118.79 165.96 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.021 1.329 . . . . 0.0 110.927 177.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -68.06 161.79 26.01 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.544 1.138 . . . . 0.0 110.995 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.2 tp -153.37 136.29 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.436 1.095 . . . . 0.0 109.667 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -127.21 161.3 28.86 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.197 1.799 . . . . 0.0 109.741 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -132.01 154.37 49.43 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 126.098 1.759 . . . . 0.0 110.749 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -76.09 124.74 27.89 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 169.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -67.43 175.68 2.67 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 122.241 1.019 . . . . 0.0 111.327 170.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -59.81 -11.73 5.92 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.234 2.213 . . . . 0.0 114.778 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.8 t -116.51 12.93 15.26 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.111 1.364 . . . . 0.0 112.821 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.31 19.71 79.38 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 121.312 -0.867 . . . . 0.0 114.615 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -95.59 129.38 42.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.778 1.231 . . . . 0.0 109.477 176.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -68.98 127.75 34.25 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.637 -0.664 . . . . 0.0 110.567 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.7 t -138.86 147.04 41.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.878 1.671 . . . . 0.0 110.241 -175.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -66.49 137.38 56.77 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.051 -1.031 . . . . 0.0 111.626 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.8 tp -110.83 -46.9 3.29 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.876 0.87 . . . . 0.0 112.291 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.27 -133.31 2.39 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 121.703 0.613 . . . . 0.0 114.612 -174.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -132.65 155.91 47.9 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.511 1.924 . . . . 0.0 110.953 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.8 tp -122.96 104.27 9.14 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.275 1.43 . . . . 0.0 110.539 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.4 t -81.57 97.48 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.48 1.512 . . . . 0.0 109.462 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.03 117.47 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.914 1.286 . . . . 0.0 109.671 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 . . . . . 0 N--CA 1.475 0.822 0 C-N-CA 126.925 2.09 . . . . 0.0 110.535 -179.342 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.838 0 N-CA-C 113.964 0.346 . . . . 0.0 113.964 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 68.5 mt -122.1 136.84 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.928 0.891 . . . . 0.0 109.52 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.65 142.82 47.29 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.15 1.38 . . . . 0.0 109.253 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.1 p -133.54 139.85 46.85 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.277 0.631 . . . . 0.0 110.016 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.61 107.83 0.65 Allowed Glycine 0 CA--C 1.521 0.421 0 CA-C-O 121.843 0.69 . . . . 0.0 111.61 -169.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 33.1 tp -64.09 144.56 57.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.616 1.166 . . . . 0.0 110.174 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 . . . . . 0 CA--C 1.542 0.661 0 C-N-CA 126.917 2.087 . . . . 0.0 109.294 179.144 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.7 m -58.82 118.34 5.63 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.024 -1.047 . . . . 0.0 109.313 169.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -82.22 -48.45 11.26 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.001 -0.437 . . . . 0.0 109.949 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -164.82 161.4 20.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.836 0.855 . . . . 0.0 113.074 170.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.87 149.41 33.2 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.985 1.374 . . . . 0.0 113.08 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.424 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.5 OUTLIER -135.92 160.31 38.99 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.31 1.444 . . . . 0.0 111.715 -175.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -80.13 165.99 21.92 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.3 0.64 . . . . 0.0 112.387 -175.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -54.18 -34.85 61.49 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.136 0.975 . . . . 0.0 112.771 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -67.65 -4.58 12.43 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.578 1.151 . . . . 0.0 114.086 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.84 -3.57 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.336 1.054 . . . . 0.0 111.399 -175.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.9 t -51.21 -65.38 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.261 1.424 . . . . 0.0 111.352 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -69.11 -24.06 64.07 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -50.51 68.76 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.321 1.449 . . . . 0.0 110.438 172.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -61.43 -42.56 98.95 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 124.666 1.186 . . . . 0.0 111.798 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.5 t -56.04 -35.14 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.103 0.561 . . . . 0.0 110.882 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -69.94 -54.26 14.15 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.939 1.296 . . . . 0.0 112.949 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.0 m -74.34 -6.33 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 120.933 -1.104 . . . . 0.0 112.967 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.527 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -97.77 -4.85 36.18 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.028 1.731 . . . . 0.0 111.742 176.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 44.7 p -132.06 -17.5 2.73 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.733 1.213 . . . . 0.0 113.496 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -131.76 -11.13 3.46 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.15 1.78 . . . . 0.0 113.667 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.21 155.8 11.62 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.977 1.275 . . . . 0.0 113.738 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 164.12 -159.43 32.25 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 121.784 -0.833 . . . . 0.0 114.299 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.6 p -154.09 89.35 1.29 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -168.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -124.42 141.71 51.87 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.769 1.628 . . . . 0.0 110.528 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -69.87 162.62 27.6 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.462 0.705 . . . . 0.0 111.54 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.2 p -130.51 147.64 52.22 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.507 1.523 . . . . 0.0 111.391 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.424 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 5.1 t -65.27 -40.36 93.82 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.874 0.87 . . . . 0.0 111.858 -178.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.8 mt -150.73 137.71 19.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.686 1.594 . . . . 0.0 111.794 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -139.03 100.54 4.05 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.642 0.777 . . . . 0.0 110.868 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -94.95 -38.59 10.62 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.13 -169.78 16.58 Favored Glycine 0 CA--C 1.543 1.815 0 C-N-CA 125.032 1.301 . . . . 0.0 115.478 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 31.5 t80 . . . . . 0 CA--C 1.549 0.936 0 C-N-CA 124.169 0.988 . . . . 0.0 112.62 169.73 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.003 0 CA-C-O 121.626 0.57 . . . . 0.0 113.574 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.2 mt -140.83 101.66 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.036 1.335 . . . . 0.0 107.738 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -69.32 145.07 53.3 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.191 0.519 . . . . 0.0 111.32 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 60.38 20.79 10.37 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.673 1.589 . . . . 0.0 113.821 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -55.37 123.65 14.56 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.864 1.266 . . . . 0.0 111.161 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -71.58 127.62 33.16 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.832 0.853 . . . . 0.0 110.319 170.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.3 mm -123.01 117.69 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.687 1.195 . . . . 0.0 108.56 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.37 99.01 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 125.178 1.391 . . . . 0.0 107.8 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.7 p -81.55 157.06 24.92 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.726 0.774 . . . . 0.0 111.064 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -151.52 137.56 18.22 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.467 1.107 . . . . 0.0 110.808 176.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 52.4 mt -80.6 132.67 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 . . . . . 0 N--CA 1.466 0.333 0 C-N-CA 125.375 1.47 . . . . 0.0 110.314 175.156 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -107.02 166.18 10.8 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.154 1.382 . . . . 0.0 110.382 171.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.0 tp -118.08 137.87 50.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 125.414 1.485 . . . . 0.0 108.296 169.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.6 p -125.94 155.95 40.52 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.44 0.696 . . . . 0.0 110.024 174.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -150.51 137.47 19.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.167 0.987 . . . . 0.0 111.213 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.7 m -78.81 119.19 21.67 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.526 1.131 . . . . 0.0 110.691 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.4 -156.29 32.58 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.929 1.252 . . . . 0.0 113.256 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -66.51 161.78 22.17 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.253 1.021 . . . . 0.0 112.694 171.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -77.93 110.06 12.52 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.665 1.186 . . . . 0.0 110.506 173.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.591 0 CA-C-O 121.21 0.528 . . . . 0.0 111.929 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.472 0.655 0 CA-C-O 120.845 0.355 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.83 130.22 43.89 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 168.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -128.0 143.73 51.09 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.571 1.177 . . . . 0.0 111.488 173.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -135.55 169.8 16.95 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 126.093 1.757 . . . . 0.0 111.069 -169.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.83 135.22 24.3 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 122.934 0.494 . . . . 0.0 110.248 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.457 ' CG2' HD11 ' A' ' 166' ' ' LEU . 63.2 mt -127.32 141.24 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 123.738 0.815 . . . . 0.0 108.98 175.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.8 m -62.2 94.74 0.06 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.204 1.002 . . . . 0.0 109.753 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.504 ' HA ' HD12 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -54.05 -32.93 56.01 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.904 0.882 . . . . 0.0 111.464 174.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -66.74 -30.62 70.89 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -82.57 -32.14 28.65 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.053 0.941 . . . . 0.0 111.851 173.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.527 HD13 ' HG3' ' A' ' 100' ' ' MET . 18.7 mt -60.39 -45.98 91.64 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.645 0.778 . . . . 0.0 111.39 175.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.431 ' HE3' HD21 ' A' ' 163' ' ' LEU . 77.0 mttt -51.29 -42.63 61.28 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 119.044 0.838 . . . . 0.0 112.833 175.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 86.8 mttt . . . . . 0 N--CA 1.484 1.23 0 C-N-CA 125.244 1.418 . . . . 0.0 113.996 -178.439 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.3 pttp . . . . . 0 N--CA 1.467 0.411 0 CA-C-O 121.287 0.565 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -140.95 166.6 24.33 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.935 1.294 . . . . 0.0 111.42 170.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 m -134.74 130.35 36.06 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.591 0.357 . . . . 0.0 110.744 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.1 m -128.24 165.27 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.795 1.638 . . . . 0.0 110.853 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -63.42 163.02 11.48 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.58 1.152 . . . . 0.0 111.736 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.3 tp -159.28 137.04 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.787 1.235 . . . . 0.0 110.044 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -129.06 162.62 27.25 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.043 2.137 . . . . 0.0 109.362 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -129.3 157.9 40.59 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.152 1.381 . . . . 0.0 111.116 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -78.83 119.96 22.78 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 169.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.89 172.47 1.7 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.51 1.124 . . . . 0.0 112.154 171.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -53.29 -18.02 2.17 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.199 1.8 . . . . 0.0 115.518 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.9 m -112.07 13.53 20.68 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.322 1.049 . . . . 0.0 113.16 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.54 20.67 79.49 Favored Glycine 0 CA--C 1.537 1.45 0 O-C-N 121.213 -0.93 . . . . 0.0 114.181 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -97.4 125.87 42.29 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.797 1.239 . . . . 0.0 109.703 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -67.09 126.22 28.5 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.772 -0.58 . . . . 0.0 110.628 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.3 t -141.16 140.1 34.01 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.834 1.254 . . . . 0.0 110.842 -174.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -56.77 135.03 55.47 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.229 1.012 . . . . 0.0 112.781 -175.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.6 tp -109.18 -48.39 3.27 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.695 0.798 . . . . 0.0 111.139 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.5 -113.14 0.51 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 123.137 0.399 . . . . 0.0 113.663 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -146.61 157.56 43.74 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.439 1.495 . . . . 0.0 109.949 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.1 tp -122.9 102.19 7.87 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.504 1.521 . . . . 0.0 110.022 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.67 95.58 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.636 1.574 . . . . 0.0 109.561 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.8 t -84.18 104.57 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.211 1.804 . . . . 0.0 110.252 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 . . . . . 0 N--CA 1.476 0.858 0 C-N-CA 127.098 2.159 . . . . 0.0 111.346 176.556 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.056 0 CA-C-O 122.056 0.809 . . . . 0.0 114.026 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.3 mt -111.76 140.32 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.12 0.968 . . . . 0.0 109.404 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -128.99 130.1 46.24 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.282 1.433 . . . . 0.0 109.6 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.2 p -119.79 148.51 43.35 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.375 -0.828 . . . . 0.0 111.198 -172.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.49 125.01 2.64 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-O 121.513 0.507 . . . . 0.0 112.788 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.8 138.2 52.48 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.077 1.751 . . . . 0.0 110.402 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.2 t30 . . . . . 0 CA--C 1.546 0.808 0 C-N-CA 126.119 1.768 . . . . 0.0 110.885 -176.254 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.695 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.5 m -54.89 130.76 42.45 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 121.382 -0.824 . . . . 0.0 110.612 170.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -97.5 -50.91 4.33 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.897 0.879 . . . . 0.0 110.175 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -163.86 158.45 19.94 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.883 0.873 . . . . 0.0 112.728 171.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.46 133.25 27.29 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 122.092 0.948 . . . . 0.0 111.943 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.442 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -108.3 160.38 15.9 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.108 1.363 . . . . 0.0 111.669 -178.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -76.95 165.4 24.72 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.91 0.862 . . . . 0.0 112.334 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -60.04 -26.6 66.25 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.021 0.928 . . . . 0.0 112.764 172.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -74.21 -3.96 33.02 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 172.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.1 t -117.91 -2.7 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.347 1.059 . . . . 0.0 110.883 -173.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.2 m -57.14 -29.33 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -176.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -98.96 -25.91 14.43 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.281 1.033 . . . . 0.0 111.851 171.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -71.27 -49.16 45.86 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.906 1.682 . . . . 0.0 111.6 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -59.68 -45.33 92.39 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.373 1.069 . . . . 0.0 110.918 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 73.3 t -55.67 -39.4 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.724 0.81 . . . . 0.0 110.367 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -60.58 -55.22 35.93 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.533 1.533 . . . . 0.0 112.224 174.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.0 m -70.9 -14.91 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 121.12 -0.987 . . . . 0.0 112.785 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.456 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -91.3 -4.6 55.71 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.274 1.83 . . . . 0.0 111.824 178.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.5 p -127.84 -15.56 4.85 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.63 1.172 . . . . 0.0 114.002 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -134.24 -9.8 2.58 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.272 1.429 . . . . 0.0 114.281 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.97 156.42 9.89 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.159 1.362 . . . . 0.0 113.825 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.03 -170.61 32.64 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.65 1.119 . . . . 0.0 113.524 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.503 ' HB3' HG23 ' A' ' 130' ' ' ILE . 56.7 p -144.36 103.81 4.01 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.756 1.222 . . . . 0.0 113.423 -168.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -133.81 156.54 47.85 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.145 1.778 . . . . 0.0 110.289 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 165.01 20.13 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.272 -0.892 . . . . 0.0 111.288 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.6 p -131.91 146.57 52.19 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.299 1.439 . . . . 0.0 111.273 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.442 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 9.4 t -54.88 -44.33 74.0 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.96 1.304 . . . . 0.0 112.084 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.5 mt -152.67 146.49 25.2 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.366 1.867 . . . . 0.0 110.942 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.431 ' CD2' HD11 ' A' ' 129' ' ' ILE . 39.6 t80 -139.72 111.38 7.25 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.27 0.628 . . . . 0.0 110.253 174.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -98.19 -39.56 8.81 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.129 1.372 . . . . 0.0 114.038 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.63 178.12 7.47 Favored Glycine 0 CA--C 1.544 1.906 0 C-N-CA 125.003 1.287 . . . . 0.0 115.409 -169.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 41.2 t80 . . . . . 0 CA--C 1.551 0.988 0 C-N-CA 124.894 1.278 . . . . 0.0 113.006 170.22 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.509 0 CA-C-O 122.046 0.804 . . . . 0.0 114.755 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.6 mt -114.07 115.0 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.149 1.38 . . . . 0.0 108.643 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -70.7 144.28 51.06 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.028 0.442 . . . . 0.0 111.198 172.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 58.14 26.36 13.61 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.334 1.454 . . . . 0.0 113.518 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -61.79 125.66 24.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.543 1.137 . . . . 0.0 111.187 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -72.32 122.81 21.76 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.542 1.537 . . . . 0.0 111.953 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.431 HD11 ' CD2' ' A' ' 111' ' ' TYR . 34.9 mm -119.58 116.17 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.122 0.969 . . . . 0.0 109.477 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.503 HG23 ' HB3' ' A' ' 105' ' ' SER . 3.6 mp -110.32 96.66 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.928 1.291 . . . . 0.0 108.425 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.9 p -80.62 156.46 26.38 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.983 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -151.53 139.58 20.11 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.88 1.272 . . . . 0.0 111.495 174.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.9 mt -81.07 134.08 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 . . . . . 0 N--CA 1.466 0.36 0 C-N-CA 125.055 1.342 . . . . 0.0 110.73 172.736 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 CA--C 1.543 0.696 0 CA-C-O 121.22 0.534 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -103.4 167.57 9.72 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.833 1.253 . . . . 0.0 110.69 170.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.2 tp -122.09 134.02 66.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 125.634 1.574 . . . . 0.0 108.103 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 p -120.77 156.71 31.27 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.198 0.599 . . . . 0.0 109.849 173.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -150.99 140.58 21.62 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.705 0.802 . . . . 0.0 111.312 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.7 p -71.79 118.94 15.26 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.929 0.892 . . . . 0.0 110.999 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.06 -154.39 16.18 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.717 1.151 . . . . 0.0 112.19 172.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -79.98 166.55 21.48 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.659 0.783 . . . . 0.0 111.202 169.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -79.1 105.99 10.82 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.95 -1.094 . . . . 0.0 111.286 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.434 ' CG2' ' HB2' ' A' ' 157' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.701 0 C-N-CA 123.474 0.71 . . . . 0.0 112.06 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.475 0.797 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.434 ' HB2' ' CG2' ' A' ' 149' ' ' ILE . . . -63.29 115.67 4.77 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -113.04 143.97 43.41 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.84 1.305 . . . . 0.0 111.231 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -134.65 168.06 19.68 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.202 1.801 . . . . 0.0 110.225 -169.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.89 133.46 23.54 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 69.5 mt -124.87 140.32 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.6 m -62.11 94.08 0.05 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.744 0.818 . . . . 0.0 109.226 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.54 -31.83 57.18 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.513 -0.742 . . . . 0.0 111.497 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -63.88 -27.71 69.34 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -94.78 -29.86 14.54 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.59 1.556 . . . . 0.0 111.597 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.456 HD13 ' HG3' ' A' ' 100' ' ' MET . 16.9 mt -58.04 -49.66 76.11 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.435 1.094 . . . . 0.0 110.766 170.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -49.33 -37.92 26.15 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.411 1.084 . . . . 0.0 113.445 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 48.6 mttm . . . . . 0 N--CA 1.48 1.053 0 C-N-CA 125.664 1.586 . . . . 0.0 114.268 -178.451 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt . . . . . 0 C--O 1.234 0.273 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -140.0 161.29 37.96 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.158 0.983 . . . . 0.0 109.951 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -132.6 124.92 29.28 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.739 0.304 . . . . 0.0 110.595 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.4 m -122.75 162.25 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.439 1.496 . . . . 0.0 111.18 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -60.42 157.87 13.08 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.345 1.058 . . . . 0.0 111.189 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.4 tp -156.74 137.82 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.218 1.007 . . . . 0.0 109.267 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -130.52 161.97 30.28 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 126.69 1.996 . . . . 0.0 109.628 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -128.73 159.3 36.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.042 1.337 . . . . 0.0 110.899 174.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -80.08 121.44 25.53 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 122.125 -0.36 . . . . 0.0 110.319 170.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.53 171.91 2.33 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.452 1.101 . . . . 0.0 112.258 171.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -55.13 -14.76 1.77 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.425 1.89 . . . . 0.0 115.343 174.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.9 t -113.03 11.46 18.98 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.95 1.3 . . . . 0.0 112.786 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.9 21.3 78.71 Favored Glycine 0 CA--C 1.537 1.409 0 O-C-N 120.553 -1.342 . . . . 0.0 114.334 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -98.17 127.79 44.31 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.843 1.257 . . . . 0.0 109.483 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -67.15 126.83 30.44 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.783 -0.573 . . . . 0.0 110.631 173.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.6 t -140.07 140.09 36.05 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.186 1.394 . . . . 0.0 110.138 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -58.19 141.05 51.74 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.8 tp -113.11 -48.9 2.95 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.758 0.823 . . . . 0.0 110.927 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.4 -111.85 0.47 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.141 0.4 . . . . 0.0 113.32 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -147.15 146.36 29.87 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.473 1.509 . . . . 0.0 110.008 -175.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 16.5 tp -114.68 106.66 14.49 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.674 1.189 . . . . 0.0 110.513 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.8 t -77.56 100.95 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.624 1.169 . . . . 0.0 109.137 173.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.6 t -90.02 123.79 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.156 1.382 . . . . 0.0 109.603 173.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 . . . . . 0 N--CA 1.473 0.677 0 C-N-CA 127.475 2.31 . . . . 0.0 109.792 -178.266 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.934 0 CA-C-O 121.362 0.423 . . . . 0.0 114.075 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.2 mt -117.33 142.88 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.717 0.807 . . . . 0.0 110.075 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -128.97 143.78 50.98 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.296 1.438 . . . . 0.0 109.664 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.1 p -135.31 148.83 49.61 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.299 -0.876 . . . . 0.0 112.043 -174.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.62 124.74 2.15 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-O 121.698 0.61 . . . . 0.0 112.739 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.46 HD12 ' CD1' ' A' ' 114' ' ' TYR . 3.2 tm? -74.45 139.06 43.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.147 1.779 . . . . 0.0 110.436 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.411 ' N ' HD13 ' A' ' 76' ' ' LEU . 48.4 t30 . . . . . 0 CA--C 1.547 0.849 0 C-N-CA 126.097 1.759 . . . . 0.0 111.106 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.708 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.2 m -56.01 128.34 34.84 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.523 0.729 . . . . 0.0 110.382 169.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -93.86 -51.11 5.03 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.478 0.711 . . . . 0.0 110.218 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -167.05 164.81 15.93 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.894 1.278 . . . . 0.0 112.661 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.89 146.29 28.99 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.608 1.163 . . . . 0.0 112.563 176.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.494 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -127.53 158.27 37.87 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.417 1.487 . . . . 0.0 112.111 -176.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -77.5 165.33 24.48 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.606 0.717 . . . . 0.0 112.494 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -56.0 -35.78 67.18 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.151 0.98 . . . . 0.0 112.335 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -69.0 -8.88 49.08 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.153 0.981 . . . . 0.0 113.5 175.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.9 t -113.31 -6.58 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.494 1.118 . . . . 0.0 110.834 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 67.7 t -49.85 -67.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.609 1.164 . . . . 0.0 111.87 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -67.12 -24.86 65.96 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.697 -0.627 . . . . 0.0 112.633 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -53.56 54.47 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.527 1.531 . . . . 0.0 110.813 173.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -62.51 -43.62 98.36 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.445 1.498 . . . . 0.0 111.642 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 74.3 t -56.62 -37.83 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.471 0.708 . . . . 0.0 110.733 176.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -68.1 -53.18 27.33 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.431 1.092 . . . . 0.0 113.059 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.32 -14.51 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 O-C-N 121.003 -1.06 . . . . 0.0 112.427 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.532 ' CG ' HD13 ' A' ' 166' ' ' LEU . 6.5 ttm -92.54 -4.65 53.18 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 120.465 -1.397 . . . . 0.0 112.802 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.5 p -126.75 -12.06 6.02 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.34 1.056 . . . . 0.0 113.114 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -136.98 -10.85 1.75 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.934 1.694 . . . . 0.0 114.415 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.27 154.64 10.02 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.728 1.632 . . . . 0.0 114.18 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.09 -168.66 33.04 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.672 1.13 . . . . 0.0 113.953 -175.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.7 p -146.24 107.38 4.18 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.873 1.269 . . . . 0.0 113.502 -168.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -136.44 149.42 48.24 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.308 1.843 . . . . 0.0 110.243 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -76.28 163.32 27.14 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.247 -0.908 . . . . 0.0 111.334 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.5 p -128.83 142.37 50.99 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.981 1.313 . . . . 0.0 111.32 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.494 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 8.4 t -53.52 -44.15 68.9 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.433 1.493 . . . . 0.0 112.256 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 mt -151.34 142.23 22.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.846 1.658 . . . . 0.0 111.691 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -136.12 102.66 5.08 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.072 0.949 . . . . 0.0 110.811 175.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -87.22 -48.53 7.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.01 0.924 . . . . 0.0 112.984 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.98 165.5 34.0 Favored Glycine 0 CA--C 1.545 1.933 0 C-N-CA 124.748 1.166 . . . . 0.0 112.584 -168.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.46 ' CD1' HD12 ' A' ' 76' ' ' LEU . 5.6 t80 . . . . . 0 N--CA 1.474 0.773 0 C-N-CA 124.479 1.111 . . . . 0.0 113.908 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.56 0 CA-C-O 121.312 0.396 . . . . 0.0 113.86 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.7 mt -125.72 115.83 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.807 1.643 . . . . 0.0 108.612 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -74.47 146.92 42.39 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.992 0.425 . . . . 0.0 111.836 173.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 57.47 23.36 9.01 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.136 1.774 . . . . 0.0 114.467 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -63.7 123.24 18.36 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.715 1.206 . . . . 0.0 111.727 -171.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -71.33 125.38 26.82 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.538 1.135 . . . . 0.0 111.636 177.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.7 mm -120.97 119.51 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.755 1.222 . . . . 0.0 109.169 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.3 100.27 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.88 1.272 . . . . 0.0 108.67 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 47.9 p -79.26 159.62 27.19 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.068 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.1 141.48 20.66 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.114 1.366 . . . . 0.0 111.305 171.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.5 mt -83.07 136.31 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.598 0.759 . . . . 0.0 109.275 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 . . . . . 0 N--CA 1.469 0.514 0 C-N-CA 124.877 1.271 . . . . 0.0 110.974 173.964 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 121.228 0.537 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -105.42 165.25 11.26 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.486 1.514 . . . . 0.0 111.009 170.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 6.3 tp -115.7 137.04 50.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 125.743 1.617 . . . . 0.0 107.793 169.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 p -126.95 157.63 38.96 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.499 0.72 . . . . 0.0 109.772 173.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -151.27 138.63 19.42 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.015 0.926 . . . . 0.0 111.603 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.3 m -78.88 111.28 14.88 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.074 0.95 . . . . 0.0 110.821 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.71 -161.95 32.74 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.435 1.016 . . . . 0.0 113.125 175.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -63.69 170.58 3.19 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-O 121.898 0.856 . . . . 0.0 112.568 169.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -92.21 108.21 19.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.623 1.569 . . . . 0.0 111.517 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.477 0.876 0 C-N-CA 123.36 0.664 . . . . 0.0 112.192 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.476 0.861 0 CA-C-O 120.47 0.176 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.45 108.89 2.54 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 169.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -110.11 143.0 40.81 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.378 1.085 . . . . 0.0 110.675 172.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -133.39 170.15 15.89 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.97 1.708 . . . . 0.0 110.696 -170.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.31 132.26 20.23 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.532 0.333 . . . . 0.0 110.174 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 67.3 mt -125.2 138.88 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.3 m -62.88 99.2 0.15 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.735 0.698 . . . . 0.0 109.294 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.508 ' HA ' HD12 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -56.27 -30.57 62.63 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.588 0.755 . . . . 0.0 111.829 177.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.45 -31.57 69.96 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -87.84 -22.4 24.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.091 0.956 . . . . 0.0 112.356 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.532 HD13 ' CG ' ' A' ' 100' ' ' MET . 18.1 mt -64.25 -44.02 93.1 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.94 0.896 . . . . 0.0 111.085 168.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -55.07 -40.7 70.64 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.921 0.889 . . . . 0.0 112.153 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp . . . . . 0 N--CA 1.48 1.037 0 C-N-CA 125.733 1.613 . . . . 0.0 115.319 175.379 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 121.736 0.779 . . . . 0.0 111.907 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -147.32 155.93 42.46 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.974 0.91 . . . . 0.0 109.346 166.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 m -122.24 131.19 53.81 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.572 0.349 . . . . 0.0 110.775 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.0 m -129.27 166.09 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 125.646 1.579 . . . . 0.0 111.605 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -63.89 159.24 20.17 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.706 1.202 . . . . 0.0 111.806 177.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.0 tp -154.27 136.68 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.241 1.416 . . . . 0.0 109.571 174.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -128.89 161.93 28.71 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.498 1.919 . . . . 0.0 109.848 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -131.4 156.65 45.2 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.842 1.257 . . . . 0.0 111.338 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 119.59 20.18 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 171.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -63.27 175.51 0.95 Allowed 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 122.053 0.93 . . . . 0.0 111.728 170.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -60.36 -11.45 6.67 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.725 2.01 . . . . 0.0 114.6 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.8 m -115.64 13.49 16.3 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.169 1.388 . . . . 0.0 112.86 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.71 23.18 77.28 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 121.281 -0.887 . . . . 0.0 114.318 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -100.26 124.23 45.45 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.807 1.243 . . . . 0.0 109.674 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -64.93 123.94 20.75 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.974 0.51 . . . . 0.0 110.952 173.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.0 t -138.49 137.4 37.09 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.207 1.403 . . . . 0.0 110.402 -174.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -57.43 137.08 56.59 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.345 0.658 . . . . 0.0 112.516 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.8 tp -110.39 -47.65 3.26 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.667 0.787 . . . . 0.0 111.173 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.03 -128.98 1.55 Allowed Glycine 0 CA--C 1.528 0.86 0 CA-C-O 121.341 0.412 . . . . 0.0 113.665 -173.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -140.58 155.75 46.49 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.734 1.613 . . . . 0.0 109.621 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.8 tp -120.19 99.46 6.6 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.453 1.501 . . . . 0.0 109.662 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.3 t -76.71 101.96 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 125.321 1.448 . . . . 0.0 109.491 175.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.1 t -92.08 92.97 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.088 1.755 . . . . 0.0 109.712 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 . . . . . 0 N--CA 1.471 0.606 0 C-N-CA 125.814 1.645 . . . . 0.0 110.564 175.277 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.996 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.4 mt -124.12 145.49 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.159 0.984 . . . . 0.0 109.657 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -137.1 128.81 28.79 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.184 0.994 . . . . 0.0 110.593 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.8 p -117.54 147.25 42.96 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.381 1.072 . . . . 0.0 111.318 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -139.16 120.83 1.97 Allowed Glycine 0 CA--C 1.522 0.497 0 O-C-N 121.909 -0.495 . . . . 0.0 112.444 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.71 121.81 17.25 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.459 1.504 . . . . 0.0 109.107 173.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.1 t30 . . . . . 0 CA--C 1.538 0.516 0 C-N-CA 126.453 1.901 . . . . 0.0 109.112 -177.085 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.738 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.1 m -55.4 136.21 49.66 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.05 -1.031 . . . . 0.0 110.887 171.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -106.49 -51.46 2.95 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.564 1.146 . . . . 0.0 110.417 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -164.4 154.8 14.67 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.412 0.685 . . . . 0.0 112.388 170.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.55 154.85 44.83 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.431 1.11 . . . . 0.0 111.44 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.476 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -141.34 159.75 41.56 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.967 1.307 . . . . 0.0 111.647 -174.504 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -79.83 165.71 22.44 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.592 0.757 . . . . 0.0 112.029 -175.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -55.74 -32.31 63.28 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.138 -0.976 . . . . 0.0 113.422 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.47 -14.13 62.79 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 t -106.83 -8.23 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.38 1.072 . . . . 0.0 111.262 -174.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 97' ' ' VAL . 81.0 t -49.92 -63.38 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 125.23 1.412 . . . . 0.0 111.462 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -69.63 -25.67 64.04 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -52.08 59.19 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.217 1.407 . . . . 0.0 110.72 174.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -61.78 -43.34 99.04 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.633 1.573 . . . . 0.0 111.505 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 93' ' ' VAL . 73.6 t -54.5 -38.27 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.252 1.021 . . . . 0.0 110.566 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -69.37 -53.75 17.93 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.585 1.154 . . . . 0.0 112.541 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.7 m -72.3 -20.6 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 121.028 -1.045 . . . . 0.0 112.248 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.58 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -83.46 -4.67 58.72 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.239 -1.538 . . . . 0.0 112.103 174.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 79.9 p -128.53 -12.56 4.94 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -137.68 -10.5 1.6 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.036 1.734 . . . . 0.0 114.166 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.33 155.33 11.05 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.879 1.704 . . . . 0.0 113.86 -174.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.87 -171.66 33.8 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.673 1.13 . . . . 0.0 113.292 -174.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.0 p -145.47 103.83 3.85 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.518 1.127 . . . . 0.0 113.184 -168.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -131.66 150.53 52.12 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.962 1.705 . . . . 0.0 110.152 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.71 157.22 30.19 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.265 -0.897 . . . . 0.0 111.578 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.6 p -122.94 155.84 35.93 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.162 1.785 . . . . 0.0 110.687 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.476 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 77.1 p -71.09 -38.09 72.41 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.7 -0.625 . . . . 0.0 111.568 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.8 mt -154.43 137.67 15.71 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.147 1.779 . . . . 0.0 111.809 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -134.89 102.62 5.3 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.878 0.871 . . . . 0.0 110.48 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -86.77 -45.2 11.14 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.381 1.073 . . . . 0.0 113.381 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.29 -178.77 30.14 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 124.8 1.19 . . . . 0.0 113.865 -169.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 24.4 t80 . . . . . 0 CA--C 1.554 1.13 0 C-N-CA 125.291 1.436 . . . . 0.0 113.351 171.373 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.271 0 CA-C-O 121.914 0.73 . . . . 0.0 112.841 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 55.9 mt -124.63 109.62 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.501 1.52 . . . . 0.0 107.402 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -68.93 145.14 53.9 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.179 0.514 . . . . 0.0 111.139 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 60.71 21.04 11.05 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.573 1.549 . . . . 0.0 114.389 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 21.2 tptp -56.24 123.91 16.15 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.571 1.148 . . . . 0.0 111.287 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -73.41 128.87 36.7 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.968 0.907 . . . . 0.0 110.237 170.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 38.2 mm -121.73 112.61 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.187 0.995 . . . . 0.0 109.112 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.11 91.12 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.842 1.257 . . . . 0.0 109.103 -174.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 44.8 p -75.46 155.23 36.46 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.326 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -152.29 141.45 21.36 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.028 1.331 . . . . 0.0 111.399 172.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.1 mt -80.04 132.27 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.239 0.615 . . . . 0.0 109.405 175.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 . . . . . 0 N--CA 1.469 0.516 0 C-N-CA 125.082 1.353 . . . . 0.0 111.021 172.475 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 CA--C 1.536 0.436 0 CA-C-O 121.278 0.561 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -106.73 169.12 8.72 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.275 1.43 . . . . 0.0 110.444 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.0 tp -123.82 134.11 67.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 125.531 1.532 . . . . 0.0 108.283 172.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 p -121.36 153.75 37.37 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.192 0.597 . . . . 0.0 110.151 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -151.81 144.98 24.63 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.237 1.015 . . . . 0.0 111.29 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 p -77.7 116.45 18.24 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.195 1.398 . . . . 0.0 111.746 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.29 -158.67 30.21 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.575 1.56 . . . . 0.0 112.214 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.07 164.31 20.48 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 122.022 0.915 . . . . 0.0 113.422 170.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -81.61 102.59 10.75 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.175 0.99 . . . . 0.0 111.086 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.471 0.619 0 C-N-CA 123.404 0.681 . . . . 0.0 112.684 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.471 0.586 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -59.98 133.1 55.78 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 168.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -125.55 143.68 50.9 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.51 1.148 . . . . 0.0 110.473 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -131.23 169.18 16.3 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.851 1.661 . . . . 0.0 110.687 -170.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.28 130.67 19.82 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.901 0.48 . . . . 0.0 110.013 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.476 ' CG2' HD11 ' A' ' 166' ' ' LEU . 60.9 mt -126.24 140.54 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.883 0.873 . . . . 0.0 108.847 177.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.0 m -65.78 94.55 0.21 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.038 0.935 . . . . 0.0 109.772 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.553 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.0 OUTLIER -53.68 -33.06 54.08 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.512 1.125 . . . . 0.0 111.682 175.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -66.94 -27.27 67.33 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 176.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -89.91 -29.9 18.22 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.115 0.966 . . . . 0.0 112.875 174.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.58 HD13 ' HG3' ' A' ' 100' ' ' MET . 20.3 mt -59.3 -47.61 84.75 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.45 0.7 . . . . 0.0 110.643 172.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -50.89 -37.79 45.88 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.563 1.145 . . . . 0.0 113.746 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 179.735 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.0 pttm . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 120.851 0.358 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -142.26 174.28 10.76 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.146 1.378 . . . . 0.0 110.763 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -140.43 137.2 33.77 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.286 -0.884 . . . . 0.0 111.097 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.2 m -133.4 162.06 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 125.444 1.497 . . . . 0.0 111.718 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -61.75 155.14 23.65 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.443 1.097 . . . . 0.0 111.893 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.4 tp -150.94 136.16 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.789 1.236 . . . . 0.0 109.784 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -125.75 161.82 26.46 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.906 2.082 . . . . 0.0 109.488 176.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -130.8 154.58 47.87 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.162 1.385 . . . . 0.0 111.077 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -79.41 117.51 20.45 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.957 -0.464 . . . . 0.0 109.841 169.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -64.24 172.47 2.46 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 122.619 1.199 . . . . 0.0 111.176 169.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -57.0 -22.38 38.1 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.42 2.288 . . . . 0.0 113.125 173.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.4 m -83.67 -4.1 58.32 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.696 1.598 . . . . 0.0 114.15 174.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.68 34.42 66.86 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.846 1.213 . . . . 0.0 114.133 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -122.29 139.19 54.09 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.259 1.424 . . . . 0.0 110.689 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -70.93 119.96 15.82 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.645 1.178 . . . . 0.0 110.9 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -133.87 141.87 47.56 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.149 1.38 . . . . 0.0 110.138 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -59.21 140.2 56.18 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -173.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.5 tp -114.11 -47.86 2.93 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.032 0.933 . . . . 0.0 111.34 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.79 -119.02 0.81 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 123.267 0.461 . . . . 0.0 113.176 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -145.37 152.7 40.28 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.639 1.576 . . . . 0.0 110.184 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.2 tp -117.46 104.58 11.23 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.777 1.231 . . . . 0.0 110.525 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.4 t -77.82 100.37 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.507 1.123 . . . . 0.0 109.619 174.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 52.1 t -90.1 113.09 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.031 1.332 . . . . 0.0 110.36 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 . . . . . 0 N--CA 1.473 0.686 0 C-N-CA 127.044 2.138 . . . . 0.0 110.566 176.807 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.183 0 N-CA-C 113.971 0.348 . . . . 0.0 113.971 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.1 mt -119.61 143.2 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.101 0.96 . . . . 0.0 109.401 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -135.81 138.59 42.72 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.092 0.957 . . . . 0.0 110.059 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.5 p -131.54 147.63 52.55 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.488 -0.758 . . . . 0.0 111.724 -169.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.96 124.48 2.36 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-O 121.636 0.575 . . . . 0.0 112.954 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.9 137.05 51.3 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.103 1.761 . . . . 0.0 110.212 176.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.6 t30 . . . . . 0 CA--C 1.544 0.739 0 C-N-CA 126.031 1.733 . . . . 0.0 110.274 179.606 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.523 0 CA-C-O 120.772 0.32 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.2 m -55.54 132.75 49.39 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.485 -0.759 . . . . 0.0 110.146 169.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -99.89 -51.1 3.8 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.884 0.874 . . . . 0.0 109.842 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -163.98 161.57 22.81 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.12 0.968 . . . . 0.0 112.286 170.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.44 150.77 36.27 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.829 0.852 . . . . 0.0 111.512 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.51 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.8 OUTLIER -141.24 156.25 45.92 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.288 1.435 . . . . 0.0 111.845 -174.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -77.79 165.33 24.31 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.482 0.713 . . . . 0.0 112.601 -172.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -52.85 -34.0 52.28 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.605 1.162 . . . . 0.0 112.897 172.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -66.65 -11.81 55.5 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.87 1.268 . . . . 0.0 113.658 175.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.8 t -116.22 -5.23 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.971 1.308 . . . . 0.0 111.357 -172.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 69.6 t -50.18 -62.41 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 125.293 1.437 . . . . 0.0 111.899 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -70.25 -28.13 64.99 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -62.29 -50.48 71.52 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.446 1.498 . . . . 0.0 110.909 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -60.18 -43.84 95.52 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.996 1.318 . . . . 0.0 111.327 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 42.1 t -62.1 -34.16 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 123.705 0.802 . . . . 0.0 111.349 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -63.8 -54.56 33.19 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.459 1.104 . . . . 0.0 111.996 172.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -73.17 -2.55 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.587 ' CG ' HD13 ' A' ' 166' ' ' LEU . 2.3 ttm -114.48 1.91 14.47 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.038 1.335 . . . . 0.0 112.925 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.5 p -124.76 -12.56 7.1 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.762 1.225 . . . . 0.0 112.156 168.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -138.1 -15.14 1.32 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.79 155.09 26.81 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 124.895 1.236 . . . . 0.0 114.125 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.13 -160.1 31.35 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 123.963 0.792 . . . . 0.0 114.363 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.5 p -151.91 98.75 2.49 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -170.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -131.65 146.06 51.99 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.275 1.83 . . . . 0.0 110.132 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.23 155.75 36.47 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.461 -0.774 . . . . 0.0 110.778 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 47.0 p -114.69 158.11 22.23 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.539 1.136 . . . . 0.0 111.009 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.51 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 77.0 p -70.54 -37.87 74.12 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.387 -0.821 . . . . 0.0 110.823 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.2 mt -148.04 150.83 34.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.962 2.105 . . . . 0.0 112.171 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -143.7 107.95 4.78 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.382 1.073 . . . . 0.0 110.252 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -96.88 -40.46 8.9 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.411 1.084 . . . . 0.0 113.585 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.66 178.51 29.99 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.796 1.188 . . . . 0.0 115.616 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 33.6 t80 . . . . . 0 CA--C 1.548 0.896 0 C-N-CA 123.915 0.886 . . . . 0.0 112.075 169.446 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.577 0 N-CA-C 114.576 0.59 . . . . 0.0 114.576 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.2 mt -126.62 112.17 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.874 1.67 . . . . 0.0 108.536 174.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -70.98 145.24 50.16 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.101 0.477 . . . . 0.0 111.311 172.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 59.29 22.53 10.86 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.713 1.605 . . . . 0.0 114.137 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -54.13 127.86 28.48 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.92 1.288 . . . . 0.0 111.248 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -75.12 130.12 38.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.085 0.554 . . . . 0.0 110.544 170.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 32.8 mm -126.55 120.28 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.835 1.254 . . . . 0.0 108.668 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.68 101.55 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 125.303 1.441 . . . . 0.0 108.71 -176.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.4 p -86.29 159.3 19.47 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.485 0.714 . . . . 0.0 112.317 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -154.89 139.24 16.72 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.066 1.346 . . . . 0.0 111.736 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 26.2 mt -77.29 133.57 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.087 0.555 . . . . 0.0 109.911 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 CA--C 1.538 0.512 0 C-N-CA 125.747 1.619 . . . . 0.0 111.038 171.957 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 . . . . . 0 CA--C 1.537 0.467 0 CA-C-O 121.28 0.562 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -112.68 165.92 11.83 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.33 1.452 . . . . 0.0 110.692 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.1 tp -120.77 132.27 70.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 125.472 1.509 . . . . 0.0 108.117 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.3 p -122.45 154.76 37.34 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.571 0.748 . . . . 0.0 110.05 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -150.95 148.08 27.96 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.709 0.804 . . . . 0.0 111.844 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.4 p -80.74 125.42 30.04 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.695 1.198 . . . . 0.0 111.552 174.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.66 -151.77 26.63 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.085 1.326 . . . . 0.0 113.187 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -78.92 172.19 14.13 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.465 1.506 . . . . 0.0 110.331 168.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -82.31 119.29 23.94 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.709 -1.245 . . . . 0.0 110.805 173.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.773 0 C-N-CA 122.818 0.447 . . . . 0.0 111.36 173.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.51 117.62 7.0 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -117.96 140.23 50.02 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 122.181 0.991 . . . . 0.0 110.17 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -133.1 168.54 18.32 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.304 1.442 . . . . 0.0 111.327 -169.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.82 130.64 18.09 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.264 0.626 . . . . 0.0 109.9 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.42 ' CG2' HD11 ' A' ' 166' ' ' LEU . 69.6 mt -122.57 140.33 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.135 0.974 . . . . 0.0 108.536 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.9 m -64.11 95.81 0.13 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.192 0.997 . . . . 0.0 110.049 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.531 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.3 tt -55.32 -31.87 62.02 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.501 1.12 . . . . 0.0 111.757 175.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -69.48 -29.72 67.44 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.59 -33.51 47.52 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.292 0.951 . . . . 0.0 112.681 171.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.587 HD13 ' CG ' ' A' ' 100' ' ' MET . 22.4 mt -62.28 -48.82 78.21 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.309 1.043 . . . . 0.0 110.741 175.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -48.81 -38.19 21.42 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.785 1.175 . . . . 0.0 113.531 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.6 mttt . . . . . 0 N--CA 1.486 1.354 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 177.885 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -140.93 165.62 27.03 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.091 0.956 . . . . 0.0 110.842 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -136.04 132.76 36.65 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.16 -0.338 . . . . 0.0 111.322 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.1 m -131.79 159.77 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.353 1.461 . . . . 0.0 111.866 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -57.98 153.75 13.79 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.747 0.819 . . . . 0.0 112.45 175.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.0 tp -149.96 137.16 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.336 1.455 . . . . 0.0 109.714 174.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -132.57 161.25 34.31 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.718 2.007 . . . . 0.0 109.674 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -134.62 160.08 39.21 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.367 1.067 . . . . 0.0 112.162 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.21 114.45 21.82 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.545 0.738 . . . . 0.0 110.625 173.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -73.59 -176.65 2.41 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.779 0.832 . . . . 0.0 112.276 175.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt -55.92 -26.65 48.62 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.489 1.916 . . . . 0.0 113.167 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.0 m -73.75 -8.25 55.28 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.342 1.457 . . . . 0.0 113.87 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.24 40.46 97.38 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.258 0.932 . . . . 0.0 112.4 -169.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -132.61 137.64 47.11 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.562 1.945 . . . . 0.0 109.097 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -67.3 130.64 43.71 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.64 0.776 . . . . 0.0 111.178 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.3 t -137.53 138.46 39.67 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.942 1.297 . . . . 0.0 110.317 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -57.17 125.88 24.71 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.443 1.097 . . . . 0.0 112.286 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.9 tp -100.73 -45.87 5.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.863 0.865 . . . . 0.0 111.092 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.86 -120.36 0.91 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.473 0.559 . . . . 0.0 113.468 -177.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -145.5 155.76 43.3 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.565 1.546 . . . . 0.0 109.575 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.5 tp -121.83 104.81 9.83 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.5 1.12 . . . . 0.0 110.698 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.2 t -77.72 98.95 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.847 1.259 . . . . 0.0 109.355 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 51.6 t -86.06 117.44 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.042 1.737 . . . . 0.0 110.197 174.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 . . . . . 0 N--CA 1.473 0.72 0 C-N-CA 126.973 2.109 . . . . 0.0 110.82 179.322 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.184 0 CA-C-O 121.182 0.323 . . . . 0.0 113.341 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.4 mt -117.31 143.96 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.074 0.95 . . . . 0.0 109.708 171.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -131.35 140.9 49.81 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.107 1.363 . . . . 0.0 109.459 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.7 p -133.15 146.92 52.01 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.134 -0.979 . . . . 0.0 112.433 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.05 126.51 3.25 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-O 121.769 0.649 . . . . 0.0 112.944 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.05 137.35 53.51 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.561 1.945 . . . . 0.0 110.128 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.9 t30 . . . . . 0 CA--C 1.547 0.838 0 C-N-CA 126.1 1.76 . . . . 0.0 110.678 -176.04 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.728 0 N-CA-C 111.413 0.153 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.3 m -58.55 136.4 57.56 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.24 -0.913 . . . . 0.0 109.262 169.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -104.45 -48.29 3.86 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.904 0.882 . . . . 0.0 110.022 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -162.38 170.5 18.7 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.416 1.086 . . . . 0.0 112.307 169.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.77 158.09 43.73 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.764 1.226 . . . . 0.0 111.62 170.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.521 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -140.5 158.38 44.09 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.926 1.29 . . . . 0.0 111.466 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -80.05 165.13 22.84 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.15 0.58 . . . . 0.0 111.834 -174.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -53.11 -33.96 54.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.602 1.161 . . . . 0.0 112.857 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -67.26 -8.44 31.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.937 1.295 . . . . 0.0 113.556 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.61 -6.69 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.586 1.154 . . . . 0.0 111.306 -172.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 79.5 t -52.12 -60.91 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 O-C-N 120.404 -1.435 . . . . 0.0 112.231 -176.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -69.0 -27.01 65.31 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.47 -52.79 59.89 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.477 1.511 . . . . 0.0 110.856 175.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.96 -46.65 89.84 Favored 'General case' 0 C--O 1.227 -0.093 0 C-N-CA 125.041 1.336 . . . . 0.0 110.484 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.74 -35.48 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.232 0.613 . . . . 0.0 111.461 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -63.07 -54.69 34.04 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.416 1.086 . . . . 0.0 112.215 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -70.25 -12.24 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 121.551 -0.718 . . . . 0.0 112.419 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.56 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -94.44 -4.63 47.93 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.745 2.018 . . . . 0.0 112.186 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 34.3 p -126.39 -15.0 5.76 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 169.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -130.75 -10.55 3.93 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.942 1.297 . . . . 0.0 114.257 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.64 155.93 7.78 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.241 1.4 . . . . 0.0 113.698 -174.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.8 -170.51 32.49 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.032 0.825 . . . . 0.0 114.064 -174.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.4 p -143.44 109.4 5.25 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.927 1.291 . . . . 0.0 113.529 -168.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -138.05 148.45 45.1 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.364 1.866 . . . . 0.0 109.825 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 155.65 35.1 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.691 -0.63 . . . . 0.0 110.913 177.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 58.9 p -117.85 158.25 25.17 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.921 1.688 . . . . 0.0 110.958 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.521 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 60.0 p -74.35 -39.96 62.44 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.576 -0.703 . . . . 0.0 111.121 -177.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.3 mt -151.11 143.19 24.0 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.631 1.973 . . . . 0.0 111.919 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -138.22 98.52 3.64 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.885 0.874 . . . . 0.0 111.583 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -86.55 -40.12 15.54 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.67 178.26 7.65 Favored Glycine 0 CA--C 1.546 1.971 0 C-N-CA 124.378 0.989 . . . . 0.0 114.339 -169.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 40.5 t80 . . . . . 0 CA--C 1.55 0.947 0 C-N-CA 124.78 1.232 . . . . 0.0 112.546 169.92 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.423 0 CA-C-O 121.875 0.708 . . . . 0.0 113.199 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 62.5 mt -126.59 110.79 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.502 1.521 . . . . 0.0 108.149 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -69.7 145.27 52.46 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.305 0.574 . . . . 0.0 111.419 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 60.07 19.85 9.05 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.773 1.629 . . . . 0.0 114.466 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -54.73 124.06 15.24 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.638 1.175 . . . . 0.0 111.735 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -72.44 129.81 39.23 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.214 1.006 . . . . 0.0 110.644 171.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.0 mm -126.82 119.35 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.764 1.225 . . . . 0.0 108.922 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.75 98.32 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.274 1.43 . . . . 0.0 108.679 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.5 p -81.92 155.56 25.21 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.709 0.804 . . . . 0.0 112.125 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -151.39 140.05 20.71 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.098 1.359 . . . . 0.0 111.182 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 46.1 mt -79.95 133.06 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 . . . . . 0 N--CA 1.469 0.483 0 C-N-CA 125.188 1.395 . . . . 0.0 110.953 176.348 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 . . . . . 0 CA--C 1.54 0.57 0 CA-C-O 121.174 0.511 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -113.25 169.12 9.17 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.281 1.432 . . . . 0.0 109.91 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.9 tp -120.77 133.66 66.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.06 1.344 . . . . 0.0 108.519 169.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.1 p -121.8 155.08 36.08 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.596 0.758 . . . . 0.0 110.214 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -147.14 145.02 29.42 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.598 0.759 . . . . 0.0 112.246 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.3 p -74.91 108.71 7.82 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.982 1.313 . . . . 0.0 111.49 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.77 -162.35 33.47 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 123.83 0.729 . . . . 0.0 113.535 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -69.6 173.78 5.71 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 121.673 -0.898 . . . . 0.0 110.029 167.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -84.17 137.77 33.34 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.659 -1.276 . . . . 0.0 111.661 173.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.779 0 C-N-CA 123.174 0.589 . . . . 0.0 111.74 169.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -72.94 88.94 1.38 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.352 0.661 . . . . 0.0 109.763 173.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -76.64 147.39 37.56 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 122.113 0.959 . . . . 0.0 110.675 168.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -131.83 172.93 11.7 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.902 1.681 . . . . 0.0 111.013 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.34 131.72 18.59 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.324 0.65 . . . . 0.0 110.232 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 68.9 mt -123.6 140.76 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.185 0.994 . . . . 0.0 109.021 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.3 m -63.88 97.4 0.16 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.22 1.008 . . . . 0.0 109.865 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.6 tt -54.19 -32.43 55.62 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.218 1.007 . . . . 0.0 111.571 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.18 -28.12 69.17 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -85.88 -33.27 21.29 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.35 0.977 . . . . 0.0 112.923 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.56 HD13 ' HG3' ' A' ' 100' ' ' MET . 44.8 mt -58.45 -47.47 83.9 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.261 1.024 . . . . 0.0 110.19 175.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -53.93 -23.61 13.48 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 175.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 93.0 mttt . . . . . 0 N--CA 1.483 1.195 0 C-N-CA 124.672 1.189 . . . . 0.0 114.163 179.786 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? . . . . . 0 N--CA 1.465 0.312 0 CA-C-O 121.624 0.726 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -143.25 170.3 16.02 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.061 1.744 . . . . 0.0 110.664 169.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.29 134.26 34.1 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.668 -0.645 . . . . 0.0 110.435 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.1 m -130.16 163.54 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.237 1.415 . . . . 0.0 111.321 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -60.35 156.35 15.97 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.969 0.908 . . . . 0.0 111.649 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.3 tp -151.3 135.09 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.695 1.198 . . . . 0.0 109.282 172.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -126.59 156.81 40.31 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.43 1.892 . . . . 0.0 108.777 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -126.03 155.09 42.05 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.67 1.188 . . . . 0.0 111.196 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -80.12 118.49 21.87 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 168.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -67.43 178.04 1.71 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 122.326 1.06 . . . . 0.0 113.119 170.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -17.19 50.63 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.923 1.289 . . . . 0.0 113.589 176.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.2 m -95.73 1.78 53.56 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.61 1.164 . . . . 0.0 112.508 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.37 21.31 79.06 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-N 119.64 1.109 . . . . 0.0 114.494 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -102.2 137.24 40.72 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.646 1.178 . . . . 0.0 110.822 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -67.84 123.96 22.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.824 0.849 . . . . 0.0 110.35 170.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -140.7 143.09 34.85 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.705 1.202 . . . . 0.0 110.453 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -58.18 139.19 55.39 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.2 tp -114.68 -46.76 2.93 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.947 0.899 . . . . 0.0 111.181 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.76 -115.01 0.61 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 122.971 0.32 . . . . 0.0 113.212 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -147.64 153.84 39.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.055 1.342 . . . . 0.0 110.148 -174.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.6 tp -121.31 105.02 10.15 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.963 1.305 . . . . 0.0 110.033 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.8 t -76.27 94.15 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.923 1.289 . . . . 0.0 109.331 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 42.8 t -81.29 99.0 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.897 1.679 . . . . 0.0 109.071 173.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 . . . . . 0 CA--C 1.54 0.57 0 C-N-CA 125.189 1.395 . . . . 0.0 111.015 174.387 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.02 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.0 mt -122.22 136.06 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.965 0.906 . . . . 0.0 110.433 173.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -123.61 141.9 51.56 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.838 2.055 . . . . 0.0 111.984 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.5 p -137.19 136.78 38.48 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.217 -0.927 . . . . 0.0 112.341 -175.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.21 127.85 5.82 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.189 0.423 . . . . 0.0 112.79 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.06 135.58 51.02 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.689 1.596 . . . . 0.0 110.22 174.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 . . . . . 0 CA--C 1.549 0.906 0 C-N-CA 125.541 1.537 . . . . 0.0 110.815 -173.74 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.678 0 CA-C-O 120.639 0.257 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 57.2 m -57.86 132.71 54.17 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.248 -0.908 . . . . 0.0 109.387 168.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -99.54 -47.49 5.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.737 0.815 . . . . 0.0 110.541 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -166.62 169.25 13.79 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.744 1.218 . . . . 0.0 112.387 171.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.53 138.51 16.36 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.43 1.092 . . . . 0.0 112.347 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.511 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -118.73 160.0 22.65 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.649 1.58 . . . . 0.0 111.767 179.063 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -83.12 167.19 18.04 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.388 0.675 . . . . 0.0 112.324 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -57.67 -32.3 67.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.073 0.949 . . . . 0.0 112.666 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -70.11 -3.8 18.34 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.436 1.094 . . . . 0.0 113.849 175.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.0 t -119.79 -3.12 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.354 1.062 . . . . 0.0 111.046 -175.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 97' ' ' VAL . 69.5 t -55.57 -61.78 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 120.461 -1.4 . . . . 0.0 111.635 -175.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -68.24 -25.0 64.97 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -54.0 40.51 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.425 1.49 . . . . 0.0 110.584 173.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -61.96 -44.23 97.19 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.35 1.46 . . . . 0.0 111.238 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 93' ' ' VAL . 63.3 t -53.98 -36.72 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.519 1.128 . . . . 0.0 111.003 177.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -70.92 -54.05 12.79 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.848 1.259 . . . . 0.0 112.379 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -70.84 -21.01 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 O-C-N 120.786 -1.196 . . . . 0.0 112.568 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.599 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -82.8 -5.11 58.79 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.093 1.757 . . . . 0.0 111.703 175.502 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.6 p -129.66 -14.77 4.06 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -136.61 -10.05 1.87 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.186 1.794 . . . . 0.0 113.932 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.42 155.18 10.93 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.722 1.63 . . . . 0.0 113.967 -175.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.64 -170.86 33.03 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.475 1.036 . . . . 0.0 113.641 -174.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.1 p -144.03 109.87 5.29 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.748 1.219 . . . . 0.0 113.527 -169.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -138.51 145.88 41.3 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.47 1.908 . . . . 0.0 109.986 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.51 147.15 42.1 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.078 -1.014 . . . . 0.0 111.754 175.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.6 p -106.58 168.1 9.4 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.603 1.561 . . . . 0.0 111.443 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.511 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 16.5 p -74.55 -39.63 62.18 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.524 -0.735 . . . . 0.0 111.118 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.0 mt -155.85 144.2 20.07 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.406 2.282 . . . . 0.0 110.605 -174.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -138.71 105.47 5.37 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.098 0.959 . . . . 0.0 111.263 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -89.42 -40.29 12.82 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.93 179.39 15.88 Favored Glycine 0 CA--C 1.545 1.928 0 C-N-CA 124.977 1.275 . . . . 0.0 114.142 -168.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 57.8 t80 . . . . . 0 CA--C 1.55 0.967 0 C-N-CA 124.261 1.024 . . . . 0.0 112.519 169.675 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.17 0 CA-C-O 122.251 0.917 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 35.2 mt -133.04 108.48 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 125.712 1.605 . . . . 0.0 107.17 172.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -68.74 145.86 53.44 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.069 0.462 . . . . 0.0 111.201 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 59.09 25.02 13.39 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.639 1.575 . . . . 0.0 114.262 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.52 130.55 43.55 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.022 1.329 . . . . 0.0 112.108 -172.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -78.75 117.97 20.37 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.972 0.909 . . . . 0.0 112.333 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 28.5 mm -108.69 118.73 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.063 0.945 . . . . 0.0 109.66 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 mp -109.98 98.51 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.212 1.405 . . . . 0.0 108.816 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 65.8 p -80.31 157.79 26.29 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.174 174.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -154.35 142.17 20.05 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.178 1.391 . . . . 0.0 111.744 172.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.7 mt -80.86 133.32 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.652 0.781 . . . . 0.0 109.222 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 CA--C 1.536 0.439 0 C-N-CA 125.604 1.562 . . . . 0.0 110.046 171.756 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 121.278 0.561 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -110.27 168.95 9.06 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.283 1.433 . . . . 0.0 110.526 173.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.2 tp -124.97 133.44 69.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 125.498 1.519 . . . . 0.0 108.474 172.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.4 p -120.55 156.99 30.43 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.547 0.739 . . . . 0.0 109.949 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -149.02 136.91 20.61 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.695 0.798 . . . . 0.0 111.626 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.6 m -75.15 107.43 7.23 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.787 1.235 . . . . 0.0 110.896 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.61 -164.24 39.54 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.554 1.073 . . . . 0.0 114.32 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -63.63 160.97 15.69 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.912 0.885 . . . . 0.0 111.475 170.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -76.86 131.95 38.88 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.187 -0.946 . . . . 0.0 110.331 172.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.468 0.472 0 C-N-CA 124.242 1.017 . . . . 0.0 111.294 173.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 120.967 0.413 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.24 93.76 0.33 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.618 1.167 . . . . 0.0 109.852 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -99.99 144.92 28.48 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 122.413 1.101 . . . . 0.0 111.462 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -137.63 174.26 10.78 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.751 1.62 . . . . 0.0 111.211 -172.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.31 133.22 20.17 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.479 0.712 . . . . 0.0 110.127 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.43 ' CG2' HD11 ' A' ' 166' ' ' LEU . 64.3 mt -125.21 140.83 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.153 0.981 . . . . 0.0 108.889 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.0 m -66.17 95.37 0.29 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.041 0.936 . . . . 0.0 109.511 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.54 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.1 tt -54.75 -31.87 59.15 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.738 1.215 . . . . 0.0 111.86 177.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -70.3 -26.29 63.72 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -89.31 -26.72 20.97 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.833 0.853 . . . . 0.0 112.439 174.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.599 HD13 ' HG3' ' A' ' 100' ' ' MET . 23.6 mt -61.55 -48.59 80.29 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.057 0.943 . . . . 0.0 110.759 169.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -51.85 -37.61 52.75 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.365 1.066 . . . . 0.0 113.636 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -178.305 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt . . . . . 0 CA--C 1.534 0.359 0 CA-C-O 121.555 0.693 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -149.15 164.48 34.62 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.168 0.987 . . . . 0.0 110.261 170.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.74 123.49 25.0 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.566 0.222 . . . . 0.0 110.658 -178.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.5 m -120.53 161.75 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.2 1.4 . . . . 0.0 111.186 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -62.14 160.36 12.94 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.793 1.237 . . . . 0.0 111.303 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.3 tp -155.96 138.21 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.576 1.15 . . . . 0.0 109.339 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -130.98 161.94 30.85 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.221 1.808 . . . . 0.0 109.729 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -134.2 159.23 41.54 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.147 1.379 . . . . 0.0 111.704 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.17 119.62 25.76 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.283 0.633 . . . . 0.0 110.535 174.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -73.7 179.94 3.92 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.238 0.615 . . . . 0.0 112.41 174.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -58.05 -24.44 58.44 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.892 1.677 . . . . 0.0 113.435 173.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.9 m -78.93 -5.49 53.86 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.848 1.259 . . . . 0.0 113.806 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.42 32.84 84.81 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.289 0.947 . . . . 0.0 113.704 -171.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -116.64 141.98 47.49 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.792 1.637 . . . . 0.0 109.854 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -69.85 133.21 47.13 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.758 0.823 . . . . 0.0 111.26 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.3 t -145.54 142.98 29.67 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.931 1.293 . . . . 0.0 110.537 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -56.98 135.89 56.22 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.284 1.034 . . . . 0.0 112.415 -174.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.1 tp -109.12 -47.76 3.37 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.591 0.756 . . . . 0.0 111.731 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.24 -130.39 2.05 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 121.712 0.618 . . . . 0.0 113.713 -175.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -137.06 152.6 50.24 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.528 1.931 . . . . 0.0 110.8 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.5 tp -119.79 104.61 10.37 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.427 1.491 . . . . 0.0 110.806 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.43 99.86 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.388 1.075 . . . . 0.0 109.544 175.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.2 t -85.11 128.06 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.161 1.385 . . . . 0.0 109.633 173.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 . . . . . 0 N--CA 1.473 0.718 0 C-N-CA 127.193 2.197 . . . . 0.0 110.137 -175.647 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.116 0 CA-C-O 121.279 0.377 . . . . 0.0 113.882 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.4 mt -112.45 139.55 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.709 0.804 . . . . 0.0 109.116 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -127.2 139.76 52.71 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.822 0.849 . . . . 0.0 110.094 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.1 p -132.09 137.27 47.68 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.59 0.756 . . . . 0.0 111.025 -173.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.29 110.48 0.83 Allowed Glycine 0 CA--C 1.52 0.387 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -170.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 32.0 tp -64.0 148.11 50.45 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.979 1.312 . . . . 0.0 110.345 175.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.3 t30 . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 126.044 1.738 . . . . 0.0 109.603 176.901 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.631 0 CA-C-O 120.692 0.282 . . . . 0.0 111.401 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.9 m -58.74 116.45 3.74 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.33 -0.856 . . . . 0.0 109.144 169.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -81.99 -52.29 7.19 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.624 0.647 . . . . 0.0 109.841 -178.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -166.19 162.44 17.55 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.94 1.296 . . . . 0.0 112.383 170.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.58 156.81 44.7 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.956 1.303 . . . . 0.0 111.399 177.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.535 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -140.97 157.93 44.65 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.104 1.362 . . . . 0.0 112.282 -177.36 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -77.09 165.34 24.72 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.535 0.734 . . . . 0.0 112.021 -173.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -57.47 -30.0 64.69 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.318 -0.864 . . . . 0.0 112.357 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -69.98 -8.31 47.98 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.549 1.54 . . . . 0.0 114.027 175.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 t -119.26 -4.38 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.777 1.231 . . . . 0.0 111.3 -173.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.3 t -50.31 -66.47 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 125.169 1.388 . . . . 0.0 111.663 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -67.69 -24.42 65.41 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.38 -51.96 63.66 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.104 1.362 . . . . 0.0 110.511 173.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -60.17 -44.13 95.29 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 124.84 1.256 . . . . 0.0 111.926 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 92.4 t -55.58 -36.25 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 122.967 0.507 . . . . 0.0 110.855 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.7 tttp -68.29 -54.94 14.04 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.534 1.133 . . . . 0.0 112.678 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -72.7 -14.6 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 121.063 -1.023 . . . . 0.0 112.518 -174.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.505 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -88.07 -6.41 57.95 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.544 1.537 . . . . 0.0 112.081 176.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 44.4 p -130.5 -14.89 3.65 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -131.74 -9.57 3.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.612 1.565 . . . . 0.0 113.849 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.4 156.5 7.95 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.473 1.511 . . . . 0.0 113.683 -176.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.1 -169.04 34.69 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.993 0.806 . . . . 0.0 113.966 -175.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 61.6 p -146.32 94.72 2.5 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.389 1.075 . . . . 0.0 113.488 -167.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -128.49 140.14 51.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.667 1.587 . . . . 0.0 109.885 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -69.45 153.17 43.95 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.454 0.701 . . . . 0.0 110.947 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.8 p -115.11 160.86 19.15 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.76 1.624 . . . . 0.0 110.942 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.535 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 82.4 p -76.38 -39.17 54.43 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.391 -0.818 . . . . 0.0 111.019 -177.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.3 mt -153.45 138.71 17.49 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.37 1.868 . . . . 0.0 111.694 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -137.45 101.6 4.55 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.246 1.018 . . . . 0.0 111.005 176.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -91.72 -36.87 13.35 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 174.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.42 -176.13 48.18 Favored Glycine 0 CA--C 1.544 1.86 0 CA-C-N 118.936 0.789 . . . . 0.0 113.902 -170.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.2 t80 . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -178.643 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.234 0 CA-C-O 122.088 0.826 . . . . 0.0 113.649 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.6 mt -133.47 103.24 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.31 1.444 . . . . 0.0 107.651 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -67.01 143.58 56.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.189 0.518 . . . . 0.0 110.834 173.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 61.82 19.33 10.51 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.468 1.507 . . . . 0.0 114.381 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 16.4 tptp -53.62 123.88 13.48 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.893 1.277 . . . . 0.0 111.456 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -70.86 127.48 32.76 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.952 0.901 . . . . 0.0 110.388 170.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.7 mm -124.88 116.53 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.386 1.075 . . . . 0.0 108.48 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.8 mp -110.31 92.42 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.006 1.322 . . . . 0.0 108.379 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.1 p -75.03 154.91 37.78 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.123 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -150.68 139.38 20.71 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.948 1.299 . . . . 0.0 111.135 174.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.4 mt -81.93 132.85 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 . . . . . 0 N--CA 1.466 0.353 0 C-N-CA 125.273 1.429 . . . . 0.0 110.126 174.33 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 . . . . . 0 CA--C 1.543 0.685 0 CA-C-O 121.057 0.456 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -106.38 166.15 10.75 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.271 1.428 . . . . 0.0 110.607 170.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.8 tp -118.66 138.19 50.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 125.525 1.53 . . . . 0.0 108.207 169.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.1 p -127.34 156.82 41.39 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.619 0.767 . . . . 0.0 109.933 174.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -150.79 146.14 26.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.13 0.972 . . . . 0.0 111.235 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 p -78.71 109.56 13.06 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.735 1.214 . . . . 0.0 111.402 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.43 -165.23 32.23 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 123.897 0.761 . . . . 0.0 113.204 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -65.33 164.3 13.85 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 122.254 1.026 . . . . 0.0 112.481 170.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -84.34 106.06 15.66 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.159 1.383 . . . . 0.0 111.172 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.802 0 CA-C-O 121.413 0.625 . . . . 0.0 112.093 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.476 0.828 0 CA-C-O 120.541 0.21 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.25 94.94 0.55 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.432 0.693 . . . . 0.0 109.442 172.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -92.31 145.45 24.47 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 122.164 0.983 . . . . 0.0 111.288 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -136.25 169.99 16.75 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.739 1.616 . . . . 0.0 111.112 -172.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.86 134.6 23.53 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 122.97 0.508 . . . . 0.0 110.495 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.466 ' CG2' HD11 ' A' ' 166' ' ' LEU . 59.7 mt -126.75 139.19 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.807 0.843 . . . . 0.0 109.263 175.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.5 m -63.09 96.9 0.1 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.232 1.013 . . . . 0.0 109.791 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.553 ' HA ' HD12 ' A' ' 166' ' ' LEU . 0.8 OUTLIER -55.35 -31.39 61.71 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.471 1.109 . . . . 0.0 111.884 177.067 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -67.86 -29.43 68.56 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -88.41 -18.88 27.39 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.036 0.934 . . . . 0.0 112.64 174.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.553 HD12 ' HA ' ' A' ' 163' ' ' LEU . 20.0 mt -70.92 -46.38 62.59 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.476 -0.765 . . . . 0.0 110.173 168.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -49.43 -48.26 47.46 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.851 1.26 . . . . 0.0 113.538 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 30.6 pttt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -177.625 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 pttm . . . . . 0 N--CA 1.475 0.807 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -154.74 170.69 21.01 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.471 1.109 . . . . 0.0 111.931 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.87 134.08 44.13 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.217 0.607 . . . . 0.0 111.261 174.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.9 m -131.13 164.19 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 125.793 1.637 . . . . 0.0 111.33 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.22 160.41 13.06 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.626 1.17 . . . . 0.0 112.111 177.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 tp -155.29 137.0 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.321 1.448 . . . . 0.0 109.963 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -127.33 159.76 33.42 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.607 1.963 . . . . 0.0 109.547 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -128.88 159.69 35.01 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.79 1.236 . . . . 0.0 111.493 176.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -87.47 118.21 26.78 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.459 0.304 . . . . 0.0 110.868 173.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -69.52 178.08 2.64 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.958 0.885 . . . . 0.0 112.712 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -60.25 -22.65 63.31 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.158 1.783 . . . . 0.0 115.035 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.8 t -85.52 -4.87 59.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.95 0.9 . . . . 0.0 112.608 174.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.4 32.35 57.99 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 121.108 -0.995 . . . . 0.0 113.299 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -109.6 142.04 41.27 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.964 1.306 . . . . 0.0 110.72 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -76.14 122.06 23.76 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.594 0.758 . . . . 0.0 110.937 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.5 t -137.43 139.39 40.64 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.135 1.374 . . . . 0.0 110.32 -175.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -57.63 141.24 48.91 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -176.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.1 tp -114.56 -47.74 2.89 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.659 0.783 . . . . 0.0 111.023 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.92 -116.27 0.64 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 123.378 0.514 . . . . 0.0 113.044 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -146.33 156.25 43.21 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.693 1.597 . . . . 0.0 109.729 -176.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.8 tp -121.16 102.27 8.2 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.153 1.381 . . . . 0.0 110.29 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.82 101.19 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.083 0.953 . . . . 0.0 109.02 171.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.9 t -88.35 127.07 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.274 1.43 . . . . 0.0 109.803 172.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 . . . . . 0 N--CA 1.475 0.782 0 C-N-CA 127.697 2.399 . . . . 0.0 110.928 -175.327 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.277 0 N-CA-C 115.096 0.799 . . . . 0.0 115.096 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 69.1 mt -113.37 142.17 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.345 1.058 . . . . 0.0 109.922 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -131.77 139.6 48.98 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.211 1.805 . . . . 0.0 109.315 -177.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.8 p -131.74 146.53 52.21 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.318 -0.864 . . . . 0.0 111.549 -171.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.45 124.0 2.41 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-O 121.699 0.61 . . . . 0.0 113.088 -177.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.72 136.18 52.47 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.434 1.894 . . . . 0.0 110.189 175.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.2 t30 . . . . . 0 CA--C 1.547 0.848 0 C-N-CA 126.367 1.867 . . . . 0.0 110.475 -175.249 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 112.278 0.474 . . . . 0.0 112.278 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.2 m -55.02 135.04 49.25 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.279 -0.888 . . . . 0.0 110.468 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -102.89 -52.6 3.03 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.796 1.238 . . . . 0.0 109.89 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -163.07 162.66 25.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.824 0.85 . . . . 0.0 112.65 170.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.25 141.31 27.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.718 0.807 . . . . 0.0 111.538 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.557 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.8 OUTLIER -121.38 156.72 32.04 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.365 1.866 . . . . 0.0 111.501 -176.305 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -75.79 163.46 27.23 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.578 0.704 . . . . 0.0 112.608 -176.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -54.93 -28.03 47.91 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.038 1.335 . . . . 0.0 113.596 171.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -72.01 -15.65 62.05 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 121.104 -0.998 . . . . 0.0 113.251 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.6 t -106.32 -5.25 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.744 1.217 . . . . 0.0 110.671 -171.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.5 m -53.8 -35.03 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -96.79 -23.33 16.45 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.677 0.791 . . . . 0.0 112.307 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -68.69 -48.87 62.8 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.623 1.569 . . . . 0.0 111.318 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -60.71 -43.28 97.99 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.271 1.428 . . . . 0.0 111.338 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.7 t -53.69 -42.76 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.247 1.019 . . . . 0.0 109.914 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -60.84 -56.08 25.38 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.416 1.086 . . . . 0.0 112.313 175.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 m -72.86 -3.34 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 121.02 -1.05 . . . . 0.0 113.456 -177.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.497 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -107.46 -3.83 19.08 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.543 1.937 . . . . 0.0 111.902 179.723 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.7 p -129.81 -13.26 4.18 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.253 1.421 . . . . 0.0 113.29 172.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -134.03 -14.71 2.35 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.076 1.75 . . . . 0.0 114.116 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.16 154.82 11.74 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 124.797 1.189 . . . . 0.0 114.26 -176.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.28 -158.35 30.39 Favored Glycine 0 CA--C 1.533 1.162 0 O-C-N 121.58 -0.953 . . . . 0.0 114.073 -176.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.6 p -151.38 105.02 3.14 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -174.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -136.56 157.97 45.54 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.481 1.913 . . . . 0.0 110.537 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -83.58 161.57 21.12 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.16 -0.963 . . . . 0.0 111.996 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.4 p -122.96 158.59 30.12 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.853 1.661 . . . . 0.0 110.225 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.557 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 88.3 p -68.8 -36.49 78.33 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.768 -1.207 . . . . 0.0 111.139 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.4 mt -148.49 159.59 43.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.984 2.114 . . . . 0.0 111.604 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -149.93 112.47 4.73 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.475 1.11 . . . . 0.0 110.473 170.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -96.27 -47.58 5.96 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.978 0.911 . . . . 0.0 112.465 174.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.84 178.68 27.21 Favored Glycine 0 CA--C 1.544 1.856 0 C-N-CA 125.757 1.646 . . . . 0.0 113.993 -169.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 45.2 t80 . . . . . 0 CA--C 1.549 0.917 0 O-C-N 121.311 -1.111 . . . . 0.0 113.44 175.222 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.624 0 CA-C-O 121.603 0.557 . . . . 0.0 114.074 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 68.9 mt -112.38 114.61 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.721 1.608 . . . . 0.0 108.319 175.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -70.64 147.64 48.94 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.004 -0.435 . . . . 0.0 111.42 173.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 58.79 22.89 10.6 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.91 1.684 . . . . 0.0 114.465 175.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -65.8 130.7 44.2 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.297 1.439 . . . . 0.0 112.068 -171.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -79.68 122.55 26.69 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.586 1.155 . . . . 0.0 112.723 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 28.5 mm -113.93 117.66 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.419 1.088 . . . . 0.0 110.002 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mp -107.85 101.06 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.228 1.411 . . . . 0.0 107.889 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.5 p -87.08 160.61 18.51 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.585 0.707 . . . . 0.0 111.578 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -152.82 139.78 19.15 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.702 1.201 . . . . 0.0 111.191 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.9 mt -78.49 132.14 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 173.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 . . . . . 0 N--CA 1.465 0.316 0 C-N-CA 125.387 1.475 . . . . 0.0 110.088 174.183 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 CA--C 1.54 0.582 0 CA-C-O 121.192 0.52 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -106.64 167.29 9.96 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.09 1.356 . . . . 0.0 110.387 170.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.8 tp -118.77 136.92 54.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.398 1.479 . . . . 0.0 108.114 169.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.1 p -125.71 159.38 32.45 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.717 0.807 . . . . 0.0 110.151 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -149.81 144.8 26.23 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.965 0.906 . . . . 0.0 111.709 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.3 p -82.28 112.48 19.31 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.767 1.227 . . . . 0.0 111.057 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.1 -163.75 38.99 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.286 0.946 . . . . 0.0 113.158 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -72.02 168.92 17.06 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.583 0.706 . . . . 0.0 111.545 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -72.04 131.55 43.03 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.12 -0.988 . . . . 0.0 110.939 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 121.335 0.588 . . . . 0.0 112.295 172.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.476 0.863 0 CA-C-O 120.823 0.344 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.1 105.66 2.53 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.654 0.781 . . . . 0.0 109.284 175.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -109.05 144.57 36.89 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 122.087 0.946 . . . . 0.0 111.09 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -135.6 168.28 19.55 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.443 1.497 . . . . 0.0 111.536 -171.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.64 132.18 20.97 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.122 0.569 . . . . 0.0 110.004 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.4 ' CG2' HD11 ' A' ' 166' ' ' LEU . 66.3 mt -123.95 140.2 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.82 0.848 . . . . 0.0 108.766 176.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.2 m -65.49 95.43 0.21 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.833 0.853 . . . . 0.0 109.432 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.415 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.0 OUTLIER -53.67 -32.64 52.41 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.577 1.151 . . . . 0.0 111.767 176.299 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -67.86 -25.81 65.72 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -86.35 -34.06 20.36 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.584 1.153 . . . . 0.0 112.237 171.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.497 HD13 ' HG3' ' A' ' 100' ' ' MET . 22.7 mt -58.65 -43.47 89.82 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.211 -0.931 . . . . 0.0 111.277 176.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -53.98 -33.0 55.78 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.487 1.115 . . . . 0.0 113.816 174.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 61.2 mttm . . . . . 0 N--CA 1.48 1.058 0 C-N-CA 125.281 1.433 . . . . 0.0 114.205 179.039 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.1 pttt . . . . . 0 N--CA 1.469 0.496 0 CA-C-O 121.141 0.496 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -156.4 165.67 35.67 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.913 0.885 . . . . 0.0 110.338 170.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.56 134.33 48.6 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.2 m -132.06 161.52 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.082 1.353 . . . . 0.0 112.097 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -67.47 141.63 56.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.359 1.063 . . . . 0.0 110.268 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.2 tp -138.7 135.73 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.33 1.452 . . . . 0.0 108.751 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -128.86 161.56 29.55 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.152 1.781 . . . . 0.0 109.38 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -129.96 155.13 46.58 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.017 1.327 . . . . 0.0 111.043 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.7 118.49 22.3 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 169.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.5 p30 -68.21 178.47 1.89 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.466 1.127 . . . . 0.0 113.54 171.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -58.18 -11.83 2.99 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.355 1.862 . . . . 0.0 114.846 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.9 t -107.57 4.14 25.68 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.236 1.414 . . . . 0.0 112.514 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.69 22.35 78.41 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 120.643 -1.286 . . . . 0.0 114.505 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -105.05 138.9 40.54 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.486 1.143 . . . . 0.0 110.932 174.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -69.93 126.42 29.66 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.108 0.963 . . . . 0.0 110.538 173.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 t -142.14 143.71 33.13 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.963 1.305 . . . . 0.0 110.324 -177.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -54.65 135.61 46.54 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.726 0.811 . . . . 0.0 113.048 -176.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.0 tp -111.55 -49.88 2.97 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.058 0.943 . . . . 0.0 111.075 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.57 -131.47 2.07 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 121.395 0.442 . . . . 0.0 114.108 -173.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.79 135.29 29.52 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.255 1.422 . . . . 0.0 110.123 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.454 HD11 ' HB ' ' A' ' 74' ' ' THR . 1.2 tm? -106.19 108.66 20.29 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.291 1.436 . . . . 0.0 109.224 -176.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.463 HG12 ' HG3' ' A' ' 66' ' ' ARG . 60.7 t -85.95 96.53 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.797 1.239 . . . . 0.0 109.295 174.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.6 t -71.46 110.18 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.154 0.981 . . . . 0.0 109.286 168.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.463 ' HG3' HG12 ' A' ' 64' ' ' VAL . 66.8 mtp85 . . . . . 0 N--CA 1.475 0.805 0 C-N-CA 127.122 2.169 . . . . 0.0 110.217 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.701 0 N-CA-C 114.344 0.498 . . . . 0.0 114.344 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 70.1 mt -128.48 137.21 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.275 1.03 . . . . 0.0 108.919 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.07 146.32 46.04 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.336 1.454 . . . . 0.0 108.879 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.454 ' HB ' HD11 ' A' ' 63' ' ' LEU . 75.9 p -132.58 143.25 49.58 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.198 -0.939 . . . . 0.0 110.205 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.77 136.13 8.15 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -92.49 131.55 37.54 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.666 1.987 . . . . 0.0 109.94 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 . . . . . 0 CA--C 1.543 0.68 0 C-N-CA 125.204 1.401 . . . . 0.0 110.459 -174.208 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 51.9 m -59.48 123.42 16.77 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.403 -0.811 . . . . 0.0 109.039 168.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -87.3 -50.37 6.63 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.866 0.466 . . . . 0.0 110.124 -176.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -166.38 164.2 17.44 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.251 1.02 . . . . 0.0 112.977 172.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 p -150.32 147.48 27.68 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.859 1.314 . . . . 0.0 113.227 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.413 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.5 OUTLIER -133.58 162.69 31.23 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.269 1.428 . . . . 0.0 111.656 -177.042 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -81.93 166.7 19.65 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.582 0.753 . . . . 0.0 112.368 -175.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -55.79 -34.19 65.06 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.07 -1.019 . . . . 0.0 112.423 175.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -67.98 -3.28 9.52 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.461 1.505 . . . . 0.0 113.913 175.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 t -122.09 -3.39 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.318 1.047 . . . . 0.0 111.567 -177.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.2 t -53.22 -65.44 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 120.492 -1.38 . . . . 0.0 110.863 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -64.7 -27.74 69.12 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.744 -0.597 . . . . 0.0 112.227 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.33 -53.54 53.55 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.72 1.608 . . . . 0.0 110.359 174.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -62.99 -42.39 99.84 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.475 1.11 . . . . 0.0 111.937 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 92.7 t -58.5 -37.04 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 122.885 0.474 . . . . 0.0 110.844 176.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -64.71 -55.02 22.58 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.61 1.164 . . . . 0.0 112.784 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.7 -9.6 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 121.577 -0.702 . . . . 0.0 112.28 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.466 ' CG ' HD13 ' A' ' 166' ' ' LEU . 20.8 ttm -95.73 -4.72 43.59 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.589 -1.319 . . . . 0.0 112.934 177.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.9 p -127.49 -13.1 5.5 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.725 0.81 . . . . 0.0 112.875 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -131.54 -12.11 3.48 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.522 1.529 . . . . 0.0 114.434 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.19 155.96 9.85 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.074 1.321 . . . . 0.0 113.662 -175.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 156.21 -168.3 33.55 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.357 0.979 . . . . 0.0 113.556 -175.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 36.0 p -146.51 105.83 3.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.483 1.113 . . . . 0.0 113.463 -168.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -136.32 143.55 44.21 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.162 1.785 . . . . 0.0 110.246 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -74.84 153.05 38.88 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.543 -0.723 . . . . 0.0 111.297 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.4 p -118.87 135.86 54.34 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.327 1.451 . . . . 0.0 110.875 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.413 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 6.6 t -48.15 -42.25 29.0 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.103 1.361 . . . . 0.0 113.235 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.4 mt -147.53 145.51 29.11 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.67 1.588 . . . . 0.0 112.769 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -143.89 101.18 3.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.272 1.029 . . . . 0.0 110.783 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -91.99 -37.16 12.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.157 0.983 . . . . 0.0 113.298 176.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.75 -176.95 8.42 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.414 1.483 . . . . 0.0 114.824 -172.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.0 t80 . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 174.065 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.365 0 CA-C-O 121.724 0.625 . . . . 0.0 113.356 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.3 mt -121.34 116.22 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.228 1.411 . . . . 0.0 108.078 173.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -68.34 140.56 55.9 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.977 0.418 . . . . 0.0 111.617 170.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 55.41 29.34 12.97 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.878 1.671 . . . . 0.0 114.279 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -59.52 127.75 33.62 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.804 1.242 . . . . 0.0 111.564 -175.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -75.79 119.5 19.87 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.017 0.527 . . . . 0.0 111.336 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.5 mm -112.16 116.82 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.832 1.253 . . . . 0.0 109.08 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.12 97.97 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 124.724 1.21 . . . . 0.0 108.491 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 43.0 p -76.97 159.58 29.84 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.87 174.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -153.3 142.49 21.44 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.791 1.236 . . . . 0.0 111.061 170.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mt -83.32 135.03 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.402 0.681 . . . . 0.0 109.245 174.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 . . . . . 0 N--CA 1.469 0.486 0 C-N-CA 124.887 1.275 . . . . 0.0 111.195 174.103 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 CA--C 1.541 0.619 0 CA-C-O 121.253 0.549 . . . . 0.0 110.42 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -108.72 166.3 10.91 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.919 1.688 . . . . 0.0 110.62 170.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.2 tp -116.13 135.04 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.769 1.628 . . . . 0.0 108.043 169.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.1 p -125.31 155.8 39.65 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.547 0.739 . . . . 0.0 109.957 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -146.4 138.37 24.89 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.795 0.838 . . . . 0.0 111.221 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.0 p -75.69 113.38 13.07 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.325 1.05 . . . . 0.0 111.202 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.17 -156.59 26.5 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.577 1.084 . . . . 0.0 113.014 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.26 -174.05 0.34 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.04 0.936 . . . . 0.0 112.991 169.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -100.51 113.98 27.21 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.141 0.976 . . . . 0.0 111.716 169.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.766 0 C-N-CA 124.074 0.95 . . . . 0.0 112.25 177.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.42 86.85 1.53 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.09 0.556 . . . . 0.0 110.475 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -90.21 145.3 25.12 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.524 1.154 . . . . 0.0 112.057 172.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -138.75 169.0 18.57 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 126.359 1.863 . . . . 0.0 110.857 -173.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.44 132.26 21.33 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.079 0.551 . . . . 0.0 110.246 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.458 ' CG2' HD11 ' A' ' 166' ' ' LEU . 58.2 mt -125.06 139.98 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.145 0.978 . . . . 0.0 108.871 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.0 m -67.16 95.21 0.39 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.477 -0.764 . . . . 0.0 110.048 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.556 HD21 ' HE2' ' A' ' 167' ' ' LYS . 1.0 OUTLIER -52.23 -33.52 41.78 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.574 1.15 . . . . 0.0 111.766 176.164 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -67.2 -29.56 69.26 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -84.82 -27.54 26.72 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.175 0.99 . . . . 0.0 111.859 172.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 163' ' ' LEU . 40.8 mt -68.01 -43.01 79.8 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.558 0.743 . . . . 0.0 110.158 175.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.556 ' HE2' HD21 ' A' ' 163' ' ' LEU . 15.3 mtmt -57.32 -20.0 25.93 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.6 mttt . . . . . 0 N--CA 1.481 1.08 0 C-N-CA 124.502 1.121 . . . . 0.0 114.021 178.049 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.0 pttt . . . . . 0 N--CA 1.468 0.432 0 CA-C-O 120.886 0.374 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -143.8 171.02 14.79 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.027 0.931 . . . . 0.0 110.786 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -142.26 122.35 13.75 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.699 -0.626 . . . . 0.0 110.77 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.6 m -123.76 161.24 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 126.351 1.86 . . . . 0.0 111.095 -176.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 160.09 13.72 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.535 0.734 . . . . 0.0 112.496 176.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.0 tp -152.72 138.5 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.712 1.605 . . . . 0.0 109.085 174.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -129.14 159.33 36.36 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.613 1.965 . . . . 0.0 109.333 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -134.86 160.94 36.63 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.731 1.213 . . . . 0.0 111.866 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.67 119.81 25.23 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.603 0.361 . . . . 0.0 110.619 172.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.9 p30 -68.81 177.08 2.71 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 122.636 1.208 . . . . 0.0 113.625 170.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.8 mtmm -58.25 -23.16 55.07 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.107 1.763 . . . . 0.0 113.337 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 m -84.03 -11.18 57.15 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.013 1.325 . . . . 0.0 113.076 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.72 33.38 42.55 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.201 1.381 . . . . 0.0 114.291 -175.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -120.72 145.65 47.28 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.363 1.465 . . . . 0.0 111.18 175.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -67.76 130.83 44.23 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.708 0.803 . . . . 0.0 111.054 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.4 t -143.12 142.84 31.61 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.824 1.249 . . . . 0.0 110.652 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -56.41 132.47 51.23 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.252 1.021 . . . . 0.0 112.342 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.9 tp -108.12 -49.87 3.13 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.571 0.749 . . . . 0.0 111.22 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.47 -119.05 0.82 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.761 0.696 . . . . 0.0 112.916 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -143.05 158.09 43.93 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.589 1.555 . . . . 0.0 111.064 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.8 tp -122.47 103.75 8.92 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.861 1.664 . . . . 0.0 110.137 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.1 t -74.73 98.85 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.572 1.149 . . . . 0.0 109.383 172.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.8 t -87.07 115.47 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.717 1.207 . . . . 0.0 110.057 173.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 . . . . . 0 N--CA 1.476 0.828 0 C-N-CA 126.906 2.083 . . . . 0.0 110.359 178.233 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.77 0 CA-C-O 121.501 0.501 . . . . 0.0 113.709 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.9 mt -117.77 142.55 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.669 0.788 . . . . 0.0 109.168 173.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -131.28 136.06 47.84 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.762 1.225 . . . . 0.0 109.138 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.6 p -129.4 150.27 50.83 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.516 0.727 . . . . 0.0 111.636 -171.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -144.32 122.73 1.85 Allowed Glycine 0 C--N 1.335 0.506 0 O-C-N 121.746 -0.596 . . . . 0.0 112.446 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -65.87 136.37 56.05 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.291 1.436 . . . . 0.0 109.621 174.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 . . . . . 0 CA--C 1.542 0.673 0 C-N-CA 126.891 2.076 . . . . 0.0 108.964 178.016 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.3 m -55.61 128.38 34.35 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 121.269 -0.895 . . . . 0.0 110.281 170.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -95.53 -51.6 4.48 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.345 0.658 . . . . 0.0 110.151 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -164.8 163.17 21.31 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.025 0.93 . . . . 0.0 112.527 170.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.05 146.79 31.08 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.005 1.322 . . . . 0.0 111.94 177.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.523 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -128.13 160.06 33.2 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.795 1.638 . . . . 0.0 111.429 -176.471 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -78.29 164.82 24.54 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.468 0.707 . . . . 0.0 112.299 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -56.67 -33.76 66.69 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.352 1.461 . . . . 0.0 114.496 174.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -69.78 -9.64 55.34 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.581 1.153 . . . . 0.0 112.957 173.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.8 t -112.51 -8.09 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.294 1.038 . . . . 0.0 111.054 -173.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.5 t -46.62 -67.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 125.623 1.569 . . . . 0.0 111.905 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -67.22 -26.97 66.87 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.501 -0.749 . . . . 0.0 112.737 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -63.56 -52.08 62.61 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.701 1.6 . . . . 0.0 110.703 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -59.47 -46.7 88.04 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 125.476 1.51 . . . . 0.0 111.031 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 82.8 t -56.19 -36.15 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.468 0.707 . . . . 0.0 110.806 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -65.87 -54.47 26.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.857 1.263 . . . . 0.0 112.659 174.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 m -71.55 -16.88 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 120.913 -1.117 . . . . 0.0 112.539 -176.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.644 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -87.32 -5.2 58.99 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.169 1.788 . . . . 0.0 111.693 177.042 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 65.0 p -128.56 -15.05 4.56 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -134.18 -10.02 2.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.493 1.517 . . . . 0.0 114.183 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.49 156.31 10.89 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.642 1.592 . . . . 0.0 113.96 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 157.66 -166.01 33.71 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.129 0.871 . . . . 0.0 113.838 -175.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 61.2 p -148.56 103.26 3.39 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -170.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -134.76 143.68 47.26 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.05 1.74 . . . . 0.0 110.137 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -71.15 162.73 28.94 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.457 -0.777 . . . . 0.0 111.636 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 81.5 p -127.43 154.12 45.43 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.441 1.497 . . . . 0.0 110.972 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.523 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 82.4 p -71.07 -38.79 72.46 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.427 -0.796 . . . . 0.0 111.103 -177.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.2 mt -152.83 140.37 19.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.71 2.004 . . . . 0.0 111.468 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -134.5 102.57 5.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.999 0.92 . . . . 0.0 110.046 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -87.49 -46.88 9.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.51 1.124 . . . . 0.0 112.76 175.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.43 173.99 34.51 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.204 1.383 . . . . 0.0 113.636 -168.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.8 t80 . . . . . 0 CA--C 1.546 0.827 0 C-N-CA 124.122 0.969 . . . . 0.0 111.922 169.568 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.366 0 CA-C-O 121.447 0.471 . . . . 0.0 113.475 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.6 mt -113.38 112.95 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.073 1.349 . . . . 0.0 108.168 176.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -74.18 147.92 42.13 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.015 0.436 . . . . 0.0 111.384 172.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 59.31 21.91 10.2 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.659 1.583 . . . . 0.0 113.976 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -63.24 126.31 26.99 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.954 1.302 . . . . 0.0 111.515 -172.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -74.88 122.36 23.28 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.36 1.464 . . . . 0.0 112.267 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.5 mm -118.48 118.02 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.184 0.993 . . . . 0.0 109.835 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.7 92.64 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.485 1.514 . . . . 0.0 109.18 -177.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.2 p -74.86 156.58 36.29 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.498 174.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -153.48 142.7 21.46 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.182 1.393 . . . . 0.0 111.646 173.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 21.8 mt -81.49 132.02 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.068 0.547 . . . . 0.0 109.721 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 . . . . . 0 CA--C 1.538 0.489 0 C-N-CA 125.694 1.598 . . . . 0.0 110.232 173.833 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -109.17 167.88 9.78 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.471 1.508 . . . . 0.0 110.447 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.4 tp -123.16 132.04 72.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 125.331 1.452 . . . . 0.0 108.31 171.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.2 p -120.25 152.64 37.46 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.588 0.755 . . . . 0.0 109.878 177.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -145.63 147.55 32.14 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.306 0.574 . . . . 0.0 111.602 178.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.5 p -73.06 109.69 6.79 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.272 1.029 . . . . 0.0 111.21 174.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.77 -166.47 30.61 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 122.139 0.855 . . . . 0.0 113.232 172.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -65.65 162.0 19.34 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.148 0.979 . . . . 0.0 113.015 170.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -84.3 101.09 11.67 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.866 1.266 . . . . 0.0 111.853 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.68 0 C-N-CA 123.458 0.703 . . . . 0.0 112.574 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.7 m . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 120.502 0.191 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.59 83.2 0.42 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.338 1.055 . . . . 0.0 110.478 176.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -81.08 141.92 33.84 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 122.157 0.979 . . . . 0.0 111.717 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -135.31 169.71 17.06 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.73 1.612 . . . . 0.0 111.534 -173.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.35 132.55 18.38 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.576 0.75 . . . . 0.0 110.446 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.46 ' CG2' HD11 ' A' ' 166' ' ' LEU . 68.0 mt -124.98 141.5 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.09 0.956 . . . . 0.0 108.88 177.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.3 m -66.33 93.44 0.22 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.64 1.176 . . . . 0.0 110.194 176.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.59 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.4 tt -54.98 -30.81 60.02 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.226 1.41 . . . . 0.0 112.45 178.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -71.65 -30.51 65.82 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -82.64 -30.7 29.2 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.01 0.924 . . . . 0.0 112.237 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.644 HD13 ' HG3' ' A' ' 100' ' ' MET . 20.7 mt -57.22 -49.77 74.96 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.914 0.886 . . . . 0.0 110.779 173.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -50.45 -38.21 42.38 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.263 1.025 . . . . 0.0 113.391 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.889 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.303 0 CA-C-O 121.132 0.492 . . . . 0.0 110.168 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -150.2 167.09 27.9 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.069 0.948 . . . . 0.0 110.921 173.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -131.15 131.0 43.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.855 0.462 . . . . 0.0 111.037 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 m -129.34 167.85 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 126.179 1.791 . . . . 0.0 111.026 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -65.3 166.78 9.4 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.741 1.217 . . . . 0.0 111.943 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.422 HG21 ' CD2' ' A' ' 76' ' ' LEU . 5.4 tp -161.82 135.72 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.128 1.371 . . . . 0.0 109.933 172.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -129.07 160.11 33.82 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.509 1.924 . . . . 0.0 109.324 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -127.19 160.25 31.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.337 1.455 . . . . 0.0 111.072 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -81.49 121.82 26.76 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 122.048 -0.407 . . . . 0.0 110.565 171.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -64.09 175.47 1.23 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.411 1.085 . . . . 0.0 112.105 171.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -59.76 -13.73 11.52 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.692 1.997 . . . . 0.0 114.737 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.6 m -117.05 15.55 15.06 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.932 1.293 . . . . 0.0 112.771 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.13 20.84 77.0 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 121.203 -0.936 . . . . 0.0 114.378 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -96.46 127.62 42.63 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.609 1.164 . . . . 0.0 109.485 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -69.05 125.92 28.19 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.633 -0.667 . . . . 0.0 110.639 174.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.2 t -141.78 138.32 32.19 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.851 1.26 . . . . 0.0 111.009 -172.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -57.67 137.19 56.7 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.142 0.977 . . . . 0.0 112.979 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 44.4 tp -111.03 -46.33 3.34 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.827 0.851 . . . . 0.0 111.723 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.47 -121.95 0.95 Allowed Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.351 0.501 . . . . 0.0 113.327 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -147.49 153.44 39.53 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.308 1.443 . . . . 0.0 110.482 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.8 tp -118.84 107.57 13.77 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.121 1.368 . . . . 0.0 111.005 -176.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.458 HG23 ' ND2' ' A' ' 77' ' ' ASN . 57.7 t -82.48 102.28 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.705 1.202 . . . . 0.0 108.327 173.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.07 103.25 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.769 1.628 . . . . 0.0 109.448 176.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 . . . . . 0 N--CA 1.478 0.934 0 C-N-CA 125.859 1.664 . . . . 0.0 110.965 -178.221 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.225 0 N-CA-C 115.965 1.146 . . . . 0.0 115.965 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.439 HG13 HG22 ' A' ' 93' ' ' VAL . 35.5 mt -121.91 136.57 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.327 1.051 . . . . 0.0 109.304 173.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.04 117.19 19.64 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 126.413 1.885 . . . . 0.0 109.411 -175.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.2 p -106.24 149.78 26.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.012 0.925 . . . . 0.0 111.32 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.09 128.32 3.84 Favored Glycine 0 C--N 1.336 0.581 0 O-C-N 121.265 -0.897 . . . . 0.0 111.876 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.422 ' CD2' HG21 ' A' ' 48' ' ' ILE . 3.2 tm? -85.3 127.75 34.44 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 127.157 2.183 . . . . 0.0 110.623 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.458 ' ND2' HG23 ' A' ' 64' ' ' VAL . 2.6 m-80 . . . . . 0 CA--C 1.538 0.509 0 C-N-CA 125.761 1.624 . . . . 0.0 109.748 -174.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.615 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.9 m -55.39 122.86 12.12 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.876 0.87 . . . . 0.0 110.366 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -91.15 -49.91 6.13 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.78 0.432 . . . . 0.0 110.015 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -160.36 171.12 19.68 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.764 0.792 . . . . 0.0 113.093 171.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.3 136.97 12.25 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.397 -0.815 . . . . 0.0 112.764 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.484 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -132.03 155.31 48.26 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.464 1.906 . . . . 0.0 111.188 -174.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -79.44 168.04 20.01 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.384 0.674 . . . . 0.0 112.598 -171.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.457 ' HA ' HG23 ' A' ' 93' ' ' VAL . 2.7 tm-20 -57.63 -34.3 69.17 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.425 1.09 . . . . 0.0 112.328 176.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -63.2 -16.33 59.8 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.643 1.577 . . . . 0.0 114.023 171.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.4 t -111.18 -8.25 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.603 1.161 . . . . 0.0 111.087 -173.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.457 HG23 ' HA ' ' A' ' 90' ' ' GLU . 54.7 t -47.78 -64.62 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 125.726 1.611 . . . . 0.0 111.486 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -68.93 -28.22 66.46 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -49.71 75.36 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.536 1.534 . . . . 0.0 110.367 176.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -61.88 -42.42 99.05 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.107 1.363 . . . . 0.0 112.07 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 95.3 t -56.95 -37.18 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.615 0.766 . . . . 0.0 110.679 176.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -68.4 -54.01 20.03 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.427 1.091 . . . . 0.0 112.447 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 m -73.5 -8.79 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 O-C-N 120.834 -1.166 . . . . 0.0 113.093 -175.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.561 ' CG ' HD13 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -98.58 -3.2 36.83 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.855 1.262 . . . . 0.0 112.387 176.473 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.9 p -129.6 -13.82 4.21 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.474 1.11 . . . . 0.0 113.041 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -135.74 -11.15 2.07 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.342 1.857 . . . . 0.0 114.1 177.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.93 154.94 11.29 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.067 1.318 . . . . 0.0 114.034 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.64 -159.51 31.4 Favored Glycine 0 CA--C 1.532 1.155 0 O-C-N 121.756 -0.849 . . . . 0.0 114.201 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 88.1 p -153.94 100.39 2.35 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -170.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -131.93 142.94 49.79 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.866 1.667 . . . . 0.0 110.091 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.4 154.61 39.95 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 121.465 -0.772 . . . . 0.0 111.106 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.7 p -118.4 156.9 28.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.231 1.412 . . . . 0.0 111.011 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.484 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 8.4 t -67.93 -41.14 83.02 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.307 1.043 . . . . 0.0 111.314 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 mt -155.56 137.69 14.67 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.243 1.817 . . . . 0.0 111.152 -177.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -134.38 103.84 5.89 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.485 1.114 . . . . 0.0 110.275 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -90.27 -39.66 12.62 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.43 175.34 6.46 Favored Glycine 0 CA--C 1.543 1.807 0 C-N-CA 124.926 1.251 . . . . 0.0 114.508 -169.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.3 t80 . . . . . 0 CA--C 1.55 0.947 0 O-C-N 121.497 -1.002 . . . . 0.0 112.272 169.386 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.177 0 CA-C-O 121.677 0.598 . . . . 0.0 113.007 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.4 mt -127.02 105.42 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.023 1.329 . . . . 0.0 107.885 169.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -67.67 146.35 53.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.074 0.464 . . . . 0.0 111.095 172.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 57.45 24.69 10.51 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.355 1.462 . . . . 0.0 113.993 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -53.95 127.51 26.58 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.077 1.351 . . . . 0.0 111.039 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -76.9 127.71 33.21 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 122.064 -0.397 . . . . 0.0 110.252 169.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 33.3 mm -122.57 115.76 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.845 1.258 . . . . 0.0 108.334 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -112.08 100.69 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 125.264 1.426 . . . . 0.0 107.875 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.7 p -83.18 159.21 22.07 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.666 0.746 . . . . 0.0 111.775 176.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -152.07 138.66 18.7 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.67 1.188 . . . . 0.0 110.863 173.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.4 mt -80.07 132.27 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 . . . . . 0 N--CA 1.465 0.31 0 C-N-CA 125.31 1.444 . . . . 0.0 110.344 175.042 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 . . . . . 0 CA--C 1.535 0.4 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -106.33 164.06 12.33 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.694 1.197 . . . . 0.0 110.485 171.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.1 tp -117.5 134.83 59.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 125.615 1.566 . . . . 0.0 107.615 169.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.1 p -124.09 155.75 37.82 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.356 0.662 . . . . 0.0 109.854 175.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -150.89 147.03 26.71 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.447 0.699 . . . . 0.0 112.179 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 55.2 p -76.24 108.17 8.98 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.059 1.344 . . . . 0.0 111.833 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.98 -160.38 17.87 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 123.999 0.809 . . . . 0.0 113.528 173.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -67.22 159.77 28.38 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.89 0.876 . . . . 0.0 112.836 171.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -78.21 106.25 9.99 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.838 1.255 . . . . 0.0 110.358 172.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 123.22 0.608 . . . . 0.0 112.326 174.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 120.915 0.388 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.26 98.67 0.83 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.392 0.677 . . . . 0.0 110.227 170.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -91.94 144.45 25.45 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.346 1.069 . . . . 0.0 111.592 172.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -134.28 169.64 16.9 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 126.106 1.763 . . . . 0.0 110.962 -173.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.07 133.44 21.79 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.184 0.594 . . . . 0.0 109.991 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.434 ' CG2' HD11 ' A' ' 166' ' ' LEU . 62.0 mt -126.5 138.63 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 123.736 0.815 . . . . 0.0 108.822 175.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.9 m -64.55 98.2 0.24 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.863 0.865 . . . . 0.0 109.43 177.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.559 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.0 OUTLIER -53.83 -32.74 53.91 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.693 1.197 . . . . 0.0 111.634 177.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -68.32 -32.21 72.17 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -82.56 -27.74 31.4 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.335 -0.853 . . . . 0.0 112.836 173.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.561 HD13 ' CG ' ' A' ' 100' ' ' MET . 18.8 mt -62.59 -51.03 68.95 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.644 0.778 . . . . 0.0 110.912 172.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -48.75 -43.36 37.61 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.853 1.261 . . . . 0.0 113.24 176.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.6 mttt . . . . . 0 N--CA 1.482 1.147 0 C-N-CA 125.542 1.537 . . . . 0.0 114.32 -178.625 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.8 pttt . . . . . 0 C--O 1.233 0.235 0 CA-C-O 121.299 0.571 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -147.39 165.86 28.93 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.297 1.439 . . . . 0.0 110.527 177.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -130.64 134.13 46.71 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.08 -0.387 . . . . 0.0 110.881 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.0 m -128.05 165.1 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.083 1.753 . . . . 0.0 109.979 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -68.55 163.39 23.66 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.56 0.744 . . . . 0.0 110.96 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.5 tp -147.01 136.12 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.078 0.951 . . . . 0.0 109.254 170.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -126.5 160.1 31.53 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.626 1.971 . . . . 0.0 109.105 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.4 161.56 35.48 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.905 0.882 . . . . 0.0 112.06 176.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.74 118.16 23.71 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.847 0.459 . . . . 0.0 110.209 173.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -72.06 178.85 3.56 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.403 0.621 . . . . 0.0 112.459 175.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -57.67 -26.37 61.57 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.87 1.668 . . . . 0.0 113.111 173.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.3 t -70.65 -17.69 62.86 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.799 1.64 . . . . 0.0 113.747 173.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.45 36.39 62.88 Favored Glycine 0 CA--C 1.534 1.233 0 O-C-N 121.072 -1.018 . . . . 0.0 113.287 -171.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -125.09 143.81 50.73 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.994 1.718 . . . . 0.0 109.85 175.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -67.64 132.83 48.25 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.814 0.846 . . . . 0.0 111.141 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 t -142.44 136.62 29.66 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.838 1.255 . . . . 0.0 110.509 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -56.98 133.14 54.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.04 0.936 . . . . 0.0 112.446 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.1 tp -111.36 -45.83 3.36 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.112 0.965 . . . . 0.0 111.212 -176.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.26 -137.89 4.02 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 122.067 0.815 . . . . 0.0 113.813 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -129.0 163.59 25.04 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.511 1.925 . . . . 0.0 110.608 173.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 16.2 tp -130.1 106.39 8.59 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.49 2.316 . . . . 0.0 110.256 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.0 t -80.31 99.44 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.659 1.184 . . . . 0.0 109.332 174.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.89 117.12 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.504 1.522 . . . . 0.0 109.587 173.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 . . . . . 0 N--CA 1.476 0.829 0 C-N-CA 127.124 2.17 . . . . 0.0 110.726 178.77 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.836 0 CA-C-O 121.656 0.587 . . . . 0.0 113.78 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.2 mt -126.22 138.84 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.899 0.879 . . . . 0.0 109.589 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -127.7 129.89 47.91 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.276 1.43 . . . . 0.0 109.036 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.9 p -121.55 137.63 54.65 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.502 -0.749 . . . . 0.0 110.207 -175.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.6 108.88 0.71 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -170.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 tt -64.04 142.24 58.48 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.771 0.828 . . . . 0.0 110.612 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.8 t30 . . . . . 0 CA--C 1.543 0.702 0 C-N-CA 126.18 1.792 . . . . 0.0 109.313 178.938 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 93.7 m -60.77 123.03 16.29 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 121.099 -1.0 . . . . 0.0 109.286 169.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -85.46 -51.4 6.56 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.442 0.697 . . . . 0.0 109.849 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -162.57 170.27 18.86 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.275 1.03 . . . . 0.0 112.744 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.99 144.01 23.01 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 122.536 1.16 . . . . 0.0 113.198 175.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.482 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -129.46 154.93 46.49 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.813 1.645 . . . . 0.0 111.845 -175.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -78.31 167.21 21.7 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.406 0.682 . . . . 0.0 112.263 -173.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -53.68 -35.67 61.32 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.017 0.927 . . . . 0.0 112.646 173.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -65.48 -8.49 19.57 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.617 1.167 . . . . 0.0 113.684 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.9 t -118.13 -4.63 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.591 1.156 . . . . 0.0 111.224 -173.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.6 t -50.87 -65.08 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 125.13 1.372 . . . . 0.0 111.334 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -68.51 -25.77 65.11 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.88 -50.92 69.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.327 1.451 . . . . 0.0 110.603 173.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -58.65 -43.79 89.91 Favored 'General case' 0 C--N 1.335 -0.064 0 C-N-CA 124.964 1.305 . . . . 0.0 111.608 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 73.3 t -56.44 -37.6 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.902 0.481 . . . . 0.0 110.867 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -66.01 -54.51 25.07 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.444 1.098 . . . . 0.0 112.513 176.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 m -74.81 -3.67 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 121.13 -0.981 . . . . 0.0 113.402 -175.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.475 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -103.67 -4.25 24.02 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.156 1.782 . . . . 0.0 112.008 179.128 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 43.8 p -131.84 -15.36 3.05 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.779 1.232 . . . . 0.0 113.541 174.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -131.5 -12.42 3.47 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.649 1.579 . . . . 0.0 113.847 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.34 156.14 12.45 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.678 1.132 . . . . 0.0 113.752 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.78 -159.26 31.62 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 121.742 -0.858 . . . . 0.0 113.471 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.486 ' HB3' HG23 ' A' ' 130' ' ' ILE . 31.6 p -154.21 96.82 1.98 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -131.22 143.68 50.76 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.97 1.708 . . . . 0.0 110.606 -176.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -74.08 162.74 28.69 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.831 0.852 . . . . 0.0 111.49 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.0 p -129.66 143.76 50.97 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.217 1.407 . . . . 0.0 111.365 -177.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.482 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 24.4 p -57.81 -37.03 73.04 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.321 1.448 . . . . 0.0 112.839 -178.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mt -156.4 145.58 20.5 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.07 2.148 . . . . 0.0 110.549 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -141.62 109.83 5.9 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.023 0.929 . . . . 0.0 110.246 176.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -95.59 -57.73 2.31 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.385 1.074 . . . . 0.0 112.463 175.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.46 -169.6 29.06 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.244 1.402 . . . . 0.0 113.796 -171.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 12.6 t80 . . . . . 0 CA--C 1.543 0.688 0 O-C-N 121.739 -0.859 . . . . 0.0 113.102 -179.456 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.407 0 CA-C-O 121.206 0.337 . . . . 0.0 113.105 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 62.3 mt -119.77 113.14 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.076 1.35 . . . . 0.0 108.766 174.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -72.7 147.45 45.67 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.278 0.561 . . . . 0.0 111.565 172.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 57.12 22.44 7.47 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.034 1.734 . . . . 0.0 114.06 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -56.01 123.64 15.07 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.568 1.147 . . . . 0.0 110.534 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -71.07 127.91 34.17 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.87 0.868 . . . . 0.0 110.304 171.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 36.2 mm -123.93 117.67 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.351 1.06 . . . . 0.0 108.529 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.486 HG23 ' HB3' ' A' ' 105' ' ' SER . 3.9 mp -111.4 100.12 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.047 1.339 . . . . 0.0 107.746 -177.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.4 p -82.74 158.98 22.65 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.595 0.712 . . . . 0.0 111.674 175.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.2 ptpt -152.44 139.09 18.76 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.744 1.218 . . . . 0.0 111.069 175.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.5 mt -79.38 133.84 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 . . . . . 0 N--CA 1.468 0.453 0 C-N-CA 125.207 1.403 . . . . 0.0 110.622 173.593 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 . . . . . 0 CA--C 1.54 0.586 0 CA-C-O 121.261 0.553 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -105.41 168.97 8.73 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.362 1.465 . . . . 0.0 110.389 170.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.6 tp -120.38 134.85 62.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 125.597 1.559 . . . . 0.0 107.342 169.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.2 p -119.88 160.04 23.46 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.19 0.596 . . . . 0.0 109.462 171.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -148.45 142.33 25.77 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.797 0.839 . . . . 0.0 110.795 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.5 p -74.08 116.14 14.37 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.525 0.679 . . . . 0.0 110.53 173.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.74 -166.14 40.95 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.72 0.676 . . . . 0.0 112.139 174.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.29 172.16 12.94 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 121.981 0.896 . . . . 0.0 111.234 168.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -76.57 132.0 39.25 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.508 1.123 . . . . 0.0 110.43 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.905 0 O-C-N 121.472 -0.767 . . . . 0.0 111.81 171.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.472 0.635 0 CA-C-O 120.858 0.361 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -74.85 91.27 2.43 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.18 0.592 . . . . 0.0 110.517 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -77.93 151.44 33.72 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 122.32 1.057 . . . . 0.0 111.086 168.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -134.33 173.53 11.51 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.219 1.808 . . . . 0.0 110.884 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.91 138.09 24.06 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.659 0.663 . . . . 0.0 110.835 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 59.5 mt -128.8 141.53 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.05 0.94 . . . . 0.0 109.314 174.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.6 m -64.19 97.1 0.17 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.078 0.951 . . . . 0.0 109.764 175.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.519 ' HA ' HD12 ' A' ' 166' ' ' LEU . 0.8 OUTLIER -54.95 -30.95 60.03 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.582 1.153 . . . . 0.0 112.023 175.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -67.31 -25.82 66.22 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -93.53 -15.32 25.6 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.64 1.176 . . . . 0.0 113.153 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 163' ' ' LEU . 22.0 mt -73.87 -46.27 45.82 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.487 -0.758 . . . . 0.0 110.314 169.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -50.24 -45.12 53.76 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.704 1.202 . . . . 0.0 114.087 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 31.9 pttt . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -176.408 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.2 pttp . . . . . 0 N--CA 1.47 0.552 0 CA-C-O 120.962 0.41 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -141.21 168.32 20.06 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.68 1.192 . . . . 0.0 110.486 173.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -134.38 127.99 32.71 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.951 0.5 . . . . 0.0 110.081 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 m -126.08 158.16 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.233 1.413 . . . . 0.0 111.291 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -60.8 152.76 26.23 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.736 0.814 . . . . 0.0 111.35 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.1 tp -147.48 135.44 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.385 1.074 . . . . 0.0 109.585 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -127.68 158.72 36.81 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.465 1.906 . . . . 0.0 108.727 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -127.83 156.1 43.06 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.356 1.062 . . . . 0.0 111.106 175.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.23 119.85 22.89 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 170.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -67.66 176.33 2.5 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 122.01 0.91 . . . . 0.0 111.765 173.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -56.11 -16.13 4.67 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.91 2.084 . . . . 0.0 115.4 176.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -110.45 12.35 22.98 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.761 1.225 . . . . 0.0 113.349 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.65 20.9 79.37 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 120.973 -1.08 . . . . 0.0 114.515 176.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -102.27 144.07 31.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.529 1.132 . . . . 0.0 110.446 174.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -75.2 126.65 31.46 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.027 0.442 . . . . 0.0 110.418 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.9 t -131.57 135.18 46.8 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.317 1.447 . . . . 0.0 109.325 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -55.51 136.71 49.71 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.21 0.604 . . . . 0.0 111.816 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.3 tp -111.25 -46.38 3.31 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.799 0.84 . . . . 0.0 110.718 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.38 -111.37 0.44 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 123.103 0.382 . . . . 0.0 113.485 175.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -146.06 154.66 42.09 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.291 1.436 . . . . 0.0 110.261 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.8 tp -119.61 102.66 8.78 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.407 1.483 . . . . 0.0 109.899 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.9 t -75.46 98.12 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.07 1.348 . . . . 0.0 109.191 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.9 t -83.51 87.93 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.252 1.421 . . . . 0.0 110.062 175.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 . . . . . 0 N--CA 1.478 0.971 0 C-N-CA 124.823 1.249 . . . . 0.0 111.425 171.965 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.159 0 CA-C-O 121.284 0.38 . . . . 0.0 113.034 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.3 mt -88.9 141.0 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 121.601 -0.94 . . . . 0.0 108.899 177.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -131.26 89.7 2.76 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.061 1.344 . . . . 0.0 111.157 -174.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.6 p -83.71 152.63 24.62 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.531 -0.73 . . . . 0.0 112.778 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.76 128.22 3.4 Favored Glycine 0 CA--C 1.527 0.802 0 O-C-N 121.368 -0.833 . . . . 0.0 113.185 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.23 139.18 48.0 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.25 1.82 . . . . 0.0 110.125 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 42.0 t30 . . . . . 0 CA--C 1.543 0.697 0 C-N-CA 125.917 1.687 . . . . 0.0 111.042 -179.711 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.804 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.5 m -54.8 128.78 34.52 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.315 1.046 . . . . 0.0 110.766 171.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -96.98 -52.55 3.82 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.989 0.515 . . . . 0.0 110.376 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -164.16 154.29 14.7 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.891 0.876 . . . . 0.0 112.881 172.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.04 116.0 10.34 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 123.158 1.456 . . . . 0.0 113.343 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.94 171.61 9.46 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.967 1.307 . . . . 0.0 112.526 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -80.6 161.35 24.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.401 1.081 . . . . 0.0 112.266 176.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -55.6 -35.03 65.38 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.163 0.985 . . . . 0.0 113.055 172.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -68.07 -17.89 64.51 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 175.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.9 t -100.81 -10.58 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.831 0.852 . . . . 0.0 111.577 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 97' ' ' VAL . 75.9 t -47.08 -51.37 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.549 1.14 . . . . 0.0 111.577 176.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -73.24 -29.07 62.51 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 177.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -76.68 -39.42 52.14 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.138 -0.976 . . . . 0.0 111.981 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -57.18 -46.06 83.17 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 124.804 1.242 . . . . 0.0 110.815 173.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 93' ' ' VAL . 72.4 t -52.61 -42.94 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.498 1.119 . . . . 0.0 110.728 175.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -66.81 -55.01 16.77 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.507 1.523 . . . . 0.0 113.002 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 m -72.83 -5.95 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 O-C-N 121.424 -0.797 . . . . 0.0 112.983 -176.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.44 ' CG ' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -98.42 -5.77 31.9 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.727 1.611 . . . . 0.0 112.155 178.425 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.403 ' HB ' ' HE2' ' A' ' 167' ' ' LYS . 32.0 p -127.55 -13.16 5.45 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.934 0.894 . . . . 0.0 112.695 176.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -132.72 -11.21 3.08 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.656 1.582 . . . . 0.0 114.392 177.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.6 156.81 9.79 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.098 1.333 . . . . 0.0 113.821 -174.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.88 -153.93 24.95 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 121.655 -0.909 . . . . 0.0 113.106 -175.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.6 p -145.83 153.23 40.67 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.177 0.991 . . . . 0.0 112.936 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -148.73 179.55 7.75 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.317 1.847 . . . . 0.0 111.769 173.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -114.97 151.92 33.3 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.733 1.213 . . . . 0.0 110.025 168.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 62.4 p -117.28 133.58 55.81 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.766 0.827 . . . . 0.0 111.271 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.1 t -51.0 -37.85 47.62 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.308 1.043 . . . . 0.0 112.557 175.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.7 mt -146.48 147.23 30.98 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.029 1.731 . . . . 0.0 111.719 173.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -136.85 115.37 11.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 170.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -96.57 -49.01 5.3 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.8 0.84 . . . . 0.0 112.543 174.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.45 172.11 34.31 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 125.718 1.628 . . . . 0.0 113.423 -169.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 49.1 t80 . . . . . 0 CA--C 1.552 1.036 0 C-N-CA 124.131 0.972 . . . . 0.0 112.486 169.618 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.516 0 CA-C-O 121.201 0.334 . . . . 0.0 113.513 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.2 mt -122.51 119.23 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.636 1.574 . . . . 0.0 108.828 176.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -80.66 148.58 30.15 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 54.46 25.71 6.4 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.362 1.865 . . . . 0.0 113.979 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -63.08 126.57 27.8 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.283 1.433 . . . . 0.0 111.239 -172.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -78.95 130.42 35.56 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.013 0.525 . . . . 0.0 111.461 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.7 mm -126.87 120.36 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 125.862 1.665 . . . . 0.0 109.215 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.95 105.17 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.266 1.427 . . . . 0.0 108.71 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.7 p -78.69 159.88 27.77 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.725 0.774 . . . . 0.0 112.198 174.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -150.55 140.88 22.32 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.983 1.313 . . . . 0.0 110.523 171.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.4 mt -81.92 132.72 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 . . . . . 0 N--CA 1.467 0.412 0 C-N-CA 125.06 1.344 . . . . 0.0 110.563 174.019 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 CA--C 1.54 0.577 0 N-CA-C 109.56 -0.534 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -108.39 168.54 9.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.332 1.453 . . . . 0.0 110.227 171.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 tp -120.09 136.2 57.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 125.363 1.465 . . . . 0.0 108.25 170.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 p -123.25 155.64 36.77 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.337 0.655 . . . . 0.0 110.026 172.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -148.56 137.09 21.35 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.174 0.99 . . . . 0.0 111.024 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.7 p -70.52 115.55 9.82 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.168 0.987 . . . . 0.0 111.642 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.13 -163.23 38.65 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.739 1.162 . . . . 0.0 112.949 174.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -68.63 169.41 11.16 Favored 'General case' 0 CA--C 1.553 1.077 0 O-C-N 121.663 -0.904 . . . . 0.0 112.125 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -85.82 114.56 22.85 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.144 1.377 . . . . 0.0 111.265 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.748 0 C-N-CA 123.617 0.767 . . . . 0.0 111.687 174.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.8 m . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.16 93.94 0.64 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 169.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -90.55 147.8 23.11 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 122.272 1.034 . . . . 0.0 111.085 169.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -134.45 171.1 14.77 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.817 1.647 . . . . 0.0 110.932 -172.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.59 134.02 23.21 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.584 0.629 . . . . 0.0 110.5 177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.476 ' CG2' HD11 ' A' ' 166' ' ' LEU . 61.6 mt -127.13 140.59 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.187 0.995 . . . . 0.0 108.914 175.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.0 m -65.33 95.89 0.21 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.228 1.011 . . . . 0.0 109.914 177.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.553 HD21 ' HE3' ' A' ' 167' ' ' LYS . 1.2 tt -53.42 -33.5 54.22 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.18 0.992 . . . . 0.0 111.377 175.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -67.91 -28.87 67.86 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -79.06 -36.31 41.15 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.657 0.662 . . . . 0.0 111.807 169.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.476 HD11 ' CG2' ' A' ' 161' ' ' ILE . 16.1 mt -59.88 -37.32 79.04 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.554 -0.716 . . . . 0.0 111.794 176.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.553 ' HE3' HD21 ' A' ' 163' ' ' LEU . 73.6 mttt -62.14 -6.97 3.42 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 172.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 65.3 mttm . . . . . 0 N--CA 1.485 1.297 0 C-N-CA 124.985 1.314 . . . . 0.0 114.104 178.303 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.8 pttm . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 120.854 0.359 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -147.87 168.96 20.87 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.309 1.444 . . . . 0.0 110.72 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 m -136.55 134.82 37.91 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.91 0.484 . . . . 0.0 111.127 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.0 m -131.51 161.7 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.218 1.407 . . . . 0.0 112.304 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.34 153.15 23.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.742 1.217 . . . . 0.0 111.899 174.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.1 tp -152.94 136.79 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.442 1.497 . . . . 0.0 109.358 177.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -130.56 160.09 35.19 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.191 1.796 . . . . 0.0 109.759 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -132.93 158.76 41.82 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.845 1.258 . . . . 0.0 112.462 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 120.31 25.75 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.002 0.521 . . . . 0.0 110.76 173.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -72.63 179.71 3.45 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.401 0.68 . . . . 0.0 112.642 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -55.65 -29.35 59.13 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.734 1.614 . . . . 0.0 113.284 173.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.5 t -82.84 -6.8 59.6 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.127 1.371 . . . . 0.0 113.244 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.02 34.73 51.82 Favored Glycine 0 CA--C 1.533 1.219 0 O-C-N 120.855 -1.153 . . . . 0.0 114.058 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -119.05 145.39 45.93 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.362 1.465 . . . . 0.0 111.002 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -72.38 123.55 23.29 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.743 0.817 . . . . 0.0 111.181 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.0 t -139.2 141.76 37.91 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.208 1.403 . . . . 0.0 110.547 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -56.1 141.39 40.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.866 0.866 . . . . 0.0 113.054 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 tp -117.52 -47.87 2.62 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.741 0.816 . . . . 0.0 111.694 -178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.58 -117.6 0.71 Allowed Glycine 0 CA--C 1.529 0.906 0 CA-C-O 121.254 0.363 . . . . 0.0 113.663 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -145.08 156.04 43.68 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.518 1.527 . . . . 0.0 109.643 -177.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.2 tp -121.16 100.44 7.06 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.983 1.313 . . . . 0.0 110.065 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 t -76.0 96.3 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.161 1.384 . . . . 0.0 109.096 175.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.6 t -85.38 105.54 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.31 1.444 . . . . 0.0 110.031 173.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 63.3 mtt-85 . . . . . 0 N--CA 1.471 0.597 0 C-N-CA 126.482 1.913 . . . . 0.0 110.158 172.632 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.983 0 CA-C-O 121.551 0.528 . . . . 0.0 114.375 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.3 mt -122.96 145.25 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.427 1.091 . . . . 0.0 110.065 176.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -134.54 132.83 39.62 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.548 1.539 . . . . 0.0 109.763 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.6 p -126.33 147.37 49.74 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.929 -1.107 . . . . 0.0 111.883 -171.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.29 120.77 1.75 Allowed Glycine 0 CA--C 1.527 0.791 0 O-C-N 121.818 -0.551 . . . . 0.0 112.977 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.41 141.23 57.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.961 1.704 . . . . 0.0 110.036 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.553 1.074 0 C-N-CA 126.373 1.869 . . . . 0.0 111.034 -169.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.794 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.6 m -54.95 123.57 13.94 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.167 -0.958 . . . . 0.0 110.245 171.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -90.91 -51.84 5.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.599 0.76 . . . . 0.0 110.2 -177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -164.33 161.09 21.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.848 0.859 . . . . 0.0 112.613 172.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.14 153.7 43.15 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.998 1.319 . . . . 0.0 111.965 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.516 ' HA ' ' H ' ' A' ' 109' ' ' SER . 1.7 pp -140.77 154.78 46.42 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.411 1.485 . . . . 0.0 111.188 -175.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -78.52 166.96 21.97 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.602 0.715 . . . . 0.0 112.208 -172.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -59.57 -21.7 60.7 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 121.388 -0.82 . . . . 0.0 112.543 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -72.92 -12.98 61.16 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 121.045 -1.034 . . . . 0.0 113.583 173.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.7 t -112.13 -2.07 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 120.901 -1.124 . . . . 0.0 110.852 -171.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.0 m -60.96 -26.07 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -97.87 -25.57 14.97 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.693 0.679 . . . . 0.0 111.863 170.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -70.25 -53.7 15.84 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.583 1.553 . . . . 0.0 111.166 -178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -58.05 -44.58 87.5 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.571 1.148 . . . . 0.0 111.236 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 74.1 t -57.16 -36.86 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.957 0.903 . . . . 0.0 111.022 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -62.54 -57.5 10.93 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.464 1.105 . . . . 0.0 111.997 173.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -70.06 -17.16 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 O-C-N 121.331 -0.855 . . . . 0.0 112.573 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.483 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -87.2 -6.91 58.43 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.27 1.828 . . . . 0.0 111.91 177.637 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 46.2 p -128.1 -10.49 5.34 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 173.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -134.88 -9.96 2.34 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.578 1.551 . . . . 0.0 113.954 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.51 155.76 6.4 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.722 1.629 . . . . 0.0 113.824 -174.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.1 -170.8 33.3 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.267 0.937 . . . . 0.0 114.096 -175.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.8 p -143.95 103.32 4.02 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.729 1.211 . . . . 0.0 113.493 -168.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -132.86 162.02 32.65 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.423 1.889 . . . . 0.0 110.398 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.58 160.26 17.51 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.644 0.735 . . . . 0.0 111.387 177.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.9 p -126.57 153.8 44.75 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.279 1.831 . . . . 0.0 110.113 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.516 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 76.9 p -68.9 -39.74 79.55 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.527 -0.733 . . . . 0.0 111.283 -175.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.8 mt -151.61 143.27 23.64 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.904 2.082 . . . . 0.0 111.451 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.41 ' CD2' HD11 ' A' ' 129' ' ' ILE . 39.7 t80 -136.64 101.81 4.73 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.268 1.027 . . . . 0.0 109.299 174.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -87.52 -51.94 5.63 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.68 0.792 . . . . 0.0 111.764 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.44 178.34 49.54 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 124.526 1.06 . . . . 0.0 114.379 -173.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.5 t80 . . . . . 0 CA--C 1.545 0.769 0 C-N-CA 124.408 1.083 . . . . 0.0 111.561 170.092 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.295 0 CA-C-O 121.95 0.75 . . . . 0.0 113.702 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 36.7 mt -127.89 108.4 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.901 1.68 . . . . 0.0 107.846 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -69.21 147.64 51.0 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.176 0.512 . . . . 0.0 111.185 173.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 57.83 22.05 8.18 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.38 1.472 . . . . 0.0 114.162 178.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -56.79 123.9 16.61 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.939 1.296 . . . . 0.0 111.585 -176.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -72.01 128.97 37.39 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.545 1.138 . . . . 0.0 110.768 170.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.41 HD11 ' CD2' ' A' ' 111' ' ' TYR . 38.2 mm -122.94 115.78 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.734 1.214 . . . . 0.0 109.293 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.89 90.02 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.158 1.383 . . . . 0.0 108.671 -174.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.8 p -75.74 154.2 36.53 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.394 175.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -151.54 140.97 21.54 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.215 1.406 . . . . 0.0 111.099 174.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.35 133.97 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.053 0.541 . . . . 0.0 109.754 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 . . . . . 0 N--CA 1.468 0.43 0 C-N-CA 125.303 1.441 . . . . 0.0 111.107 175.368 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -107.18 168.17 9.4 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.319 1.447 . . . . 0.0 110.133 169.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.2 tp -119.04 135.03 60.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.227 1.411 . . . . 0.0 108.56 170.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.0 p -124.03 153.59 41.12 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.835 0.854 . . . . 0.0 109.955 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -151.01 145.67 25.69 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.065 0.946 . . . . 0.0 111.833 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.6 m -82.57 117.9 22.88 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.499 1.12 . . . . 0.0 111.084 176.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.86 -151.87 24.56 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.88 1.705 . . . . 0.0 113.143 177.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -72.2 173.49 8.51 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 170.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -92.4 102.29 14.76 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.084 0.954 . . . . 0.0 111.923 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.475 0.775 0 C-N-CA 124.032 0.933 . . . . 0.0 113.064 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 121.067 0.461 . . . . 0.0 110.78 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.74 124.29 19.98 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 170.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -126.23 144.33 50.82 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 122.243 1.02 . . . . 0.0 111.222 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -137.91 172.14 13.37 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.493 1.517 . . . . 0.0 111.878 -168.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.68 131.48 18.01 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.507 0.723 . . . . 0.0 110.057 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 70.5 mt -124.19 139.93 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 123.959 0.904 . . . . 0.0 108.796 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.8 m -63.86 96.86 0.14 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.11 0.964 . . . . 0.0 109.601 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.43 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.1 tt -55.76 -33.0 63.91 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.072 0.949 . . . . 0.0 111.778 176.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -66.95 -27.67 67.65 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 176.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -87.06 -31.39 20.53 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.892 0.877 . . . . 0.0 112.113 174.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.483 HD13 ' HG3' ' A' ' 100' ' ' MET . 19.4 mt -60.76 -44.1 97.17 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.77 0.828 . . . . 0.0 111.233 172.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -51.71 -32.7 31.3 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.547 -1.346 . . . . 0.0 113.639 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 90.4 mttt . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -179.887 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.7 pttm . . . . . 0 N--CA 1.469 0.505 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -145.96 166.21 26.69 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.112 0.965 . . . . 0.0 111.15 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 m -132.62 126.48 32.8 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.8 0.44 . . . . 0.0 110.628 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.2 m -121.91 169.12 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.839 1.656 . . . . 0.0 110.697 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -67.81 169.2 10.11 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.855 0.862 . . . . 0.0 111.622 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 tp -159.27 137.56 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.936 1.294 . . . . 0.0 109.862 171.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -129.57 158.82 38.22 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.377 2.271 . . . . 0.0 108.942 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -131.39 159.8 36.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.388 1.075 . . . . 0.0 111.766 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -88.08 119.51 28.52 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.15 0.58 . . . . 0.0 110.727 172.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -72.89 179.77 3.54 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.445 0.64 . . . . 0.0 112.191 173.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -57.55 -21.58 39.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.977 1.711 . . . . 0.0 114.428 176.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.0 m -91.56 2.38 56.49 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.045 0.938 . . . . 0.0 113.258 177.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.3 31.26 71.5 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.563 1.077 . . . . 0.0 113.8 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -109.93 140.19 44.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.992 1.317 . . . . 0.0 110.822 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -74.57 121.23 21.24 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.869 0.868 . . . . 0.0 110.77 175.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.6 t -137.42 138.62 40.02 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.915 1.286 . . . . 0.0 110.5 -176.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -58.33 143.48 44.74 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -174.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.2 tp -118.81 -46.42 2.55 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.137 0.975 . . . . 0.0 111.542 -177.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 171.87 -129.5 1.76 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-O 121.457 0.476 . . . . 0.0 113.655 -175.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -141.39 158.9 43.26 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.039 1.736 . . . . 0.0 109.461 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.4 tp -126.22 103.24 7.57 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.884 1.274 . . . . 0.0 110.497 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.1 t -76.56 96.23 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.408 1.083 . . . . 0.0 109.012 175.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.4 t -83.86 113.11 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.586 1.555 . . . . 0.0 109.697 173.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 . . . . . 0 N--CA 1.475 0.823 0 C-N-CA 126.438 1.895 . . . . 0.0 110.175 176.596 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.276 0 N-CA-C 114.761 0.664 . . . . 0.0 114.761 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.3 mt -125.08 142.06 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.237 1.015 . . . . 0.0 109.315 171.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -133.98 134.87 43.02 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.174 1.39 . . . . 0.0 108.729 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.2 p -132.72 143.21 49.46 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.676 0.79 . . . . 0.0 111.268 -173.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.66 122.77 2.69 Favored Glycine 0 C--N 1.336 0.541 0 O-C-N 121.921 -0.487 . . . . 0.0 112.695 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -66.44 126.09 27.74 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.887 1.675 . . . . 0.0 109.124 173.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 37.3 t30 . . . . . 0 CA--C 1.536 0.431 0 C-N-CA 125.864 1.666 . . . . 0.0 109.187 179.937 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.696 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.3 m -59.57 131.24 50.33 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.209 -0.932 . . . . 0.0 110.811 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -98.97 -53.63 3.21 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.168 0.987 . . . . 0.0 109.516 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -161.03 159.09 28.91 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.967 0.907 . . . . 0.0 112.557 170.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.14 149.78 33.68 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 123.052 1.406 . . . . 0.0 112.303 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.434 ' HA ' ' H ' ' A' ' 109' ' ' SER . 2.1 pp -142.92 152.82 42.45 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.695 1.598 . . . . 0.0 110.819 -172.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -79.43 167.81 20.32 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.476 0.711 . . . . 0.0 112.146 -170.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -52.63 -35.84 55.38 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.291 -0.881 . . . . 0.0 112.654 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.2 -8.08 22.11 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.869 1.268 . . . . 0.0 114.179 175.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 t -116.5 -5.45 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.239 1.016 . . . . 0.0 111.41 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.1 t -53.58 -61.72 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 120.476 1.489 . . . . 0.0 111.651 -177.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -69.57 -24.81 63.75 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.82 -52.42 56.85 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.695 1.598 . . . . 0.0 110.706 172.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -59.86 -44.88 93.91 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 125.222 1.409 . . . . 0.0 110.62 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.2 -36.39 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.82 0.848 . . . . 0.0 111.206 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -54.99 29.45 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.075 0.95 . . . . 0.0 111.716 173.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 m -76.0 -2.62 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -176.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.637 ' SD ' HD13 ' A' ' 166' ' ' LEU . 40.7 tpp -108.62 -4.22 17.3 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.426 1.49 . . . . 0.0 112.47 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 43.2 p -125.42 -11.75 6.82 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.184 0.994 . . . . 0.0 112.573 171.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -135.25 -12.4 2.13 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.3 156.58 19.15 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 124.697 1.142 . . . . 0.0 113.865 -175.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.05 -160.35 31.54 Favored Glycine 0 CA--C 1.533 1.193 0 O-C-N 121.665 -0.903 . . . . 0.0 113.894 -175.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 85.0 p -150.72 104.49 3.19 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -171.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -135.04 153.3 52.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.066 1.746 . . . . 0.0 110.369 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -80.72 159.58 25.2 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.546 -0.721 . . . . 0.0 111.145 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.2 p -124.93 149.1 47.96 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.9 1.68 . . . . 0.0 110.595 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.434 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 8.1 t -62.59 -44.33 96.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.824 0.85 . . . . 0.0 111.336 -177.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mt -149.61 143.13 25.34 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.459 1.504 . . . . 0.0 111.845 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -140.87 106.08 5.02 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.891 0.876 . . . . 0.0 110.735 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -90.64 -40.26 12.0 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.054 0.942 . . . . 0.0 113.104 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.92 -178.11 40.73 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 124.658 1.123 . . . . 0.0 113.877 -170.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 22.9 t80 . . . . . 0 CA--C 1.541 0.612 0 O-C-N 121.694 -0.886 . . . . 0.0 112.511 172.412 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.546 0 CA-C-O 121.077 0.265 . . . . 0.0 113.341 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 95.3 mt -116.2 109.49 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.17 1.388 . . . . 0.0 109.318 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -69.36 146.71 51.91 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.128 0.971 . . . . 0.0 112.146 172.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 54.68 24.47 5.57 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.283 1.833 . . . . 0.0 114.586 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -55.58 123.07 12.8 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.292 1.437 . . . . 0.0 111.696 -178.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -72.37 128.45 35.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.058 0.943 . . . . 0.0 110.618 170.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.5 mm -124.14 116.33 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.819 1.248 . . . . 0.0 108.649 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.13 94.04 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.435 1.494 . . . . 0.0 108.097 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.8 p -80.14 157.61 26.57 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.859 0.838 . . . . 0.0 111.776 176.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -154.12 146.71 24.12 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.891 1.276 . . . . 0.0 111.469 174.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 16.2 mt -84.29 131.47 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.175 0.59 . . . . 0.0 110.019 173.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 . . . . . 0 CA--C 1.536 0.441 0 C-N-CA 126.291 1.836 . . . . 0.0 110.077 176.321 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 . . . . . 0 CA--C 1.539 0.537 0 CA-C-O 121.218 0.532 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -109.0 158.19 17.95 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.398 1.479 . . . . 0.0 110.735 174.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 6.8 tp -100.92 144.68 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 166.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.7 p -133.12 156.48 47.37 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.624 0.77 . . . . 0.0 109.157 169.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -151.49 145.99 25.58 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.923 0.889 . . . . 0.0 111.457 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.2 p -76.22 115.45 15.96 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.701 1.2 . . . . 0.0 110.979 174.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.66 -162.22 38.05 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.379 0.99 . . . . 0.0 112.917 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.99 161.39 26.71 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.755 0.822 . . . . 0.0 112.682 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -78.12 103.94 8.38 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.448 0.699 . . . . 0.0 110.636 172.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.556 ' CG2' ' HB2' ' A' ' 157' ' ' ALA . 0.2 OUTLIER . . . . . 0 CA--C 1.54 0.569 0 C-N-CA 125.031 1.332 . . . . 0.0 112.687 179.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 N--CA 1.477 0.887 0 CA-C-O 120.921 0.391 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.556 ' HB2' ' CG2' ' A' ' 149' ' ' ILE . . . -63.77 100.07 0.27 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.737 0.815 . . . . 0.0 109.599 171.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -93.79 145.77 24.35 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.174 0.988 . . . . 0.0 110.974 173.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -135.14 166.85 22.12 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.697 1.599 . . . . 0.0 111.417 -172.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.88 135.51 23.26 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.894 0.477 . . . . 0.0 110.555 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 59.0 mt -130.34 142.07 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.563 1.145 . . . . 0.0 109.076 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.5 m -63.95 96.55 0.14 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.389 1.076 . . . . 0.0 110.033 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -56.62 -30.55 63.39 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.413 -0.804 . . . . 0.0 111.899 176.25 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -67.17 -28.04 67.78 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -90.1 -25.95 20.47 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.178 0.991 . . . . 0.0 112.247 176.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.637 HD13 ' SD ' ' A' ' 100' ' ' MET . 12.6 mt -65.87 -47.92 73.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.573 1.149 . . . . 0.0 111.213 171.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -49.31 -40.21 34.18 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.374 1.07 . . . . 0.0 112.765 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt . . . . . 0 N--CA 1.484 1.264 0 C-N-CA 125.447 1.499 . . . . 0.0 114.43 178.046 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 120.668 0.27 . . . . 0.0 110.665 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.4 tt -138.66 147.3 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.569 1.548 . . . . 0.0 110.417 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 -146.79 131.66 18.08 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.492 1.117 . . . . 0.0 109.655 173.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.7 t -150.42 153.67 36.36 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.941 1.297 . . . . 0.0 110.642 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.7 t -155.11 159.0 39.88 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.982 1.313 . . . . 0.0 111.185 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -150.37 149.54 30.21 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.606 1.562 . . . . 0.0 110.783 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -160.05 136.81 9.14 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.653 1.181 . . . . 0.0 110.83 173.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -138.45 151.34 47.33 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.065 1.346 . . . . 0.0 110.926 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -150.4 144.68 25.61 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.814 1.245 . . . . 0.0 110.51 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.7 t -150.99 155.48 39.16 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.004 1.322 . . . . 0.0 110.974 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.6 t -156.04 165.86 35.18 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.194 1.398 . . . . 0.0 111.273 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -168.65 159.56 32.74 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.225 1.393 . . . . 0.0 112.371 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -150.82 130.04 12.76 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.935 1.294 . . . . 0.0 110.111 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 t -157.98 159.76 36.78 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.312 1.045 . . . . 0.0 111.606 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -116.39 29.79 7.74 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.158 1.783 . . . . 0.0 111.801 -174.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -101.4 91.79 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.768 2.027 . . . . 0.0 110.974 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -140.26 165.66 26.79 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.365 1.866 . . . . 0.0 111.439 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -50.94 150.44 3.01 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.604 1.962 . . . . 0.0 112.667 176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.4 mm -62.53 150.47 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.858 1.263 . . . . 0.0 112.117 -172.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -51.36 -22.92 3.23 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.545 1.538 . . . . 0.0 114.714 173.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -78.77 -1.58 35.41 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.248 1.419 . . . . 0.0 114.032 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.9 m -125.62 -48.19 1.67 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.756 1.622 . . . . 0.0 111.804 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.7 pttm -155.07 166.13 34.56 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.424 1.49 . . . . 0.0 111.274 169.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -144.43 166.99 23.54 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.17 0.988 . . . . 0.0 110.724 171.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -134.93 135.48 41.56 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.713 0.405 . . . . 0.0 110.896 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.72 162.94 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.694 1.598 . . . . 0.0 111.457 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -64.32 159.3 21.32 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.258 1.023 . . . . 0.0 112.499 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.0 tp -153.26 136.94 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.891 1.276 . . . . 0.0 109.632 174.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -130.24 156.49 44.54 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.815 2.046 . . . . 0.0 108.952 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -128.78 159.52 35.46 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.527 1.131 . . . . 0.0 111.914 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.58 117.04 23.48 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 122.93 0.492 . . . . 0.0 110.568 173.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -71.8 -179.96 2.89 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.309 0.644 . . . . 0.0 112.298 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -56.14 -26.87 51.98 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.64 1.576 . . . . 0.0 113.424 172.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.1 m -80.07 0.59 31.27 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.668 1.587 . . . . 0.0 114.148 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.44 34.08 87.04 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.657 1.122 . . . . 0.0 114.411 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -123.49 143.2 50.32 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.75 1.62 . . . . 0.0 109.744 177.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -67.33 126.62 29.83 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.967 0.907 . . . . 0.0 110.834 177.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -136.72 142.05 43.08 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.437 1.495 . . . . 0.0 110.18 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -57.55 140.19 51.49 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.1 tp -118.69 -48.59 2.47 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.828 0.851 . . . . 0.0 111.623 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.85 -119.83 0.86 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 123.261 0.458 . . . . 0.0 113.236 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -144.92 159.58 42.69 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.582 1.553 . . . . 0.0 110.284 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.5 tp -124.52 104.93 9.0 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.707 1.603 . . . . 0.0 110.131 -178.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.2 t -78.76 99.43 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 125.073 1.349 . . . . 0.0 109.563 175.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.4 t -85.27 101.98 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.969 1.708 . . . . 0.0 110.239 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 46.3 mtp180 -87.44 121.33 29.75 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.901 1.68 . . . . 0.0 110.773 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -88.54 86.48 7.03 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.127 1.371 . . . . 0.0 110.4 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -76.3 173.88 10.86 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.629 1.172 . . . . 0.0 112.2 174.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -75.25 -33.51 61.31 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.897 -1.127 . . . . 0.0 113.527 173.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -109.88 53.59 0.69 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.449 1.5 . . . . 0.0 111.106 -172.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 109.09 -160.52 13.51 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.034 0.826 . . . . 0.0 113.967 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.9 mt -122.83 141.72 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.003 0.921 . . . . 0.0 109.609 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -130.7 127.5 38.96 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.881 1.272 . . . . 0.0 109.609 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.0 p -121.44 148.54 44.28 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.7 -0.625 . . . . 0.0 111.526 -173.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.96 124.99 2.47 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-O 121.497 0.498 . . . . 0.0 113.081 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -66.77 135.44 53.97 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.029 1.731 . . . . 0.0 109.827 175.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -137.12 85.09 2.11 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.086 1.755 . . . . 0.0 110.448 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.53 177.73 6.71 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.497 1.519 . . . . 0.0 112.744 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.01 53.64 2.17 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 126.256 1.884 . . . . 0.0 114.689 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 143.72 -1.19 1.3 Allowed Glycine 0 CA--C 1.539 1.575 0 C-N-CA 125.46 1.505 . . . . 0.0 115.222 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -150.4 151.39 32.73 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 118.813 1.306 . . . . 0.0 112.294 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 88.2 p -151.47 146.57 26.01 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 170.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.22 162.0 28.09 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.554 1.542 . . . . 0.0 111.592 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.6 m -55.37 132.0 47.11 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.257 -0.902 . . . . 0.0 110.529 169.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -99.83 -50.86 3.89 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.032 0.933 . . . . 0.0 110.26 -178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -163.42 159.92 22.83 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.894 0.878 . . . . 0.0 112.349 170.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.75 148.3 30.82 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 123.151 1.453 . . . . 0.0 112.873 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.449 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -136.18 157.85 45.82 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.046 1.338 . . . . 0.0 111.527 -171.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -78.49 167.5 21.19 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.29 0.567 . . . . 0.0 112.312 -174.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -56.74 -35.61 68.8 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.324 -0.86 . . . . 0.0 112.354 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -68.52 -5.05 17.37 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.846 1.259 . . . . 0.0 113.495 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.2 t -117.46 -5.22 11.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 124.247 1.019 . . . . 0.0 111.292 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.7 t -49.35 -63.81 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-N 120.455 1.479 . . . . 0.0 112.006 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -69.88 -28.85 65.98 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.801 -0.562 . . . . 0.0 112.138 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -63.05 -51.09 68.05 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.881 1.672 . . . . 0.0 110.899 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -59.93 -45.34 92.9 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 125.032 1.333 . . . . 0.0 110.522 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 37.4 t -59.24 -39.87 79.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.062 0.545 . . . . 0.0 110.523 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -59.28 -52.5 65.39 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.479 1.112 . . . . 0.0 112.183 174.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 m -73.29 -10.43 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 121.509 -0.744 . . . . 0.0 112.641 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.597 ' CG ' HD13 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -103.41 0.12 30.79 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.445 -1.41 . . . . 0.0 112.614 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.6 p -123.42 -12.62 7.74 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.236 1.015 . . . . 0.0 112.77 169.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -137.8 -14.36 1.42 Allowed 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.23 155.74 26.85 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.111 1.339 . . . . 0.0 113.954 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.09 -169.58 32.59 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.712 1.148 . . . . 0.0 113.829 -174.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 26.8 p -145.25 100.71 3.51 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.213 1.405 . . . . 0.0 113.34 -168.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -129.99 146.85 51.69 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.83 1.652 . . . . 0.0 110.037 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -74.95 157.52 34.84 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.466 -0.771 . . . . 0.0 111.021 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.7 p -121.66 147.65 45.6 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.28 1.432 . . . . 0.0 110.812 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.449 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 7.6 t -60.79 -43.6 97.9 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.686 0.794 . . . . 0.0 111.407 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mt -150.27 142.4 24.06 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.454 1.502 . . . . 0.0 112.251 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -134.02 106.04 7.03 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.078 0.951 . . . . 0.0 110.14 174.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -90.45 -47.77 7.52 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.297 1.039 . . . . 0.0 112.571 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.32 175.46 30.09 Favored Glycine 0 CA--C 1.544 1.847 0 C-N-CA 125.679 1.609 . . . . 0.0 114.595 -170.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -58.33 163.38 3.04 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.722 1.209 . . . . 0.0 112.568 169.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -64.32 166.67 7.79 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.891 -1.131 . . . . 0.0 112.321 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 72.14 36.35 1.13 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.878 1.671 . . . . 0.0 113.228 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -133.94 174.44 10.47 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.47 1.508 . . . . 0.0 112.503 -173.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -88.01 -35.59 17.49 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.804 0.841 . . . . 0.0 111.966 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 41.8 p -72.58 -42.38 64.65 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 175.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.6 p -58.02 -21.41 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 124.851 1.26 . . . . 0.0 114.087 -170.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 66.3 mt -53.92 -39.65 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 126.552 1.941 . . . . 0.0 111.916 174.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -144.54 -38.35 0.29 Allowed 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 -177.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 113.13 155.86 12.05 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 127.084 2.278 . . . . 0.0 112.689 -176.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 57.4 mt -110.63 115.11 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.785 1.234 . . . . 0.0 108.76 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -73.97 148.49 42.06 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.109 0.481 . . . . 0.0 111.873 172.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 57.43 22.35 7.86 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.224 1.81 . . . . 0.0 114.277 177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -63.71 126.2 26.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.009 1.323 . . . . 0.0 111.682 -171.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -75.88 121.39 22.57 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.609 1.164 . . . . 0.0 111.907 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 31.7 mm -114.8 112.07 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.296 1.039 . . . . 0.0 109.537 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -105.94 104.34 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.899 1.28 . . . . 0.0 108.387 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 47.6 p -89.8 156.89 18.19 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.456 1.102 . . . . 0.0 112.006 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.4 137.74 16.65 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.093 1.357 . . . . 0.0 111.586 175.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.7 mt -77.99 132.93 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.141 0.577 . . . . 0.0 109.684 174.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -151.02 136.59 17.89 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.435 1.494 . . . . 0.0 110.976 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.1 157.66 34.37 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.021 -1.049 . . . . 0.0 110.908 168.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 37.0 mt -131.15 -49.88 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.165 0.986 . . . . 0.0 111.031 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -145.84 29.42 1.11 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.659 0.784 . . . . 0.0 112.548 -175.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 105.66 -18.82 40.22 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 124.735 1.159 . . . . 0.0 113.91 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 53.8 m -92.11 139.23 30.84 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.253 1.021 . . . . 0.0 108.763 169.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -71.97 126.65 30.29 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.794 -0.566 . . . . 0.0 110.025 169.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -111.3 167.83 9.99 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.939 1.295 . . . . 0.0 110.743 173.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 tp -124.75 131.46 72.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.599 1.56 . . . . 0.0 108.395 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.8 p -118.82 154.47 32.81 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.677 0.791 . . . . 0.0 110.124 177.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -152.83 145.07 23.92 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.431 0.692 . . . . 0.0 112.155 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.6 m -82.32 111.03 18.01 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.539 1.136 . . . . 0.0 110.443 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.17 -155.61 19.59 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.374 1.464 . . . . 0.0 113.302 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.49 170.42 2.45 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 169.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -94.9 102.16 13.99 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.596 0.758 . . . . 0.0 111.13 173.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.72 164.22 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.924 0.89 . . . . 0.0 112.163 178.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.4 tptp -113.4 12.35 18.74 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -113.78 14.45 18.68 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.785 1.634 . . . . 0.0 112.935 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 2.0 t -132.48 -47.31 0.89 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 130.74 67.18 0.1 OUTLIER Glycine 0 N--CA 1.476 1.338 0 CA-C-N 118.99 0.814 . . . . 0.0 113.939 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 55.91 28.02 11.95 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.795 1.638 . . . . 0.0 114.168 -174.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -88.48 174.79 7.9 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.445 -0.784 . . . . 0.0 108.896 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.4 m -105.8 139.26 27.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 123.386 0.674 . . . . 0.0 109.54 170.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.92 116.61 5.44 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 169.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -118.19 149.19 41.49 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 122.362 1.077 . . . . 0.0 110.297 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -137.97 174.84 10.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.106 -1.406 . . . . 0.0 111.9 -169.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.61 130.06 16.79 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.81 0.844 . . . . 0.0 109.791 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.45 ' CG2' HD11 ' A' ' 166' ' ' LEU . 69.8 mt -121.9 138.99 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.192 0.997 . . . . 0.0 108.807 176.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -63.82 95.89 0.12 Allowed 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.744 0.818 . . . . 0.0 109.7 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.602 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.3 tt -53.98 -31.27 50.3 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.876 1.27 . . . . 0.0 111.879 175.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -69.38 -28.09 65.87 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -86.77 -26.7 24.03 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.165 0.986 . . . . 0.0 112.522 175.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 163' ' ' LEU . 27.9 mt -62.9 -53.04 60.23 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.412 1.085 . . . . 0.0 109.796 169.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 35.8 mttm -46.53 -37.69 8.3 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -53.67 -28.4 33.2 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.033 1.333 . . . . 0.0 114.149 177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -122.46 -2.14 9.01 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.96 1.704 . . . . 0.0 113.178 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.2 mp -104.23 -27.49 12.0 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.015 1.726 . . . . 0.0 112.242 -177.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 35.8 mttm . . . . . 0 C--O 1.254 1.317 0 C-N-CA 126.063 1.745 . . . . 0.0 113.235 173.345 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.1 mttp . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 120.433 0.159 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.2 pt -99.46 172.46 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 125.5 1.52 . . . . 0.0 111.348 173.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.0 m170 54.33 29.09 10.24 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.714 1.605 . . . . 0.0 114.384 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.8 p -94.03 155.5 17.08 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.106 1.363 . . . . 0.0 112.08 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.0 p -139.07 140.7 38.11 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.105 1.362 . . . . 0.0 110.013 169.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -146.63 149.66 33.94 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.904 1.282 . . . . 0.0 109.877 -177.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -103.24 156.06 17.99 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.391 1.076 . . . . 0.0 112.318 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.4 mp0 -135.74 157.03 47.86 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.836 1.254 . . . . 0.0 111.604 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -149.57 85.63 1.44 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.767 1.227 . . . . 0.0 111.749 -174.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.7 t -151.66 -174.57 4.89 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.028 1.331 . . . . 0.0 112.253 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.9 p -132.06 53.87 1.97 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.825 2.05 . . . . 0.0 111.664 -176.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.78 -133.89 2.7 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.258 1.885 . . . . 0.0 111.708 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -45.71 134.8 7.24 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.168 1.387 . . . . 0.0 112.841 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.4 m -159.69 160.9 34.67 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.153 1.381 . . . . 0.0 111.902 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -76.57 151.7 36.21 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.328 1.451 . . . . 0.0 110.904 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 t -138.28 49.34 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-O 122.608 1.194 . . . . 0.0 111.47 -170.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.28 -174.6 4.97 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 127.089 2.156 . . . . 0.0 111.276 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.64 116.93 3.7 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.978 1.311 . . . . 0.0 110.742 171.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 mm -105.37 153.05 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.104 0.962 . . . . 0.0 110.512 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -67.81 -12.44 60.61 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -77.26 -165.73 0.62 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.038 1.735 . . . . 0.0 113.231 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.56 -40.01 94.79 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.784 1.233 . . . . 0.0 112.699 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -65.31 148.18 52.14 Favored 'General case' 0 C--N 1.341 0.235 0 CA-C-O 121.622 0.725 . . . . 0.0 110.588 169.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -135.44 175.53 9.5 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 124.966 1.306 . . . . 0.0 110.523 171.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -141.19 145.17 35.31 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.411 -0.805 . . . . 0.0 111.172 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.4 m -139.88 152.48 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.782 0.833 . . . . 0.0 112.341 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -56.63 139.5 49.92 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.666 1.187 . . . . 0.0 110.782 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.8 tp -137.53 136.32 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.798 1.239 . . . . 0.0 109.278 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -131.15 158.61 40.0 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.485 1.914 . . . . 0.0 108.826 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -130.37 161.4 31.41 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.423 1.089 . . . . 0.0 111.707 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.38 122.52 31.97 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.186 0.594 . . . . 0.0 111.026 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.22 -176.98 5.88 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 176.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -58.07 -24.48 58.71 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.441 1.896 . . . . 0.0 114.145 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.0 m -88.12 2.64 51.57 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.394 1.078 . . . . 0.0 113.386 176.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.5 35.48 91.99 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.698 1.142 . . . . 0.0 113.882 -176.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -114.51 143.4 45.02 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.374 1.47 . . . . 0.0 110.392 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.7 m95 -73.26 119.93 18.17 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.269 0.628 . . . . 0.0 110.622 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.0 t -129.14 135.3 48.68 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.77 1.628 . . . . 0.0 109.69 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -57.39 142.18 44.68 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -175.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.1 tp -117.33 -48.01 2.63 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.777 0.831 . . . . 0.0 111.4 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.84 -109.89 0.37 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.29 0.471 . . . . 0.0 113.698 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -149.72 156.84 42.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.222 1.809 . . . . 0.0 109.819 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 tp -122.46 102.29 8.0 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.593 1.157 . . . . 0.0 110.124 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.3 t -75.76 101.62 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 123.56 0.744 . . . . 0.0 109.263 176.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.9 t -88.0 94.25 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 125.731 1.612 . . . . 0.0 109.159 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 47.9 mtp85 -76.25 110.84 11.08 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.258 1.423 . . . . 0.0 110.458 172.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 13.4 mmtp -69.26 123.03 20.07 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 168.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -113.2 170.61 8.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.533 1.133 . . . . 0.0 111.116 175.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -74.57 -26.4 59.92 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.742 -1.224 . . . . 0.0 112.708 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -115.66 32.96 5.75 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.455 1.502 . . . . 0.0 112.433 -169.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.66 -158.37 21.27 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.484 1.516 . . . . 0.0 113.469 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.5 mt -128.18 143.13 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.769 0.828 . . . . 0.0 110.168 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -131.71 125.58 32.38 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.422 1.089 . . . . 0.0 110.703 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.2 p -116.56 146.01 42.94 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.617 -0.677 . . . . 0.0 111.813 -174.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -139.99 123.67 2.5 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 123.278 0.466 . . . . 0.0 112.083 -178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.33 137.19 54.44 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.24 1.416 . . . . 0.0 110.179 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -132.65 95.43 3.6 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.182 2.193 . . . . 0.0 109.48 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -98.69 175.1 6.1 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.506 1.122 . . . . 0.0 111.829 173.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.56 -27.13 60.72 Favored Glycine 0 CA--C 1.538 1.512 0 N-CA-C 115.719 1.048 . . . . 0.0 115.719 -172.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -145.66 25.55 1.81 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.194 1.378 . . . . 0.0 113.687 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -154.62 149.58 26.77 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.192 0.997 . . . . 0.0 112.634 -175.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 88.8 p -155.96 149.88 25.26 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 170.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -166.19 163.45 17.87 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.966 1.706 . . . . 0.0 111.309 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.7 m -56.51 131.35 48.36 Favored 'General case' 0 N--CA 1.481 1.097 0 O-C-N 121.212 -0.93 . . . . 0.0 109.191 168.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -98.0 -49.65 4.69 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.503 0.592 . . . . 0.0 110.142 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -167.35 159.09 12.24 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.867 0.867 . . . . 0.0 112.503 170.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.36 149.5 32.9 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 122.961 1.362 . . . . 0.0 112.525 -178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.427 ' HA ' ' H ' ' A' ' 109' ' ' SER . 2.4 pp -141.04 156.12 46.06 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.363 1.465 . . . . 0.0 110.836 -170.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -83.2 167.81 17.37 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.287 0.635 . . . . 0.0 112.111 -172.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -55.67 -32.0 62.86 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.022 -1.049 . . . . 0.0 112.535 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -66.4 -6.13 13.32 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.25 1.42 . . . . 0.0 114.022 174.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.88 -3.17 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 119.451 1.023 . . . . 0.0 111.555 -175.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.517 ' O ' HG23 ' A' ' 97' ' ' VAL . 71.3 t -52.6 -64.53 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 120.314 1.415 . . . . 0.0 111.524 -177.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -68.38 -27.24 66.06 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.317 0.647 . . . . 0.0 112.237 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.06 -54.2 41.87 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.413 1.485 . . . . 0.0 110.43 174.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -60.58 -46.13 91.36 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 125.135 1.374 . . . . 0.0 111.373 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 93' ' ' VAL . 87.8 t -54.46 -34.84 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.011 0.925 . . . . 0.0 110.72 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -72.69 -53.96 10.3 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.117 1.367 . . . . 0.0 113.539 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 m -68.86 -16.65 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 120.813 -1.179 . . . . 0.0 112.374 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.653 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -86.37 -4.55 59.19 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.247 1.819 . . . . 0.0 111.971 176.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 51.0 p -130.96 -15.76 3.33 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -130.34 -10.63 4.13 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.1 1.76 . . . . 0.0 113.668 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.01 156.68 7.58 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.459 1.504 . . . . 0.0 113.642 -173.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 156.33 -170.61 33.96 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.379 0.99 . . . . 0.0 113.712 -174.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 93.7 p -146.05 95.36 2.61 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.608 1.163 . . . . 0.0 113.229 -168.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -125.97 141.13 52.11 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.751 1.62 . . . . 0.0 109.737 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -69.09 156.8 38.05 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.708 -0.62 . . . . 0.0 110.569 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.4 p -120.53 156.61 31.2 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.302 1.441 . . . . 0.0 110.804 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.427 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 7.9 t -70.11 -44.54 68.78 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.004 0.521 . . . . 0.0 111.169 -178.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.6 mt -148.29 140.32 24.01 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.566 1.546 . . . . 0.0 111.352 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -134.92 103.41 5.58 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.934 0.894 . . . . 0.0 110.39 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -89.84 -44.32 10.02 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.195 0.998 . . . . 0.0 113.36 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.02 -179.94 12.81 Favored Glycine 0 CA--C 1.543 1.808 0 C-N-CA 124.986 1.279 . . . . 0.0 114.307 -169.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -57.7 160.18 4.63 Favored 'General case' 0 CA--C 1.551 1.008 0 O-C-N 121.603 -0.94 . . . . 0.0 112.03 169.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.617 ' HA ' HG11 ' A' ' 120' ' ' VAL . 26.3 mttp -60.47 174.32 0.58 Allowed 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 173.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 64.04 33.7 11.93 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.043 1.337 . . . . 0.0 112.667 -177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.587 ' HG3' HG22 ' A' ' 149' ' ' ILE . 12.0 tt0 -136.45 157.43 46.81 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.874 1.67 . . . . 0.0 111.063 -170.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -77.73 -14.69 59.53 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.079 -1.013 . . . . 0.0 113.197 -176.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 16.5 p -92.38 -34.04 14.32 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.861 1.664 . . . . 0.0 114.195 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.617 HG11 ' HA ' ' A' ' 115' ' ' LYS . 10.0 p -67.07 -16.38 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.259 1.024 . . . . 0.0 113.52 -173.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 35.9 mm -54.52 -51.8 46.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.635 1.974 . . . . 0.0 112.237 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 51.6 m-20 -144.7 1.16 1.01 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.033 1.333 . . . . 0.0 113.587 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 81.93 170.76 45.04 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.219 1.39 . . . . 0.0 112.934 -171.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 50.1 mt -126.3 108.13 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.962 1.305 . . . . 0.0 109.192 176.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -63.98 141.26 58.83 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.7 0.8 . . . . 0.0 112.006 172.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 58.29 22.67 9.57 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.719 1.608 . . . . 0.0 114.456 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 19.0 tptp -55.21 122.94 12.17 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.352 1.061 . . . . 0.0 111.52 -178.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -69.73 129.81 40.62 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.228 1.011 . . . . 0.0 110.22 169.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.7 mm -127.28 119.75 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 124.197 0.999 . . . . 0.0 108.661 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mp -113.13 96.45 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 125.053 1.341 . . . . 0.0 108.311 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.9 p -77.44 153.99 33.04 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.835 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.4 ptpt -150.61 137.83 19.42 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.857 1.263 . . . . 0.0 111.115 175.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.8 mt -81.85 131.54 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 176.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -137.95 122.89 18.96 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.434 1.493 . . . . 0.0 110.644 173.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.9 mttp -73.84 107.58 6.15 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.193 0.997 . . . . 0.0 109.721 171.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 26.1 mt -95.25 97.81 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 175.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 59.02 16.06 4.43 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 126.475 1.91 . . . . 0.0 115.401 -176.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 123.74 -32.32 4.28 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.149 1.357 . . . . 0.0 113.572 177.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 92.0 m -71.64 124.79 25.51 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.102 0.961 . . . . 0.0 108.92 170.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -74.71 118.49 17.73 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 121.735 -0.603 . . . . 0.0 109.383 173.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -107.59 166.13 10.9 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.991 1.316 . . . . 0.0 110.367 170.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.6 tp -119.9 133.68 65.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 125.15 1.38 . . . . 0.0 108.341 170.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.0 p -121.9 155.5 35.33 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.45 0.7 . . . . 0.0 109.909 175.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -148.11 140.85 24.64 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.889 0.875 . . . . 0.0 110.925 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.5 m -79.48 110.12 14.49 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.713 0.805 . . . . 0.0 110.197 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.02 -162.17 27.85 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 125.214 1.388 . . . . 0.0 112.535 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -68.26 162.88 24.09 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.641 -0.917 . . . . 0.0 112.874 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -76.26 108.19 9.03 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.293 1.037 . . . . 0.0 111.185 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.587 HG22 ' HG3' ' A' ' 117' ' ' GLU . 0.2 OUTLIER -62.49 163.52 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.283 1.033 . . . . 0.0 112.612 177.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -102.94 1.85 34.32 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.695 1.369 . . . . 0.0 114.695 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -108.83 13.84 24.64 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.478 1.511 . . . . 0.0 113.761 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.435 ' HB3' HD11 ' A' ' 149' ' ' ILE . 1.4 t -140.28 176.66 8.58 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.165 1.386 . . . . 0.0 112.267 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -78.95 61.36 4.1 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.998 1.761 . . . . 0.0 114.361 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 51.4 40.73 27.25 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.009 1.723 . . . . 0.0 113.145 -173.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -87.1 -177.94 6.14 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.885 0.874 . . . . 0.0 109.42 175.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 10.8 m -111.91 146.2 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.018 1.327 . . . . 0.0 110.308 170.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.01 114.46 3.71 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 173.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -117.5 138.85 51.6 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.309 1.052 . . . . 0.0 109.898 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -134.68 169.6 17.08 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 125.416 1.486 . . . . 0.0 111.199 -169.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.03 131.58 19.83 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.4 0.68 . . . . 0.0 109.909 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.425 ' CG2' HD11 ' A' ' 166' ' ' LEU . 59.0 mt -124.78 138.26 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.072 0.949 . . . . 0.0 108.739 177.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.2 m -63.71 94.82 0.1 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.224 1.01 . . . . 0.0 109.649 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.592 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.4 tt -55.03 -32.2 61.68 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.325 1.05 . . . . 0.0 111.849 176.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -68.48 -29.59 68.25 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 176.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -84.19 -31.37 25.14 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.906 0.882 . . . . 0.0 112.095 174.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.653 HD13 ' HG3' ' A' ' 100' ' ' MET . 17.9 mt -57.63 -49.5 76.23 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.012 0.925 . . . . 0.0 110.953 173.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -50.01 -40.79 45.7 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.443 1.097 . . . . 0.0 113.448 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -69.3 -17.86 63.77 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.43 1.492 . . . . 0.0 114.259 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -122.3 -3.28 8.96 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.359 1.464 . . . . 0.0 113.722 -174.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 13.1 mt -92.98 -24.09 18.48 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.042 1.337 . . . . 0.0 111.934 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.252 0 C-N-CA 126.737 2.015 . . . . 0.0 113.925 -174.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 pp -68.91 166.1 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.621 0.768 . . . . 0.0 112.526 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -139.71 145.74 38.73 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.705 1.202 . . . . 0.0 111.307 176.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.8 p -67.23 111.54 4.02 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.619 1.167 . . . . 0.0 111.606 175.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.5 t -151.37 121.19 7.05 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.938 1.295 . . . . 0.0 110.435 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -159.23 163.34 35.96 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.084 1.754 . . . . 0.0 111.07 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -154.4 135.92 14.25 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.98 1.312 . . . . 0.0 109.928 175.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -114.75 99.54 7.58 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.711 1.204 . . . . 0.0 110.55 -173.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -70.51 133.54 46.88 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.938 0.895 . . . . 0.0 112.277 -173.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.8 t -86.91 75.65 9.54 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.947 1.299 . . . . 0.0 111.625 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 p -143.73 123.76 13.6 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.059 1.344 . . . . 0.0 111.327 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.95 -109.05 3.73 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.087 1.327 . . . . 0.0 112.893 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -142.03 51.34 1.5 Allowed 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.36 1.464 . . . . 0.0 111.095 -174.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.8 t -68.87 164.27 22.44 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.484 1.114 . . . . 0.0 112.702 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -64.5 136.28 56.89 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.611 1.164 . . . . 0.0 111.538 173.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.5 t -144.27 138.9 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.374 1.87 . . . . 0.0 108.327 176.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.37 173.27 7.46 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.718 1.607 . . . . 0.0 111.579 174.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -139.44 163.12 33.37 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.456 1.902 . . . . 0.0 110.403 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.1 mm -65.32 132.96 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.764 0.826 . . . . 0.0 110.577 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.21 35.6 3.02 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.606 1.562 . . . . 0.0 111.234 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -91.92 -9.4 43.27 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.065 0.946 . . . . 0.0 113.21 173.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.5 m -77.56 -22.06 51.57 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.791 1.637 . . . . 0.0 113.817 177.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -152.74 158.58 42.51 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.782 1.633 . . . . 0.0 110.788 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -143.06 168.14 20.44 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.949 0.9 . . . . 0.0 111.118 174.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -133.97 131.98 39.62 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.645 0.378 . . . . 0.0 111.229 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.5 162.01 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.959 1.704 . . . . 0.0 111.229 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -62.15 159.03 15.5 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.13 0.972 . . . . 0.0 111.776 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.9 tp -153.98 136.43 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.45 1.1 . . . . 0.0 109.876 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -128.82 159.49 35.56 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.105 1.762 . . . . 0.0 109.26 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -130.53 153.8 48.46 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.687 1.195 . . . . 0.0 111.03 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -81.47 119.18 23.4 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 122.152 -0.343 . . . . 0.0 110.505 174.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -71.67 -178.84 2.37 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.563 0.745 . . . . 0.0 112.752 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -54.77 -30.7 57.38 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.702 1.201 . . . . 0.0 113.552 174.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.7 m -81.09 -0.87 41.93 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.071 0.949 . . . . 0.0 113.515 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.99 29.95 73.83 Favored Glycine 0 CA--C 1.536 1.37 0 O-C-N 121.505 -0.747 . . . . 0.0 113.379 -173.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -111.3 135.46 51.81 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.415 1.486 . . . . 0.0 110.043 178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -69.01 124.73 24.54 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.031 0.932 . . . . 0.0 110.8 175.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.2 t -137.89 137.48 38.1 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.782 1.233 . . . . 0.0 110.787 -177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -56.04 130.75 45.26 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.965 1.306 . . . . 0.0 112.027 -173.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.0 tp -106.54 -47.35 3.79 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.233 0.613 . . . . 0.0 111.521 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.03 -115.83 0.62 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.247 0.451 . . . . 0.0 113.267 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -146.48 157.13 43.71 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.218 1.407 . . . . 0.0 110.087 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.5 tp -121.51 102.72 8.43 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.284 1.434 . . . . 0.0 110.342 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.6 t -78.19 95.13 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.185 1.394 . . . . 0.0 109.07 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.7 t -81.84 99.48 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.735 1.614 . . . . 0.0 109.582 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 42.2 mtt-85 -98.42 147.19 24.97 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.007 1.323 . . . . 0.0 111.808 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -91.26 128.24 37.01 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.41 1.084 . . . . 0.0 110.353 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -102.18 177.95 4.74 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.927 1.291 . . . . 0.0 111.534 169.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -56.15 -36.82 68.72 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.462 1.105 . . . . 0.0 113.72 177.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -134.5 67.58 1.5 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.917 1.287 . . . . 0.0 111.901 -175.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 122.85 -158.61 17.5 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 115.337 0.895 . . . . 0.0 115.337 174.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.6 mt -119.3 137.34 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.233 1.013 . . . . 0.0 109.797 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.26 104.05 6.01 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.271 1.828 . . . . 0.0 109.364 -171.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.9 p -98.07 156.14 16.79 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.32 -1.488 . . . . 0.0 111.455 -173.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.52 122.98 1.79 Allowed Glycine 0 CA--C 1.526 0.726 0 O-C-N 121.271 -0.893 . . . . 0.0 112.16 -177.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -70.87 138.39 50.16 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.002 1.721 . . . . 0.0 110.403 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -134.4 85.3 2.18 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.808 1.643 . . . . 0.0 110.482 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -100.82 80.92 2.21 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.062 1.745 . . . . 0.0 110.871 -176.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.04 -103.7 0.83 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 124.092 0.854 . . . . 0.0 112.814 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -96.97 9.72 65.79 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.152 1.358 . . . . 0.0 114.851 178.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -132.84 128.75 37.34 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.789 1.235 . . . . 0.0 110.919 -178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 54.3 p -146.68 141.58 26.98 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -176.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.89 160.41 37.62 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.147 1.379 . . . . 0.0 111.659 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.4 m -55.36 127.17 28.22 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.427 -0.795 . . . . 0.0 110.132 170.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -95.09 -48.33 6.0 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.096 0.407 . . . . 0.0 110.644 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -162.9 168.67 20.89 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 122.201 1.001 . . . . 0.0 113.162 170.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.84 139.49 18.81 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 121.316 -0.865 . . . . 0.0 112.381 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.481 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -129.45 156.13 44.6 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.848 1.659 . . . . 0.0 111.187 -176.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -77.48 167.46 21.61 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.433 0.635 . . . . 0.0 112.363 -174.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -55.41 -36.33 66.34 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.105 0.962 . . . . 0.0 112.394 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -69.4 -2.92 12.27 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.758 1.223 . . . . 0.0 114.1 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.3 t -119.59 -5.66 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-N 119.56 1.073 . . . . 0.0 111.453 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.4 t -48.96 -65.18 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 125.279 1.432 . . . . 0.0 111.85 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -68.45 -27.02 65.81 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.497 -0.752 . . . . 0.0 112.632 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -52.04 65.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.435 1.494 . . . . 0.0 110.596 175.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -60.83 -45.84 92.92 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 124.586 1.154 . . . . 0.0 111.617 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.582 HG22 HD22 ' A' ' 170' ' ' LEU . 87.6 t -56.29 -34.16 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.432 0.693 . . . . 0.0 111.25 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -66.98 -57.75 6.27 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.01 0.924 . . . . 0.0 112.278 174.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 m -69.8 -22.19 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 O-C-N 120.821 -1.175 . . . . 0.0 112.551 -175.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.648 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -78.61 -6.64 56.15 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.933 1.693 . . . . 0.0 111.88 175.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 81.7 p -131.4 -12.26 3.52 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -137.45 -6.03 1.78 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.668 1.587 . . . . 0.0 113.771 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.07 156.29 5.3 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 126.04 1.781 . . . . 0.0 113.843 -175.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.99 -171.37 33.27 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.165 0.888 . . . . 0.0 113.12 -174.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 85.1 p -145.1 104.04 3.92 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.507 1.123 . . . . 0.0 113.366 -168.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -134.29 143.77 47.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.179 1.792 . . . . 0.0 110.277 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -71.64 162.66 29.1 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.374 -0.829 . . . . 0.0 112.106 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 69.2 p -129.56 144.79 51.42 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.456 1.503 . . . . 0.0 111.023 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.481 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 6.7 t -59.07 -43.75 91.79 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.354 1.462 . . . . 0.0 112.534 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.0 mt -155.73 134.41 11.85 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.829 1.652 . . . . 0.0 111.296 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -129.54 102.1 6.23 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.643 1.177 . . . . 0.0 110.696 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -90.38 -41.81 11.28 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.613 1.165 . . . . 0.0 113.965 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 58.15 -173.53 2.97 Favored Glycine 0 CA--C 1.547 2.058 0 C-N-CA 126.222 1.867 . . . . 0.0 115.465 -169.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -62.14 167.07 4.23 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.509 1.124 . . . . 0.0 113.966 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.82 -23.63 53.5 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -72.7 -23.76 60.91 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.538 1.135 . . . . 0.0 113.278 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -62.55 145.46 54.28 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.08 1.752 . . . . 0.0 112.075 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -73.23 -30.95 63.83 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.073 -1.017 . . . . 0.0 112.875 173.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 55.7 m -86.46 -6.76 58.83 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -174.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.2 p -51.64 -23.28 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 175.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.4 mt -62.18 -43.15 97.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.895 1.278 . . . . 0.0 111.969 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -135.75 -13.59 1.94 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.812 1.245 . . . . 0.0 114.245 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.91 174.51 45.16 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 126.725 2.107 . . . . 0.0 113.646 -171.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.4 mt -119.41 115.53 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.6 1.56 . . . . 0.0 108.152 175.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -72.96 144.39 47.29 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.097 0.475 . . . . 0.0 111.55 173.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 58.41 24.89 12.25 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 125.754 1.622 . . . . 0.0 114.042 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -62.72 122.81 16.81 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.698 1.199 . . . . 0.0 111.817 -173.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -73.22 124.16 25.1 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.322 1.049 . . . . 0.0 111.428 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 29.7 mm -118.3 117.79 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.809 1.244 . . . . 0.0 108.882 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.8 mp -110.09 103.37 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 124.984 1.313 . . . . 0.0 108.231 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 59.1 p -85.08 153.14 22.9 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.805 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.17 136.67 20.23 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.163 1.385 . . . . 0.0 111.15 176.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 17.3 mt -81.09 131.67 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -147.69 142.73 27.02 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.793 1.637 . . . . 0.0 110.109 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -84.39 154.85 22.59 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.441 -0.787 . . . . 0.0 109.982 169.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 49.2 mt -126.55 -46.47 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.989 0.916 . . . . 0.0 110.843 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -148.34 27.49 0.92 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.667 0.787 . . . . 0.0 112.78 -178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 110.43 -23.0 21.45 Favored Glycine 0 N--CA 1.472 1.096 0 O-C-N 121.233 -0.917 . . . . 0.0 113.71 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 52.8 m -87.58 141.45 28.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.693 0.797 . . . . 0.0 108.888 169.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.74 121.88 23.2 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.484 0.714 . . . . 0.0 109.35 170.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -107.69 165.16 11.64 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.416 1.486 . . . . 0.0 110.522 174.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.8 tp -122.21 132.22 71.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 125.327 1.451 . . . . 0.0 107.848 172.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.4 p -119.47 156.59 29.94 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.188 0.595 . . . . 0.0 109.794 176.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -152.03 141.51 21.64 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.103 0.961 . . . . 0.0 111.297 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.2 m -78.7 114.38 17.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.478 1.111 . . . . 0.0 110.484 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.33 -167.26 43.13 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.308 0.956 . . . . 0.0 112.876 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -68.08 171.47 6.87 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.749 -0.853 . . . . 0.0 112.62 168.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -81.05 136.26 35.94 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.243 -0.911 . . . . 0.0 112.114 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.46 163.11 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.815 0.846 . . . . 0.0 112.729 171.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -99.47 -14.62 19.02 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 173.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -95.46 22.5 6.92 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.38 1.472 . . . . 0.0 113.022 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.86 -34.22 0.32 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 178.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 113.79 74.72 0.65 Allowed Glycine 0 N--CA 1.476 1.328 0 CA-C-N 119.323 0.965 . . . . 0.0 113.725 170.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 57.86 29.63 17.83 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.35 1.46 . . . . 0.0 113.549 -176.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -96.04 150.71 20.17 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.607 1.163 . . . . 0.0 108.472 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.9 m -86.88 137.22 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 122.781 0.432 . . . . 0.0 110.061 171.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -70.09 117.16 11.31 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 171.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -106.1 148.81 27.38 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 122.009 0.909 . . . . 0.0 109.743 171.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -132.8 172.42 12.6 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.122 1.369 . . . . 0.0 111.491 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.86 133.09 23.08 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.518 0.727 . . . . 0.0 110.156 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.409 ' CG2' HD11 ' A' ' 166' ' ' LEU . 64.0 mt -126.47 138.66 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.133 0.973 . . . . 0.0 108.918 175.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.4 m -64.54 97.39 0.2 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.362 -0.836 . . . . 0.0 110.225 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.5 tt -54.16 -31.03 51.44 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.111 1.364 . . . . 0.0 112.179 175.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -72.73 -26.03 61.43 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -89.43 -26.03 21.19 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.972 -1.08 . . . . 0.0 112.053 173.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.648 HD13 ' HG3' ' A' ' 100' ' ' MET . 14.5 mt -61.49 -46.55 89.52 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 123.849 0.86 . . . . 0.0 110.813 172.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -55.18 -36.93 66.4 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -67.91 -15.24 63.52 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -124.22 -6.04 7.76 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.094 1.358 . . . . 0.0 114.111 -175.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.582 HD22 HG22 ' A' ' 97' ' ' VAL . 13.4 mt -93.29 -26.29 17.38 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.471 1.508 . . . . 0.0 112.396 -175.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt . . . . . 0 C--O 1.252 1.217 0 C-N-CA 126.271 1.828 . . . . 0.0 112.916 175.827 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? . . . . . 0 N--CA 1.498 1.928 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.9 pt -105.63 171.04 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 125.037 1.335 . . . . 0.0 111.483 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -129.83 122.47 28.8 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.847 1.259 . . . . 0.0 109.835 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.4 t -65.15 162.69 16.53 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.432 0.693 . . . . 0.0 111.962 174.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.0 p 44.94 33.6 1.05 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.675 1.99 . . . . 0.0 115.237 -175.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -56.61 149.74 16.99 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.033 1.333 . . . . 0.0 113.334 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.93 130.09 42.69 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.542 0.737 . . . . 0.0 111.623 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -127.25 34.24 4.75 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.856 1.662 . . . . 0.0 111.913 -174.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 65.39 50.86 1.65 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.213 1.805 . . . . 0.0 111.753 -177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 72.9 m -143.33 140.52 30.59 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.642 1.577 . . . . 0.0 112.168 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.3 p -76.23 116.71 17.19 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.595 1.158 . . . . 0.0 111.911 175.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 161.05 79.88 0.03 OUTLIER Glycine 0 CA--C 1.533 1.193 0 C-N-CA 123.679 0.657 . . . . 0.0 113.782 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -68.64 174.33 4.34 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.907 0.883 . . . . 0.0 113.252 173.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.7 m -58.38 167.42 1.38 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.69 1.596 . . . . 0.0 113.834 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -70.89 73.7 0.59 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.727 1.611 . . . . 0.0 112.892 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 p -158.67 148.14 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 127.628 2.371 . . . . 0.0 108.579 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.26 164.01 26.53 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.052 1.741 . . . . 0.0 110.798 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.69 160.01 31.07 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.142 0.977 . . . . 0.0 111.755 174.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.0 mm -66.94 128.19 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.371 0.668 . . . . 0.0 111.736 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -118.08 13.25 13.82 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.09 1.356 . . . . 0.0 112.772 -177.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -79.01 -7.89 58.48 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 120.857 -1.152 . . . . 0.0 113.548 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 47.3 m -87.49 15.61 6.43 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.893 2.077 . . . . 0.0 113.307 173.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 30.9 pttt -145.28 165.83 27.28 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.726 1.21 . . . . 0.0 111.31 172.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -144.3 169.39 17.99 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.553 1.141 . . . . 0.0 110.587 170.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -132.6 129.35 38.83 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 121.742 -0.599 . . . . 0.0 110.17 175.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.35 167.99 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 125.196 1.399 . . . . 0.0 110.896 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.34 164.22 7.47 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.639 1.176 . . . . 0.0 111.428 175.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.6 tp -158.72 137.26 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.774 1.229 . . . . 0.0 109.558 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -127.82 162.63 26.22 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.417 1.887 . . . . 0.0 110.073 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -132.12 156.69 45.92 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.304 1.441 . . . . 0.0 111.232 176.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -78.51 121.27 24.37 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 171.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -63.88 174.6 1.41 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.065 0.946 . . . . 0.0 111.992 171.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -57.58 -14.79 5.81 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.343 1.857 . . . . 0.0 114.857 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.2 m -115.56 14.16 16.51 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.885 1.274 . . . . 0.0 112.872 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.04 21.07 78.95 Favored Glycine 0 CA--C 1.537 1.438 0 O-C-N 121.335 -0.853 . . . . 0.0 114.393 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -96.59 125.79 41.31 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.68 1.192 . . . . 0.0 109.649 177.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -66.87 126.14 28.15 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.898 -0.501 . . . . 0.0 110.873 174.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.2 t -140.75 136.02 32.11 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.715 1.206 . . . . 0.0 110.81 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -55.7 131.57 46.9 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.771 1.229 . . . . 0.0 112.354 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 38.8 tp -104.87 -47.73 3.95 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.985 0.914 . . . . 0.0 111.279 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.75 -118.96 0.78 Allowed Glycine 0 CA--C 1.529 0.963 0 N-CA-C 113.978 0.351 . . . . 0.0 113.978 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -141.16 151.73 44.11 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.356 1.462 . . . . 0.0 110.366 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.4 tp -116.96 101.45 8.52 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.409 1.484 . . . . 0.0 109.878 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.1 t -77.45 97.46 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.098 1.359 . . . . 0.0 109.336 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.3 t -84.3 84.42 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.614 1.566 . . . . 0.0 110.296 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -73.9 110.7 8.4 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.795 0.838 . . . . 0.0 110.406 170.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.57 ' HE2' HG11 ' A' ' 93' ' ' VAL . 26.1 tptp -78.47 88.49 4.44 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.656 1.182 . . . . 0.0 109.227 169.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -67.54 172.09 5.47 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.908 1.283 . . . . 0.0 112.485 173.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -65.4 -39.36 92.1 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.697 -1.252 . . . . 0.0 113.383 175.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -117.6 40.66 3.03 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.407 1.483 . . . . 0.0 112.806 -169.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.06 -161.01 24.82 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.934 1.73 . . . . 0.0 114.051 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.445 HD11 HG13 ' A' ' 93' ' ' VAL . 45.1 mt -119.71 142.95 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.938 0.895 . . . . 0.0 109.431 169.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -132.72 92.43 3.05 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.331 1.453 . . . . 0.0 110.573 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.8 p -84.54 150.36 25.28 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.24 -0.912 . . . . 0.0 112.508 -174.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.73 120.01 1.57 Allowed Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.42 -0.8 . . . . 0.0 113.791 -178.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -70.88 139.92 50.93 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.53 1.932 . . . . 0.0 110.588 178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -134.07 78.22 1.75 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.193 1.797 . . . . 0.0 110.708 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -91.98 86.48 5.86 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.123 0.969 . . . . 0.0 110.939 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 62.45 -98.41 0.2 Allowed Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.566 1.079 . . . . 0.0 112.974 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.98 15.49 33.67 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.7 1.619 . . . . 0.0 114.424 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -132.72 73.14 1.51 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.803 1.241 . . . . 0.0 111.66 -174.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 77.6 p -87.35 149.74 24.3 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -167.4 157.66 11.0 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.411 1.484 . . . . 0.0 112.189 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.3 m -54.05 124.42 15.52 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.3 1.04 . . . . 0.0 110.791 171.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -92.07 -52.64 4.61 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.883 0.473 . . . . 0.0 110.426 -178.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -163.92 153.05 13.97 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.871 0.868 . . . . 0.0 112.691 172.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.56 128.11 21.46 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 122.75 1.262 . . . . 0.0 112.553 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.96 163.79 16.04 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.13 1.772 . . . . 0.0 111.38 -173.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -79.72 162.05 25.41 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.404 1.082 . . . . 0.0 112.436 -175.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -55.44 -33.05 63.24 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.319 1.047 . . . . 0.0 113.055 172.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -70.33 -8.38 50.02 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 175.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 37.5 t -114.29 -14.56 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 121.3 -0.875 . . . . 0.0 112.028 -171.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.57 HG11 ' HE2' ' A' ' 67' ' ' LYS . 42.2 t -48.15 -55.81 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 124.502 1.121 . . . . 0.0 111.372 177.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -65.41 -32.87 74.72 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -69.8 -43.63 71.71 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.029 0.932 . . . . 0.0 111.343 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -58.83 -46.88 86.64 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.632 1.173 . . . . 0.0 110.736 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 93' ' ' VAL . 92.6 t -53.94 -37.51 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.395 1.078 . . . . 0.0 111.377 175.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.87 -57.38 4.67 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.5 1.52 . . . . 0.0 112.656 176.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -71.91 -7.5 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 O-C-N 121.212 -0.93 . . . . 0.0 113.125 -175.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.408 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -94.58 -5.69 45.26 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.01 1.724 . . . . 0.0 111.932 176.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 47.4 p -128.89 -14.85 4.41 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.909 0.883 . . . . 0.0 112.958 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -131.97 -9.73 3.44 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.617 1.567 . . . . 0.0 114.593 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.63 157.14 7.51 Favored Glycine 0 CA--C 1.539 1.574 0 C-N-CA 125.294 1.426 . . . . 0.0 113.76 -173.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.52 -153.62 24.66 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 121.543 -0.975 . . . . 0.0 113.175 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 80.1 p -145.52 151.98 39.02 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.18 0.992 . . . . 0.0 113.148 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -148.27 -177.69 5.9 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.55 1.94 . . . . 0.0 112.177 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? -117.41 156.16 28.4 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.937 1.295 . . . . 0.0 111.657 170.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.9 p -126.17 130.81 51.73 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.977 0.911 . . . . 0.0 111.892 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.9 t -51.9 -37.55 52.85 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.409 1.084 . . . . 0.0 112.995 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 11.0 mt -147.62 141.31 25.61 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.233 1.413 . . . . 0.0 112.364 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -136.35 93.55 2.91 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.525 1.13 . . . . 0.0 110.643 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -81.7 -49.06 10.9 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.829 0.851 . . . . 0.0 113.121 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.21 177.42 43.2 Favored Glycine 0 CA--C 1.543 1.816 0 C-N-CA 125.06 1.314 . . . . 0.0 113.874 -169.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -62.93 165.4 6.85 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.085 0.954 . . . . 0.0 112.253 170.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.6 ttpp -57.93 -26.02 61.68 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.19 44.47 0.41 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.331 1.452 . . . . 0.0 113.041 177.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -135.0 166.02 24.01 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 127.053 2.141 . . . . 0.0 112.289 -173.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -88.81 -42.84 11.66 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.59 0.756 . . . . 0.0 111.409 169.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 13.6 t -59.01 -43.07 91.5 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.2 p -48.92 -24.67 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 115.759 1.762 . . . . 0.0 115.759 -169.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 56.8 mt -61.18 -35.17 63.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 126.721 2.008 . . . . 0.0 113.051 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -140.05 -39.01 0.45 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.575 1.55 . . . . 0.0 114.321 -171.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 104.27 166.2 24.75 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.136 1.827 . . . . 0.0 114.055 -176.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 52.7 mt -123.39 120.44 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 126.095 1.758 . . . . 0.0 108.866 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -82.31 145.01 30.2 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 57.79 24.49 10.81 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.478 1.911 . . . . 0.0 113.938 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -60.34 125.74 24.82 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.856 1.262 . . . . 0.0 111.363 -173.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -76.61 126.61 31.29 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.845 0.458 . . . . 0.0 110.925 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.3 mm -119.95 120.59 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 126.094 1.758 . . . . 0.0 109.065 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.1 mp -115.06 105.93 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 125.233 1.413 . . . . 0.0 108.231 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.8 p -80.97 161.63 24.21 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.777 0.799 . . . . 0.0 112.203 174.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.9 ptpt -152.15 142.22 22.24 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.91 1.284 . . . . 0.0 110.77 171.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 52.4 mt -82.61 132.14 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 173.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -139.89 120.34 14.06 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.303 1.441 . . . . 0.0 110.273 174.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -72.19 117.89 14.38 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.85 -0.531 . . . . 0.0 109.79 169.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 24.6 mt -103.8 97.86 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 60.85 12.04 3.58 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.688 1.995 . . . . 0.0 115.917 -177.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 130.21 -34.9 2.62 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.997 1.284 . . . . 0.0 113.358 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 91.5 m -72.81 126.19 29.32 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.395 1.078 . . . . 0.0 109.413 171.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -74.79 118.78 18.14 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 173.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -107.93 165.9 11.11 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.821 1.248 . . . . 0.0 110.055 170.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.9 tp -117.0 137.28 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 125.332 1.453 . . . . 0.0 107.922 169.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 p -124.88 156.87 37.21 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 118.571 0.623 . . . . 0.0 110.098 172.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -149.63 135.89 19.02 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.988 0.915 . . . . 0.0 111.158 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 18.2 t -70.61 127.89 34.22 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.065 0.46 . . . . 0.0 110.381 172.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.59 -154.25 26.06 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.816 1.674 . . . . 0.0 112.044 175.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -69.07 169.33 12.07 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 121.936 0.874 . . . . 0.0 112.352 169.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -87.98 112.07 22.19 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.451 1.5 . . . . 0.0 111.528 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.414 ' CG2' ' HB2' ' A' ' 157' ' ' ALA . 0.2 OUTLIER -69.83 162.54 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.628 0.771 . . . . 0.0 112.009 177.596 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -100.03 -23.19 14.96 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.703 0.801 . . . . 0.0 113.066 171.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -66.32 -8.43 25.1 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.557 1.543 . . . . 0.0 114.887 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.04 -30.56 3.48 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.012 1.325 . . . . 0.0 113.566 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 139.59 -78.42 0.3 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.179 1.371 . . . . 0.0 112.843 169.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -142.32 22.09 2.04 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.164 2.186 . . . . 0.0 110.8 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -86.04 167.58 14.88 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.497 1.119 . . . . 0.0 109.337 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.3 m -100.64 139.35 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.304 0.642 . . . . 0.0 110.288 175.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.414 ' HB2' ' CG2' ' A' ' 149' ' ' ILE . . . -65.94 104.28 1.08 Allowed 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 171.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -104.53 145.7 29.92 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.523 1.154 . . . . 0.0 110.86 175.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -134.47 167.15 21.29 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.679 1.591 . . . . 0.0 110.719 -169.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.02 134.93 26.87 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.346 0.521 . . . . 0.0 110.349 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.501 ' CG2' HD11 ' A' ' 166' ' ' LEU . 51.3 mt -129.67 139.89 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.802 0.841 . . . . 0.0 109.334 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.7 m -63.73 95.46 0.11 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.018 0.927 . . . . 0.0 109.848 177.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.444 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.0 OUTLIER -53.07 -33.32 51.55 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.602 1.161 . . . . 0.0 111.516 175.459 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -67.56 -27.49 66.98 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -86.73 -31.53 20.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.991 0.916 . . . . 0.0 111.949 172.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.501 HD11 ' CG2' ' A' ' 161' ' ' ILE . 18.9 mt -62.1 -44.1 97.4 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.847 0.859 . . . . 0.0 111.264 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -50.5 -41.8 53.9 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.31 1.044 . . . . 0.0 112.84 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -67.67 -20.2 65.27 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -109.42 1.98 20.29 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.897 1.679 . . . . 0.0 112.704 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.508 HD22 HG22 ' A' ' 97' ' ' VAL . 17.2 mt -112.31 -17.6 12.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.535 1.534 . . . . 0.0 113.691 -176.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt . . . . . 0 C--O 1.253 1.261 0 C-N-CA 126.279 1.832 . . . . 0.0 113.252 173.026 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.914 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 tp -68.03 148.86 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 O-C-N 120.154 -1.591 . . . . 0.0 111.666 175.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -150.92 162.89 39.93 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.928 1.291 . . . . 0.0 111.828 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -154.96 164.35 39.01 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.638 1.575 . . . . 0.0 110.924 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 52.7 m -127.56 49.1 2.15 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.373 1.869 . . . . 0.0 110.46 -176.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 67.28 26.02 8.68 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.787 2.035 . . . . 0.0 113.96 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -85.37 149.6 25.33 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.172 1.389 . . . . 0.0 112.882 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -154.18 139.82 17.93 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.135 1.774 . . . . 0.0 110.413 175.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -103.59 73.72 1.2 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.817 1.247 . . . . 0.0 111.278 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.7 m -61.75 103.19 0.32 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.266 1.426 . . . . 0.0 112.335 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.2 p -77.04 59.35 1.66 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.776 2.03 . . . . 0.0 113.268 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.24 75.94 2.13 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 126.084 1.802 . . . . 0.0 114.181 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -101.32 158.06 16.33 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.861 1.264 . . . . 0.0 112.812 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.6 t -155.02 179.58 9.01 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.894 1.678 . . . . 0.0 111.752 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -109.15 54.72 0.65 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.692 1.997 . . . . 0.0 111.547 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 t -132.91 56.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 125.785 1.634 . . . . 0.0 110.636 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -143.72 171.27 14.43 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 126.765 2.026 . . . . 0.0 112.048 176.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -52.48 141.64 19.6 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.676 1.591 . . . . 0.0 111.289 173.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 37.0 mm -65.97 136.99 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.713 0.805 . . . . 0.0 111.33 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -116.25 -12.67 11.14 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.865 1.266 . . . . 0.0 113.393 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -91.73 -6.78 51.33 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.5 t -56.87 -34.37 67.78 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.109 1.763 . . . . 0.0 112.735 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -144.93 162.94 35.64 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.408 1.483 . . . . 0.0 111.081 169.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -145.89 165.69 28.18 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.769 1.228 . . . . 0.0 110.495 173.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -131.76 125.79 32.82 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.596 0.358 . . . . 0.0 110.464 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.9 m -118.79 165.96 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.021 1.329 . . . . 0.0 110.927 177.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -68.06 161.79 26.01 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.544 1.138 . . . . 0.0 110.995 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.2 tp -153.37 136.29 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.436 1.095 . . . . 0.0 109.667 175.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -127.21 161.3 28.86 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 126.197 1.799 . . . . 0.0 109.741 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -132.01 154.37 49.43 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 126.098 1.759 . . . . 0.0 110.749 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -76.09 124.74 27.89 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 169.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -67.43 175.68 2.67 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 122.241 1.019 . . . . 0.0 111.327 170.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -59.81 -11.73 5.92 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.234 2.213 . . . . 0.0 114.778 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.8 t -116.51 12.93 15.26 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.111 1.364 . . . . 0.0 112.821 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.31 19.71 79.38 Favored Glycine 0 CA--C 1.536 1.395 0 O-C-N 121.312 -0.867 . . . . 0.0 114.615 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -95.59 129.38 42.79 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.778 1.231 . . . . 0.0 109.477 176.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -68.98 127.75 34.25 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.637 -0.664 . . . . 0.0 110.567 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.7 t -138.86 147.04 41.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.878 1.671 . . . . 0.0 110.241 -175.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -66.49 137.38 56.77 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.051 -1.031 . . . . 0.0 111.626 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.8 tp -110.83 -46.9 3.29 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.876 0.87 . . . . 0.0 112.291 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.27 -133.31 2.39 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 121.703 0.613 . . . . 0.0 114.612 -174.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -132.65 155.91 47.9 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.511 1.924 . . . . 0.0 110.953 174.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.8 tp -122.96 104.27 9.14 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.275 1.43 . . . . 0.0 110.539 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.4 t -81.57 97.48 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.48 1.512 . . . . 0.0 109.462 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.03 117.47 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.914 1.286 . . . . 0.0 109.671 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -113.77 128.24 56.33 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.925 2.09 . . . . 0.0 110.535 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -83.64 83.67 7.82 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.155 0.982 . . . . 0.0 110.629 174.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -65.77 171.66 4.13 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.073 0.949 . . . . 0.0 112.193 170.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -68.89 -31.98 71.3 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.002 -1.062 . . . . 0.0 113.746 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -126.54 47.07 2.35 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.761 1.224 . . . . 0.0 112.356 -168.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.12 -155.99 21.75 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.834 1.207 . . . . 0.0 113.964 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 68.5 mt -122.1 136.84 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.928 0.891 . . . . 0.0 109.52 175.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.65 142.82 47.29 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.15 1.38 . . . . 0.0 109.253 174.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.1 p -133.54 139.85 46.85 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.277 0.631 . . . . 0.0 110.016 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.61 107.83 0.65 Allowed Glycine 0 CA--C 1.521 0.421 0 CA-C-O 121.843 0.69 . . . . 0.0 111.61 -169.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 33.1 tp -64.09 144.56 57.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.616 1.166 . . . . 0.0 110.174 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -134.47 70.35 1.45 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.917 2.087 . . . . 0.0 109.294 179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.38 77.81 9.86 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.402 1.081 . . . . 0.0 112.092 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.36 -81.51 1.08 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.506 1.527 . . . . 0.0 113.437 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -134.74 24.45 3.48 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.086 1.803 . . . . 0.0 112.993 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -135.84 50.18 2.1 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.383 1.473 . . . . 0.0 110.917 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 75.4 p -64.26 141.66 58.69 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.321 -0.862 . . . . 0.0 113.056 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -164.05 158.22 19.2 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.128 1.371 . . . . 0.0 111.885 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.7 m -58.82 118.34 5.63 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 121.024 -1.047 . . . . 0.0 109.313 169.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -82.22 -48.45 11.26 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.001 -0.437 . . . . 0.0 109.949 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -164.82 161.4 20.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.836 0.855 . . . . 0.0 113.074 170.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.87 149.41 33.2 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.985 1.374 . . . . 0.0 113.08 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.424 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.5 OUTLIER -135.92 160.31 38.99 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.31 1.444 . . . . 0.0 111.715 -175.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -80.13 165.99 21.92 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.3 0.64 . . . . 0.0 112.387 -175.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -54.18 -34.85 61.49 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.136 0.975 . . . . 0.0 112.771 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -67.65 -4.58 12.43 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.578 1.151 . . . . 0.0 114.086 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.84 -3.57 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.336 1.054 . . . . 0.0 111.399 -175.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.9 t -51.21 -65.38 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.261 1.424 . . . . 0.0 111.352 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -69.11 -24.06 64.07 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -50.51 68.76 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.321 1.449 . . . . 0.0 110.438 172.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -61.43 -42.56 98.95 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 124.666 1.186 . . . . 0.0 111.798 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.507 HG22 HD22 ' A' ' 170' ' ' LEU . 89.5 t -56.04 -35.14 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.103 0.561 . . . . 0.0 110.882 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -69.94 -54.26 14.15 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.939 1.296 . . . . 0.0 112.949 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.0 m -74.34 -6.33 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 O-C-N 120.933 -1.104 . . . . 0.0 112.967 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.527 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -97.77 -4.85 36.18 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.028 1.731 . . . . 0.0 111.742 176.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 44.7 p -132.06 -17.5 2.73 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.733 1.213 . . . . 0.0 113.496 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -131.76 -11.13 3.46 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.15 1.78 . . . . 0.0 113.667 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.21 155.8 11.62 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.977 1.275 . . . . 0.0 113.738 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 164.12 -159.43 32.25 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 121.784 -0.833 . . . . 0.0 114.299 -177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 52.6 p -154.09 89.35 1.29 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -168.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -124.42 141.71 51.87 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.769 1.628 . . . . 0.0 110.528 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -69.87 162.62 27.6 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.462 0.705 . . . . 0.0 111.54 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.2 p -130.51 147.64 52.22 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.507 1.523 . . . . 0.0 111.391 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.424 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 5.1 t -65.27 -40.36 93.82 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.874 0.87 . . . . 0.0 111.858 -178.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.8 mt -150.73 137.71 19.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.686 1.594 . . . . 0.0 111.794 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -139.03 100.54 4.05 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.642 0.777 . . . . 0.0 110.868 178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -94.95 -38.59 10.62 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.13 -169.78 16.58 Favored Glycine 0 CA--C 1.543 1.815 0 C-N-CA 125.032 1.301 . . . . 0.0 115.478 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -71.15 165.9 22.61 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.169 0.988 . . . . 0.0 112.62 169.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -52.83 -28.64 23.74 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.643 1.577 . . . . 0.0 115.236 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -54.76 -35.91 64.27 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 174.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -67.16 132.48 47.89 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.964 0.906 . . . . 0.0 112.682 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -56.73 -35.14 68.21 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.602 1.161 . . . . 0.0 113.239 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.83 16.5 12.31 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -176.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.5 p -60.25 -17.36 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 55.3 mt -112.41 -47.47 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.905 0.882 . . . . 0.0 111.476 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -71.27 -20.8 62.17 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.95 0.9 . . . . 0.0 112.565 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 61.22 -174.77 5.83 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.75 1.643 . . . . 0.0 113.574 -170.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 41.2 mt -140.83 101.66 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.036 1.335 . . . . 0.0 107.738 175.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -69.32 145.07 53.3 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.191 0.519 . . . . 0.0 111.32 173.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 60.38 20.79 10.37 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.673 1.589 . . . . 0.0 113.821 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -55.37 123.65 14.56 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.864 1.266 . . . . 0.0 111.161 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -71.58 127.62 33.16 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.832 0.853 . . . . 0.0 110.319 170.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.3 mm -123.01 117.69 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.687 1.195 . . . . 0.0 108.56 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mp -110.37 99.01 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 125.178 1.391 . . . . 0.0 107.8 -178.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.7 p -81.55 157.06 24.92 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.726 0.774 . . . . 0.0 111.064 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -151.52 137.56 18.22 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.467 1.107 . . . . 0.0 110.808 176.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 52.4 mt -80.6 132.67 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -139.56 121.67 15.78 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.375 1.47 . . . . 0.0 110.314 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -74.26 115.6 13.94 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.855 -0.528 . . . . 0.0 109.806 169.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.5 mt -102.02 96.68 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 60.82 13.28 4.31 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.743 2.017 . . . . 0.0 115.917 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 128.8 -33.32 3.12 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 124.955 1.264 . . . . 0.0 113.405 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 88.5 m -73.18 125.65 28.23 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.495 1.118 . . . . 0.0 109.228 171.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -75.94 117.72 17.96 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.699 -0.625 . . . . 0.0 109.646 174.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -107.02 166.18 10.8 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.154 1.382 . . . . 0.0 110.382 171.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.0 tp -118.08 137.87 50.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 125.414 1.485 . . . . 0.0 108.296 169.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.6 p -125.94 155.95 40.52 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.44 0.696 . . . . 0.0 110.024 174.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -150.51 137.47 19.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.167 0.987 . . . . 0.0 111.213 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.7 m -78.81 119.19 21.67 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.526 1.131 . . . . 0.0 110.691 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.4 -156.29 32.58 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.929 1.252 . . . . 0.0 113.256 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -66.51 161.78 22.17 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.253 1.021 . . . . 0.0 112.694 171.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -77.93 110.06 12.52 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.665 1.186 . . . . 0.0 110.506 173.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.61 157.47 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.21 0.528 . . . . 0.0 111.929 175.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.24 -27.06 15.7 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 176.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -76.28 -20.91 56.89 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.379 1.071 . . . . 0.0 113.247 -176.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 3.9 t -96.36 -41.07 8.81 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 109.66 83.89 1.5 Allowed Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.335 0.969 . . . . 0.0 113.53 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 62.23 13.98 6.33 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.151 1.78 . . . . 0.0 114.92 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -90.18 154.05 20.05 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.946 0.898 . . . . 0.0 108.885 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.3 m -91.51 143.1 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 122.712 0.405 . . . . 0.0 110.548 173.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -62.83 130.22 43.89 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 168.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -128.0 143.73 51.09 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.571 1.177 . . . . 0.0 111.488 173.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -135.55 169.8 16.95 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 126.093 1.757 . . . . 0.0 111.069 -169.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.83 135.22 24.3 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 122.934 0.494 . . . . 0.0 110.248 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.457 ' CG2' HD11 ' A' ' 166' ' ' LEU . 63.2 mt -127.32 141.24 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 123.738 0.815 . . . . 0.0 108.98 175.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.8 m -62.2 94.74 0.06 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.204 1.002 . . . . 0.0 109.753 175.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.504 ' HA ' HD12 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -54.05 -32.93 56.01 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.904 0.882 . . . . 0.0 111.464 174.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -66.74 -30.62 70.89 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -82.57 -32.14 28.65 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.053 0.941 . . . . 0.0 111.851 173.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.527 HD13 ' HG3' ' A' ' 100' ' ' MET . 18.7 mt -60.39 -45.98 91.64 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.645 0.778 . . . . 0.0 111.39 175.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.431 ' HE3' HD21 ' A' ' 163' ' ' LEU . 77.0 mttt -51.29 -42.63 61.28 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 119.044 0.838 . . . . 0.0 112.833 175.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -64.7 -18.53 65.08 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.244 1.418 . . . . 0.0 113.996 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -116.32 -2.49 12.1 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.876 1.67 . . . . 0.0 113.287 -177.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.507 HD22 HG22 ' A' ' 97' ' ' VAL . 19.3 mt -104.01 -24.49 13.22 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.522 1.529 . . . . 0.0 113.342 -177.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 82.3 mttt . . . . . 0 C--O 1.254 1.342 0 C-N-CA 126.865 2.066 . . . . 0.0 113.245 174.835 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.4 mttm . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.6 pt -67.67 168.69 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.904 0.882 . . . . 0.0 112.494 174.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -123.44 153.8 39.94 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.301 1.441 . . . . 0.0 111.109 175.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.5 t -148.91 163.59 36.99 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.327 1.451 . . . . 0.0 111.122 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.8 m -129.4 172.87 11.08 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.728 1.611 . . . . 0.0 111.458 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -119.02 76.56 1.12 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.696 1.199 . . . . 0.0 110.869 -174.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -72.64 69.84 0.91 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.28 1.832 . . . . 0.0 112.989 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -144.09 159.15 43.11 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.58 1.552 . . . . 0.0 111.189 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -60.39 130.69 47.85 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.472 1.109 . . . . 0.0 111.948 177.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.7 m -151.04 159.45 44.53 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.421 1.489 . . . . 0.0 111.97 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.3 p -84.99 159.29 20.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.026 1.33 . . . . 0.0 112.525 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 135.0 -110.04 0.81 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.919 1.247 . . . . 0.0 112.344 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 54.3 27.06 7.49 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.272 1.829 . . . . 0.0 113.956 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.8 t -91.0 61.97 4.77 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.853 1.661 . . . . 0.0 111.799 -174.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.97 169.61 17.75 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.744 1.618 . . . . 0.0 112.192 175.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.6 m -124.11 41.74 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 126.341 1.856 . . . . 0.0 110.711 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -147.94 167.06 25.83 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.938 2.095 . . . . 0.0 110.853 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -36.92 117.13 0.49 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.519 1.928 . . . . 0.0 112.28 173.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.409 HG22 ' H ' ' A' ' 41' ' ' PHE . 15.8 mm -71.66 154.78 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.193 0.597 . . . . 0.0 109.739 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.0 -21.91 66.42 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 172.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.409 ' H ' HG22 ' A' ' 39' ' ' ILE . 9.5 m-85 -80.97 172.1 14.16 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.211 1.805 . . . . 0.0 112.485 174.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.0 m -75.25 -25.59 58.19 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.326 1.05 . . . . 0.0 112.872 175.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -97.04 161.68 13.72 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.53 1.132 . . . . 0.0 111.589 174.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -140.95 166.6 24.33 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.935 1.294 . . . . 0.0 111.42 170.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 m -134.74 130.35 36.06 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.591 0.357 . . . . 0.0 110.744 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.1 m -128.24 165.27 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.795 1.638 . . . . 0.0 110.853 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -63.42 163.02 11.48 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.58 1.152 . . . . 0.0 111.736 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.3 tp -159.28 137.04 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.787 1.235 . . . . 0.0 110.044 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -129.06 162.62 27.25 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.043 2.137 . . . . 0.0 109.362 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -129.3 157.9 40.59 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.152 1.381 . . . . 0.0 111.116 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -78.83 119.96 22.78 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 169.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.89 172.47 1.7 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.51 1.124 . . . . 0.0 112.154 171.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -53.29 -18.02 2.17 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.199 1.8 . . . . 0.0 115.518 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.9 m -112.07 13.53 20.68 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.322 1.049 . . . . 0.0 113.16 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.54 20.67 79.49 Favored Glycine 0 CA--C 1.537 1.45 0 O-C-N 121.213 -0.93 . . . . 0.0 114.181 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -97.4 125.87 42.29 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.797 1.239 . . . . 0.0 109.703 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -67.09 126.22 28.5 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.772 -0.58 . . . . 0.0 110.628 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.3 t -141.16 140.1 34.01 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.834 1.254 . . . . 0.0 110.842 -174.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -56.77 135.03 55.47 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.229 1.012 . . . . 0.0 112.781 -175.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.6 tp -109.18 -48.39 3.27 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.695 0.798 . . . . 0.0 111.139 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.5 -113.14 0.51 Allowed Glycine 0 CA--C 1.528 0.864 0 C-N-CA 123.137 0.399 . . . . 0.0 113.663 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -146.61 157.56 43.74 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.439 1.495 . . . . 0.0 109.949 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.1 tp -122.9 102.19 7.87 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.504 1.521 . . . . 0.0 110.022 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.67 95.58 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.636 1.574 . . . . 0.0 109.561 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.8 t -84.18 104.57 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.211 1.804 . . . . 0.0 110.252 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -94.33 122.65 37.1 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 127.098 2.159 . . . . 0.0 111.346 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -87.69 98.64 11.55 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.105 1.362 . . . . 0.0 110.321 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -89.33 177.47 6.58 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.813 1.245 . . . . 0.0 111.764 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -71.21 -19.15 62.42 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 175.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -131.2 73.85 1.56 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.894 1.677 . . . . 0.0 110.883 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.67 -170.33 40.1 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.354 0.978 . . . . 0.0 114.026 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.3 mt -111.76 140.32 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.12 0.968 . . . . 0.0 109.404 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -128.99 130.1 46.24 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.282 1.433 . . . . 0.0 109.6 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.2 p -119.79 148.51 43.35 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.375 -0.828 . . . . 0.0 111.198 -172.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.49 125.01 2.64 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-O 121.513 0.507 . . . . 0.0 112.788 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.8 138.2 52.48 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.077 1.751 . . . . 0.0 110.402 177.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -136.05 75.96 1.58 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.119 1.768 . . . . 0.0 110.885 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.99 173.95 9.57 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.709 1.604 . . . . 0.0 112.237 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.12 93.56 0.07 OUTLIER Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.225 1.393 . . . . 0.0 113.255 175.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.73 14.66 77.36 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.813 1.197 . . . . 0.0 115.079 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -150.41 125.02 9.67 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 118.98 1.39 . . . . 0.0 111.391 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 77.3 p -145.79 142.34 28.79 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -164.88 164.27 20.9 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.706 1.603 . . . . 0.0 111.594 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.5 m -54.89 130.76 42.45 Favored 'General case' 0 N--CA 1.478 0.93 0 O-C-N 121.382 -0.824 . . . . 0.0 110.612 170.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -97.5 -50.91 4.33 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.897 0.879 . . . . 0.0 110.175 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -163.86 158.45 19.94 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.883 0.873 . . . . 0.0 112.728 171.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.46 133.25 27.29 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 122.092 0.948 . . . . 0.0 111.943 176.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.442 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -108.3 160.38 15.9 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.108 1.363 . . . . 0.0 111.669 -178.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -76.95 165.4 24.72 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.91 0.862 . . . . 0.0 112.334 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -60.04 -26.6 66.25 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.021 0.928 . . . . 0.0 112.764 172.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -74.21 -3.96 33.02 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 172.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.1 t -117.91 -2.7 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.347 1.059 . . . . 0.0 110.883 -173.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.2 m -57.14 -29.33 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -176.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -98.96 -25.91 14.43 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.281 1.033 . . . . 0.0 111.851 171.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -71.27 -49.16 45.86 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.906 1.682 . . . . 0.0 111.6 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -59.68 -45.33 92.39 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.373 1.069 . . . . 0.0 110.918 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 73.3 t -55.67 -39.4 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.724 0.81 . . . . 0.0 110.367 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 41.5 tttt -60.58 -55.22 35.93 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.533 1.533 . . . . 0.0 112.224 174.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.0 m -70.9 -14.91 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 121.12 -0.987 . . . . 0.0 112.785 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.456 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -91.3 -4.6 55.71 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.274 1.83 . . . . 0.0 111.824 178.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.5 p -127.84 -15.56 4.85 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.63 1.172 . . . . 0.0 114.002 174.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -134.24 -9.8 2.58 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.272 1.429 . . . . 0.0 114.281 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.97 156.42 9.89 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.159 1.362 . . . . 0.0 113.825 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.03 -170.61 32.64 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.65 1.119 . . . . 0.0 113.524 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.503 ' HB3' HG23 ' A' ' 130' ' ' ILE . 56.7 p -144.36 103.81 4.01 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.756 1.222 . . . . 0.0 113.423 -168.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -133.81 156.54 47.85 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.145 1.778 . . . . 0.0 110.289 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.88 165.01 20.13 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.272 -0.892 . . . . 0.0 111.288 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.6 p -131.91 146.57 52.19 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.299 1.439 . . . . 0.0 111.273 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.442 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 9.4 t -54.88 -44.33 74.0 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.96 1.304 . . . . 0.0 112.084 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.5 mt -152.67 146.49 25.2 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.366 1.867 . . . . 0.0 110.942 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.431 ' CD2' HD11 ' A' ' 129' ' ' ILE . 39.6 t80 -139.72 111.38 7.25 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.27 0.628 . . . . 0.0 110.253 174.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -98.19 -39.56 8.81 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.129 1.372 . . . . 0.0 114.038 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.63 178.12 7.47 Favored Glycine 0 CA--C 1.544 1.906 0 C-N-CA 125.003 1.287 . . . . 0.0 115.409 -169.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -60.99 170.48 1.55 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.894 1.278 . . . . 0.0 113.006 170.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -26.55 63.21 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 119.755 -1.841 . . . . 0.0 114.263 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -68.49 -20.58 64.6 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.116 0.966 . . . . 0.0 113.565 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.0 141.81 57.45 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.493 1.117 . . . . 0.0 112.088 176.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.0 mm100 -71.49 -23.14 61.75 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.773 -1.205 . . . . 0.0 113.915 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 55.9 p -88.87 -12.92 40.46 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.9 p -53.36 -24.41 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -171.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.507 ' H ' HD12 ' A' ' 121' ' ' ILE . 4.9 mp -63.21 -36.46 76.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 125.537 1.535 . . . . 0.0 112.602 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -146.64 -16.85 0.42 Allowed 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 116.159 1.911 . . . . 0.0 116.159 -169.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.34 166.53 23.02 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 126.699 2.095 . . . . 0.0 114.755 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.6 mt -114.07 115.0 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.149 1.38 . . . . 0.0 108.643 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -70.7 144.28 51.06 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.028 0.442 . . . . 0.0 111.198 172.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 58.14 26.36 13.61 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.334 1.454 . . . . 0.0 113.518 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -61.79 125.66 24.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.543 1.137 . . . . 0.0 111.187 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -72.32 122.81 21.76 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.542 1.537 . . . . 0.0 111.953 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.431 HD11 ' CD2' ' A' ' 111' ' ' TYR . 34.9 mm -119.58 116.17 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.122 0.969 . . . . 0.0 109.477 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.503 HG23 ' HB3' ' A' ' 105' ' ' SER . 3.6 mp -110.32 96.66 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.928 1.291 . . . . 0.0 108.425 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.9 p -80.62 156.46 26.38 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.983 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -151.53 139.58 20.11 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.88 1.272 . . . . 0.0 111.495 174.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 32.9 mt -81.07 134.08 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 175.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -141.84 123.81 15.36 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.055 1.342 . . . . 0.0 110.73 172.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -73.17 119.99 18.18 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.787 -0.571 . . . . 0.0 109.99 169.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 25.8 mt -107.86 100.6 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 176.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 58.1 15.32 3.17 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.534 1.934 . . . . 0.0 115.821 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 123.91 -25.05 6.22 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.728 1.156 . . . . 0.0 114.016 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 93.6 m -82.47 126.49 32.29 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.892 0.877 . . . . 0.0 109.506 173.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -72.86 113.27 9.71 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.545 -0.722 . . . . 0.0 110.146 173.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -103.4 167.57 9.72 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.833 1.253 . . . . 0.0 110.69 170.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.2 tp -122.09 134.02 66.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 125.634 1.574 . . . . 0.0 108.103 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 p -120.77 156.71 31.27 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.198 0.599 . . . . 0.0 109.849 173.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -150.99 140.58 21.62 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.705 0.802 . . . . 0.0 111.312 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.7 p -71.79 118.94 15.26 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.929 0.892 . . . . 0.0 110.999 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.06 -154.39 16.18 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.717 1.151 . . . . 0.0 112.19 172.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -79.98 166.55 21.48 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.659 0.783 . . . . 0.0 111.202 169.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -79.1 105.99 10.82 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 120.95 -1.094 . . . . 0.0 111.286 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.434 ' CG2' ' HB2' ' A' ' 157' ' ' ALA . 0.2 OUTLIER -68.12 161.18 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.474 0.71 . . . . 0.0 112.06 178.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -100.15 -22.74 15.06 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.114 0.966 . . . . 0.0 112.628 172.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -67.87 -7.57 29.23 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.37 -16.04 5.0 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.398 1.479 . . . . 0.0 114.605 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 125.38 -86.94 0.36 Allowed Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.519 1.533 . . . . 0.0 113.002 173.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -140.22 25.21 2.28 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 127.061 2.144 . . . . 0.0 110.709 179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -84.74 170.72 12.96 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.975 0.91 . . . . 0.0 108.911 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 23.5 m -104.37 140.96 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.128 0.571 . . . . 0.0 109.77 171.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.434 ' HB2' ' CG2' ' A' ' 149' ' ' ILE . . . -63.29 115.67 4.77 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -113.04 143.97 43.41 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 122.84 1.305 . . . . 0.0 111.231 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -134.65 168.06 19.68 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.202 1.801 . . . . 0.0 110.225 -169.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.89 133.46 23.54 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 69.5 mt -124.87 140.32 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 175.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.6 m -62.11 94.08 0.05 Allowed 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.744 0.818 . . . . 0.0 109.226 173.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.54 -31.83 57.18 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.513 -0.742 . . . . 0.0 111.497 174.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -63.88 -27.71 69.34 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -94.78 -29.86 14.54 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.59 1.556 . . . . 0.0 111.597 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.456 HD13 ' HG3' ' A' ' 100' ' ' MET . 16.9 mt -58.04 -49.66 76.11 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.435 1.094 . . . . 0.0 110.766 170.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -49.33 -37.92 26.15 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.411 1.084 . . . . 0.0 113.445 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -69.94 -18.35 63.36 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.664 1.586 . . . . 0.0 114.268 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -115.98 -9.53 11.75 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.194 1.798 . . . . 0.0 113.983 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 41.2 mt -98.02 -20.28 17.49 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.631 1.572 . . . . 0.0 112.87 -173.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 78.4 mttt . . . . . 0 C--O 1.254 1.296 0 C-N-CA 127.516 2.326 . . . . 0.0 113.584 173.327 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt . . . . . 0 N--CA 1.495 1.804 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.4 pt -61.67 162.58 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.077 0.951 . . . . 0.0 112.77 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -142.54 167.29 22.43 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.299 1.44 . . . . 0.0 111.292 175.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.5 p -128.08 137.38 52.13 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.038 1.335 . . . . 0.0 110.668 177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.3 p -159.28 166.25 31.69 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.51 1.524 . . . . 0.0 111.041 -175.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -136.51 158.03 45.39 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.582 1.153 . . . . 0.0 110.833 173.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -141.28 124.43 16.42 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.077 1.351 . . . . 0.0 109.607 -177.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -62.44 124.65 21.5 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.616 0.722 . . . . 0.0 112.275 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -156.37 168.48 27.2 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.561 1.544 . . . . 0.0 111.406 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.8 t -145.54 122.97 11.66 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.808 1.243 . . . . 0.0 109.732 173.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.5 p -142.8 -40.07 0.33 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.665 1.186 . . . . 0.0 113.58 -172.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 169.23 29.97 0.02 OUTLIER Glycine 0 CA--C 1.536 1.375 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 175.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -102.41 160.36 14.62 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 118.826 1.313 . . . . 0.0 112.851 -175.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.6 m -65.48 171.19 4.19 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.284 1.434 . . . . 0.0 113.236 173.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -134.14 154.11 51.41 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.322 1.449 . . . . 0.0 110.949 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.7 m -113.24 42.58 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.544 1.938 . . . . 0.0 111.34 -176.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -127.18 144.06 51.12 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.452 1.901 . . . . 0.0 111.654 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.4 tptm -168.01 162.96 13.57 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.822 1.649 . . . . 0.0 112.082 -177.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.5 mm -87.36 154.14 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 124.478 1.111 . . . . 0.0 110.462 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -57.25 -19.73 23.26 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 172.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -78.97 -8.32 58.81 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 175.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.5 t -77.47 -4.59 46.26 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.868 1.267 . . . . 0.0 113.728 173.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -122.51 154.38 37.93 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.788 1.235 . . . . 0.0 108.9 167.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -140.0 161.29 37.96 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 124.158 0.983 . . . . 0.0 109.951 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -132.6 124.92 29.28 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.739 0.304 . . . . 0.0 110.595 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.4 m -122.75 162.25 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.439 1.496 . . . . 0.0 111.18 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -60.42 157.87 13.08 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.345 1.058 . . . . 0.0 111.189 176.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.4 tp -156.74 137.82 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.218 1.007 . . . . 0.0 109.267 176.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -130.52 161.97 30.28 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 126.69 1.996 . . . . 0.0 109.628 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -128.73 159.3 36.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.042 1.337 . . . . 0.0 110.899 174.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -80.08 121.44 25.53 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 122.125 -0.36 . . . . 0.0 110.319 170.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.53 171.91 2.33 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.452 1.101 . . . . 0.0 112.258 171.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -55.13 -14.76 1.77 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.425 1.89 . . . . 0.0 115.343 174.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.9 t -113.03 11.46 18.98 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.95 1.3 . . . . 0.0 112.786 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.9 21.3 78.71 Favored Glycine 0 CA--C 1.537 1.409 0 O-C-N 120.553 -1.342 . . . . 0.0 114.334 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -98.17 127.79 44.31 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.843 1.257 . . . . 0.0 109.483 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -67.15 126.83 30.44 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.783 -0.573 . . . . 0.0 110.631 173.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.6 t -140.07 140.09 36.05 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.186 1.394 . . . . 0.0 110.138 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -58.19 141.05 51.74 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.8 tp -113.11 -48.9 2.95 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.758 0.823 . . . . 0.0 110.927 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.4 -111.85 0.47 Allowed Glycine 0 CA--C 1.528 0.9 0 C-N-CA 123.141 0.4 . . . . 0.0 113.32 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -147.15 146.36 29.87 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.473 1.509 . . . . 0.0 110.008 -175.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 16.5 tp -114.68 106.66 14.49 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.674 1.189 . . . . 0.0 110.513 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.8 t -77.56 100.95 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.624 1.169 . . . . 0.0 109.137 173.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.6 t -90.02 123.79 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.156 1.382 . . . . 0.0 109.603 173.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -110.94 111.98 23.49 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 127.475 2.31 . . . . 0.0 109.792 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -82.49 88.25 6.63 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.896 1.278 . . . . 0.0 110.252 175.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -84.31 176.1 8.95 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.616 1.166 . . . . 0.0 111.785 176.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -74.97 -42.8 56.92 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 120.738 -1.226 . . . . 0.0 112.541 172.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -93.37 50.34 1.49 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.003 1.321 . . . . 0.0 111.669 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.46 -163.94 14.1 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.433 1.016 . . . . 0.0 114.075 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.2 mt -117.33 142.88 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.717 0.807 . . . . 0.0 110.075 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -128.97 143.78 50.98 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.296 1.438 . . . . 0.0 109.664 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.1 p -135.31 148.83 49.61 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.299 -0.876 . . . . 0.0 112.043 -174.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -145.62 124.74 2.15 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-O 121.698 0.61 . . . . 0.0 112.739 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.46 HD12 ' CD1' ' A' ' 114' ' ' TYR . 3.2 tm? -74.45 139.06 43.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.147 1.779 . . . . 0.0 110.436 178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.411 ' N ' HD13 ' A' ' 76' ' ' LEU . 48.4 t30 -135.45 81.36 1.89 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.097 1.759 . . . . 0.0 111.106 -178.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.91 66.12 7.81 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.243 1.817 . . . . 0.0 112.199 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.48 -87.82 0.72 Allowed Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.617 1.103 . . . . 0.0 113.634 176.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.6 10.59 35.51 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.789 1.661 . . . . 0.0 113.941 177.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -136.83 118.51 14.99 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.434 1.493 . . . . 0.0 109.845 -174.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 77.6 p -143.81 145.58 32.45 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -173.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.8 159.88 24.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.872 1.269 . . . . 0.0 111.929 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 15.2 m -56.01 128.34 34.84 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.523 0.729 . . . . 0.0 110.382 169.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -93.86 -51.11 5.03 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.478 0.711 . . . . 0.0 110.218 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -167.05 164.81 15.93 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.894 1.278 . . . . 0.0 112.661 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.89 146.29 28.99 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.608 1.163 . . . . 0.0 112.563 176.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.494 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -127.53 158.27 37.87 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.417 1.487 . . . . 0.0 112.111 -176.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -77.5 165.33 24.48 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.606 0.717 . . . . 0.0 112.494 -175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -56.0 -35.78 67.18 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.151 0.98 . . . . 0.0 112.335 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -69.0 -8.88 49.08 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.153 0.981 . . . . 0.0 113.5 175.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.9 t -113.31 -6.58 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.494 1.118 . . . . 0.0 110.834 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 67.7 t -49.85 -67.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.609 1.164 . . . . 0.0 111.87 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -67.12 -24.86 65.96 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 121.697 -0.627 . . . . 0.0 112.633 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -53.56 54.47 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.527 1.531 . . . . 0.0 110.813 173.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -62.51 -43.62 98.36 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.445 1.498 . . . . 0.0 111.642 -179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.479 HG22 HD22 ' A' ' 170' ' ' LEU . 74.3 t -56.62 -37.83 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.471 0.708 . . . . 0.0 110.733 176.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -68.1 -53.18 27.33 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.431 1.092 . . . . 0.0 113.059 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.32 -14.51 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 O-C-N 121.003 -1.06 . . . . 0.0 112.427 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.532 ' CG ' HD13 ' A' ' 166' ' ' LEU . 6.5 ttm -92.54 -4.65 53.18 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 120.465 -1.397 . . . . 0.0 112.802 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 56.5 p -126.75 -12.06 6.02 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.34 1.056 . . . . 0.0 113.114 176.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -136.98 -10.85 1.75 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.934 1.694 . . . . 0.0 114.415 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.27 154.64 10.02 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 125.728 1.632 . . . . 0.0 114.18 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.09 -168.66 33.04 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.672 1.13 . . . . 0.0 113.953 -175.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.7 p -146.24 107.38 4.18 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.873 1.269 . . . . 0.0 113.502 -168.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -136.44 149.42 48.24 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.308 1.843 . . . . 0.0 110.243 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -76.28 163.32 27.14 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 121.247 -0.908 . . . . 0.0 111.334 177.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.5 p -128.83 142.37 50.99 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.981 1.313 . . . . 0.0 111.32 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.494 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 8.4 t -53.52 -44.15 68.9 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.433 1.493 . . . . 0.0 112.256 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 mt -151.34 142.23 22.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.846 1.658 . . . . 0.0 111.691 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -136.12 102.66 5.08 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.072 0.949 . . . . 0.0 110.811 175.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -87.22 -48.53 7.96 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.01 0.924 . . . . 0.0 112.984 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 80.98 165.5 34.0 Favored Glycine 0 CA--C 1.545 1.933 0 C-N-CA 124.748 1.166 . . . . 0.0 112.584 -168.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.46 ' CD1' HD12 ' A' ' 76' ' ' LEU . 5.6 t80 -58.76 -65.3 0.68 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.479 1.111 . . . . 0.0 113.908 -178.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.39 176.84 1.57 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 128.527 2.731 . . . . 0.0 108.357 -172.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 63.91 5.42 2.34 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 125.147 1.379 . . . . 0.0 113.968 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -90.39 150.83 21.7 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.95 2.1 . . . . 0.0 111.269 -172.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -73.94 -12.93 60.8 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 172.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 34.9 m -122.15 -7.14 8.85 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.8 p -57.34 -23.47 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-N 121.356 1.889 . . . . 0.0 113.452 175.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 33.1 mm -56.39 -36.87 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 126.407 1.883 . . . . 0.0 112.909 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -139.24 -26.1 0.84 Allowed 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.33 169.16 37.48 Favored Glycine 0 CA--C 1.539 1.56 0 C-N-CA 126.213 1.864 . . . . 0.0 113.86 -173.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 46.7 mt -125.72 115.83 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.807 1.643 . . . . 0.0 108.612 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -74.47 146.92 42.39 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.992 0.425 . . . . 0.0 111.836 173.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 57.47 23.36 9.01 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.136 1.774 . . . . 0.0 114.467 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -63.7 123.24 18.36 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.715 1.206 . . . . 0.0 111.727 -171.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -71.33 125.38 26.82 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.538 1.135 . . . . 0.0 111.636 177.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.7 mm -120.97 119.51 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.755 1.222 . . . . 0.0 109.169 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 mp -111.3 100.27 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.88 1.272 . . . . 0.0 108.67 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 47.9 p -79.26 159.62 27.19 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.068 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.1 141.48 20.66 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.114 1.366 . . . . 0.0 111.305 171.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 41.5 mt -83.07 136.31 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.598 0.759 . . . . 0.0 109.275 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -142.52 127.17 18.01 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.877 1.271 . . . . 0.0 110.974 173.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -77.07 105.62 8.27 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.303 0.641 . . . . 0.0 110.311 170.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 27.2 mt -92.07 98.79 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 174.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 57.78 15.45 2.98 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.682 1.993 . . . . 0.0 115.779 -176.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 125.73 -28.14 5.02 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.036 1.303 . . . . 0.0 113.924 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 99.6 m -78.33 126.68 31.12 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.8 0.84 . . . . 0.0 109.498 172.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -73.29 116.16 13.5 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.228 0.537 . . . . 0.0 110.322 172.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -105.42 165.25 11.26 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.486 1.514 . . . . 0.0 111.009 170.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 6.3 tp -115.7 137.04 50.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 125.743 1.617 . . . . 0.0 107.793 169.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.5 p -126.95 157.63 38.96 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.499 0.72 . . . . 0.0 109.772 173.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -151.27 138.63 19.42 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.015 0.926 . . . . 0.0 111.603 -177.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.3 m -78.88 111.28 14.88 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.074 0.95 . . . . 0.0 110.821 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.71 -161.95 32.74 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.435 1.016 . . . . 0.0 113.125 175.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -63.69 170.58 3.19 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-O 121.898 0.856 . . . . 0.0 112.568 169.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -92.21 108.21 19.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.623 1.569 . . . . 0.0 111.517 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.32 159.73 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.36 0.664 . . . . 0.0 112.192 176.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.5 tttp -90.27 -31.65 16.88 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 172.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -66.89 -40.59 87.78 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -171.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.5 t -75.55 -34.76 60.74 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.242 0.617 . . . . 0.0 112.411 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 142.35 -76.37 0.31 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.81 1.672 . . . . 0.0 111.948 172.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -144.23 22.22 1.71 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.325 1.85 . . . . 0.0 111.173 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -81.49 -175.72 5.66 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.075 0.95 . . . . 0.0 109.489 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.71 144.61 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.307 0.643 . . . . 0.0 110.743 172.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -66.45 108.89 2.54 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 169.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -110.11 143.0 40.81 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 122.378 1.085 . . . . 0.0 110.675 172.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -133.39 170.15 15.89 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.97 1.708 . . . . 0.0 110.696 -170.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.31 132.26 20.23 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.532 0.333 . . . . 0.0 110.174 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 67.3 mt -125.2 138.88 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 174.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.3 m -62.88 99.2 0.15 Allowed 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.735 0.698 . . . . 0.0 109.294 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.508 ' HA ' HD12 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -56.27 -30.57 62.63 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.588 0.755 . . . . 0.0 111.829 177.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -69.45 -31.57 69.96 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -87.84 -22.4 24.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.091 0.956 . . . . 0.0 112.356 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.532 HD13 ' CG ' ' A' ' 100' ' ' MET . 18.1 mt -64.25 -44.02 93.1 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.94 0.896 . . . . 0.0 111.085 168.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -55.07 -40.7 70.64 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.921 0.889 . . . . 0.0 112.153 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 9.5 mtpp -56.96 -19.4 17.88 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.733 1.613 . . . . 0.0 115.319 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -126.02 -5.44 6.78 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.781 1.233 . . . . 0.0 114.302 -175.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.479 HD22 HG22 ' A' ' 97' ' ' VAL . 20.7 mt -98.77 -23.37 15.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.143 1.377 . . . . 0.0 112.21 -177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm . . . . . 0 C--O 1.254 1.303 0 C-N-CA 125.895 1.678 . . . . 0.0 112.899 178.146 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 119.625 -0.226 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.7 mm -113.92 -35.71 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 124.79 1.236 . . . . 0.0 112.388 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 35.3 p80 -129.93 170.31 14.1 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.393 1.477 . . . . 0.0 111.438 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.8 t -127.33 159.27 34.9 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.372 1.069 . . . . 0.0 111.391 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.9 m -120.37 138.04 53.96 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.429 1.492 . . . . 0.0 110.366 -176.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -63.45 -24.69 67.94 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.905 0.882 . . . . 0.0 113.37 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -76.17 83.62 2.99 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.283 1.433 . . . . 0.0 112.278 173.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -151.01 147.44 27.13 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.877 1.271 . . . . 0.0 111.619 175.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -76.52 154.42 34.62 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.483 1.113 . . . . 0.0 112.34 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.1 p -63.0 168.93 3.63 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.247 1.419 . . . . 0.0 113.991 172.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.6 t -131.48 -35.99 1.28 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.848 1.259 . . . . 0.0 113.713 -176.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -167.42 -174.91 36.93 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 124.621 1.105 . . . . 0.0 113.36 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -134.8 173.02 12.16 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.29 1.436 . . . . 0.0 112.383 -173.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.7 m -56.64 151.85 13.11 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.893 1.277 . . . . 0.0 112.801 172.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -116.36 66.51 0.71 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.337 1.455 . . . . 0.0 112.964 -168.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.6 m -78.96 39.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 126.991 2.117 . . . . 0.0 114.518 -175.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -93.94 -177.91 4.48 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.221 1.809 . . . . 0.0 111.773 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.9 pptp? -57.04 153.1 11.97 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.859 1.264 . . . . 0.0 112.708 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.9 mm -71.75 140.35 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 123.179 0.592 . . . . 0.0 109.917 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -65.81 -8.29 20.8 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -55.48 -15.1 2.4 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 127.161 2.185 . . . . 0.0 115.584 -175.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 m -61.43 -15.9 41.57 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.618 1.567 . . . . 0.0 113.627 169.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -151.17 176.53 11.1 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.392 1.477 . . . . 0.0 111.907 169.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -147.32 155.93 42.46 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 123.974 0.91 . . . . 0.0 109.346 166.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 m -122.24 131.19 53.81 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.572 0.349 . . . . 0.0 110.775 175.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.0 m -129.27 166.09 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 125.646 1.579 . . . . 0.0 111.605 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -63.89 159.24 20.17 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.706 1.202 . . . . 0.0 111.806 177.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.0 tp -154.27 136.68 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.241 1.416 . . . . 0.0 109.571 174.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -128.89 161.93 28.71 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.498 1.919 . . . . 0.0 109.848 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -131.4 156.65 45.2 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.842 1.257 . . . . 0.0 111.338 176.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.02 119.59 20.18 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 171.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -63.27 175.51 0.95 Allowed 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 122.053 0.93 . . . . 0.0 111.728 170.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -60.36 -11.45 6.67 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.725 2.01 . . . . 0.0 114.6 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.8 m -115.64 13.49 16.3 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.169 1.388 . . . . 0.0 112.86 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.71 23.18 77.28 Favored Glycine 0 CA--C 1.536 1.397 0 O-C-N 121.281 -0.887 . . . . 0.0 114.318 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -100.26 124.23 45.45 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.807 1.243 . . . . 0.0 109.674 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -64.93 123.94 20.75 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.974 0.51 . . . . 0.0 110.952 173.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.0 t -138.49 137.4 37.09 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.207 1.403 . . . . 0.0 110.402 -174.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -57.43 137.08 56.59 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.345 0.658 . . . . 0.0 112.516 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.8 tp -110.39 -47.65 3.26 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.667 0.787 . . . . 0.0 111.173 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.03 -128.98 1.55 Allowed Glycine 0 CA--C 1.528 0.86 0 CA-C-O 121.341 0.412 . . . . 0.0 113.665 -173.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -140.58 155.75 46.49 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.734 1.613 . . . . 0.0 109.621 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.8 tp -120.19 99.46 6.6 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.453 1.501 . . . . 0.0 109.662 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.3 t -76.71 101.96 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 125.321 1.448 . . . . 0.0 109.491 175.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.1 t -92.08 92.97 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 126.088 1.755 . . . . 0.0 109.712 179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -77.28 126.33 30.76 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.814 1.645 . . . . 0.0 110.564 175.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -82.9 93.56 7.53 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.246 1.418 . . . . 0.0 109.115 175.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -78.54 165.24 23.94 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 122.074 0.94 . . . . 0.0 111.936 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -75.11 -24.6 58.1 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 120.9 -1.125 . . . . 0.0 112.937 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -126.88 47.71 2.29 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.304 1.842 . . . . 0.0 111.378 -176.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.72 -156.91 22.13 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.58 1.086 . . . . 0.0 115.36 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.4 mt -124.12 145.49 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.159 0.984 . . . . 0.0 109.657 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -137.1 128.81 28.79 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.184 0.994 . . . . 0.0 110.593 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.8 p -117.54 147.25 42.96 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.381 1.072 . . . . 0.0 111.318 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -139.16 120.83 1.97 Allowed Glycine 0 CA--C 1.522 0.497 0 O-C-N 121.909 -0.495 . . . . 0.0 112.444 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.71 121.81 17.25 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.459 1.504 . . . . 0.0 109.107 173.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -128.58 79.77 1.93 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.453 1.901 . . . . 0.0 109.112 -177.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.64 178.05 8.56 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-O 121.462 0.649 . . . . 0.0 112.109 -178.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.73 48.39 1.28 Allowed Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.877 1.703 . . . . 0.0 115.289 -175.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.47 -10.51 0.1 Allowed Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.742 1.639 . . . . 0.0 115.147 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -152.95 156.09 38.21 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.359 1.464 . . . . 0.0 112.835 -173.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 84.6 p -144.3 140.63 29.28 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 170.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -156.55 161.38 39.98 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.942 1.297 . . . . 0.0 112.245 174.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 10.1 m -55.4 136.21 49.66 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 121.05 -1.031 . . . . 0.0 110.887 171.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -106.49 -51.46 2.95 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.564 1.146 . . . . 0.0 110.417 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -164.4 154.8 14.67 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.412 0.685 . . . . 0.0 112.388 170.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -142.55 154.85 44.83 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.431 1.11 . . . . 0.0 111.44 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.476 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -141.34 159.75 41.56 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.967 1.307 . . . . 0.0 111.647 -174.504 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -79.83 165.71 22.44 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.592 0.757 . . . . 0.0 112.029 -175.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -55.74 -32.31 63.28 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.138 -0.976 . . . . 0.0 113.422 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.47 -14.13 62.79 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 t -106.83 -8.23 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.38 1.072 . . . . 0.0 111.262 -174.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 97' ' ' VAL . 81.0 t -49.92 -63.38 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 125.23 1.412 . . . . 0.0 111.462 -178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -69.63 -25.67 64.04 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -52.08 59.19 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.217 1.407 . . . . 0.0 110.72 174.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -61.78 -43.34 99.04 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.633 1.573 . . . . 0.0 111.505 179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 93' ' ' VAL . 73.6 t -54.5 -38.27 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.252 1.021 . . . . 0.0 110.566 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -69.37 -53.75 17.93 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.585 1.154 . . . . 0.0 112.541 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.7 m -72.3 -20.6 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 121.028 -1.045 . . . . 0.0 112.248 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.58 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -83.46 -4.67 58.72 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.239 -1.538 . . . . 0.0 112.103 174.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 79.9 p -128.53 -12.56 4.94 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -137.68 -10.5 1.6 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.036 1.734 . . . . 0.0 114.166 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.33 155.33 11.05 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.879 1.704 . . . . 0.0 113.86 -174.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.87 -171.66 33.8 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.673 1.13 . . . . 0.0 113.292 -174.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.0 p -145.47 103.83 3.85 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.518 1.127 . . . . 0.0 113.184 -168.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -131.66 150.53 52.12 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.962 1.705 . . . . 0.0 110.152 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.71 157.22 30.19 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.265 -0.897 . . . . 0.0 111.578 176.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.6 p -122.94 155.84 35.93 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.162 1.785 . . . . 0.0 110.687 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.476 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 77.1 p -71.09 -38.09 72.41 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.7 -0.625 . . . . 0.0 111.568 -178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.8 mt -154.43 137.67 15.71 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.147 1.779 . . . . 0.0 111.809 -176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -134.89 102.62 5.3 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.878 0.871 . . . . 0.0 110.48 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -86.77 -45.2 11.14 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.381 1.073 . . . . 0.0 113.381 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.29 -178.77 30.14 Favored Glycine 0 CA--C 1.543 1.788 0 C-N-CA 124.8 1.19 . . . . 0.0 113.865 -169.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -58.16 164.78 2.21 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 125.291 1.436 . . . . 0.0 113.351 171.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -65.0 -25.9 68.05 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 119.784 -1.823 . . . . 0.0 113.805 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -87.53 51.97 2.37 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.998 1.319 . . . . 0.0 111.643 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -135.3 166.71 22.5 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.733 2.013 . . . . 0.0 111.303 -175.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -87.05 -14.48 41.41 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.8 m -126.85 3.25 6.64 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -171.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.6 p -63.41 -21.99 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 75.4 mt -66.77 -41.38 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.02 -1.05 . . . . 0.0 111.609 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -123.01 -18.3 6.44 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.536 1.134 . . . . 0.0 113.342 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.22 178.7 52.29 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.37 0.986 . . . . 0.0 112.841 -171.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 55.9 mt -124.63 109.62 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.501 1.52 . . . . 0.0 107.402 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -68.93 145.14 53.9 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.179 0.514 . . . . 0.0 111.139 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 60.71 21.04 11.05 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.573 1.549 . . . . 0.0 114.389 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 21.2 tptp -56.24 123.91 16.15 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.571 1.148 . . . . 0.0 111.287 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -73.41 128.87 36.7 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.968 0.907 . . . . 0.0 110.237 170.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 38.2 mm -121.73 112.61 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.187 0.995 . . . . 0.0 109.112 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.11 91.12 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.842 1.257 . . . . 0.0 109.103 -174.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 44.8 p -75.46 155.23 36.46 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.326 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -152.29 141.45 21.36 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.028 1.331 . . . . 0.0 111.399 172.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 23.1 mt -80.04 132.27 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.239 0.615 . . . . 0.0 109.405 175.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -148.41 138.03 22.16 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.082 1.353 . . . . 0.0 111.021 172.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.8 mmtm -76.39 154.38 34.94 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.34 -0.85 . . . . 0.0 110.334 169.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 44.9 mt -129.98 -47.83 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.875 0.87 . . . . 0.0 111.092 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -146.63 32.01 0.96 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.822 0.849 . . . . 0.0 112.463 -177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 101.69 -14.96 57.49 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.486 1.041 . . . . 0.0 114.109 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 65.5 m -96.23 139.41 32.41 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.614 1.166 . . . . 0.0 108.738 169.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -73.98 123.28 24.02 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.278 0.561 . . . . 0.0 109.834 171.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -106.73 169.12 8.72 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.275 1.43 . . . . 0.0 110.444 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.0 tp -123.82 134.11 67.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 125.531 1.532 . . . . 0.0 108.283 172.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 p -121.36 153.75 37.37 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.192 0.597 . . . . 0.0 110.151 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -151.81 144.98 24.63 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.237 1.015 . . . . 0.0 111.29 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 p -77.7 116.45 18.24 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.195 1.398 . . . . 0.0 111.746 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.29 -158.67 30.21 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 125.575 1.56 . . . . 0.0 112.214 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -68.07 164.31 20.48 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 122.022 0.915 . . . . 0.0 113.422 170.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -81.61 102.59 10.75 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.175 0.99 . . . . 0.0 111.086 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.03 160.99 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 123.404 0.681 . . . . 0.0 112.684 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -98.5 -24.9 14.95 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.159 0.983 . . . . 0.0 112.939 174.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -67.54 -16.15 64.04 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.64 -29.81 7.32 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.029 1.332 . . . . 0.0 113.501 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 138.42 -82.85 0.25 Allowed Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.21 1.386 . . . . 0.0 112.741 172.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -140.95 22.25 2.27 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 127.297 2.239 . . . . 0.0 110.459 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -82.14 174.17 11.45 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 177.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.6 m -106.84 139.77 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 169.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -59.98 133.1 55.78 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 168.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -125.55 143.68 50.9 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.51 1.148 . . . . 0.0 110.473 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -131.23 169.18 16.3 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.851 1.661 . . . . 0.0 110.687 -170.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.28 130.67 19.82 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 122.901 0.48 . . . . 0.0 110.013 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.476 ' CG2' HD11 ' A' ' 166' ' ' LEU . 60.9 mt -126.24 140.54 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.883 0.873 . . . . 0.0 108.847 177.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.0 m -65.78 94.55 0.21 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.038 0.935 . . . . 0.0 109.772 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.553 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.0 OUTLIER -53.68 -33.06 54.08 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.512 1.125 . . . . 0.0 111.682 175.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -66.94 -27.27 67.33 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 176.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -89.91 -29.9 18.22 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.115 0.966 . . . . 0.0 112.875 174.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.58 HD13 ' HG3' ' A' ' 100' ' ' MET . 20.3 mt -59.3 -47.61 84.75 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.45 0.7 . . . . 0.0 110.643 172.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -50.89 -37.79 45.88 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.563 1.145 . . . . 0.0 113.746 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -71.55 -14.18 62.02 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -124.94 -3.64 7.62 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.882 1.273 . . . . 0.0 113.844 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 15.1 mt -96.36 -14.82 22.24 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.443 1.497 . . . . 0.0 112.968 -176.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 6.6 ptmt . . . . . 0 C--O 1.254 1.326 0 C-N-CA 126.998 2.119 . . . . 0.0 115.86 179.024 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.3 tt -107.51 155.27 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.336 1.454 . . . . 0.0 110.928 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -128.52 160.21 33.04 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.586 1.554 . . . . 0.0 110.366 173.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.1 m -123.66 121.05 34.54 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.695 0.798 . . . . 0.0 110.134 -171.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.1 m -67.73 -13.17 61.89 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -174.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -137.89 158.5 44.22 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.321 1.848 . . . . 0.0 110.971 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -150.96 160.84 43.67 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.668 1.187 . . . . 0.0 112.813 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 -134.58 53.18 2.01 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.48 1.512 . . . . 0.0 111.656 -171.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -58.95 103.37 0.16 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.26 1.024 . . . . 0.0 111.757 170.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 28.9 t -73.73 -40.37 63.6 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.081 0.952 . . . . 0.0 112.239 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.1 p -86.19 173.05 10.06 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.352 1.461 . . . . 0.0 112.346 172.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.04 95.3 0.14 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.273 0.939 . . . . 0.0 112.29 -177.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -58.42 132.41 53.62 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.657 1.183 . . . . 0.0 112.089 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.8 t -154.57 155.43 34.76 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.891 1.276 . . . . 0.0 111.707 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -154.98 127.86 8.14 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.71 1.604 . . . . 0.0 110.908 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.54 120.78 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.826 1.251 . . . . 0.0 111.134 173.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -152.47 177.72 10.32 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 127.73 2.412 . . . . 0.0 110.502 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -90.7 102.09 14.84 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.239 1.416 . . . . 0.0 110.085 169.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -117.97 156.5 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.606 1.562 . . . . 0.0 109.682 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -56.05 -19.65 13.77 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 172.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -78.15 -7.48 57.1 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.467 1.107 . . . . 0.0 113.8 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.99 11.34 25.47 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.498 1.919 . . . . 0.0 112.633 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -142.75 166.66 24.05 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.547 1.539 . . . . 0.0 111.441 170.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -142.26 174.28 10.76 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.146 1.378 . . . . 0.0 110.763 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -140.43 137.2 33.77 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.286 -0.884 . . . . 0.0 111.097 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.2 m -133.4 162.06 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 125.444 1.497 . . . . 0.0 111.718 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -61.75 155.14 23.65 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.443 1.097 . . . . 0.0 111.893 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.4 tp -150.94 136.16 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.789 1.236 . . . . 0.0 109.784 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -125.75 161.82 26.46 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 126.906 2.082 . . . . 0.0 109.488 176.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -130.8 154.58 47.87 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.162 1.385 . . . . 0.0 111.077 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -79.41 117.51 20.45 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.957 -0.464 . . . . 0.0 109.841 169.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -64.24 172.47 2.46 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 122.619 1.199 . . . . 0.0 111.176 169.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -57.0 -22.38 38.1 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.42 2.288 . . . . 0.0 113.125 173.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.4 m -83.67 -4.1 58.32 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.696 1.598 . . . . 0.0 114.15 174.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.68 34.42 66.86 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.846 1.213 . . . . 0.0 114.133 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -122.29 139.19 54.09 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.259 1.424 . . . . 0.0 110.689 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -70.93 119.96 15.82 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.645 1.178 . . . . 0.0 110.9 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -133.87 141.87 47.56 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.149 1.38 . . . . 0.0 110.138 -177.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -59.21 140.2 56.18 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 -173.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.5 tp -114.11 -47.86 2.93 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.032 0.933 . . . . 0.0 111.34 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.79 -119.02 0.81 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 123.267 0.461 . . . . 0.0 113.176 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -145.37 152.7 40.28 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.639 1.576 . . . . 0.0 110.184 -177.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.2 tp -117.46 104.58 11.23 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.777 1.231 . . . . 0.0 110.525 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.4 t -77.82 100.37 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.507 1.123 . . . . 0.0 109.619 174.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 52.1 t -90.1 113.09 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.031 1.332 . . . . 0.0 110.36 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -95.8 125.32 40.29 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.044 2.138 . . . . 0.0 110.566 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.88 86.58 6.34 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.852 1.261 . . . . 0.0 109.722 176.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -78.33 170.26 16.92 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.922 0.868 . . . . 0.0 111.495 177.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 35.3 tp10 -73.38 -31.0 63.66 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 120.661 -1.275 . . . . 0.0 112.787 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -107.15 24.81 12.23 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.482 1.513 . . . . 0.0 112.805 -169.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.72 -160.68 24.34 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.964 1.745 . . . . 0.0 113.971 -176.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.1 mt -119.61 143.2 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.101 0.96 . . . . 0.0 109.401 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -135.81 138.59 42.72 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.092 0.957 . . . . 0.0 110.059 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.5 p -131.54 147.63 52.55 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.488 -0.758 . . . . 0.0 111.724 -169.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.96 124.48 2.36 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-O 121.636 0.575 . . . . 0.0 112.954 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.9 137.05 51.3 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.103 1.761 . . . . 0.0 110.212 176.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -132.2 91.92 3.02 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.031 1.733 . . . . 0.0 110.274 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -109.39 82.26 1.57 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.864 1.666 . . . . 0.0 110.885 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.0 -103.98 0.95 Allowed Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.202 0.906 . . . . 0.0 112.948 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -99.17 7.67 60.39 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.16 1.362 . . . . 0.0 114.588 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -127.29 120.79 29.45 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.966 1.306 . . . . 0.0 109.899 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.6 p -142.11 141.88 32.74 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 121.544 -0.722 . . . . 0.0 112.694 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -160.57 161.14 32.52 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.883 1.273 . . . . 0.0 111.614 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.2 m -55.54 132.75 49.39 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.485 -0.759 . . . . 0.0 110.146 169.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -99.89 -51.1 3.8 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.884 0.874 . . . . 0.0 109.842 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -163.98 161.57 22.81 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.12 0.968 . . . . 0.0 112.286 170.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.44 150.77 36.27 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.829 0.852 . . . . 0.0 111.512 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.51 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.8 OUTLIER -141.24 156.25 45.92 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 125.288 1.435 . . . . 0.0 111.845 -174.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -77.79 165.33 24.31 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.482 0.713 . . . . 0.0 112.601 -172.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -52.85 -34.0 52.28 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.605 1.162 . . . . 0.0 112.897 172.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -66.65 -11.81 55.5 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.87 1.268 . . . . 0.0 113.658 175.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.8 t -116.22 -5.23 11.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.971 1.308 . . . . 0.0 111.357 -172.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 69.6 t -50.18 -62.41 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 125.293 1.437 . . . . 0.0 111.899 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -70.25 -28.13 64.99 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -62.29 -50.48 71.52 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.446 1.498 . . . . 0.0 110.909 177.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -60.18 -43.84 95.52 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.996 1.318 . . . . 0.0 111.327 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 42.1 t -62.1 -34.16 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 123.705 0.802 . . . . 0.0 111.349 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -63.8 -54.56 33.19 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.459 1.104 . . . . 0.0 111.996 172.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -73.17 -2.55 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.587 ' CG ' HD13 ' A' ' 166' ' ' LEU . 2.3 ttm -114.48 1.91 14.47 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.038 1.335 . . . . 0.0 112.925 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.5 p -124.76 -12.56 7.1 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.762 1.225 . . . . 0.0 112.156 168.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -138.1 -15.14 1.32 Allowed 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.79 155.09 26.81 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 124.895 1.236 . . . . 0.0 114.125 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.13 -160.1 31.35 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 123.963 0.792 . . . . 0.0 114.363 -176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.5 p -151.91 98.75 2.49 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -170.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -131.65 146.06 51.99 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.275 1.83 . . . . 0.0 110.132 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.23 155.75 36.47 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.461 -0.774 . . . . 0.0 110.778 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 47.0 p -114.69 158.11 22.23 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.539 1.136 . . . . 0.0 111.009 175.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.51 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 77.0 p -70.54 -37.87 74.12 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 121.387 -0.821 . . . . 0.0 110.823 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.2 mt -148.04 150.83 34.65 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.962 2.105 . . . . 0.0 112.171 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -143.7 107.95 4.78 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.382 1.073 . . . . 0.0 110.252 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -96.88 -40.46 8.9 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.411 1.084 . . . . 0.0 113.585 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.66 178.51 29.99 Favored Glycine 0 CA--C 1.54 1.598 0 C-N-CA 124.796 1.188 . . . . 0.0 115.616 -172.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -65.63 170.91 4.6 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.915 0.886 . . . . 0.0 112.075 169.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -58.5 -23.99 59.39 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 120.484 -1.385 . . . . 0.0 114.653 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -67.06 -23.81 65.91 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 171.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -70.38 133.7 47.16 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.441 1.496 . . . . 0.0 111.43 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -64.56 -23.53 67.3 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 120.718 -1.239 . . . . 0.0 113.98 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.03 -7.43 45.78 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.439 1.496 . . . . 0.0 114.79 -176.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.07 -25.44 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 60.2 mt -69.99 -37.87 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 125.059 1.343 . . . . 0.0 112.468 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -133.84 -16.42 2.27 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -169.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.4 175.19 39.77 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 126.449 1.976 . . . . 0.0 114.576 -174.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.2 mt -126.62 112.17 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.874 1.67 . . . . 0.0 108.536 174.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -70.98 145.24 50.16 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.101 0.477 . . . . 0.0 111.311 172.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 59.29 22.53 10.86 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.713 1.605 . . . . 0.0 114.137 177.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -54.13 127.86 28.48 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.92 1.288 . . . . 0.0 111.248 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -75.12 130.12 38.71 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.085 0.554 . . . . 0.0 110.544 170.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 32.8 mm -126.55 120.28 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.835 1.254 . . . . 0.0 108.668 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.68 101.55 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 125.303 1.441 . . . . 0.0 108.71 -176.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 30.4 p -86.29 159.3 19.47 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.485 0.714 . . . . 0.0 112.317 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -154.89 139.24 16.72 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.066 1.346 . . . . 0.0 111.736 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 26.2 mt -77.29 133.57 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.087 0.555 . . . . 0.0 109.911 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -149.44 139.56 22.13 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.747 1.619 . . . . 0.0 111.038 171.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.6 mmtt -78.35 153.37 31.72 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.09 -1.006 . . . . 0.0 109.902 168.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 47.8 mt -128.77 -46.8 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.8 0.84 . . . . 0.0 111.261 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -144.22 20.9 1.74 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.929 0.892 . . . . 0.0 112.796 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 111.14 -18.74 25.66 Favored Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.789 1.185 . . . . 0.0 113.647 -177.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 53.0 m -91.28 140.53 29.7 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.742 1.217 . . . . 0.0 109.085 169.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -74.97 126.87 31.91 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.28 0.562 . . . . 0.0 110.316 170.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -112.68 165.92 11.83 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.33 1.452 . . . . 0.0 110.692 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.1 tp -120.77 132.27 70.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 125.472 1.509 . . . . 0.0 108.117 171.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.3 p -122.45 154.76 37.34 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.571 0.748 . . . . 0.0 110.05 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -150.95 148.08 27.96 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.709 0.804 . . . . 0.0 111.844 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.4 p -80.74 125.42 30.04 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.695 1.198 . . . . 0.0 111.552 174.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.66 -151.77 26.63 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.085 1.326 . . . . 0.0 113.187 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -78.92 172.19 14.13 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.465 1.506 . . . . 0.0 110.331 168.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -82.31 119.29 23.94 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 120.709 -1.245 . . . . 0.0 110.805 173.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.31 161.67 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 122.818 0.447 . . . . 0.0 111.36 173.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -93.67 -31.26 14.53 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.547 0.739 . . . . 0.0 112.689 172.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -61.37 -47.73 84.49 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.177 0.991 . . . . 0.0 112.983 -175.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.89 -31.99 51.61 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 139.98 -76.29 0.33 Allowed Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.008 1.289 . . . . 0.0 113.497 170.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -146.44 21.07 1.35 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 127.332 2.253 . . . . 0.0 111.926 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -78.13 172.17 13.94 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.525 1.13 . . . . 0.0 108.592 172.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 16.0 m -108.19 141.12 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 122.87 0.468 . . . . 0.0 110.102 173.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -63.51 117.62 7.0 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 175.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -117.96 140.23 50.02 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 122.181 0.991 . . . . 0.0 110.17 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -133.1 168.54 18.32 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.304 1.442 . . . . 0.0 111.327 -169.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.82 130.64 18.09 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.264 0.626 . . . . 0.0 109.9 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.42 ' CG2' HD11 ' A' ' 166' ' ' LEU . 69.6 mt -122.57 140.33 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.135 0.974 . . . . 0.0 108.536 178.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.9 m -64.11 95.81 0.13 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.192 0.997 . . . . 0.0 110.049 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.531 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.3 tt -55.32 -31.87 62.02 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.501 1.12 . . . . 0.0 111.757 175.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -69.48 -29.72 67.44 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.59 -33.51 47.52 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.292 0.951 . . . . 0.0 112.681 171.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.587 HD13 ' CG ' ' A' ' 100' ' ' MET . 22.4 mt -62.28 -48.82 78.21 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.309 1.043 . . . . 0.0 110.741 175.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -48.81 -38.19 21.42 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.785 1.175 . . . . 0.0 113.531 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -58.52 -24.08 59.69 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 114.814 1.412 . . . . 0.0 114.814 177.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -126.84 4.44 6.62 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.004 2.121 . . . . 0.0 113.622 -177.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.7 mp -106.76 -31.13 8.54 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.984 1.714 . . . . 0.0 111.933 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm . . . . . 0 C--O 1.254 1.294 0 C-N-CA 125.922 1.689 . . . . 0.0 112.558 170.535 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.2 mt -137.25 110.38 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 120.253 -1.53 . . . . 0.0 109.152 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -76.09 151.25 37.11 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.014 0.925 . . . . 0.0 112.136 176.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.7 p -71.05 113.34 7.99 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.473 1.109 . . . . 0.0 112.001 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 61.6 p -84.98 -20.61 30.29 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -72.7 138.07 46.37 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.419 1.088 . . . . 0.0 112.188 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -87.83 79.51 8.1 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.701 1.2 . . . . 0.0 112.206 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -145.29 137.59 25.82 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.821 1.248 . . . . 0.0 111.028 176.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 13.7 tm0? -148.87 109.14 4.13 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.829 1.252 . . . . 0.0 109.615 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.2 p -160.73 170.81 20.02 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.814 1.645 . . . . 0.0 111.508 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.9 m 57.25 21.32 6.54 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.657 1.583 . . . . 0.0 115.168 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.37 -31.91 1.75 Allowed Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.979 1.276 . . . . 0.0 114.56 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -72.79 150.96 42.33 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 118.646 1.223 . . . . 0.0 110.819 169.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.2 p -143.11 176.45 9.1 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.057 1.343 . . . . 0.0 112.406 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -58.9 142.69 50.04 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.995 1.318 . . . . 0.0 112.349 170.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.4 t -140.42 60.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 125.584 1.554 . . . . 0.0 109.759 -176.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -99.64 157.98 16.09 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.347 1.459 . . . . 0.0 111.542 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -138.23 103.77 5.02 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.925 1.69 . . . . 0.0 110.379 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.3 mp -94.5 118.78 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 125.814 1.646 . . . . 0.0 109.265 -176.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -96.06 49.11 1.13 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.152 1.381 . . . . 0.0 110.951 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -86.48 -18.49 31.5 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 173.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.1 t -115.78 -5.86 12.1 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.757 1.623 . . . . 0.0 113.033 -175.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -137.16 158.07 45.26 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.3 1.84 . . . . 0.0 109.558 169.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -140.93 165.62 27.03 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.091 0.956 . . . . 0.0 110.842 176.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -136.04 132.76 36.65 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.16 -0.338 . . . . 0.0 111.322 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.1 m -131.79 159.77 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.353 1.461 . . . . 0.0 111.866 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -57.98 153.75 13.79 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.747 0.819 . . . . 0.0 112.45 175.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.0 tp -149.96 137.16 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.336 1.455 . . . . 0.0 109.714 174.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -132.57 161.25 34.31 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.718 2.007 . . . . 0.0 109.674 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -134.62 160.08 39.21 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.367 1.067 . . . . 0.0 112.162 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.21 114.45 21.82 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.545 0.738 . . . . 0.0 110.625 173.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -73.59 -176.65 2.41 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.779 0.832 . . . . 0.0 112.276 175.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.0 mtpt -55.92 -26.65 48.62 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.489 1.916 . . . . 0.0 113.167 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 51.0 m -73.75 -8.25 55.28 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.342 1.457 . . . . 0.0 113.87 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.24 40.46 97.38 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.258 0.932 . . . . 0.0 112.4 -169.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -132.61 137.64 47.11 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.562 1.945 . . . . 0.0 109.097 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -67.3 130.64 43.71 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.64 0.776 . . . . 0.0 111.178 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.3 t -137.53 138.46 39.67 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.942 1.297 . . . . 0.0 110.317 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -57.17 125.88 24.71 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.443 1.097 . . . . 0.0 112.286 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.9 tp -100.73 -45.87 5.34 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.863 0.865 . . . . 0.0 111.092 -178.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.86 -120.36 0.91 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.473 0.559 . . . . 0.0 113.468 -177.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -145.5 155.76 43.3 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.565 1.546 . . . . 0.0 109.575 -177.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.5 tp -121.83 104.81 9.83 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.5 1.12 . . . . 0.0 110.698 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.2 t -77.72 98.95 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.847 1.259 . . . . 0.0 109.355 174.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 51.6 t -86.06 117.44 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.042 1.737 . . . . 0.0 110.197 174.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -104.46 122.87 46.41 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.973 2.109 . . . . 0.0 110.82 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -85.78 78.87 9.46 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.185 1.394 . . . . 0.0 110.204 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -67.6 171.49 6.22 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.443 1.097 . . . . 0.0 111.721 172.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -73.08 -38.99 66.22 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 120.508 -1.37 . . . . 0.0 113.93 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -109.22 30.31 6.71 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.331 1.453 . . . . 0.0 113.302 -169.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.68 -163.55 26.51 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 126.908 2.194 . . . . 0.0 113.341 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.4 mt -117.31 143.96 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.074 0.95 . . . . 0.0 109.708 171.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -131.35 140.9 49.81 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.107 1.363 . . . . 0.0 109.459 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.7 p -133.15 146.92 52.01 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.134 -0.979 . . . . 0.0 112.433 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.05 126.51 3.25 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-O 121.769 0.649 . . . . 0.0 112.944 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.05 137.35 53.51 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.561 1.945 . . . . 0.0 110.128 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -137.24 73.75 1.46 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.1 1.76 . . . . 0.0 110.678 -176.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.09 177.59 8.69 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.376 1.87 . . . . 0.0 112.596 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.24 93.71 0.02 OUTLIER Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.72 1.629 . . . . 0.0 113.903 176.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.64 21.68 77.84 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.855 1.217 . . . . 0.0 115.182 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -148.61 135.62 20.05 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 119.06 1.43 . . . . 0.0 111.973 -175.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 77.4 p -150.19 148.82 29.38 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.83 161.89 26.24 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.713 1.605 . . . . 0.0 111.413 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.3 m -58.55 136.4 57.56 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.24 -0.913 . . . . 0.0 109.262 169.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -104.45 -48.29 3.86 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.904 0.882 . . . . 0.0 110.022 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -162.38 170.5 18.7 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.416 1.086 . . . . 0.0 112.307 169.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.77 158.09 43.73 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.764 1.226 . . . . 0.0 111.62 170.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.521 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -140.5 158.38 44.09 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.926 1.29 . . . . 0.0 111.466 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -80.05 165.13 22.84 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.15 0.58 . . . . 0.0 111.834 -174.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -53.11 -33.96 54.54 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.602 1.161 . . . . 0.0 112.857 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -67.26 -8.44 31.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.937 1.295 . . . . 0.0 113.556 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.61 -6.69 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.586 1.154 . . . . 0.0 111.306 -172.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 79.5 t -52.12 -60.91 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 O-C-N 120.404 -1.435 . . . . 0.0 112.231 -176.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -69.0 -27.01 65.31 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.47 -52.79 59.89 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.477 1.511 . . . . 0.0 110.856 175.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -60.96 -46.65 89.84 Favored 'General case' 0 C--O 1.227 -0.093 0 C-N-CA 125.041 1.336 . . . . 0.0 110.484 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.74 -35.48 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.232 0.613 . . . . 0.0 111.461 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.5 ttmt -63.07 -54.69 34.04 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.416 1.086 . . . . 0.0 112.215 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -70.25 -12.24 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 121.551 -0.718 . . . . 0.0 112.419 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.56 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -94.44 -4.63 47.93 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.745 2.018 . . . . 0.0 112.186 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.404 HG23 HD23 ' A' ' 170' ' ' LEU . 34.3 p -126.39 -15.0 5.76 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 169.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -130.75 -10.55 3.93 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.942 1.297 . . . . 0.0 114.257 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.64 155.93 7.78 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.241 1.4 . . . . 0.0 113.698 -174.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.8 -170.51 32.49 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.032 0.825 . . . . 0.0 114.064 -174.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 57.4 p -143.44 109.4 5.25 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.927 1.291 . . . . 0.0 113.529 -168.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -138.05 148.45 45.1 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.364 1.866 . . . . 0.0 109.825 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 155.65 35.1 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.691 -0.63 . . . . 0.0 110.913 177.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 58.9 p -117.85 158.25 25.17 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.921 1.688 . . . . 0.0 110.958 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.521 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 60.0 p -74.35 -39.96 62.44 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.576 -0.703 . . . . 0.0 111.121 -177.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.3 mt -151.11 143.19 24.0 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.631 1.973 . . . . 0.0 111.919 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -138.22 98.52 3.64 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.885 0.874 . . . . 0.0 111.583 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -86.55 -40.12 15.54 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.67 178.26 7.65 Favored Glycine 0 CA--C 1.546 1.971 0 C-N-CA 124.378 0.989 . . . . 0.0 114.339 -169.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -63.7 168.05 5.26 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.78 1.232 . . . . 0.0 112.546 169.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -59.29 -21.48 59.74 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -64.45 -24.82 67.75 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 171.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -69.74 141.15 53.51 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.879 1.671 . . . . 0.0 111.862 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -69.61 -32.6 71.42 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 58.5 m -92.23 2.6 56.51 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.47 -24.86 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 120.501 1.5 . . . . 0.0 114.605 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.7 mt -64.49 -37.85 81.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.636 1.174 . . . . 0.0 112.27 -178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -134.58 -12.58 2.33 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -173.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.03 177.02 35.61 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.975 1.274 . . . . 0.0 113.199 -170.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 62.5 mt -126.59 110.79 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.502 1.521 . . . . 0.0 108.149 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -69.7 145.27 52.46 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.305 0.574 . . . . 0.0 111.419 174.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 60.07 19.85 9.05 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.773 1.629 . . . . 0.0 114.466 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -54.73 124.06 15.24 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.638 1.175 . . . . 0.0 111.735 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -72.44 129.81 39.23 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.214 1.006 . . . . 0.0 110.644 171.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.0 mm -126.82 119.35 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.764 1.225 . . . . 0.0 108.922 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.75 98.32 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.274 1.43 . . . . 0.0 108.679 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 68.5 p -81.92 155.56 25.21 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.709 0.804 . . . . 0.0 112.125 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -151.39 140.05 20.71 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.098 1.359 . . . . 0.0 111.182 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 46.1 mt -79.95 133.06 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 175.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -140.34 122.94 16.22 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.188 1.395 . . . . 0.0 110.953 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -74.37 111.02 9.14 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.244 1.017 . . . . 0.0 109.971 172.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 22.7 mt -98.45 96.75 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.9 t70 61.32 17.4 8.25 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.492 1.917 . . . . 0.0 115.641 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.89 -24.03 8.52 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.539 1.066 . . . . 0.0 113.865 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 85.5 m -82.99 127.15 33.29 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.248 1.024 . . . . 0.0 109.261 171.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -73.61 123.54 24.21 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.585 -0.697 . . . . 0.0 110.091 173.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -113.25 169.12 9.17 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.281 1.432 . . . . 0.0 109.91 169.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.9 tp -120.77 133.66 66.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 125.06 1.344 . . . . 0.0 108.519 169.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.1 p -121.8 155.08 36.08 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.596 0.758 . . . . 0.0 110.214 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -147.14 145.02 29.42 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.598 0.759 . . . . 0.0 112.246 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.3 p -74.91 108.71 7.82 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.982 1.313 . . . . 0.0 111.49 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.77 -162.35 33.47 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 123.83 0.729 . . . . 0.0 113.535 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -69.6 173.78 5.71 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 121.673 -0.898 . . . . 0.0 110.029 167.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -84.17 137.77 33.34 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 120.659 -1.276 . . . . 0.0 111.661 173.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.26 160.11 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.174 0.589 . . . . 0.0 111.74 169.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -90.63 -32.6 16.17 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.915 0.886 . . . . 0.0 111.837 169.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -60.76 -16.57 41.64 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.45 1.9 . . . . 0.0 114.775 -177.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.13 2.61 10.41 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.436 1.494 . . . . 0.0 113.458 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 107.87 -85.41 0.41 Allowed Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.929 1.728 . . . . 0.0 113.037 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -144.31 33.92 1.2 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.578 1.951 . . . . 0.0 110.408 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -97.45 155.07 17.09 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.853 1.261 . . . . 0.0 108.968 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.1 m -89.42 141.0 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 122.53 0.332 . . . . 0.0 110.141 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -72.94 88.94 1.38 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.352 0.661 . . . . 0.0 109.763 173.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -76.64 147.39 37.56 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 122.113 0.959 . . . . 0.0 110.675 168.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -131.83 172.93 11.7 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 125.902 1.681 . . . . 0.0 111.013 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.34 131.72 18.59 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.324 0.65 . . . . 0.0 110.232 175.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 68.9 mt -123.6 140.76 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.185 0.994 . . . . 0.0 109.021 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.3 m -63.88 97.4 0.16 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.22 1.008 . . . . 0.0 109.865 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.6 tt -54.19 -32.43 55.62 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.218 1.007 . . . . 0.0 111.571 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.18 -28.12 69.17 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -85.88 -33.27 21.29 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.35 0.977 . . . . 0.0 112.923 173.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.56 HD13 ' HG3' ' A' ' 100' ' ' MET . 44.8 mt -58.45 -47.47 83.9 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.261 1.024 . . . . 0.0 110.19 175.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -53.93 -23.61 13.48 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 175.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -80.73 -16.1 54.75 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.672 1.189 . . . . 0.0 114.163 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -126.85 1.79 6.66 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.961 1.304 . . . . 0.0 113.554 -174.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.404 HD23 HG23 ' A' ' 101' ' ' THR . 3.5 mp -102.49 -17.94 15.55 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.986 1.715 . . . . 0.0 112.022 -176.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm . . . . . 0 C--O 1.253 1.264 0 C-N-CA 125.672 1.589 . . . . 0.0 112.477 169.52 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt . . . . . 0 N--CA 1.498 1.944 0 N-CA-C 110.732 -0.099 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.19 162.42 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.661 1.185 . . . . 0.0 112.298 174.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -143.84 143.93 31.54 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.752 1.221 . . . . 0.0 111.253 171.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 m -146.54 144.08 29.35 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.908 1.683 . . . . 0.0 109.56 176.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.1 p -148.94 140.28 23.25 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.268 1.027 . . . . 0.0 112.218 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -160.1 143.36 13.85 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.609 1.564 . . . . 0.0 110.769 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -149.69 161.99 41.12 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.521 1.928 . . . . 0.0 110.034 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -120.39 141.52 50.03 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.794 1.238 . . . . 0.0 110.767 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -150.95 151.74 32.56 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.262 1.025 . . . . 0.0 112.17 -174.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.3 p -72.44 2.45 6.23 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.397 1.879 . . . . 0.0 115.14 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 t -66.98 -175.4 0.42 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.386 1.474 . . . . 0.0 112.72 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -52.28 -21.01 7.64 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 125.844 1.688 . . . . 0.0 115.796 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -63.74 -14.85 56.16 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 172.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 63.2 m -64.44 148.79 49.79 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.116 0.966 . . . . 0.0 112.785 170.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.94 160.08 24.76 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.582 1.153 . . . . 0.0 110.862 174.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 t -141.14 128.88 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 125.243 1.417 . . . . 0.0 109.369 -172.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -122.55 -169.27 1.88 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.23 1.412 . . . . 0.0 112.64 -169.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 30.1 mttp -62.19 128.56 36.69 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.668 1.587 . . . . 0.0 109.923 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mm -105.64 151.82 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.367 1.067 . . . . 0.0 109.806 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -73.77 -8.52 56.36 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 177.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -82.92 -168.39 2.04 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.517 1.927 . . . . 0.0 113.136 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.6 m -64.32 -31.7 73.01 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.297 1.839 . . . . 0.0 113.011 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -85.62 160.38 19.62 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.419 1.088 . . . . 0.0 111.964 173.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -143.25 170.3 16.02 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 126.061 1.744 . . . . 0.0 110.664 169.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.29 134.26 34.1 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.668 -0.645 . . . . 0.0 110.435 -177.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.1 m -130.16 163.54 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.237 1.415 . . . . 0.0 111.321 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -60.35 156.35 15.97 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.969 0.908 . . . . 0.0 111.649 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 5.3 tp -151.3 135.09 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.695 1.198 . . . . 0.0 109.282 172.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -126.59 156.81 40.31 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.43 1.892 . . . . 0.0 108.777 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -126.03 155.09 42.05 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.67 1.188 . . . . 0.0 111.196 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -80.12 118.49 21.87 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 168.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.4 p30 -67.43 178.04 1.71 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 122.326 1.06 . . . . 0.0 113.119 170.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -17.19 50.63 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.923 1.289 . . . . 0.0 113.589 176.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.2 m -95.73 1.78 53.56 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.61 1.164 . . . . 0.0 112.508 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.37 21.31 79.06 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-N 119.64 1.109 . . . . 0.0 114.494 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -102.2 137.24 40.72 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.646 1.178 . . . . 0.0 110.822 173.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 68.9 m95 -67.84 123.96 22.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.824 0.849 . . . . 0.0 110.35 170.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.9 t -140.7 143.09 34.85 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.705 1.202 . . . . 0.0 110.453 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -58.18 139.19 55.39 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.2 tp -114.68 -46.76 2.93 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.947 0.899 . . . . 0.0 111.181 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.76 -115.01 0.61 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 122.971 0.32 . . . . 0.0 113.212 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -147.64 153.84 39.87 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.055 1.342 . . . . 0.0 110.148 -174.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.6 tp -121.31 105.02 10.15 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.963 1.305 . . . . 0.0 110.033 -178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.8 t -76.27 94.15 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.923 1.289 . . . . 0.0 109.331 175.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 42.8 t -81.29 99.0 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.897 1.679 . . . . 0.0 109.071 173.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.9 mtt180 -81.85 160.76 23.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.189 1.395 . . . . 0.0 111.015 174.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -116.81 80.99 1.56 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.213 1.005 . . . . 0.0 110.971 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -62.13 171.44 1.79 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 122.722 1.249 . . . . 0.0 113.344 169.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -74.36 -40.3 62.21 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.521 1.129 . . . . 0.0 113.086 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -110.88 42.23 1.65 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.917 1.287 . . . . 0.0 112.41 -171.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 134.88 -156.2 22.38 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.964 1.268 . . . . 0.0 114.808 177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.0 mt -122.22 136.06 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.965 0.906 . . . . 0.0 110.433 173.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -123.61 141.9 51.56 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.838 2.055 . . . . 0.0 111.984 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.5 p -137.19 136.78 38.48 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.217 -0.927 . . . . 0.0 112.341 -175.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.21 127.85 5.82 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.189 0.423 . . . . 0.0 112.79 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.06 135.58 51.02 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.689 1.596 . . . . 0.0 110.22 174.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -138.81 73.8 1.45 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.541 1.537 . . . . 0.0 110.815 -173.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.13 174.5 9.98 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.497 1.519 . . . . 0.0 112.199 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.52 -47.97 67.34 Favored Glycine 0 CA--C 1.536 1.389 0 C-N-CA 123.828 0.727 . . . . 0.0 114.025 -177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -117.06 11.82 14.7 Favored Glycine 0 N--CA 1.473 1.133 0 CA-C-O 119.04 -0.867 . . . . 0.0 114.722 -177.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -156.18 145.65 20.83 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.753 1.276 . . . . 0.0 112.923 -171.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 80.5 p -149.58 147.97 28.79 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 170.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -164.35 162.65 22.37 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.433 1.493 . . . . 0.0 111.674 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 57.2 m -57.86 132.71 54.17 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 121.248 -0.908 . . . . 0.0 109.387 168.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -99.54 -47.49 5.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.737 0.815 . . . . 0.0 110.541 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -166.62 169.25 13.79 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.744 1.218 . . . . 0.0 112.387 171.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.53 138.51 16.36 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.43 1.092 . . . . 0.0 112.347 175.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.511 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -118.73 160.0 22.65 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.649 1.58 . . . . 0.0 111.767 179.063 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -83.12 167.19 18.04 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.388 0.675 . . . . 0.0 112.324 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -57.67 -32.3 67.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.073 0.949 . . . . 0.0 112.666 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -70.11 -3.8 18.34 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.436 1.094 . . . . 0.0 113.849 175.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.0 t -119.79 -3.12 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 124.354 1.062 . . . . 0.0 111.046 -175.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 97' ' ' VAL . 69.5 t -55.57 -61.78 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 120.461 -1.4 . . . . 0.0 111.635 -175.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -68.24 -25.0 64.97 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -54.0 40.51 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.425 1.49 . . . . 0.0 110.584 173.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -61.96 -44.23 97.19 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.35 1.46 . . . . 0.0 111.238 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 93' ' ' VAL . 63.3 t -53.98 -36.72 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.519 1.128 . . . . 0.0 111.003 177.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -70.92 -54.05 12.79 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.848 1.259 . . . . 0.0 112.379 176.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 m -70.84 -21.01 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 O-C-N 120.786 -1.196 . . . . 0.0 112.568 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.599 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -82.8 -5.11 58.79 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.093 1.757 . . . . 0.0 111.703 175.502 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.6 p -129.66 -14.77 4.06 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -136.61 -10.05 1.87 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.186 1.794 . . . . 0.0 113.932 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.42 155.18 10.93 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.722 1.63 . . . . 0.0 113.967 -175.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.64 -170.86 33.03 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.475 1.036 . . . . 0.0 113.641 -174.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 44.1 p -144.03 109.87 5.29 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.748 1.219 . . . . 0.0 113.527 -169.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -138.51 145.88 41.3 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.47 1.908 . . . . 0.0 109.986 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.51 147.15 42.1 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.078 -1.014 . . . . 0.0 111.754 175.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 72.6 p -106.58 168.1 9.4 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.603 1.561 . . . . 0.0 111.443 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.511 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 16.5 p -74.55 -39.63 62.18 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.524 -0.735 . . . . 0.0 111.118 178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.0 mt -155.85 144.2 20.07 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.406 2.282 . . . . 0.0 110.605 -174.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -138.71 105.47 5.37 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.098 0.959 . . . . 0.0 111.263 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -89.42 -40.29 12.82 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 175.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 67.93 179.39 15.88 Favored Glycine 0 CA--C 1.545 1.928 0 C-N-CA 124.977 1.275 . . . . 0.0 114.142 -168.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -57.88 164.86 1.99 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.261 1.024 . . . . 0.0 112.519 169.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -63.47 172.42 2.04 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.23 1.012 . . . . 0.0 113.006 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 67.69 13.93 9.37 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.775 1.63 . . . . 0.0 114.107 -178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.77 167.66 11.5 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.929 2.092 . . . . 0.0 113.272 -177.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -77.02 -23.7 52.16 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 174.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.1 m -118.92 -1.36 11.02 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -172.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.65 -13.94 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 173.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 75.5 mt -60.62 -47.27 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.166 1.386 . . . . 0.0 111.787 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -142.63 -5.26 0.93 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.89 1.276 . . . . 0.0 114.414 -176.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 93.04 -169.52 30.93 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.456 1.503 . . . . 0.0 113.024 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 35.2 mt -133.04 108.48 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 125.712 1.605 . . . . 0.0 107.17 172.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -68.74 145.86 53.44 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.069 0.462 . . . . 0.0 111.201 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 59.09 25.02 13.39 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.639 1.575 . . . . 0.0 114.262 176.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -66.52 130.55 43.55 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.022 1.329 . . . . 0.0 112.108 -172.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -78.75 117.97 20.37 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.972 0.909 . . . . 0.0 112.333 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 28.5 mm -108.69 118.73 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 124.063 0.945 . . . . 0.0 109.66 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 mp -109.98 98.51 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 125.212 1.405 . . . . 0.0 108.816 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 65.8 p -80.31 157.79 26.29 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.174 174.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -154.35 142.17 20.05 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.178 1.391 . . . . 0.0 111.744 172.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.7 mt -80.86 133.32 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.652 0.781 . . . . 0.0 109.222 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -149.95 143.18 25.06 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.604 1.562 . . . . 0.0 110.046 171.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -82.19 158.38 23.61 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.23 -0.919 . . . . 0.0 109.801 169.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 40.5 mt -126.93 -46.61 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.814 0.846 . . . . 0.0 111.029 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -145.19 15.6 1.5 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 -178.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 123.22 -25.11 6.42 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 124.372 0.987 . . . . 0.0 113.666 -177.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 60.8 m -86.74 142.54 28.08 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.213 1.005 . . . . 0.0 108.941 170.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -75.49 125.14 28.41 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.278 0.561 . . . . 0.0 109.855 170.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -110.27 168.95 9.06 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.283 1.433 . . . . 0.0 110.526 173.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.2 tp -124.97 133.44 69.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 125.498 1.519 . . . . 0.0 108.474 172.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.4 p -120.55 156.99 30.43 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.547 0.739 . . . . 0.0 109.949 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -149.02 136.91 20.61 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.695 0.798 . . . . 0.0 111.626 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.6 m -75.15 107.43 7.23 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.787 1.235 . . . . 0.0 110.896 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.61 -164.24 39.54 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.554 1.073 . . . . 0.0 114.32 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -63.63 160.97 15.69 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.912 0.885 . . . . 0.0 111.475 170.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -76.86 131.95 38.88 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.187 -0.946 . . . . 0.0 110.331 172.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.436 HD11 ' HB3' ' A' ' 152' ' ' SER . 0.2 OUTLIER -87.25 159.23 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 124.242 1.017 . . . . 0.0 111.294 173.352 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -92.53 -28.34 16.84 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.836 0.854 . . . . 0.0 112.542 172.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -67.21 -6.42 18.03 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.28 1.432 . . . . 0.0 114.569 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.436 ' HB3' HD11 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -128.42 -14.15 4.79 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 -179.491 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 120.55 -84.35 0.37 Allowed Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.312 1.434 . . . . 0.0 113.183 172.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -137.55 24.41 2.91 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.203 1.801 . . . . 0.0 111.174 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -89.88 165.41 14.12 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.645 1.178 . . . . 0.0 109.502 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.6 m -101.55 143.18 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.289 0.635 . . . . 0.0 111.14 176.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -67.24 93.76 0.33 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.618 1.167 . . . . 0.0 109.852 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -99.99 144.92 28.48 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 122.413 1.101 . . . . 0.0 111.462 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -137.63 174.26 10.78 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 125.751 1.62 . . . . 0.0 111.211 -172.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.31 133.22 20.17 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.479 0.712 . . . . 0.0 110.127 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.43 ' CG2' HD11 ' A' ' 166' ' ' LEU . 64.3 mt -125.21 140.83 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.153 0.981 . . . . 0.0 108.889 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.0 m -66.17 95.37 0.29 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.041 0.936 . . . . 0.0 109.511 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.54 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.1 tt -54.75 -31.87 59.15 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.738 1.215 . . . . 0.0 111.86 177.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -70.3 -26.29 63.72 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -89.31 -26.72 20.97 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.833 0.853 . . . . 0.0 112.439 174.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.599 HD13 ' HG3' ' A' ' 100' ' ' MET . 23.6 mt -61.55 -48.59 80.29 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.057 0.943 . . . . 0.0 110.759 169.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -51.85 -37.61 52.75 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.365 1.066 . . . . 0.0 113.636 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -73.11 -11.49 60.56 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -127.1 -3.63 6.33 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.2 1.4 . . . . 0.0 114.241 -175.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 26.0 mt -92.81 -21.79 19.7 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.872 1.269 . . . . 0.0 112.303 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 C--O 1.254 1.314 0 C-N-CA 126.258 1.823 . . . . 0.0 112.93 174.522 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 119.551 -0.261 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.6 pt -123.05 -8.95 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -127.53 57.63 1.5 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.27 1.428 . . . . 0.0 109.657 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.2 t -56.12 146.57 22.65 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.502 0.721 . . . . 0.0 111.695 172.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.0 p -117.31 -24.26 7.5 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.357 1.463 . . . . 0.0 112.747 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -81.33 150.33 28.51 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.951 1.3 . . . . 0.0 111.223 169.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -151.78 127.83 10.42 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.183 1.393 . . . . 0.0 110.386 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 48.57 36.64 7.83 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.604 1.562 . . . . 0.0 113.516 -174.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.99 116.06 23.65 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.919 1.688 . . . . 0.0 108.837 -177.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.7 t -134.62 148.8 50.48 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.327 1.451 . . . . 0.0 110.543 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.0 t -128.48 104.74 7.86 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.564 1.146 . . . . 0.0 110.966 -172.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.86 165.01 33.76 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.852 1.691 . . . . 0.0 111.648 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -124.02 160.2 28.17 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.835 1.254 . . . . 0.0 110.681 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.7 m -140.97 164.32 30.57 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.399 1.48 . . . . 0.0 111.049 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -109.8 145.56 36.48 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.383 1.473 . . . . 0.0 110.725 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.4 t -135.8 120.54 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.043 1.337 . . . . 0.0 108.796 -174.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.12 164.54 34.4 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.765 1.626 . . . . 0.0 111.676 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -137.95 114.75 10.64 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.615 1.566 . . . . 0.0 110.002 174.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.452 HG22 ' H ' ' A' ' 41' ' ' PHE . 3.0 mp -117.02 131.9 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.772 1.629 . . . . 0.0 108.908 177.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -74.5 -8.49 56.48 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.452 ' H ' HG22 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -58.84 -15.4 12.33 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -178.285 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.5 m -67.72 -10.29 51.18 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.239 1.416 . . . . 0.0 113.322 171.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -134.38 166.94 21.68 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.794 1.638 . . . . 0.0 110.257 169.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -149.15 164.48 34.62 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.168 0.987 . . . . 0.0 110.261 170.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.74 123.49 25.0 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.566 0.222 . . . . 0.0 110.658 -178.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.5 m -120.53 161.75 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.2 1.4 . . . . 0.0 111.186 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -62.14 160.36 12.94 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.793 1.237 . . . . 0.0 111.303 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.3 tp -155.96 138.21 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.576 1.15 . . . . 0.0 109.339 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -130.98 161.94 30.85 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.221 1.808 . . . . 0.0 109.729 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -134.2 159.23 41.54 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.147 1.379 . . . . 0.0 111.704 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.17 119.62 25.76 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.283 0.633 . . . . 0.0 110.535 174.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -73.7 179.94 3.92 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.238 0.615 . . . . 0.0 112.41 174.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -58.05 -24.44 58.44 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.892 1.677 . . . . 0.0 113.435 173.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.9 m -78.93 -5.49 53.86 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.848 1.259 . . . . 0.0 113.806 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.42 32.84 84.81 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.289 0.947 . . . . 0.0 113.704 -171.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -116.64 141.98 47.49 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.792 1.637 . . . . 0.0 109.854 177.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -69.85 133.21 47.13 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.758 0.823 . . . . 0.0 111.26 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.3 t -145.54 142.98 29.67 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.931 1.293 . . . . 0.0 110.537 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -56.98 135.89 56.22 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.284 1.034 . . . . 0.0 112.415 -174.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 55.1 tp -109.12 -47.76 3.37 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.591 0.756 . . . . 0.0 111.731 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.24 -130.39 2.05 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 121.712 0.618 . . . . 0.0 113.713 -175.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -137.06 152.6 50.24 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.528 1.931 . . . . 0.0 110.8 177.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.5 tp -119.79 104.61 10.37 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.427 1.491 . . . . 0.0 110.806 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.43 99.86 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.388 1.075 . . . . 0.0 109.544 175.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.2 t -85.11 128.06 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.161 1.385 . . . . 0.0 109.633 173.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -119.39 118.42 31.13 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 127.193 2.197 . . . . 0.0 110.137 -175.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -85.54 103.76 14.69 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.15 1.38 . . . . 0.0 109.861 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -105.26 171.91 7.07 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.697 1.199 . . . . 0.0 111.694 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -76.19 -15.65 60.01 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 120.825 -1.172 . . . . 0.0 113.664 176.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -119.1 45.69 2.04 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.6 1.96 . . . . 0.0 112.053 -175.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.24 -165.39 20.58 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.002 1.286 . . . . 0.0 113.882 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 53.4 mt -112.45 139.55 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.709 0.804 . . . . 0.0 109.116 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -127.2 139.76 52.71 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.822 0.849 . . . . 0.0 110.094 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.1 p -132.09 137.27 47.68 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.59 0.756 . . . . 0.0 111.025 -173.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.29 110.48 0.83 Allowed Glycine 0 CA--C 1.52 0.387 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -170.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 32.0 tp -64.0 148.11 50.45 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.979 1.312 . . . . 0.0 110.345 175.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -138.35 76.99 1.6 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.044 1.738 . . . . 0.0 109.603 176.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.87 77.61 9.87 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.349 1.059 . . . . 0.0 112.338 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.42 -73.9 2.15 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.682 1.611 . . . . 0.0 113.796 174.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -137.89 18.7 3.35 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.967 1.746 . . . . 0.0 113.194 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -138.4 71.92 1.4 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.247 1.419 . . . . 0.0 110.933 -172.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.9 p -75.14 150.7 38.68 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 175.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.68 156.79 20.95 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.751 1.62 . . . . 0.0 111.401 176.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.9 m -58.74 116.45 3.74 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.33 -0.856 . . . . 0.0 109.144 169.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -81.99 -52.29 7.19 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.624 0.647 . . . . 0.0 109.841 -178.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -166.19 162.44 17.55 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.94 1.296 . . . . 0.0 112.383 170.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.58 156.81 44.7 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.956 1.303 . . . . 0.0 111.399 177.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.535 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -140.97 157.93 44.65 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.104 1.362 . . . . 0.0 112.282 -177.36 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -77.09 165.34 24.72 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.535 0.734 . . . . 0.0 112.021 -173.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -57.47 -30.0 64.69 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.318 -0.864 . . . . 0.0 112.357 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -69.98 -8.31 47.98 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.549 1.54 . . . . 0.0 114.027 175.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 t -119.26 -4.38 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.777 1.231 . . . . 0.0 111.3 -173.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 53.3 t -50.31 -66.47 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 125.169 1.388 . . . . 0.0 111.663 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -67.69 -24.42 65.41 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.38 -51.96 63.66 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.104 1.362 . . . . 0.0 110.511 173.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -60.17 -44.13 95.29 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 124.84 1.256 . . . . 0.0 111.926 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.543 HG22 HD22 ' A' ' 170' ' ' LEU . 92.4 t -55.58 -36.25 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 122.967 0.507 . . . . 0.0 110.855 178.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.7 tttp -68.29 -54.94 14.04 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.534 1.133 . . . . 0.0 112.678 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -72.7 -14.6 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 121.063 -1.023 . . . . 0.0 112.518 -174.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.505 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -88.07 -6.41 57.95 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.544 1.537 . . . . 0.0 112.081 176.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 44.4 p -130.5 -14.89 3.65 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -131.74 -9.57 3.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.612 1.565 . . . . 0.0 113.849 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.4 156.5 7.95 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.473 1.511 . . . . 0.0 113.683 -176.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 158.1 -169.04 34.69 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 123.993 0.806 . . . . 0.0 113.966 -175.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 61.6 p -146.32 94.72 2.5 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.389 1.075 . . . . 0.0 113.488 -167.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -128.49 140.14 51.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.667 1.587 . . . . 0.0 109.885 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -69.45 153.17 43.95 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.454 0.701 . . . . 0.0 110.947 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.8 p -115.11 160.86 19.15 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.76 1.624 . . . . 0.0 110.942 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.535 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 82.4 p -76.38 -39.17 54.43 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.391 -0.818 . . . . 0.0 111.019 -177.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.3 mt -153.45 138.71 17.49 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.37 1.868 . . . . 0.0 111.694 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -137.45 101.6 4.55 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.246 1.018 . . . . 0.0 111.005 176.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -91.72 -36.87 13.35 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 174.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.42 -176.13 48.18 Favored Glycine 0 CA--C 1.544 1.86 0 CA-C-N 118.936 0.789 . . . . 0.0 113.902 -170.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -58.12 -76.24 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -179.71 171.77 1.16 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 128.666 2.786 . . . . 0.0 109.211 -171.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 55.6 38.1 29.74 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 122.494 1.14 . . . . 0.0 112.213 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -130.52 147.9 52.26 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.209 1.804 . . . . 0.0 110.226 -168.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -67.23 -11.1 56.54 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -172.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 10.6 m -132.15 7.47 4.29 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -177.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 10.0 p -68.91 -14.01 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.253 -1.53 . . . . 0.0 114.253 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 66.6 mt -84.96 -38.67 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.458 1.103 . . . . 0.0 111.674 -177.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -123.7 -10.51 7.81 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.833 1.253 . . . . 0.0 113.684 -173.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.95 -178.49 43.27 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 125.087 1.327 . . . . 0.0 113.649 -176.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 44.6 mt -133.47 103.24 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.31 1.444 . . . . 0.0 107.651 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -67.01 143.58 56.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.189 0.518 . . . . 0.0 110.834 173.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 61.82 19.33 10.51 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.468 1.507 . . . . 0.0 114.381 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 16.4 tptp -53.62 123.88 13.48 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.893 1.277 . . . . 0.0 111.456 -177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -70.86 127.48 32.76 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.952 0.901 . . . . 0.0 110.388 170.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.7 mm -124.88 116.53 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 124.386 1.075 . . . . 0.0 108.48 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.8 mp -110.31 92.42 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.006 1.322 . . . . 0.0 108.379 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.1 p -75.03 154.91 37.78 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.123 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -150.68 139.38 20.71 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.948 1.299 . . . . 0.0 111.135 174.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.4 mt -81.93 132.85 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 175.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -140.45 122.45 15.61 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.273 1.429 . . . . 0.0 110.126 174.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -72.67 119.27 16.66 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 169.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.3 mt -105.37 97.09 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 175.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 61.15 11.4 3.46 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.603 1.961 . . . . 0.0 115.793 -176.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 132.84 -36.29 2.18 Favored Glycine 0 N--CA 1.473 1.117 0 C-N-CA 124.746 1.165 . . . . 0.0 113.31 176.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 88.3 m -71.85 126.74 30.52 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.472 1.109 . . . . 0.0 109.445 172.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -73.63 116.88 14.73 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.164 0.585 . . . . 0.0 109.848 173.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -106.38 166.15 10.75 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.271 1.428 . . . . 0.0 110.607 170.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.8 tp -118.66 138.19 50.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 125.525 1.53 . . . . 0.0 108.207 169.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.1 p -127.34 156.82 41.39 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.619 0.767 . . . . 0.0 109.933 174.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -150.79 146.14 26.19 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.13 0.972 . . . . 0.0 111.235 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 p -78.71 109.56 13.06 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.735 1.214 . . . . 0.0 111.402 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.43 -165.23 32.23 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 123.897 0.761 . . . . 0.0 113.204 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -65.33 164.3 13.85 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 122.254 1.026 . . . . 0.0 112.481 170.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -84.34 106.06 15.66 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.159 1.383 . . . . 0.0 111.172 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.89 157.38 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.413 0.625 . . . . 0.0 112.093 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -88.23 -33.07 18.24 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.215 1.006 . . . . 0.0 112.25 174.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -64.31 -42.29 96.41 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.5 -22.45 35.09 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 131.89 -80.24 0.34 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.484 1.516 . . . . 0.0 112.699 172.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -140.29 18.22 2.41 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.297 1.839 . . . . 0.0 111.424 178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -79.92 -175.33 4.88 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.082 0.953 . . . . 0.0 109.674 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.9 m -117.91 142.83 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.892 0.877 . . . . 0.0 110.863 175.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.25 94.94 0.55 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.432 0.693 . . . . 0.0 109.442 172.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -92.31 145.45 24.47 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 122.164 0.983 . . . . 0.0 111.288 174.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -136.25 169.99 16.75 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.739 1.616 . . . . 0.0 111.112 -172.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.86 134.6 23.53 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 122.97 0.508 . . . . 0.0 110.495 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.466 ' CG2' HD11 ' A' ' 166' ' ' LEU . 59.7 mt -126.75 139.19 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.807 0.843 . . . . 0.0 109.263 175.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.5 m -63.09 96.9 0.1 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.232 1.013 . . . . 0.0 109.791 175.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.553 ' HA ' HD12 ' A' ' 166' ' ' LEU . 0.8 OUTLIER -55.35 -31.39 61.71 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.471 1.109 . . . . 0.0 111.884 177.067 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -67.86 -29.43 68.56 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 176.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -88.41 -18.88 27.39 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.036 0.934 . . . . 0.0 112.64 174.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.553 HD12 ' HA ' ' A' ' 163' ' ' LEU . 20.0 mt -70.92 -46.38 62.59 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.476 -0.765 . . . . 0.0 110.173 168.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -49.43 -48.26 47.46 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.851 1.26 . . . . 0.0 113.538 -179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 30.6 pttt -62.06 -29.74 70.51 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -93.74 -18.36 22.17 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.177 1.391 . . . . 0.0 112.492 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.543 HD22 HG22 ' A' ' 97' ' ' VAL . 14.4 mt -89.4 -30.66 18.2 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.221 1.409 . . . . 0.0 112.828 -177.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt . . . . . 0 C--O 1.253 1.289 0 C-N-CA 126.986 2.114 . . . . 0.0 113.428 169.978 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.2 mttp . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 120.443 0.163 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.8 mt -98.58 126.62 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.652 1.181 . . . . 0.0 109.153 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -155.51 154.18 31.4 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.012 1.325 . . . . 0.0 110.846 173.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.3 p -143.9 136.47 27.02 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.902 1.281 . . . . 0.0 111.668 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.3 m -65.89 161.0 22.1 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.167 0.987 . . . . 0.0 112.664 172.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -149.01 179.98 7.46 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.851 1.66 . . . . 0.0 111.28 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -127.93 147.23 50.47 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.839 1.256 . . . . 0.0 112.033 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -152.85 136.65 16.18 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.821 1.249 . . . . 0.0 110.681 -174.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -70.07 141.64 52.78 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.523 0.729 . . . . 0.0 111.61 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.2 t -150.42 90.81 1.68 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.552 1.141 . . . . 0.0 111.21 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.8 p -86.25 175.19 8.61 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.484 1.514 . . . . 0.0 112.585 174.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.76 110.66 0.46 Allowed Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.366 0.984 . . . . 0.0 112.644 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -68.98 138.59 54.67 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.199 0.999 . . . . 0.0 111.453 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.3 t 52.11 26.88 4.11 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.683 1.593 . . . . 0.0 114.968 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt -93.43 25.63 3.34 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.461 1.504 . . . . 0.0 113.533 -174.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.7 t -84.45 82.7 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.985 1.314 . . . . 0.0 110.209 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -141.62 163.65 32.35 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.931 1.693 . . . . 0.0 111.326 174.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -69.13 129.81 40.93 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.562 0.745 . . . . 0.0 109.609 168.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.1 mm -109.7 143.26 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.87 1.268 . . . . 0.0 109.01 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.2 -8.17 43.25 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -53.65 -16.64 1.7 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 127.045 2.138 . . . . 0.0 115.477 -175.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.0 t -61.38 -22.9 65.38 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.721 1.609 . . . . 0.0 113.82 170.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -145.35 162.32 37.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.253 1.021 . . . . 0.0 112.582 174.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -154.74 170.69 21.01 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.471 1.109 . . . . 0.0 111.931 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.87 134.08 44.13 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.217 0.607 . . . . 0.0 111.261 174.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.9 m -131.13 164.19 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 125.793 1.637 . . . . 0.0 111.33 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.22 160.41 13.06 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.626 1.17 . . . . 0.0 112.111 177.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 tp -155.29 137.0 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.321 1.448 . . . . 0.0 109.963 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -127.33 159.76 33.42 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.607 1.963 . . . . 0.0 109.547 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -128.88 159.69 35.01 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.79 1.236 . . . . 0.0 111.493 176.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -87.47 118.21 26.78 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.459 0.304 . . . . 0.0 110.868 173.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -69.52 178.08 2.64 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.958 0.885 . . . . 0.0 112.712 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.8 mmtt -60.25 -22.65 63.31 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.158 1.783 . . . . 0.0 115.035 176.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.8 t -85.52 -4.87 59.29 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.95 0.9 . . . . 0.0 112.608 174.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.4 32.35 57.99 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 121.108 -0.995 . . . . 0.0 113.299 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -109.6 142.04 41.27 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.964 1.306 . . . . 0.0 110.72 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -76.14 122.06 23.76 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.594 0.758 . . . . 0.0 110.937 176.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.5 t -137.43 139.39 40.64 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.135 1.374 . . . . 0.0 110.32 -175.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -57.63 141.24 48.91 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -176.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.1 tp -114.56 -47.74 2.89 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.659 0.783 . . . . 0.0 111.023 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.92 -116.27 0.64 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 123.378 0.514 . . . . 0.0 113.044 179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -146.33 156.25 43.21 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.693 1.597 . . . . 0.0 109.729 -176.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.8 tp -121.16 102.27 8.2 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.153 1.381 . . . . 0.0 110.29 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.9 t -74.82 101.19 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.083 0.953 . . . . 0.0 109.02 171.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.9 t -88.35 127.07 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.274 1.43 . . . . 0.0 109.803 172.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.7 mtp180 -126.49 133.76 51.1 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.697 2.399 . . . . 0.0 110.928 -175.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.8 91.35 7.9 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.933 1.293 . . . . 0.0 109.766 176.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -73.06 174.45 7.89 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.721 1.208 . . . . 0.0 112.11 175.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -64.53 -31.61 72.9 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 120.14 -1.6 . . . . 0.0 114.017 -176.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -130.05 48.35 2.4 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.436 1.495 . . . . 0.0 112.515 -173.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 132.47 -164.0 23.98 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.727 1.632 . . . . 0.0 115.096 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 69.1 mt -113.37 142.17 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.345 1.058 . . . . 0.0 109.922 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -131.77 139.6 48.98 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.211 1.805 . . . . 0.0 109.315 -177.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.8 p -131.74 146.53 52.21 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.318 -0.864 . . . . 0.0 111.549 -171.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.45 124.0 2.41 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-O 121.699 0.61 . . . . 0.0 113.088 -177.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.72 136.18 52.47 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.434 1.894 . . . . 0.0 110.189 175.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -134.15 75.36 1.59 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.367 1.867 . . . . 0.0 110.475 -175.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.4 173.09 8.92 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.106 1.362 . . . . 0.0 112.075 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.68 94.44 0.04 OUTLIER Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.43 1.491 . . . . 0.0 113.648 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.63 17.2 79.04 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.855 1.216 . . . . 0.0 115.146 -177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -149.53 114.14 5.3 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 119.134 1.467 . . . . 0.0 111.471 -176.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.1 m -141.83 136.27 30.44 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -173.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.73 165.49 25.51 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.354 1.461 . . . . 0.0 112.278 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 24.2 m -55.02 135.04 49.25 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.279 -0.888 . . . . 0.0 110.468 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -102.89 -52.6 3.03 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.796 1.238 . . . . 0.0 109.89 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -163.07 162.66 25.91 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.824 0.85 . . . . 0.0 112.65 170.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.25 141.31 27.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.718 0.807 . . . . 0.0 111.538 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.557 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.8 OUTLIER -121.38 156.72 32.04 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.365 1.866 . . . . 0.0 111.501 -176.305 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -75.79 163.46 27.23 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.578 0.704 . . . . 0.0 112.608 -176.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -54.93 -28.03 47.91 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.038 1.335 . . . . 0.0 113.596 171.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -72.01 -15.65 62.05 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 121.104 -0.998 . . . . 0.0 113.251 173.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.6 t -106.32 -5.25 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.744 1.217 . . . . 0.0 110.671 -171.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.5 m -53.8 -35.03 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 -176.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -96.79 -23.33 16.45 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.677 0.791 . . . . 0.0 112.307 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -68.69 -48.87 62.8 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.623 1.569 . . . . 0.0 111.318 177.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -60.71 -43.28 97.99 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 125.271 1.428 . . . . 0.0 111.338 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.7 t -53.69 -42.76 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.247 1.019 . . . . 0.0 109.914 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -60.84 -56.08 25.38 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.416 1.086 . . . . 0.0 112.313 175.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 m -72.86 -3.34 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 121.02 -1.05 . . . . 0.0 113.456 -177.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.497 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -107.46 -3.83 19.08 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.543 1.937 . . . . 0.0 111.902 179.723 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.7 p -129.81 -13.26 4.18 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.253 1.421 . . . . 0.0 113.29 172.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -134.03 -14.71 2.35 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.076 1.75 . . . . 0.0 114.116 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.16 154.82 11.74 Favored Glycine 0 CA--C 1.539 1.563 0 C-N-CA 124.797 1.189 . . . . 0.0 114.26 -176.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.28 -158.35 30.39 Favored Glycine 0 CA--C 1.533 1.162 0 O-C-N 121.58 -0.953 . . . . 0.0 114.073 -176.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.6 p -151.38 105.02 3.14 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -174.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -136.56 157.97 45.54 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.481 1.913 . . . . 0.0 110.537 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -83.58 161.57 21.12 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.16 -0.963 . . . . 0.0 111.996 176.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.4 p -122.96 158.59 30.12 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.853 1.661 . . . . 0.0 110.225 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.557 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 88.3 p -68.8 -36.49 78.33 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 120.768 -1.207 . . . . 0.0 111.139 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.4 mt -148.49 159.59 43.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.984 2.114 . . . . 0.0 111.604 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -149.93 112.47 4.73 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.475 1.11 . . . . 0.0 110.473 170.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -96.27 -47.58 5.96 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.978 0.911 . . . . 0.0 112.465 174.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.84 178.68 27.21 Favored Glycine 0 CA--C 1.544 1.856 0 C-N-CA 125.757 1.646 . . . . 0.0 113.993 -169.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -62.37 162.44 10.04 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 121.311 -1.111 . . . . 0.0 113.44 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -75.17 52.66 0.59 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.675 1.99 . . . . 0.0 112.972 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -144.67 8.62 1.32 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.712 1.605 . . . . 0.0 112.92 178.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -130.41 175.61 8.82 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.452 -1.405 . . . . 0.0 113.342 -175.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -84.86 -21.42 29.8 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -175.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 40.2 p -75.85 -25.7 56.47 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.34 -20.47 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -171.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 59.9 mt -59.51 -47.24 91.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 125.413 1.485 . . . . 0.0 111.889 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -137.34 -11.19 1.66 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.095 1.358 . . . . 0.0 114.186 -176.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.69 164.65 26.78 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.958 1.742 . . . . 0.0 114.074 -170.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 68.9 mt -112.38 114.61 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.721 1.608 . . . . 0.0 108.319 175.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -70.64 147.64 48.94 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.004 -0.435 . . . . 0.0 111.42 173.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 58.79 22.89 10.6 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.91 1.684 . . . . 0.0 114.465 175.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -65.8 130.7 44.2 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.297 1.439 . . . . 0.0 112.068 -171.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -79.68 122.55 26.69 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.586 1.155 . . . . 0.0 112.723 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 28.5 mm -113.93 117.66 56.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.419 1.088 . . . . 0.0 110.002 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 mp -107.85 101.06 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.228 1.411 . . . . 0.0 107.889 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.5 p -87.08 160.61 18.51 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.585 0.707 . . . . 0.0 111.578 176.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.7 ptpt -152.82 139.78 19.15 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.702 1.201 . . . . 0.0 111.191 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 38.9 mt -78.49 132.14 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 173.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -139.68 124.35 18.35 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.387 1.475 . . . . 0.0 110.088 174.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -73.79 124.67 26.5 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.707 -0.62 . . . . 0.0 109.449 169.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.2 mt -110.23 96.27 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 60.71 11.25 3.04 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.79 2.036 . . . . 0.0 115.947 -175.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 132.56 -35.46 2.33 Favored Glycine 0 N--CA 1.474 1.211 0 C-N-CA 124.977 1.275 . . . . 0.0 113.478 176.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 87.5 m -70.2 126.93 31.09 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.828 1.251 . . . . 0.0 109.424 172.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -75.33 117.01 16.67 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.668 -0.645 . . . . 0.0 109.672 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -106.64 167.29 9.96 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.09 1.356 . . . . 0.0 110.387 170.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.8 tp -118.77 136.92 54.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 125.398 1.479 . . . . 0.0 108.114 169.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.1 p -125.71 159.38 32.45 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.717 0.807 . . . . 0.0 110.151 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -149.81 144.8 26.23 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.965 0.906 . . . . 0.0 111.709 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 46.3 p -82.28 112.48 19.31 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.767 1.227 . . . . 0.0 111.057 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.1 -163.75 38.99 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.286 0.946 . . . . 0.0 113.158 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -72.02 168.92 17.06 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.583 0.706 . . . . 0.0 111.545 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -72.04 131.55 43.03 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 121.12 -0.988 . . . . 0.0 110.939 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -80.86 165.12 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 121.335 0.588 . . . . 0.0 112.295 172.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -102.72 -12.03 17.95 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.08 1.352 . . . . 0.0 114.288 173.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -88.84 11.79 16.95 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.226 1.81 . . . . 0.0 113.3 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.68 170.02 18.43 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.995 1.718 . . . . 0.0 112.358 -175.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -76.1 67.77 2.39 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.827 1.679 . . . . 0.0 114.183 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 57.8 34.47 24.44 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.78 1.632 . . . . 0.0 113.869 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -90.19 167.98 12.3 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.766 1.226 . . . . 0.0 109.794 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.6 m -101.52 145.26 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.651 1.18 . . . . 0.0 111.62 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.1 105.66 2.53 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.654 0.781 . . . . 0.0 109.284 175.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -109.05 144.57 36.89 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 122.087 0.946 . . . . 0.0 111.09 177.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -135.6 168.28 19.55 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.443 1.497 . . . . 0.0 111.536 -171.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.64 132.18 20.97 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.122 0.569 . . . . 0.0 110.004 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.4 ' CG2' HD11 ' A' ' 166' ' ' LEU . 66.3 mt -123.95 140.2 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.82 0.848 . . . . 0.0 108.766 176.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.2 m -65.49 95.43 0.21 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.833 0.853 . . . . 0.0 109.432 176.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.415 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.0 OUTLIER -53.67 -32.64 52.41 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.577 1.151 . . . . 0.0 111.767 176.299 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -67.86 -25.81 65.72 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -86.35 -34.06 20.36 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.584 1.153 . . . . 0.0 112.237 171.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.497 HD13 ' HG3' ' A' ' 100' ' ' MET . 22.7 mt -58.65 -43.47 89.82 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.211 -0.931 . . . . 0.0 111.277 176.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -53.98 -33.0 55.78 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.487 1.115 . . . . 0.0 113.816 174.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -75.48 -8.21 56.15 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.281 1.433 . . . . 0.0 114.205 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -128.83 -3.57 5.22 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.613 1.565 . . . . 0.0 114.301 -174.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 89.6 mt -109.67 1.71 19.71 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.621 1.569 . . . . 0.0 112.436 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt . . . . . 0 C--O 1.253 1.268 0 C-N-CA 128.3 2.64 . . . . 0.0 115.521 174.505 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.8 tttm . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.3 tp -147.3 147.46 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.99 1.316 . . . . 0.0 110.773 177.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -103.0 103.77 13.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.549 1.139 . . . . 0.0 110.213 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.3 p -69.17 163.6 24.53 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.094 0.958 . . . . 0.0 111.993 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.1 t -137.14 -50.78 0.64 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.158 0.983 . . . . 0.0 111.741 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 11.7 t80 47.01 37.18 4.76 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.699 1.599 . . . . 0.0 113.55 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -57.52 135.41 56.63 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.935 1.294 . . . . 0.0 113.262 -175.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -86.54 165.83 15.92 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.268 1.027 . . . . 0.0 112.515 177.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -142.96 165.38 27.52 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.561 1.544 . . . . 0.0 111.834 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 76.4 p -115.85 165.86 12.61 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.847 1.659 . . . . 0.0 111.481 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 43.6 p -128.38 -54.13 1.27 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.017 0.927 . . . . 0.0 113.475 -170.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.49 -167.56 28.58 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.369 0.985 . . . . 0.0 114.198 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -87.8 83.12 7.17 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.201 1.4 . . . . 0.0 111.134 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.4 m -142.78 -174.28 4.12 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.953 1.701 . . . . 0.0 110.99 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -61.06 117.63 5.75 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.22 -0.925 . . . . 0.0 110.15 172.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.95 45.74 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.862 2.065 . . . . 0.0 110.859 -175.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.09 156.07 4.22 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.443 1.097 . . . . 0.0 111.991 174.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -138.07 163.02 32.66 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.62 1.568 . . . . 0.0 111.23 177.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 49.7 mm -57.62 134.32 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.445 1.098 . . . . 0.0 110.44 174.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -130.57 -4.15 4.21 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -62.92 -14.21 44.01 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.118 1.367 . . . . 0.0 114.605 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.2 m -65.69 -12.36 52.94 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.589 1.955 . . . . 0.0 113.863 172.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -150.07 174.93 12.19 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.798 1.639 . . . . 0.0 110.756 175.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -156.4 165.67 35.67 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.913 0.885 . . . . 0.0 110.338 170.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.56 134.33 48.6 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -178.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.2 m -132.06 161.52 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.082 1.353 . . . . 0.0 112.097 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -67.47 141.63 56.89 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.359 1.063 . . . . 0.0 110.268 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 3.2 tp -138.7 135.73 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.33 1.452 . . . . 0.0 108.751 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -128.86 161.56 29.55 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 126.152 1.781 . . . . 0.0 109.38 -178.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -129.96 155.13 46.58 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.017 1.327 . . . . 0.0 111.043 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.7 118.49 22.3 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 169.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.5 p30 -68.21 178.47 1.89 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 122.466 1.127 . . . . 0.0 113.54 171.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -58.18 -11.83 2.99 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.355 1.862 . . . . 0.0 114.846 174.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.9 t -107.57 4.14 25.68 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.236 1.414 . . . . 0.0 112.514 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.69 22.35 78.41 Favored Glycine 0 CA--C 1.535 1.312 0 O-C-N 120.643 -1.286 . . . . 0.0 114.505 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -105.05 138.9 40.54 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.486 1.143 . . . . 0.0 110.932 174.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -69.93 126.42 29.66 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.108 0.963 . . . . 0.0 110.538 173.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.6 t -142.14 143.71 33.13 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.963 1.305 . . . . 0.0 110.324 -177.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -54.65 135.61 46.54 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.726 0.811 . . . . 0.0 113.048 -176.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.0 tp -111.55 -49.88 2.97 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.058 0.943 . . . . 0.0 111.075 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.57 -131.47 2.07 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 121.395 0.442 . . . . 0.0 114.108 -173.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.79 135.29 29.52 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.255 1.422 . . . . 0.0 110.123 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.454 HD11 ' HB ' ' A' ' 74' ' ' THR . 1.2 tm? -106.19 108.66 20.29 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.291 1.436 . . . . 0.0 109.224 -176.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.463 HG12 ' HG3' ' A' ' 66' ' ' ARG . 60.7 t -85.95 96.53 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.797 1.239 . . . . 0.0 109.295 174.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.6 t -71.46 110.18 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.154 0.981 . . . . 0.0 109.286 168.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.463 ' HG3' HG12 ' A' ' 64' ' ' VAL . 66.8 mtp85 -106.43 123.88 48.75 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 127.122 2.169 . . . . 0.0 110.217 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -87.19 86.92 7.32 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.821 0.848 . . . . 0.0 110.785 176.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -64.66 169.25 5.14 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 122.257 1.027 . . . . 0.0 112.835 170.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.76 -36.33 78.66 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.96 1.304 . . . . 0.0 113.732 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -132.75 62.75 1.65 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.675 1.19 . . . . 0.0 112.097 -173.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 133.67 -155.41 21.75 Favored Glycine 0 N--CA 1.467 0.701 0 C-N-CA 124.388 0.994 . . . . 0.0 114.344 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 70.1 mt -128.48 137.21 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.275 1.03 . . . . 0.0 108.919 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.07 146.32 46.04 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.336 1.454 . . . . 0.0 108.879 175.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.454 ' HB ' HD11 ' A' ' 63' ' ' LEU . 75.9 p -132.58 143.25 49.58 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.198 -0.939 . . . . 0.0 110.205 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.77 136.13 8.15 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -92.49 131.55 37.54 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.666 1.987 . . . . 0.0 109.94 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -135.74 75.23 1.54 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.204 1.401 . . . . 0.0 110.459 -174.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.51 169.78 14.71 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.496 1.519 . . . . 0.0 113.116 178.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.98 49.91 2.21 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.856 1.693 . . . . 0.0 114.285 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.83 -6.48 0.45 Allowed Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.48 1.515 . . . . 0.0 115.251 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -153.08 154.03 34.02 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.876 1.338 . . . . 0.0 111.967 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.0 p -154.57 152.13 29.68 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -169.43 160.28 9.15 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.009 1.324 . . . . 0.0 112.611 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 51.9 m -59.48 123.42 16.77 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.403 -0.811 . . . . 0.0 109.039 168.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -87.3 -50.37 6.63 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.866 0.466 . . . . 0.0 110.124 -176.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -166.38 164.2 17.44 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.251 1.02 . . . . 0.0 112.977 172.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 1.4 p -150.32 147.48 27.68 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 122.859 1.314 . . . . 0.0 113.227 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.413 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.5 OUTLIER -133.58 162.69 31.23 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.269 1.428 . . . . 0.0 111.656 -177.042 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -81.93 166.7 19.65 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.582 0.753 . . . . 0.0 112.368 -175.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -55.79 -34.19 65.06 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.07 -1.019 . . . . 0.0 112.423 175.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -67.98 -3.28 9.52 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.461 1.505 . . . . 0.0 113.913 175.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.1 t -122.09 -3.39 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 124.318 1.047 . . . . 0.0 111.567 -177.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 92.2 t -53.22 -65.44 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 O-C-N 120.492 -1.38 . . . . 0.0 110.863 -178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -64.7 -27.74 69.12 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.744 -0.597 . . . . 0.0 112.227 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.33 -53.54 53.55 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.72 1.608 . . . . 0.0 110.359 174.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -62.99 -42.39 99.84 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.475 1.11 . . . . 0.0 111.937 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.527 HG22 HD22 ' A' ' 170' ' ' LEU . 92.7 t -58.5 -37.04 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 122.885 0.474 . . . . 0.0 110.844 176.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -64.71 -55.02 22.58 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.61 1.164 . . . . 0.0 112.784 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.7 -9.6 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 O-C-N 121.577 -0.702 . . . . 0.0 112.28 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.466 ' CG ' HD13 ' A' ' 166' ' ' LEU . 20.8 ttm -95.73 -4.72 43.59 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 120.589 -1.319 . . . . 0.0 112.934 177.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 20.9 p -127.49 -13.1 5.5 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.725 0.81 . . . . 0.0 112.875 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -131.54 -12.11 3.48 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.522 1.529 . . . . 0.0 114.434 177.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.19 155.96 9.85 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.074 1.321 . . . . 0.0 113.662 -175.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 156.21 -168.3 33.55 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.357 0.979 . . . . 0.0 113.556 -175.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 36.0 p -146.51 105.83 3.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.483 1.113 . . . . 0.0 113.463 -168.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -136.32 143.55 44.21 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.162 1.785 . . . . 0.0 110.246 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -74.84 153.05 38.88 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.543 -0.723 . . . . 0.0 111.297 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.4 p -118.87 135.86 54.34 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.327 1.451 . . . . 0.0 110.875 178.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.413 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 6.6 t -48.15 -42.25 29.0 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.103 1.361 . . . . 0.0 113.235 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.4 mt -147.53 145.51 29.11 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.67 1.588 . . . . 0.0 112.769 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -143.89 101.18 3.7 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.272 1.029 . . . . 0.0 110.783 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -91.99 -37.16 12.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.157 0.983 . . . . 0.0 113.298 176.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.75 -176.95 8.42 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.414 1.483 . . . . 0.0 114.824 -172.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -61.7 160.43 11.69 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 174.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -77.86 52.98 1.09 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.25 1.82 . . . . 0.0 112.592 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -145.52 19.89 1.52 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.097 1.759 . . . . 0.0 111.54 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -137.2 171.55 14.32 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 120.831 -1.168 . . . . 0.0 114.08 -173.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -82.52 -23.3 34.65 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.731 0.812 . . . . 0.0 113.07 -175.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.7 m -92.86 -12.86 29.97 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.9 p -60.57 -14.54 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 174.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 83.8 mt -55.06 -53.33 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.814 1.645 . . . . 0.0 111.751 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -140.41 -2.2 1.44 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.405 1.482 . . . . 0.0 113.791 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 81.29 176.61 51.07 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.113 1.34 . . . . 0.0 113.356 -171.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 43.3 mt -121.34 116.22 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.228 1.411 . . . . 0.0 108.078 173.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -68.34 140.56 55.9 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.977 0.418 . . . . 0.0 111.617 170.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 55.41 29.34 12.97 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.878 1.671 . . . . 0.0 114.279 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -59.52 127.75 33.62 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.804 1.242 . . . . 0.0 111.564 -175.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -75.79 119.5 19.87 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.017 0.527 . . . . 0.0 111.336 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.5 mm -112.16 116.82 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.832 1.253 . . . . 0.0 109.08 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.12 97.97 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 124.724 1.21 . . . . 0.0 108.491 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 43.0 p -76.97 159.58 29.84 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.87 174.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -153.3 142.49 21.44 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.791 1.236 . . . . 0.0 111.061 170.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 43.1 mt -83.32 135.03 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.402 0.681 . . . . 0.0 109.245 174.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -141.43 125.59 17.38 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.887 1.275 . . . . 0.0 111.195 174.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -75.38 104.31 5.9 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.359 0.664 . . . . 0.0 110.28 169.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.6 mt -90.88 99.37 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 172.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.7 t0 57.63 24.64 10.73 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.114 1.766 . . . . 0.0 115.536 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 112.5 -25.23 12.44 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.806 1.194 . . . . 0.0 113.703 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 97.7 m -82.41 122.99 28.71 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 118.046 0.923 . . . . 0.0 109.438 172.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -71.38 119.64 15.82 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.65 -0.656 . . . . 0.0 110.42 171.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -108.72 166.3 10.91 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.919 1.688 . . . . 0.0 110.62 170.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.2 tp -116.13 135.04 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.769 1.628 . . . . 0.0 108.043 169.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.1 p -125.31 155.8 39.65 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.547 0.739 . . . . 0.0 109.957 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -146.4 138.37 24.89 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.795 0.838 . . . . 0.0 111.221 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.0 p -75.69 113.38 13.07 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.325 1.05 . . . . 0.0 111.202 176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.17 -156.59 26.5 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.577 1.084 . . . . 0.0 113.014 176.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.26 -174.05 0.34 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.04 0.936 . . . . 0.0 112.991 169.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -100.51 113.98 27.21 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.141 0.976 . . . . 0.0 111.716 169.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.405 HD11 ' HB3' ' A' ' 152' ' ' SER . 0.2 OUTLIER -70.05 160.46 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.074 0.95 . . . . 0.0 112.25 177.015 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -90.13 -34.62 15.8 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 172.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -59.18 -37.92 78.56 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.886 1.274 . . . . 0.0 113.941 -175.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.405 ' HB3' HD11 ' A' ' 149' ' ' ILE . 1.0 OUTLIER -88.39 -31.34 18.91 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -179.683 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 133.53 -79.22 0.34 Allowed Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.161 1.362 . . . . 0.0 112.938 173.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -139.31 22.02 2.57 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 126.922 2.089 . . . . 0.0 110.826 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.49 179.52 6.83 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.257 1.023 . . . . 0.0 109.123 177.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.9 m -115.37 149.77 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 123.238 0.615 . . . . 0.0 111.852 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -73.42 86.85 1.53 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.09 0.556 . . . . 0.0 110.475 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -90.21 145.3 25.12 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.524 1.154 . . . . 0.0 112.057 172.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -138.75 169.0 18.57 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 126.359 1.863 . . . . 0.0 110.857 -173.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.44 132.26 21.33 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.079 0.551 . . . . 0.0 110.246 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.458 ' CG2' HD11 ' A' ' 166' ' ' LEU . 58.2 mt -125.06 139.98 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.145 0.978 . . . . 0.0 108.871 176.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 44.0 m -67.16 95.21 0.39 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.477 -0.764 . . . . 0.0 110.048 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.556 HD21 ' HE2' ' A' ' 167' ' ' LYS . 1.0 OUTLIER -52.23 -33.52 41.78 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.574 1.15 . . . . 0.0 111.766 176.164 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -67.2 -29.56 69.26 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -84.82 -27.54 26.72 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.175 0.99 . . . . 0.0 111.859 172.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 163' ' ' LEU . 40.8 mt -68.01 -43.01 79.8 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.558 0.743 . . . . 0.0 110.158 175.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.556 ' HE2' HD21 ' A' ' 163' ' ' LEU . 15.3 mtmt -57.32 -20.0 25.93 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -86.83 -15.42 39.25 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.502 1.121 . . . . 0.0 114.021 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -123.01 -3.06 8.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.385 1.474 . . . . 0.0 113.437 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.527 HD22 HG22 ' A' ' 97' ' ' VAL . 13.2 mt -92.31 -18.56 23.19 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.339 1.456 . . . . 0.0 112.639 -177.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp . . . . . 0 C--O 1.253 1.243 0 C-N-CA 126.668 1.987 . . . . 0.0 113.572 171.49 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.7 pttp . . . . . 0 N--CA 1.495 1.808 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.1 tt -66.55 -37.61 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 O-C-N 120.335 -1.478 . . . . 0.0 112.658 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -81.98 134.21 35.36 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.424 1.09 . . . . 0.0 110.886 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 46.5 p -111.22 173.37 6.37 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.766 1.627 . . . . 0.0 110.892 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.7 t -133.67 160.37 37.73 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.602 0.761 . . . . 0.0 111.965 -179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -141.14 161.18 38.48 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.064 1.746 . . . . 0.0 111.396 -174.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -149.92 164.47 35.33 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.749 1.62 . . . . 0.0 111.426 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -138.9 149.21 44.57 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.18 1.392 . . . . 0.0 110.645 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -138.85 100.15 3.97 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.961 1.304 . . . . 0.0 110.306 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.8 m -72.39 168.84 17.58 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.203 1.001 . . . . 0.0 112.117 173.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.7 p -125.77 -42.08 1.94 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.649 1.18 . . . . 0.0 112.938 175.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.72 -148.91 50.67 Favored Glycine 0 CA--C 1.538 1.489 0 CA-C-N 118.746 0.703 . . . . 0.0 113.254 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -68.72 93.64 0.54 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.742 1.217 . . . . 0.0 112.066 176.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.1 m -147.22 169.15 19.98 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.411 1.884 . . . . 0.0 111.674 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -71.71 125.47 27.2 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.014 0.926 . . . . 0.0 110.911 171.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.8 p -167.23 148.48 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 127.025 2.13 . . . . 0.0 108.737 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -129.86 171.59 12.57 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.292 1.437 . . . . 0.0 112.516 177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.79 128.45 35.32 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.754 1.622 . . . . 0.0 110.265 173.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.0 mm -78.14 159.5 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.193 0.997 . . . . 0.0 109.538 174.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -59.4 -14.7 13.06 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.846 -1.159 . . . . 0.0 113.933 171.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -94.43 0.87 55.72 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.495 1.518 . . . . 0.0 113.953 175.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.4 t -60.76 -22.03 63.64 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.578 1.551 . . . . 0.0 113.221 176.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -140.08 161.19 38.21 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.067 1.347 . . . . 0.0 110.269 168.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -143.8 171.02 14.79 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.027 0.931 . . . . 0.0 110.786 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.5 m -142.26 122.35 13.75 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.699 -0.626 . . . . 0.0 110.77 -177.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.6 m -123.76 161.24 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 126.351 1.86 . . . . 0.0 111.095 -176.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.25 160.09 13.72 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.535 0.734 . . . . 0.0 112.496 176.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.0 tp -152.72 138.5 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.712 1.605 . . . . 0.0 109.085 174.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -129.14 159.33 36.36 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.613 1.965 . . . . 0.0 109.333 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -134.86 160.94 36.63 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.731 1.213 . . . . 0.0 111.866 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.67 119.81 25.23 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 122.603 0.361 . . . . 0.0 110.619 172.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.9 p30 -68.81 177.08 2.71 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 122.636 1.208 . . . . 0.0 113.625 170.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 19.8 mtmm -58.25 -23.16 55.07 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.107 1.763 . . . . 0.0 113.337 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 m -84.03 -11.18 57.15 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.013 1.325 . . . . 0.0 113.076 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.72 33.38 42.55 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.201 1.381 . . . . 0.0 114.291 -175.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -120.72 145.65 47.28 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.363 1.465 . . . . 0.0 111.18 175.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 62.2 m95 -67.76 130.83 44.23 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.708 0.803 . . . . 0.0 111.054 175.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.4 t -143.12 142.84 31.61 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.824 1.249 . . . . 0.0 110.652 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -56.41 132.47 51.23 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.252 1.021 . . . . 0.0 112.342 -177.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.9 tp -108.12 -49.87 3.13 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.571 0.749 . . . . 0.0 111.22 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.47 -119.05 0.82 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.761 0.696 . . . . 0.0 112.916 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -143.05 158.09 43.93 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.589 1.555 . . . . 0.0 111.064 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.8 tp -122.47 103.75 8.92 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.861 1.664 . . . . 0.0 110.137 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.1 t -74.73 98.85 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.572 1.149 . . . . 0.0 109.383 172.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.8 t -87.07 115.47 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.717 1.207 . . . . 0.0 110.057 173.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -104.6 116.66 32.46 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.906 2.083 . . . . 0.0 110.359 178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -81.11 87.39 6.05 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.524 1.13 . . . . 0.0 110.51 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -76.97 173.5 11.7 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.31 1.044 . . . . 0.0 112.307 171.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -74.38 -33.54 63.09 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.697 -1.252 . . . . 0.0 113.543 174.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -108.76 45.14 1.06 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.284 1.434 . . . . 0.0 111.418 -170.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 113.94 -164.19 12.09 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.204 1.383 . . . . 0.0 113.709 -176.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.9 mt -117.77 142.55 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.669 0.788 . . . . 0.0 109.168 173.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -131.28 136.06 47.84 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.762 1.225 . . . . 0.0 109.138 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.6 p -129.4 150.27 50.83 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.516 0.727 . . . . 0.0 111.636 -171.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -144.32 122.73 1.85 Allowed Glycine 0 C--N 1.335 0.506 0 O-C-N 121.746 -0.596 . . . . 0.0 112.446 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -65.87 136.37 56.05 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.291 1.436 . . . . 0.0 109.621 174.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -133.51 99.66 4.57 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.891 2.076 . . . . 0.0 108.964 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -118.87 100.42 7.37 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.568 1.547 . . . . 0.0 111.089 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 61.52 -113.81 6.08 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.299 0.952 . . . . 0.0 112.408 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -96.06 15.71 62.47 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 125.004 1.288 . . . . 0.0 114.744 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -140.56 143.54 35.38 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.02 1.41 . . . . 0.0 112.885 -174.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 46.3 m -147.0 151.27 36.69 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.064 0.946 . . . . 0.0 113.014 -175.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -158.79 158.36 33.41 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.292 1.437 . . . . 0.0 111.804 175.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.3 m -55.61 128.38 34.35 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 121.269 -0.895 . . . . 0.0 110.281 170.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -95.53 -51.6 4.48 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.345 0.658 . . . . 0.0 110.151 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -164.8 163.17 21.31 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.025 0.93 . . . . 0.0 112.527 170.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.05 146.79 31.08 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.005 1.322 . . . . 0.0 111.94 177.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.523 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -128.13 160.06 33.2 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.795 1.638 . . . . 0.0 111.429 -176.471 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -78.29 164.82 24.54 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.468 0.707 . . . . 0.0 112.299 -177.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -56.67 -33.76 66.69 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.352 1.461 . . . . 0.0 114.496 174.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -69.78 -9.64 55.34 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.581 1.153 . . . . 0.0 112.957 173.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.8 t -112.51 -8.09 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.294 1.038 . . . . 0.0 111.054 -173.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 76.5 t -46.62 -67.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 125.623 1.569 . . . . 0.0 111.905 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -67.22 -26.97 66.87 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.501 -0.749 . . . . 0.0 112.737 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -63.56 -52.08 62.61 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.701 1.6 . . . . 0.0 110.703 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -59.47 -46.7 88.04 Favored 'General case' 0 C--O 1.227 -0.09 0 C-N-CA 125.476 1.51 . . . . 0.0 111.031 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.516 HG22 HD22 ' A' ' 170' ' ' LEU . 82.8 t -56.19 -36.15 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.468 0.707 . . . . 0.0 110.806 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.0 ttpt -65.87 -54.47 26.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.857 1.263 . . . . 0.0 112.659 174.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 m -71.55 -16.88 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 120.913 -1.117 . . . . 0.0 112.539 -176.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.644 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -87.32 -5.2 58.99 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.169 1.788 . . . . 0.0 111.693 177.042 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 65.0 p -128.56 -15.05 4.56 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 176.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -134.18 -10.02 2.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.493 1.517 . . . . 0.0 114.183 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 79.49 156.31 10.89 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.642 1.592 . . . . 0.0 113.96 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 157.66 -166.01 33.71 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.129 0.871 . . . . 0.0 113.838 -175.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 61.2 p -148.56 103.26 3.39 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -170.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -134.76 143.68 47.26 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.05 1.74 . . . . 0.0 110.137 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -71.15 162.73 28.94 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 121.457 -0.777 . . . . 0.0 111.636 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 81.5 p -127.43 154.12 45.43 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.441 1.497 . . . . 0.0 110.972 -178.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.523 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 82.4 p -71.07 -38.79 72.46 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.427 -0.796 . . . . 0.0 111.103 -177.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.2 mt -152.83 140.37 19.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.71 2.004 . . . . 0.0 111.468 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -134.5 102.57 5.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.999 0.92 . . . . 0.0 110.046 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -87.49 -46.88 9.21 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.51 1.124 . . . . 0.0 112.76 175.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 75.43 173.99 34.51 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.204 1.383 . . . . 0.0 113.636 -168.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -57.39 162.87 2.57 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.122 0.969 . . . . 0.0 111.922 169.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -60.17 160.51 8.17 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.23 -0.919 . . . . 0.0 111.426 170.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 65.1 37.69 6.54 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.026 0.93 . . . . 0.0 113.075 -171.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -120.51 170.43 9.4 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.757 1.623 . . . . 0.0 111.416 170.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -86.44 -11.17 52.59 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.274 1.029 . . . . 0.0 113.763 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.8 p -103.76 -27.3 12.33 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.927 1.291 . . . . 0.0 113.96 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.9 p -60.16 -22.06 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -174.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 3.6 mp -59.62 -36.79 67.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 125.819 1.648 . . . . 0.0 112.585 175.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -146.76 -38.26 0.22 Allowed 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 115.613 1.708 . . . . 0.0 115.613 -168.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 104.4 156.32 23.57 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 126.898 2.19 . . . . 0.0 113.475 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 45.6 mt -113.38 112.95 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.073 1.349 . . . . 0.0 108.168 176.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -74.18 147.92 42.13 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.015 0.436 . . . . 0.0 111.384 172.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 59.31 21.91 10.2 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.659 1.583 . . . . 0.0 113.976 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -63.24 126.31 26.99 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.954 1.302 . . . . 0.0 111.515 -172.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 64.2 tt0 -74.88 122.36 23.28 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.36 1.464 . . . . 0.0 112.267 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.5 mm -118.48 118.02 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.184 0.993 . . . . 0.0 109.835 -178.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.7 92.64 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.485 1.514 . . . . 0.0 109.18 -177.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 64.2 p -74.86 156.58 36.29 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.498 174.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -153.48 142.7 21.46 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.182 1.393 . . . . 0.0 111.646 173.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 21.8 mt -81.49 132.02 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.068 0.547 . . . . 0.0 109.721 175.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -149.08 141.75 24.48 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.694 1.598 . . . . 0.0 110.232 173.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -82.61 158.26 23.1 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.274 -0.892 . . . . 0.0 110.198 169.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 38.5 mt -128.36 -46.31 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.242 1.017 . . . . 0.0 110.726 178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -142.96 10.96 1.78 Allowed 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 122.39 -24.37 6.92 Favored Glycine 0 N--CA 1.473 1.127 0 C-N-CA 124.226 0.917 . . . . 0.0 113.137 -174.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 62.2 m -87.07 141.3 28.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.042 0.937 . . . . 0.0 108.642 169.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -76.44 124.5 27.65 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 170.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -109.17 167.88 9.78 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.471 1.508 . . . . 0.0 110.447 174.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.4 tp -123.16 132.04 72.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 125.331 1.452 . . . . 0.0 108.31 171.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.2 p -120.25 152.64 37.46 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.588 0.755 . . . . 0.0 109.878 177.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -145.63 147.55 32.14 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.306 0.574 . . . . 0.0 111.602 178.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.5 p -73.06 109.69 6.79 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.272 1.029 . . . . 0.0 111.21 174.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.77 -166.47 30.61 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 122.139 0.855 . . . . 0.0 113.232 172.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -65.65 162.0 19.34 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.148 0.979 . . . . 0.0 113.015 170.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -84.3 101.09 11.67 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.866 1.266 . . . . 0.0 111.853 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.417 HD11 ' HB3' ' A' ' 152' ' ' SER . 0.2 OUTLIER -66.28 161.79 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.458 0.703 . . . . 0.0 112.574 178.51 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.2 ttpt -109.27 8.11 25.56 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.226 1.01 . . . . 0.0 113.487 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -116.88 21.62 13.19 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.351 1.86 . . . . 0.0 112.534 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.417 ' HB3' HD11 ' A' ' 149' ' ' ILE . 1.9 t -138.05 -41.05 0.53 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.55 1.14 . . . . 0.0 113.601 173.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 124.58 69.3 0.2 Allowed Glycine 0 N--CA 1.476 1.357 0 C-N-CA 123.972 0.796 . . . . 0.0 113.954 171.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 57.64 25.07 11.25 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.387 1.475 . . . . 0.0 113.673 -173.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -87.44 174.61 8.41 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.236 1.014 . . . . 0.0 109.036 173.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 13.7 m -110.98 146.71 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.772 0.829 . . . . 0.0 110.848 175.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.59 83.2 0.42 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.338 1.055 . . . . 0.0 110.478 176.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -81.08 141.92 33.84 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 122.157 0.979 . . . . 0.0 111.717 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -135.31 169.71 17.06 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.73 1.612 . . . . 0.0 111.534 -173.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -147.35 132.55 18.38 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.576 0.75 . . . . 0.0 110.446 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.46 ' CG2' HD11 ' A' ' 166' ' ' LEU . 68.0 mt -124.98 141.5 44.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.09 0.956 . . . . 0.0 108.88 177.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.3 m -66.33 93.44 0.22 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.64 1.176 . . . . 0.0 110.194 176.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.59 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.4 tt -54.98 -30.81 60.02 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.226 1.41 . . . . 0.0 112.45 178.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -71.65 -30.51 65.82 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -82.64 -30.7 29.2 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.01 0.924 . . . . 0.0 112.237 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.644 HD13 ' HG3' ' A' ' 100' ' ' MET . 20.7 mt -57.22 -49.77 74.96 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.914 0.886 . . . . 0.0 110.779 173.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -50.45 -38.21 42.38 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.263 1.025 . . . . 0.0 113.391 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -64.29 -21.14 66.49 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -120.82 -4.29 9.68 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.534 1.533 . . . . 0.0 113.421 -174.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.516 HD22 HG22 ' A' ' 97' ' ' VAL . 15.3 mt -98.09 -22.33 16.29 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.596 1.558 . . . . 0.0 112.736 -175.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp . . . . . 0 C--O 1.254 1.309 0 C-N-CA 125.951 1.7 . . . . 0.0 113.363 175.023 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.005 0.431 . . . . 0.0 112.125 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.2 pt -136.6 172.6 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 126.788 2.035 . . . . 0.0 110.642 173.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 23.7 p-80 -58.83 162.45 4.08 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.636 0.775 . . . . 0.0 112.741 171.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 54.0 p -130.88 159.39 37.54 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.809 1.243 . . . . 0.0 111.636 178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 58.1 m -140.04 162.97 33.94 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.467 1.507 . . . . 0.0 110.863 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -141.19 150.01 42.18 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.151 1.381 . . . . 0.0 110.883 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -90.85 127.62 36.43 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.993 0.917 . . . . 0.0 110.357 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.55 150.79 48.46 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.494 -0.754 . . . . 0.0 111.575 169.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 53.42 24.31 3.88 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.47 1.508 . . . . 0.0 114.481 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.4 t -64.11 163.17 12.94 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.018 1.327 . . . . 0.0 112.962 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.0 t -114.96 163.29 15.79 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.379 1.472 . . . . 0.0 112.292 -177.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -88.75 -148.95 18.63 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.54 1.543 . . . . 0.0 112.853 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -143.21 148.01 35.78 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.684 1.194 . . . . 0.0 111.354 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.7 m -62.83 153.27 33.64 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.627 1.171 . . . . 0.0 112.958 177.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.7 tmmm? -91.91 100.58 13.22 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.38 1.072 . . . . 0.0 110.429 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.9 p -155.24 145.39 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.077 1.751 . . . . 0.0 109.6 174.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -143.35 155.4 44.42 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.521 1.528 . . . . 0.0 111.441 172.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -149.96 166.57 29.23 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.198 2.199 . . . . 0.0 110.321 175.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 44.2 mm -66.36 135.99 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.864 0.866 . . . . 0.0 110.279 170.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -128.72 8.77 5.84 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.668 1.187 . . . . 0.0 113.217 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -68.82 -4.25 15.48 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.973 1.309 . . . . 0.0 114.445 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.4 m -58.76 -25.08 62.68 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 127.24 2.216 . . . . 0.0 114.086 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.88 166.96 23.23 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.652 1.181 . . . . 0.0 110.168 166.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -150.2 167.09 27.9 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.069 0.948 . . . . 0.0 110.921 173.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 m -131.15 131.0 43.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.855 0.462 . . . . 0.0 111.037 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 m -129.34 167.85 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 126.179 1.791 . . . . 0.0 111.026 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -65.3 166.78 9.4 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.741 1.217 . . . . 0.0 111.943 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.422 HG21 ' CD2' ' A' ' 76' ' ' LEU . 5.4 tp -161.82 135.72 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.128 1.371 . . . . 0.0 109.933 172.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -129.07 160.11 33.82 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.509 1.924 . . . . 0.0 109.324 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -127.19 160.25 31.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.337 1.455 . . . . 0.0 111.072 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -81.49 121.82 26.76 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 122.048 -0.407 . . . . 0.0 110.565 171.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -64.09 175.47 1.23 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.411 1.085 . . . . 0.0 112.105 171.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -59.76 -13.73 11.52 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.692 1.997 . . . . 0.0 114.737 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.6 m -117.05 15.55 15.06 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.932 1.293 . . . . 0.0 112.771 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.13 20.84 77.0 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 121.203 -0.936 . . . . 0.0 114.378 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -96.46 127.62 42.63 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.609 1.164 . . . . 0.0 109.485 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -69.05 125.92 28.19 Favored 'General case' 0 CA--C 1.537 0.466 0 O-C-N 121.633 -0.667 . . . . 0.0 110.639 174.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.2 t -141.78 138.32 32.19 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.851 1.26 . . . . 0.0 111.009 -172.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -57.67 137.19 56.7 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.142 0.977 . . . . 0.0 112.979 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 44.4 tp -111.03 -46.33 3.34 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.827 0.851 . . . . 0.0 111.723 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.47 -121.95 0.95 Allowed Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.351 0.501 . . . . 0.0 113.327 -178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -147.49 153.44 39.53 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.308 1.443 . . . . 0.0 110.482 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.8 tp -118.84 107.57 13.77 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.121 1.368 . . . . 0.0 111.005 -176.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.458 HG23 ' ND2' ' A' ' 77' ' ' ASN . 57.7 t -82.48 102.28 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.705 1.202 . . . . 0.0 108.327 173.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.07 103.25 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.769 1.628 . . . . 0.0 109.448 176.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -98.19 140.51 32.38 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.859 1.664 . . . . 0.0 110.965 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -99.68 90.79 4.59 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.06 1.344 . . . . 0.0 109.844 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -68.78 171.38 7.92 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 122.406 1.098 . . . . 0.0 113.278 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -62.17 -28.06 69.39 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.275 1.03 . . . . 0.0 113.224 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -137.19 40.32 2.48 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.941 1.696 . . . . 0.0 112.778 -171.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 147.85 -157.95 27.53 Favored Glycine 0 CA--C 1.534 1.225 0 N-CA-C 115.965 1.146 . . . . 0.0 115.965 175.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.439 HG13 HG22 ' A' ' 93' ' ' VAL . 35.5 mt -121.91 136.57 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.327 1.051 . . . . 0.0 109.304 173.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.04 117.19 19.64 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 126.413 1.885 . . . . 0.0 109.411 -175.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.2 p -106.24 149.78 26.53 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.012 0.925 . . . . 0.0 111.32 -175.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.09 128.32 3.84 Favored Glycine 0 C--N 1.336 0.581 0 O-C-N 121.265 -0.897 . . . . 0.0 111.876 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.422 ' CD2' HG21 ' A' ' 48' ' ' ILE . 3.2 tm? -85.3 127.75 34.44 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 127.157 2.183 . . . . 0.0 110.623 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.458 ' ND2' HG23 ' A' ' 64' ' ' VAL . 2.6 m-80 -122.79 86.88 2.65 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.761 1.624 . . . . 0.0 109.748 -174.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -97.49 122.5 40.62 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.328 1.051 . . . . 0.0 110.054 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 50.89 -94.2 0.01 OUTLIER Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.39 1.471 . . . . 0.0 114.479 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -125.89 15.85 6.95 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 126.002 1.763 . . . . 0.0 114.62 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.81 157.51 21.28 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.565 1.546 . . . . 0.0 110.857 171.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 64.3 p -146.05 136.66 24.16 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.385 0.674 . . . . 0.0 112.623 169.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -147.92 152.61 37.84 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.059 0.944 . . . . 0.0 112.385 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 19.9 m -55.39 122.86 12.12 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.876 0.87 . . . . 0.0 110.366 174.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -91.15 -49.91 6.13 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.78 0.432 . . . . 0.0 110.015 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -160.36 171.12 19.68 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.764 0.792 . . . . 0.0 113.093 171.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.3 136.97 12.25 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.397 -0.815 . . . . 0.0 112.764 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.484 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -132.03 155.31 48.26 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 126.464 1.906 . . . . 0.0 111.188 -174.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -79.44 168.04 20.01 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.384 0.674 . . . . 0.0 112.598 -171.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.457 ' HA ' HG23 ' A' ' 93' ' ' VAL . 2.7 tm-20 -57.63 -34.3 69.17 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.425 1.09 . . . . 0.0 112.328 176.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -63.2 -16.33 59.8 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.643 1.577 . . . . 0.0 114.023 171.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.4 t -111.18 -8.25 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.603 1.161 . . . . 0.0 111.087 -173.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.457 HG23 ' HA ' ' A' ' 90' ' ' GLU . 54.7 t -47.78 -64.62 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 125.726 1.611 . . . . 0.0 111.486 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -68.93 -28.22 66.46 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -49.71 75.36 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.536 1.534 . . . . 0.0 110.367 176.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -61.88 -42.42 99.05 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.107 1.363 . . . . 0.0 112.07 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.581 HG22 HD22 ' A' ' 170' ' ' LEU . 95.3 t -56.95 -37.18 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.615 0.766 . . . . 0.0 110.679 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -68.4 -54.01 20.03 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.427 1.091 . . . . 0.0 112.447 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.6 m -73.5 -8.79 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 O-C-N 120.834 -1.166 . . . . 0.0 113.093 -175.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.561 ' CG ' HD13 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -98.58 -3.2 36.83 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.855 1.262 . . . . 0.0 112.387 176.473 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.9 p -129.6 -13.82 4.21 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.474 1.11 . . . . 0.0 113.041 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -135.74 -11.15 2.07 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.342 1.857 . . . . 0.0 114.1 177.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.93 154.94 11.29 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.067 1.318 . . . . 0.0 114.034 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.64 -159.51 31.4 Favored Glycine 0 CA--C 1.532 1.155 0 O-C-N 121.756 -0.849 . . . . 0.0 114.201 -177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 88.1 p -153.94 100.39 2.35 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -170.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -131.93 142.94 49.79 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.866 1.667 . . . . 0.0 110.091 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.4 154.61 39.95 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 121.465 -0.772 . . . . 0.0 111.106 178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 44.7 p -118.4 156.9 28.18 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.231 1.412 . . . . 0.0 111.011 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.484 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 8.4 t -67.93 -41.14 83.02 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.307 1.043 . . . . 0.0 111.314 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 mt -155.56 137.69 14.67 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.243 1.817 . . . . 0.0 111.152 -177.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -134.38 103.84 5.89 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.485 1.114 . . . . 0.0 110.275 177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -90.27 -39.66 12.62 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.43 175.34 6.46 Favored Glycine 0 CA--C 1.543 1.807 0 C-N-CA 124.926 1.251 . . . . 0.0 114.508 -169.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -61.5 159.09 13.52 Favored 'General case' 0 CA--C 1.55 0.947 0 O-C-N 121.497 -1.002 . . . . 0.0 112.272 169.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.535 ' HA ' HG21 ' A' ' 120' ' ' VAL . 24.6 mmtp -52.65 166.77 0.17 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.385 1.874 . . . . 0.0 113.324 174.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 69.9 37.49 1.77 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.349 1.46 . . . . 0.0 112.167 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -147.06 144.43 29.09 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.848 1.259 . . . . 0.0 112.087 -169.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -68.42 -15.79 63.68 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -173.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.4 p -87.73 -18.43 29.48 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.535 HG21 ' HA ' ' A' ' 115' ' ' LYS . 11.8 t -67.15 -25.38 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 CA-C-N 120.738 1.608 . . . . 0.0 111.644 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 74.9 mt -53.15 -47.22 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.816 1.647 . . . . 0.0 112.211 -176.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -147.68 -7.15 0.44 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 92.59 176.92 41.48 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.156 1.836 . . . . 0.0 113.007 -172.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 47.4 mt -127.02 105.42 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.023 1.329 . . . . 0.0 107.885 169.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -67.67 146.35 53.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.074 0.464 . . . . 0.0 111.095 172.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 57.45 24.69 10.51 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.355 1.462 . . . . 0.0 113.993 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -53.95 127.51 26.58 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.077 1.351 . . . . 0.0 111.039 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -76.9 127.71 33.21 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 122.064 -0.397 . . . . 0.0 110.252 169.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 33.3 mm -122.57 115.76 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 124.845 1.258 . . . . 0.0 108.334 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -112.08 100.69 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 125.264 1.426 . . . . 0.0 107.875 -176.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.7 p -83.18 159.21 22.07 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.666 0.746 . . . . 0.0 111.775 176.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -152.07 138.66 18.7 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.67 1.188 . . . . 0.0 110.863 173.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.4 mt -80.07 132.27 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 174.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -139.91 123.0 16.79 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.31 1.444 . . . . 0.0 110.344 175.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -74.32 114.98 13.31 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 169.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 27.3 mt -101.67 98.07 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 175.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 58.87 15.03 3.6 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.695 1.998 . . . . 0.0 115.764 -176.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 124.3 -26.66 5.74 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.028 1.299 . . . . 0.0 114.07 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.0 m -77.8 128.61 34.27 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.587 1.155 . . . . 0.0 108.74 171.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -78.79 116.12 18.92 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.555 -0.715 . . . . 0.0 109.285 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -106.33 164.06 12.33 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.694 1.197 . . . . 0.0 110.485 171.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.1 tp -117.5 134.83 59.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 125.615 1.566 . . . . 0.0 107.615 169.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.1 p -124.09 155.75 37.82 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.356 0.662 . . . . 0.0 109.854 175.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -150.89 147.03 26.71 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.447 0.699 . . . . 0.0 112.179 -178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 55.2 p -76.24 108.17 8.98 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.059 1.344 . . . . 0.0 111.833 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -78.98 -160.38 17.87 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 123.999 0.809 . . . . 0.0 113.528 173.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -67.22 159.77 28.38 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.89 0.876 . . . . 0.0 112.836 171.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -78.21 106.25 9.99 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.838 1.255 . . . . 0.0 110.358 172.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -61.3 161.38 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.22 0.608 . . . . 0.0 112.326 174.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -92.26 -31.78 15.28 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 176.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -71.82 -37.66 70.29 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.7 t -80.87 169.34 17.68 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.401 0.68 . . . . 0.0 112.086 176.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -77.27 65.9 2.98 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.642 1.591 . . . . 0.0 114.106 -176.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 55.37 36.63 27.49 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.14 1.776 . . . . 0.0 113.47 -173.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -92.59 170.03 10.06 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.379 1.072 . . . . 0.0 109.393 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 31.3 m -104.56 148.23 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.824 0.85 . . . . 0.0 111.255 174.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -68.26 98.67 0.83 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.392 0.677 . . . . 0.0 110.227 170.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -91.94 144.45 25.45 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 122.346 1.069 . . . . 0.0 111.592 172.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -134.28 169.64 16.9 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 126.106 1.763 . . . . 0.0 110.962 -173.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.07 133.44 21.79 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.184 0.594 . . . . 0.0 109.991 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.434 ' CG2' HD11 ' A' ' 166' ' ' LEU . 62.0 mt -126.5 138.63 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 123.736 0.815 . . . . 0.0 108.822 175.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.9 m -64.55 98.2 0.24 Allowed 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.863 0.865 . . . . 0.0 109.43 177.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.559 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.0 OUTLIER -53.83 -32.74 53.91 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.693 1.197 . . . . 0.0 111.634 177.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -68.32 -32.21 72.17 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -82.56 -27.74 31.4 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.335 -0.853 . . . . 0.0 112.836 173.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.561 HD13 ' CG ' ' A' ' 100' ' ' MET . 18.8 mt -62.59 -51.03 68.95 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.644 0.778 . . . . 0.0 110.912 172.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -48.75 -43.36 37.61 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.853 1.261 . . . . 0.0 113.24 176.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -64.28 -21.01 66.44 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.542 1.537 . . . . 0.0 114.32 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -119.77 -8.91 9.82 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.138 1.375 . . . . 0.0 113.918 -176.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.581 HD22 HG22 ' A' ' 97' ' ' VAL . 13.0 mt -87.21 -28.66 22.26 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.506 1.523 . . . . 0.0 112.231 -178.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? . . . . . 0 C--O 1.252 1.198 0 C-N-CA 126.393 1.877 . . . . 0.0 113.231 176.48 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.9 tttm . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.7 mm -74.69 124.85 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 120.15 -1.594 . . . . 0.0 109.207 175.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -126.77 135.64 51.34 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.11 1.364 . . . . 0.0 109.532 174.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 67.3 p -136.64 164.08 29.05 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.483 1.513 . . . . 0.0 110.482 -176.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.1 t -148.48 154.2 39.51 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.394 1.077 . . . . 0.0 110.972 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -150.13 166.15 30.67 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.796 1.238 . . . . 0.0 111.604 179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.5 143.76 51.09 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.397 1.479 . . . . 0.0 111.301 -173.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -151.01 167.94 26.12 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.87 1.268 . . . . 0.0 111.257 -173.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -58.69 149.87 24.97 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.276 1.03 . . . . 0.0 113.428 176.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.5 t -87.23 152.3 22.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.855 1.262 . . . . 0.0 111.642 174.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 65.4 m -139.73 174.16 10.79 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.106 1.763 . . . . 0.0 111.739 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.97 -162.37 3.66 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 124.806 1.193 . . . . 0.0 114.227 172.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 60.04 31.59 20.68 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.341 1.456 . . . . 0.0 113.376 -176.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.6 p -62.35 163.36 8.63 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.321 1.448 . . . . 0.0 113.632 174.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -134.85 163.49 29.7 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.321 1.849 . . . . 0.0 110.712 -171.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.8 t -121.79 58.46 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 125.056 1.342 . . . . 0.0 109.908 -174.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -136.78 172.03 13.61 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.872 2.069 . . . . 0.0 111.378 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -77.29 52.95 0.97 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.897 2.079 . . . . 0.0 113.24 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 mm -68.97 160.67 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.599 1.16 . . . . 0.0 110.998 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -57.1 -14.62 4.09 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.352 1.461 . . . . 0.0 114.812 174.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -107.44 -4.54 18.39 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 175.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.0 t -55.88 -33.62 64.75 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.213 1.405 . . . . 0.0 112.194 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 49.8 pttt -111.5 154.47 24.7 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.273 1.029 . . . . 0.0 110.556 168.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -147.39 165.86 28.93 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.297 1.439 . . . . 0.0 110.527 177.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -130.64 134.13 46.71 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.08 -0.387 . . . . 0.0 110.881 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.0 m -128.05 165.1 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 126.083 1.753 . . . . 0.0 109.979 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -68.55 163.39 23.66 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.56 0.744 . . . . 0.0 110.96 177.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.5 tp -147.01 136.12 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.078 0.951 . . . . 0.0 109.254 170.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -126.5 160.1 31.53 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 126.626 1.971 . . . . 0.0 109.105 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.4 161.56 35.48 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.905 0.882 . . . . 0.0 112.06 176.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.74 118.16 23.71 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 122.847 0.459 . . . . 0.0 110.209 173.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -72.06 178.85 3.56 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.403 0.621 . . . . 0.0 112.459 175.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -57.67 -26.37 61.57 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.87 1.668 . . . . 0.0 113.111 173.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.3 t -70.65 -17.69 62.86 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.799 1.64 . . . . 0.0 113.747 173.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.45 36.39 62.88 Favored Glycine 0 CA--C 1.534 1.233 0 O-C-N 121.072 -1.018 . . . . 0.0 113.287 -171.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -125.09 143.81 50.73 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.994 1.718 . . . . 0.0 109.85 175.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -67.64 132.83 48.25 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.814 0.846 . . . . 0.0 111.141 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 t -142.44 136.62 29.66 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.838 1.255 . . . . 0.0 110.509 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -56.98 133.14 54.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.04 0.936 . . . . 0.0 112.446 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.1 tp -111.36 -45.83 3.36 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.112 0.965 . . . . 0.0 111.212 -176.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.26 -137.89 4.02 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-O 122.067 0.815 . . . . 0.0 113.813 -176.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -129.0 163.59 25.04 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.511 1.925 . . . . 0.0 110.608 173.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 16.2 tp -130.1 106.39 8.59 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.49 2.316 . . . . 0.0 110.256 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 36.0 t -80.31 99.44 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.659 1.184 . . . . 0.0 109.332 174.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.9 t -81.89 117.12 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.504 1.522 . . . . 0.0 109.587 173.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 -112.22 118.21 34.69 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.124 2.17 . . . . 0.0 110.726 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -74.19 95.89 2.68 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.542 1.137 . . . . 0.0 109.61 169.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -72.63 171.94 11.54 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.922 0.868 . . . . 0.0 111.831 171.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.4 tp10 -60.9 -35.73 77.43 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.018 -1.051 . . . . 0.0 112.999 174.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -133.27 57.35 1.81 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.262 1.425 . . . . 0.0 111.26 -169.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 128.44 -163.82 21.84 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.431 1.491 . . . . 0.0 113.78 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.2 mt -126.22 138.84 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.899 0.879 . . . . 0.0 109.589 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -127.7 129.89 47.91 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.276 1.43 . . . . 0.0 109.036 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.9 p -121.55 137.63 54.65 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.502 -0.749 . . . . 0.0 110.207 -175.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.6 108.88 0.71 Allowed Glycine 0 C--N 1.332 0.334 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -170.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 tt -64.04 142.24 58.48 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.771 0.828 . . . . 0.0 110.612 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -138.1 75.79 1.54 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.18 1.792 . . . . 0.0 109.313 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.88 171.32 4.49 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.12 0.968 . . . . 0.0 112.041 173.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -55.48 -22.66 32.21 Favored Glycine 0 CA--C 1.54 1.611 0 N-CA-C 116.203 1.241 . . . . 0.0 116.203 -174.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -153.55 23.97 0.74 Allowed Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.748 1.166 . . . . 0.0 114.73 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -153.96 135.56 14.34 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.472 1.109 . . . . 0.0 110.879 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -141.93 134.32 28.0 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.36 -0.838 . . . . 0.0 111.657 -174.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -159.89 160.86 34.1 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.107 1.363 . . . . 0.0 112.13 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 93.7 m -60.77 123.03 16.29 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 121.099 -1.0 . . . . 0.0 109.286 169.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -85.46 -51.4 6.56 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.442 0.697 . . . . 0.0 109.849 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -162.57 170.27 18.86 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.275 1.03 . . . . 0.0 112.744 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.99 144.01 23.01 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 122.536 1.16 . . . . 0.0 113.198 175.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.482 ' HA ' ' H ' ' A' ' 109' ' ' SER . 0.7 OUTLIER -129.46 154.93 46.49 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.813 1.645 . . . . 0.0 111.845 -175.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -78.31 167.21 21.7 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.406 0.682 . . . . 0.0 112.263 -173.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -53.68 -35.67 61.32 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.017 0.927 . . . . 0.0 112.646 173.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -65.48 -8.49 19.57 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.617 1.167 . . . . 0.0 113.684 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 3.9 t -118.13 -4.63 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.591 1.156 . . . . 0.0 111.224 -173.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.6 t -50.87 -65.08 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 125.13 1.372 . . . . 0.0 111.334 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -68.51 -25.77 65.11 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.88 -50.92 69.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.327 1.451 . . . . 0.0 110.603 173.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -58.65 -43.79 89.91 Favored 'General case' 0 C--N 1.335 -0.064 0 C-N-CA 124.964 1.305 . . . . 0.0 111.608 177.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.541 HG22 HD22 ' A' ' 170' ' ' LEU . 73.3 t -56.44 -37.6 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 122.902 0.481 . . . . 0.0 110.867 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -66.01 -54.51 25.07 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.444 1.098 . . . . 0.0 112.513 176.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 m -74.81 -3.67 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 121.13 -0.981 . . . . 0.0 113.402 -175.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.475 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -103.67 -4.25 24.02 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.156 1.782 . . . . 0.0 112.008 179.128 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 43.8 p -131.84 -15.36 3.05 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.779 1.232 . . . . 0.0 113.541 174.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -131.5 -12.42 3.47 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.649 1.579 . . . . 0.0 113.847 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.34 156.14 12.45 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.678 1.132 . . . . 0.0 113.752 -177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.78 -159.26 31.62 Favored Glycine 0 CA--C 1.531 1.068 0 O-C-N 121.742 -0.858 . . . . 0.0 113.471 -176.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.486 ' HB3' HG23 ' A' ' 130' ' ' ILE . 31.6 p -154.21 96.82 1.98 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -131.22 143.68 50.76 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.97 1.708 . . . . 0.0 110.606 -176.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -74.08 162.74 28.69 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.831 0.852 . . . . 0.0 111.49 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 73.0 p -129.66 143.76 50.97 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.217 1.407 . . . . 0.0 111.365 -177.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.482 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 24.4 p -57.81 -37.03 73.04 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.321 1.448 . . . . 0.0 112.839 -178.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.6 mt -156.4 145.58 20.5 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.07 2.148 . . . . 0.0 110.549 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -141.62 109.83 5.9 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.023 0.929 . . . . 0.0 110.246 176.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -95.59 -57.73 2.31 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.385 1.074 . . . . 0.0 112.463 175.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.46 -169.6 29.06 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.244 1.402 . . . . 0.0 113.796 -171.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -67.17 -75.08 0.1 Allowed 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.739 -0.859 . . . . 0.0 113.102 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.06 172.29 1.28 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 128.532 2.733 . . . . 0.0 108.879 -171.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 53.73 35.12 20.53 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.083 1.353 . . . . 0.0 113.853 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -131.89 156.89 45.32 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.266 1.826 . . . . 0.0 110.991 -169.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -80.55 -19.72 45.06 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 120.689 -1.257 . . . . 0.0 113.171 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 43.8 p -79.42 -39.22 32.93 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.361 1.065 . . . . 0.0 113.599 172.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.3 p -66.05 -14.86 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -170.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.12 -47.09 95.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.556 1.543 . . . . 0.0 112.063 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -136.94 -11.98 1.72 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.889 1.275 . . . . 0.0 114.16 -175.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.99 158.67 29.78 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.89 1.709 . . . . 0.0 113.105 -170.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 62.3 mt -119.77 113.14 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.076 1.35 . . . . 0.0 108.766 174.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -72.7 147.45 45.67 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.278 0.561 . . . . 0.0 111.565 172.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 57.12 22.44 7.47 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.034 1.734 . . . . 0.0 114.06 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -56.01 123.64 15.07 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.568 1.147 . . . . 0.0 110.534 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -71.07 127.91 34.17 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.87 0.868 . . . . 0.0 110.304 171.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 36.2 mm -123.93 117.67 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 124.351 1.06 . . . . 0.0 108.529 179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.486 HG23 ' HB3' ' A' ' 105' ' ' SER . 3.9 mp -111.4 100.12 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.047 1.339 . . . . 0.0 107.746 -177.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.4 p -82.74 158.98 22.65 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.595 0.712 . . . . 0.0 111.674 175.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.2 ptpt -152.44 139.09 18.76 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.744 1.218 . . . . 0.0 111.069 175.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.5 mt -79.38 133.84 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -140.04 124.55 18.06 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.207 1.403 . . . . 0.0 110.622 173.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -74.62 115.72 14.49 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.809 -0.557 . . . . 0.0 109.747 169.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.0 mt -102.74 98.43 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 175.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 60.0 12.91 3.4 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.77 2.028 . . . . 0.0 115.78 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 128.78 -34.46 2.86 Favored Glycine 0 N--CA 1.473 1.122 0 C-N-CA 124.919 1.247 . . . . 0.0 113.445 177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 88.6 m -72.01 127.63 33.16 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.371 1.068 . . . . 0.0 109.549 171.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -75.5 116.44 16.22 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.741 -0.599 . . . . 0.0 109.889 173.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -105.41 168.97 8.73 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.362 1.465 . . . . 0.0 110.389 170.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 4.6 tp -120.38 134.85 62.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 125.597 1.559 . . . . 0.0 107.342 169.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.2 p -119.88 160.04 23.46 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.19 0.596 . . . . 0.0 109.462 171.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -148.45 142.33 25.77 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 123.797 0.839 . . . . 0.0 110.795 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.5 p -74.08 116.14 14.37 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.525 0.679 . . . . 0.0 110.53 173.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.74 -166.14 40.95 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.72 0.676 . . . . 0.0 112.139 174.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -75.29 172.16 12.94 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 121.981 0.896 . . . . 0.0 111.234 168.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -76.57 132.0 39.25 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.508 1.123 . . . . 0.0 110.43 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.15 162.0 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.472 -0.767 . . . . 0.0 111.81 171.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -96.99 -24.94 15.57 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -69.26 -19.04 63.92 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.453 1.501 . . . . 0.0 113.625 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.02 61.31 1.58 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.491 1.916 . . . . 0.0 110.059 176.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 57.9 -91.11 0.03 OUTLIER Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.659 2.076 . . . . 0.0 115.473 171.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -146.93 25.41 1.15 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.928 2.091 . . . . 0.0 112.374 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -85.99 155.82 20.71 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.928 1.291 . . . . 0.0 108.893 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.6 m -89.2 140.2 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 122.713 0.405 . . . . 0.0 110.799 176.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -74.85 91.27 2.43 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.18 0.592 . . . . 0.0 110.517 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -77.93 151.44 33.72 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 122.32 1.057 . . . . 0.0 111.086 168.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -134.33 173.53 11.51 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.219 1.808 . . . . 0.0 110.884 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.91 138.09 24.06 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 118.659 0.663 . . . . 0.0 110.835 172.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 59.5 mt -128.8 141.53 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.05 0.94 . . . . 0.0 109.314 174.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.6 m -64.19 97.1 0.17 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.078 0.951 . . . . 0.0 109.764 175.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.519 ' HA ' HD12 ' A' ' 166' ' ' LEU . 0.8 OUTLIER -54.95 -30.95 60.03 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.582 1.153 . . . . 0.0 112.023 175.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -67.31 -25.82 66.22 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -93.53 -15.32 25.6 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.64 1.176 . . . . 0.0 113.153 174.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 163' ' ' LEU . 22.0 mt -73.87 -46.27 45.82 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.487 -0.758 . . . . 0.0 110.314 169.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -50.24 -45.12 53.76 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.704 1.202 . . . . 0.0 114.087 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -60.53 -29.19 68.97 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -176.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -98.34 -11.62 22.33 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.025 1.33 . . . . 0.0 112.905 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.541 HD22 HG22 ' A' ' 97' ' ' VAL . 17.1 mt -97.95 -24.4 15.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.132 1.373 . . . . 0.0 112.986 -174.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt . . . . . 0 C--O 1.253 1.272 0 C-N-CA 126.108 1.763 . . . . 0.0 113.17 169.503 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 110.441 -0.207 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.3 tt -61.56 149.73 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.764 0.826 . . . . 0.0 111.56 170.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -144.94 150.96 37.9 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.218 1.407 . . . . 0.0 111.148 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.8 p -116.66 73.31 0.85 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.742 1.617 . . . . 0.0 110.348 -173.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.2 m 56.52 43.81 25.2 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.496 1.518 . . . . 0.0 113.308 -175.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -127.36 131.53 50.36 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.462 1.505 . . . . 0.0 111.156 -177.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -81.75 113.24 19.59 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.361 1.064 . . . . 0.0 110.874 176.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -62.99 166.56 5.63 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 170.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -60.71 139.09 58.0 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.604 -0.685 . . . . 0.0 111.564 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.5 m -125.43 177.67 6.05 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.73 1.612 . . . . 0.0 111.494 -176.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.4 t -52.67 -50.63 62.86 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.925 0.89 . . . . 0.0 112.912 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 49.2 -135.69 22.12 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 124.879 1.228 . . . . 0.0 114.536 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.39 161.55 16.75 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.204 1.002 . . . . 0.0 112.649 170.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 62.6 p -58.87 168.34 1.3 Allowed 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.241 -0.912 . . . . 0.0 113.22 170.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -51.43 124.18 11.4 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.46 1.104 . . . . 0.0 111.889 169.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.6 m -126.69 44.16 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 127.008 2.123 . . . . 0.0 111.102 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -57.45 160.54 4.05 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.018 1.327 . . . . 0.0 113.042 175.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.47 153.41 43.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.553 1.141 . . . . 0.0 111.252 175.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.5 mm -71.54 156.77 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.769 1.228 . . . . 0.0 111.01 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -59.65 -12.99 7.89 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.267 1.427 . . . . 0.0 114.249 171.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -95.65 -4.12 44.95 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.289 1.436 . . . . 0.0 113.33 173.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.3 m -114.66 -28.51 7.1 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 126.697 1.999 . . . . 0.0 112.246 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -138.52 158.74 43.67 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.796 1.238 . . . . 0.0 110.84 168.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -141.21 168.32 20.06 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 124.68 1.192 . . . . 0.0 110.486 173.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -134.38 127.99 32.71 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.951 0.5 . . . . 0.0 110.081 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 m -126.08 158.16 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.233 1.413 . . . . 0.0 111.291 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -60.8 152.76 26.23 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.736 0.814 . . . . 0.0 111.35 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.1 tp -147.48 135.44 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.385 1.074 . . . . 0.0 109.585 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -127.68 158.72 36.81 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.465 1.906 . . . . 0.0 108.727 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -127.83 156.1 43.06 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.356 1.062 . . . . 0.0 111.106 175.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.23 119.85 22.89 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 170.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -67.66 176.33 2.5 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 122.01 0.91 . . . . 0.0 111.765 173.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -56.11 -16.13 4.67 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.91 2.084 . . . . 0.0 115.4 176.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -110.45 12.35 22.98 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.761 1.225 . . . . 0.0 113.349 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.65 20.9 79.37 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 120.973 -1.08 . . . . 0.0 114.515 176.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -102.27 144.07 31.25 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.529 1.132 . . . . 0.0 110.446 174.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -75.2 126.65 31.46 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.027 0.442 . . . . 0.0 110.418 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.9 t -131.57 135.18 46.8 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.317 1.447 . . . . 0.0 109.325 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -55.51 136.71 49.71 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.21 0.604 . . . . 0.0 111.816 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 39.3 tp -111.25 -46.38 3.31 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.799 0.84 . . . . 0.0 110.718 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.38 -111.37 0.44 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 123.103 0.382 . . . . 0.0 113.485 175.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -146.06 154.66 42.09 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.291 1.436 . . . . 0.0 110.261 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.8 tp -119.61 102.66 8.78 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.407 1.483 . . . . 0.0 109.899 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.9 t -75.46 98.12 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.07 1.348 . . . . 0.0 109.191 173.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.9 t -83.51 87.93 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.252 1.421 . . . . 0.0 110.062 175.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -82.9 125.71 31.67 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.823 1.249 . . . . 0.0 111.425 171.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.3 mmmt -78.05 137.9 38.49 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.786 0.834 . . . . 0.0 109.932 167.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -135.36 171.52 14.32 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.602 1.561 . . . . 0.0 110.837 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -67.98 -33.88 75.49 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 120.602 -1.311 . . . . 0.0 113.025 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -89.94 22.47 3.17 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.171 1.388 . . . . 0.0 112.975 -177.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 109.36 -168.71 13.4 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.804 1.668 . . . . 0.0 113.034 -175.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.3 mt -88.9 141.0 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 O-C-N 121.601 -0.94 . . . . 0.0 108.899 177.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -131.26 89.7 2.76 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.061 1.344 . . . . 0.0 111.157 -174.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 30.6 p -83.71 152.63 24.62 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.531 -0.73 . . . . 0.0 112.778 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.76 128.22 3.4 Favored Glycine 0 CA--C 1.527 0.802 0 O-C-N 121.368 -0.833 . . . . 0.0 113.185 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.23 139.18 48.0 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.25 1.82 . . . . 0.0 110.125 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -136.9 87.11 2.26 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.917 1.687 . . . . 0.0 111.042 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.92 5.0 46.05 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.51 62.24 1.41 Allowed Glycine 0 CA--C 1.53 1.028 0 O-C-N 121.413 -0.804 . . . . 0.0 113.2 174.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.67 -4.92 22.84 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.28 1.419 . . . . 0.0 113.7 -174.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -141.71 64.83 1.39 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.371 1.468 . . . . 0.0 110.717 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 51.9 p -94.84 144.12 25.91 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.204 1.002 . . . . 0.0 112.955 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -162.98 160.78 25.09 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.336 1.454 . . . . 0.0 112.15 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.5 m -54.8 128.78 34.52 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.315 1.046 . . . . 0.0 110.766 171.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -96.98 -52.55 3.82 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.989 0.515 . . . . 0.0 110.376 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -164.16 154.29 14.7 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.891 0.876 . . . . 0.0 112.881 172.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.04 116.0 10.34 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 123.158 1.456 . . . . 0.0 113.343 179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.94 171.61 9.46 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.967 1.307 . . . . 0.0 112.526 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -80.6 161.35 24.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.401 1.081 . . . . 0.0 112.266 176.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -55.6 -35.03 65.38 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.163 0.985 . . . . 0.0 113.055 172.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -68.07 -17.89 64.51 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 175.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 41.9 t -100.81 -10.58 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.831 0.852 . . . . 0.0 111.577 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 97' ' ' VAL . 75.9 t -47.08 -51.37 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.549 1.14 . . . . 0.0 111.577 176.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -73.24 -29.07 62.51 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 177.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -76.68 -39.42 52.14 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.138 -0.976 . . . . 0.0 111.981 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -57.18 -46.06 83.17 Favored 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 124.804 1.242 . . . . 0.0 110.815 173.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.66 HG22 HD22 ' A' ' 170' ' ' LEU . 72.4 t -52.61 -42.94 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.498 1.119 . . . . 0.0 110.728 175.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -66.81 -55.01 16.77 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.507 1.523 . . . . 0.0 113.002 178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 m -72.83 -5.95 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 O-C-N 121.424 -0.797 . . . . 0.0 112.983 -176.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.44 ' CG ' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -98.42 -5.77 31.9 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.727 1.611 . . . . 0.0 112.155 178.425 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.403 ' HB ' ' HE2' ' A' ' 167' ' ' LYS . 32.0 p -127.55 -13.16 5.45 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.934 0.894 . . . . 0.0 112.695 176.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -132.72 -11.21 3.08 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.656 1.582 . . . . 0.0 114.392 177.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.6 156.81 9.79 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.098 1.333 . . . . 0.0 113.821 -174.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 159.88 -153.93 24.95 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 121.655 -0.909 . . . . 0.0 113.106 -175.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.6 p -145.83 153.23 40.67 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.177 0.991 . . . . 0.0 112.936 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -148.73 179.55 7.75 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.317 1.847 . . . . 0.0 111.769 173.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -114.97 151.92 33.3 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.733 1.213 . . . . 0.0 110.025 168.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 62.4 p -117.28 133.58 55.81 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.766 0.827 . . . . 0.0 111.271 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.1 t -51.0 -37.85 47.62 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.308 1.043 . . . . 0.0 112.557 175.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.7 mt -146.48 147.23 30.98 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.029 1.731 . . . . 0.0 111.719 173.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -136.85 115.37 11.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 170.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -96.57 -49.01 5.3 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.8 0.84 . . . . 0.0 112.543 174.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.45 172.11 34.31 Favored Glycine 0 CA--C 1.541 1.665 0 C-N-CA 125.718 1.628 . . . . 0.0 113.423 -169.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -58.21 165.82 1.84 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.131 0.972 . . . . 0.0 112.486 169.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -56.35 -30.34 62.51 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 120.728 -1.232 . . . . 0.0 114.152 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -75.67 58.25 1.06 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.707 1.203 . . . . 0.0 112.031 173.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.55 ' HG3' ' H ' ' A' ' 119' ' ' SER . 6.3 tp10 -148.67 149.03 30.77 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.893 1.277 . . . . 0.0 111.382 -175.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -74.95 -22.16 58.75 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.356 -0.84 . . . . 0.0 112.98 172.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.55 ' H ' ' HG3' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -83.44 -41.77 17.7 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.815 1.646 . . . . 0.0 114.174 -177.104 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.6 p -50.38 -25.32 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 126.274 1.83 . . . . 0.0 115.689 -169.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 53.0 mt -59.46 -35.8 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 126.221 1.808 . . . . 0.0 112.306 175.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -135.74 -38.82 0.72 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.471 1.508 . . . . 0.0 113.83 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.28 166.35 29.98 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 127.162 2.315 . . . . 0.0 113.513 -175.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.2 mt -122.51 119.23 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.636 1.574 . . . . 0.0 108.828 176.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -80.66 148.58 30.15 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 173.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 28.5 m-80 54.46 25.71 6.4 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.362 1.865 . . . . 0.0 113.979 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -63.08 126.57 27.8 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.283 1.433 . . . . 0.0 111.239 -172.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -78.95 130.42 35.56 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.013 0.525 . . . . 0.0 111.461 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.7 mm -126.87 120.36 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 125.862 1.665 . . . . 0.0 109.215 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.95 105.17 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.266 1.427 . . . . 0.0 108.71 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 25.7 p -78.69 159.88 27.77 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.725 0.774 . . . . 0.0 112.198 174.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -150.55 140.88 22.32 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.983 1.313 . . . . 0.0 110.523 171.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 39.4 mt -81.92 132.72 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 173.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -140.06 121.56 15.14 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.06 1.344 . . . . 0.0 110.563 174.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -72.1 120.01 17.1 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.738 -0.602 . . . . 0.0 109.742 169.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 24.3 mt -106.79 97.19 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 175.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 60.86 12.22 3.7 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.774 2.03 . . . . 0.0 115.816 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 130.22 -34.98 2.6 Favored Glycine 0 N--CA 1.473 1.106 0 C-N-CA 125.071 1.32 . . . . 0.0 113.316 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 73.0 m -71.81 125.26 26.7 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.382 1.073 . . . . 0.0 109.47 171.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -74.97 119.23 18.87 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.72 -0.613 . . . . 0.0 109.56 173.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -108.39 168.54 9.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.332 1.453 . . . . 0.0 110.227 171.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.4 tp -120.09 136.2 57.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 125.363 1.465 . . . . 0.0 108.25 170.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 p -123.25 155.64 36.77 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.337 0.655 . . . . 0.0 110.026 172.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -148.56 137.09 21.35 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.174 0.99 . . . . 0.0 111.024 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.7 p -70.52 115.55 9.82 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.168 0.987 . . . . 0.0 111.642 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.13 -163.23 38.65 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.739 1.162 . . . . 0.0 112.949 174.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -68.63 169.41 11.16 Favored 'General case' 0 CA--C 1.553 1.077 0 O-C-N 121.663 -0.904 . . . . 0.0 112.125 169.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.2 mttt -85.82 114.56 22.85 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.144 1.377 . . . . 0.0 111.265 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.29 162.36 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.617 0.767 . . . . 0.0 111.687 174.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.7 tptt -101.85 -13.43 17.67 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 171.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -78.06 6.59 7.6 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.696 1.598 . . . . 0.0 113.799 176.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.78 171.08 14.54 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.03 1.332 . . . . 0.0 111.97 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -80.29 74.77 2.29 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.472 1.51 . . . . 0.0 113.698 -176.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . 0.253 4.1 p30 48.1 41.22 15.08 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.289 1.836 . . . . 0.0 115.109 -175.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -92.16 175.65 6.78 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.022 0.929 . . . . 0.0 110.004 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.8 m -111.33 146.52 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.17 0.988 . . . . 0.0 109.833 173.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -69.16 93.94 0.64 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 169.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -90.55 147.8 23.11 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 122.272 1.034 . . . . 0.0 111.085 169.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -134.45 171.1 14.77 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.817 1.647 . . . . 0.0 110.932 -172.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.59 134.02 23.21 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.584 0.629 . . . . 0.0 110.5 177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.476 ' CG2' HD11 ' A' ' 166' ' ' LEU . 61.6 mt -127.13 140.59 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.187 0.995 . . . . 0.0 108.914 175.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.0 m -65.33 95.89 0.21 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.228 1.011 . . . . 0.0 109.914 177.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.553 HD21 ' HE3' ' A' ' 167' ' ' LYS . 1.2 tt -53.42 -33.5 54.22 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.18 0.992 . . . . 0.0 111.377 175.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -67.91 -28.87 67.86 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 178.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -79.06 -36.31 41.15 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 118.657 0.662 . . . . 0.0 111.807 169.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.476 HD11 ' CG2' ' A' ' 161' ' ' ILE . 16.1 mt -59.88 -37.32 79.04 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 121.554 -0.716 . . . . 0.0 111.794 176.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.553 ' HE3' HD21 ' A' ' 163' ' ' LEU . 73.6 mttt -62.14 -6.97 3.42 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 172.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -98.43 -15.31 19.7 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.985 1.314 . . . . 0.0 114.104 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -122.59 1.94 9.52 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.781 1.632 . . . . 0.0 113.408 -178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.66 HD22 HG22 ' A' ' 97' ' ' VAL . 53.0 mt -103.57 -17.86 15.0 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.146 0.978 . . . . 0.0 113.14 176.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm . . . . . 0 C--O 1.253 1.245 0 C-N-CA 125.858 1.663 . . . . 0.0 112.769 169.509 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.3 mm 46.43 73.26 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 126.851 2.06 . . . . 0.0 112.617 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -126.1 57.59 1.38 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.013 1.325 . . . . 0.0 111.627 -174.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 34.5 m -132.22 143.23 49.79 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.355 1.862 . . . . 0.0 109.223 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.8 m 54.42 32.87 17.44 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.018 1.327 . . . . 0.0 114.0 -173.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -63.63 166.65 6.64 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.548 1.139 . . . . 0.0 112.799 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -146.37 150.83 36.43 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.86 1.264 . . . . 0.0 111.477 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -66.51 143.94 56.76 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.899 0.88 . . . . 0.0 112.46 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -65.89 148.42 51.82 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.49 0.716 . . . . 0.0 111.951 171.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.9 m -63.87 132.91 52.27 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.493 1.117 . . . . 0.0 112.005 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 m -66.45 161.83 21.9 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.249 1.02 . . . . 0.0 112.137 170.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.75 -75.63 0.74 Allowed Glycine 0 CA--C 1.534 1.278 0 O-C-N 121.712 -0.618 . . . . 0.0 112.558 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -161.35 142.57 11.42 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.463 1.505 . . . . 0.0 111.633 173.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -163.61 170.36 17.27 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.387 1.475 . . . . 0.0 111.658 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.0 mmmt -69.29 96.49 0.86 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.036 1.734 . . . . 0.0 111.081 172.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.2 m -99.6 42.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 126.125 1.77 . . . . 0.0 112.116 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -63.03 169.37 3.39 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.496 1.518 . . . . 0.0 112.237 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -139.1 155.23 48.06 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.917 1.687 . . . . 0.0 111.069 -173.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.5 mp -122.66 156.5 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 126.016 1.726 . . . . 0.0 109.493 -176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -60.1 -14.59 17.61 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -79.77 -8.62 59.36 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.532 1.133 . . . . 0.0 113.831 172.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.4 t -88.85 11.23 18.5 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.298 1.839 . . . . 0.0 112.899 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -143.69 165.87 26.44 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.764 1.626 . . . . 0.0 111.639 174.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -147.87 168.96 20.87 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.309 1.444 . . . . 0.0 110.72 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 m -136.55 134.82 37.91 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.91 0.484 . . . . 0.0 111.127 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.0 m -131.51 161.7 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.218 1.407 . . . . 0.0 112.304 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.34 153.15 23.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.742 1.217 . . . . 0.0 111.899 174.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.1 tp -152.94 136.79 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.442 1.497 . . . . 0.0 109.358 177.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -130.56 160.09 35.19 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.191 1.796 . . . . 0.0 109.759 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -132.93 158.76 41.82 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.845 1.258 . . . . 0.0 112.462 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 120.31 25.75 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.002 0.521 . . . . 0.0 110.76 173.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -72.63 179.71 3.45 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.401 0.68 . . . . 0.0 112.642 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -55.65 -29.35 59.13 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.734 1.614 . . . . 0.0 113.284 173.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.5 t -82.84 -6.8 59.6 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.127 1.371 . . . . 0.0 113.244 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.02 34.73 51.82 Favored Glycine 0 CA--C 1.533 1.219 0 O-C-N 120.855 -1.153 . . . . 0.0 114.058 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -119.05 145.39 45.93 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.362 1.465 . . . . 0.0 111.002 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 63.4 m95 -72.38 123.55 23.29 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.743 0.817 . . . . 0.0 111.181 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.0 t -139.2 141.76 37.91 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.208 1.403 . . . . 0.0 110.547 -178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -56.1 141.39 40.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.866 0.866 . . . . 0.0 113.054 -175.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.4 tp -117.52 -47.87 2.62 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.741 0.816 . . . . 0.0 111.694 -178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.58 -117.6 0.71 Allowed Glycine 0 CA--C 1.529 0.906 0 CA-C-O 121.254 0.363 . . . . 0.0 113.663 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -145.08 156.04 43.68 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.518 1.527 . . . . 0.0 109.643 -177.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.2 tp -121.16 100.44 7.06 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.983 1.313 . . . . 0.0 110.065 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 t -76.0 96.3 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.161 1.384 . . . . 0.0 109.096 175.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.6 t -85.38 105.54 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.31 1.444 . . . . 0.0 110.031 173.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 63.3 mtt-85 -91.12 121.16 32.67 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.482 1.913 . . . . 0.0 110.158 172.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -83.89 91.27 7.53 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.52 0.728 . . . . 0.0 109.288 170.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -71.05 171.9 10.06 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.82 1.248 . . . . 0.0 112.776 176.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -63.87 -32.87 74.54 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.444 1.098 . . . . 0.0 113.734 176.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -125.58 86.91 2.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.413 1.485 . . . . 0.0 109.787 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.57 -157.95 24.07 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.878 0.751 . . . . 0.0 114.375 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.3 mt -122.96 145.25 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.427 1.091 . . . . 0.0 110.065 176.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -134.54 132.83 39.62 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.548 1.539 . . . . 0.0 109.763 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.6 p -126.33 147.37 49.74 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.929 -1.107 . . . . 0.0 111.883 -171.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.29 120.77 1.75 Allowed Glycine 0 CA--C 1.527 0.791 0 O-C-N 121.818 -0.551 . . . . 0.0 112.977 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.41 141.23 57.1 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.961 1.704 . . . . 0.0 110.036 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -134.93 60.81 1.69 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.373 1.869 . . . . 0.0 111.034 -169.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.37 66.44 3.93 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.128 1.371 . . . . 0.0 113.768 -174.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.68 -58.51 4.48 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.615 1.578 . . . . 0.0 114.15 172.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -155.46 24.27 0.58 Allowed Glycine 0 CA--C 1.536 1.393 0 C-N-CA 126.499 2.0 . . . . 0.0 113.383 177.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -135.72 44.48 2.5 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.764 1.625 . . . . 0.0 110.806 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.3 p -66.21 141.77 57.94 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -157.35 152.88 26.47 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.154 1.382 . . . . 0.0 112.482 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.6 m -54.95 123.57 13.94 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.167 -0.958 . . . . 0.0 110.245 171.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -90.91 -51.84 5.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.599 0.76 . . . . 0.0 110.2 -177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -164.33 161.09 21.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.848 0.859 . . . . 0.0 112.613 172.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -143.14 153.7 43.15 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.998 1.319 . . . . 0.0 111.965 175.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.516 ' HA ' ' H ' ' A' ' 109' ' ' SER . 1.7 pp -140.77 154.78 46.42 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 125.411 1.485 . . . . 0.0 111.188 -175.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -78.52 166.96 21.97 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.602 0.715 . . . . 0.0 112.208 -172.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -59.57 -21.7 60.7 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 121.388 -0.82 . . . . 0.0 112.543 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -72.92 -12.98 61.16 Favored 'General case' 0 CA--C 1.549 0.919 0 O-C-N 121.045 -1.034 . . . . 0.0 113.583 173.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.7 t -112.13 -2.07 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 120.901 -1.124 . . . . 0.0 110.852 -171.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.0 m -60.96 -26.07 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 -175.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -97.87 -25.57 14.97 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.693 0.679 . . . . 0.0 111.863 170.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -70.25 -53.7 15.84 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.583 1.553 . . . . 0.0 111.166 -178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -58.05 -44.58 87.5 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.571 1.148 . . . . 0.0 111.236 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.501 HG22 HD22 ' A' ' 170' ' ' LEU . 74.1 t -57.16 -36.86 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.957 0.903 . . . . 0.0 111.022 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -62.54 -57.5 10.93 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.464 1.105 . . . . 0.0 111.997 173.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -70.06 -17.16 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 O-C-N 121.331 -0.855 . . . . 0.0 112.573 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.483 ' HG3' HD13 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -87.2 -6.91 58.43 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.27 1.828 . . . . 0.0 111.91 177.637 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 46.2 p -128.1 -10.49 5.34 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 173.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -134.88 -9.96 2.34 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.578 1.551 . . . . 0.0 113.954 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 76.51 155.76 6.4 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 125.722 1.629 . . . . 0.0 113.824 -174.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.1 -170.8 33.3 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.267 0.937 . . . . 0.0 114.096 -175.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 67.8 p -143.95 103.32 4.02 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.729 1.211 . . . . 0.0 113.493 -168.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -132.86 162.02 32.65 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.423 1.889 . . . . 0.0 110.398 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.58 160.26 17.51 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.644 0.735 . . . . 0.0 111.387 177.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.9 p -126.57 153.8 44.75 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.279 1.831 . . . . 0.0 110.113 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.516 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 76.9 p -68.9 -39.74 79.55 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.527 -0.733 . . . . 0.0 111.283 -175.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.8 mt -151.61 143.27 23.64 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.904 2.082 . . . . 0.0 111.451 177.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.41 ' CD2' HD11 ' A' ' 129' ' ' ILE . 39.7 t80 -136.64 101.81 4.73 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.268 1.027 . . . . 0.0 109.299 174.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -87.52 -51.94 5.63 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.68 0.792 . . . . 0.0 111.764 174.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.44 178.34 49.54 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 124.526 1.06 . . . . 0.0 114.379 -173.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -61.98 155.14 24.54 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.408 1.083 . . . . 0.0 111.561 170.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -58.44 -26.65 63.56 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.945 1.298 . . . . 0.0 114.0 -176.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -78.65 -12.06 60.0 Favored 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 174.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -72.14 174.76 6.7 Favored 'General case' 0 CA--C 1.552 1.044 0 O-C-N 120.711 -1.243 . . . . 0.0 112.483 170.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.44 -26.6 14.4 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -167.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 50.9 m -102.86 -1.26 29.95 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.355 1.062 . . . . 0.0 113.058 -177.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.7 p -54.81 -24.41 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 126.524 1.929 . . . . 0.0 115.543 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.419 ' H ' HD12 ' A' ' 121' ' ' ILE . 4.8 mp -69.07 -39.92 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.259 1.023 . . . . 0.0 112.134 -178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -123.45 -18.75 6.1 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.647 1.179 . . . . 0.0 113.661 -173.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.0 173.48 38.56 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.439 1.495 . . . . 0.0 113.702 -171.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 36.7 mt -127.89 108.4 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.901 1.68 . . . . 0.0 107.846 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -69.21 147.64 51.0 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.176 0.512 . . . . 0.0 111.185 173.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 57.83 22.05 8.18 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.38 1.472 . . . . 0.0 114.162 178.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -56.79 123.9 16.61 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.939 1.296 . . . . 0.0 111.585 -176.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -72.01 128.97 37.39 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.545 1.138 . . . . 0.0 110.768 170.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.41 HD11 ' CD2' ' A' ' 111' ' ' TYR . 38.2 mm -122.94 115.78 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.734 1.214 . . . . 0.0 109.293 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -108.89 90.02 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.158 1.383 . . . . 0.0 108.671 -174.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 60.8 p -75.74 154.2 36.53 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.394 175.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -151.54 140.97 21.54 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.215 1.406 . . . . 0.0 111.099 174.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 63.5 mt -80.35 133.97 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.053 0.541 . . . . 0.0 109.754 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -139.13 122.42 17.06 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.303 1.441 . . . . 0.0 111.107 175.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -72.57 105.26 4.15 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.693 1.197 . . . . 0.0 110.357 170.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 25.6 mt -95.18 99.11 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 174.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 57.0 19.53 4.69 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.583 1.953 . . . . 0.0 115.696 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 118.03 -22.35 9.82 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.555 1.074 . . . . 0.0 114.291 177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 89.6 m -82.9 128.09 34.12 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 117.942 0.871 . . . . 0.0 109.016 170.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.74 117.85 17.03 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.629 -0.669 . . . . 0.0 109.525 172.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -107.18 168.17 9.4 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.319 1.447 . . . . 0.0 110.133 169.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.2 tp -119.04 135.03 60.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.227 1.411 . . . . 0.0 108.56 170.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.0 p -124.03 153.59 41.12 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.835 0.854 . . . . 0.0 109.955 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -151.01 145.67 25.69 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.065 0.946 . . . . 0.0 111.833 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 50.6 m -82.57 117.9 22.88 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.499 1.12 . . . . 0.0 111.084 176.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.86 -151.87 24.56 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.88 1.705 . . . . 0.0 113.143 177.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -72.2 173.49 8.51 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 170.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -92.4 102.29 14.76 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.084 0.954 . . . . 0.0 111.923 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -61.61 156.43 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.032 0.933 . . . . 0.0 113.064 -178.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.403 ' HA ' ' HE3' ' A' ' 150' ' ' LYS . 0.4 OUTLIER -91.12 -27.4 18.58 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.754 0.821 . . . . 0.0 112.491 177.275 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -64.27 -47.81 78.11 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.903 1.281 . . . . 0.0 113.083 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.82 -36.18 37.27 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -176.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 142.19 -74.79 0.33 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.852 1.215 . . . . 0.0 113.111 171.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -146.07 20.16 1.42 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.654 1.982 . . . . 0.0 112.46 177.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -77.87 178.59 7.3 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.035 0.934 . . . . 0.0 108.885 174.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 19.5 m -110.89 142.33 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.291 0.637 . . . . 0.0 110.78 173.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -60.74 124.29 19.98 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 170.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -126.23 144.33 50.82 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 122.243 1.02 . . . . 0.0 111.222 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -137.91 172.14 13.37 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 125.493 1.517 . . . . 0.0 111.878 -168.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -146.68 131.48 18.01 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.507 0.723 . . . . 0.0 110.057 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 70.5 mt -124.19 139.93 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 123.959 0.904 . . . . 0.0 108.796 174.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.8 m -63.86 96.86 0.14 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.11 0.964 . . . . 0.0 109.601 176.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.43 ' HA ' HD12 ' A' ' 166' ' ' LEU . 1.1 tt -55.76 -33.0 63.91 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.072 0.949 . . . . 0.0 111.778 176.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -66.95 -27.67 67.65 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 176.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -87.06 -31.39 20.53 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.892 0.877 . . . . 0.0 112.113 174.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.483 HD13 ' HG3' ' A' ' 100' ' ' MET . 19.4 mt -60.76 -44.1 97.17 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.77 0.828 . . . . 0.0 111.233 172.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 44.0 mttm -51.71 -32.7 31.3 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.547 -1.346 . . . . 0.0 113.639 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -68.22 -18.48 64.58 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -126.66 0.25 6.79 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.769 1.628 . . . . 0.0 114.134 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.501 HD22 HG22 ' A' ' 97' ' ' VAL . 29.1 mt -102.78 -21.49 14.05 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.697 1.599 . . . . 0.0 112.444 176.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm . . . . . 0 C--O 1.255 1.382 0 C-N-CA 127.033 2.133 . . . . 0.0 112.092 173.39 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.3 pttt . . . . . 0 N--CA 1.496 1.843 0 N-CA-C 115.551 1.685 . . . . 0.0 115.551 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -122.74 7.93 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 121.094 1.77 . . . . 0.0 114.52 -173.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -64.78 158.42 24.97 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.387 -0.821 . . . . 0.0 112.564 174.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 t -150.54 143.84 24.94 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.869 1.267 . . . . 0.0 110.875 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 75.2 m -148.01 110.5 4.68 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.385 1.474 . . . . 0.0 110.136 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -64.15 137.68 58.08 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.255 0.55 . . . . 0.0 111.759 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -68.97 169.97 10.68 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.297 1.039 . . . . 0.0 112.711 171.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -130.23 146.44 51.85 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.897 1.279 . . . . 0.0 110.711 178.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -117.87 152.64 34.99 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.185 1.394 . . . . 0.0 110.902 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.5 p -149.53 133.73 17.29 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.773 1.229 . . . . 0.0 111.119 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.1 p -79.83 166.18 21.97 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.58 1.152 . . . . 0.0 111.962 172.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -120.37 162.09 14.44 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.895 1.236 . . . . 0.0 112.624 175.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.92 151.46 31.7 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.75 0.82 . . . . 0.0 112.767 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.5 t -159.96 148.73 17.4 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.906 1.283 . . . . 0.0 111.343 173.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -78.7 99.2 6.53 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.39 1.476 . . . . 0.0 110.09 174.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.6 t -125.88 68.89 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 125.785 1.634 . . . . 0.0 109.585 -176.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -69.47 157.12 37.74 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.071 0.948 . . . . 0.0 111.898 172.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm -149.73 156.7 42.3 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.575 1.95 . . . . 0.0 111.045 175.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.0 mm -67.84 155.79 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.449 1.5 . . . . 0.0 110.523 177.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -61.98 -6.01 2.57 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 173.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -96.96 -1.12 46.3 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.602 1.561 . . . . 0.0 113.554 171.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.0 t -130.83 0.13 4.29 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.853 2.061 . . . . 0.0 113.15 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -149.7 153.84 37.59 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.122 1.769 . . . . 0.0 109.534 169.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -145.96 166.21 26.69 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.112 0.965 . . . . 0.0 111.15 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 m -132.62 126.48 32.8 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.8 0.44 . . . . 0.0 110.628 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.2 m -121.91 169.12 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.839 1.656 . . . . 0.0 110.697 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -67.81 169.2 10.11 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.855 0.862 . . . . 0.0 111.622 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 4.5 tp -159.27 137.56 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.936 1.294 . . . . 0.0 109.862 171.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -129.57 158.82 38.22 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 127.377 2.271 . . . . 0.0 108.942 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -131.39 159.8 36.94 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.388 1.075 . . . . 0.0 111.766 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -88.08 119.51 28.52 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.15 0.58 . . . . 0.0 110.727 172.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -72.89 179.77 3.54 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.445 0.64 . . . . 0.0 112.191 173.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -57.55 -21.58 39.29 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.977 1.711 . . . . 0.0 114.428 176.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.0 m -91.56 2.38 56.49 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.045 0.938 . . . . 0.0 113.258 177.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.3 31.26 71.5 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.563 1.077 . . . . 0.0 113.8 -178.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -109.93 140.19 44.19 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.992 1.317 . . . . 0.0 110.822 177.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -74.57 121.23 21.24 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.869 0.868 . . . . 0.0 110.77 175.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.6 t -137.42 138.62 40.02 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.915 1.286 . . . . 0.0 110.5 -176.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -58.33 143.48 44.74 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -174.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.2 tp -118.81 -46.42 2.55 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.137 0.975 . . . . 0.0 111.542 -177.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 171.87 -129.5 1.76 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-O 121.457 0.476 . . . . 0.0 113.655 -175.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -141.39 158.9 43.26 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.039 1.736 . . . . 0.0 109.461 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.4 tp -126.22 103.24 7.57 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.884 1.274 . . . . 0.0 110.497 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.1 t -76.56 96.23 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.408 1.083 . . . . 0.0 109.012 175.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.4 t -83.86 113.11 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.586 1.555 . . . . 0.0 109.697 173.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -103.65 123.05 46.27 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.438 1.895 . . . . 0.0 110.175 176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -82.15 84.5 7.02 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.553 1.141 . . . . 0.0 109.626 172.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -66.13 166.95 10.85 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 122.282 1.039 . . . . 0.0 111.961 173.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -72.81 -23.39 60.78 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.137 -0.977 . . . . 0.0 113.306 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -131.46 42.62 3.17 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.812 1.645 . . . . 0.0 112.903 -173.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.08 -157.73 25.55 Favored Glycine 0 N--CA 1.475 1.276 0 C-N-CA 125.667 1.603 . . . . 0.0 114.761 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.3 mt -125.08 142.06 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 124.237 1.015 . . . . 0.0 109.315 171.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -133.98 134.87 43.02 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.174 1.39 . . . . 0.0 108.729 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.2 p -132.72 143.21 49.46 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.676 0.79 . . . . 0.0 111.268 -173.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.66 122.77 2.69 Favored Glycine 0 C--N 1.336 0.541 0 O-C-N 121.921 -0.487 . . . . 0.0 112.695 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -66.44 126.09 27.74 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.887 1.675 . . . . 0.0 109.124 173.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -129.88 91.36 3.12 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.864 1.666 . . . . 0.0 109.187 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.14 1.27 48.67 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 104.9 -48.99 0.93 Allowed Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.706 1.622 . . . . 0.0 112.982 172.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -86.59 -13.8 66.85 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.399 1.0 . . . . 0.0 113.621 171.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -146.52 153.73 40.73 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.781 2.032 . . . . 0.0 111.557 177.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 52.3 p -147.56 124.06 11.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.529 1.131 . . . . 0.0 111.8 174.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -150.0 161.44 42.31 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.823 0.849 . . . . 0.0 112.453 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.3 m -59.57 131.24 50.33 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.209 -0.932 . . . . 0.0 110.811 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -98.97 -53.63 3.21 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.168 0.987 . . . . 0.0 109.516 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -161.03 159.09 28.91 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.967 0.907 . . . . 0.0 112.557 170.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.14 149.78 33.68 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 123.052 1.406 . . . . 0.0 112.303 178.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.434 ' HA ' ' H ' ' A' ' 109' ' ' SER . 2.1 pp -142.92 152.82 42.45 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.695 1.598 . . . . 0.0 110.819 -172.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -79.43 167.81 20.32 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.476 0.711 . . . . 0.0 112.146 -170.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -52.63 -35.84 55.38 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.291 -0.881 . . . . 0.0 112.654 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -66.2 -8.08 22.11 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.869 1.268 . . . . 0.0 114.179 175.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.9 t -116.5 -5.45 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.239 1.016 . . . . 0.0 111.41 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 95.1 t -53.58 -61.72 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-N 120.476 1.489 . . . . 0.0 111.651 -177.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -69.57 -24.81 63.75 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.82 -52.42 56.85 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.695 1.598 . . . . 0.0 110.706 172.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -59.86 -44.88 93.91 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 125.222 1.409 . . . . 0.0 110.62 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.2 -36.39 57.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 123.82 0.848 . . . . 0.0 111.206 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.06 -54.99 29.45 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.075 0.95 . . . . 0.0 111.716 173.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 m -76.0 -2.62 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -176.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.637 ' SD ' HD13 ' A' ' 166' ' ' LEU . 40.7 tpp -108.62 -4.22 17.3 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.426 1.49 . . . . 0.0 112.47 -179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 43.2 p -125.42 -11.75 6.82 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.184 0.994 . . . . 0.0 112.573 171.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -135.25 -12.4 2.13 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 177.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.3 156.58 19.15 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 124.697 1.142 . . . . 0.0 113.865 -175.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 160.05 -160.35 31.54 Favored Glycine 0 CA--C 1.533 1.193 0 O-C-N 121.665 -0.903 . . . . 0.0 113.894 -175.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 85.0 p -150.72 104.49 3.19 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -171.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -135.04 153.3 52.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.066 1.746 . . . . 0.0 110.369 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -80.72 159.58 25.2 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.546 -0.721 . . . . 0.0 111.145 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.2 p -124.93 149.1 47.96 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.9 1.68 . . . . 0.0 110.595 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.434 ' H ' ' HA ' ' A' ' 88' ' ' LEU . 8.1 t -62.59 -44.33 96.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.824 0.85 . . . . 0.0 111.336 -177.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.1 mt -149.61 143.13 25.34 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.459 1.504 . . . . 0.0 111.845 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -140.87 106.08 5.02 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.891 0.876 . . . . 0.0 110.735 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -90.64 -40.26 12.0 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.054 0.942 . . . . 0.0 113.104 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.92 -178.11 40.73 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 124.658 1.123 . . . . 0.0 113.877 -170.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -57.77 147.65 27.4 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.694 -0.886 . . . . 0.0 112.511 172.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -53.79 158.86 1.82 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.119 1.768 . . . . 0.0 112.634 177.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 65.6 52.64 1.31 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.265 1.426 . . . . 0.0 112.334 -175.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -148.92 156.5 42.38 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.034 1.334 . . . . 0.0 112.211 -172.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -66.07 -29.01 69.27 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 -170.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 27.8 t -74.6 -41.18 60.92 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.082 0.855 . . . . 0.0 112.966 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 78.5 t -48.58 -29.87 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 126.102 1.761 . . . . 0.0 113.809 -171.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 41.0 mm -43.22 -46.62 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 126.853 2.061 . . . . 0.0 113.389 170.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -147.41 -16.83 0.38 Allowed 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -176.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.02 163.01 38.84 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 126.044 1.783 . . . . 0.0 113.341 -171.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 95.3 mt -116.2 109.49 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.17 1.388 . . . . 0.0 109.318 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -69.36 146.71 51.91 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.128 0.971 . . . . 0.0 112.146 172.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 54.68 24.47 5.57 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.283 1.833 . . . . 0.0 114.586 177.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -55.58 123.07 12.8 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.292 1.437 . . . . 0.0 111.696 -178.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -72.37 128.45 35.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.058 0.943 . . . . 0.0 110.618 170.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.5 mm -124.14 116.33 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.819 1.248 . . . . 0.0 108.649 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.13 94.04 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.435 1.494 . . . . 0.0 108.097 -177.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.8 p -80.14 157.61 26.57 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.859 0.838 . . . . 0.0 111.776 176.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -154.12 146.71 24.12 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.891 1.276 . . . . 0.0 111.469 174.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 16.2 mt -84.29 131.47 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.175 0.59 . . . . 0.0 110.019 173.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -147.34 140.44 25.16 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.291 1.836 . . . . 0.0 110.077 176.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -83.84 154.87 23.24 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.158 -0.964 . . . . 0.0 110.243 169.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 42.0 mt -128.51 -45.15 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.175 0.99 . . . . 0.0 110.944 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -145.29 19.96 1.56 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.897 0.879 . . . . 0.0 112.885 -178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 113.63 -22.25 15.24 Favored Glycine 0 N--CA 1.474 1.226 0 O-C-N 121.244 -0.91 . . . . 0.0 113.582 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 53.8 m -88.96 143.2 27.03 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.089 0.956 . . . . 0.0 109.067 169.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -76.26 123.96 26.73 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.737 0.815 . . . . 0.0 110.264 171.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -109.0 158.19 17.95 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.398 1.479 . . . . 0.0 110.735 174.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 6.8 tp -100.92 144.68 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 166.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.7 p -133.12 156.48 47.37 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.624 0.77 . . . . 0.0 109.157 169.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -151.49 145.99 25.58 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.923 0.889 . . . . 0.0 111.457 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.2 p -76.22 115.45 15.96 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.701 1.2 . . . . 0.0 110.979 174.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.66 -162.22 38.05 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.379 0.99 . . . . 0.0 112.917 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -67.99 161.39 26.71 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.755 0.822 . . . . 0.0 112.682 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -78.12 103.94 8.38 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.448 0.699 . . . . 0.0 110.636 172.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.556 ' CG2' ' HB2' ' A' ' 157' ' ' ALA . 0.2 OUTLIER -65.75 157.91 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.031 1.332 . . . . 0.0 112.687 179.013 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -92.49 -22.28 19.67 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -78.19 3.56 14.89 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.418 ' HB3' HD11 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -134.76 -32.26 1.0 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -178.619 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 139.79 -80.31 0.27 Allowed Glycine 0 N--CA 1.472 1.074 0 C-N-CA 124.718 1.152 . . . . 0.0 112.71 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -142.43 19.06 2.05 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 127.056 2.142 . . . . 0.0 110.665 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -80.95 165.03 22.13 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.681 1.192 . . . . 0.0 108.756 176.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.7 m -102.03 141.82 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 120.921 0.391 . . . . 0.0 110.316 171.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.556 ' HB2' ' CG2' ' A' ' 149' ' ' ILE . . . -63.77 100.07 0.27 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.737 0.815 . . . . 0.0 109.599 171.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -93.79 145.77 24.35 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.174 0.988 . . . . 0.0 110.974 173.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -135.14 166.85 22.12 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.697 1.599 . . . . 0.0 111.417 -172.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.88 135.51 23.26 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.894 0.477 . . . . 0.0 110.555 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 59.0 mt -130.34 142.07 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.563 1.145 . . . . 0.0 109.076 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 5.5 m -63.95 96.55 0.14 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.389 1.076 . . . . 0.0 110.033 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -56.62 -30.55 63.39 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.413 -0.804 . . . . 0.0 111.899 176.25 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -67.17 -28.04 67.78 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -90.1 -25.95 20.47 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.178 0.991 . . . . 0.0 112.247 176.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.637 HD13 ' SD ' ' A' ' 100' ' ' MET . 12.6 mt -65.87 -47.92 73.28 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.573 1.149 . . . . 0.0 111.213 171.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -49.31 -40.21 34.18 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.374 1.07 . . . . 0.0 112.765 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -52.38 -24.27 7.4 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.447 1.499 . . . . 0.0 114.43 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -122.51 -1.53 9.06 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.698 1.599 . . . . 0.0 113.671 -177.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 72.4 mt -118.39 -13.6 9.78 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.292 1.437 . . . . 0.0 113.692 -176.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp . . . . . 0 C--O 1.256 1.4 0 C-N-CA 125.721 1.609 . . . . 0.0 112.94 168.38 . . . . . . . . 0 0 . 1 stop_ save_